Citrus Sinensis ID: 019728

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330------
Protein Sequence
MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Secondary Structure (PSIPRED)
ccEEEEEEcccccEEEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEEEcHHcHHHHHHHccccccHHHHHHHHHHHHHHHccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccHHHHcccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEEEccccEEEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccccccEEEEEEcccEEHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEcccHccccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
msvklrgeydDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIkdiirppkkdtfndVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYvhsasvlhrdlkpsnlllnascdlkigdfglarttsetdfMTEYVVTrwyrapelllncteyTAAIDIWSVGCIlgeimtreplfpgkdyvHQLRLITELigspddaslgflrsdnARRYVRqlprcrkqqfatrfpnkssgAVDLLEKMlvfdpnkritveealrhpylqslhdlndepvcprpfhfdfehsscteDHIRELIWResvkfnpdptc
Flexible Loop (DISEMBL)
msvklrgeyddiiFFIFSAAVNSETREEVAIKKignafdniiDARRTLREIKLLRHMEHEnviaikdiirppkkdTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFglarttsetdfMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELigspddaslgflRSDNARRYVRQLprcrkqqfatrfpnkssgavDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIwresvkfnpdptc
Low Complexity Region (SEG)
MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Disordered region (IsUnstruct)
******GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESV********
Disordered Region (DISOPRED)
MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP******FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP****
Disordered Region (DISEMBL)
MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Disordered Region (DISPRO)
MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	336	2.2.26 [Sep-21-2011]
Q39024	376	Mitogen-activated protein	yes	no	0.958	0.856	0.822	1e-160
Q40353	371	Mitogen-activated protein	N/A	no	0.964	0.873	0.808	1e-158
Q5J4W4	394	Mitogen-activated protein	yes	no	0.949	0.809	0.818	1e-157
Q336X9	376	Mitogen-activated protein	no	no	0.964	0.861	0.799	1e-157
Q9LMM5	369	Mitogen-activated protein	no	no	0.943	0.859	0.832	1e-155
Q8GYQ5	372	Mitogen-activated protein	no	no	0.946	0.854	0.789	1e-151
Q39025	376	Mitogen-activated protein	no	no	0.967	0.864	0.757	1e-148
Q40531	371	Mitogen-activated protein	N/A	no	0.961	0.870	0.740	1e-144
Q9LQQ9	363	Mitogen-activated protein	no	no	0.952	0.881	0.726	1e-139
Q40532	393	Mitogen-activated protein	N/A	no	0.949	0.811	0.706	1e-138

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  565 bits (1456), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 269/327 (82%), Positives = 300/327 (91%), Gaps = 5/327 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AA NSET EEVAIKKIGNAFDNIIDA+RTLREIKLL+HM+HENVIA+
Sbjct: 51  RGAYG-----IVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAV 105

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDII+PP+++ FNDVYIVYELMDTDLHQIIRS+Q LTDDHC++FLYQLLRGLKYVHSA+V
Sbjct: 106 KDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANV 165

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 166 LHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 225

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGE MTREPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+
Sbjct: 226 DIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQ 285

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             +Q FA RFPN S+GAVDLLEKMLVFDP++RITV+EAL HPYL  LHD+N+EPVC RPF
Sbjct: 286 YPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPF 345

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNP 332
           +FDFE  + TE++I+ELI+RE+VKFNP
Sbjct: 346 NFDFEQPTLTEENIKELIYRETVKFNP 372

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  558 bits (1439), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 266/329 (80%), Positives = 298/329 (90%), Gaps = 5/329 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AAVN+ETREEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENV++I
Sbjct: 45  RGAYG-----IVCAAVNAETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVMSI 99

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPP+K+ FN VYIV ELMDTDLHQIIRS+Q +TDDHC+YF+YQLLRGLKYVHSA+V
Sbjct: 100 KDIIRPPQKENFNHVYIVSELMDTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANV 159

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC++YTAAI
Sbjct: 160 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAI 219

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGEI+TR+PLFPG+DYVHQLRL+TELIGSPDDASLGFLRS+NARRYVRQLP+
Sbjct: 220 DIWSVGCILGEIVTRQPLFPGRDYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQ 279

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             KQ F+ RFPN S GAVDLLEKML+FDP+KRI V+EAL HPY+  LHD+N+EPVC RPF
Sbjct: 280 YPKQNFSARFPNMSPGAVDLLEKMLIFDPSKRIKVDEALCHPYMAPLHDINEEPVCARPF 339

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDP 334
            FDFE    TE+ I+ELIW+ESV+FNPDP
Sbjct: 340 SFDFEEPMFTEEDIKELIWKESVRFNPDP 368

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1

 Score =  556 bits (1432), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 261/319 (81%), Positives = 294/319 (92%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I  A VN++TR+EVAIKKIGNAFDN IDA+RTLREIKLLRHM+H+NVI+IKDIIRPP+++
Sbjct: 74  IICAVVNAQTRQEVAIKKIGNAFDNQIDAKRTLREIKLLRHMDHDNVISIKDIIRPPRRE 133

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            FNDVYIVYELMDTDLH ++RS+Q LTDDHCQYFLYQ+LRGLKYVHSA+VLHRDL+PSNL
Sbjct: 134 NFNDVYIVYELMDTDLHHLLRSNQPLTDDHCQYFLYQVLRGLKYVHSANVLHRDLRPSNL 193

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           LLNA CDLKIGDFGLARTT+ETDFM EYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILG
Sbjct: 194 LLNAKCDLKIGDFGLARTTNETDFMMEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 253

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           EI+TREPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNARRYVR LP+  KQQF  RF
Sbjct: 254 EIVTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRSLPQYPKQQFRARF 313

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
           P  SSGA+DLLE+MLVFDP+KRITV+EAL HPYL SLH++ DEPVCP PF FDFE  S T
Sbjct: 314 PTMSSGAMDLLERMLVFDPSKRITVDEALCHPYLASLHEIYDEPVCPAPFSFDFEQPSLT 373

Query: 316 EDHIRELIWRESVKFNPDP 334
           E+ I+E+IWRE++KFNP+P
Sbjct: 374 EEDIKEIIWREALKFNPEP 392

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1

 Score =  553 bits (1424), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 263/329 (79%), Positives = 294/329 (89%), Gaps = 5/329 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AAVNSE  EEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HEN+IAI
Sbjct: 51  RGAYG-----IVCAAVNSENGEEVAIKKIGNAFDNHIDAKRTLREIKLLRHMDHENIIAI 105

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPP++D FNDVYIV ELMDTDLHQIIRS+Q LTDDHCQYFLYQLLRGLKYVHSA+V
Sbjct: 106 KDIIRPPRRDNFNDVYIVSELMDTDLHQIIRSNQPLTDDHCQYFLYQLLRGLKYVHSANV 165

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNL LNA+CDLKI DFGLARTT+ETD MTEYVVTRWYRAPELLLNC++YTAAI
Sbjct: 166 LHRDLKPSNLFLNANCDLKIADFGLARTTTETDLMTEYVVTRWYRAPELLLNCSQYTAAI 225

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+WSVGCILGEI+TR+PLFPG+DY+ QL+LITELIGSPDD+SLGFLRSDNARRY++QLP+
Sbjct: 226 DVWSVGCILGEIVTRQPLFPGRDYIQQLKLITELIGSPDDSSLGFLRSDNARRYMKQLPQ 285

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             +Q F  RF N S+GAVDLLEKMLVFDP++RITV+EAL HPYL SLHD+N+EP CP PF
Sbjct: 286 YPRQDFRLRFRNMSAGAVDLLEKMLVFDPSRRITVDEALHHPYLASLHDINEEPTCPAPF 345

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDP 334
            FDFE  S TE+HI+ELIWRES+ FNPDP
Sbjct: 346 SFDFEQPSFTEEHIKELIWRESLAFNPDP 374

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  547 bits (1409), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 264/317 (83%), Positives = 289/317 (91%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I  AA NSET EEVAIKKIGNAF NIIDA+RTLREIKLL+HM+H+NVIAI DIIRPP+ D
Sbjct: 53  IVCAAWNSETGEEVAIKKIGNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPD 112

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            FNDV+IVYELMDTDLH IIRS+Q LTDDH ++FLYQLLRGLKYVHSA+VLHRDLKPSNL
Sbjct: 113 NFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNL 172

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           LLNA+CDLKIGDFGLART SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILG
Sbjct: 173 LLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 232

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           EIMTREPLFPG+DYV QLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RF
Sbjct: 233 EIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARF 292

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
           PN S  AVDLL+KMLVFDPN+RITV+EAL HPYL  LH+ N+EPVC RPFHFDFE  S T
Sbjct: 293 PNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLT 352

Query: 316 EDHIRELIWRESVKFNP 332
           E++I+ELI+RESVKFNP
Sbjct: 353 EENIKELIYRESVKFNP 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q8GYQ5|MPK12_ARATH Mitogen-activated protein kinase 12 OS=Arabidopsis thaliana GN=MPK12 PE=1 SV=1

 Score =  533 bits (1374), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 251/318 (78%), Positives = 286/318 (89%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I  AAVNS T E+VAIKKIGNAFDNIIDA+RTLREIKLLRHM+HENVI IKDI+RPP++D
Sbjct: 54  IVCAAVNSVTGEKVAIKKIGNAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRD 113

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            FNDVYIVYELMDTDL +I+RS+Q LT D C++ +YQLLRGLKYVHSA++LHRDL+PSN+
Sbjct: 114 IFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNV 173

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           LLN+  +LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILG
Sbjct: 174 LLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 233

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           EIMT +PLFPGKDYVHQLRLITEL+GSPD++SLGFLRSDNARRYVRQLPR  KQQFA RF
Sbjct: 234 EIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARF 293

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
           P   + A+DLLE+MLVFDPN+RI+V+EAL H YL   HD+  EPVC  PF FDFEH SCT
Sbjct: 294 PKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCT 353

Query: 316 EDHIRELIWRESVKFNPD 333
           E+HI+ELI++ESVKFNPD
Sbjct: 354 EEHIKELIYKESVKFNPD 371

Negative regulator of the auxin transduction signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  524 bits (1349), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 250/330 (75%), Positives = 286/330 (86%), Gaps = 5/330 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y  +      AAV+SET EE+AIKKIG AFDN +DA+RTLREIKLLRH+EHENV+ I
Sbjct: 51  RGAYGFV-----CAAVDSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVI 105

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPPKK+ F DVYIV+ELMDTDLHQIIRS+Q L DDHCQYFLYQ+LRGLKY+HSA+V
Sbjct: 106 KDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANV 165

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLN++CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLLN +EYT+AI
Sbjct: 166 LHRDLKPSNLLLNSNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAI 225

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+WSVGCI  EIMTREPLFPGKDYVHQL+LITELIGSPD ASL FLRS NAR+YV++LP+
Sbjct: 226 DVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPK 285

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             +Q F+ RFP+ +S A+DLLEKMLVFDP KRITVEEAL +PYL +LHDLNDEPVC   F
Sbjct: 286 FPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHF 345

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDPT 335
            F FE  S TE+ I+EL+W ESVKFNP P+
Sbjct: 346 SFHFEDPSSTEEEIKELVWLESVKFNPLPS 375

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  511 bits (1316), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 243/328 (74%), Positives = 281/328 (85%), Gaps = 5/328 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      +   A NSET+EEVAIKKIGNAF+N IDA+RTLREIKLL HM+HEN+I I
Sbjct: 46  RGAYG-----MVCCATNSETKEEVAIKKIGNAFENRIDAKRTLREIKLLSHMDHENIIKI 100

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDI+RPP ++ FNDVYIVYELMDTDLHQIIRS Q LTDDHCQYFLYQLLRGLKYVHSA+V
Sbjct: 101 KDIVRPPDREEFNDVYIVYELMDTDLHQIIRSSQALTDDHCQYFLYQLLRGLKYVHSANV 160

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKI DFGLARTTSE DFMTEYVVTRWYRAPELLLNCTEYTAAI
Sbjct: 161 LHRDLKPSNLLLNANCDLKICDFGLARTTSEADFMTEYVVTRWYRAPELLLNCTEYTAAI 220

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCIL E++ REPLFPG+DY  QL LI  L+GSP+D+ LGFLRSDNAR+YV+ LPR
Sbjct: 221 DIWSVGCILMELIKREPLFPGRDYAQQLGLIIALLGSPEDSDLGFLRSDNARKYVKHLPR 280

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             +  F+ +FP+ S  A+DL E+MLVFDP KRITVE+AL HP+L SLH++N+EPVC  PF
Sbjct: 281 VPRHPFSQKFPDVSPLALDLAERMLVFDPAKRITVEDALNHPFLISLHEINEEPVCDSPF 340

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPD 333
           +FDFE +S +ED I+ELIW E++KF+P+
Sbjct: 341 NFDFEQASLSEDDIKELIWNEALKFDPN 368

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LQQ9|MPK13_ARATH Mitogen-activated protein kinase 13 OS=Arabidopsis thaliana GN=MPK13 PE=1 SV=1

 Score =  493 bits (1270), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 236/325 (72%), Positives = 271/325 (83%), Gaps = 5/325 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I   A NSET EEVAIKKI NAFDN +DA+RTLREIKLL HM+H+NVI I
Sbjct: 41  RGAYG-----IVCCATNSETNEEVAIKKIANAFDNRVDAKRTLREIKLLSHMDHDNVIKI 95

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDII  P+K+ F DVYIVYELMDTDLHQIIRS Q LTDDHCQYFLYQ+LRGLKY+HSA+V
Sbjct: 96  KDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYIHSANV 155

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNL+LN +CDLKI DFGLART++ET+ MTEYVVTRWYRAPELLLN +EYT AI
Sbjct: 156 LHRDLKPSNLVLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLLNSSEYTGAI 215

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCI  EI+ RE LFPGKDYV QL+LITEL+GSPDD+ L FLRSDNAR+YV+QLP 
Sbjct: 216 DIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNARKYVKQLPH 275

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
            +KQ F  +FPN S  A+DL EKMLVFDP+KRITV+EAL+ PYL SLH++N+EP CP PF
Sbjct: 276 VQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEINEEPTCPTPF 335

Query: 306 HFDFEHSSCTEDHIRELIWRESVKF 330
            FDFE ++  E  I+EL+WRES+ F
Sbjct: 336 SFDFEETALDEQDIKELVWRESLHF 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  491 bits (1264), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 226/320 (70%), Positives = 278/320 (86%), Gaps = 1/320 (0%)

Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + I  +A+NSET E VAIKKI NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP+
Sbjct: 71  YGIVCSALNSETNEHVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQ 130

Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           ++ FNDVYI YELMDTDLHQIIRS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 131 REAFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 190

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           NLLLNA+CDLKI DFGLAR TSETDFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI
Sbjct: 191 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 250

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
             E+M R+PLFPG+D+VHQLRL+ ELIG+P +A + FL ++NA+RY+RQLP  R+Q F  
Sbjct: 251 FMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAEMEFL-NENAKRYIRQLPLYRRQSFVE 309

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS 313
           +FP+ +  A+DL+EKML FDP +RITVE+AL HPYL SLHD++DEPVC  PF+FDFE  +
Sbjct: 310 KFPHVNPAAIDLVEKMLTFDPRRRITVEDALAHPYLTSLHDISDEPVCMTPFNFDFEQHA 369

Query: 314 CTEDHIRELIWRESVKFNPD 333
            TE+ ++ELI+RE + FNP+
Sbjct: 370 LTEEQMKELIYREGLAFNPE 389

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	336
297748121	377	mitogen-activated protein kinase 4 [Goss	0.949	0.846	0.906	1e-171
255537569	387	big map kinase/bmk, putative [Ricinus co	0.964	0.837	0.881	1e-170
449452284	383	PREDICTED: mitogen-activated protein kin	0.961	0.843	0.868	1e-168
224075008	362	predicted protein [Populus trichocarpa]	0.961	0.892	0.868	1e-167
225426166	375	PREDICTED: mitogen-activated protein kin	0.967	0.866	0.869	1e-166
25052804	374	mitogen-activated protein kinase 4 [Petr	0.964	0.866	0.851	1e-165
315258227	373	mitogen-activated protein kinase 4 [Nico	0.967	0.871	0.836	1e-164
356528691	380	PREDICTED: mitogen-activated protein kin	0.955	0.844	0.847	1e-164
224053859	377	predicted protein [Populus trichocarpa]	0.970	0.864	0.839	1e-164
359489658	375	PREDICTED: mitogen-activated protein kin	0.964	0.864	0.841	1e-163

>gi|297748121|gb|ADI52627.1| mitogen-activated protein kinase 4 [Gossypium hirsutum]

 Score =  606 bits (1563), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 290/320 (90%), Positives = 304/320 (95%), Gaps = 1/320 (0%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I  AAVNSETR+EVAIKKIGNAFDNIIDARRTLREIKLLRHM+HENVIAIKDIIRPPKK+
Sbjct: 58  IVCAAVNSETRQEVAIKKIGNAFDNIIDARRTLREIKLLRHMDHENVIAIKDIIRPPKKE 117

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           TFNDVYIVYELMDTDLH IIRSDQ LTDDHCQYFLYQLLRGLKYVHSA+VLHRDLKPS+L
Sbjct: 118 TFNDVYIVYELMDTDLHHIIRSDQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSSL 177

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           LLNA CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAID+WSVGCI G
Sbjct: 178 LLNAKCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDMWSVGCIFG 237

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NARRY RQLP+CRKQQF+ RF
Sbjct: 238 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNARRYFRQLPQCRKQQFSARF 297

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
           PN S GAVDLLEKMLVFDPNKRIT EEAL HPYL SLHD+NDEPVCPRPF FDFE SSCT
Sbjct: 298 PNMSPGAVDLLEKMLVFDPNKRIT-EEALCHPYLASLHDINDEPVCPRPFSFDFEQSSCT 356

Query: 316 EDHIRELIWRESVKFNPDPT 335
           EDHI+ELIWRES++FNPDP 
Sbjct: 357 EDHIKELIWRESLQFNPDPV 376

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255537569|ref|XP_002509851.1| big map kinase/bmk, putative [Ricinus communis] gi|223549750|gb|EEF51238.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  603 bits (1555), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 290/329 (88%), Positives = 306/329 (93%), Gaps = 5/329 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AAVNSETREEVAIKKIGNAFDN +DA+RTLREIKLLRHM+HEN+IAI
Sbjct: 61  RGAYG-----IVCAAVNSETREEVAIKKIGNAFDNRVDAKRTLREIKLLRHMDHENIIAI 115

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           +DIIRPPKK+ FNDVYIVYELMDTDLH IIRSDQ LTDDHCQYFLYQLLRGLKYVHSA V
Sbjct: 116 RDIIRPPKKEAFNDVYIVYELMDTDLHHIIRSDQPLTDDHCQYFLYQLLRGLKYVHSAHV 175

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 176 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 235

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGEI+TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP+
Sbjct: 236 DIWSVGCILGEIVTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQ 295

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
            RKQ F  RFPN S+GA DLLEKMLVFDPNKRITVEEAL HPYL SLHD+NDEPVCPRPF
Sbjct: 296 YRKQNFTLRFPNVSAGAADLLEKMLVFDPNKRITVEEALCHPYLSSLHDINDEPVCPRPF 355

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDP 334
           HFDFEH SCTE+HI++LIWRES+KFNPDP
Sbjct: 356 HFDFEHPSCTEEHIKDLIWRESMKFNPDP 384

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452284|ref|XP_004143889.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus] gi|449518403|ref|XP_004166231.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus]

 Score =  598 bits (1541), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 285/328 (86%), Positives = 305/328 (92%), Gaps = 5/328 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      +  AAVNSET EEVAIKKIGNAFDNIIDA+RTLREIKLL HMEHEN+IAI
Sbjct: 51  RGAYG-----LVCAAVNSETHEEVAIKKIGNAFDNIIDAKRTLREIKLLCHMEHENIIAI 105

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           +DIIRPPK++ FNDVYIVYELMDTDLHQIIRSDQ LTDDHCQYFLYQLLRGLKYVHSA V
Sbjct: 106 RDIIRPPKREVFNDVYIVYELMDTDLHQIIRSDQPLTDDHCQYFLYQLLRGLKYVHSAKV 165

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 166 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 225

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+WSVGCILGEIMTREPLFPGKDYVHQLRLITEL+GSPDDASLGFLRSDNARRYV+QLP+
Sbjct: 226 DVWSVGCILGEIMTREPLFPGKDYVHQLRLITELLGSPDDASLGFLRSDNARRYVKQLPQ 285

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
            RKQQF+ RFPN S  A+DLLEKMLVFDPNKRITVEEAL HPYLQSLHD+NDEPVC RPF
Sbjct: 286 YRKQQFSARFPNMSPSALDLLEKMLVFDPNKRITVEEALCHPYLQSLHDINDEPVCARPF 345

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPD 333
           +FDFE  SCTE+HI+ELIW+ESV+FNPD
Sbjct: 346 NFDFEQPSCTEEHIKELIWKESVRFNPD 373

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075008|ref|XP_002304516.1| predicted protein [Populus trichocarpa] gi|222841948|gb|EEE79495.1| predicted protein [Populus trichocarpa]

 Score =  592 bits (1527), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 285/328 (86%), Positives = 302/328 (92%), Gaps = 5/328 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AAVNS+T EEVAIKKIGNAFDN IDA+RTLREI LLRHM+HENVIAI
Sbjct: 38  RGAYG-----IVCAAVNSDTHEEVAIKKIGNAFDNRIDAKRTLREIMLLRHMDHENVIAI 92

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           +DI RPPKK+ FNDVYIVYELMDTDLHQIIRSDQ L DDHCQYFLYQLLRGLKYVHSA+V
Sbjct: 93  RDITRPPKKEAFNDVYIVYELMDTDLHQIIRSDQALNDDHCQYFLYQLLRGLKYVHSANV 152

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLN++CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 153 LHRDLKPSNLLLNSNCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 212

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NARRYVRQLP+
Sbjct: 213 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNARRYVRQLPQ 272

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
            +KQ F+ RFPN S GAVDLLEKMLVFDPN RITV+EAL H YL SLHD+NDEPVCPRPF
Sbjct: 273 YKKQNFSARFPNMSPGAVDLLEKMLVFDPNNRITVDEALCHSYLSSLHDINDEPVCPRPF 332

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPD 333
           HFDFEH SCTE+HI+ELIWRESVKFNPD
Sbjct: 333 HFDFEHPSCTEEHIKELIWRESVKFNPD 360

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426166|ref|XP_002278860.1| PREDICTED: mitogen-activated protein kinase homolog MMK2 [Vitis vinifera] gi|297742231|emb|CBI34380.3| unnamed protein product [Vitis vinifera]

 Score =  590 bits (1521), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 287/330 (86%), Positives = 303/330 (91%), Gaps = 5/330 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AAVNSET EEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVIAI
Sbjct: 50  RGAYG-----IVCAAVNSETHEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAI 104

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPPKK+TFNDVYIVYELMDTDLHQII S+Q LTDDHCQYFLYQLLRGLKYVHSA+V
Sbjct: 105 KDIIRPPKKETFNDVYIVYELMDTDLHQIICSNQSLTDDHCQYFLYQLLRGLKYVHSANV 164

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 224

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL+GSPDDASLGFLRS+NARRYVRQLP+
Sbjct: 225 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELLGSPDDASLGFLRSNNARRYVRQLPQ 284

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             KQQ + RFPN S  AVDLLEKMLVFDP KRITV+EAL HPYL SLHD+NDEPVCP PF
Sbjct: 285 YPKQQISARFPNMSPSAVDLLEKMLVFDPTKRITVDEALCHPYLSSLHDINDEPVCPSPF 344

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDPT 335
            FDFE SS TE++I+ELIWRESVKFNPDPT
Sbjct: 345 SFDFEQSSITEENIKELIWRESVKFNPDPT 374

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|25052804|gb|AAN65180.1| mitogen-activated protein kinase 4 [Petroselinum crispum]

 Score =  587 bits (1514), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 280/329 (85%), Positives = 307/329 (93%), Gaps = 5/329 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AA+NS+TREEVAIKKIGNAFDN IDA+RTLREIKLLRHM HENVIAI
Sbjct: 49  RGAYG-----IVCAAMNSDTREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMNHENVIAI 103

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPP+ ++FNDVYIVYELMDTDLHQIIRS+QQLTDDHC+YFLYQLLRGLKYVHSA+V
Sbjct: 104 KDIIRPPQIESFNDVYIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANV 163

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 164 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 223

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGE+MTR+PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP+
Sbjct: 224 DIWSVGCILGEVMTRQPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQ 283

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             KQQF+ RF NKS GA+DLLEKML+FDPN+RITV+EAL HPYL +LHD+N+EPVCPRPF
Sbjct: 284 YPKQQFSARFLNKSPGALDLLEKMLIFDPNRRITVDEALCHPYLAALHDINEEPVCPRPF 343

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDP 334
            FDFE  +CTE++I+ELIW+ESVKFNPDP
Sbjct: 344 SFDFEQPTCTEENIKELIWKESVKFNPDP 372

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|315258227|gb|ADT91692.1| mitogen-activated protein kinase 4 [Nicotiana attenuata]

 Score =  583 bits (1504), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 276/330 (83%), Positives = 306/330 (92%), Gaps = 5/330 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AA+NSETREEVAIKKIGNAFDN IDA+RTLREIKLLRHM+H+NVIAI
Sbjct: 48  RGAYG-----IVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHDNVIAI 102

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPP+ + FNDVYIVYELMDTDLHQIIRS+QQLTDDHC+YFLYQ+LRGLKY+HSA+V
Sbjct: 103 KDIIRPPQTENFNDVYIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQILRGLKYIHSANV 162

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLK+GDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 163 LHRDLKPSNLLLNANCDLKVGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 222

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGE+MTR+PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP+
Sbjct: 223 DIWSVGCILGEMMTRQPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQ 282

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             +QQFA RFPN S GAVDLLEKMLVFDP++R+TV++AL HPYL  LHD+N+EP+CP+PF
Sbjct: 283 YPRQQFAARFPNSSPGAVDLLEKMLVFDPSRRVTVDQALCHPYLAPLHDINEEPICPKPF 342

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDPT 335
            FDFE  S TE++I+ELIWRESVKFNPDPT
Sbjct: 343 SFDFEQPSFTEENIKELIWRESVKFNPDPT 372

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528691|ref|XP_003532933.1| PREDICTED: mitogen-activated protein kinase 2-like [Glycine max]

 Score =  583 bits (1504), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 272/321 (84%), Positives = 303/321 (94%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I  AAVNSET E+VAIKKIGNAFDNIIDA+RTLREIKLLRHM+H+N+IAIKDIIRPPKK+
Sbjct: 60  IVCAAVNSETHEQVAIKKIGNAFDNIIDAKRTLREIKLLRHMDHDNIIAIKDIIRPPKKE 119

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           TFNDVYIVYELMDTDLH II SDQ L+++HCQYFLYQLLRGLKYVHSA+VLHRDLKPSNL
Sbjct: 120 TFNDVYIVYELMDTDLHHIIHSDQPLSEEHCQYFLYQLLRGLKYVHSANVLHRDLKPSNL 179

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+NA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYT+AID+WSVGCILG
Sbjct: 180 LMNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTSAIDVWSVGCILG 239

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           EIMTREPLFPGKDYVHQLRLITEL+GSPDDASL FLRSDNARRY+RQLP+ RKQ+F+TRF
Sbjct: 240 EIMTREPLFPGKDYVHQLRLITELLGSPDDASLEFLRSDNARRYIRQLPQYRKQKFSTRF 299

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
           PN    A+DLLEKML+FDPNKRITV+EAL HPYL SLH++NDEPVCPRPF FDF+  +CT
Sbjct: 300 PNMLPKALDLLEKMLIFDPNKRITVDEALCHPYLSSLHNINDEPVCPRPFSFDFDQPTCT 359

Query: 316 EDHIRELIWRESVKFNPDPTC 336
           E+H++ELIW+ESVKFNPDP C
Sbjct: 360 EEHMKELIWKESVKFNPDPPC 380

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053859|ref|XP_002298015.1| predicted protein [Populus trichocarpa] gi|222845273|gb|EEE82820.1| predicted protein [Populus trichocarpa]

 Score =  583 bits (1502), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 278/331 (83%), Positives = 302/331 (91%), Gaps = 5/331 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AAVNSET EEVAIKKIGNAFDN IDA+RTLREIKLL HM+HENVIA+
Sbjct: 52  RGAYG-----IVCAAVNSETHEEVAIKKIGNAFDNRIDAKRTLREIKLLCHMDHENVIAM 106

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           +DIIRPPK + FNDVYIVYELMDTDLHQIIRS+Q L DDHCQYFLYQLLRGLKYVHSA+V
Sbjct: 107 RDIIRPPKMEAFNDVYIVYELMDTDLHQIIRSEQSLNDDHCQYFLYQLLRGLKYVHSANV 166

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLN++CDLKIGDFGLARTT+ETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 167 LHRDLKPSNLLLNSNCDLKIGDFGLARTTAETDFMTEYVVTRWYRAPELLLNCSEYTAAI 226

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NARRYVRQLP+
Sbjct: 227 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNARRYVRQLPQ 286

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
            +K+ F+  FPN S GA+DLLEKMLVFDP+ RITV+EAL H YL SLH +NDEPVCPRPF
Sbjct: 287 YKKKIFSATFPNMSPGAIDLLEKMLVFDPSNRITVDEALCHQYLSSLHAINDEPVCPRPF 346

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDPTC 336
           HFDFE  SCTE+HI+ELIWRES+KFNPDP+C
Sbjct: 347 HFDFEQPSCTEEHIKELIWRESMKFNPDPSC 377

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359489658|ref|XP_003633959.1| PREDICTED: mitogen-activated protein kinase homolog MMK2-like [Vitis vinifera] gi|147786894|emb|CAN75543.1| hypothetical protein VITISV_000466 [Vitis vinifera] gi|297745345|emb|CBI40425.3| unnamed protein product [Vitis vinifera]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 277/329 (84%), Positives = 301/329 (91%), Gaps = 5/329 (1%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y      I  AA+NSETREEVAIKKIGNAFDN IDA+RTLREIKLLRHM+HENVI +
Sbjct: 49  RGAYG-----IVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIVL 103

Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           KDIIRPPK++ FNDVYIVYELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKYVHSA+V
Sbjct: 104 KDIIRPPKRENFNDVYIVYELMDTDLHQIIRSNQPLNDDHCRYFLYQVLRGLKYVHSANV 163

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           LHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC+EYTAAI
Sbjct: 164 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 223

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWSVGCILGEIMTR+PLFPG+DYVHQLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+
Sbjct: 224 DIWSVGCILGEIMTRQPLFPGRDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQ 283

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             +QQF  RFPN S GA+DLLEKMLVFDPN+RITVE AL HPYL  LHD+N+EPVCPRPF
Sbjct: 284 YPRQQFQARFPNMSPGAIDLLEKMLVFDPNRRITVEGALSHPYLAPLHDINEEPVCPRPF 343

Query: 306 HFDFEHSSCTEDHIRELIWRESVKFNPDP 334
            FDFE  S TE++I+ELIWRESVKFNPDP
Sbjct: 344 VFDFEQPSFTEENIKELIWRESVKFNPDP 372

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	336
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.943	0.843	0.839	5.7e-146
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.943	0.859	0.832	1.3e-141
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.946	0.854	0.789	1.7e-137
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.943	0.843	0.779	7.7e-135
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.937	0.867	0.739	4.2e-127
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.943	0.802	0.691	6.5e-122
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.943	0.856	0.646	1.3e-116
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.943	0.806	0.638	5.3e-111
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.949	0.603	0.583	3.4e-100
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.943	0.861	0.551	6.6e-97

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
 Identities = 266/317 (83%), Positives = 297/317 (93%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I  AA NSET EEVAIKKIGNAFDNIIDA+RTLREIKLL+HM+HENVIA+KDII+PP+++
Sbjct:    56 IVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRE 115

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              FNDVYIVYELMDTDLHQIIRS+Q LTDDHC++FLYQLLRGLKYVHSA+VLHRDLKPSNL
Sbjct:   116 NFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNL 175

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             LLNA+CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILG
Sbjct:   176 LLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 235

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             E MTREPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RF
Sbjct:   236 ETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARF 295

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
             PN S+GAVDLLEKMLVFDP++RITV+EAL HPYL  LHD+N+EPVC RPF+FDFE  + T
Sbjct:   296 PNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLT 355

Query:   316 EDHIRELIWRESVKFNP 332
             E++I+ELI+RE+VKFNP
Sbjct:   356 EENIKELIYRETVKFNP 372

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1385 (492.6 bits), Expect = 1.3e-141, P = 1.3e-141
 Identities = 264/317 (83%), Positives = 289/317 (91%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I  AA NSET EEVAIKKIGNAF NIIDA+RTLREIKLL+HM+H+NVIAI DIIRPP+ D
Sbjct:    53 IVCAAWNSETGEEVAIKKIGNAFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPD 112

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              FNDV+IVYELMDTDLH IIRS+Q LTDDH ++FLYQLLRGLKYVHSA+VLHRDLKPSNL
Sbjct:   113 NFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNL 172

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             LLNA+CDLKIGDFGLART SETDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILG
Sbjct:   173 LLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 232

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             EIMTREPLFPG+DYV QLRLITELIGSPDD+SLGFLRSDNARRYVRQLP+  +Q FA RF
Sbjct:   233 EIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARF 292

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
             PN S  AVDLL+KMLVFDPN+RITV+EAL HPYL  LH+ N+EPVC RPFHFDFE  S T
Sbjct:   293 PNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLT 352

Query:   316 EDHIRELIWRESVKFNP 332
             E++I+ELI+RESVKFNP
Sbjct:   353 EENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1346 (478.9 bits), Expect = 1.7e-137, P = 1.7e-137
 Identities = 251/318 (78%), Positives = 286/318 (89%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I  AAVNS T E+VAIKKIGNAFDNIIDA+RTLREIKLLRHM+HENVI IKDI+RPP++D
Sbjct:    54 IVCAAVNSVTGEKVAIKKIGNAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRD 113

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              FNDVYIVYELMDTDL +I+RS+Q LT D C++ +YQLLRGLKYVHSA++LHRDL+PSN+
Sbjct:   114 IFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNV 173

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             LLN+  +LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCILG
Sbjct:   174 LLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 233

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             EIMT +PLFPGKDYVHQLRLITEL+GSPD++SLGFLRSDNARRYVRQLPR  KQQFA RF
Sbjct:   234 EIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARF 293

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
             P   + A+DLLE+MLVFDPN+RI+V+EAL H YL   HD+  EPVC  PF FDFEH SCT
Sbjct:   294 PKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCT 353

Query:   316 EDHIRELIWRESVKFNPD 333
             E+HI+ELI++ESVKFNPD
Sbjct:   354 EEHIKELIYKESVKFNPD 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1321 (470.1 bits), Expect = 7.7e-135, P = 7.7e-135
 Identities = 247/317 (77%), Positives = 282/317 (88%)

Query:    19 AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             AAV+SET EE+AIKKIG AFDN +DA+RTLREIKLLRH+EHENV+ IKDIIRPPKK+ F 
Sbjct:    59 AAVDSETHEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFV 118

Query:    79 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
             DVYIV+ELMDTDLHQIIRS+Q L DDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN
Sbjct:   119 DVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 178

Query:   139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
             ++CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLLN +EYT+AID+WSVGCI  EIM
Sbjct:   179 SNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIM 238

Query:   199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             TREPLFPGKDYVHQL+LITELIGSPD ASL FLRS NAR+YV++LP+  +Q F+ RFP+ 
Sbjct:   239 TREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSM 298

Query:   259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDH 318
             +S A+DLLEKMLVFDP KRITVEEAL +PYL +LHDLNDEPVC   F F FE  S TE+ 
Sbjct:   299 NSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEE 358

Query:   319 IRELIWRESVKFNPDPT 335
             I+EL+W ESVKFNP P+
Sbjct:   359 IKELVWLESVKFNPLPS 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
 Identities = 233/315 (73%), Positives = 268/315 (85%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I   A NSET EEVAIKKI NAFDN +DA+RTLREIKLL HM+H+NVI IKDII  P+K+
Sbjct:    46 IVCCATNSETNEEVAIKKIANAFDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKE 105

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              F DVYIVYELMDTDLHQIIRS Q LTDDHCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNL
Sbjct:   106 RFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 165

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +LN +CDLKI DFGLART++ET+ MTEYVVTRWYRAPELLLN +EYT AIDIWSVGCI  
Sbjct:   166 VLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFM 225

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             EI+ RE LFPGKDYV QL+LITEL+GSPDD+ L FLRSDNAR+YV+QLP  +KQ F  +F
Sbjct:   226 EILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKF 285

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
             PN S  A+DL EKMLVFDP+KRITV+EAL+ PYL SLH++N+EP CP PF FDFE ++  
Sbjct:   286 PNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALD 345

Query:   316 EDHIRELIWRESVKF 330
             E  I+EL+WRES+ F
Sbjct:   346 EQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
 Identities = 220/318 (69%), Positives = 271/318 (85%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I  +A+NSET E VAIKKI NAFDN IDA+RTLREIKLLRHM+HEN++AI+DII PP ++
Sbjct:    76 IVCSAMNSETNESVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPLRN 135

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              FNDVYI YELMDTDLHQIIRS+Q L+++HCQYFLYQ+LRGLKY+HSA+VLHRDLKPSNL
Sbjct:   136 AFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 195

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             LLNA+CDLKI DFGLAR TSE+DFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  
Sbjct:   196 LLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 255

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             E+M R+PLFPG+D+VHQLRL+ ELIG+P +  L FL ++NA+RY+RQLP   +Q    +F
Sbjct:   256 ELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFL-NENAKRYIRQLPPYPRQSITDKF 314

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
             P     A+DL+EKML FDP +RITV +AL HPYL SLHD++DEP C  PF+FDFE+ + +
Sbjct:   315 PTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPECTIPFNFDFENHALS 374

Query:   316 EDHIRELIWRESVKFNPD 333
             E+ ++ELI+RE++ FNP+
Sbjct:   375 EEQMKELIYREALAFNPE 392

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
 Identities = 205/317 (64%), Positives = 265/317 (83%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I  + +++ET E VA+KKI NAFDN +DA+RTLREIKLLRH++HEN+IAI+D++ PP + 
Sbjct:    51 IVCSVLDTETNELVAMKKIANAFDNHMDAKRTLREIKLLRHLDHENIIAIRDVVPPPLRR 110

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              F+DVYI  ELMDTDLHQIIRS+Q L+++HCQYFLYQLLRGLKY+HSA+++HRDLKPSNL
Sbjct:   111 QFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNL 170

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             LLNA+CDLKI DFGLAR TSE DFMTEYVVTRWYRAPELLLN ++YTAAID+WSVGCI  
Sbjct:   171 LLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 230

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             E+M R+PLFPGKD+VHQ+RL+TEL+G+P ++ LGF  +++A+RY+RQLP   +Q  A  F
Sbjct:   231 ELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLF 290

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
              + +  A+DL+++ML FDPN+RITVE+AL H YL  LHD NDEP+C +PF F+FE     
Sbjct:   291 SHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPICQKPFSFEFEQQPLD 350

Query:   316 EDHIRELIWRESVKFNP 332
             E+ I+E+I++E++  NP
Sbjct:   351 EEQIKEMIYQEAIALNP 367

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
 Identities = 203/318 (63%), Positives = 255/318 (80%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             I  +AV+SET E+VAIKKI   FDN I+A+RTLREIKLLRH +HEN++AI+D+I PP++D
Sbjct:    73 IVCSAVDSETNEKVAIKKITQVFDNTIEAKRTLREIKLLRHFDHENIVAIRDVILPPQRD 132

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +F DVYIV ELM+ DL++ ++SDQ+LT DH  YF+YQ+LRGLKY+HSA+VLHRDLKPSNL
Sbjct:   133 SFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNL 192

Query:   136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             LL+  CDLKI DFGLAR T E++ MTEYVVTRWYRAPELLL  ++YTAAID+WSVGCI  
Sbjct:   193 LLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFM 252

Query:   196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             EIM REPLFPGKD V+QLRL+ ELIG+P +  LG L S+ A+RY+RQLP   +Q F  +F
Sbjct:   253 EIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSL-SEYAKRYIRQLPTLPRQSFTEKF 311

Query:   256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
             PN    A+DL+EKML FDP +RI+V+EAL HPYL S HD+ DEP C  PF+FD +    +
Sbjct:   312 PNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDEPECSEPFNFDLDEHPFS 371

Query:   316 EDHIRELIWRESVKFNPD 333
             E+  RELI+ E++ FNP+
Sbjct:   372 EEQFRELIYCEALAFNPE 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
 Identities = 188/322 (58%), Positives = 240/322 (74%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             +  +A ++ T E+VAIKKI  AFDN+ D +RTLREI LLRH +HEN+I+IKDI++P  K+
Sbjct:   162 VVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHENLISIKDILKPNSKE 221

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              F DVYIV ELMDTDLHQII S Q L+DDHCQYF+YQ+LRGLK++HSA+VLHRDLKPSNL
Sbjct:   222 QFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNL 281

Query:   136 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
             L+N  C LKI D GLAR    T   FMTEYV TRWYRAPE++L+  +YT AIDIWSVGCI
Sbjct:   282 LINEDCLLKICDLGLARVEDATHQGFMTEYVATRWYRAPEVILSWNKYTKAIDIWSVGCI 341

Query:   194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
               E++ R+PLF GKDY+HQ+ LI E IGSP +  +  + ++ AR+++R +    K  FA 
Sbjct:   342 FAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQARQFIRNMGNQPKVNFAN 401

Query:   254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS 313
              FP  +  A+DLLE+ML FDP+KR+TVEEAL HPY QSLHD +DEP+C   F  +FE   
Sbjct:   402 MFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPSDEPICLHKFSLNFEAWD 461

Query:   314 CTEDHIRELIWRESVKFNP-DP 334
                D ++ELI+ E + ++P DP
Sbjct:   462 LNRDLLKELIYNEMLAYHPEDP 483

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 963 (344.1 bits), Expect = 6.6e-97, P = 6.6e-97
 Identities = 176/319 (55%), Positives = 237/319 (74%)

Query:    16 IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
             +  +++N ET E VAIKKI N F+N +DA RTLRE+KLLRH+ HENVIA+KD++ P  + 
Sbjct:    45 VVCSSINRETNERVAIKKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRS 104

Query:    76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +F DVY+VYELMDTDLHQII+S Q L+DDHC+YFL+QLLRGLKY+HSA++LHRDLKP NL
Sbjct:   105 SFKDVYLVYELMDTDLHQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNL 164

Query:   136 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             L+NA+CDLKI DFGLART+   + FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI 
Sbjct:   165 LVNANCDLKICDFGLARTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF 224

Query:   195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
              EI+ R+P+FPG + ++QL+LI  ++GS  ++ + F+ +  ARR+++ LP  R    +  
Sbjct:   225 AEILGRKPIFPGTECLNQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNL 284

Query:   255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSC 314
             +P  +  A+DLL++MLVFDP KRI+V +AL HPY+  L D    P    P   D + +  
Sbjct:   285 YPQANPLAIDLLQRMLVFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENM- 343

Query:   315 TEDHIRELIWRESVKFNPD 333
              E  IRE++W E + ++P+
Sbjct:   344 EEPVIREMMWNEMLYYHPE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q336X9	MPK6_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.7993	0.9642	0.8617	no	no
Q8GYQ5	MPK12_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7893	0.9464	0.8548	no	no
Q40884	MAPK_PETHY	2, ., 7, ., 1, 1, ., 2, 4	0.5653	0.9583	0.8385	N/A	no
Q9LMM5	MPK11_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8328	0.9434	0.8590	no	no
Q9LQQ9	MPK13_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7261	0.9523	0.8815	no	no
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.7093	0.9494	0.8015	no	no
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.7062	0.9494	0.8096	N/A	no
Q5J4W4	MPK2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8181	0.9494	0.8096	yes	no
P0CP67	CPK1_CRYNB	2, ., 7, ., 1, 1, ., 2, 4	0.5212	0.9315	0.8551	N/A	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.6371	0.9613	0.8753	N/A	no
P42525	ERK1_DICDI	2, ., 7, ., 1, 1, ., 2, 4	0.5776	0.9523	0.6049	yes	no
O42781	MAPK2_PNECA	2, ., 7, ., 1, 1, ., 2, 4	0.5276	0.9404	0.9002	N/A	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7408	0.9613	0.8706	N/A	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7062	0.9494	0.8117	N/A	no
P0CP66	CPK1_CRYNJ	2, ., 7, ., 1, 1, ., 2, 4	0.5212	0.9315	0.8551	yes	no
Q40517	NTF3_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5653	0.9583	0.8655	N/A	no
Q00859	MAPK_FUSSO	2, ., 7, ., 1, 1, ., 2, 4	0.5131	0.9732	0.9211	N/A	no
P26696	MK01_XENLA	2, ., 7, ., 1, 1, ., 2, 4	0.5108	0.9434	0.8781	N/A	no
Q39025	MPK5_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7575	0.9672	0.8643	no	no
Q39024	MPK4_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8226	0.9583	0.8563	yes	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5506	0.8601	0.7768	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7093	0.9494	0.8242	N/A	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.8085	0.9642	0.8733	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.979
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	336
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.0
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-163
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-155
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-143
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-141
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-132
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-121
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-113
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-111
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-109
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-109
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-106
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-106
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-103
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-99
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-97
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-93
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-87
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-86
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-85
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-81
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-80
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-78
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-77
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-76
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-76
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-76
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-71
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-71
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-71
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-71
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-70
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-69
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-68
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-68
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-67
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-65
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-64
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-63
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-63
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-63
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-60
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-60
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-59
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-59
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-59
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-59
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-57
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-55
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-53
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-50
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-46
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-45
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-44
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-39
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-37
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-32
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-30
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-22
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-22
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-18
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  624 bits (1611), Expect = 0.0
 Identities = 236/318 (74%), Positives = 273/318 (85%), Gaps = 1/318 (0%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I  +A NSET E+VAIKKI NAFDN IDA+RTLREIKLLRH++HENVIAIKDI+ PP ++
Sbjct: 20  IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            FNDVYIVYELMDTDLHQIIRS Q L+DDHCQYFLYQLLRGLKY+HSA+VLHRDLKPSNL
Sbjct: 80  AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139

Query: 136 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           LLNA+CDLKI DFGLARTTSE  DFMTEYVVTRWYRAPELLLNC+EYT AID+WSVGCI 
Sbjct: 140 LLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIF 199

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++ R+PLFPGKDYVHQL+LITEL+GSP +  LGF+R++ ARRY+R LP   +Q FA  
Sbjct: 200 AELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARL 259

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSC 314
           FP+ +  A+DLLEKMLVFDP+KRITVEEAL HPYL SLHD +DEPVC  PF FDFE  + 
Sbjct: 260 FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDAL 319

Query: 315 TEDHIRELIWRESVKFNP 332
           TE+ I+ELI+ E + ++P
Sbjct: 320 TEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  524 bits (1353), Expect = 0.0
 Identities = 192/313 (61%), Positives = 241/313 (76%), Gaps = 5/313 (1%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           +AV+  T  +VAIKKI N FD++IDA+R LREIKLLRH+ HEN+I + DI+RPP  + FN
Sbjct: 18  SAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           DVYIV ELM+TDLH++I+S Q LTDDH QYFLYQ+LRGLKY+HSA+V+HRDLKPSN+L+N
Sbjct: 78  DVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN 137

Query: 139 ASCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           ++CDLKI DFGLAR       E  F+TEYVVTRWYRAPELLL+ + YT AIDIWSVGCI 
Sbjct: 138 SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF 197

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++TR+PLFPG+DY+ QL LI E++G+P +  L F+ S+ AR Y++ LP+  K+  +  
Sbjct: 198 AELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL 257

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF-DFEHSS 313
           FP  S  A+DLLEKMLVFDP KRIT +EAL HPYL  LHD  DEPV   PF F  F+   
Sbjct: 258 FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDE 317

Query: 314 CTEDHIRELIWRE 326
            TE+ ++ELI+ E
Sbjct: 318 LTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  458 bits (1180), Expect = e-163
 Identities = 181/319 (56%), Positives = 233/319 (73%), Gaps = 7/319 (2%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           +  +A +  T  +VAIKKI + F++    +RTLREIK+LR  +HEN+I I DIIRPP  +
Sbjct: 20  MVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           +FNDVYIV ELM+TDL+++I++ Q L++DH QYFLYQ+LRGLKY+HSA+VLHRDLKPSNL
Sbjct: 79  SFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNL 137

Query: 136 LLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           LLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT AIDIWSVG
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           CIL E+++  PLFPGKDY+HQL LI  ++G+P    L  + S  AR Y++ LP   K  +
Sbjct: 198 CILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPW 257

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE- 310
              FPN    A+DLL+KML F+P+KRITVEEAL HPYL+  HD +DEPV   PF FDFE 
Sbjct: 258 NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFEL 317

Query: 311 HSSCTEDHIRELIWRESVK 329
                ++ ++ELI+ E ++
Sbjct: 318 FDDLPKEKLKELIFEEIMR 336

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  438 bits (1129), Expect = e-155
 Identities = 178/315 (56%), Positives = 240/315 (76%), Gaps = 6/315 (1%)

Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A+++ + ++VAIKKI +AFD    A+RTLRE+K+LRH +H+N+IAI+DI+RPP 
Sbjct: 18  YGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77

Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            D F DVY+V +LM++DLH II SDQ LT++H +YFLYQLLRGLKY+HSA+V+HRDLKPS
Sbjct: 78  AD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPS 136

Query: 134 NLLLNASCDLKIGDFGLAR--TTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           NLL+N  C+L+IGDFG+AR  ++S T+   FMTEYV TRWYRAPELLL+  EYT AID+W
Sbjct: 137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMW 196

Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           SVGCI  E++ R  LFPGK+YVHQL+LI  ++GSP +  L  + SD  R+Y++ LPR + 
Sbjct: 197 SVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQP 256

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD 308
             ++  FP  S  A+DLL +ML FDP +RITVE+AL+HP+L   HD +DEP CP PF FD
Sbjct: 257 VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFD 316

Query: 309 FEHSSCTEDHIRELI 323
           FE    + + ++E I
Sbjct: 317 FEAIELSREQLKEAI 331

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  408 bits (1052), Expect = e-143
 Identities = 158/316 (50%), Positives = 218/316 (68%), Gaps = 5/316 (1%)

Query: 18  SAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DT 76
            +A +++T  +VAIKK+   F + I A+RT RE++LL+HM+HENVI + D+  P    + 
Sbjct: 32  CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91

Query: 77  FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           F DVY+V  LM  DL+ I++  Q+L+DDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSN+ 
Sbjct: 92  FQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 150

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +N  C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E
Sbjct: 151 VNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++T + LFPG D++ QL+ I  L+G+PD+  L  + S++AR Y++ LP+  K+ F   F 
Sbjct: 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFS 268

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE 316
             +  A+DLLEKMLV DP+KRIT  EAL HPYL   HD  DEPV P P+   FE    T 
Sbjct: 269 GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP-PYDQSFESRDLTV 327

Query: 317 DHIRELIWRESVKFNP 332
           D  +EL+++E + F P
Sbjct: 328 DEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  401 bits (1032), Expect = e-141
 Identities = 179/321 (55%), Positives = 226/321 (70%), Gaps = 14/321 (4%)

Query: 16  IFSAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAI--KDIIR 70
           I  +A N+ET EE  VAIKKI N F   I A+R LRE+KLLRH   H+N+  +   DI+ 
Sbjct: 15  IVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74

Query: 71  PPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
           P     FN++Y+  ELM+ DLHQIIRS Q LTD H Q F+YQ+L GLKY+HSA+VLHRDL
Sbjct: 75  P---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDL 131

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           KP NLL+NA C+LKI DFGLAR  SE       FMTEYV TRWYRAPE++L+   YT AI
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+WSVGCIL E++ R+P+F GKDYV QL  I +++G+PD+ +L  + S  A+ Y+R LP 
Sbjct: 192 DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPN 251

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
             K+ F + FPN +  A+DLLEK+L FDP KRI+VEEAL HPYL   HD +DEPVC +PF
Sbjct: 252 IPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPF 311

Query: 306 HFDFEHSSCTEDHIRELIWRE 326
            F FE     E+ +R++I  E
Sbjct: 312 DFSFESEDSMEE-LRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  380 bits (978), Expect = e-132
 Identities = 160/324 (49%), Positives = 226/324 (69%), Gaps = 13/324 (4%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           +A+++ T E+VAIKKI + F+++ DA R LREIKLLR + H +++ IK I+ PP +  F 
Sbjct: 18  SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           D+Y+V+ELM++DLHQ+I+++  LT +H Q+FLYQLLR LKY+H+A+V HRDLKP N+L N
Sbjct: 78  DIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN 137

Query: 139 ASCDLKIGDFGLART----TSETDFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSV 190
           A C LKI DFGLAR     T    F T+YV TRWYRAPEL   C    ++YT AIDIWS+
Sbjct: 138 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSI 194

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           GCI  E++T +PLFPGK+ VHQL LIT+L+G+P   ++  +R++ ARRY+  + + +   
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC-PRP-FHFD 308
           F+ +FPN    A+ LLE++L FDP  R T EEAL  PY + L  +  EP   P     F+
Sbjct: 255 FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFE 314

Query: 309 FEHSSCTEDHIRELIWRESVKFNP 332
           FE    T++ +RELI+RE ++++P
Sbjct: 315 FERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  352 bits (906), Expect = e-121
 Identities = 139/292 (47%), Positives = 199/292 (68%), Gaps = 11/292 (3%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
           A++  T+E VA+KKI +AF N  DA+RT REI  L+ + +H N++ + ++I+    +   
Sbjct: 26  AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK---AENDK 82

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           D+Y+V+E M+TDLH +IR++  L D H +Y +YQLL+ LKY+HS +V+HRDLKPSN+LLN
Sbjct: 83  DIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN 141

Query: 139 ASCDLKIGDFGLARTTSETD------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           + C +K+ DFGLAR+ SE +       +T+YV TRWYRAPE+LL  T YT  +D+WSVGC
Sbjct: 142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGC 201

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           ILGE++  +PLFPG   ++QL  I E+IG P    +  ++S  A   +  LP   ++   
Sbjct: 202 ILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD 261

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 304
              P  S  A+DLL+K+LVF+PNKR+T EEAL HPY+   H+ +DEPV P P
Sbjct: 262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYP 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  331 bits (851), Expect = e-113
 Identities = 152/313 (48%), Positives = 205/313 (65%), Gaps = 7/313 (2%)

Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +  +A +  T + VAIKKI   F   + A+RT RE+KLL+H+ HEN+I++ DI   P 
Sbjct: 23  FGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP- 81

Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
                D+Y V EL+ TDLH+++ S + L     QYFLYQ+LRGLKYVHSA V+HRDLKPS
Sbjct: 82  ---LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPS 137

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           N+L+N +CDLKI DFGLAR       MT YV TR+YRAPE++L   +Y   +DIWS GCI
Sbjct: 138 NILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCI 195

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
             E++  +PLFPGKD+V+Q  +IT+L+G+P D  +  + S+N  R+V+ LP+     F+ 
Sbjct: 196 FAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSE 255

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS 313
           +F N    A+DLLEKMLVFDP KRI+  EAL HPYL   HD  DEPV    F + F  + 
Sbjct: 256 KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDAD 315

Query: 314 CTEDHIRELIWRE 326
              D  + +++ E
Sbjct: 316 LPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  325 bits (835), Expect = e-111
 Identities = 128/273 (46%), Positives = 168/273 (61%), Gaps = 8/273 (2%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
            A +  T E VAIKKI   F++    +  LREIKLL+ + H N+I + D+ R        
Sbjct: 17  KARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----G 71

Query: 79  DVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           D+Y+V+E MDTDL+++I+  Q+ L +   + +LYQLL+GL + HS  +LHRDLKP NLL+
Sbjct: 72  DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI 131

Query: 138 NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    LK+ DFGLAR+  S     T YVVTRWYRAPELLL    Y+  +DIWSVGCI  E
Sbjct: 132 NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAE 191

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           +++R PLFPGK  + QL  I   +G+PD        S  AR Y    P+         FP
Sbjct: 192 LLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSFPKKAGMPLPKLFP 250

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           N S  A+DLL +ML +DP+KRIT E+AL HPY 
Sbjct: 251 NASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  322 bits (826), Expect = e-109
 Identities = 156/315 (49%), Positives = 210/315 (66%), Gaps = 5/315 (1%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 35  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94

Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 95  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 153

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 154 NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 271

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 272 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 330

Query: 318 HIRELIWRESVKFNP 332
             + L + E + F P
Sbjct: 331 EWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  320 bits (821), Expect = e-109
 Identities = 148/316 (46%), Positives = 209/316 (66%), Gaps = 5/316 (1%)

Query: 18  SAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DT 76
            +A ++  R++VA+KK+   F ++I ARRT RE++LL+HM+HENVI + D+  P    + 
Sbjct: 32  CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91

Query: 77  FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           FN+VY+V  LM  DL+ I++  Q+L+D+H Q+ +YQLLRGLKY+HSA ++HRDLKPSN+ 
Sbjct: 92  FNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVA 150

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +N  C+L+I DFGLAR     D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E
Sbjct: 151 VNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++  + LFPG DY+ QL+ I E++G+P    L  + S++AR+Y++ LP   +Q     F 
Sbjct: 209 LLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFR 268

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE 316
             +  A+DLLEKMLV D +KRI+  EAL HPY    HD  DEP    P+    E+   T 
Sbjct: 269 GANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAE-PYDESPENKERTI 327

Query: 317 DHIRELIWRESVKFNP 332
           +  +EL + E   F P
Sbjct: 328 EEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  313 bits (805), Expect = e-106
 Identities = 135/323 (41%), Positives = 197/323 (60%), Gaps = 29/323 (8%)

Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VA+KK+ N F N++  +R  RE+K+L   +H+NV++  DI++PP  D F ++Y+V ELM 
Sbjct: 28  VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ 87

Query: 89  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
           +DLH+II S Q L+ DH + FLYQ+LRGLKY+HSA +LHRD+KP NLL+N++C LKI DF
Sbjct: 88  SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDF 147

Query: 149 GLARTTS--ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 206
           GLAR     E+  MT+ VVT++YRAPE+L+    YT+A+DIWSVGCI  E++ R  LF  
Sbjct: 148 GLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207

Query: 207 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG----A 262
           +  + QL LIT+L+G+P   ++       AR ++ + P   K          SS     A
Sbjct: 208 QSPIQQLDLITDLLGTPSLEAMRSACE-GARAHILRGP--HKPPSLPVLYTLSSQATHEA 264

Query: 263 VDLLEKMLVFDPNKRITVEEALRHPYLQS--------------------LHDLNDEPVCP 302
           V LL +MLVFDP+KRI+  +AL HPYL                      ++  + EP   
Sbjct: 265 VHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSAN 324

Query: 303 RPFHFDFEHSSCTEDHIRELIWR 325
            PF  ++E +  +   ++E + +
Sbjct: 325 PPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  312 bits (802), Expect = e-106
 Identities = 143/315 (45%), Positives = 198/315 (62%), Gaps = 6/315 (1%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP-PKKDTF 77
           +A++  T E+VAIKK+   F + I A+R  RE+ LL+HM+HENVI + D+       D F
Sbjct: 33  SAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92

Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            D Y+V   M TDL +I+     L++D  QY +YQ+L GLKY+HSA ++HRDLKP NL +
Sbjct: 93  QDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV 150

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR       MT YVVTRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 151 NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LP+  ++ F+T FP 
Sbjct: 209 LTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK 268

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            S  AVDLLEKML  D +KR+T  EAL HPY  S  D ++E    +P+    E+   + D
Sbjct: 269 ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE-QQPYDDSLENEKLSVD 327

Query: 318 HIRELIWRESVKFNP 332
             ++ I++E   F+P
Sbjct: 328 EWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  306 bits (785), Expect = e-103
 Identities = 143/318 (44%), Positives = 209/318 (65%), Gaps = 5/318 (1%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
              +A++  T  +VAIKK+   F + + A+R  RE++LL+HM+HENVI + D+  P    
Sbjct: 30  TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           D F+D Y+V   M TDL ++++  ++L++D  Q+ +YQ+L+GLKY+H+A ++HRDLKP N
Sbjct: 90  DRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN 148

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           L +N  C+LKI DFGLAR T     MT YVVTRWYRAPE++LN   YT  +DIWSVGCI+
Sbjct: 149 LAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++T +PLF G D++ QL  I ++ G+P    +  L+S++A+ YV++LPR RK+ F + 
Sbjct: 207 AEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSL 266

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSC 314
            PN +  AV++LEKMLV D   RIT  EAL HPY +  HD  DE   P P+   F+    
Sbjct: 267 LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP-PYDDSFDEVDQ 325

Query: 315 TEDHIRELIWRESVKFNP 332
           + +  + L + E + F P
Sbjct: 326 SLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  294 bits (756), Expect = 1e-99
 Identities = 111/275 (40%), Positives = 158/275 (57%), Gaps = 15/275 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDA--RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A + +T E VA+KKI    DN  +      LREI LL+ ++H N++ + D+I   +K   
Sbjct: 18  ARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK--- 72

Query: 78  NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
             +Y+V+E  D DL + +      L+ +  +  +YQLLRGL Y HS  +LHRDLKP N+L
Sbjct: 73  --LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL 130

Query: 137 LNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +N    LK+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+DIWSVGCI  
Sbjct: 131 INRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFA 190

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDAS-LGFLRSDNARRYVRQLPRCRKQQFATR 254
           E++T +PLFPG   + QL  I +++G+P + S  G  +  +   Y    P+   +     
Sbjct: 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD---YKPTFPKFPPKDLEKV 247

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            P      +DLL KML ++P KRI+ +EAL+HPY 
Sbjct: 248 LPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  292 bits (749), Expect = 1e-97
 Identities = 140/329 (42%), Positives = 198/329 (60%), Gaps = 25/329 (7%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++ T + VAIKK+   F N+  A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 31  IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+ D  L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 91  EEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 149 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 207

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   I E +G+P D  +  L+    R YV   P+     F   
Sbjct: 208 GEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-TVRNYVENRPKYAGYSFEEL 266

Query: 255 FP-------------NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 301
           FP              K+S A DLL KMLV DP KRI+V++AL+HPY+   +D   E   
Sbjct: 267 FPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD-PSEVEA 325

Query: 302 PRPFHFDFEHSSCTEDHI----RELIWRE 326
           P P  +D  HS    +H     +ELI++E
Sbjct: 326 PPPAPYD--HSIDEREHTVEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  277 bits (711), Expect = 9e-93
 Identities = 107/276 (38%), Positives = 160/276 (57%), Gaps = 14/276 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIID--ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A N +T E VA+KKI    +N  +      +REIKLL+ + H N++ +K+I+    K   
Sbjct: 18  ARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK--- 72

Query: 78  NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
             +Y+V+E MD DL  ++ S + + T+   + ++ QLL GL+Y+HS  +LHRD+K SN+L
Sbjct: 73  GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL 132

Query: 137 LNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +N    LK+ DFGLAR  +   +   T  V+T WYR PELLL  T Y   +D+WSVGCIL
Sbjct: 133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCIL 192

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQFAT 253
            E+   +P+F G   + QL  I EL GSP D +  G  +         +  +  K++   
Sbjct: 193 AELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL--KPKKPYKRRLRE 250

Query: 254 RFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
            F +     A+DLL+K+L  DP KRI+ ++AL+H Y
Sbjct: 251 FFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  264 bits (677), Expect = 7e-87
 Identities = 129/336 (38%), Positives = 190/336 (56%), Gaps = 40/336 (11%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           +FSA V+S+  + VA+KKI     +    +  LREIK++R ++H+N++ + +++ P   D
Sbjct: 21  VFSA-VDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD 77

Query: 76  ---------TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 126
                      N VYIV E M+TDL  ++     L+++H + F+YQLLRGLKY+HSA+VL
Sbjct: 78  LTEDVGSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSANVL 136

Query: 127 HRDLKPSNLLLNA-SCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCTEY 181
           HRDLKP+N+ +N     LKIGDFGLAR      S   +++E +VT+WYR+P LLL+   Y
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196

Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG--------FLRS 233
           T AID+W+ GCI  E++T +PLF G   + Q++LI E +    +            F+R+
Sbjct: 197 TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRN 256

Query: 234 DNA--RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           D    RR +R L            P  +  A+D LE++L F+P  R+T EEAL HPY+  
Sbjct: 257 DGGEPRRPLRDL-----------LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305

Query: 292 LHDLNDEPVCPRPFHFDFEHSSCTE-DHIRELIWRE 326
                DEPV   PFH + E         I  +I+  
Sbjct: 306 YSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNW 341

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  261 bits (669), Expect = 3e-86
 Identities = 116/276 (42%), Positives = 156/276 (56%), Gaps = 17/276 (6%)

Query: 20  AVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK 74
           A + ET   VAIKKI       A D I      LREIKLL+ ++H N+I + D+     K
Sbjct: 19  ARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHPNIIGLLDVF--GHK 74

Query: 75  DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
              N   +V+E M+TDL ++I+     LT    + ++   LRGL+Y+HS  +LHRDLKP+
Sbjct: 75  SNIN---LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPN 131

Query: 134 NLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           NLL+ +   LK+ DFGLAR+  S    MT  VVTRWYRAPELL     Y   +D+WSVGC
Sbjct: 132 NLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC 191

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I  E++ R P  PG   + QL  I E +G+P + +   + S     YV   P        
Sbjct: 192 IFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP--DYVEFKPF-PPTPLK 248

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
             FP  S  A+DLL+++L  +PNKRIT  +AL HPY
Sbjct: 249 QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  256 bits (656), Expect = 8e-85
 Identities = 98/271 (36%), Positives = 149/271 (54%), Gaps = 35/271 (12%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A + +T + VAIK I        D  R LREIK+L+ ++H N++ + D+      +  + 
Sbjct: 18  ARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRLYDVF-----EDEDK 71

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +Y+V E  +  DL  +++   +L++D  +++L Q+L  L+Y+HS  ++HRDLKP N+LL+
Sbjct: 72  LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD 131

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
               +K+ DFGLAR     + +T +V T  Y APE+LL    Y  A+DIWS+G IL E++
Sbjct: 132 EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGKAVDIWSLGVILYELL 190

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
           T +P FPG D   QL  + + IG P                        K  F     + 
Sbjct: 191 TGKPPFPGDD---QLLELFKKIGKP------------------------KPPFPPPEWDI 223

Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           S  A DL+ K+LV DP KR+T EEAL+HP+ 
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  249 bits (638), Expect = 1e-81
 Identities = 102/277 (36%), Positives = 162/277 (58%), Gaps = 17/277 (6%)

Query: 20  AVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A + ET E VA+KK+        I    + LREIK L+  +H  V+ + D+         
Sbjct: 19  AKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQHPYVVKLLDVFPHG----- 71

Query: 78  NDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +   +V E M +DL +++R  ++ L +   + ++  LL+G+ Y+H+  ++HRDLKP+NLL
Sbjct: 72  SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131

Query: 137 LNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           ++A   LKI DFGLAR  SE +    +  V TRWYRAPELL    +Y   +D+W+VGCI 
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIF 191

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--DNARRYVRQLPRCRKQQFA 252
            E++   PLFPG++ + QL ++   +G+P++ +   L S  D  +    +      ++  
Sbjct: 192 AELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI- 250

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             FP+ S  A+DLL+ +LV+DP+KR++  EALRHPY 
Sbjct: 251 --FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 2e-80
 Identities = 106/283 (37%), Positives = 160/283 (56%), Gaps = 30/283 (10%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
           A N ET E VAIKK+   F +  +    LRE+K LR + EH N++ +K++ R       +
Sbjct: 18  ARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVKLKEVFR-----END 71

Query: 79  DVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           ++Y V+E M+ +L+Q+++  +    ++   +  +YQ+L+GL ++H     HRDLKP NLL
Sbjct: 72  ELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL 131

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +KI DFGLAR        T+YV TRWYRAPE+LL  T Y++ +DIW++GCI+ E
Sbjct: 132 VSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDD----------ASLGFLRSDNARRYVRQLPRC 246
           + T  PLFPG   + QL  I  ++G+P            + LGF           + P+ 
Sbjct: 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF-----------RFPQF 240

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                    PN S  A+DL++ ML +DP KR T  +AL+HPY 
Sbjct: 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  239 bits (613), Expect = 6e-78
 Identities = 108/277 (38%), Positives = 158/277 (57%), Gaps = 16/277 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIID--ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A + +T E VA+KK+    +   +     +LREI +L  ++H N++ +K+++        
Sbjct: 24  ARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV---VGSNL 78

Query: 78  NDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           + +Y+V E ++ DL  ++    Q       +  + QLL G+ ++H   +LHRDLK SNLL
Sbjct: 79  DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138

Query: 137 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           LN    LKI DFGLAR         T+ VVT WYRAPELLL   EY+ AID+WSVGCI  
Sbjct: 139 LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFA 198

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQ-LPRCRKQQFAT 253
           E++T++PLFPGK  + QL  I +L+G+P +    GF     A++      P     Q   
Sbjct: 199 ELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYN---QLRK 255

Query: 254 RFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           +FP    S    DLL ++L +DP KRI+ E+AL+HPY
Sbjct: 256 KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  239 bits (611), Expect = 7e-77
 Identities = 134/325 (41%), Positives = 197/325 (60%), Gaps = 18/325 (5%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 208

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 267

Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V+EAL+HPY+   +D  + E   
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPP 327

Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 328 PQIYDKQLDEREHTIEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  238 bits (609), Expect = 1e-76
 Identities = 135/328 (41%), Positives = 192/328 (58%), Gaps = 24/328 (7%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VA+KK+   F N   A+R  RE+ LL+ + H+N+I++ ++  P K  
Sbjct: 36  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I  +  L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 96  EEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART      MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 154 IVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 212

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--DNARRYVRQLPRCRKQQFA 252
           GE++    +F G D++ Q   + E +G+P   S  F+       R YV   P+     F 
Sbjct: 213 GELVKGSVIFQGTDHIDQWNKVIEQLGTP---SAEFMNRLQPTVRNYVENRPQYPGISFE 269

Query: 253 TRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
             FP+            K+S A DLL KMLV DP+KRI+V+EALRHPY+   +D   E  
Sbjct: 270 ELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD-PAEAE 328

Query: 301 CPRPFHFD--FEHSSCTEDHIRELIWRE 326
            P P  +D   E      +  +ELI++E
Sbjct: 329 APPPQIYDAQLEEREHAIEEWKELIYKE 356

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  237 bits (606), Expect = 5e-76
 Identities = 133/325 (40%), Positives = 192/325 (59%), Gaps = 18/325 (5%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 215

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274

Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD-LNDEPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D    E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334

Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  233 bits (596), Expect = 9e-76
 Identities = 89/272 (32%), Positives = 142/272 (52%), Gaps = 31/272 (11%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A +  T + VA+K +    +     +   REI++LR + H N++ + D          + 
Sbjct: 18  AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE-----DKDH 72

Query: 80  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +Y+V E  +  DL   +     L++D  +    Q+LRGL+Y+HS  ++HRDLKP N+LL+
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLD 132

Query: 139 ASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            +  +KI DFGLA+   ++   +T +V T WY APE+LL    Y   +D+WS+G IL E+
Sbjct: 133 ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T +P F G++ + QL+LI  ++G P +       S                        
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS------------------------ 228

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            S  A DL++K L  DP+KR T EE L+HP+ 
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  223 bits (571), Expect = 1e-71
 Identities = 111/280 (39%), Positives = 156/280 (55%), Gaps = 24/280 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A +  T E VA+KKI    ++       +REI LL+ + H N++ + D++    K     
Sbjct: 18  ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK----- 72

Query: 80  VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +D DL + + S     L     + +LYQLL+G+ Y HS  VLHRDLKP NLL+
Sbjct: 73  LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132

Query: 138 NASCDLKIGDFGLARTTSETDF------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           +    LK+ DFGLAR      F       T  VVT WYRAPE+LL   +Y+  +DIWS+G
Sbjct: 133 DREGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--DNARRYVRQLPRCRKQ 249
           CI  E++ R PLFPG   + QL  I   +G+PD+     + S  D    Y    P+  +Q
Sbjct: 188 CIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD----YKPTFPKWARQ 243

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             +   PN     +DLL KMLV+DP KRI+ + AL+HPY 
Sbjct: 244 DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  223 bits (570), Expect = 2e-71
 Identities = 99/272 (36%), Positives = 156/272 (57%), Gaps = 9/272 (3%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T E VAIKK   + D+    +  LRE+K+LR + HEN++ +K+  R   +     +Y
Sbjct: 22  NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-----LY 76

Query: 82  IVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +V+E ++  L +++  S   L  D  + +++QLL+ + Y HS +++HRD+KP N+L++ S
Sbjct: 77  LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES 136

Query: 141 CDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
             LK+ DFG AR         +T+YV TRWYRAPELL+  T Y   +D+W++GCI+ E++
Sbjct: 137 GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EPLFPG   + QL LI + +G    +      S+     V      + +    R+P K
Sbjct: 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGK 256

Query: 259 SSG-AVDLLEKMLVFDPNKRITVEEALRHPYL 289
            S  A+D L+  L  DP +R+T +E L+HPY 
Sbjct: 257 VSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  222 bits (569), Expect = 6e-71
 Identities = 112/297 (37%), Positives = 154/297 (51%), Gaps = 41/297 (13%)

Query: 20  AVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDII--RPPK- 73
           A   +T   VA+KKI   N  D   I A   LREIK+L+ ++H NV+ + D+   RP K 
Sbjct: 27  ARQIKTGRVVALKKILMHNEKDGFPITA---LREIKILKKLKHPNVVPLIDMAVERPDKS 83

Query: 74  KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           K     VY+V   MD DL  ++ +   +LT+   + ++ QLL G+ Y+H   +LHRD+K 
Sbjct: 84  KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKA 143

Query: 133 SNLLLNASCDLKIGDFGLAR-------------TTSETDFMTEYVVTRWYRAPELLLNCT 179
           +N+L++    LKI DFGLAR                   + T  VVTRWYR PELLL   
Sbjct: 144 ANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNLVVTRWYRPPELLLGER 202

Query: 180 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 239
            YT A+DIW +GC+  E+ TR P+  GK  + QL LI +L G+P + +    RS      
Sbjct: 203 RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS------ 256

Query: 240 VRQLPRCRKQQFATRFPNK--------SSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
              LP C      T +P              +DLL K+L  DP KR+T  +AL HPY
Sbjct: 257 ---LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  221 bits (565), Expect = 8e-71
 Identities = 96/269 (35%), Positives = 154/269 (57%), Gaps = 13/269 (4%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDII--RPPKKDTFNDV 80
           +T +  AIK +   F ++ +    LREI+ LR +  H N++ + +++  R   +      
Sbjct: 22  KTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL--- 77

Query: 81  YIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
             V+ELMD +L+++I+  ++ L +   + ++YQLL+ L ++H   + HRD+KP N+L+  
Sbjct: 78  --VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              LK+ DFG  R        TEY+ TRWYRAPE LL    Y   +DIW+VGC+  EI++
Sbjct: 136 DI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
             PLFPG + + Q+  I +++G+PD   L   R      Y    P  +        PN S
Sbjct: 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY--NFPSKKGTGLRKLLPNAS 252

Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           +  +DLL+K+L +DP++RIT ++ALRHPY
Sbjct: 253 AEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  221 bits (566), Expect = 1e-70
 Identities = 110/276 (39%), Positives = 161/276 (58%), Gaps = 12/276 (4%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR--RTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A ++ + E VA+KK+    DN  D     +LREI LL ++ H N++ +K+++        
Sbjct: 26  ARDTTSGEIVALKKV--RMDNERDGIPISSLREITLLLNLRHPNIVELKEVV---VGKHL 80

Query: 78  NDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           + +++V E  + DL  ++ +     ++   +  + QLLRGL+Y+H   ++HRDLK SNLL
Sbjct: 81  DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140

Query: 137 LNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L     LKI DFGLART       MT  VVT WYRAPELLL CT YT AID+W+VGCIL 
Sbjct: 141 LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILA 200

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQFATR 254
           E++  +PL PGK  + QL LI +L+G+P+++   GF       ++   LP+        +
Sbjct: 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT--LPKQPYNNLKHK 258

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           FP  S   + LL  +L++DP KR T EEAL   Y +
Sbjct: 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  218 bits (557), Expect = 2e-69
 Identities = 99/254 (38%), Positives = 140/254 (55%), Gaps = 22/254 (8%)

Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR--SDQQL 101
           TLREI LL+ +E   H N++ + D+   P+ D    + +V+E +D DL   +       L
Sbjct: 45  TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGL 104

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  + QLLRG+ ++HS  ++HRDLKP N+L+ +   +KI DFGLAR  S    +T
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT 164

Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  + Y   +D+WSVGCI  E+  R PLF G     QL  I ++IG
Sbjct: 165 SVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223

Query: 222 S------PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 275
                  P + SL   RS          P    + F +  P      +DLL+KML F+P+
Sbjct: 224 LPSEEEWPRNVSL--PRS--------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH 273

Query: 276 KRITVEEALRHPYL 289
           KRI+  EAL+HPY 
Sbjct: 274 KRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  215 bits (549), Expect = 2e-68
 Identities = 105/277 (37%), Positives = 154/277 (55%), Gaps = 24/277 (8%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           N  T E VA+K+I       +DA        +REI L++ ++HEN++ + D+I      T
Sbjct: 21  NRTTGEIVALKEIH------LDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----T 69

Query: 77  FNDVYIVYELMDTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            N + +V+E MD DL + + +      L  +  + F YQLL+G+ + H   VLHRDLKP 
Sbjct: 70  ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ 129

Query: 134 NLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           NLL+N   +LK+ DFGLAR        F  E VVT WYRAP++LL    Y+ +IDIWSVG
Sbjct: 130 NLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLGSRTYSTSIDIWSVG 188

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           CI+ E++T  PLFPG +   QL  I  ++G+P +++           Y    PR   Q  
Sbjct: 189 CIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP--GISQLPEYKPTFPRYPPQDL 246

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
              FP+     +DLL ++L  +P  RI+  +AL+HP+
Sbjct: 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  216 bits (552), Expect = 3e-68
 Identities = 110/323 (34%), Positives = 173/323 (53%), Gaps = 53/323 (16%)

Query: 20  AVNSETREEVAIKKIGN-AFDNIIDARR-----------TLREIKLLRHMEHENVIAIKD 67
           A ++ T + VAIKK+      N +   R           TLRE+K++  ++HEN++ + D
Sbjct: 28  AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87

Query: 68  IIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +    + D  N   +V ++M +DL +++    +LT+   +  L Q+L GL  +H    +H
Sbjct: 88  VY--VEGDFIN---LVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMH 142

Query: 128 RDLKPSNLLLNASCDLKIGDFGLAR---------------TTSETDFMTEYVVTRWYRAP 172
           RDL P+N+ +N+    KI DFGLAR               T    + MT  VVT WYRAP
Sbjct: 143 RDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP 202

Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 232
           ELL+   +Y  A+D+WSVGCI  E++T +PLFPG++ + QL  I EL+G+P         
Sbjct: 203 ELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP--------- 253

Query: 233 SDNARRYVRQLP------RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
           +++     ++LP        + +   T FPN S  A+DLL+ +L  +P +RI+ +EAL+H
Sbjct: 254 NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313

Query: 287 PYLQSLHDLNDEPVCPR--PFHF 307
            Y +S    +  P  P   PF+F
Sbjct: 314 EYFKS----DPLPCDPSQLPFNF 332

Length = 335

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  211 bits (538), Expect = 9e-67
 Identities = 107/272 (39%), Positives = 151/272 (55%), Gaps = 10/272 (3%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I    K     
Sbjct: 19  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK----- 73

Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 74  LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 133

Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 134 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 193

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 194 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPDYKPSFPKWARQDFSKVVP 251

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
                  DLL +ML +DPNKRI+ + AL HP+
Sbjct: 252 PLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  207 bits (529), Expect = 3e-65
 Identities = 107/274 (39%), Positives = 156/274 (56%), Gaps = 11/274 (4%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E +A+KKI    ++       +REI LL+ M+H N++ ++D++   K+     +Y+V+
Sbjct: 26  TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR-----LYLVF 80

Query: 85  ELMDTDLHQIIRSDQQLTDDH--CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           E +D DL + + S      +    + +LYQ+LRG+ Y HS  VLHRDLKP NLL++   +
Sbjct: 81  EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140

Query: 143 -LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
            LK+ DFGLAR         T  VVT WYRAPE+LL    Y+  +DIWSVGCI  E++ +
Sbjct: 141 ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200

Query: 201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS 260
           +PLFPG   + +L  I  ++G+P++ +   + S     Y    P+   +  AT  P    
Sbjct: 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFPKWPPKDLATVVPTLEP 258

Query: 261 GAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
             VDLL KML  DP+KRIT   AL H Y + L D
Sbjct: 259 AGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  204 bits (522), Expect = 3e-64
 Identities = 104/277 (37%), Positives = 147/277 (53%), Gaps = 26/277 (9%)

Query: 25  TREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           T + VA+K+I      G  F  I       RE  LL+ ++H N++ + DII   K  T  
Sbjct: 29  TGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHANIVTLHDIIHTKKTLTL- 80

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
               V+E +DTDL Q +         H  + FL+QLLRGL Y H   VLHRDLKP NLL+
Sbjct: 81  ----VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136

Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +   +LK+ DFGLAR  S  +   +  VVT WYR P++LL  TEY+ ++D+W VGCI  E
Sbjct: 137 SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYE 196

Query: 197 IMTREPLFPG-KDYVHQLRLITELIGSP-DDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           + T  PLFPG  D   QL  I  ++G+P ++   G   +   + Y    P    +     
Sbjct: 197 MATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY--SFPFYPPRPLINH 254

Query: 255 FP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            P  ++     +L  K L ++P KRI+  EA++HPY 
Sbjct: 255 APRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  203 bits (518), Expect = 1e-63
 Identities = 118/287 (41%), Positives = 165/287 (57%), Gaps = 27/287 (9%)

Query: 20  AVNSETREEVAIKKIGNAFDN-----IIDARRTLREIKLLRHMEHENVIAIKDIIRPP-- 72
           A + +T E VA+KK+    DN      I A   +REIK+LR + H N++ +K+I+     
Sbjct: 26  ARDKDTGELVALKKV--RLDNEKEGFPITA---IREIKILRQLNHRNIVNLKEIVTDKQD 80

Query: 73  ----KKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
               KKD     Y+V+E MD DL  ++ S     ++DH + F+ QLL GL Y H  + LH
Sbjct: 81  ALDFKKDKGA-FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139

Query: 128 RDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           RD+K SN+LLN    +K+ DFGLAR   + E+   T  V+T WYR PELLL    Y  AI
Sbjct: 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI 199

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA---SLGFLRSDNARRYVRQ 242
           D+WS GCILGE+ T++P+F     + QL LI+ L GSP  A    +  L   N  +  +Q
Sbjct: 200 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259

Query: 243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             R  +++F+   P   + A+DLL+ ML  DP+KR T EEAL  P+L
Sbjct: 260 YRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  202 bits (516), Expect = 2e-63
 Identities = 106/274 (38%), Positives = 153/274 (55%), Gaps = 14/274 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N ET E VA+K++    D+       LREI LL+ ++H+N++ + D++   KK T   
Sbjct: 19  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLT--- 75

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
             +V+E  D DL +   S     D    + F++QLL+GL + HS +VLHRDLKP NLL+N
Sbjct: 76  --LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN 133

Query: 139 ASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
            + +LK+ DFGLAR        +  E VVT WYR P++L     Y+ +ID+WS GCI  E
Sbjct: 134 KNGELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 192

Query: 197 IMTR-EPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQFATR 254
           +     PLFPG D   QL+ I  L+G+P + S  G  +  + + Y               
Sbjct: 193 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVV-- 250

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
            P  +S   DLL+ +LV +P +RI+ EEAL+HPY
Sbjct: 251 -PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  201 bits (513), Expect = 6e-63
 Identities = 97/274 (35%), Positives = 153/274 (55%), Gaps = 11/274 (4%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             N +T + VA+KKI    +        +REI LL+ ++H N++ ++D++    +     
Sbjct: 19  GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR----- 73

Query: 80  VYIVYELMDTDLHQI---IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +Y+++E +  DL +    +   Q +  +  + +LYQ+L+G+ + HS  VLHRDLKP NLL
Sbjct: 74  LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL 133

Query: 137 LNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           ++    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+  +DIWS+G I  
Sbjct: 134 IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFA 193

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E+ T++PLF G   + QL  I  ++G+P +     + S     Y    P+ +K    +  
Sbjct: 194 EMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LPDYKNTFPKWKKGSLRSAV 251

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            N     +DLLEKML++DP KRI+ ++AL HPY 
Sbjct: 252 KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  195 bits (497), Expect = 2e-60
 Identities = 102/248 (41%), Positives = 142/248 (57%), Gaps = 10/248 (4%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-C 106
           +RE+ LL+ ++H N++ + DII   K  T     +V+E +D DL Q +       + H  
Sbjct: 52  IREVSLLKDLKHANIVTLHDIIHTEKSLT-----LVFEYLDKDLKQYLDDCGNSINMHNV 106

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 165
           + FL+QLLRGL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VV
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T WYR P++LL  T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I  ++G+P +
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226

Query: 226 ASL-GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 284
            +  G L ++  + Y    P+ R        P   S   +LL K+L F+  KRI+ EEA+
Sbjct: 227 ETWPGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 285 RHPYLQSL 292
           +HPY   L
Sbjct: 285 KHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  194 bits (494), Expect = 9e-60
 Identities = 105/299 (35%), Positives = 156/299 (52%), Gaps = 38/299 (12%)

Query: 22  NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           N +  +E AIKK  G+       ++   REI LLR ++HENV+++ ++     +     V
Sbjct: 23  NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFL---EHADKSV 79

Query: 81  YIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           Y++++  + DL QII+         +     +  L+Q+L G+ Y+HS  VLHRDLKP+N+
Sbjct: 80  YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI 139

Query: 136 LLNASCD----LKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           L+         +KIGD GLAR         ++ D     VVT WYRAPELLL    YT A
Sbjct: 140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVVVTIWYRAPELLLGARHYTKA 196

Query: 185 IDIWSVGCILGEIMTREPLFPGKD---------YVHQLRLITELIGSPDDASLGFLRS-- 233
           IDIW++GCI  E++T EP+F G++            QL  I E++G+P +     ++   
Sbjct: 197 IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMP 256

Query: 234 --DNARRYVRQL--PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
             D   +  +    P     ++  +     S   DLL K+L +DP KRIT EEAL HPY
Sbjct: 257 EYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  193 bits (493), Expect = 1e-59
 Identities = 102/289 (35%), Positives = 153/289 (52%), Gaps = 30/289 (10%)

Query: 20  AVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A + +T++ VA+KK+   N  +   I A   LREIK+L+ ++HENV+ + +I R      
Sbjct: 31  ARHKKTKQIVALKKVLMENEKEGFPITA---LREIKILQLLKHENVVNLIEICRTKATPY 87

Query: 77  FN---DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                  Y+V+E  + DL  ++ +   + T    +  +  LL GL Y+H   +LHRD+K 
Sbjct: 88  NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA 147

Query: 133 SNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           +N+L+     LK+ DFGLAR  S +     +  T  VVT WYR PELLL   +Y   ID+
Sbjct: 148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDM 207

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS------PDDASLGFLRSDNARRYVR 241
           W  GCI+ E+ TR P+  G    HQL LI++L GS      P    L   +         
Sbjct: 208 WGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK-------KM 260

Query: 242 QLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           +LP+ +K++   R     K   A+DL++K+LV DP KRI  + AL H +
Sbjct: 261 ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  192 bits (490), Expect = 2e-59
 Identities = 101/278 (36%), Positives = 154/278 (55%), Gaps = 13/278 (4%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFN 78
           A +  T + VA+KK     D        LREI LL+ +     ++ + D+    +K+   
Sbjct: 20  ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79

Query: 79  DVYIVYELMDTDLHQIIRSDQQ-----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +Y+V+E +D+DL + + S+ +     L     + F+YQLL+G+ + H   V+HRDLKP 
Sbjct: 80  SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139

Query: 134 NLLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           NLL++     LKI D GL R  +      T  +VT WYRAPE+LL  T Y+  +DIWSVG
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQ 250
           CI  E+  ++PLFPG   + QL  I +L+G+P +    G  +  +   +    P+ + Q 
Sbjct: 200 CIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF----PQWKPQD 255

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
            +   P+ S   +DLL+KML +DP KRI+ + AL HPY
Sbjct: 256 LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  191 bits (486), Expect = 5e-59
 Identities = 99/245 (40%), Positives = 145/245 (59%), Gaps = 10/245 (4%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-C 106
           +RE+ LL++++H N++ + DII   +  T     +V+E +D+DL Q + +   L   H  
Sbjct: 51  IREVSLLKNLKHANIVTLHDIIHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMHNV 105

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 165
           + F++QLLRGL Y H   +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VV
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-D 224
           T WYR P++LL  TEY+  ID+W VGCIL E+ T  P+FPG     +L LI  L+G+P +
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225

Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 284
           +   G   ++  R Y+   P+ R Q      P   +  +DLL  +L+++   RI+ E AL
Sbjct: 226 ETWPGITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283

Query: 285 RHPYL 289
           RH Y 
Sbjct: 284 RHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  190 bits (485), Expect = 8e-59
 Identities = 92/271 (33%), Positives = 159/271 (58%), Gaps = 11/271 (4%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N ET + VAIKK   + D+ +  +  LREI++L+ ++H N++ + ++ R  +K     ++
Sbjct: 22  NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-----LH 76

Query: 82  IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +V+E  D T L+++ ++ + + +   +  ++Q L+ + + H  + +HRD+KP N+L+   
Sbjct: 77  LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ 136

Query: 141 CDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ DFG AR  +      T+YV TRWYRAPELL+  T+Y   +D+W++GC+  E++T
Sbjct: 137 GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Query: 200 REPLFPGKDYVHQLRLITELIGS--PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
            +PL+PGK  V QL LI + +G   P    + F  +   +      P  R+    ++FPN
Sbjct: 197 GQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI-FSTNQFFKGLSIPEPETRE-PLESKFPN 254

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
            SS A+  L+  L  DP +R++ EE L HPY
Sbjct: 255 ISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  186 bits (474), Expect = 6e-57
 Identities = 99/248 (39%), Positives = 144/248 (58%), Gaps = 10/248 (4%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-C 106
           +RE+ LL+ ++H N++ + DI+   K  T     +V+E +D DL Q +     +   H  
Sbjct: 52  IREVSLLKDLKHANIVTLHDIVHTDKSLT-----LVFEYLDKDLKQYMDDCGNIMSMHNV 106

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 165
           + FLYQ+LRGL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VV
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-D 224
           T WYR P++LL  +EY+  ID+W VGCI  E+ +  PLFPG     +L LI  L+G+P +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226

Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 284
           +   G   +D  + Y    P+ + Q      P   +  ++LL K L ++  KRI+ EEA+
Sbjct: 227 ETWPGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284

Query: 285 RHPYLQSL 292
           +H Y +SL
Sbjct: 285 KHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  182 bits (463), Expect = 2e-55
 Identities = 97/272 (35%), Positives = 164/272 (60%), Gaps = 13/272 (4%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + ET + VAIKK   + D+ +  +  +REI++L+ + HEN++ + ++ R  K+     +Y
Sbjct: 22  HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-----LY 76

Query: 82  IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +V+E +D T L  + +    L +   + +L+Q+LRG+++ HS +++HRD+KP N+L++ S
Sbjct: 77  LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136

Query: 141 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ DFG ART  +  +  T+YV TRWYRAPELL+  T+Y  A+DIW+VGC++ E++T
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Query: 200 REPLFPGKDYVHQLRLITELIG--SPDDASLGFLRSDNARRYVRQLPRCRK-QQFATRFP 256
            EPLFPG   + QL  I + +G   P    + F +  N      +LP  ++ +    RFP
Sbjct: 197 GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQK--NPLFAGMRLPEVKEIEPLEKRFP 253

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
             S   +DL ++ L  DP+ R +  + L H +
Sbjct: 254 KLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  175 bits (446), Expect = 5e-53
 Identities = 93/246 (37%), Positives = 142/246 (57%), Gaps = 9/246 (3%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ-IIRSDQQLTDDHC 106
           +RE  LL+ ++H N++ + DII   +  TF     V+E M TDL Q +I+    L   + 
Sbjct: 51  IREASLLKGLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNV 105

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 165
           + F++QLLRGL Y+H   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VV
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSP- 223
           T WYR P++LL  T+Y++A+DIW  GCI  E++  +P FPG  D   QL  I  ++G P 
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225

Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           +D   G  +  N +       + ++ +   +  ++   A DL  +ML+  P  RI+ ++A
Sbjct: 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285

Query: 284 LRHPYL 289
           L HPY 
Sbjct: 286 LLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  169 bits (428), Expect = 2e-50
 Identities = 99/271 (36%), Positives = 157/271 (57%), Gaps = 12/271 (4%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + ET+E VAIKK  ++ +N      TLRE+K+LR ++ EN++ +K+  R   K     +Y
Sbjct: 22  HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK-----LY 76

Query: 82  IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +V+E ++ ++ +++      +  +  + ++YQL++ + + H   ++HRD+KP NLL++ +
Sbjct: 77  LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN 136

Query: 141 CDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
             LK+ DFG AR  SE      TEYV TRWYR+PELLL    Y  A+D+WSVGCILGE+ 
Sbjct: 137 DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELS 195

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC-RKQQFATRFPN 257
             +PLFPG+  + QL  I +++G P  A    L   N R +  + P     Q    R+  
Sbjct: 196 DGQPLFPGESEIDQLFTIQKVLG-PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLG 254

Query: 258 KSSGA-VDLLEKMLVFDPNKRITVEEALRHP 287
             SG  +DL++ +L  +P  R   E+ L HP
Sbjct: 255 ILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  163 bits (415), Expect = 2e-48
 Identities = 93/253 (36%), Positives = 135/253 (53%), Gaps = 20/253 (7%)

Query: 47  TLREIKLLR---HMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQL 101
           T+RE+ LL+     +H N++ + D+    + D    V +V+E +D DL   +       L
Sbjct: 46  TVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL 105

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T
Sbjct: 106 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT 165

Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 166 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224

Query: 222 SPDDASLGFLRSDNARRYVRQLPRC----RKQQFATRF-PNKSSGAVDLLEKMLVFDPNK 276
            P +        D+  R V  LPR     R  +      P        LL +ML F+P+K
Sbjct: 225 LPPE--------DDWPRDV-TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHK 275

Query: 277 RITVEEALRHPYL 289
           RI+   AL+HP+ 
Sbjct: 276 RISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (399), Expect = 7e-47
 Identities = 63/182 (34%), Positives = 105/182 (57%), Gaps = 10/182 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A + +T ++VAIK I    D+       LREI++L+ + H N++ +  +      +  N 
Sbjct: 12  ARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENH 65

Query: 80  VYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V E  +   L  +++ ++  L++D     L Q+L GL+Y+HS  ++HRDLKP N+LL
Sbjct: 66  LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL 125

Query: 138 NASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           ++    +K+ DFGL++  TS+   +   V T  Y APE+LL    Y+   DIWS+G IL 
Sbjct: 126 DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILY 185

Query: 196 EI 197
           E+
Sbjct: 186 EL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  157 bits (399), Expect = 3e-46
 Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 36/276 (13%)

Query: 18  SAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
             A++ +T E +A+K +  + D+  +     REI++L  ++H N++      R  +K+T 
Sbjct: 17  YLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76

Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           N   I  E +    L  +++   +L +   + +  Q+L GL Y+HS  ++HRD+K +N+L
Sbjct: 77  N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL 133

Query: 137 LNASCDLKIGDFGLART--TSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +++   +K+ DFG A+     ET   T  V  T ++ APE ++   EY  A DIWS+GC 
Sbjct: 134 VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCT 192

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           + E+ T +P +               IGS  +                ++P         
Sbjct: 193 VIEMATGKPPWSELGNPMAALY---KIGSSGE--------------PPEIP--------- 226

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              + S  A D L K L  DP KR T +E L+HP+L
Sbjct: 227 --EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  155 bits (394), Expect = 2e-45
 Identities = 93/251 (37%), Positives = 135/251 (53%), Gaps = 18/251 (7%)

Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQL 101
           T+RE+ +LRH+E   H NV+ + D+    + D    + +V+E +D DL   +    +  +
Sbjct: 48  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 107

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T
Sbjct: 108 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 167

Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG
Sbjct: 168 SVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226

Query: 222 SPDDA----SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 277
            P +      +   R     +          Q       +      DLL K L F+P KR
Sbjct: 227 LPGEEDWPRDVALPRQAFHSK--------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278

Query: 278 ITVEEALRHPY 288
           I+   AL HPY
Sbjct: 279 ISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  153 bits (387), Expect = 3e-44
 Identities = 94/259 (36%), Positives = 144/259 (55%), Gaps = 29/259 (11%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHC 106
           +RE  LL+ ++H N++ + DII    K+T     +V+E + TDL Q + +    L  ++ 
Sbjct: 51  IREASLLKGLKHANIVLLHDIIH--TKETLT---LVFEYVHTDLCQYMDKHPGGLHPENV 105

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 165
           + FL+QLLRGL Y+H   +LHRDLKP NLL++ + +LK+ DFGLAR  S  +   +  VV
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPD 224
           T WYR P++LL  TEY+  +D+W VGCI  E++     FPG KD   QL  I  ++G+P+
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225

Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-----------SGAVDLLEKMLVFD 273
           + +   + S         LP  + ++F T +  K+           + A DL  K+L   
Sbjct: 226 EDTWPGVHS---------LPHFKPERF-TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275

Query: 274 PNKRITVEEALRHPYLQSL 292
           P  R++ + AL H Y   L
Sbjct: 276 PKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  152 bits (384), Expect = 2e-42
 Identities = 93/292 (31%), Positives = 157/292 (53%), Gaps = 22/292 (7%)

Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI----- 68
           F +   A+  +T E+VAIKK+      + D +   RE+ +++++ H N+I +KD      
Sbjct: 79  FGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132

Query: 69  IRPPKKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            +  +K+ F +V  V E +   +H+ +    R++  L     + + YQL R L Y+HS  
Sbjct: 133 FKKNEKNIFLNV--VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190

Query: 125 VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 183
           + HRDLKP NLL++ +   LK+ DFG A+          Y+ +R+YRAPEL+L  T YT 
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT 250

Query: 184 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 243
            ID+WS+GCI+ E++   P+F G+  V QL  I +++G+P +  L  +  + A     + 
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD---IKF 307

Query: 244 PRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           P  + +     FP  +   A++ + + L ++P KR+   EAL  P+   L D
Sbjct: 308 PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  144 bits (362), Expect = 6e-40
 Identities = 74/304 (24%), Positives = 126/304 (41%), Gaps = 39/304 (12%)

Query: 26  REEVAIKKIGNAFDNIIDA-RRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV 83
           R+ VA+K +    ++      R LREI++L  +    N++ + D  +         +Y+V
Sbjct: 22  RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSLYLV 76

Query: 84  YELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
            E +D   L  +++   +   L++    + L Q+L  L+Y+HS  ++HRD+KP N+LL+ 
Sbjct: 77  MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR 136

Query: 140 -SCDLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLL--NCTEYTAAIDIWS 189
               +K+ DFGLA+   +           +  V T  Y APE+LL  +    +++ DIWS
Sbjct: 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G  L E++T  P F G+          ++I                       P     
Sbjct: 197 LGITLYELLTGLPPFEGEKNSSATSQTLKII------------------LELPTPSLASP 238

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
              +     S  A DLL+K+L  DP  R++    L H  L  L     +           
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Query: 310 EHSS 313
               
Sbjct: 299 PLRL 302

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  138 bits (350), Expect = 5e-39
 Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 48/277 (17%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND-- 79
                +   +K+I  +  +  +    L E+K+L+ + H N+I   +        +F +  
Sbjct: 21  RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE--------SFEEKG 72

Query: 80  -VYIVYELMD-TDLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            + IV E  D  DL Q I+  ++      ++    +  QL   LKY+HS  +LHRD+KP 
Sbjct: 73  KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+ L ++  +K+GDFG+++  S T  + + VV T +Y +PEL  N   Y    DIWS+GC
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGC 191

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L E+ T +  F G+   + L L  +++                        + +     
Sbjct: 192 VLYELCTLKHPFEGE---NLLELALKIL------------------------KGQYPPIP 224

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           +++   SS   +L+  +L  DP +R ++ + L+ P++
Sbjct: 225 SQY---SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  137 bits (346), Expect = 6e-38
 Identities = 96/280 (34%), Positives = 138/280 (49%), Gaps = 48/280 (17%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR---------SDQ 99
           REI LLR ++H NVIA++ +       +   V+++++  + DL  II+            
Sbjct: 47  REIALLRELKHPNVIALQKVFL---SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPM 103

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTS 155
           QL     +  LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 156 ET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--- 208
                   +   VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F  +    
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223

Query: 209 ------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS--- 259
                 +  QL  I  ++G P D     +R       + + P  +K    T + N S   
Sbjct: 224 KTSNPFHHDQLDRIFSVMGFPADKDWEDIRK------MPEYPTLQKDFRRTTYANSSLIK 277

Query: 260 ----------SGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                     S    LL+K+L  DP KRIT E+AL+ PY 
Sbjct: 278 YMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  135 bits (341), Expect = 2e-37
 Identities = 81/280 (28%), Positives = 135/280 (48%), Gaps = 50/280 (17%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF- 77
            A +  T +EVAIKK+     N       + EI +++  +H N++   D       D++ 
Sbjct: 37  KATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIV---DYY-----DSYL 85

Query: 78  --NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
             +++++V E MD    TD+  I ++  ++ +    Y   ++L+GL+Y+HS +V+HRD+K
Sbjct: 86  VGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK 143

Query: 132 PSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
             N+LL+    +K+ DFG  A+ T E       V T ++ APE++    +Y   +DIWS+
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSL 202

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G +  E+   EP +  +  +  L LIT   G P           N  ++           
Sbjct: 203 GIMCIEMAEGEPPYLREPPLRALFLITTK-GIP--------PLKNPEKW----------- 242

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   S    D L K LV DP KR + EE L+HP+L+
Sbjct: 243 --------SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (334), Expect = 8e-37
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 46/275 (16%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFN 78
           A +  T +EVAIK I    ++     + + EI++L+  +H N++      ++       +
Sbjct: 19  ARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK------D 70

Query: 79  DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++IV E      L  +++S +Q LT+    Y   +LL+GL+Y+HS  ++HRD+K +N+L
Sbjct: 71  ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           L +  ++K+ DFGL+   S+T      V T ++ APE ++N   Y    DIWS+G    E
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAIE 189

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           +   +P  P  +                      L    A   +                
Sbjct: 190 LAEGKP--PYSE----------------------LPPMKALFKIATNG-------PPGLR 218

Query: 257 NK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           N    S    D L+K L  +P KR T E+ L+HP+
Sbjct: 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  133 bits (335), Expect = 2e-36
 Identities = 95/274 (34%), Positives = 140/274 (51%), Gaps = 36/274 (13%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--------- 99
           REI LLR ++H NVI+++ +           V+++++  + DL  II+  +         
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPV 103

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTS 155
           QL     +  LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +
Sbjct: 104 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 156 ET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--- 208
                   +   VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F  +    
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223

Query: 209 -----YVH-QLRLITELIGSPDDASLGFLR-----SDNARRYVRQ-LPRCRKQQFATRFP 256
                Y H QL  I  ++G P D     ++     S   + + R     C   ++  +  
Sbjct: 224 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 283

Query: 257 NK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            K  S A  LL+K+L  DP KRIT E+A++ PY 
Sbjct: 284 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (307), Expect = 9e-33
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 56/284 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVI----AIKDIIRPPKK 74
             +  T +  A+KKI    D   + R+ L RE+K LR  E   V+    A     +    
Sbjct: 20  VRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF---YKE--- 71

Query: 75  DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKP 132
               ++ IV E MD   L  +++   ++ +    Y   Q+L+GL Y+H+   ++HRD+KP
Sbjct: 72  ---GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKP 128

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           SNLL+N+  ++KI DFG+++    T      +V T  Y +PE  +    Y+ A DIWS+G
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIWSLG 187

Query: 192 CILGE-IMTREPLFPGK--DYVHQLRLI--TELIGSPDDASLGFLRSDNARRYVRQLPRC 246
             L E  + + P  P     +   ++ I        P +       S   R ++     C
Sbjct: 188 LTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF-----SPEFRDFIS---AC 239

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                              L+K    DP KR +  E L+HP+++
Sbjct: 240 -------------------LQK----DPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 6e-32
 Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 38/272 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            +N ET + VAIK+I          +  ++EI LL++++H N++     I      T + 
Sbjct: 19  GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDS 73

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +YI+ E  +   L QII+      +     ++YQ+L+GL Y+H   V+HRD+K +N+L  
Sbjct: 74  LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT 133

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +K+ DFG+A   ++       VV T ++ APE++   +  + A DIWS+GC + E+
Sbjct: 134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIEL 192

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T  P +   + +  L  I +    P                   LP             
Sbjct: 193 LTGNPPYYDLNPMAALFRIVQDDHPP-------------------LP-----------EG 222

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            S    D L +    DPN R T ++ L+HP++
Sbjct: 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  116 bits (294), Expect = 7e-31
 Identities = 75/252 (29%), Positives = 124/252 (49%), Gaps = 47/252 (18%)

Query: 50  EIKLLRHMEHENVIAIKD-IIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTD 103
           E+ +LR ++H N++   D II    +     +YIV E  +  DL Q+I    +  + + +
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEE 104

Query: 104 DHCQYFLYQLLRGLKYVH-----SASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSET 157
           +     L QLL  L   H       +VLHRDLKP+N+ L+A+ ++K+GDFGLA+    ++
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164

Query: 158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 217
            F   YV T +Y +PE L +   Y    DIWS+GC++ E+    P F  ++   QL+L +
Sbjct: 165 SFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLAS 220

Query: 218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 277
           ++                     R++P              SS   ++++ ML  DP+KR
Sbjct: 221 KIKEGK----------------FRRIP-----------YRYSSELNEVIKSMLNVDPDKR 253

Query: 278 ITVEEALRHPYL 289
            + EE L+ P +
Sbjct: 254 PSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  115 bits (291), Expect = 2e-30
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 23/199 (11%)

Query: 21  VNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                  EVA+K +    D         LRE +++R ++H N++ +  +    +      
Sbjct: 23  KGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP----- 75

Query: 80  VYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           + IV E M   DL   +R    ++L+      F  Q+ RG++Y+ S + +HRDL   N L
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSV 190
           +  +  +KI DFGL+R   + D    Y V       RW  APE L    ++T+  D+WS 
Sbjct: 136 VGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-APESLKEG-KFTSKSDVWSF 190

Query: 191 GCILGEIMTR-EPLFPGKD 208
           G +L EI T  E  +PG  
Sbjct: 191 GVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (288), Expect = 6e-30
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 22/197 (11%)

Query: 22  NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
             + + EVA+K +  +A +  I+    LRE +++R ++H NV+ +  +    +      +
Sbjct: 24  GGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHPNVVKLLGVCTEEEP-----L 76

Query: 81  YIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           YIV E M+  DL   +R +  +L+      F  Q+ RG++Y+ S + +HRDL   N L+ 
Sbjct: 77  YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 136

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGC 192
            +  +KI DFGL+R   + D    Y         RW  APE L    ++T+  D+WS G 
Sbjct: 137 ENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-APESLKEG-KFTSKSDVWSFGV 191

Query: 193 ILGEIMTR-EPLFPGKD 208
           +L EI T  E  +PG  
Sbjct: 192 LLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  113 bits (284), Expect = 2e-29
 Identities = 67/284 (23%), Positives = 126/284 (44%), Gaps = 58/284 (20%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL----REIKLLRHMEHENVIAIKDIIRPPKKD 75
            +N +  +  A+K++ +  D+    +  +    +EI LL  ++H N++      R     
Sbjct: 19  GLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN- 76

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
               +YI  EL+    L ++++      +   + +  Q+L GL+Y+H  + +HRD+K +N
Sbjct: 77  ----LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGAN 132

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +L++ +  +K+ DFG+A+   E  F   +  + ++ APE++     Y  A DIWS+GC +
Sbjct: 133 ILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192

Query: 195 GEIMTREPLFPGKDYVHQLRLITEL--IGS-------PDDASLGFLRSDNARRYVRQLPR 245
            E+ T +P +       QL  +  +  IG        PD        SD A+ ++ +   
Sbjct: 193 LEMATGKPPW------SQLEGVAAVFKIGRSKELPPIPDHL------SDEAKDFILKC-- 238

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                                   L  DP+ R T  E L HP++
Sbjct: 239 ------------------------LQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-29
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 39/219 (17%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T   +Y+V E     +L   +  + + +++  +++  +++  L+Y+HS  +++RDLKP N
Sbjct: 64  TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123

Query: 135 LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +LL+A   +K+ DFGLA+  +SE      +  T  Y APE+LL    Y  A+D WS+G +
Sbjct: 124 ILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVL 182

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           L E++T +P F  +D       I E I          L+                     
Sbjct: 183 LYEMLTGKPPFYAEDRK----EIYEKI----------LKDP------------------L 210

Query: 254 RFP-NKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPY 288
           RFP   S  A DL+  +L  DP KR+     EE   HP+
Sbjct: 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  112 bits (283), Expect = 3e-29
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 76/297 (25%)

Query: 19  AAVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENV-----IAIKD 67
            AVN +T E +A+K+I            I D      E+K+L  ++H N+     + +  
Sbjct: 18  TAVNLDTGELMAVKEIRIQDNDPKTIKEIAD------EMKVLELLKHPNLVKYYGVEVHR 71

Query: 68  IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHC-QYFLYQLLRGLKYVHSASV 125
                       VYI  E      L +++   + L D+H  + +  QLL GL Y+HS  +
Sbjct: 72  ----------EKVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLHSHGI 120

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPELLLN--C 178
           +HRD+KP+N+ L+ +  +K+GDFG A      TT+  + +     T  Y APE++     
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 179 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS------PDDASLGFLR 232
             +  A DIWS+GC++ E+ T +  +   D   Q   I   +G+      PD   L    
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVGAGHKPPIPDSLQL---- 233

Query: 233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                                     S    D L++ L  DP KR T  E L+HP++
Sbjct: 234 --------------------------SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (261), Expect = 6e-26
 Identities = 81/306 (26%), Positives = 124/306 (40%), Gaps = 91/306 (29%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIK----------LLRHMEHENVIAIKDIIRPPK 73
           ET +E AIK        I+D R+ ++E K          L R   H  +I          
Sbjct: 24  ETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII---------- 65

Query: 74  K--DTFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           K   TF D   +Y V E   + +L Q IR    L +   +++  ++L  L+Y+HS  ++H
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIH 125

Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---------------------YVVT 166
           RDLKP N+LL+    +KI DFG A+                               +V T
Sbjct: 126 RDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT 185

Query: 167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 226
             Y +PELL        + D+W++GCI+ +++T +P F G +     + I +        
Sbjct: 186 AEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-------- 236

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EE 282
                                +  F   FP     A DL+EK+LV DP  R+ V    +E
Sbjct: 237 --------------------LEYSFPPNFPPD---AKDLIEKLLVLDPQDRLGVNEGYDE 273

Query: 283 ALRHPY 288
              HP+
Sbjct: 274 LKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  101 bits (254), Expect = 4e-25
 Identities = 64/191 (33%), Positives = 105/191 (54%), Gaps = 25/191 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A+       VA+KK+   F+ ++DA+     L+EI LL+ ++H NVI            +
Sbjct: 21  AICLLDGRVVALKKV-QIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYLA--------S 70

Query: 77  F---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLLRGLKYVHSASVLH 127
           F   N++ IV EL D  DL ++I   +  ++L  +    +YF  QL   L+++HS  ++H
Sbjct: 71  FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLCSALEHMHSKRIMH 129

Query: 128 RDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
           RD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE +     Y    D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSD 188

Query: 187 IWSVGCILGEI 197
           IWS+GC+L E+
Sbjct: 189 IWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  100 bits (251), Expect = 9e-25
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 23/197 (11%)

Query: 23  SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 82
             T  +VA+K +     +  +    L E  +++ + H N++ +  +    +      +YI
Sbjct: 25  EGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEP-----LYI 78

Query: 83  VYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           V E M   DL   +R   ++LT         Q+ +G++Y+ S + +HRDL   N L+  +
Sbjct: 79  VTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN 138

Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCI 193
             +KI DFGL+R   E D    Y          +W  APE L +  ++T+  D+WS G +
Sbjct: 139 LVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-APESLKDG-KFTSKSDVWSFGVL 193

Query: 194 LGEIMT--REPLFPGKD 208
           L EI T   +P +PG  
Sbjct: 194 LWEIFTLGEQP-YPGMS 209

Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 98.7 bits (246), Expect = 4e-24
 Identities = 71/256 (27%), Positives = 116/256 (45%), Gaps = 54/256 (21%)

Query: 45  RRTLREIKLLRHMEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RS 97
           R  L EI +L  ++H N+IA     + D          N + I  E  +   L+  I R 
Sbjct: 44  RDALNEIVILSLLQHPNIIAYYNHFMDD----------NTLLIEMEYANGGTLYDKIVRQ 93

Query: 98  DQQLTDDH-CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 156
             QL ++    ++L+Q++  + Y+H A +LHRD+K  N+ L  +  +K+GDFG+++    
Sbjct: 94  KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153

Query: 157 TDFMTEYVV-TRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 213
              M E VV T +Y +PEL   C   +Y    DIW++GC+L E++T +  F   +    L
Sbjct: 154 EYSMAETVVGTPYYMSPEL---CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PL 207

Query: 214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 273
            L+ +++            +     Y                   SS  + L+  +L  D
Sbjct: 208 NLVVKIVQGN--------YTPVVSVY-------------------SSELISLVHSLLQQD 240

Query: 274 PNKRITVEEALRHPYL 289
           P KR T +E L  P L
Sbjct: 241 PEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.5 bits (246), Expect = 7e-24
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 43/229 (18%)

Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
            ++Y+V E +   DL  ++ +   L +D  + ++ +++  L+Y+HS  ++HRDLKP N+L
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 137 LNASCDLKIGDFGLARTT---------SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           ++++  LK+ DFGL++            +       V T  Y APE++L    ++  +D 
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDW 184

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+GCIL E +   P F G+          E+               N      + P   
Sbjct: 185 WSLGCILYEFLVGIPPFHGET-------PEEIF-------------QNILNGKIEWPED- 223

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH 293
                      S  A+DL+ K+LV DP KR+   ++EE   HP+ + + 
Sbjct: 224 --------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.9 bits (244), Expect = 8e-24
 Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 48/251 (19%)

Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDVYIVYELMD-TDLHQIIRSDQQ-- 100
            + EI++L  + H N+I+ K+         F   N + IV E     DL + I   ++  
Sbjct: 46  AVNEIRILASVNHPNIISYKE--------AFLDGNKLCIVMEYAPFGDLSKAISKRKKKR 97

Query: 101 --LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 158
             + +        QLLRGL+ +H   +LHRDLK +N+LL A+  +KIGD G+++   +  
Sbjct: 98  KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157

Query: 159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 218
             T+ + T  Y APE+      Y+   DIWS+GC+L E+ T  P F  +  +  LR    
Sbjct: 158 AKTQ-IGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRY--- 211

Query: 219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 278
                                     + ++ ++    P  S    + +  ML   P  R 
Sbjct: 212 --------------------------KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRP 245

Query: 279 TVEEALRHPYL 289
             ++ L  P +
Sbjct: 246 NCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 97.2 bits (243), Expect = 1e-23
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
                 EVA+K +     +  + +  L+E ++++ + H NV+ +  +           +Y
Sbjct: 19  KDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLY 72

Query: 82  IVYELMD-TDLHQIIRS---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           +V E M+  DL   +R             L+      F  Q+ +G++Y+ S   +HRDL 
Sbjct: 73  LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAA 184
             N L+     +KI DFGL+R   + D+   Y          RW  APE L +   +T+ 
Sbjct: 133 ARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWM-APESLKD-GIFTSK 187

Query: 185 IDIWSVGCILGEIMTR--EPLFPGKDYVHQLRLITE 218
            D+WS G +L EI T    P +PG      L  + +
Sbjct: 188 SDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 1e-23
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 51/278 (18%)

Query: 20  AVNSETREEVAIKK--IGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A++ ET + VAIK   +      II      +EI +L+  +   ++          K+  
Sbjct: 22  AIHKETGQVVAIKVVPVEEDLQEII------KEISILKQCDSPYIVKYYGSYF---KN-- 70

Query: 78  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            D++IV E       +D+ +I      LT++     LYQ L+GL+Y+HS   +HRD+K  
Sbjct: 71  TDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAG 128

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+LLN     K+ DFG++   ++T      V+ T ++ APE++     Y    DIWS+G 
Sbjct: 129 NILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGI 187

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
              E+   +P  P  D +H +R I  +   P                            +
Sbjct: 188 TAIEMAEGKP--PYSD-IHPMRAIFMIPNKP------------------------PPTLS 220

Query: 253 TRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              P K S    D ++K LV DP +R +  + L+HP++
Sbjct: 221 D--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 2e-22
 Identities = 68/272 (25%), Positives = 126/272 (46%), Gaps = 55/272 (20%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + ET++EV      NA +          EI+LL++++HE ++     +R  +      + 
Sbjct: 41  SPETKKEV------NALEC---------EIQLLKNLQHERIVQYYGCLRDDET-----LS 80

Query: 82  IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           I  E M    +   +++   LT+   + +  Q+L G++Y+HS  ++HRD+K +N+L +++
Sbjct: 81  IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA 140

Query: 141 CDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
            ++K+GDFG    L    S    M     T ++ +PE++     Y    D+WSVGC + E
Sbjct: 141 GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVE 199

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++T +P  P  ++   +  I ++   P +                QLP            
Sbjct: 200 MLTEKP--PWAEF-EAMAAIFKIATQPTNP---------------QLP-----------S 230

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           + S  A + L +  V +  KR + EE LRH +
Sbjct: 231 HVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.8 bits (231), Expect = 7e-22
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 53/274 (19%)

Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-------NDVY 81
           +A+K I    +  I  ++ LRE+ +L       ++             F        D+ 
Sbjct: 29  MAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIV------------GFYGAFYNNGDIS 75

Query: 82  IVYELMD-TDLHQIIRSDQQLTDDHCQYFL-YQLLRGLKYVHSA-SVLHRDLKPSNLLLN 138
           I  E MD   L +I++  Q    +     +   +L+GL Y+H    ++HRD+KPSN+L+N
Sbjct: 76  ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           +   +K+ DFG++     +   T +V T  Y APE  +   +Y+   DIWS+G  L E+ 
Sbjct: 136 SRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSLIELA 193

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
           T    FP                  +D   G            +L +    +   R P+ 
Sbjct: 194 TGR--FP--------------YPPENDPPDGIF----------ELLQYIVNEPPPRLPSG 227

Query: 259 --SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             S    D +   L+ DP +R + +E L HP+++
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 7e-22
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 39/219 (17%)

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +Y+V E ++  D   +I++   L +D  + ++ +++ G++ +H   ++HRD+KP NLL++
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
            +  LK+ DFGL+R   E     ++V T  Y APE +L   +     D WS+GC++ E +
Sbjct: 132 QTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFL 187

Query: 199 TREPLFPGK--DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
              P F  +  D V    +++  I  P++                               
Sbjct: 188 FGYPPFHAETPDAVFD-NILSRRINWPEEV----------------------------KE 218

Query: 257 NKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSL 292
             S  AVDL+ ++L  DP KR+     +E   HP+ +S+
Sbjct: 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 92.3 bits (229), Expect = 8e-22
 Identities = 60/180 (33%), Positives = 92/180 (51%), Gaps = 15/180 (8%)

Query: 37  AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII 95
           +   + D+R+   E  LL  M+H N++A K+       +    +YIV E  D  DL Q I
Sbjct: 38  SSSAVEDSRK---EAVLLAKMKHPNIVAFKESF-----EADGHLYIVMEYCDGGDLMQKI 89

Query: 96  RSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 152
           +  Q+     +D    +  Q+  G++++H   VLHRD+K  N+ L  +  +K+GDFG AR
Sbjct: 90  K-LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148

Query: 153 T-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 211
             TS   +   YV T +Y  PE+  N   Y    DIWS+GCIL E+ T +  F    + +
Sbjct: 149 LLTSPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 9e-22
 Identities = 70/249 (28%), Positives = 114/249 (45%), Gaps = 44/249 (17%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY 108
           REI LL+ ++HEN++                 Y+    +   L+     ++ L  +    
Sbjct: 55  REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN---- 110

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 167
           F+ Q+L+GL Y+H+  ++HRD+K +N+L++    +KI DFG+++        T+    R 
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 168 ------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
                 ++ APE++   T YT   DIWS+GC++ E++T +  FP    +  +  I E   
Sbjct: 171 SLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA- 228

Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITV 280
           SP+                               P N SS A+D LEK    D NKR T 
Sbjct: 229 SPE------------------------------IPSNISSEAIDFLEKTFEIDHNKRPTA 258

Query: 281 EEALRHPYL 289
            E L+HP+L
Sbjct: 259 AELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 1e-21
 Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 43/282 (15%)

Query: 20  AVNSETREEVAIKKI-------GNAFDNIIDARRTLR-EIKLLRHMEHENVIAIKDIIRP 71
           A+N  T E +A+K++       G       D  + LR EI+ L+ ++H N++        
Sbjct: 20  ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT 79

Query: 72  PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
                   + I  E +    +   +R+  +  +   ++F  Q+L GL Y+HS  +LHRDL
Sbjct: 80  E-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDL 134

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTE-YTAAID 186
           K  NLL++A    KI DFG+++ + +    D       + ++ APE++ + ++ Y+A +D
Sbjct: 135 KADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194

Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           IWS+GC++ E      +F G+        I  +        LG  RS         +P  
Sbjct: 195 IWSLGCVVLE------MFAGRRPWSDEEAIAAMF------KLGNKRS------APPIP-- 234

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
                     N S  A+D L      +P+ R T  E L+HP+
Sbjct: 235 -----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 59/282 (20%)

Query: 20  AVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVI-----AIKDIIRPP 72
           A++  T + VAIK I    A D I D     +EI+ L       +       +K      
Sbjct: 20  AIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYITKYYGSFLKG----- 71

Query: 73  KKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
                + ++I+ E        DL +  +    L + +  + L ++L GL+Y+H    +HR
Sbjct: 72  -----SKLWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLGLEYLHEEGKIHR 122

Query: 129 DLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           D+K +N+LL+   D+K+ DFG++ + TS       +V T ++ APE++   + Y    DI
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADI 181

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G    E+   EP  P  D  H +R++  +  +   +  G   S   + +V     C 
Sbjct: 182 WSLGITAIELAKGEP--PLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL---C- 234

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                                 L  DP +R + +E L+H ++
Sbjct: 235 ----------------------LNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 62/254 (24%), Positives = 114/254 (44%), Gaps = 47/254 (18%)

Query: 44  ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND---VYIVYELM-DTDLHQIIRSDQ 99
            R  L E ++L+ + H  ++ +          +F D   +Y+V +L+   DL   +    
Sbjct: 44  VRNVLNERRILQELNHPFLVNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKV 95

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 159
           + +++  ++++ +++  L+Y+HS  ++HRD+KP N+LL+    + I DF +A   +    
Sbjct: 96  KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155

Query: 160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 219
            T    T  Y APE +L    Y+ A+D WS+G    E +  +  + G       R I + 
Sbjct: 156 TTSTSGTPGYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS-----RTIRDQ 209

Query: 220 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-FPNK-SSGAVDLLEKMLVFDPNKR 277
           I                           KQ+ A   +P   S+ A+D + K+L  DP KR
Sbjct: 210 I-------------------------RAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244

Query: 278 I--TVEEALRHPYL 289
           +   +++   HPY 
Sbjct: 245 LGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 89.1 bits (221), Expect = 1e-20
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 44/266 (16%)

Query: 30  AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT 89
           A+K+I  +  N  +    + E ++L  ++   +I   +      K     + IV E  + 
Sbjct: 29  AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK-----LNIVMEYAEN 83

Query: 90  -DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
            DLH++++    + L +D    F  Q+L GL ++HS  +LHRD+K  NL L+A  ++KIG
Sbjct: 84  GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIG 143

Query: 147 DFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPL 203
           D G+A+  S  T+F    V T +Y +PEL   C +  Y    D+W++G +L E  T +  
Sbjct: 144 DLGVAKLLSDNTNFANTIVGTPYYLSPEL---CEDKPYNEKSDVWALGVVLYECCTGK-- 198

Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
                              P DA       +N    + ++ R      +  +   S    
Sbjct: 199 ------------------HPFDA-------NNQGALILKIIRGVFPPVSQMY---SQQLA 230

Query: 264 DLLEKMLVFDPNKRITVEEALRHPYL 289
            L+++ L  D  +R    + LR+P L
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.5 bits (219), Expect = 2e-20
 Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 42/279 (15%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I+ A   S++ E   IK+I      + +   + +E+ LL  M+H N++      +   + 
Sbjct: 16  IYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR- 73

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
               ++IV E  D  DL + I   + +  ++D    +  Q+  GLK++H   +LHRD+K 
Sbjct: 74  ----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKS 129

Query: 133 SNLLLNASCDL-KIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
            N+ L+ +  + K+GDFG+AR  +++ +     V T +Y +PE+  N   Y    DIWS+
Sbjct: 130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSL 188

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           GC+L E+ T +  F G +  HQL L                              C+   
Sbjct: 189 GCVLYELCTLKHPFEGNNL-HQLVLKI----------------------------CQG-Y 218

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           FA   PN S     L+ ++    P  R ++   L+ P+L
Sbjct: 219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.2 bits (218), Expect = 4e-20
 Identities = 72/234 (30%), Positives = 119/234 (50%), Gaps = 47/234 (20%)

Query: 26  REEVAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVIAIKDIIRPPKKDTF---ND 79
           R+ VA+KK+   F+ ++DA+     ++EI LL+ + H NVI   D        +F   N+
Sbjct: 27  RKPVALKKV-QIFE-MMDAKARQDCVKEIDLLKQLNHPNVIKYLD--------SFIEDNE 76

Query: 80  VYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLLRGLKYVHSASVLHRDLKPS 133
           + IV EL D  DL Q+I   +  ++L  +    +YF+ QL   ++++HS  V+HRD+KP+
Sbjct: 77  LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLCSAVEHMHSRRVMHRDIKPA 135

Query: 134 NLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+ + A+  +K+GD GL R  +S+T      V T +Y +PE  ++   Y    DIWS+GC
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGC 194

Query: 193 ILGEIMTRE----------------------PLFPGKDYVHQLRLITELIGSPD 224
           +L E+   +                      P  P + Y  +LR +  +   PD
Sbjct: 195 LLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)

Query: 76  TFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           TF D   +Y LM+     +L  I+R      +   ++++  ++   +Y+H+  +++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           P NLLL+++  +K+ DFG A+          +  T  Y APE++LN   Y  ++D WS+G
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLG 179

Query: 192 CILGEIMTREPLFPGKD 208
            +L E++T  P F   D
Sbjct: 180 ILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 7e-20
 Identities = 70/256 (27%), Positives = 118/256 (46%), Gaps = 48/256 (18%)

Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTF---NDVYIVYELMDTD-LHQII-RSDQQLTDD 104
           EI +L   +H N++ + +         +   N ++I+ E  D   L  I+   ++ LT+ 
Sbjct: 52  EIDILSECKHPNIVGLYE--------AYFYENKLWILIEFCDGGALDSIMLELERGLTEP 103

Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEY 163
             +Y   Q+L  L ++HS  V+HRDLK  N+LL    D+K+ DFG+ A+  S       +
Sbjct: 104 QIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163

Query: 164 VVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 218
           + T ++ APE ++ C       Y    DIWS+G  L E+   EP  P  + ++ +R++ +
Sbjct: 164 IGTPYWMAPE-VVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLK 219

Query: 219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 278
            I   +  +L     D   ++                   SS   D L+  LV DP+ R 
Sbjct: 220 -ILKSEPPTL-----DQPSKW-------------------SSSFNDFLKSCLVKDPDDRP 254

Query: 279 TVEEALRHPYLQSLHD 294
           T  E L+HP++    D
Sbjct: 255 TAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVY 81
            R  VAIK + +  D+++  +   +E++ L+ + H+++I++  +     P        VY
Sbjct: 29  NRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP--------VY 78

Query: 82  IVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           I+ ELM+   L   +RS   Q L          Q+  G+ Y+   + +HRDL   N+L+ 
Sbjct: 79  IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138

Query: 139 ASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
                K+ DFGLAR   E  +++    +  +W  APE   +   ++   D+WS G +L E
Sbjct: 139 EDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILLYE 196

Query: 197 IMTREPL-FPGKDYVHQLRLITE 218
           + T   + +PG +       IT 
Sbjct: 197 MFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 68/199 (34%), Positives = 103/199 (51%), Gaps = 25/199 (12%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
            ++  T    A+K I GN  D +   R+  REI++LR + H NV+   D+      D   
Sbjct: 93  VIHRPTGRLYALKVIYGNHEDTV--RRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145

Query: 79  DVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           ++ ++ E MD       H  I  +Q L D        Q+L G+ Y+H   ++HRD+KPSN
Sbjct: 146 EIQVLLEFMDGGSLEGTH--IADEQFLAD-----VARQILSGIAYLHRRHIVHRDIKPSN 198

Query: 135 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL---LNCTEYTA-AIDIWS 189
           LL+N++ ++KI DFG++R  ++T D     V T  Y +PE +   LN   Y   A DIWS
Sbjct: 199 LLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWS 258

Query: 190 VG-CILGEIMTREPLFPGK 207
           +G  IL   + R P   G+
Sbjct: 259 LGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.1 bits (210), Expect = 4e-19
 Identities = 72/233 (30%), Positives = 117/233 (50%), Gaps = 51/233 (21%)

Query: 29  VAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVIA-----IKDIIRPPKKDTFNDV 80
           VA+KK+   FD ++DA+     ++EI LL+ + H NVI      I+D          N++
Sbjct: 30  VALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----------NEL 77

Query: 81  YIVYELMDT-DLHQIIR---SDQQLTDDHC--QYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            IV EL D  DL ++I+     ++L  +    +YF+ QL   L+++HS  V+HRD+KP+N
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-QLCSALEHMHSRRVMHRDIKPAN 136

Query: 135 LLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           + + A+  +K+GD GL R  +S+T      V T +Y +PE  ++   Y    DIWS+GC+
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCL 195

Query: 194 LGEIMTRE----------------------PLFPGKDYVHQLRLITELIGSPD 224
           L E+   +                      P  P   Y  +LR +  +  +PD
Sbjct: 196 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.1 bits (211), Expect = 4e-19
 Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 58/280 (20%)

Query: 27  EEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---N 78
           E+VAIK+I       + D +       +E++ +    H NV+            +F   +
Sbjct: 27  EKVAIKRIDLEKCQTSVDEL------RKEVQAMSQCNHPNVVK--------YYTSFVVGD 72

Query: 79  DVYIVYELMDT-DLHQIIRS--DQQLTDDHC-QYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           ++++V   +    L  I++S   +   D+      L ++L+GL+Y+HS   +HRD+K  N
Sbjct: 73  ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTE-----YVVTRWYRAPELLLNCTEYTAAIDIWS 189
           +LL     +KI DFG++ + ++    T      +V T  + APE++     Y    DIWS
Sbjct: 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWS 192

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR-K 248
            G    E+ T     P   Y     L+  L   P                   L      
Sbjct: 193 FGITAIELATGAA--PYSKYPPMKVLMLTLQNDPP-----------------SLETGADY 233

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           ++++  F         ++   L  DP+KR T EE L+H +
Sbjct: 234 KKYSKSFR-------KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 84.6 bits (209), Expect = 5e-19
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 33/204 (16%)

Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           +D  L ++  + + L+++    +  QLL G+ Y+H   +LHRDLK  N+ L  +  LKIG
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 147 DFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG++R      D  T +  T +Y +PE L +   Y +  DIWS+GCIL E+      F 
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
           G+++   L ++  ++  P  +                LP    +Q  +           +
Sbjct: 207 GQNF---LSVVLRIVEGPTPS----------------LPETYSRQLNS-----------I 236

Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           ++ ML  DP+ R +  E LR+P++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.8 bits (210), Expect = 7e-19
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 49/281 (17%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPK 73
           I   A +  T  +VA+KK+    D     RR L   E+ ++R  +H N++ +        
Sbjct: 34  IVCIATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS------ 83

Query: 74  KDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
             ++   +++++V E ++      I +  ++ ++        +L+ L ++H+  V+HRD+
Sbjct: 84  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDI 141

Query: 131 KPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           K  ++LL +   +K+ DFG  A+ + E       V T ++ APE++     Y   +DIWS
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWS 200

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G ++ E++  EP +  +  +  ++ I               R +   +           
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRI---------------RDNLPPKL---------- 235

Query: 250 QFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 289
               +  +K S  +   L++MLV DP +R T  E L HP+L
Sbjct: 236 ----KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 52/190 (27%), Positives = 99/190 (52%), Gaps = 16/190 (8%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + E  ++  IK+I  +  +  +   + +E+ +L +M+H N++  ++        +F +  
Sbjct: 21  SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE--------SFEENG 72

Query: 82  IVYELMD----TDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            +Y +MD     DL++ I + + +   +D    +  Q+   LK+VH   +LHRD+K  N+
Sbjct: 73  NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 132

Query: 136 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
            L     +K+GDFG+AR  + T +     + T +Y +PE+  N   Y    DIW++GC+L
Sbjct: 133 FLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVL 191

Query: 195 GEIMTREPLF 204
            E+ T +  F
Sbjct: 192 YEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.5 bits (206), Expect = 1e-18
 Identities = 61/234 (26%), Positives = 124/234 (52%), Gaps = 23/234 (9%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHENVIAIKDIIRPPKK 74
           +++T  E+A+K++   FD   ++  T +E       I+LL+++ HE ++     +R P +
Sbjct: 23  DADTGRELAVKQV--QFDP--ESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78

Query: 75  DTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            T +   I  E M    +   ++S   LT++  + +  Q+L G+ Y+HS  ++HRD+K +
Sbjct: 79  RTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135

Query: 134 NLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           N+L ++  ++K+GDFG ++           M     T ++ +PE +++   Y    DIWS
Sbjct: 136 NILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWS 194

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 243
           VGC + E++T +P  P  ++   +  I ++   P +  L    SD+ R +++++
Sbjct: 195 VGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 57/299 (19%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPK 73
           I   A    T ++VA+KK+    D     RR L   E+ ++R   HENV+          
Sbjct: 37  IVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYHHENVV---------- 82

Query: 74  KDTFN------DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 127
            D +N      ++++V E ++      I +  ++ ++        +LR L Y+H+  V+H
Sbjct: 83  -DMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIH 141

Query: 128 RDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
           RD+K  ++LL +   +K+ DFG  A+ + E       V T ++ APE +++   Y   +D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVD 200

Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           IWS+G ++ E++  EP +  +  +  +R I                 DN    V+   + 
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI----------------RDNLPPRVKDSHKV 244

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 305
                       SS     L+ MLV +P++R T +E L+HP+L+    L   P C  P 
Sbjct: 245 ------------SSVLRGFLDLMLVREPSQRATAQELLQHPFLK----LAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 38/264 (14%)

Query: 47  TLREIKLLRHMEHENVIAIKD-IIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDD 104
           TL E  LL+++ H +VI +KD ++            +V     +DL+  + +  + L  D
Sbjct: 104 TLIEAMLLQNVNHPSVIRMKDTLVSGAI------TCMVLPHYSSDLYTYLTKRSRPLPID 157

Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEY 163
                  Q+L GL+Y+H+  ++HRD+K  N+ +N    + IGD G A+       F+   
Sbjct: 158 QALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-L 216

Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT------REPLFPGKDYV-----HQ 212
             T    APE+L    +Y +  DIWS G +L E++        +P    ++YV     H 
Sbjct: 217 AGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 213 LRLITELIGSPDDASLGFLRSDNAR---RYVRQLPRCRKQQFATRFPNKS------SGAV 263
           L++I+ L   P++    F R   +R    ++       +Q + TR+P          G  
Sbjct: 276 LKIISTLKVHPEE----FPRDPGSRLVRGFIE-YASLERQPY-TRYPCFQRVNLPIDGEF 329

Query: 264 DLLEKMLVFDPNKRITVEEALRHP 287
            L+ KML FD   R + EE L +P
Sbjct: 330 -LVHKMLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 45/284 (15%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF 77
            A + +T + VAIK +    D   + +    E  +LR    H N+               
Sbjct: 24  KARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIATFYGAFIKKNPPGN 80

Query: 78  ND-VYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           +D +++V EL      TDL + + +  ++L ++   Y L + LRGL Y+H   V+HRD+K
Sbjct: 81  DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE-----YTAAI 185
             N+LL  + ++K+ DFG++     T      ++ T ++ APE++  C E     Y A  
Sbjct: 141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA-CDEQPDASYDARS 199

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+WS+G    E+   +P  P  D +H +R + ++  +P       L+S          P 
Sbjct: 200 DVWSLGITAIELADGKP--PLCD-MHPMRALFKIPRNPPPT----LKS----------PE 242

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              ++F            D + + L+ +  +R  +EE L HP++
Sbjct: 243 NWSKKF-----------NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.2 bits (203), Expect = 5e-18
 Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 21/176 (11%)

Query: 37  AFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFND-VYIVYELMD-TDLHQ 93
           +  +I+       E+ +++  + H N      I+R  K    ND +YIV +L++   L +
Sbjct: 51  SIGDIVS------EVTIIKEQLRHPN------IVRYYKTFLENDRLYIVMDLIEGAPLGE 98

Query: 94  IIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASCDLKIGDF 148
              S     Q+ T++       Q++  L+Y+H    ++HRDL P+N++L     + I DF
Sbjct: 99  HFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158

Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           GLA+       +T  V T  Y  PE++ N   Y    D+W+ GCIL ++ T +P F
Sbjct: 159 GLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 81.6 bits (201), Expect = 6e-18
 Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 43/270 (15%)

Query: 26  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 85
            ++  IKK+     +  + +   +E +LL  ++H N++A ++      +D    +YIV  
Sbjct: 25  GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE--GEDGL--LYIVMG 80

Query: 86  LMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
             +  DL+  ++    + L ++    +  Q+   L+Y+H   +LHRDLK  N+ L  +  
Sbjct: 81  FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI 140

Query: 143 LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 201
           +K+GD G+AR   ++ D  +  + T +Y +PEL  N   Y    D+W++GC + E+ T +
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLK 199

Query: 202 PLFPGKDYVHQLRLITE--LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
             F  KD    +  I E  L   P D             Y  +L                
Sbjct: 200 HAFNAKDMNSLVYRIIEGKLPPMPKD-------------YSPEL---------------- 230

Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
               +L+  ML   P KR +V+  LR PY+
Sbjct: 231 ---GELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (202), Expect = 6e-18
 Identities = 60/235 (25%), Positives = 128/235 (54%), Gaps = 25/235 (10%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLRE-------IKLLRHMEHENVIAIKDIIRPPKK 74
           +++T  E+A+K++   FD   D++ T +E       I+LL+++ H+ ++     +R P++
Sbjct: 23  DADTGRELAVKQV--PFDP--DSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78

Query: 75  DTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
              +   I  E M    +   +++   LT++  + +  Q+L+G+ Y+HS  ++HRD+K +
Sbjct: 79  KKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELLLNCTEYTAAIDIW 188
           N+L +++ ++K+GDFG ++   +T  M+   +     T ++ +PE +++   Y    D+W
Sbjct: 136 NILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVW 193

Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 243
           SV C + E++T +P  P  +Y   +  I ++   P    L    SD  R +++Q+
Sbjct: 194 SVACTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.3 bits (200), Expect = 1e-17
 Identities = 56/245 (22%), Positives = 118/245 (48%), Gaps = 37/245 (15%)

Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 109
           EI+LL++++HE ++     +R   + T   +++ Y +    +   +++   LT+   + +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKY 111

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVV 165
             Q+L G+ Y+HS  ++HRD+K +N+L +++ ++K+GDFG ++           +     
Sbjct: 112 TRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T ++ +PE++ +   Y    D+WS+GC + E++T +P  P  +Y   +  I ++   P +
Sbjct: 172 TPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTN 227

Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
             L    S++AR ++  +                             +   R + EE LR
Sbjct: 228 PQLPSHISEHARDFLGCI---------------------------FVEARHRPSAEELLR 260

Query: 286 HPYLQ 290
           HP+ Q
Sbjct: 261 HPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 16/194 (8%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           AA +  T+  +AIK+I          +    EI L  +++H N      I++    D+ N
Sbjct: 26  AARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRN------IVQYLGSDSEN 77

Query: 79  DVYIVY--ELMDTDLHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHSASVLHRDLKPS 133
             + ++  ++    L  ++RS      D+ Q   ++  Q+L GLKY+H   ++HRD+K  
Sbjct: 78  GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137

Query: 134 NLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE-YTAAIDIWSV 190
           N+L+N  S  +KI DFG ++  +  +  TE +  T  Y APE++      Y A  DIWS+
Sbjct: 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197

Query: 191 GCILGEIMTREPLF 204
           GC + E+ T +P F
Sbjct: 198 GCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.1 bits (200), Expect = 1e-17
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 38/267 (14%)

Query: 25  TREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 82
           T E+VA+K  K  +  ++I D ++   EI++LR++ HEN++  K I     +D  N + +
Sbjct: 32  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGIC---TEDGGNGIKL 85

Query: 83  VYELMDT-DLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           + E + +  L + + R+  ++       +  Q+ +G+ Y+ S   +HRDL   N+L+ + 
Sbjct: 86  IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 145

Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGC 192
             +KIGDFGL +   ETD   EY   +        WY APE L+    Y A+ D+WS G 
Sbjct: 146 HQVKIGDFGLTKAI-ETD--KEYYTVKDDLDSPVFWY-APECLIQSKFYIAS-DVWSFGV 200

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
            L E++T    +   +    + L  ++IG P    +   R        ++LPR       
Sbjct: 201 TLYELLT----YCDSES-SPMTLFLKMIG-PTHGQMTVTRLVRVLEEGKRLPRP------ 248

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRIT 279
              PN       L+ K   F P+KR T
Sbjct: 249 ---PNCPEEVYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 59/244 (24%), Positives = 104/244 (42%), Gaps = 64/244 (26%)

Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLT 102
            L E ++L+ + H  ++ +          +F D   +Y +M+     +L   +R   +  
Sbjct: 48  VLNEKRILQSIRHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFP 99

Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
           +   +++  Q++  L+Y+HS  +++RDLKP NLLL++   +KI DFG A+          
Sbjct: 100 EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK---------- 149

Query: 163 YVVTR-W-------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 214
            V  R +       Y APE++L+   Y  A+D W++G ++ E++   P F    +     
Sbjct: 150 RVKGRTYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPF----FDDNPI 204

Query: 215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFD 273
            I E I        G +                      RFP+  S    DL+  +L  D
Sbjct: 205 QIYEKILE------GKV----------------------RFPSFFSPDAKDLIRNLLQVD 236

Query: 274 PNKR 277
             KR
Sbjct: 237 LTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 19/189 (10%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
              T E+VA+K + N            REI++LR ++HEN++  K +   P       + 
Sbjct: 29  GDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---RSLR 84

Query: 82  IVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++ E + +   +      +   +  +  L+  Q+ +G+ Y+ S   +HRDL   N+L+ +
Sbjct: 85  LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES 144

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVG 191
              +KI DFGLA+   E     +Y   +        WY APE L      +A+ D+WS G
Sbjct: 145 EDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIFWY-APECLRTSKFSSAS-DVWSFG 199

Query: 192 CILGEIMTR 200
             L E+ T 
Sbjct: 200 VTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.5 bits (196), Expect = 4e-17
 Identities = 52/190 (27%), Positives = 97/190 (51%), Gaps = 24/190 (12%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-----DTDLHQIIRSDQQLTD 103
           +EI+L+  + H ++I +       +   FN   +  E M        L +     + +  
Sbjct: 52  KEIRLMARLNHPHIIRMLGATC--EDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVII 106

Query: 104 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLA-----RTTSET 157
           ++ +    QLLRGL Y+H   ++HRD+K +NLL++++   L+I DFG A     + T   
Sbjct: 107 NYTE----QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162

Query: 158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 217
           +F  + + T  + APE+L    +Y  + D+WSVGC++ E+ T +P +  + + + L LI 
Sbjct: 163 EFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF 221

Query: 218 EL---IGSPD 224
           ++     +P 
Sbjct: 222 KIASATTAPS 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 64/249 (25%), Positives = 113/249 (45%), Gaps = 39/249 (15%)

Query: 45  RRTL--REIKLLRHMEHENVIAI-KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL 101
           RR L   E+ ++R  +H+NV+ + K  +         +++++ E +       I S  +L
Sbjct: 61  RRELLFNEVVIMRDYQHQNVVEMYKSYL------VGEELWVLMEFLQGGALTDIVSQTRL 114

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFM 160
            ++        +L+ L Y+HS  V+HRD+K  ++LL     +K+ DFG  A+ + +    
Sbjct: 115 NEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174

Query: 161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
              V T ++ APE++   T Y   +DIWS+G ++ E++  EP +     V  ++    L 
Sbjct: 175 KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLR 230

Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
            SP             +   +  P  R                D LE+ML  +P +R T 
Sbjct: 231 DSP---------PPKLKNAHKISPVLR----------------DFLERMLTREPQERATA 265

Query: 281 EEALRHPYL 289
           +E L HP+L
Sbjct: 266 QELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 57/189 (30%), Positives = 99/189 (52%), Gaps = 16/189 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A NS T E VA+KK+  +     +  +  ++E+K L+ ++H N I  K      K+ T  
Sbjct: 40  ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--KEHT-- 95

Query: 79  DVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             ++V E      +DL ++ +  + L +       +  L+GL Y+HS +++HRD+K  N+
Sbjct: 96  -AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 152

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCI 193
           LL     +K+ DFG A  +S  +    +V T ++ APE++L   E  Y   +D+WS+G  
Sbjct: 153 LLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 209

Query: 194 LGEIMTREP 202
             E+  R+P
Sbjct: 210 CIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 81/295 (27%), Positives = 135/295 (45%), Gaps = 59/295 (20%)

Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 62
           G Y D+       A +  T E VAIK I    G+ F+ I       +EI +L+   H N+
Sbjct: 14  GTYGDVY-----KARDIATGELVAIKVIKLEPGDDFEIIQ------QEISMLKECRHPNI 62

Query: 63  IA-IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 117
           +A     +R  K      ++IV E        D++Q+ R    L++    Y   + L+GL
Sbjct: 63  VAYFGSYLRRDK------LWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGL 114

Query: 118 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 176
            Y+H    +HRD+K +N+LL    D+K+ DFG+ A+ T+       ++ T ++ APE+  
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 177 NCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 234
              +  Y    DIW++G    E+   +P  P  D +H +R +             FL S 
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQP--PMFD-LHPMRAL-------------FLISK 218

Query: 235 NARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           +        P+ + K++++  F        D ++K L  DP KR T  + L+HP+
Sbjct: 219 SN----FPPPKLKDKEKWSPVF-------HDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)

Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 48  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 98

Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 99  LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158

Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APE L++   Y   +DIWS+G ++ E++  EP + 
Sbjct: 159 DFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217

Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 218 NEPPLKAMKMI----------------RDNLPPKLKNLHKV------------SPSLKGF 249

Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 43/275 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A++  T +EVAIK++     N+    +    + EI ++R  +H N++   D         
Sbjct: 38  AIDVATGQEVAIKQM-----NLQQQPKKELIINEILVMRENKHPNIVNYLD-----SYLV 87

Query: 77  FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
            +++++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+L
Sbjct: 88  GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 147

Query: 137 LNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAI 206

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E++  EP +  ++ +  L LI    G+P+                  L    K     R 
Sbjct: 207 EMVEGEPPYLNENPLRALYLIAT-NGTPE------------------LQNPEKLSAIFR- 246

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   D L + L  D  KR + +E L+HP+L+
Sbjct: 247 --------DFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 14/202 (6%)

Query: 21  VNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR---PPKKD 75
            +  T   VA+K I      D++ D +R   E+ LL  +         +I +      K 
Sbjct: 21  KHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS---QPPNITKYYGSYLKG 74

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
               ++I+ E  +    + +     + + +    + ++L  LKY+H   V+HRD+K +N+
Sbjct: 75  P--RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANI 132

Query: 136 LLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           L+  + ++K+ DFG+ A     +   + +V T ++ APE++     Y    DIWS+G  +
Sbjct: 133 LVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITI 192

Query: 195 GEIMTREPLFPGKDYVHQLRLI 216
            E+ T  P +   D    + LI
Sbjct: 193 YEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 56/313 (17%)

Query: 15  FIFSAAVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHMEHENVIAIKDIIRPP 72
           F F A ++++T E V IK            +R  T  E  +LR + H ++I +K      
Sbjct: 107 FAF-ACIDNKTCEHVVIKA----------GQRGGTATEAHILRAINHPSIIQLKGTF--- 152

Query: 73  KKDTFNDVY-IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
              T+N    ++     TDL+  + + + +           +LR ++Y+H   ++HRD+K
Sbjct: 153 ---TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIK 209

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY--------RAPELLLNCTEYTA 183
             N+ +N   D+ +GDFG A       F  +    ++Y         APELL     Y  
Sbjct: 210 AENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWAGTIATNAPELLAR-DPYGP 262

Query: 184 AIDIWSVGCILGEIMT-------REPLFPGKDYVHQLRLITELIGS-----PDDASLGFL 231
           A+DIWS G +L E+ T       ++ L    D   Q++LI    G+     P DA     
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ---- 318

Query: 232 RSDNARRYVRQLPR-CRKQQFATRFPNKSSGAVD---LLEKMLVFDPNKRITVEEALRHP 287
            ++    Y+    +  RK      + N     +D   L+ KML FD + R + E  L   
Sbjct: 319 -ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377

Query: 288 YLQSLHDLNDEPV 300
             Q + D    P+
Sbjct: 378 AFQDIPDPYPNPM 390

Length = 391

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)

Query: 79  DVYIVYELMDTDLH----QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPS 133
           DV+I  E+MDT L     ++      + +D        +++ L+Y+HS  SV+HRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWSV 190
           N+L+N +  +K+ DFG++    ++   T     + Y APE +   LN   Y    D+WS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 191 GCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           G  + E+ T R P    K    QL+ + E                         P+   +
Sbjct: 194 GITMIELATGRFPYDSWKTPFQQLKQVVE--EPS--------------------PQLPAE 231

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           +F+  F        D + K L  +  +R    E L+HP+ +
Sbjct: 232 KFSPEF-------QDFVNKCLKKNYKERPNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 81/304 (26%), Positives = 137/304 (45%), Gaps = 54/304 (17%)

Query: 30  AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE-LMD 88
           A+K +  A   + D  RT  E  +L  + H  ++ +    +   K     +Y++ + L  
Sbjct: 28  AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK-----LYLILDFLRG 82

Query: 89  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
            DL   +  +   T++  +++L +L   L ++HS  +++RDLKP N+LL+    +K+ DF
Sbjct: 83  GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDF 142

Query: 149 GLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 207
           GL++ + + +     +  T  Y APE ++N   +T + D WS G ++ E++T    F GK
Sbjct: 143 GLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201

Query: 208 DYVHQLRLITELIGSPDDASLG---FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 264
           D    + +I +       A LG   FL S  A+  +R L +        R P    GA  
Sbjct: 202 DRKETMTMILK-------AKLGMPQFL-SPEAQSLLRALFK--------RNPANRLGAGP 245

Query: 265 LLEKMLVFDPNKRITVEEALRHPYLQSLHDLND----------EPVCPRP---FHFDFEH 311
                          VEE  RHP+  ++ D N           +P   RP   F+FD E 
Sbjct: 246 D-------------GVEEIKRHPFFSTI-DWNKLYRREIKPPFKPAVGRPDDTFYFDPEF 291

Query: 312 SSCT 315
           +S T
Sbjct: 292 TSRT 295

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 47/268 (17%)

Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC 106
           TL E ++L++  H  + ++K   +   +  F   Y+       +L   +  ++  ++D  
Sbjct: 42  TLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV----NGGELFFHLSRERVFSEDRT 97

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVV 165
           +++  +++  L Y+HS  +++RDLK  NL+L+    +KI DFGL +   ++   M  +  
Sbjct: 98  RFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+     LI         
Sbjct: 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------- 207

Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----T 279
                L  D                   +FP   S+ A  LL  +L+ DPNKR+      
Sbjct: 208 -----LMED------------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDD 244

Query: 280 VEEALRHPYLQSLH--DLNDEPVCPRPF 305
            +E +RH +   ++  D+ D+ + P PF
Sbjct: 245 AKEIMRHSFFTGVNWQDVYDKKLVP-PF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 40/242 (16%)

Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHC 106
           E ++L+ + H N+I   +     K      + IV E      L + I  R +  L +D  
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQKRCNSLLDEDTI 103

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVV 165
            +F  Q+L  L +VH+  +LHRDLK  N+LL+     +KIGDFG+++  S        V 
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG 163

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y +PE L     Y    DIW++GC+L E+ + +  F   +    L  +   I S   
Sbjct: 164 TPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LPALVLKIMSGTF 218

Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
           A +    S + R+                          L+  ML  DP+KR  + + + 
Sbjct: 219 APISDRYSPDLRQ--------------------------LILSMLNLDPSKRPQLSQIMA 252

Query: 286 HP 287
            P
Sbjct: 253 QP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.7 bits (183), Expect = 2e-15
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 17/180 (9%)

Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
           L + +    L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 161 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 219
              +V T ++ APE++   + Y    DIWS+G    E+   EP  P  D +H +R++  L
Sbjct: 158 RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-L 212

Query: 220 IGSPDDASLGFLRSDNARRYVRQL----PRCR-------KQQFATRFPNKSSGAVDLLEK 268
           I      +L    S   + +V       PR R       K +F TR+  K+S   +L+++
Sbjct: 213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 272

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 66/281 (23%), Positives = 123/281 (43%), Gaps = 51/281 (18%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------T 76
           +T E VA+K++          +  L ++  +RH+  E     +DI+   K +        
Sbjct: 24  DTGEIVALKRM---------KKSLLFKLNEVRHVLTE-----RDILTTTKSEWLVKLLYA 69

Query: 77  FNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           F D   +Y  M+     D   ++ +   L++DH ++++ ++   +  +H    +HRDLKP
Sbjct: 70  FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKP 129

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
            N L++AS  +K+ DFGL++      +    V +  Y APE +L    Y   +D WS+GC
Sbjct: 130 ENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGC 186

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L E +   P F G               +P++        +N + +   L R       
Sbjct: 187 MLYEFLCGFPPFSGS--------------TPNET------WENLKYWKETLQRPVYDD-- 224

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 293
               N S  A DL+ K++     +  ++E+   HP+ + + 
Sbjct: 225 -PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 64/277 (23%), Positives = 122/277 (44%), Gaps = 46/277 (16%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLR----EIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
             + +A+K++     N++ A +       E+ LL+ ++H N++     +     D  N +
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY---LGTCLDD--NTI 77

Query: 81  YIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
            I  E +    +  I+     L +     +  Q+L G+ Y+H+  V+HRD+K +N++L  
Sbjct: 78  SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP 137

Query: 140 SCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           +  +K+ DFG AR         + ++ +     T ++ APE ++N + Y    DIWS+GC
Sbjct: 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGC 196

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
            + E+ T +P     D +  +  I                    R  + +LP        
Sbjct: 197 TVFEMATGKPPLASMDRLAAMFYI-----------------GAHRGLMPRLPD------- 232

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             F   S+ A+D +   L  D ++R +  + LRH +L
Sbjct: 233 -SF---SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 26/197 (13%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T +D+Y+V + M   +L   ++ + + ++D  ++++ +L+  L+++H   +++RDLKP N
Sbjct: 67  TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126

Query: 135 LLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +LL+A+  + + DFGL++   ++      +  T  Y APE+LL+   YT  +D WS+G +
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR------SDNARRYVRQLPRCR 247
           + E+      F  +D     R I          + G +R      SD  R++V+ L    
Sbjct: 187 VFEMCCGWSPFYAEDTQQMYRNI----------AFGKVRFPKNVLSDEGRQFVKGL---- 232

Query: 248 KQQFATRFPNKSSGAVD 264
                 R P    GA  
Sbjct: 233 ----LNRNPQHRLGAHR 245

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 37/192 (19%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
           ++  Q++ GL+++H   +++RDLKP N+LL+   +++I D GLA        +     T 
Sbjct: 99  FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDA 226
            Y APE+L     Y  ++D +++GC L E I  R P    K+ V +              
Sbjct: 159 GYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------- 203

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TV 280
                          +L R R  + A  +P+K S  A DL E +L  DP KR+     + 
Sbjct: 204 --------------EELKR-RTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSA 248

Query: 281 EEALRHPYLQSL 292
           +E   HP  + L
Sbjct: 249 DEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 44/252 (17%)

Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E  +L  +    ++ +K   + P+K     +Y+V   ++  +L   ++ + +     
Sbjct: 40  TLAERTVLAQVNCPFIVPLKFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSR 94

Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +LL  L+ +H  +V++RDLKP N+LL+    + + DFGL +    + D    + 
Sbjct: 95  ARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154

Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y APELLL    YT A+D W++G +L E++T  P F  ++     R I        
Sbjct: 155 GTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL------- 206

Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITV--- 280
                                    Q   RFP      A DLL  +L  DP +R+     
Sbjct: 207 -------------------------QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241

Query: 281 EEALRHPYLQSL 292
           +E   HP+   L
Sbjct: 242 QEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 39/209 (18%)

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 166
            ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E + +   V T
Sbjct: 105 VFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164

Query: 167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 226
             Y APE++ N   YT + D W +GC++ E++  +  F  +                   
Sbjct: 165 VGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQR------------------- 204

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVE 281
                +    R  V +  +  +++++ +F   S  A  +  ++L  DP  R+       E
Sbjct: 205 -----KEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAE 256

Query: 282 EALRHPYLQSLH------DLNDEPVCPRP 304
           E   HP+ ++ +       + + P CP P
Sbjct: 257 EVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 27/230 (11%)

Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 72  GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI 131

Query: 136 LLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           L+N+  ++K+ DFG++      D M   +V TR Y +PE L   T YT   DIWS+G  L
Sbjct: 132 LVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSL 188

Query: 195 GEIMT-REPLFP--GKDYVHQLRLITELIGSPDDASLGFLRSDNARR---------YV-- 240
            E+   R P+ P   K+             + +          ++ R         Y+  
Sbjct: 189 VEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN 248

Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
              P+     F+  F        D ++K L  +P +R  ++E  +HP+++
Sbjct: 249 EPPPKLPSGAFSDEF-------QDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 43/220 (19%)

Query: 95  IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART- 153
           +  ++  ++D  +++  +++  L Y+HS  V++RDLK  NL+L+    +KI DFGL +  
Sbjct: 86  LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145

Query: 154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 213
            S+   M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+    
Sbjct: 146 ISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 200

Query: 214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVF 272
             + ELI   +                             RFP   S  A  LL  +L  
Sbjct: 201 EKLFELILMEE----------------------------IRFPRTLSPEAKSLLAGLLKK 232

Query: 273 DPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 305
           DP +R+       +E + H +  S+   D+  + + P PF
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP-PF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 37/206 (17%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDII---RPPKKDTFND 79
             +E VA+K +     N  DAR+   RE +LL + +HEN++    +     PP       
Sbjct: 33  NDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGDPP------- 83

Query: 80  VYIVYELMDT-DLHQIIRSD--------------QQLTDDHCQYFLYQLLRGLKYVHSAS 124
             +V+E M+  DL++ +RS                +LT         Q+  G+ Y+ S  
Sbjct: 84  -IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142

Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTE 180
            +HRDL   N L+     +KIGDFG++R    TD+        +  RW   PE ++    
Sbjct: 143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-PPESIMYRK- 200

Query: 181 YTAAIDIWSVGCILGEIMT--REPLF 204
           +T   D+WS G +L EI T  ++P +
Sbjct: 201 FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 32/204 (15%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++ A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +  ++      
Sbjct: 22  VWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------ 70

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           T   +YI+ E M    L   ++SD+       +L D     F  Q+  G+ ++   + +H
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQRNYIH 125

Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAA 184
           RDL+ +N+L++AS   KI DFGLAR   + ++          +W  APE  +N   +T  
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIK 183

Query: 185 IDIWSVGCILGEIMT--REPLFPG 206
            D+WS G +L EI+T  R P +PG
Sbjct: 184 SDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 17/192 (8%)

Query: 20  AVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A +  T E VAIKK+  +   +    +  ++E++ L+ + H N I  K      ++ T  
Sbjct: 34  ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--REHT-- 89

Query: 79  DVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             ++V E      +D+ ++ +  + L +       +  L+GL Y+HS   +HRD+K  N+
Sbjct: 90  -AWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI 146

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCI 193
           LL     +K+ DFG A   S  +    +V T ++ APE++L   E  Y   +D+WS+G  
Sbjct: 147 LLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203

Query: 194 LGEIMTRE-PLF 204
             E+  R+ PLF
Sbjct: 204 CIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 32/181 (17%)

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRW 168
           L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 169 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 228
           + APE++   + Y +  DIWS+G    E+   EP  P  D +H +R++  +  +      
Sbjct: 167 WMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLT 222

Query: 229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
           G                    +F+  F        + ++  L  DP+ R T +E L+H +
Sbjct: 223 G--------------------EFSKPFK-------EFIDACLNKDPSFRPTAKELLKHKF 255

Query: 289 L 289
           +
Sbjct: 256 I 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.7 bits (175), Expect = 4e-14
 Identities = 64/273 (23%), Positives = 123/273 (45%), Gaps = 39/273 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAIK++             + EI ++R  ++ N++   D          ++
Sbjct: 38  AIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDE 90

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L ++HS  V+HRD+K  N+LL  
Sbjct: 91  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150

Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 151 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMV 209

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P +
Sbjct: 210 EGEPPYLNENPLRALYLIAT-NGTPE----------------------------LQNPER 240

Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D ++R + +E L+HP+L+
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.3 bits (174), Expect = 4e-14
 Identities = 64/273 (23%), Positives = 122/273 (44%), Gaps = 39/273 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 39  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDE 91

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL  
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151

Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 152 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 210

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P K
Sbjct: 211 EGEPPYLNENPLRALYLIAT-NGTPE----------------------------LQNPEK 241

Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D  KR + +E L+H +L+
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 26/165 (15%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 107
           L E  ++    H N+I ++ ++       F    I+ E M+         D+ L D   +
Sbjct: 54  LSEASIMGQFSHHNIIRLEGVV-----TKFKPAMIITEYMENG-----ALDKYLRDHDGE 103

Query: 108 YFLYQL---LRG----LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
           +  YQL   LRG    +KY+   + +HRDL   N+L+N++ + K+ DFGL+R   E D  
Sbjct: 104 FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPE 162

Query: 161 TEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             Y  +      RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 163 GTYTTSGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 6/105 (5%)

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 158
           + LT      F YQ+ RG++++ S   +HRDL   N+L+     +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 159 FMTEYVVTR----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           +  +    R    W  APE L +   YT   D+WS G +L EI T
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 17/188 (9%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           +   +   A+K + N   ++ +  + L+E  +++   H NV+++  I  P +      V 
Sbjct: 19  SDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL--VV 75

Query: 82  IVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           + Y +   DL   IRS+    T      F  Q+ +G++Y+ S   +HRDL   N +L+ S
Sbjct: 76  LPY-MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES 134

Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL--------LLNCTEYTAAIDIWSVGC 192
             +K+ DFGLAR   +     EY     +   +L         L   ++T   D+WS G 
Sbjct: 135 FTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 190

Query: 193 ILGEIMTR 200
           +L E+MTR
Sbjct: 191 LLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 57/242 (23%), Positives = 104/242 (42%), Gaps = 39/242 (16%)

Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KD    V  +    D   H     +    ++   ++  ++L GL+ +H  + ++RDLKP 
Sbjct: 72  KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPE 131

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           N+LL+    ++I D GLA    E + +   V T  Y APE+L N   YT + D W +GC+
Sbjct: 132 NILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCL 190

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           + E++  +  F G+                        +    R  V +     ++ ++ 
Sbjct: 191 IYEMIEGQSPFRGR------------------------KEKVKREEVDRRVLETEEVYSA 226

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVE-----EALRHPYLQSLH------DLNDEPVCP 302
           +F   S  A  + + +L  DP +R+  +     E  RHP+ ++++       + D P  P
Sbjct: 227 KF---SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVP 283

Query: 303 RP 304
            P
Sbjct: 284 DP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 71.3 bits (174), Expect = 5e-14
 Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 18/190 (9%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIAIKDI-IRPPKKDTF 77
           A +  T E VAIKK+  +     +  +  ++E+K L+ ++H N I  K   +R       
Sbjct: 44  ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE------ 97

Query: 78  NDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           +  ++V E      +DL ++ +  + L +       +  L+GL Y+HS +++HRD+K  N
Sbjct: 98  HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 155

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGC 192
           +LL     +K+ DFG A   S  +    +V T ++ APE++L   E  Y   +D+WS+G 
Sbjct: 156 ILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212

Query: 193 ILGEIMTREP 202
              E+  R+P
Sbjct: 213 TCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 50/294 (17%)

Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           GE  D  F     A N ET    A K I    +   +    + EI +L   +H N++ + 
Sbjct: 11  GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLL 68

Query: 67  DIIRPPKKDTFNDVYIVYEL-----MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           D          N+++I+ E      +D  + ++ R    LT+   +    Q L  L Y+H
Sbjct: 69  DAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLH 120

Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE 180
              ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T 
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 181 ----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 236
               Y    D+WS+G  L E+   EP        H+L                     N 
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPH------HEL---------------------NP 213

Query: 237 RRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            R + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 214 MRVLLKIAKSEPPTLAQ--PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N
Sbjct: 67  TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +LL+    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G +
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVL 185

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           L E++  +  F G D         EL  S        +R DN   Y R L R        
Sbjct: 186 LYEMLIGQSPFHGHDE-------EELFQS--------IRMDNP-CYPRWLTR-------- 221

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSL 292
                   A D+L K+ V +P +R+ V+  +R HP+ + +
Sbjct: 222 -------EAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 6e-14
 Identities = 63/266 (23%), Positives = 120/266 (45%), Gaps = 39/266 (14%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           +EVAIK+I             + EI +++ +++ N++   D          +++++V E 
Sbjct: 45  QEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEY 97

Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           +       + ++  + +        + L+ L+++H+  V+HRD+K  N+LL     +K+ 
Sbjct: 98  LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT 157

Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++  EP + 
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-D 264
            ++ +  L LI    G+P+                             + P K S    D
Sbjct: 217 NENPLRALYLIAT-NGTPE----------------------------LQNPEKLSPIFRD 247

Query: 265 LLEKMLVFDPNKRITVEEALRHPYLQ 290
            L + L  D  KR + +E L+HP+L+
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 17/181 (9%)

Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDD---- 104
           EI  L  + HEN++ I++I+R        + Y++ +  D DL+  +        D     
Sbjct: 213 EILALGRLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY- 163
             +  + QLL  ++Y+H   ++HRD+K  N+ LN    + +GDFG A    +     +Y 
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327

Query: 164 -VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE--PLFPGKDYVHQ--LRLITE 218
            V T    +PE+L     Y    DIWS G IL ++++ +  P+  G     +  L++I  
Sbjct: 328 WVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386

Query: 219 L 219
           L
Sbjct: 387 L 387

Length = 501

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 48/214 (22%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   I+   +  +   +++  +++ GL+++H   +++RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 150 LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           + +     + +   V T        Y APE+L     Y  A+D W++G +L E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G D               +D     +  D   RY R L               S  A 
Sbjct: 196 FEGDD---------------EDELFQSILEDEV-RYPRWL---------------SKEAK 224

Query: 264 DLLEKMLVFDPNKRITV-----EEALRHPYLQSL 292
            +L+  L  +P KR+       ++   HP+ + +
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 35/185 (18%)

Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 173
           L+GL Y+HS  ++HRD+KPSN+LL     +K+ DFG++     +   T +  T +Y APE
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE 173

Query: 174 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFP--GKDYVHQLRLITELIGSP-----DDA 226
            +     Y+   D+WS+G  L E+      FP  G+  +  + L++ ++  P     D+ 
Sbjct: 174 RIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
             G   S+  +                          D +++ L  DP +R T  + L H
Sbjct: 233 GNGIKWSEEFK--------------------------DFIKQCLEKDPTRRPTPWDMLEH 266

Query: 287 PYLQS 291
           P++++
Sbjct: 267 PWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 29/167 (17%)

Query: 48  LREIKLLRHM-EHENVIAIKD--IIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQ--L 101
           + E+K++ H+  HEN++ +     I  P       + ++ E     DL   +R  ++  L
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRESFL 138

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
           T +    F YQ+ +G+ ++ S + +HRDL   N+LL     +KI DFGLAR     D M 
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMN 193

Query: 162 E--YVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           +  YVV        +W  APE + NC  YT   D+WS G +L EI +
Sbjct: 194 DSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 61/247 (24%), Positives = 109/247 (44%), Gaps = 38/247 (15%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   I+S  +  +   +++  +++ GL+++H   +++RDLK  N+LL+    +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 150 LARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           + +     +     +  T  Y APE+L    +Y  ++D WS G +L E++  +  F G+D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 268
                          +D     + +D    + R +               S  A D L K
Sbjct: 201 ---------------EDELFDSILNDRP-HFPRWI---------------SKEAKDCLSK 229

Query: 269 MLVFDPNKRITVEEALR-HPYLQSLH--DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWR 325
           +   DP KR+ V+  +R HP+ + +    L    + P PF    +  S   +  RE    
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP-PFKPKVKSPSDASNFDREFT-N 287

Query: 326 ESVKFNP 332
           E V+ +P
Sbjct: 288 EKVRLSP 294

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 52/226 (23%)

Query: 76  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + V  V E     DL   I +D   ++    ++   ++ GL+Y+H   +++RDLK  N
Sbjct: 73  TEDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131

Query: 135 LLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           LLL+    +KI DFGL +        TS       +  T  + APE+L   T YT A+D 
Sbjct: 132 LLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPEVLTE-TSYTRAVDW 184

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           W +G ++ E++  E  FPG D               ++     + +D   RY R L R  
Sbjct: 185 WGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIVNDEV-RYPRFLSR-- 226

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 288
                         A+ ++ ++L  +P +R+       E+  + P+
Sbjct: 227 -------------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 31/197 (15%)

Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K + +A DN   AR+   RE +LL +++HE+++    +         + + +V+E M
Sbjct: 38  VAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYM 89

Query: 88  D-TDLHQIIRSD-------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
              DL++ +R+               +LT     +   Q+  G+ Y+ S   +HRDL   
Sbjct: 90  KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149

Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           N L+  +  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D+WS
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWS 207

Query: 190 VGCILGEIMT--REPLF 204
           +G +L EI T  ++P +
Sbjct: 208 LGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSE 156
           D+ LT+   Q    Q+L  L+Y+HS  ++HRDLK  N+LL    D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 157 TDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 211
                 ++ T ++ APE+++ C     T Y    DIWS+G  L E+   EP        H
Sbjct: 164 LQRRDSFIGTPYWMAPEVVM-CETMKDTPYDYKADIWSLGITLIEMAQIEPPH------H 216

Query: 212 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKML 270
           +L                     N  R + ++ +      +   P+K S    D L+  L
Sbjct: 217 EL---------------------NPMRVLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTAL 253

Query: 271 VFDPNKRITVEEALRHPYLQSL 292
              P  R +  + L HP++ S+
Sbjct: 254 DKHPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 34/232 (14%)

Query: 7   GEYDDIIFFIFSAAVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIA 64
           G +  +  + +  A N  T E VA+K  K      N        +EI +L+ + HEN++ 
Sbjct: 15  GHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQN---TSGWKKEINILKTLYHENIVK 70

Query: 65  IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            K             + ++ E +     +      +L       F  Q+  G+ Y+HS  
Sbjct: 71  YKGCCSEQGGKG---LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLL 176
            +HRDL   N+LL+    +KIGDFGLA+   E     EY   R        WY A E L 
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-AVECLK 183

Query: 177 NCTEYTAAIDIWSVGCILGEIMTR------------EPLFPGKDYVHQLRLI 216
                 A+ D+WS G  L E++T             E + P +  +  +RLI
Sbjct: 184 ENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 28/191 (14%)

Query: 22  NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDT 76
             +   +VAIK  K G++    +D    L E  ++   +H N+I ++ ++   RP     
Sbjct: 28  PGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPNIIRLEGVVTKSRP----- 79

Query: 77  FNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              V I+ E M+   L + +R +D + T       L  +  G+KY+   + +HRDL   N
Sbjct: 80  ---VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN 136

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIW 188
           +L+N++   K+ DFGL+R   +++    Y         RW  APE  +   ++T+A D+W
Sbjct: 137 ILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIRW-TAPE-AIAYRKFTSASDVW 192

Query: 189 SVGCILGEIMT 199
           S G ++ E+M+
Sbjct: 193 SFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 58/263 (22%), Positives = 114/263 (43%), Gaps = 57/263 (21%)

Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-------NDVYIVYELMDTD-LHQIIR 96
           ++ LRE++++       ++            +F       N++ +  E MD   L +I +
Sbjct: 48  KQILRELQIMHECRSPYIV------------SFYGAFLNENNICMCMEFMDCGSLDRIYK 95

Query: 97  SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFG----LA 151
               +  +        ++ GL Y+++   ++HRD+KPSN+L+N+   +K+ DFG    L 
Sbjct: 96  KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155

Query: 152 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 211
            + ++T     +V T  Y +PE  +   +YT   D+WS+G  + E+   +  FP      
Sbjct: 156 NSIADT-----FVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK--FPFAF--- 204

Query: 212 QLRLITELIGSPDDASLGFLRSDNARRYVRQ----LPRCRKQQFATRFPNKSSGAVDLLE 267
                + +     D  +G L  D  ++ V++    LP       ++ FP       D ++
Sbjct: 205 -----SNIDDDGQDDPMGIL--DLLQQIVQEPPPRLP-------SSDFPED---LRDFVD 247

Query: 268 KMLVFDPNKRITVEEALRHPYLQ 290
             L+ DP +R T ++    P   
Sbjct: 248 ACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 68/263 (25%), Positives = 104/263 (39%), Gaps = 50/263 (19%)

Query: 24  ETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
            T  EVAIK +    D   +     R  RE  L   + H N++A+ D    P       +
Sbjct: 1   MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP--PGL--L 54

Query: 81  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           + V+E +    L +++ +D  L        + Q+L  L   H+  ++HRDLKP N++++ 
Sbjct: 55  FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 140 SCD---LKIGDFGL------------ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           +      K+ DFG+            A  T      TE + T  Y APE L      T  
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRG-EPVTPN 169

Query: 185 IDIWSVGCILGEIMTREPLFPGKD----YVHQLRLITELIGSPDDASL-----GFLRSDN 235
            D+++ G I  E +T + +  G         QL        SP D SL     G      
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQGASVAEILYQQL--------SPVDVSLPPWIAGHPLGQV 221

Query: 236 ARRYVRQLPRCRK---QQFATRF 255
            R+ + + PR R       A RF
Sbjct: 222 LRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 19/192 (9%)

Query: 17  FSAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           F A +  E T ++VA+K I       + A+  L E  ++  + H+N++ +  +I      
Sbjct: 19  FGAVLQGEYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVI------ 68

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL--LRGLKYVHSASVLHRDLKP 132
             N +YIV ELM   +L   +R+  +      Q   + L    G++Y+ S  ++HRDL  
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
            N+L++     K+ DFGLAR  S     ++  V +W  APE L +  ++++  D+WS G 
Sbjct: 129 RNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKH-KKFSSKSDVWSYGV 185

Query: 193 ILGEIMT--REP 202
           +L E+ +  R P
Sbjct: 186 LLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 52/189 (27%), Positives = 97/189 (51%), Gaps = 16/189 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDA-RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A +    E VAIKK+  +     +  +  ++E++ L+ + H N I  +      ++ T  
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHT-- 89

Query: 79  DVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             ++V E      +DL ++ +  + L +       +  L+GL Y+HS +++HRD+K  N+
Sbjct: 90  -AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCI 193
           LL+    +K+GDFG A   +  +    +V T ++ APE++L   E  Y   +D+WS+G  
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203

Query: 194 LGEIMTREP 202
             E+  R+P
Sbjct: 204 CIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 43/221 (19%)

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVV 165
             YQ++  L  VHS  ++HRDLK +N+ L  +  +K+GDFG ++  S++   D  + +  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T +Y APEL      Y+   D+WS+G IL E++T    F G      ++ +  L G  D 
Sbjct: 234 TPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYDP 290

Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                                            SSG   LL+ +L  +P  R T ++ L 
Sbjct: 291 FPCPV----------------------------SSGMKALLDPLLSKNPALRPTTQQLLH 322

Query: 286 HPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 326
             +L+ + +L  + V          HS     H RE I R+
Sbjct: 323 TEFLKYVANLFQDIV---------RHSETISPHDREEILRQ 354

Length = 478

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 69.8 bits (170), Expect = 4e-13
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 35/205 (17%)

Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL---TDDH 105
           E+ ++R ++H+N++   D  R   K     +YI+ E  D  DL + I+   ++    ++H
Sbjct: 62  EVNVMRELKHKNIVRYID--RFLNKAN-QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 106 CQY-FLYQLLRGLKYVHS-------ASVLHRDLKPSNLLL-----------------NAS 140
                  QLL  L Y H+         VLHRDLKP N+ L                 N  
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMT 199
              KIGDFGL++           V T +Y +PELLL+ T+ Y    D+W++GCI+ E+ +
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 200 REPLFPGKDYVHQLRLITELIGSPD 224
            +  F   +   Q  LI+EL   PD
Sbjct: 239 GKTPFHKANNFSQ--LISELKRGPD 261

Length = 1021

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 40/217 (18%)

Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           N VY + E ++  +L   +R   +  +D  +++  +L+   +Y+HS  +++RDLKP NLL
Sbjct: 91  NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           L+    +K+ DFG A+   +  F      T  Y APE ++    +  A+D W++G +L E
Sbjct: 151 LDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYE 207

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
            +   P F                   DD           R Y + L    + +F   F 
Sbjct: 208 FIAGYPPF------------------FDDTPF--------RIYEKILA--GRLKFPNWFD 239

Query: 257 NKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 288
            +   A DL++ +L  D  KR+      V +   HPY
Sbjct: 240 GR---ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 16/163 (9%)

Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSKP-----VMIVTEYMENGSLDAFLRKHDGQFT 104

Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R   E D    
Sbjct: 105 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAA 163

Query: 163 YVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           Y         RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 164 YTTRGGKIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.8 bits (165), Expect = 5e-13
 Identities = 65/257 (25%), Positives = 120/257 (46%), Gaps = 51/257 (19%)

Query: 49  REIKLLRHMEHENVIA------IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSD 98
           +EI +L+   H   IA      IK    PP  D  + +++V E       TDL +  + +
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGN 106

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET- 157
             L ++   Y   ++LRGL ++H   V+HRD+K  N+LL  + ++K+ DFG++     T 
Sbjct: 107 T-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165

Query: 158 DFMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 212
                ++ T ++ APE++  C E     Y    D+WS+G    E+    P  P  D +H 
Sbjct: 166 GRRNTFIGTPYWMAPEVIA-CDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHP 221

Query: 213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF 272
           +R +  +  +P                    PR + ++++ +F +        +E  LV 
Sbjct: 222 MRALFLIPRNP-------------------APRLKSKKWSKKFQS-------FIESCLVK 255

Query: 273 DPNKRITVEEALRHPYL 289
           + ++R T E+ ++HP++
Sbjct: 256 NHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 4/106 (3%)

Query: 97  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 156
            D+Q+T        YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  + 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Query: 157 TDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 66/251 (26%), Positives = 98/251 (39%), Gaps = 21/251 (8%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY 108
           REI +L+ + H  +I +    R   K T   V   Y+    DL   +     L  +    
Sbjct: 135 REIDILKTISHRAIINLIHAYR--WKSTVCMVMPKYK---CDLFTYVDRSGPLPLEQAIT 189

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVV 165
              +LL  L Y+H   ++HRD+K  N+ L+   +  +GDFG A          +   +  
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF--PGKDYVHQLRLITELIGS 222
           T    +PELL     Y A  DIWS G +L E+      LF    K    QLR I   I  
Sbjct: 250 TLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI---IRC 305

Query: 223 PDDASLGFLRSDNAR---RYVRQLPRCRKQQFATRFPNKSSGAVD---LLEKMLVFDPNK 276
                L F ++ +      + +     R          K    +D   L+ KML FD   
Sbjct: 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365

Query: 277 RITVEEALRHP 287
           R + ++ L  P
Sbjct: 366 RPSAQDILSLP 376

Length = 392

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 43/130 (33%), Positives = 75/130 (57%), Gaps = 5/130 (3%)

Query: 79  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 136
           ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 197 I-MTREPLFP 205
           + + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 33/107 (30%), Positives = 64/107 (59%), Gaps = 2/107 (1%)

Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
           +D   ++L ++   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 163 -YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
            +  T  Y APE+L+    +  A+D WS+G ++ +++T  P F  ++
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 9e-13
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 32/192 (16%)

Query: 113 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 172
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+ DFG++     +     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAP 162

Query: 173 ELLLNCTEYTAAIDIWSVGCILGEI-MTREP---LFPGKDYVHQLRLITELIGSPDDASL 228
           E +    +Y    D+WS+G    E+ + R P   +   +  +  L+L+  ++   D+   
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---DEDP- 217

Query: 229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
                          P     QF+ +F       V  + + +   P +R   E  + HP+
Sbjct: 218 ---------------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255

Query: 289 LQSLHDLNDEPV 300
           +   +D N E V
Sbjct: 256 IVQYNDGNAEVV 267

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 37/196 (18%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIV 83
           +VA+K  K G      +     L+E ++++ + H+ ++ +  +     P       +YIV
Sbjct: 32  KVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-------IYIV 79

Query: 84  YELMDT-DLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            E M    L   ++S         QL D        Q+  G+ Y+ S + +HRDL   N+
Sbjct: 80  TEYMSKGSLLDFLKSGEGKKLRLPQLVD-----MAAQIAEGMAYLESRNYIHRDLAARNI 134

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGC 192
           L+  +   KI DFGLAR   E D  T     ++   + APE   N   +T   D+WS G 
Sbjct: 135 LVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKSDVWSFGI 192

Query: 193 ILGEIMT--REPLFPG 206
           +L EI+T  R P +PG
Sbjct: 193 LLTEIVTYGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 3/145 (2%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++HS  +++RDLK  N
Sbjct: 72  TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           ++L+A   +KI DFG+ +        T  +  T  Y APE++     Y  ++D W+ G +
Sbjct: 132 VMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVL 190

Query: 194 LGEIMTREPLFPGKDYVHQLRLITE 218
           L E++  +P F G+D     + I E
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 56/186 (30%), Positives = 98/186 (52%), Gaps = 22/186 (11%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++    +  R   REI++L+ ++H+N++  K +     +    ++ +V 
Sbjct: 32  TGEVVAVKKLQHSTAEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLRLVM 86

Query: 85  E-LMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           E L    L   ++  ++  D H +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +  
Sbjct: 87  EYLPYGSLRDYLQKHRERLD-HRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN 145

Query: 142 DLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCI 193
            +KIGDFGL +   +     EY   R        WY APE  L  ++++ A D+WS G +
Sbjct: 146 RVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVV 200

Query: 194 LGEIMT 199
           L E+ T
Sbjct: 201 LYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 46/167 (27%), Positives = 86/167 (51%), Gaps = 17/167 (10%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDD 104
           L E  L++ ++H  ++ +  ++      T   +YI+ E M+   L   +++ +  +LT +
Sbjct: 49  LAEANLMKQLQHPRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPEGIKLTIN 102

Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-- 162
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 103 KLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162

Query: 163 -YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 206
                +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 163 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 10/147 (6%)

Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDF 159
            T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   
Sbjct: 92  FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151

Query: 160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI-TE 218
           M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+     LI  E
Sbjct: 152 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210

Query: 219 LIG-----SPDDASL--GFLRSDNARR 238
            I      SP+  SL  G L+ D  +R
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 39/208 (18%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
           ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E   +   V T 
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 165

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 227
            Y APE++ N   YT + D W++GC+L E++  +                    SP    
Sbjct: 166 GYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQR 204

Query: 228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEE 282
              ++ +   R V+++     ++++ +F   S  A  L + +L  DP +R+        E
Sbjct: 205 KKKIKREEVERLVKEVQ----EEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGARE 257

Query: 283 ALRHPYLQSLH------DLNDEPVCPRP 304
              HP  + ++       + + P  P P
Sbjct: 258 VKEHPLFKQINFKRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           M T L+Q        ++D  +++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 147 DFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           DFGL++   + E +    +  T  Y APE++     +  A+D WS+G ++ E++T    F
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Query: 205 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAV 263
                         L G  +       +S+ +RR ++  P          FP+     A 
Sbjct: 208 -------------TLEGERNT------QSEVSRRILKCDP---------PFPSFIGPEAQ 239

Query: 264 DLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 305
           DLL K+L  DP KR+        E   HP+ + L    L    V   PF
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV-NPPF 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 67/256 (26%), Positives = 119/256 (46%), Gaps = 51/256 (19%)

Query: 50  EIKLLRHMEHENVIA------IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQ 99
           EI +L+   H   IA      IK    PP  D  + +++V E       TDL +  + + 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKK--SPPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNA 117

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D 158
            L +D   Y   ++LRGL ++H+  V+HRD+K  N+LL  + ++K+ DFG++     T  
Sbjct: 118 -LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176

Query: 159 FMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 213
               ++ T ++ APE++  C E     Y    DIWS+G    E+    P  P  D +H +
Sbjct: 177 RRNTFIGTPYWMAPEVIA-CDENPDATYDYRSDIWSLGITAIEMAEGAP--PLCD-MHPM 232

Query: 214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 273
           R +  +  +P                    P+ + ++++ +F       +D +E  LV +
Sbjct: 233 RALFLIPRNPP-------------------PKLKSKKWSKKF-------IDFIEGCLVKN 266

Query: 274 PNKRITVEEALRHPYL 289
              R + E+ L+HP++
Sbjct: 267 YLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ------- 99
           L E  L++ ++H+ ++ +  ++   +      +YI+ E M    L   ++SD+       
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLP 103

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 159
           +L D     F  Q+  G+ Y+   + +HRDL+ +N+L++ S   KI DFGLAR   + ++
Sbjct: 104 KLID-----FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158

Query: 160 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                     +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 159 TAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 5/136 (3%)

Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           MD         ++QLT        YQ+ RG++Y+ S   +HRDL   N+L+     +KI 
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176

Query: 147 DFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           DFGLAR     D+  +    R    + APE L +   YT   D+WS G +L EI T    
Sbjct: 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS 235

Query: 204 -FPGKDYVHQLRLITE 218
            +PG       +L+ E
Sbjct: 236 PYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 52/291 (17%)

Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 62
           G Y D+       A N  T E  A+K I    G+ F  I       +EI +++  +H N+
Sbjct: 20  GTYGDVY-----KARNLHTGELAAVKIIKLEPGDDFSLI------QQEIFMVKECKHCNI 68

Query: 63  IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +A        +K     ++I  E      L  I      L++    Y   + L+GL Y+H
Sbjct: 69  VAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123

Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLNC 178
           S   +HRD+K +N+LL  + D+K+ DFG+ A+ T+       ++ T ++ APE+  +   
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 179 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR 238
             Y    DIW+VG    E+   +P  P  D +H +R +             FL S +   
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQP--PMFD-LHPMRAL-------------FLMSKSN-- 225

Query: 239 YVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
              Q P+ + K ++++ F N        ++  L  +P KR T E  L H +
Sbjct: 226 --FQPPKLKDKTKWSSTFHN-------FVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 25/184 (13%)

Query: 29  VAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVY 84
           VAIK + + +      RR  L E  ++   +H N+I ++ ++   RP        V I+ 
Sbjct: 35  VAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP--------VMIIT 84

Query: 85  ELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           E M+   L   +R +D Q T       L  +  G+KY+   + +HRDL   N+L+N++  
Sbjct: 85  EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV 144

Query: 143 LKIGDFGLARTTSE-------TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
            K+ DFGL+R   +       T  +   +  RW  APE  +   ++T+A D+WS G ++ 
Sbjct: 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMW 202

Query: 196 EIMT 199
           E+M+
Sbjct: 203 EVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 54/292 (18%)

Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENV 62
           G Y D+       A N  T E  AIK I    G  F  +       +EI +++  +H N+
Sbjct: 20  GTYGDVY-----KARNVNTGELAAIKVIKLEPGEDFAVV------QQEIIMMKDCKHSNI 68

Query: 63  IA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           +A     +R  K      ++I  E      L  I      L++    Y   + L+GL Y+
Sbjct: 69  VAYFGSYLRRDK------LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122

Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLN 177
           HS   +HRD+K +N+LL  +  +K+ DFG+ A+ T+       ++ T ++ APE+  +  
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 178 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 237
              Y    DIW+VG    E+   +P  P  D +H +R +             FL + +  
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQP--PMFD-LHPMRAL-------------FLMTKSN- 225

Query: 238 RYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
               Q P+ + K +++  F +        ++  L  +P KR T E+ L+HP+
Sbjct: 226 ---FQPPKLKDKMKWSNSFHH-------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.1 bits (158), Expect = 5e-12
 Identities = 34/94 (36%), Positives = 58/94 (61%), Gaps = 2/94 (2%)

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRW 168
           L ++L+GL Y+HS   +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T +
Sbjct: 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 169 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           + APE++   + Y +  DIWS+G    E+   EP
Sbjct: 167 WMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 15/169 (8%)

Query: 83  VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N+LL+   
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134

Query: 142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 201
            ++I D GLA   S+       V T  Y APE+L   T Y ++ D +S+GC+L +++   
Sbjct: 135 HVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Query: 202 PLF---PGKDYVHQLRLITELIG-------SPDDASL--GFLRSDNARR 238
             F     KD  H++  +T  +        SP+  SL  G L+ D ++R
Sbjct: 194 SPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 29/215 (13%)

Query: 6   RGEYDDIIFFIFSAAVNSETREE--VAIKKIGNAFDNII--DARRTLREIKLLRHMEHEN 61
           RGE+ ++  F+  A    E   E  V +K +    D  +  + RR   E+ + R + H+N
Sbjct: 15  RGEFGEV--FLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRKLSHKN 69

Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR---------SDQQLTDDHCQYFLY 111
           V+ +  + R  + +     Y++ E  D  DL Q +R             L+         
Sbjct: 70  VVRLLGLCR--EAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRW 168
           Q+  G+ ++ +A  +HRDL   N L+++  ++K+    L++    ++        +  RW
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184

Query: 169 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
             APE +    +++   D+WS G ++ E+ T+  L
Sbjct: 185 L-APEAVQE-DDFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 20/154 (12%)

Query: 70  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
           RPP  D   D+  V E             +QL+        YQ+ RG++Y+ S   +HRD
Sbjct: 113 RPPGPDYTFDITKVPE-------------EQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAID 186
           L   N+L+     +KI DFGLAR   + D+  +    R    + APE L +   YT   D
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSD 218

Query: 187 IWSVGCILGEIMTR--EPLFPGKDYVHQLRLITE 218
           +WS G ++ EI T    P +PG       +L+ E
Sbjct: 219 VWSFGILMWEIFTLGGSP-YPGIPVEELFKLLRE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 19/140 (13%)

Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 126
           D  R  +  ++ D  +  E+++ D       +  L  +    F YQ+ +G+ ++ S + +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCI 236

Query: 127 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCT 179
           HRDL   N+LL      KI DFGLAR     D  + YVV        +W  APE + NC 
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVVKGNARLPVKWM-APESIFNCV 292

Query: 180 EYTAAIDIWSVGCILGEIMT 199
            YT   D+WS G +L EI +
Sbjct: 293 -YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 35/201 (17%)

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSE 156
           +  T+   + ++ +++  L ++H   +++RD+K  N+LL++   + + DFGL++     E
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Query: 157 TDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 215
            +    +  T  Y APE++   +  +  A+D WS+G +  E++T    F      +    
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--- 216

Query: 216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDP 274
                           +S+ +RR ++  P          FP   S+ A D ++K+L  DP
Sbjct: 217 ----------------QSEISRRILKSKP---------PFPKTMSAEARDFIQKLLEKDP 251

Query: 275 NKRI---TVEEALRHPYLQSL 292
            KR+     +E   HP+ Q +
Sbjct: 252 KKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 13/165 (7%)

Query: 50  EIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTD 103
           E  +L+ +  H NV+    +     K     +++V EL +    T+L + ++   Q+L +
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 104 DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTE 162
               Y LY  L GL+++H+  ++HRD+K +N+LL     +K+ DFG+ A+ TS       
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 163 YVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTREP 202
            V T ++ APE++  C +     Y A  D+WS+G    E+   +P
Sbjct: 188 SVGTPFWMAPEVIA-CEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 34/188 (18%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVT 166
           ++  +++ GL+++HS  +++RDLK  N++L+    +KI DFG+ +     D   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 226
             Y APE+L    +YT ++D WS G +L E++  +  F G D               +D 
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---------------EDE 203

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR- 285
               +R D    Y R + +  K               D+LEK+   DP +R+ V   +R 
Sbjct: 204 LFESIRVDTP-HYPRWITKESK---------------DILEKLFERDPTRRLGVVGNIRG 247

Query: 286 HPYLQSLH 293
           HP+ ++++
Sbjct: 248 HPFFKTIN 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 37/136 (27%), Positives = 72/136 (52%), Gaps = 7/136 (5%)

Query: 76  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           T +D   +Y LM+     +L   +R+  + ++    ++  +++  L+Y+HS  +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           P N+LL+    +K+ DFG A+     D       T  Y APE++ +   +  A+D W++G
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALG 185

Query: 192 CILGEIMTREPLFPGK 207
            ++ E++   P F   
Sbjct: 186 ILIYEMLVGYPPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 8e-12
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 21/187 (11%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           ++VA+K +    D+   A+  L E  ++  + H N++ +  ++        N +YIV E 
Sbjct: 30  QKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIVTEY 81

Query: 87  MDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M    L   +RS     +T      F   +  G++Y+   + +HRDL   N+L++     
Sbjct: 82  MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141

Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT---- 199
           K+ DFGLA+  S+     +  V +W  APE L    +++   D+WS G +L EI +    
Sbjct: 142 KVSDFGLAKEASQGQDSGKLPV-KW-TAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRV 198

Query: 200 ---REPL 203
              R PL
Sbjct: 199 PYPRIPL 205

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 8e-12
 Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 34/166 (20%)

Query: 50  EIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-----Q 100
           E K++  + H N++ +  +    RP        ++IV E M    L   +R  +     +
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRP--------IFIVTEYMANGCLLNYLRERKGKLGTE 100

Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------T 153
              D C      +   ++Y+ S   +HRDL   N L+     +K+ DFGLAR       T
Sbjct: 101 WLLDMCS----DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156

Query: 154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           +S+    T++ V +W  AP  + + + +++  D+WS G ++ E+ +
Sbjct: 157 SSQG---TKFPV-KW--APPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)

Query: 105 HCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS----------------CDLKIGD 147
           H    ++Q    L Y H+   ++H DLKP N+L+  S                C ++I D
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 207
            G      E    T  V TR YR+PE++L    +  + D+WS+GCI+ E+ T + L+   
Sbjct: 292 LG--GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTH 348

Query: 208 DYVHQLRLITELIGS-PDD--------------ASLGFLRSDNARRYVRQLPRCRKQQFA 252
           D +  L L+ + +G  P +               S G LR     +++ ++ R R  +  
Sbjct: 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV 408

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            R         DL+  +L +D  KR+   +   HPY+
Sbjct: 409 IRDDL----LCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 19/109 (17%)

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV- 165
           F  Q+ +G+ ++ S + +HRD+   N+LL      KI DFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 166 ------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 206
                  +W  APE + +C  YT   D+WS G +L EI +  + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 31/191 (16%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
            VAIK + N   ++ +    L E  +++     +V+ +  ++      T     +V ELM
Sbjct: 38  RVAIKTV-NENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----STGQPTLVVMELM 91

Query: 88  DT-DLHQIIRSDQQLTDDHC--------QYFLY---QLLRGLKYVHSASVLHRDLKPSNL 135
              DL   +RS ++   ++         Q F+    ++  G+ Y+ +   +HRDL   N 
Sbjct: 92  AKGDLKSYLRS-RRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNC 150

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIW 188
           ++     +KIGDFG+ R   ETD+   Y          RW  APE L +   +T   D+W
Sbjct: 151 MVAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-APESLKDGV-FTTKSDVW 205

Query: 189 SVGCILGEIMT 199
           S G +L E+ T
Sbjct: 206 SFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)

Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 27/172 (15%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ------- 99
           L+E ++++ + HE ++ +  ++      +   +YIV E M    L   ++ +        
Sbjct: 49  LQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 159
           QL D        Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++
Sbjct: 103 QLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157

Query: 160 MTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 206
                     +W  APE  L    +T   D+WS G +L E+ T  R P +PG
Sbjct: 158 TARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 28/204 (13%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G + D+    +   +   T  EVA+K    +       R+ L+E ++L+  +H N++ +
Sbjct: 5   KGNFGDV----YKGVLKGNT--EVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 66  KDII--RPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
             +   + P       +YIV EL+     L  + +   +LT             G++Y+ 
Sbjct: 58  IGVCVQKQP-------IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELL 175
           S + +HRDL   N L+  +  LKI DFG++R   E   +       + +  +W  APE  
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW-TAPE-A 166

Query: 176 LNCTEYTAAIDIWSVGCILGEIMT 199
           LN   YT+  D+WS G +L E  +
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 49/220 (22%), Positives = 104/220 (47%), Gaps = 44/220 (20%)

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSE 156
           ++  +   Q +  +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159

Query: 157 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFP--GKDYVHQL 213
            +    +  T  Y AP+++      +  A+D WS+G ++ E++T    F   G+      
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-- 217

Query: 214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVF 272
                              ++ +RR ++  P          +P + S  A D+++++L+ 
Sbjct: 218 -------------------AEISRRILKSEP---------PYPQEMSALAKDIIQRLLMK 249

Query: 273 DPNKRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 305
           DP KR+       +E  +HP+ Q ++  DL  + V P PF
Sbjct: 250 DPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKV-PAPF 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 14/178 (7%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
            VA+K   N         + L+E  ++R  +H +++ +  +I      T N V+IV EL 
Sbjct: 36  AVAVKTCKNCTSPS-VREKFLQEAYIMRQFDHPHIVKLIGVI------TENPVWIVMELA 88

Query: 88  DT-DLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
              +L   +  +   L       + YQL   L Y+ S   +HRD+   N+L+++   +K+
Sbjct: 89  PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKL 148

Query: 146 GDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           GDFGL+R   +  +          +W  APE  +N   +T+A D+W  G  + EI+  
Sbjct: 149 GDFGLSRYLEDESYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 2/117 (1%)

Query: 83  VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N+LL+   
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134

Query: 142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
            ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L +++
Sbjct: 135 HVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 43/183 (23%), Positives = 95/183 (51%), Gaps = 15/183 (8%)

Query: 44  ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-----------NDVYIVYELMDT-DL 91
           A + L++  +L   E ++++A ++++    K  F             +Y V + ++  +L
Sbjct: 24  AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83

Query: 92  HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 151
              ++ ++   +   +++  ++   L Y+HS ++++RDLKP N+LL++   + + DFGL 
Sbjct: 84  FFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLC 143

Query: 152 RT-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 210
           +   +++D  T +  T  Y APE++     Y   +D W +G +L E++   P F  +D V
Sbjct: 144 KEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-V 201

Query: 211 HQL 213
            ++
Sbjct: 202 AEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 60/243 (24%), Positives = 111/243 (45%), Gaps = 40/243 (16%)

Query: 58  EHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQ 112
           +H NV+    +         + +++V EL +    TDL +  ++  +++ +    Y L++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 113 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRA 171
            L GL+++H    +HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 172 PELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 226
           PE++  C     + Y A  D+WS+G    E+   +P  P  D +H +R + ++  +P   
Sbjct: 193 PEVIA-CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKIPRNPP-- 246

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
                            P   + +        S+   D + K L  D  KR TV + L+H
Sbjct: 247 -----------------PTLHQPELW------SNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Query: 287 PYL 289
            ++
Sbjct: 284 VFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 70/295 (23%), Positives = 113/295 (38%), Gaps = 85/295 (28%)

Query: 76  TFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
           +F D   +Y +M+     DL + +IR D    ++  ++++ +L+  L  VH    +HRD+
Sbjct: 69  SFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDI 127

Query: 131 KPSNLLLNASCDLKIGDFGLA------------RTTSETDFMTEYVVTRW---------- 168
           KP N+L++A   +K+ DFGL                S      + V+ R           
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 169 --------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                   Y APE+L   T Y    D WS+G IL E++   P F                
Sbjct: 188 NSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF---------------- 230

Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKR 277
              D     + +  N +  +             RFP     S  A+DL+ + L+ DP  R
Sbjct: 231 -YSDTLQETYNKIINWKESL-------------RFPPDPPVSPEAIDLICR-LLCDPEDR 275

Query: 278 IT-VEEALRHPYLQSLHDLNDEPVCPRPF-----------HFD-FEHSSCTEDHI 319
           +   EE   HP+ + + D  +      PF           +FD FE      D++
Sbjct: 276 LGSFEEIKSHPFFKGI-DWENLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDYL 329

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 48/242 (19%)

Query: 78  NDVYIVYELM-DTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           +++Y+V E     DL  ++ R + Q  +D  Q++L +L+  +  VH    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 136 LLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLL------NCTEYTAAIDI 187
           L++ +  +K+ DFG A   T ++       V T  Y APE+L         T Y    D 
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT-YGVECDW 192

Query: 188 WSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           WS+G I  E I  R P                       ++  +    N +R++      
Sbjct: 193 WSLGVIAYEMIYGRSPF------------------HEGTSAKTYNNIMNFQRFL------ 228

Query: 247 RKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR 303
                  +FP     SS  +DL++ +L     +R+  E    HP+   + D N+      
Sbjct: 229 -------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI-DWNNIRNSLP 279

Query: 304 PF 305
           PF
Sbjct: 280 PF 281

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 41/209 (19%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
           ++  +L  GL+ +    +++RDLKP N+LL+    ++I D GLA    E + +   V T 
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTV 165

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDA 226
            Y APE++ N  +YT + D W +GC++ E I  + P    K+ V                
Sbjct: 166 GYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---------------- 208

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVE 281
                + +   R V++     +++++ +F   S  A  +   +L  +P +R+        
Sbjct: 209 -----KREEVDRRVKE----DQEEYSEKF---SEDAKSICRMLLTKNPKERLGCRGNGAA 256

Query: 282 EALRHPYLQSLH------DLNDEPVCPRP 304
              +HP  ++++      ++ + P CP P
Sbjct: 257 GVKQHPIFKNINFKRLEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 29/264 (10%)

Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDH 105
           ++ E +LLR + H  V+A+ D +R     T     +V     +DL+  +    + L    
Sbjct: 207 SVHEARLLRRLSHPAVLALLD-VRVVGGLTC----LVLPKYRSDLYTYLGARLRPLGLAQ 261

Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG---LARTTSETDFMTE 162
                 QLL  + Y+H   ++HRD+K  N+L+N   D+ +GDFG    AR +  T F   
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLF--PGKDYVHQ-----LR 214
              T    APE+L     YT ++DIWS G ++ E       LF     D         LR
Sbjct: 322 IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380

Query: 215 LITELIGSPDDASLGFLRSDNAR---RYVRQLPRCRKQQFA----TRFPNKSSGAVDLLE 267
           +I +     D+    F +   +R   +Y  +  R R+  +     TR+         L+ 
Sbjct: 381 IIRQAQVHVDE----FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVC 436

Query: 268 KMLVFDPNKRITVEEALRHPYLQS 291
           + L FD  +R +  E LR P  QS
Sbjct: 437 RALTFDGARRPSAAELLRLPLFQS 460

Length = 461

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 40/126 (31%), Positives = 72/126 (57%), Gaps = 8/126 (6%)

Query: 90  DLHQIIRSDQQLTD---DHCQYFLY-QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           DL Q I+S  +      +H    L+ Q+L  + +VHS  ++HRD+K +N+LL ++  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 146 GDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           GDFG ++  + T   D    +  T +Y APE+      Y+   D++S+G +L E++T + 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKR 243

Query: 203 LFPGKD 208
            F G++
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 34/200 (17%)

Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K +    D  + AR+   RE +LL +++HE+++    +         + + +V+E M
Sbjct: 38  VAVKALK---DPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYM 89

Query: 88  D-TDLHQIIRS---------DQQLTDDHCQYFLYQLLR-------GLKYVHSASVLHRDL 130
              DL++ +R+         D Q      +  L Q+L        G+ Y+ S   +HRDL
Sbjct: 90  KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 149

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAID 186
              N L+ A+  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D
Sbjct: 150 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESD 207

Query: 187 IWSVGCILGEIMT--REPLF 204
           +WS G IL EI T  ++P F
Sbjct: 208 VWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 38/135 (28%), Positives = 73/135 (54%), Gaps = 3/135 (2%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++HS  +++RDLK  N
Sbjct: 72  TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           ++L++   +KI DFG+ +        T+ +  T  Y APE ++    Y  ++D W+ G +
Sbjct: 132 VMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVL 190

Query: 194 LGEIMTREPLFPGKD 208
           L E++  +  F G+D
Sbjct: 191 LYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 48/193 (24%), Positives = 88/193 (45%), Gaps = 36/193 (18%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVT 166
           ++  Q++ GL+++H   +++RDLKP N+LL+   +++I D GLA    +    T+ Y  T
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160

Query: 167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 226
             + APELL    EY  ++D +++G  L E++                           A
Sbjct: 161 PGFMAPELLQG-EEYDFSVDYFALGVTLYEMI---------------------------A 192

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TV 280
           + G  R+   +   ++L + R    +  +P+K S  +    E +L  DP KR+       
Sbjct: 193 ARGPFRARGEKVENKELKQ-RILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251

Query: 281 EEALRHPYLQSLH 293
           +    HP  + L+
Sbjct: 252 DGLRTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 22/221 (9%)

Query: 39  DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-----------NDVYIVYELM 87
           D    A + L++  +L+  E  +++A ++++    K  F             +Y V + +
Sbjct: 19  DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78

Query: 88  DT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           +  +L   ++ ++   +   +++  ++   + Y+HS ++++RDLKP N+LL++   + + 
Sbjct: 79  NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLT 138

Query: 147 DFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFGL +   E +  T  +  T  Y APE+L     Y   +D W +G +L E++   P F 
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Query: 206 GKD----YVHQLRLITELIGSPDDAS----LGFLRSDNARR 238
            +D    Y + L    +L G    A+    +G L  D  RR
Sbjct: 198 SRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 41/130 (31%), Positives = 73/130 (56%), Gaps = 5/130 (3%)

Query: 79  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 136
           ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 197 I-MTREPLFP 205
           + + R P+ P
Sbjct: 195 MAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 54/231 (23%)

Query: 80  VYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN 134
           VY+  E MD      L+    + + + +D  +   Y +++GLK++    +++HRD+KP+N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 135 LLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCT-----EYTAAI 185
           +L+N +  +K+ DFG    L  + ++T+     +  + Y APE + +        YT   
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 186 DIWSVG-CILGEIMTREPLFPGKDYVH---QLRLITELIGSPDDASLGFLRSDNARRYVR 241
           D+WS+G  IL   + R P +P + Y +   QL  I +  G P                  
Sbjct: 189 DVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDPP----------------- 228

Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
            LP              S  A D + K L   PN+R T  + L HP+L   
Sbjct: 229 TLP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 39/197 (19%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVI---AIKDIIRPPKKDTFNDVYI 82
            VA+K  K G       D +  L E ++++ + H  +I   A+  +  P        +YI
Sbjct: 32  PVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP--------IYI 78

Query: 83  VYELMDT-DLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           V ELM    L + ++          QL D        Q+  G+ Y+ + + +HRDL   N
Sbjct: 79  VTELMKYGSLLEYLQGGAGRALKLPQLID-----MAAQVASGMAYLEAQNYIHRDLAARN 133

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVG 191
           +L+  +   K+ DFGLAR   E  +       ++   + APE       ++   D+WS G
Sbjct: 134 VLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPE-AALYNRFSIKSDVWSFG 191

Query: 192 CILGEIMT--REPLFPG 206
            +L EI+T  R P +PG
Sbjct: 192 ILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 54/159 (33%), Positives = 83/159 (52%), Gaps = 22/159 (13%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR------TTS------ 155
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL++      TT+      
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 156 ETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 211
           E D   F+ + V  T  Y APE++L    Y   +D W++G IL E +     F G D   
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPE 222

Query: 212 QL--RLITELIGSPD-DASLGFLRSDNARRYVRQLPRCR 247
           +L  ++I++ I  P+ D +L     D   R +RQ P  R
Sbjct: 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YV 164
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 31/192 (16%)

Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K +  A ++   AR+   RE +LL  ++H++++    +    +      + +V+E M
Sbjct: 38  VAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP-----LLMVFEYM 89

Query: 88  -DTDLHQIIRSDQ---------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
              DL++ +RS                 QLT         Q+  G+ Y+ S   +HRDL 
Sbjct: 90  RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDI 187
             N L+     +KIGDFG++R    TD+        +  RW   PE +L   ++T   DI
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTESDI 207

Query: 188 WSVGCILGEIMT 199
           WS G +L EI T
Sbjct: 208 WSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 17/203 (8%)

Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D 
Sbjct: 42  TLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDR 96

Query: 106 CQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEY 163
            +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +
Sbjct: 97  ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156

Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL-- 219
             T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+  
Sbjct: 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 215

Query: 220 --IGSPDDASL--GFLRSDNARR 238
               SP+  SL  G L+ D  +R
Sbjct: 216 PRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 46  RTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQL 101
           + L E ++L+  +H N++ +  +   R P       +YIV EL+     L  + +   +L
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVCTQRQP-------IYIVMELVPGGDFLSFLRKKKDEL 90

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
                  F      G+ Y+ S + +HRDL   N L+  +  LKI DFG++R   +  + +
Sbjct: 91  KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150

Query: 162 ---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              + +  +W  APE  LN   Y++  D+WS G +L E  +
Sbjct: 151 SGLKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 14/190 (7%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRT---LREIKLLRHMEHENVIAIKDIIRPPKKD 75
           A   +E    VAIK+   +   II  ++      E K+L ++ H   + +       K +
Sbjct: 49  ATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKILNYINHPFCVNLYGSF---KDE 103

Query: 76  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           ++  +Y+V E ++  +    +R +++  +D   ++  Q++   +Y+ S ++++RDLKP N
Sbjct: 104 SY--LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           LLL+    +K+ DFG A+      +      T  Y APE+LLN     AA D W++G  +
Sbjct: 162 LLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLGIFI 218

Query: 195 GEIMTREPLF 204
            EI+   P F
Sbjct: 219 YEILVGCPPF 228

Length = 340

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)

Query: 57  MEHENVIAIKDIIRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           M  + V+A++D  +PP          T + +Y V E ++  DL   I+   +  +    +
Sbjct: 48  MVEKRVLALQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 105

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 168
           +  ++  GL ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR 
Sbjct: 106 YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRT 160

Query: 169 ------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
                 Y APE++     Y  ++D W+ G +L E++  +P F G+D
Sbjct: 161 FCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 76/311 (24%), Positives = 130/311 (41%), Gaps = 72/311 (23%)

Query: 8   EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIK 66
           ++ +  F       N++    VA+K +    D   +AR   L+E+K+L  +   N+  + 
Sbjct: 31  DFSEKAFAEN---DNADAPVLVAVKVLRP--DASDNAREDFLKEVKILSRLSDPNIARLL 85

Query: 67  DIIR--PPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY--------FLY---Q 112
            +    PP       + ++ E M+  DL+Q ++     T               LY   Q
Sbjct: 86  GVCTVDPP-------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138

Query: 113 LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV------- 165
           +  G++Y+ S + +HRDL   N L+  +  +KI DFG++R    +D+   Y V       
Sbjct: 139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLP 195

Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITELIGSP 223
            RW     +LL   ++T   D+W+ G  L EI+T  RE  +   +++   ++I       
Sbjct: 196 IRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVI------- 243

Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML---VFDPNKRITV 280
           ++A   F R D  + Y+ + P C K               D+ E ML     D   R T 
Sbjct: 244 ENAGHFF-RDDGRQIYLPRPPNCPK---------------DIYELMLECWRRDEEDRPTF 287

Query: 281 EEALRHPYLQS 291
            E   H +LQ 
Sbjct: 288 REI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 10/131 (7%)

Query: 117 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELL 175
           L Y+HS ++++RDLKP N+LL++   + + DFGL +   E +   + +  T  Y APE+L
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-------VHQ-LRLITELIGSPDDAS 227
                Y   +D W +G +L E++   P F  +D        +++ LRL   +  S     
Sbjct: 169 RK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLL 227

Query: 228 LGFLRSDNARR 238
            G L+ D  +R
Sbjct: 228 EGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 60.6 bits (148), Expect = 1e-10
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 39/207 (18%)

Query: 88  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIG 146
           D DL  +++ + +L++   +  + QL+  L  +H  +++H D+K  N+L + + D + + 
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 147 DFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           D+GL +   T S  D   +Y       +PE  +    Y  + D W+VG +  E++T +  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
            P K+                D  L        +R  ++LP            N S  A 
Sbjct: 204 HPFKEDE--------------DEELDL--ESLLKRQQKKLP---------FIKNVSKNAN 238

Query: 264 DLLEKMLVFDPNKR-ITVEEALRHPYL 289
           D ++ ML ++ N R     E ++HP+L
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 62/287 (21%), Positives = 127/287 (44%), Gaps = 52/287 (18%)

Query: 39  DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-----------NDVYIVYELM 87
           +    A + L++  +L+  E +++++ ++++    K  F           + +Y V + +
Sbjct: 19  EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78

Query: 88  DT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           +  +L   ++ ++   +   +++  ++   L Y+HS ++++RDLKP N+LL++   + + 
Sbjct: 79  NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 138

Query: 147 DFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFGL +   E +  T  +  T  Y APE +L+   Y   +D W +G +L E++   P F 
Sbjct: 139 DFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            ++                         DN      QL            PN ++ A  L
Sbjct: 198 SRNTAEMY--------------------DNILNKPLQLK-----------PNITNSARHL 226

Query: 266 LEKMLVFDPNKRITVE----EALRHPYLQSLH--DLNDEPVCPRPFH 306
           LE +L  D  KR+  +    E   H +   ++  DL ++ + P PF+
Sbjct: 227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITP-PFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 31/103 (30%), Positives = 59/103 (57%), Gaps = 5/103 (4%)

Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
           ++  Q+  G+ ++HS  +++RD+KP N+LL+   + ++ D GLA    +   +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY 209
            Y APE+L     Y+  +D +++GC + E++  R P    KD+
Sbjct: 159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF---KDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 6/135 (4%)

Query: 69  IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
           I     ++  D Y+      T    +I     L+      F YQ+  G++++ S + +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263

Query: 129 DLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAA 184
           DL   N+L+     +KI DFGLAR    +++++++   ++  +W  APE + N   YT  
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTL 321

Query: 185 IDIWSVGCILGEIMT 199
            D+WS G +L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 32/172 (18%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 107
           L+E  ++  ++HEN+I +  ++                +M T+L  +     +L  D   
Sbjct: 44  LKEAAIMHSLDHENLIRLYGVVLTHPL-----------MMVTELAPLGSLLDRLRKDALG 92

Query: 108 YFLY--------QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 159
           +FL         Q+  G++Y+ S   +HRDL   N+LL +   +KIGDFGL R   + + 
Sbjct: 93  HFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE- 151

Query: 160 MTEYVVTRWYR-------APELLLNCTEYTAAIDIWSVGCILGEIMT--REP 202
             ++ V   +        APE  L    ++ A D+W  G  L E+ T   EP
Sbjct: 152 --DHYVMEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 41/179 (22%), Positives = 89/179 (49%), Gaps = 14/179 (7%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
           ++ + VA+K + N  ++       LRE  +++ +++  ++ +  I             +V
Sbjct: 20  KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLV 73

Query: 84  YELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            EL +   L++ ++ ++ +T+ +    ++Q+  G+KY+   + +HRDL   N+LL     
Sbjct: 74  MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY 133

Query: 143 LKIGDFGLARTTSETDFMTEYVVT-----RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
            KI DFGL++     +   +         +WY APE  +N  ++++  D+WS G ++ E
Sbjct: 134 AKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 38/118 (32%), Positives = 68/118 (57%), Gaps = 8/118 (6%)

Query: 88  DTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           D+++  ++  D  + LT      F YQ+ RG++++ S + +HRDL   N+LL     +KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278

Query: 146 GDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            DFGLAR    +++++++   ++  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 26/228 (11%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           I    V  E    VAIK + N   ++ +    L E  +++     +V+ +  ++   +  
Sbjct: 26  IAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP- 83

Query: 76  TFNDVYIVYELMDT-DLHQIIRS---DQQLTDDHCQYFLYQLLR-------GLKYVHSAS 124
                 ++ ELM   DL   +RS   + +         L ++++       G+ Y+++  
Sbjct: 84  ----TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139

Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTE 180
            +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  +PE L +   
Sbjct: 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-SPESLKDGV- 197

Query: 181 YTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 198 FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDN 245

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 34/225 (15%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +++V E ++  DL   ++  ++L ++H +++  ++   L ++H   +++RDLK  N
Sbjct: 67  TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126

Query: 135 LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +LL+A   +K+ D+G+ +      D  + +  T  Y APE+L    EY  ++D W++G +
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVL 185

Query: 194 LGEIM---------TREPLFPGKDYVHQLRLITELIGSPDDASL-------GFLRSDNAR 237
           + E+M         T  P    +DY+ Q+ ++ + I  P   S+       GFL  D   
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFLNKDPKE 244

Query: 238 RYVRQLPRCRKQQFATRFPNKSSGAV------DLLEKMLVFDPNK 276
           R       C+ Q   T F +  S         DLLEK  V  P K
Sbjct: 245 RL-----GCQPQ---TGFSDIKSHTFFRSIDWDLLEKKQVTPPFK 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 19/181 (10%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           EVA+K +          +  LRE  ++  ++H  ++ +  + +         + +V EL 
Sbjct: 25  EVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP------LMLVMELA 77

Query: 88  DTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
               L + ++  +++     +   +Q+  G+ Y+ S   +HRDL   N+LL      KI 
Sbjct: 78  PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKIS 137

Query: 147 DFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFG++R          Y  T       +WY APE  +N  ++++  D+WS G  L E  +
Sbjct: 138 DFGMSRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYGVTLWEAFS 193

Query: 200 R 200
            
Sbjct: 194 Y 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 88/305 (28%)

Query: 40  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDVYIVYELMD---- 88
             I A + LR+ ++L   +  +V A +DI+             +F D   +Y +M+    
Sbjct: 26  GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85

Query: 89  TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 147
            D+   +++ D   T++  ++++ + +  +  +H    +HRD+KP NLLL+A   +K+ D
Sbjct: 86  GDMMTLLMKKDT-FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSD 144

Query: 148 FGLARTTSETDFMTEY----------------------------------------VVTR 167
           FGL  T  +    TE+                                        V T 
Sbjct: 145 FGLC-TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP 203

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 227
            Y APE+ L  T Y    D WS+G I+ E+                     L+G P    
Sbjct: 204 DYIAPEVFLQ-TGYNKECDWWSLGVIMYEM---------------------LVGYPP--- 238

Query: 228 LGFLRSDNARRYVRQLPRCRKQ-QFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEA 283
             F  SDN +   R++   ++  QF    P  S  A DL+++ L  +  +R+    V E 
Sbjct: 239 --FC-SDNPQETYRKIINWKETLQFPDEVP-LSPEAKDLIKR-LCCEAERRLGNNGVNEI 293

Query: 284 LRHPY 288
             HP+
Sbjct: 294 KSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 28/192 (14%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 150 LART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK 207
           + +      D  + +  T  Y APE+L    +Y  ++D W++G ++ E+M  R P     
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF---- 196

Query: 208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS-GAVDLL 266
                     +++GS D+         N   Y+ Q+    KQ    R P   S  A  +L
Sbjct: 197 ----------DIVGSSDNP------DQNTEDYLFQVI-LEKQ---IRIPRSLSVKAASVL 236

Query: 267 EKMLVFDPNKRI 278
           +  L  DP +R+
Sbjct: 237 KSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.7 bits (142), Expect = 5e-10
 Identities = 42/177 (23%), Positives = 86/177 (48%), Gaps = 15/177 (8%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           +VAIK I    +  +     + E K++  + H  ++ +  +    K      +YIV E M
Sbjct: 30  KVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP-----LYIVTEFM 81

Query: 88  DTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           +    L+ + +   +L+ D        +  G++Y+   S +HRDL   N L++++  +K+
Sbjct: 82  ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKV 141

Query: 146 GDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            DFG+ R   + ++ +        +W   PE + N ++Y++  D+WS G ++ E+ T
Sbjct: 142 SDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI-IRPPKKDTFNDVYIVYEL 86
           +VA+K +  A     +    L E   ++  +H NV+ +  + ++  + + +    ++   
Sbjct: 28  KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87

Query: 87  MD-TDLHQII------RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           M   DLH  +         Q L       F+  +  G++Y+ S S +HRDL   N +LN 
Sbjct: 88  MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGE 196
           + ++ + DFGL++     D+  +  + +    + A E L +   YT   D+WS G  + E
Sbjct: 148 NMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWE 206

Query: 197 IMTR-EPLFPG------KDYVHQ 212
           I TR +  +PG       DY+ Q
Sbjct: 207 IATRGQTPYPGVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 82/239 (34%)

Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 155
           +  + L+++  +++  ++L  L+Y+H   +++RDLKP N+LL+ S  + + DF L++ + 
Sbjct: 95  QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154

Query: 156 -----------------------------ETDFMT-EYVVTRWYRAPELLLNCTEYTAAI 185
                                        E  F +  +V T  Y APE++     + +A+
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAV 213

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D W++G +L E++     F G +                                     
Sbjct: 214 DWWTLGILLYEMLYGTTPFKGSN------------------------------------- 236

Query: 246 CRKQQFAT------RFPNK---SSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQS 291
            R + F+        FP     SS A DL+ K+LV DP+KR+       E  +HP+ + 
Sbjct: 237 -RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 14/188 (7%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI-IRPPKKDTFNDVYIV 83
           + ++VA+K +     +  D    LRE   ++  +H NVI +  + +R   K       ++
Sbjct: 26  SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85

Query: 84  YELMD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
              M   DLH  +   +       L       F+  +  G++Y+ S + +HRDL   N +
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM 145

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCTEYTAAIDIWSVGC 192
           LN +  + + DFGL++     D+  +   +    +W     L  N   YT   D+W+ G 
Sbjct: 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGV 203

Query: 193 ILGEIMTR 200
            + EIMTR
Sbjct: 204 TMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 2/116 (1%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   I+  ++  +   +++  ++   L ++H   V++RDLK  N+LL+A    K+ DFG
Sbjct: 82  DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG 141

Query: 150 LARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           + +        T  +  T  Y APE+L    EY  ++D W++G ++ E+M  +P F
Sbjct: 142 MCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 32/180 (17%)

Query: 48  LREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLT 102
           L+E  +++ ++H N++ +  +    PP        YI+ E M   +L   +R    Q++ 
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVN 102

Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
                Y   Q+   ++Y+   + +HRDL   N L+  +  +K+ DFGL+R       MT 
Sbjct: 103 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTG 156

Query: 163 YVVT---------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVH 211
              T         +W  APE L     ++   D+W+ G +L EI T    P +PG D   
Sbjct: 157 DTYTAHAGAKFPIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 29/173 (16%)

Query: 48  LREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYELMDTDLHQIIRSD-------- 98
           L E ++++ + H+ ++ +  ++   P       +YIV E M          D        
Sbjct: 49  LEEAQIMKKLRHDKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKDGEGRALKL 101

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 158
             L D        Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + +
Sbjct: 102 PNLVD-----MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156

Query: 159 FMTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 206
           +          +W  APE  L    +T   D+WS G +L E++T  R P +PG
Sbjct: 157 YTARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +GE+ D++       +      +VA+K I N       A+  L E  ++  + H N++ +
Sbjct: 16  KGEFGDVM-------LGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQL 64

Query: 66  KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 122
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+ +
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + +HRDL   N+L++     K+ DFGL +  S T    +  V +W  APE L    +++
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW-TAPEALRE-KKFS 177

Query: 183 AAIDIWSVGCILGEIMT----REPLFPGKDYV 210
              D+WS G +L EI +      P  P KD V
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 29/184 (15%)

Query: 28  EVAIKKIGN---AFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVY 81
           +VAIK I     + D  I+      E K++  + HE ++ +  +    RP        +Y
Sbjct: 30  DVAIKMIKEGSMSEDEFIE------EAKVMMKLSHEKLVQLYGVCTKQRP--------IY 75

Query: 82  IVYELMDTD-LHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           IV E M    L   +R   +             +  G+ Y+ S   +HRDL   N L++ 
Sbjct: 76  IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135

Query: 140 SCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
              +K+ DFGL+R   + ++     +++ V RW   PE+LL   ++++  D+W+ G ++ 
Sbjct: 136 QGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RW-SPPEVLLYS-KFSSKSDVWAFGVLMW 192

Query: 196 EIMT 199
           E+ +
Sbjct: 193 EVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 25/195 (12%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD---IIRPPKKDTFN-- 78
            +   +A+K+I +  D         +E K L  M+ + V+   D   I++      F   
Sbjct: 27  PSGTIMAVKRIRSTVDE--------KEQKRLL-MDLDVVMRSSDCPYIVKF-YGALFREG 76

Query: 79  DVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 132
           D +I  ELMD  L +  +         + ++         ++ L Y+     ++HRD+KP
Sbjct: 77  DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP 136

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSV 190
           SN+LL+ + ++K+ DFG++    ++   T     R Y APE +       Y    D+WS+
Sbjct: 137 SNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL 196

Query: 191 GCILGEIMTREPLFP 205
           G  L E+ T +  FP
Sbjct: 197 GITLYEVATGK--FP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 29/191 (15%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDH 105
           L+E  L+ +  H N++ +  +         N+  YI+ ELM+  DL   +R  +      
Sbjct: 47  LKEAHLMSNFNHPNIVKLLGVC------LLNEPQYIIMELMEGGDLLSYLRDARVERFGP 100

Query: 106 CQYFLYQLL-------RGLKYVHSASVLHRDLKPSNLLLNAS---CD--LKIGDFGLART 153
               L +LL       +G  Y+     +HRDL   N L++      D  +KIGDFGLAR 
Sbjct: 101 PLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160

Query: 154 TSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGK 207
             ++D+  +     +  RW  APE LL+  ++T   D+WS G ++ EI+T  ++P +P  
Sbjct: 161 IYKSDYYRKEGEGLLPVRWM-APESLLD-GKFTTQSDVWSFGVLMWEILTLGQQP-YPAL 217

Query: 208 DYVHQLRLITE 218
           +    L+ +T 
Sbjct: 218 NNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 7/137 (5%)

Query: 80  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 139 ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCI 193
            S  LK+ DFG          +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 194 LGEIMTREPLFPGKDYV 210
           L E++  +  F     V
Sbjct: 237 LYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI-----IRSDQQL 101
           L+EIK++  +++ N+I +  +         + + ++ E M+  DL+Q      I S    
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 102 TDD-------HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 154
            ++       +  Y   Q+  G+KY+ S + +HRDL   N L+     +KI DFG++R  
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 155 SETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              D+        +  RW     +LL   ++T A D+W+ G  L E+ T
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 25/171 (14%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ------- 99
           L+E ++++ + H+ ++ +  ++      +   +YIV E M    L   ++          
Sbjct: 49  LQEAQIMKKLRHDKLVPLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP 102

Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 159
           QL D        Q+  G+ Y+   + +HRDL+ +N+L+  +   KI DFGLAR   + ++
Sbjct: 103 QLVD-----MAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157

Query: 160 MTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                     +W  APE  L    +T   D+WS G +L E++T+  + +PG
Sbjct: 158 TARQGAKFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 6/92 (6%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 167
           Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R     D+        +  R
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W     +LL   ++T A D+W+ G  L EI+T
Sbjct: 198 WMSWESILLG--KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 35/184 (19%)

Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDVYIVYE 85
           VA+KKI     +  D +   +EI   R ++H N++        P   +F   +++Y+V  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELYVVSP 79

Query: 86  LMDTDLHQIIRSDQQLTDDHC---------QYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           LM         S + L   H           + L  +L  L Y+HS   +HR +K S++L
Sbjct: 80  LMAYG------SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133

Query: 137 LNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELL-LNCTEYTAAIDI 187
           L+    + +     +        R     DF    V    + +PE+L  N   Y    DI
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193

Query: 188 WSVG 191
           +SVG
Sbjct: 194 YSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 40/129 (31%), Positives = 74/129 (57%), Gaps = 14/129 (10%)

Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFM---TEYV 164
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG----KDYVHQLRLITE 218
             +W  APE + +   YT   D+WS G +L EI +    P +PG    +++  +L+  T 
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEEFCQRLKDGTR 295

Query: 219 LIGSPDDAS 227
           +  +P++A+
Sbjct: 296 M-RAPENAT 303

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 60/224 (26%)

Query: 40  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDVYIVYELMD---- 88
             + A +TLR+  +L   +  +V A +DI+     +       +F D   +Y +MD    
Sbjct: 26  KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85

Query: 89  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
            D+  ++       +D  ++++ +L   ++ VH    +HRD+KP N+L++    +K+ DF
Sbjct: 86  GDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 145

Query: 149 GLA---RTTSET--------------DFMTEY---------------------------- 163
           GL    R T ++              DF  E+                            
Sbjct: 146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA 205

Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
              V T  Y APE+LL  T YT   D WSVG IL E++  +P F
Sbjct: 206 HSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 20/144 (13%)

Query: 97  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 156
             + LT +    + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 157 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG- 206
                +YV         +W  APE + +   YT   D+WS G +L EI +    P +PG 
Sbjct: 226 D---PDYVRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP-YPGV 279

Query: 207 ---KDYVHQLRLITELIGSPDDAS 227
              +++  +L+  T +  +P+ A+
Sbjct: 280 QIDEEFCRRLKEGTRM-RAPEYAT 302

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 13/155 (8%)

Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDH 105
           L+E ++L+   H N++ +  +    +      +YIV EL+   D    +R++  +L    
Sbjct: 41  LQEARILKQYSHPNIVRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGPRLKVKE 95

Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---- 161
               +     G++Y+ S   +HRDL   N L+     LKI DFG++R   +  + +    
Sbjct: 96  LIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155

Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           + +  +W  APE  LN   Y++  D+WS G +L E
Sbjct: 156 KQIPVKW-TAPE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)

Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 159
           LT +    + +Q+ +G++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 160 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 39/205 (19%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQ-IIR----SDQQLT 102
           +E +L+  ++H N++ +  +    +        +++E +   DLH+ ++R    SD    
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQP-----TCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 103 DDH--------CQYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 151
                      C  FL    Q+  G++Y+ S   +HRDL   N L+     +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 152 RTTSETDFMTEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EP 202
           R     D+   Y V        RW   PE +L   ++T   DIWS G +L EI +   +P
Sbjct: 172 RDIYSADY---YRVQSKSLLPVRWM-PPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQP 226

Query: 203 L--FPGKDYVHQLRLITELIGSPDD 225
              F  ++ +  +R   +L+  P+D
Sbjct: 227 YYGFSNQEVIEMIR-SRQLLPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 55.3 bits (133), Expect = 7e-09
 Identities = 40/182 (21%), Positives = 90/182 (49%), Gaps = 21/182 (11%)

Query: 26  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIV 83
           + +VAIK I       +     + E +++  + H  ++ +  +   R P       + +V
Sbjct: 28  KRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-------ICLV 77

Query: 84  YELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           +E M+   L   +R+ + + + +        +  G+ Y+ S++V+HRDL   N L+  + 
Sbjct: 78  FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ 137

Query: 142 DLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            +K+ DFG+ R   +  +     T++ V +W  +PE + + ++Y++  D+WS G ++ E+
Sbjct: 138 VVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSKYSSKSDVWSFGVLMWEV 194

Query: 198 MT 199
            +
Sbjct: 195 FS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 15/112 (13%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 166
           Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY        
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVP 174

Query: 167 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQL 213
            +W  A E +L+   YT   D+WS G  + E+MT   +P    P  + +  L
Sbjct: 175 IKWM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 38/202 (18%), Positives = 78/202 (38%), Gaps = 20/202 (9%)

Query: 15  FIFSAAVNSE--TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI-IRP 71
            +    ++ +  ++ +VA+K +        +    L E   ++  +H NV+ +  +    
Sbjct: 14  SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73

Query: 72  PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL--------RGLKYVHS 122
                     ++   M   DLH  +   +       +    Q L         G++Y+ +
Sbjct: 74  SSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDIALGMEYLSN 131

Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNC 178
            + +HRDL   N +L     + + DFGL++     D+  +  +     +W     L    
Sbjct: 132 RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 191

Query: 179 TEYTAAIDIWSVGCILGEIMTR 200
             YT+  D+W+ G  + EI TR
Sbjct: 192 --YTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 86  LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           L + +  Q + S QQL          Q+  G+ Y+H   V+H+D+   N +++    +KI
Sbjct: 105 LGEANNPQAL-STQQLVH-----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158

Query: 146 GDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            D  L+R     D+      E    +W  A E L+N  EY++A D+WS G +L E+MT
Sbjct: 159 TDNALSRDLFPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 32/115 (27%), Positives = 66/115 (57%), Gaps = 3/115 (2%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   ++  ++L ++H +++  ++   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 150 LART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REP 202
           + +      D  + +  T  Y APE+L    +Y  ++D W++G ++ E+M  R P
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 6/88 (6%)

Query: 116 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRA 171
           G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  A
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-A 189

Query: 172 PELLLNCTEYTAAIDIWSVGCILGEIMT 199
           PE L +   +T + D+WS G +L EI +
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 44/206 (21%)

Query: 29  VAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+KKI  +  +N +  +R LRE K+   + H  ++ +  I         +D   VY  M
Sbjct: 30  VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSI--------CSDGDPVYYTM 81

Query: 88  ----DTDLHQIIRSDQQ---LTDDHCQ-----YFL---YQLLRGLKYVHSASVLHRDLKP 132
                  L  +++S  Q   L+ +  +      FL   +++   ++YVHS  VLHRDLKP
Sbjct: 82  PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141

Query: 133 SNLLLNASCDLKIGDFGLARTT-------------------SETDFMTEYVVTRWYRAPE 173
            N+LL    ++ I D+G A                      S      + V T  Y APE
Sbjct: 142 DNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201

Query: 174 LLLNCTEYTAAIDIWSVGCILGEIMT 199
            LL     + + DI+++G IL +++T
Sbjct: 202 RLLG-VPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 9/135 (6%)

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDD----HCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           DV+I  ELM T L ++++  Q    +         + + L  LK  H   V+HRD+KPSN
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSN 145

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWSVG 191
           +LL+AS ++K+ DFG++    ++   T       Y APE +       +Y    D+WS+G
Sbjct: 146 ILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205

Query: 192 CILGEIMTREPLFPG 206
             L E+ T +  +  
Sbjct: 206 ISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 48/210 (22%)

Query: 42  IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDVYIVYELMD----TD 90
           I A + LR+  +L   +  ++ A +DI+             +F D   +Y +M+     D
Sbjct: 28  IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGD 87

Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           +  ++     L+++  Q+++ + +  +  +H    +HRD+KP NLLL+A   +K+ DFGL
Sbjct: 88  MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Query: 151 A-------RT--------TSETDFMTEYVVTR-----W----------------YRAPEL 174
                   RT           +DF  + + ++     W                Y APE+
Sbjct: 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207

Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            +  T Y    D WS+G I+ E++   P F
Sbjct: 208 FMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 10/158 (6%)

Query: 80  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS  ++HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176

Query: 139 ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCI 193
               LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGS---PDDASL 228
           L E++  +  F     V     I +   S   P+D  +
Sbjct: 237 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 38/163 (23%)

Query: 79  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           ++Y++ E +   D+  ++     LT++  Q+++ + +  +  +H    +HRD+KP NLLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134

Query: 138 NASCDLKIGDFGLA-------RT--------TSETDFMTEYVVTR-----WYR------- 170
           ++   +K+ DFGL        RT        +  +DF  + + ++     W R       
Sbjct: 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAF 194

Query: 171 ---------APELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
                    APE+ +  T Y    D WS+G I+ E++   P F
Sbjct: 195 STVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 49/298 (16%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDV 80
           EVA+ K+ NA  + + A + L + ++L+  E       +D++              F D 
Sbjct: 16  EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE 73

Query: 81  YIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +Y +MD     DL  ++ + + +L +D  +++L +++  +  VH    +HRD+KP N+
Sbjct: 74  NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTE----YTAAIDIWS 189
           L++ +  +++ DFG      E   +   V   T  Y +PE+L    +    Y    D WS
Sbjct: 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS 193

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G  + E++  E  F  +  V                            Y + +    + 
Sbjct: 194 LGVCMYEMLYGETPFYAESLVET--------------------------YGKIMNHKERF 227

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLHDLNDEPVCPRPF 305
           QF  +  + S  A DL+ +++    ++  +  +E+  +HP+   + D ++   C  P+
Sbjct: 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI-DWDNIRNCEAPY 284

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 167
           Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W     +  N   YT   D+W+ G +L EI +
Sbjct: 198 WMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 32/125 (25%), Positives = 65/125 (52%), Gaps = 3/125 (2%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + ++ V E ++  DL   I+  ++  +   +++  ++   L ++H   +++RDLK  N
Sbjct: 67  TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDN 126

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +LL+     K+ DFG+ +        T  +  T  Y APE+L     Y  ++D W++G +
Sbjct: 127 VLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVL 185

Query: 194 LGEIM 198
           L E++
Sbjct: 186 LYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTR 167
           Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  E   V  +
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  A E +L+   YT   D+WS G  + E+MT
Sbjct: 177 WM-ALESILHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 56/216 (25%)

Query: 44  ARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDVYIVYELMD----TDLH 92
           A +TLR+  +L   +  +V A +DI+     +       +F D   +Y +MD     D+ 
Sbjct: 30  AMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 93  QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA- 151
            ++       +D  ++++ +L   ++ VH    +HRD+KP N+L++    +K+ DFGL  
Sbjct: 90  SLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149

Query: 152 --RTTSETDFMTE-----------------------------------------YVVTRW 168
             R T ++ +  +                                          V T  
Sbjct: 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209

Query: 169 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           Y APE+LL  T YT   D WSVG IL E++  +P F
Sbjct: 210 YIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTR 167
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  A E +L+   +T   D+WS G  + E+MT
Sbjct: 177 WM-ALESILH-RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 12/160 (7%)

Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLT 102
           R  L E   L   +H N++ ++ +I        N + IV E M    L   +R  + QL 
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLV 105

Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG-LARTTSETDF-- 159
                  L  L  G+KY+     +H+ L    +L+N+    KI  F  L    SE  +  
Sbjct: 106 AGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165

Query: 160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           M+      W  APE  +    +++A D+WS G ++ E+M+
Sbjct: 166 MSGKSPVLW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 29/173 (16%)

Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           +E  L+  + H N++ +  ++   +      V +++E ++  DLH+ +      +D  C 
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQP-----VCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 108 Y--------------FLY---QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
                          FL+   Q+  G++Y+ S   +H+DL   N+L+     +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 151 ARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           +R     D+        +  RW   PE ++   ++++  DIWS G +L EI +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 60/220 (27%)

Query: 44  ARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDVYIVYELMD----TDLH 92
           A +TLR+  +L   +  +V A +DI+     +       +F D   +Y +MD     D+ 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 93  QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-- 150
            ++   +   +   ++++ +L   ++ VH    +HRD+KP N+L++    +K+ DFGL  
Sbjct: 90  SLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149

Query: 151 ----------------------------------------------ARTTSETDFMTEYV 164
                                                         A    +       V
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209

Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            T  Y APE+LL    YT   D WSVG IL E++  +P F
Sbjct: 210 GTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 24/80 (30%), Positives = 47/80 (58%), Gaps = 1/80 (1%)

Query: 76  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + N+VY+V E L+  D+  ++       ++    ++ ++   L Y+H   ++HRDLKP N
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134

Query: 135 LLLNASCDLKIGDFGLARTT 154
           +L++    +K+ DFGL++ T
Sbjct: 135 MLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E M       + S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+ 
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 177

Query: 140 SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCIL 194
           S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 178 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 195 GEIMTREPLF 204
            E++  +  F
Sbjct: 238 YEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.5 bits (120), Expect = 5e-07
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 16/105 (15%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTE--YVVTR 167
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 168 WYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 209
           W     + L C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 177 W-----MALECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 11/101 (10%)

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---- 162
           Q    ++  GL ++H  + +H DL   N LL A   +KIGD+GL+    + D+       
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Query: 163 YVVTRWYRAPELL------LNCTEYTAAIDIWSVGCILGEI 197
           +V  RW  APEL+      L   + T   ++WS+G  + E+
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 3/105 (2%)

Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 155
            +   L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 156 ETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 176 VYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.5 bits (118), Expect = 6e-07
 Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 17/134 (12%)

Query: 82  IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQ-----LLRGLKYVHSASVLHRDLKPSNL 135
           +V E     DL   +RS++ +     Q  + Q     +  GL ++H A  +H DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 136 LLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCTEYTAAI 185
            L A   +KIGD+GLA      D+        V  RW  APEL+      L   + T   
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKS 190

Query: 186 DIWSVGCILGEIMT 199
           +IWS+G  + E+ T
Sbjct: 191 NIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 17/119 (14%)

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 158
            ++T  +    ++Q+  G+KY+   + +HRDL   N+LL      KI DFGL++     D
Sbjct: 90  DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 159 FMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 209
               Y   R        WY APE  +N  ++++  D+WS G  + E  +    +  K Y
Sbjct: 150 ---SYYKARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWEAFS----YGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 11/145 (7%)

Query: 77  FNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  +  +H    +HRD+K
Sbjct: 70  FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129

Query: 132 PSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAI 185
           P N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L    +    Y    
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 186 DIWSVGCILGEIMTREPLFPGKDYV 210
           D WS+G  + E++  E  F  +  V
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.3 bits (117), Expect = 9e-07
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 112 QLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY- 163
           QLL        G+ Y+     +HRDL   N+L+  +   KI DFGL+R   +  ++ +  
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 164 --VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +  RW       LN + YT   D+WS G +L EI++
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 167
           Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R     D+        +  R
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           W     +L+   ++T A D+W+ G  L EI+
Sbjct: 206 WMAWECILMG--KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 51/227 (22%), Positives = 103/227 (45%), Gaps = 34/227 (14%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDVYI 82
           E  + VAIK + +  +     R   +   ++R  ++H N++ +  ++   +  +    Y 
Sbjct: 33  EQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90

Query: 83  VYELMDTDLHQII-----RSDQQLTDDHCQ-----------YFLYQLLRGLKYVHSASVL 126
            +    +DLH+ +      SD   TDD              + + Q+  G++++ S  V+
Sbjct: 91  SH----SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146

Query: 127 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYT 182
           H+DL   N+L+    ++KI D GL R     D+        +  RW  +PE ++   +++
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMY-GKFS 204

Query: 183 AAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITELIGSPDD 225
              DIWS G +L E+ +   +P   +  +D +  +R   +++  PDD
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQVLPCPDD 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 24/157 (15%)

Query: 81  YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR-------GLKYVHSASVLHRDLKP 132
           +I+ ELM   DL   +R ++   +      +  LL        G KY+     +HRD+  
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144

Query: 133 SNLLLNASCD-----LKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTA 183
            N LL  +C       KI DFG+AR      +  +     +  +W   PE  L+   +T+
Sbjct: 145 RNCLL--TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM-PPEAFLDGI-FTS 200

Query: 184 AIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITE 218
             D+WS G +L EI +    P +PG+     +  +T 
Sbjct: 201 KTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVMEFVTG 236

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
           LT      F   +  G++Y+     +HRDL   N+L+  +   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 161 TEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            +    +  RW       LN + YT   D+WS G +L EI++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 16/131 (12%)

Query: 82  IVYELMDT-DLHQIIRSDQQLTDD----HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +V+E  +  DL   +  +Q    +      Q    ++  G+ ++H  + LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 137 LNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCTEYTAAID 186
           L +   +K+GD+G+  +  + D++     + V  RW  APEL+      L   E T   +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSN 190

Query: 187 IWSVGCILGEI 197
           +W++G  L E+
Sbjct: 191 VWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 171
           +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D      V   Y A
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCA 150

Query: 172 PELLLNCTEYTAAIDIWSVGCILGEIMT 199
           PE +   +E T A D WS+G IL E++T
Sbjct: 151 PE-VGGISEETEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 56/218 (25%)

Query: 76  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           +F D   +Y +M+     DL  ++      ++D  ++++ + +  ++ VH    +HRD+K
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128

Query: 132 PSNLLLNASCDLKIGDFGLAR-------------------------------------TT 154
           P N+L++    +K+ DFGL+                                      T 
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188

Query: 155 SETDFMTEY-----------VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           S  D +  +           V T  Y APE+ L    Y    D WS+G I+ E +   P 
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPP 247

Query: 204 FPGKDYVHQLRLIT---ELIGSPDDASLGFLRSDNARR 238
           F  ++     R I    E +  PDD  L     D  RR
Sbjct: 248 FCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 19/42 (45%), Positives = 28/42 (66%)

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 151
           + Q+L GL+ +H   ++HRD+KP NLL+     +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVT-R 167
           Q+ +G+ Y+    ++HR+L   N+LL +   ++I DFG+A      D   F +E+    +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W     +L     YT   D+WS G  + E+M+
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 11/139 (7%)

Query: 77  FNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           F D   +Y +MD     DL  ++ + + +L +D  +++L +++  +  VH    +HRD+K
Sbjct: 70  FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129

Query: 132 PSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAI 185
           P N+LL+ +  +++ DFG  L      T      V T  Y +PE+L    +    Y    
Sbjct: 130 PDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC 189

Query: 186 DIWSVGCILGEIMTREPLF 204
           D WS+G  + E++  E  F
Sbjct: 190 DWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 81/231 (35%)

Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMT---- 161
           Q  + Q+L  L  +HS  ++HRD+KP N++ +  S   KI D G A      D       
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----ADLRVGINY 312

Query: 162 ---EYVVTRWYRAPELLLNCTEYTAA---------------------IDIWSVGCILGEI 197
              E+++   Y APE  +  T+  +A                      DI+S G I  ++
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR-RYVRQLPRCRKQQFATR-- 254
                 FP                         LRSD+   ++ RQL R      A R  
Sbjct: 373 A-----FPN------------------------LRSDSNLIQFNRQLKRNDYDLVAWRKL 403

Query: 255 FPNKSSGAV---------------DLLEKMLVFDPNKRITVEEALRHPYLQ 290
              ++S  +               +LL+ M+ F   +RI+ + AL HPY  
Sbjct: 404 VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 25/120 (20%), Positives = 47/120 (39%), Gaps = 17/120 (14%)

Query: 39  DNIIDARRTLREIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 96
           D  +   RT  E +LL       V    I D+      D      ++  +   DL  ++ 
Sbjct: 375 DERLRTERTRAEARLLSEARRAGVPTPVIYDV------DPEEKTIVMEYIGGKDLKDVLE 428

Query: 97  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 156
            + +L        + ++   +  +H A ++H DL  SN ++     L + DFGL + +  
Sbjct: 429 GNPEL--------VRKVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 16/203 (7%)

Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK----DII 69
             I+    N++       KK       +ID   T  EIK LR ++  N++ I     DI+
Sbjct: 34  NSIYKGIFNNKEVIIRTFKKFHKGHKVLIDI--TENEIKNLRRIDSNNILKIYGFIIDIV 91

Query: 70  RPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLH 127
                D    + ++ E      L +++  ++ L+            +GL  ++   +  +
Sbjct: 92  -----DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146

Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAID 186
           ++L   + L+  +  LKI   GL +  S   F  + V    Y + ++L +  +EYT   D
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDD 204

Query: 187 IWSVGCILGEIMTREPLFPGKDY 209
           I+S+G +L EI T +  F     
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTT 227

Length = 283

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 12/26 (46%), Positives = 15/26 (57%)

Query: 262 AVDLLEKMLVFDPNKRITVEEALRHP 287
             DL+ KML  DP KR + +E L H 
Sbjct: 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	336
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG1243	690	consensus Protein kinase [General function predict	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.44
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.43
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
COG4248	637	Uncharacterized protein with protein kinase and he	99.36
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.27
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.17
PRK09902	216	hypothetical protein; Provisional	99.14
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.9
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.9
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.88
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.6
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.56
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.4
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.3
PLN02876	822	acyl-CoA dehydrogenase	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.14
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.06
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.05
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.88
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.88
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.87
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.83
PRK05231	319	homoserine kinase; Provisional	97.78
KOG2270	520	consensus Serine/threonine protein kinase involved	97.75
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.74
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.73
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.72
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.7
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.58
PRK12396	409	5-methylribose kinase; Reviewed	97.55
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.27
PLN02756	418	S-methyl-5-thioribose kinase	97.11
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.92
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.87
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.69
PLN02236	344	choline kinase	96.53
PRK10593	297	hypothetical protein; Provisional	96.43
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.38
PTZ00384	383	choline kinase; Provisional	96.36
PRK11768	325	serine/threonine protein kinase; Provisional	96.15
PTZ00296	442	choline kinase; Provisional	95.61
PRK06148	1013	hypothetical protein; Provisional	95.28
PHA03111	444	Ser/Thr kinase; Provisional	95.2
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.11
PRK10271	188	thiK thiamine kinase; Provisional	95.03
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.03
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.75

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-67  Score=434.83  Aligned_cols=330  Identities=64%  Similarity=1.052  Sum_probs=311.0

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |..++.||.|++|.|+.|.++.+|+.||||++...+.+...+.+..+|+.+++.++|+||+.+++++..+....+..+|+
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi  103 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL  103 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence            55578999999999999999999999999999988899999999999999999999999999999999877777889999


Q ss_pred             EEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC---CCc
Q 019728           83 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDF  159 (336)
Q Consensus        83 v~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~---~~~  159 (336)
                      |+|+|+.+|...++++..++++.+..++.||+.||.|+|+.|++||||||.|++++.+..+||+|||+|+..+.   ...
T Consensus       104 V~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~  183 (359)
T KOG0660|consen  104 VFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGF  183 (359)
T ss_pred             ehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccc
Confidence            99999999999999988899999999999999999999999999999999999999999999999999998864   445


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .+.++.|.+|+|||++.....|+.+.||||+|||+.||++|+..|.+.+..+++..|...++.|++.......+..+..+
T Consensus       184 mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~y  263 (359)
T KOG0660|consen  184 MTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPY  263 (359)
T ss_pred             hhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHH
Confidence            67889999999999998878999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHH
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHI  319 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (336)
                      ..+.+...+..+...+++.++.+.+|+.+||..||.+|+|++|+|.||||..+++++++|.|...+.. +... .+.+.+
T Consensus       264 i~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-~~~~-~~~~~~  341 (359)
T KOG0660|consen  264 IKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-FEHE-LTEEEL  341 (359)
T ss_pred             HHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc-cccc-ccHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999988766554 3444 899999


Q ss_pred             HHHHHHHHhhcCCCC
Q 019728          320 RELIWRESVKFNPDP  334 (336)
Q Consensus       320 ~~~~~~~~~~~~~~~  334 (336)
                      +++++.|.++|+|..
T Consensus       342 r~~i~~e~~~~~~~~  356 (359)
T KOG0660|consen  342 RELIYKEILDFHPDV  356 (359)
T ss_pred             HHHHHHHHHhhCccc
Confidence            999999999999963

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-60  Score=385.52  Aligned_cols=287  Identities=32%  Similarity=0.603  Sum_probs=249.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|+.+.++|+|++|.||+++++.||+.||||++..+..++....-.++|+.+|++++|||+|.+.++|...     ..++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----ceeE
Confidence            58889999999999999999999999999999988888888888899999999999999999999999988     5699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CCCc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~~~  159 (336)
                      +|+|||+.++.+.++.. .+++.+.++.+++|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+... +.+.
T Consensus        78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            99999998777777654 568999999999999999999999999999999999999999999999999999877 6666


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .+.++.|.+|+|||.+.+...|+.+.|||++||++.||++|...|++.++.+++..|...++...+.....+.......-
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            77889999999999999989999999999999999999999999999999999999999999766654332222111111


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      +..-.-.........++.++..+.+|+++||+.||.+|++-+++|.|++|.++.
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            111111122334556778899999999999999999999999999999997754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.2e-59  Score=370.42  Aligned_cols=298  Identities=38%  Similarity=0.621  Sum_probs=261.9

Q ss_pred             CccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            1 MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         1 ~~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .||...+.||+|.||.||+|+|..||+.||||+++............++|++.|+.++|+||+.+.++|...     ..+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence            378999999999999999999999999999999987766666678889999999999999999999999987     669


Q ss_pred             EEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      -+|+||++.+|...++.+ ..++...++.++.+++.|++|+|++.|.||||||+|+|++.+|.+||+|||+++..+....
T Consensus        77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            999999999999999875 4689999999999999999999999999999999999999999999999999998776543


Q ss_pred             -ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 -MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                       ....+.|.+|+|||.+.|...|+...|+||.|||+.||+.|.+.|++.++.+++..|...+++|.+..|..+..-....
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence             3445789999999999999999999999999999999999999999999999999999999999998877655433322


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFH  306 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~  306 (336)
                      -....+   .......++..+.++.+|+.+||..||.+|+|+.|+|.|+||++.+.+......|.+..
T Consensus       237 ~~~~~P---~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  237 KIQQFP---KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             HHhcCC---CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence            222332   23333477888999999999999999999999999999999999877766666555544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-59  Score=402.44  Aligned_cols=285  Identities=38%  Similarity=0.652  Sum_probs=255.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      ||.++++||.|.||.||+|+...+|+.||||.+++.+.+ .....-++|+..|++++ ||||+++.+++.++.    ..+
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L   85 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RIL   85 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceE
Confidence            689999999999999999999999999999999876655 33344568999999998 999999999999883    279


Q ss_pred             EEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+|||||+.+|.++++.+ +.|++..++.|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+|+...+...
T Consensus        86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence            999999999999999764 6799999999999999999999999999999999999999888999999999999999888


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH-H
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR-R  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (336)
                      .+.++.|.+|+|||++..+..|+.+.|+|++|||++|+.+-+..|++.+..+++.+|-+.+|.|....+...  .+.+ .
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg--~~La~~  243 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG--YNLASA  243 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH--HHHHHH
Confidence            999999999999999988899999999999999999999999999999999999999999999988765432  2222 2


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .--.++......+....+..+.++.++|.+||.+||.+||||.++|+||||+.-.
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            3335566666777777888999999999999999999999999999999998754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-60  Score=397.52  Aligned_cols=262  Identities=32%  Similarity=0.517  Sum_probs=222.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh-----hHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI-----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|.+.+.||+|+||.|-+|..+.||+.||||++++.....     .......+|+++|++|+|||||+++++|..+    
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~----  248 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP----  248 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC----
Confidence            3778999999999999999999999999999997654221     1233456899999999999999999999988    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC---CCEEEEeccCCc
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR  152 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~  152 (336)
                       ...|+||||++ |+|.+.+-.++.+.++..+.+++|++.|+.|||++||+||||||+|||++.+   ..+||+|||+|+
T Consensus       249 -ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  249 -DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             -CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence             55899999997 5999999999999999999999999999999999999999999999999776   669999999999


Q ss_pred             ccCCCCcccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLG  229 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  229 (336)
                      ..+......+.|||+.|.|||++.+.  ..+..+.|+|||||++|-+|+|++||...-... ..+.|.+           
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~-----------  396 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK-----------  396 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-----------
Confidence            99988889999999999999999762  234457899999999999999999997653222 2222221           


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                      .+-...+..+..++.+..+||.+||..||++|||++|+|+||||+..+..
T Consensus       397 ----------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  397 ----------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL  446 (475)
T ss_pred             ----------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence                            11222334556789999999999999999999999999999999976543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-58  Score=406.10  Aligned_cols=255  Identities=31%  Similarity=0.487  Sum_probs=233.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|+..+.||+|||+.||.+.+..+|+.||+|++.+. ..+....+++.+|+++.++|+|||||+++++|++.     .++
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~nV   93 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NNV   93 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----Cce
Confidence            699999999999999999999999999999999764 46778889999999999999999999999999998     789


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      |||.|+|. ++|..+++.+++++|.+++.+++||+.||.|||+++|+|||||..|++++++.++||+|||+|...... +
T Consensus        94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            99999998 799999999999999999999999999999999999999999999999999999999999999987754 5


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ...+.+||+.|.|||++.. ...+..+||||+||+||-||.|++||...+..+....|...-                  
T Consensus       174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------------  234 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------------  234 (592)
T ss_pred             ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC------------------
Confidence            6678899999999999986 788999999999999999999999999998888888776521                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ...+..+|.++++||.+||+.||.+|||++++|+|+||++-.
T Consensus       235 -------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  235 -------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             -------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence                         122347799999999999999999999999999999995543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-58  Score=385.35  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=223.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc-eEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN-DVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~-~~~   81 (336)
                      ++.++.||+|..|+||+++++.|++.+|+|.+... .++....++.+|+++++.++||+||++|+.|..+     . .++
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~is  154 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEIS  154 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEE
Confidence            45678999999999999999999999999999433 4667788999999999999999999999999988     5 499


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||+ |+|.+++...+++++.....|+.+|++||.|||. .+|+||||||+|||++..|++||||||.|....+. .
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-I  233 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-h
Confidence            9999998 5999999888999999999999999999999995 99999999999999999999999999999887766 5


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ..++.||..|||||.+.+ ..|+.++||||||+.+.|+++|+.||...  ........+..+...+++..          
T Consensus       234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l----------  302 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL----------  302 (364)
T ss_pred             cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC----------
Confidence            677899999999999998 89999999999999999999999999875  12222333333332222211          


Q ss_pred             HHHHhCCccccccccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          238 RYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                       .. ..|+++++||..||++||.+||++.|+++|||++....
T Consensus       303 -----------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  303 -----------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             -----------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence                             12 36999999999999999999999999999999998654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-57  Score=372.36  Aligned_cols=289  Identities=36%  Similarity=0.587  Sum_probs=249.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|..+.+|++|.||.||.|+|+.|++.||+|+++.......----.++|+.+|.+++|||||.+.++......   ..+|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~iy  153 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKIY  153 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ceee
Confidence            4788999999999999999999999999999998766555555566799999999999999999999887655   5699


Q ss_pred             EEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +|||||+.+|.+++.+.+ +|+..+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+..+.. ..
T Consensus       154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            999999999999998765 8999999999999999999999999999999999999999999999999999987766 45


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .+..+.|.+|+|||++.+...|+.+.|+||+|||+.||+++++.|.+....+++.+|...++.|.+..+..+..-.....
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            67778899999999999988999999999999999999999999999999999999999999999988766554333221


Q ss_pred             HHhCCccccccccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          240 VRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      .. +....-......++.  ++....+|++.+|..||.+|.||+|.|.|+||...+.
T Consensus       314 ~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  314 MT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             cc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence            11 111111112223333  5699999999999999999999999999999998653

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-57  Score=389.78  Aligned_cols=288  Identities=36%  Similarity=0.575  Sum_probs=250.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|+.+++||+|.||.||+|++..+|+.||+|++......+....-..+|+.+|++|.||||+++.++..+...   ..+|
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~---~siY  194 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS---GSIY  194 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC---ceEE
Confidence            4788899999999999999999999999999997766566777778899999999999999999999988743   5699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      +|+|||+.+|.-++.+. -.|++.+++.+++||+.||.|+|++|+.|||||.+|||||.+|.+||+|||+|+......  
T Consensus       195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence            99999999999998774 479999999999999999999999999999999999999999999999999999655443  


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ..+..+.|.+|+|||++.|...|+.+.|+||+|||+.||+.|++.|.+....+++..|.++.+.|.+..|.......+..
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~  354 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI  354 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence            45677889999999999998999999999999999999999999999999999999999999999998876222221111


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      +-  ....-++.+.+.+..++....+|+..||..||.+|.||.++|.++||..-+.
T Consensus       355 ~k--p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~  408 (560)
T KOG0600|consen  355 FK--PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL  408 (560)
T ss_pred             cC--CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence            11  1111133445667889999999999999999999999999999999955443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-55  Score=390.18  Aligned_cols=331  Identities=48%  Similarity=0.891  Sum_probs=274.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            68999999999999999999999999999999875444445566788999999999999999999998765544445689


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (336)
                      +||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+.......   
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  160 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA  160 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987543221   


Q ss_pred             -cccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 -FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+....+.++............
T Consensus       161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  240 (338)
T cd07859         161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA  240 (338)
T ss_pred             ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence             12345688999999998642 5678899999999999999999999999888888888888888777665555444444


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCC--CCCCCCcCCCcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP--RPFHFDFEHSSC  314 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~--~~~~~~~~~~~~  314 (336)
                      ..+...............++..++.+.++|.+||+.||++|||++|+++||||+++......+...  ....+.+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (338)
T cd07859         241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL  320 (338)
T ss_pred             HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence            455555544444444555677889999999999999999999999999999999987655444443  234455667788


Q ss_pred             CHHHHHHHHHHHHhhcCC
Q 019728          315 TEDHIRELIWRESVKFNP  332 (336)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~  332 (336)
                      +.+..++.+..+.+.++|
T Consensus       321 ~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         321 TKEDVRELIYREILEYHP  338 (338)
T ss_pred             CHHHHHHHHHHHHHhcCC
Confidence            899999999888888776

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-56  Score=372.75  Aligned_cols=255  Identities=26%  Similarity=0.438  Sum_probs=229.1

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.+++.||.|+||+||+++.+.|++.||+|++++.. ......+....|..+|.+++||.||+++..|++.     .++|
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-----~kLy  101 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-----EKLY  101 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----CeEE
Confidence            789999999999999999999999999999998754 3445778889999999999999999999999998     7799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc-CCCCc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~-~~~~~  159 (336)
                      +|+||+.| .|...|++.+.|+++.++.++.+|+.||.|||++||+||||||+|||+|.+|+++|+|||+++.. ...+.
T Consensus       102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999985 99999999999999999999999999999999999999999999999999999999999999854 34445


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ....+||+.|||||++.+ .+++.++|.||||+++|+|++|..||.+.+......+|.....                  
T Consensus       182 t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------------  242 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------------  242 (357)
T ss_pred             cccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------------
Confidence            566899999999999998 7999999999999999999999999999988877777765321                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC----CHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----t~~ell~h~~f~~~~  293 (336)
                                  ......++.+++++|+++|..||++|.    +++++-+||||.++.
T Consensus       243 ------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  243 ------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             ------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence                        111123799999999999999999996    799999999999875

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-56  Score=371.61  Aligned_cols=323  Identities=32%  Similarity=0.542  Sum_probs=260.3

Q ss_pred             CccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            1 MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         1 ~~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      |+|.-.+.+|+|+||.||.|...++++.||||++-....      ---+|+++|+.+.|||||++..+|........-..
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            467888999999999999999999999999999854321      11279999999999999999998887655322346


Q ss_pred             EEEEecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCcccC
Q 019728           81 YIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~  155 (336)
                      .+||||++-+|.+.++.    +.+++.-.++-+.+||++|++|||+.|||||||||+|+|+|.+ |.+||||||.|+...
T Consensus        98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            68999999999999973    5788999999999999999999999999999999999999976 899999999999999


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..+.+.++..|.+|+|||.+.+...|+.+.||||.||++.||+.|++.|++.+..+++..|.+.+|.|.......+....
T Consensus       178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999988765544332


Q ss_pred             HHHHHHhCCccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCC--CCCCCCcC--
Q 019728          236 ARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP--RPFHFDFE--  310 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~--~~~~~~~~--  310 (336)
                      ..   ............. .....++++.+|+.++|..+|.+|.++.|++.||||..+.++...-+..  .+.-+++.  
T Consensus       258 ~~---~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~  334 (364)
T KOG0658|consen  258 TE---FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRA  334 (364)
T ss_pred             cc---ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHH
Confidence            21   1111111111112 3457899999999999999999999999999999999987653322222  22334444  


Q ss_pred             CCcCCHHHHHHHHHHHHhhcCC
Q 019728          311 HSSCTEDHIRELIWRESVKFNP  332 (336)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~  332 (336)
                      ......+-++.++......++.
T Consensus       335 e~~~~~~~~~~l~p~~~~~~~~  356 (364)
T KOG0658|consen  335 ELGISPELVNVLIPEHLREQEK  356 (364)
T ss_pred             HhccchHHHHhhccHhhhhhcc
Confidence            3334444555555555554443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-55  Score=380.34  Aligned_cols=255  Identities=26%  Similarity=0.444  Sum_probs=229.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|++++.||+|+|++|++|+++.+++.||||++.+.. ..+....-+..|-.+|.+| .||.|+++|..|.+.     ..
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-----~s  148 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-----ES  148 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-----cc
Confidence            3788999999999999999999999999999997765 2444456667899999999 799999999999998     66


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|+|+||++ |+|.++|..-+.|++..++.++.||+.||.|||++||+||||||+|||++++|+++|+|||.++......
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            999999997 7999999999999999999999999999999999999999999999999999999999999998654332


Q ss_pred             c------------c--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 019728          159 F------------M--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  224 (336)
Q Consensus       159 ~------------~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (336)
                      .            .  .+++||-.|.+||++.. ...++++|+|+||||+|+|+.|.+||.+.+.....++|+.+.-.  
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~--  305 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE--  305 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc--
Confidence            1            1  45899999999999987 89999999999999999999999999999999999999885322  


Q ss_pred             cccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                                   ..++.++.+++||+++|..||++|+|+++|-.||||.++.
T Consensus       306 -----------------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  306 -----------------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             -----------------------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                                         2356689999999999999999999999999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-55  Score=366.61  Aligned_cols=258  Identities=30%  Similarity=0.452  Sum_probs=232.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.+.++||+|+||+||+|+++.++..||||.+.+...+....+.+..|+.+|+.++|||||.++++....     ..+|
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~i~   85 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DFIY   85 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----CeEE
Confidence            58889999999999999999999999999999988777888889999999999999999999999999988     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC------CCEEEEeccCCccc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS------CDLKIGDFGLARTT  154 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~------~~~kl~dfg~~~~~  154 (336)
                      +|||||+ |+|.++|++.+.+++..++.++.||+.|+++||+++|+||||||+|||++..      -.+||+|||+|+..
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999998 6999999999999999999999999999999999999999999999999765      45899999999999


Q ss_pred             CCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .+.......+|++.|||||++.. .+|+.++|+||+|+|+|+|++|+.||......+....+.+.-...+          
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~----------  234 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP----------  234 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC----------
Confidence            98888889999999999999986 8999999999999999999999999999988888776655322211          


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                        ......+..+.+++...|+.+|.+|.+..+-+.|+++..-+
T Consensus       235 ------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  235 ------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                              11124577788999999999999999999999999987643

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-53  Score=376.69  Aligned_cols=331  Identities=71%  Similarity=1.164  Sum_probs=288.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|+||++.+..+++.||||.+............+..|+.+++.++||||+++++++...........|
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            68999999999999999999999999999999876544455566778899999999999999999988766444445689


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccc
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  160 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~  160 (336)
                      +++||++++|.+++...+++++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus        86 lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  165 (337)
T cd07858          86 IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM  165 (337)
T ss_pred             EEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999998765443 233


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+....+.+.+.............+.
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (337)
T cd07858         166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI  245 (337)
T ss_pred             cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHH
Confidence            34567888999999876456889999999999999999999999998888888888888888877766665666666666


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ...............+..+..+.++|++||+.||++|||++++++||||..+......+.++.++.+|+++...+.+.++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (337)
T cd07858         246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIK  325 (337)
T ss_pred             HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCHHHHH
Confidence            66555544444555678899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      +.+..|.+.+.|
T Consensus       326 ~~~~~~~~~~~~  337 (337)
T cd07858         326 ELIYNEMLAYHP  337 (337)
T ss_pred             HHHHHHHhhcCC
Confidence            999999998865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-54  Score=358.49  Aligned_cols=290  Identities=37%  Similarity=0.648  Sum_probs=247.6

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc-eeeecceecCCCC-CCcceE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~-~~~~~~   80 (336)
                      |..+++||+|.+|+||+|++..+|+.||+|++......+..-....+|+.+++.++|+| |+.+++++..... .....+
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            56678899999999999999999999999999766544445566789999999999999 9999999988642 122368


Q ss_pred             EEEEecCCccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-
Q 019728           81 YIVYELMDTDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-  155 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-  155 (336)
                      ++|+||++-+|..++....    .++...++.+++||+.||+|||++||+||||||+||+++++|.+||+|||+|+..+ 
T Consensus        93 ~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i  172 (323)
T KOG0594|consen   93 YLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI  172 (323)
T ss_pred             EEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence            9999999999999997754    57788999999999999999999999999999999999999999999999999766 


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      +........+|.+|+|||++.++..|+...||||+|||++||+++...|.+....+++..|.+.+++|....|.....-.
T Consensus       173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~  252 (323)
T KOG0594|consen  173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP  252 (323)
T ss_pred             CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence            44446777999999999999998899999999999999999999999999999999999999999999998776544322


Q ss_pred             HHHHHHhCCccc-cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          236 ARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      ....  .+.... ........+..+++..+++.+||+.+|.+|.|++.+|+||||..+..
T Consensus       253 ~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  253 DYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             cccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            2111  222222 33344455566689999999999999999999999999999998754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-54  Score=377.91  Aligned_cols=254  Identities=32%  Similarity=0.462  Sum_probs=223.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC---hhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||+|++|.+..+++.||+|++......   ......+.+|+.++++++ ||||+++++++...     
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-----   92 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-----   92 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-----
Confidence            589999999999999999999999999999977654211   234556668999999998 99999999999988     


Q ss_pred             ceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCccc-
Q 019728           78 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTT-  154 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~-  154 (336)
                      ..+|+||||+.| +|.+++.+.+++.+.+++.+++||+.|++|+|++||+||||||+|++++.+ +++||+|||++... 
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            669999999985 999999999999999999999999999999999999999999999999999 99999999999988 


Q ss_pred             CCCCcccceeeeecccCchhcccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .........+|++.|+|||++.+.. ..+.++||||+|+++|.|++|+.||...+.......+.+..             
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-------------  239 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-------------  239 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-------------
Confidence            5667788889999999999999855 45789999999999999999999999977766666543311             


Q ss_pred             chHHHHHHhCCccccccccccCCCC-ChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                        ......+ |.++.+|+++||..||.+|+|+.+++.||||+.
T Consensus       240 ------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 ------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                              1112233 999999999999999999999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.5e-53  Score=368.33  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=227.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+++.||.|+||.||+|+.+.||+.||+|++++.. ........+..|-.+|....+|.||++|..|++.     .++
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-----~~L  216 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-----EYL  216 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----Cee
Confidence            3789999999999999999999999999999998754 5667788889999999999999999999999998     779


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC---
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---  156 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~---  156 (336)
                      |+||||++ |++..+|...+.++++.++.++.+++.|+..+|+.|++||||||+|+|||..|++||+|||++.....   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999998 59999999999999999999999999999999999999999999999999999999999999842111   


Q ss_pred             -------------------CCcc--------------------------cceeeeecccCchhcccCCCCCccchHHHHH
Q 019728          157 -------------------TDFM--------------------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  191 (336)
Q Consensus       157 -------------------~~~~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (336)
                                         .+..                          .+.+||+.|+|||++.+ ..++...|.||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHH
Confidence                               0000                          22468999999999998 7799999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcC
Q 019728          192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  271 (336)
Q Consensus       192 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  271 (336)
                      ||+||||.|.+||.+.++.+...+|.........                           +....++++++|||.+||.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------------------P~~~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------------------PEEVDLSDEAKDLITRLLC  428 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------------------CCcCcccHHHHHHHHHHhc
Confidence            9999999999999999999999999875432221                           1123557999999999999


Q ss_pred             CCCCCCC---CHHHHHcCcccccCc
Q 019728          272 FDPNKRI---TVEEALRHPYLQSLH  293 (336)
Q Consensus       272 ~dp~~Rp---t~~ell~h~~f~~~~  293 (336)
                       ||.+|.   +++||-.||||+++.
T Consensus       429 -d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  429 -DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             -CHHHhcCcccHHHHhcCCccccCC
Confidence             999998   699999999999975

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-53  Score=377.98  Aligned_cols=260  Identities=30%  Similarity=0.412  Sum_probs=237.9

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |++++.||.|+-|.|.+|++..||+..|||++.+. .........+-+|+.+|+.+.|||++++|+++...     .++|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----~~ly   88 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----QHLY   88 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----ceEE
Confidence            78999999999999999999999999999999765 45666778888999999999999999999999988     7799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +|.||++ |.|++++...+++++.++.++++||+.|+.|+|..+||||||||+|+|++..+++||+|||.|....+....
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            9999997 699999999999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ...||++.|++||++.|..+.+.++||||.|||+|.||+|..||.+.+....+.++.+.                     
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G---------------------  227 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG---------------------  227 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC---------------------
Confidence            88999999999999999777799999999999999999999999988777666666442                     


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE  298 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~  298 (336)
                                ...+...+|.++++||++||..||++|.|.+|++.|||++.......+
T Consensus       228 ----------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  228 ----------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             ----------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                      234446789999999999999999999999999999999987665555

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-52  Score=368.07  Aligned_cols=327  Identities=45%  Similarity=0.833  Sum_probs=264.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|.+.+.||.|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... ......
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            6889999999999999999999999999999997654444556677899999999999999999998865432 123458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+++++++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......  .
T Consensus        96 ~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  172 (343)
T cd07878          96 YLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--M  172 (343)
T ss_pred             EEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--c
Confidence            99999999899888754 57999999999999999999999999999999999999999999999999998765443  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...............+.
T Consensus       173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07878         173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI  252 (343)
T ss_pred             CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHh
Confidence            34578899999999877567899999999999999999999999998888888888887776665544444334444444


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..............+...++.+.+||.+||+.||.+|||+.|++.||||.........+.. .+..........+.+.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  331 (343)
T cd07878         253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEA-EPYDESPENKERTIEEWK  331 (343)
T ss_pred             hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcccccc-CccccchhhhhccHHHHH
Confidence            4444444444444556678889999999999999999999999999999987665433322 344444445667778888


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      +....+...|+|
T Consensus       332 ~~~~~~~~~~~~  343 (343)
T cd07878         332 ELTYEEVSSFKP  343 (343)
T ss_pred             HHHHHHHHhcCC
Confidence            888888877766

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=349.17  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=218.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecc-eecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD-IIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~~~~~~~~   80 (336)
                      .|.|+++||.|+||.||++.+..+|+.+|.|.++...-+....+....|+.+|++|+|||||++++ .+.++ .   .-+
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~-~---evl   95 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED-N---EVL   95 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc-c---hhh
Confidence            388999999999999999999999999999999877778888899999999999999999999999 44433 1   338


Q ss_pred             EEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--eeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           81 YIVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHS--AS--VLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~--i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      +|+||+|+ |+|...++    ..+.+++..+|.++.|++.||..+|+  .+  +.||||||.||+++.+|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999998 79999985    35679999999999999999999999  45  999999999999999999999999999


Q ss_pred             cccCCCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          152 RTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       152 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      +..++... ..+.+||++||+||.+.+ .+|+.+||||||||++|||+.-+.||.+.+......+|....          
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd----------  244 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD----------  244 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC----------
Confidence            98877643 467899999999999998 899999999999999999999999999998777777765521          


Q ss_pred             cccchHHHHHHhCCccccccccccC-CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                          .++.+ ..+|.++..+|..|+.+||..||+.     +|+++.+.
T Consensus       245 --------------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  245 --------------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             --------------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                                11222 3568899999999999999999986     45554443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-51  Score=369.48  Aligned_cols=328  Identities=41%  Similarity=0.696  Sum_probs=259.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++.......+...|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            47899999999999999999999999999999876555555667888999999999999999999999877543444789


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--c
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (336)
                      +||||+.++|.+.+...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......  .
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~  160 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH  160 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987543321  2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.++........ ......
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~~~~  239 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAH  239 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh-HHHHHH
Confidence            2334678899999999875668999999999999999999999999999988999998888877654332211 111111


Q ss_pred             HHhCCcccc--ccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC--------------------CCC
Q 019728          240 VRQLPRCRK--QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD--------------------LND  297 (336)
Q Consensus       240 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~--------------------~~~  297 (336)
                      .........  ..........+.++.+||.+||+.||.+|||+.|+++||||+...-                    ...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDF  319 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCccc
Confidence            111111110  0111223456889999999999999999999999999999987421                    112


Q ss_pred             CCCCCCCCCCCcCCCcCCHHHHHHHHHHHHhhc
Q 019728          298 EPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF  330 (336)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (336)
                      ++....+++.+......+...+++.+..+..++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         320 EPSANPPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             CCCCCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence            233334455555566677788888888877665

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-53  Score=340.74  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=227.0

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.+++.||.|+||.|-+++.+.+|..||+|++.+.. -.-.+.+....|..+|+.+.||+++++++.+.+.     ..+|
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~~ly  120 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----SNLY  120 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----CeEE
Confidence            678999999999999999999999999999997643 3445667778899999999999999999999988     7799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +||||.+ |.|.+++++.++|++..++.++.||+.|++|||+++|++|||||+|||+|.+|.+||+|||+|+.....  .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            9999998 599999999999999999999999999999999999999999999999999999999999999988776  4


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      -..|||+.|+|||++.. .+++.++|.|+||+++|||+.|+.||...+......+|.+..-                   
T Consensus       199 ~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-------------------  258 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-------------------  258 (355)
T ss_pred             EEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-------------------
Confidence            56799999999999988 8999999999999999999999999999988777777755211                   


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                  ..+...++++++||+++|+.|-++|.     ...++.+||||+++.
T Consensus       259 ------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  259 ------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             ------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence                        12246699999999999999999994     678999999998863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-52  Score=354.66  Aligned_cols=260  Identities=28%  Similarity=0.405  Sum_probs=216.2

Q ss_pred             CccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            1 MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         1 ~~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      ++|..++.||+|+||+||++.+..+|+..|+|.+...  +....+.+.+|+.+|++++|||||++++.......   ..+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~   91 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEY   91 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eee
Confidence            3578899999999999999999999999999998654  22237778899999999999999999998555421   358


Q ss_pred             EEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCcccCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSE-  156 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~-  156 (336)
                      +++|||+. |+|.+++...+ ++++..++.+.+||++||+|||++||+|+||||+|||++. ++.+||+|||.+..... 
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999998 69999998876 7999999999999999999999999999999999999999 79999999999887663 


Q ss_pred             ---CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCcccccccc
Q 019728          157 ---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK-DYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                         ........||+.|||||++........++|||||||++.||+||..||... ...+.+-.+..              
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~--------------  237 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR--------------  237 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc--------------
Confidence               223446789999999999985233446999999999999999999999873 32222222211              


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                     ....+.....+|.++++||.+||..||++||||+++|+|||.++...
T Consensus       238 ---------------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  238 ---------------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ---------------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                           11122444568999999999999999999999999999999987543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-51  Score=356.23  Aligned_cols=280  Identities=36%  Similarity=0.653  Sum_probs=229.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|+||+||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~   79 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCLT   79 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEE
Confidence            5899999999999999999999999999999986542 222345667899999999999999999999876     5689


Q ss_pred             EEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+....... .
T Consensus        80 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            999999999999987644 57899999999999999999999999999999999999999999999999987644322 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch-HHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN-ARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  238 (336)
                      .....++..|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+.+..+....+.++...+....... ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            2345678899999998765678999999999999999999999999998888888888888877776554332211 111


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      +  ..+..+........+..+.++.+||++||+.||.+|||++|+++||||
T Consensus       240 ~--~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 Y--LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             c--ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            0  011111122223345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.6e-52  Score=369.33  Aligned_cols=280  Identities=33%  Similarity=0.539  Sum_probs=235.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-C-----CceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-H-----ENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----p~iv~~~~~~~~~~~~   75 (336)
                      ||.|.+.||+|+||.|.+|.|..|++.||||+++..   .....+...|+.+|+.++ |     -|+|+++++|...   
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr---  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR---  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc---
Confidence            689999999999999999999999999999999764   566788889999999996 3     4899999999998   


Q ss_pred             CcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC--CEEEEeccCC
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC--DLKIGDFGLA  151 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~  151 (336)
                        +|+|||+|.++.+|.++++.+  .+++...++.++.||+.||..||+.||+|+||||+|||+...+  .+||+|||.|
T Consensus       261 --~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  261 --NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             --cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence              889999999999999999876  5699999999999999999999999999999999999996544  5999999999


Q ss_pred             cccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          152 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      +..+..-.  .+..+..|+|||++.+ .+|+.+.||||||||++||.+|.+.|++.+..+++..|.+.++.|+.......
T Consensus       339 c~~~q~vy--tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQRVY--TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCcce--eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            88776644  7789999999999999 99999999999999999999999999999999999999999998887643321


Q ss_pred             ccchHHHHHHh----------------------------CCcc-ccc----cccccCC-CCChhHHHHHHHhcCCCCCCC
Q 019728          232 RSDNARRYVRQ----------------------------LPRC-RKQ----QFATRFP-NKSSGAVDLLEKMLVFDPNKR  277 (336)
Q Consensus       232 ~~~~~~~~~~~----------------------------~~~~-~~~----~~~~~~~-~~~~~~~~li~~~L~~dp~~R  277 (336)
                      ...  ..++.+                            .... +..    ....... .....+.+||++||.+||.+|
T Consensus       416 ~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  416 KKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             ccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence            111  111111                            0000 000    0011111 234568999999999999999


Q ss_pred             CCHHHHHcCcccccCcC
Q 019728          278 ITVEEALRHPYLQSLHD  294 (336)
Q Consensus       278 pt~~ell~h~~f~~~~~  294 (336)
                      +|+.++|+||||+....
T Consensus       494 ~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSL  510 (586)
T ss_pred             CCHHHHhcCcccccccc
Confidence            99999999999996543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.8e-51  Score=363.15  Aligned_cols=323  Identities=55%  Similarity=0.981  Sum_probs=274.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+|+.||+|.+............+.+|+.++++++||||+++++++..... .....+
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~   84 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA-DFKDVY   84 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC-CCceEE
Confidence            5889999999999999999999999999999997655445566777889999999999999999998875432 225689


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (336)
                      +||||++|+|.+++...+.+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.......   
T Consensus        85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  164 (334)
T cd07855          85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH  164 (334)
T ss_pred             EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence            99999999999999888889999999999999999999999999999999999999999999999999986543321   


Q ss_pred             --cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+....+..+....+.++............
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~  244 (334)
T cd07855         165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV  244 (334)
T ss_pred             CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence              122346788899999987646689999999999999999999999999988888888888888777665554444444


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCH
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE  316 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (336)
                      ...................+..+..+.++|++||+.||.+||++.+++.||||...+.....+.+..+++.+++..+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (334)
T cd07855         245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSR  324 (334)
T ss_pred             HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhhhcCh
Confidence            44444444333333344556789999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHH
Q 019728          317 DHIRELIWR  325 (336)
Q Consensus       317 ~~~~~~~~~  325 (336)
                      +++.+.|..
T Consensus       325 ~~~~~~~~~  333 (334)
T cd07855         325 EQLKEAIVK  333 (334)
T ss_pred             hhHHHHhhc
Confidence            999988754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-52  Score=365.97  Aligned_cols=255  Identities=30%  Similarity=0.482  Sum_probs=233.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||+|+||.||+++.+.+.+.||||.+.+...+......+.+|+.+++.++||||+.+++.|+..     .++|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceEE
Confidence            58899999999999999999999999999999998888888999999999999999999999999999987     7899


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-cc
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  160 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~  160 (336)
                      +|.|||.|+|+.++...+.++++.++.++.+++.||.|||+.+|.|+|+||.|||++..|.+|+||||+++..+... ..
T Consensus        78 vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             EEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999877664 34


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      .+..||+.|||||++.+ .+++..+|+||||||+|||..|++||.........+.|......++                
T Consensus       158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----------------  220 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----------------  220 (808)
T ss_pred             eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----------------
Confidence            56789999999999997 9999999999999999999999999998877776666655322221                


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                     ...+..+..|++.+|..||.+|.|-.+++.|||.++-.
T Consensus       221 ---------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  221 ---------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             ---------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence                           25588999999999999999999999999999998754

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.1e-50  Score=359.11  Aligned_cols=322  Identities=40%  Similarity=0.692  Sum_probs=242.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||.|+||.||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++..... ......
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            6899999999999999999999999999999997665555667778899999999999999999999875532 122458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|.+.+..  .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus       102 ~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  179 (359)
T cd07876         102 YLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM  179 (359)
T ss_pred             EEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccC
Confidence            99999999998888743  5889999999999999999999999999999999999999999999999998765544444


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+..+.+.......... ....+.
T Consensus       180 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  257 (359)
T cd07876         180 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP-TVRNYV  257 (359)
T ss_pred             CCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH-HHHHHH
Confidence            45678899999999987 7789999999999999999999999999888777777777666555433221110 111111


Q ss_pred             HhCCccccccc------------cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCC-CCCCC
Q 019728          241 RQLPRCRKQQF------------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP-RPFHF  307 (336)
Q Consensus       241 ~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~-~~~~~  307 (336)
                      ...........            .......+..+.+||.+||+.||++|||+.|+|+||||.....+......+ .....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  337 (359)
T cd07876         258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDA  337 (359)
T ss_pred             hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccccCCCcccccc
Confidence            11111110010            111223467899999999999999999999999999998654433222111 11222


Q ss_pred             CcCCCcCCHHHHHHHHHHHH
Q 019728          308 DFEHSSCTEDHIRELIWRES  327 (336)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~  327 (336)
                      .........+++.+.+....
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~  357 (359)
T cd07876         338 QLEEREHAIEEWKELIYKEV  357 (359)
T ss_pred             ccccccccHHHHHHHHHHHh
Confidence            22233444555566555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-50  Score=358.22  Aligned_cols=325  Identities=59%  Similarity=1.029  Sum_probs=281.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...........|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            68999999999999999999999999999999976554456667888999999999999999999998877533445789


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (336)
                      ++|||++++|.+++....++++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||.+.......   
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~  160 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK  160 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999988765442   


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+..............
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (330)
T cd07834         161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR  240 (330)
T ss_pred             ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence             2334467888999999987448899999999999999999999999999988888888888888777666555555566


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCC-CcCCCcCCH
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF-DFEHSSCTE  316 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~  316 (336)
                      .+................+..+..+.++|++||+.||.+||++++++.||||+++......+....++++ .++....++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (330)
T cd07834         241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTE  320 (330)
T ss_pred             hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCH
Confidence            6666666555555566677789999999999999999999999999999999999998888888888876 667888999


Q ss_pred             HHHHHHHHHH
Q 019728          317 DHIRELIWRE  326 (336)
Q Consensus       317 ~~~~~~~~~~  326 (336)
                      ++.++++.+|
T Consensus       321 ~~~~~~~~~~  330 (330)
T cd07834         321 EELKELIYEE  330 (330)
T ss_pred             HHHhHHhhcC
Confidence            9999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.9e-50  Score=358.29  Aligned_cols=323  Identities=40%  Similarity=0.665  Sum_probs=248.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++..... ......
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            6899999999999999999999999999999997665556667788899999999999999999998865432 122458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|.+.+..  .+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus       105 ~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~  182 (364)
T cd07875         105 YIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  182 (364)
T ss_pred             EEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcc
Confidence            99999999999988854  5889999999999999999999999999999999999999999999999999876655444


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.+.+......... ...+.
T Consensus       183 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  260 (364)
T cd07875         183 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYV  260 (364)
T ss_pred             cCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH-HHHHH
Confidence            55678999999999987 77899999999999999999999999999888888888777766554332221111 11111


Q ss_pred             HhCCcccc------------ccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCC-CCC
Q 019728          241 RQLPRCRK------------QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP-FHF  307 (336)
Q Consensus       241 ~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~-~~~  307 (336)
                      ........            ..........+..+++||.+||+.||.+|||+.++|+||||............+.. ..-
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~  340 (364)
T cd07875         261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK  340 (364)
T ss_pred             hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCCCCc
Confidence            11111000            00011122346689999999999999999999999999999876555443322211 122


Q ss_pred             CcCCCcCCHHHHHHHHHHHHh
Q 019728          308 DFEHSSCTEDHIRELIWRESV  328 (336)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~  328 (336)
                      +.+...-+.+++++.++.+..
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~  361 (364)
T cd07875         341 QLDEREHTIEEWKELIYKEVM  361 (364)
T ss_pred             cchhhhccHHHHHHHHHHHHH
Confidence            333445666677777766654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=361.02  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=220.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.-..+||+|+.|.||.|....+++.||||++....  ....+.++.|+.+|+..+|+|||++++.|...     ..+|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLW  346 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELW  346 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeE
Confidence            3667789999999999999999999999999996553  33456788999999999999999999999987     6699


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++| +|.+.+.. -.++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++....... .
T Consensus       347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            99999985 88888765 359999999999999999999999999999999999999999999999999987766554 5


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||++|||||+... ..|+++.||||||+++.||+.|++||...++...+..|...-. |.               
T Consensus       426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~---------------  488 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PK---------------  488 (550)
T ss_pred             cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CC---------------
Confidence            677899999999999987 8999999999999999999999999998776666655544211 11               


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                  ......+|+.+++||.+||+.|+.+|+++.|||+||||+.
T Consensus       489 ------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  489 ------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                        1223467999999999999999999999999999999953

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4e-50  Score=349.06  Aligned_cols=283  Identities=34%  Similarity=0.540  Sum_probs=224.7

Q ss_pred             ccceeeeecccceEEEEEEEeCC-CCceEEEEEecCcccChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||.|+||.||+|.+.. +++.||+|.+..............+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68999999999999999999854 467899999865543333344555677666655   69999999998865433333


Q ss_pred             ceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ..++++|||++++|.+++...  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  161 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence            568999999999999998653  458999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+....+.+.+..+.......
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (290)
T cd07862         162 FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP  240 (290)
T ss_pred             CCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc
Confidence            5444455678999999999876 678899999999999999999999999998888888888877665543321110000


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                          ...+............+..+..+.+++.+||+.||++|||+.|+|+||||
T Consensus       241 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         241 ----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ----chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                00111111222233445788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-50  Score=349.21  Aligned_cols=282  Identities=33%  Similarity=0.598  Sum_probs=223.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++...     ...|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEEE
Confidence            68999999999999999999999999999999976554555567788999999999999999999999876     6799


Q ss_pred             EEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           82 IVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      +||||+++++.+.+. ....+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......  
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            999999976655554 44679999999999999999999999999999999999999999999999999987654322  


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+....+..+..............
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            2233467889999999977 678999999999999999999999999988777777777766655443322111100000


Q ss_pred             HHH-hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVR-QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ... ................+|.++.+||++||+.||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000 000000000011123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.9e-50  Score=350.09  Aligned_cols=285  Identities=32%  Similarity=0.525  Sum_probs=220.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|+||.||+|.+..+++.||+|++..... ........+|+.+++.++||||+++++++...     ...|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~   79 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLT   79 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeEE
Confidence            58999999999999999999999999999999865432 22234567899999999999999999999877     6799


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||++++|.+++... +.+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||.+...... ..
T Consensus        80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            99999999999988654 56899999999999999999999999999999999999999999999999998754322 22


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||++.+...++.++|+|||||++|+|++|..||.+... .+.+..+....+.+....+......... 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF-  238 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc-
Confidence            23456788999999987656788999999999999999999999987543 4556666665555543322111000000 


Q ss_pred             HHHhCCccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ................+  ...+..+.+||++||+.||++|||++|+++||||++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            00000000000000001  13467899999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-49  Score=352.64  Aligned_cols=325  Identities=55%  Similarity=0.913  Sum_probs=262.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||++.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++...........|
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            689999999999999999999999999999998542 2234556678899999999999999999987766444445689


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc--
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (336)
                      +++||++++|.+.+.. +++++..++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||++........  
T Consensus        85 lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  163 (336)
T cd07849          85 IVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT  163 (336)
T ss_pred             EEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence            9999999999888755 5799999999999999999999999999999999999999999999999999876543221  


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+.......+....+.+..............
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
T cd07849         164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR  243 (336)
T ss_pred             CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhh
Confidence              123467888999998766467889999999999999999999999988888888888777776655443333333333


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCC-cCCH
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS-SCTE  316 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~  316 (336)
                      .+................+..+.++.++|++||+.||++|||+.++++||||.........+....++.+|++.. ....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (336)
T cd07849         244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPK  323 (336)
T ss_pred             hHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccccccCH
Confidence            333333333222333344567899999999999999999999999999999999988878888877777777744 3557


Q ss_pred             HHHHHHHHHHHh
Q 019728          317 DHIRELIWRESV  328 (336)
Q Consensus       317 ~~~~~~~~~~~~  328 (336)
                      ++.++++.++..
T Consensus       324 ~~~~~~~~~~~~  335 (336)
T cd07849         324 EKLKELIFEEIM  335 (336)
T ss_pred             HHHHHHHHHHhc
Confidence            788888887753

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-49  Score=353.91  Aligned_cols=327  Identities=48%  Similarity=0.869  Sum_probs=278.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|++.....+......+.+|+.+++.++|||++++++++..... ......
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            5889999999999999999999999999999987654444556677889999999999999999998876533 233458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++|+||++++|.+++.. .++++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......  .
T Consensus        96 ~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~  172 (343)
T cd07851          96 YLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--M  172 (343)
T ss_pred             EEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--c
Confidence            99999999999999876 57999999999999999999999999999999999999999999999999998765433  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+.......+....+.+++.............+.
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07851         173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI  252 (343)
T ss_pred             cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHH
Confidence            33466788999999876457789999999999999999999999998888888888888777777666666666666666


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..............+...+..+.++|++||+.||++|||+.+++.||||+........+. ..+++.+++..+...+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  331 (343)
T cd07851         253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-APPYDQSFESRDLTVDEWK  331 (343)
T ss_pred             HhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-ccccCcchhhhhcCHHHHH
Confidence            666666655566666778999999999999999999999999999999999877665444 5567778889999999999


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      .++..+..+|+|
T Consensus       332 ~~~~~~~~~~~~  343 (343)
T cd07851         332 ELVYKEIMNFKP  343 (343)
T ss_pred             HHhHHHHHhccC
Confidence            999999999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-50  Score=342.42  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=222.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++...||.|..++||+|+...+++.||||++..+..+.. .+.+.+|++.++.++||||++++..|...     ..+|
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~LW  100 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SELW  100 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec-----ceeE
Confidence            48899999999999999999999999999999987665544 78899999999999999999999999998     6799


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||++|. |++.+.+...  ..++|..+..|+++++.||.|||++|.+|||||+.|||++.+|.++|+|||.+.......
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999998 6999999763  469999999999999999999999999999999999999999999999999875433221


Q ss_pred             ----cc-cceeeeecccCchhc-ccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          159 ----FM-TEYVVTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ----~~-~~~~~~~~y~aPE~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                          .. ....++++|||||++ .....|+.++||||||++..||.+|..||....+...+  +.++.+.|+....+..+
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCcccccCC
Confidence                12 566899999999994 44478999999999999999999999999887665443  33333344322222221


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .                   .....++..++++|..||+.||++|||++++|.|+||++..
T Consensus       259 ~-------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  259 K-------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             h-------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            1                   12245577999999999999999999999999999998865

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-49  Score=346.10  Aligned_cols=283  Identities=32%  Similarity=0.532  Sum_probs=224.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||.|++|+||+|.+..+++.||+|.+..............+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            68999999999999999999999999999999865433332233445666666655   699999999998765433335


Q ss_pred             eEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+++||+++++|.+++...  ..+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            68999999999999988653  3589999999999999999999999999999999999999999999999999887655


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ........++..|+|||++.+ ..++.++|||||||++|+|++|..||......+.+..+....+.+....+........
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         161 QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             cccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            444445567889999999977 6789999999999999999999999998888888888877766554433221100000


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                          ...............+.++..+.++|.+||+.||++|||+.|++.||||
T Consensus       240 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         240 ----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                0011111122233445778899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-51  Score=349.05  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=218.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc------------ChhHHHHHHHHHHHHhhCCCCceeeeccee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD------------NIIDARRTLREIKLLRHMEHENVIAIKDII   69 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~   69 (336)
                      .|++.+.||+|.||.|.+|++..+++.||||++.+...            .....++..+|+.+|+++.|||||+++++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            58999999999999999999999999999999965421            112236888999999999999999999999


Q ss_pred             cCCCCCCcceEEEEEecCCccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEec
Q 019728           70 RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  148 (336)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (336)
                      .++..   ..+|+|+|||...-..+....++ +++++++.++++++.||.|||.+||+||||||+|+|++++|++||+||
T Consensus       178 DDP~s---~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  178 DDPES---DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cCccc---CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence            88765   77999999998543444444456 999999999999999999999999999999999999999999999999


Q ss_pred             cCCccc------CCCCcccceeeeecccCchhcccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 019728          149 GLARTT------SETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL  219 (336)
Q Consensus       149 g~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  219 (336)
                      |.+...      +..+......||+.|+|||...+.   ...+.+.||||||+++|.|+.|+.||.+....+...+|...
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~  334 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND  334 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence            998755      222334557899999999998762   34577999999999999999999999998877777777552


Q ss_pred             hCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          220 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                                   ....+..+.+...+++||.+||.+||++|.++.++.-|||...-
T Consensus       335 -----------------------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  335 -----------------------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             -----------------------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                                         11223345678899999999999999999999999999998764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.6e-49  Score=352.58  Aligned_cols=290  Identities=43%  Similarity=0.728  Sum_probs=231.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++..... ......
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            6889999999999999999999999999999997665566667788899999999999999999998875432 123458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |++|||++++|.+.+..  .+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus        98 ~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  175 (355)
T cd07874          98 YLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  175 (355)
T ss_pred             EEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcccc
Confidence            99999999999888754  5889999999999999999999999999999999999999999999999999876655444


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....+.+.+........ ....+.
T Consensus       176 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  253 (355)
T cd07874         176 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYV  253 (355)
T ss_pred             CCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH-HHHHHH
Confidence            55678999999999977 6789999999999999999999999999888777777777666554432221111 111111


Q ss_pred             HhCCcccccc------------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          241 RQLPRCRKQQ------------FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       241 ~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      ..........            ........+..+.+||.+||+.||++|||+.|+|.||||....+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            1111100000            011122346788999999999999999999999999999865433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-50  Score=347.01  Aligned_cols=253  Identities=20%  Similarity=0.313  Sum_probs=216.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++++.+.     ...
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----CeE
Confidence            5889999999999999999999999999999986532 2234456677899999999999999999998876     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||+. |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++......  
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999997 599999998889999999999999999999999999999999999999999999999999998765433  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....                   
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------------  214 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------------  214 (291)
T ss_pred             cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------
Confidence            223468899999999877 678999999999999999999999998877655544443210                   


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                  .......+..+.+||++||+.||.+|++     ++++++||||+.+.
T Consensus       215 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         215 ------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             ------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence                        0112345888999999999999999995     99999999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-49  Score=363.99  Aligned_cols=284  Identities=31%  Similarity=0.542  Sum_probs=224.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC---Ccc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---~~~   78 (336)
                      +|.+++.||.|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++......   ...
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            5899999999999999999999999999999885431      2234799999999999999999887543211   113


Q ss_pred             eEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcc
Q 019728           79 DVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLART  153 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~  153 (336)
                      .+++||||++++|.+++.    ....+++..++.++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+++.
T Consensus       141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            477999999998888774    346799999999999999999999999999999999999998765 699999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+...++.+..........
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  300 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP  300 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence            65544444567899999999987756789999999999999999999999999988888888888877765543221110


Q ss_pred             chHHHHHHhCCcccccccccc-CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          234 DNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      . ...  ..+........... ....+.++.+||++||+.||.+|||+.|+|.||||..+.+
T Consensus       301 ~-~~~--~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        301 N-YAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             h-hhc--ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            0 000  00000001111111 2246889999999999999999999999999999998754

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-49  Score=356.73  Aligned_cols=280  Identities=24%  Similarity=0.285  Sum_probs=219.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++++.||+|+||.||+|.+..+++.||+|...        ...+.+|+.++++++||||+++++++...     ...+
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~  159 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTC  159 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeE
Confidence            5899999999999999999999999999999753        23457899999999999999999999876     6689


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--Cc
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~  159 (336)
                      +++|++.++|..++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......  ..
T Consensus       160 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        160 LILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998653322  12


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCcccccccc
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-------YVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....       ....+..+....+.++..... ..
T Consensus       240 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~-~~  317 (391)
T PHA03212        240 YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI-DA  317 (391)
T ss_pred             cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc-ch
Confidence            234578999999999977 678999999999999999999998875432       344566666655554432211 11


Q ss_pred             cchHHHHH-HhCCccc-cccc---cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          233 SDNARRYV-RQLPRCR-KQQF---ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       233 ~~~~~~~~-~~~~~~~-~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                      ........ ....... ....   ......++.++.+||.+||+.||.+|||++|+|+||||+.+..+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~  386 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPY  386 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCC
Confidence            11111111 1110000 0000   011124577899999999999999999999999999999976553

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-49  Score=346.69  Aligned_cols=287  Identities=34%  Similarity=0.627  Sum_probs=232.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+..... ........+|+.++++++||||+++++++...     ...+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   80 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT   80 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence            58999999999999999999999999999999865432 22334567899999999999999999999876     6699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++++|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+....... .
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            99999999999988654 458999999999999999999999999999999999999999999999999987543322 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+....+.+....+...........
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            23346688999999987656789999999999999999999999999988888888888888777655433222111111


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                       ...............+.++.++.+||++||+.||.+|||+.|+++||||+.+...
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         241 -YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             -hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence             1111111112223345688999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-51  Score=329.04  Aligned_cols=262  Identities=28%  Similarity=0.463  Sum_probs=228.0

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc------cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF------DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      |.-.+.||.|..++|..+.++.+|+.+|+|++....      ......+...+|+.+|+++ .||+|+++.++|..+   
T Consensus        19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~---   95 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD---   95 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc---
Confidence            455678999999999999999999999999984321      1223334555899999999 599999999999988   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ..+++|+|.|+ |.|.+++.+.-.+++.+.+.|++|+++|+.|||.++||||||||+|||++++.+++|+|||+++..
T Consensus        96 --sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   96 --AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             --chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence              66899999998 899999999889999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcccceeeeecccCchhccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      .+.......+||+.|.|||.+..     ...|+...|+|++|+|+|.|+.|..||--....-++..|++..-.       
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq-------  246 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ-------  246 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc-------
Confidence            99888889999999999999863     356888999999999999999999999887777777777663221       


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                                          ...+.+.++|.+.++||++||+.||++|.|++|+|.||||..+-...
T Consensus       247 --------------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  247 --------------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             --------------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence                                12344568899999999999999999999999999999998764433

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-50  Score=341.57  Aligned_cols=252  Identities=26%  Similarity=0.442  Sum_probs=229.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      ||.+.+.||+|.||.|-+|.+..+|+.||||.+.+.. .+..+...+.+|+++|..|+||||+.+|++|...     ..+
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----dKI  128 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----DKI  128 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----ceE
Confidence            6899999999999999999999999999999997654 5677888899999999999999999999999987     559


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      .|||||.. |.|.+++...+.+++.+++.+++||.+|+.|+|+++++|||||.+|||+|.++++||.|||++.......+
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence            99999997 69999999999999999999999999999999999999999999999999999999999999999888889


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ...++|++.|.+||...+...-++..|.||||+++|-|+.|.+||.+.+.......|....                   
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga-------------------  269 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA-------------------  269 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-------------------
Confidence            9999999999999999986667899999999999999999999999998777666654411                   


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                   -..+..+.++.-||++||..+|++|.|++++.+|=|+.
T Consensus       270 -------------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  270 -------------YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -------------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                         11245577899999999999999999999999997763

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-49  Score=335.06  Aligned_cols=272  Identities=24%  Similarity=0.347  Sum_probs=230.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|.-|+||+|....++..+|+|++.+.. .......++..|.+||..+.||.++.+|..|...     ...
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~~  152 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----KYS  152 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----cee
Confidence            3788999999999999999999999999999997654 3456667778899999999999999999999988     669


Q ss_pred             EEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-
Q 019728           81 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-  156 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-  156 (336)
                      |++||||+ |+|+.+.+.+  +.|+++.++.++.+++.||+|||..|||+|||||+||||-++|++.|+||.++..... 
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999998 5999998754  6799999999999999999999999999999999999999999999999988732110 


Q ss_pred             ----------------------------------C----------------------CcccceeeeecccCchhcccCCC
Q 019728          157 ----------------------------------T----------------------DFMTEYVVTRWYRAPELLLNCTE  180 (336)
Q Consensus       157 ----------------------------------~----------------------~~~~~~~~~~~y~aPE~~~~~~~  180 (336)
                                                        .                      ....+++||-.|.|||++.+ ..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G  311 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG  311 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence                                              0                      01123567888999999998 78


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCCh
Q 019728          181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS  260 (336)
Q Consensus       181 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
                      .+.+.|.|+|||.+||||.|..||.+.+..+++.++....-.                             .+..+..+.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-----------------------------Fp~~~~vs~  362 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-----------------------------FPEEPEVSS  362 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-----------------------------CCCCCcchh
Confidence            899999999999999999999999999999988888662211                             122236678


Q ss_pred             hHHHHHHHhcCCCCCCCCC----HHHHHcCcccccCc----CCCCCCCCCCCCCCC
Q 019728          261 GAVDLLEKMLVFDPNKRIT----VEEALRHPYLQSLH----DLNDEPVCPRPFHFD  308 (336)
Q Consensus       261 ~~~~li~~~L~~dp~~Rpt----~~ell~h~~f~~~~----~~~~~~~~~~~~~~~  308 (336)
                      .++|||+++|.+||++|..    +.||-+||||++++    .....|..|.+.+..
T Consensus       363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             HHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence            9999999999999999997    99999999999986    445556666665553

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-52  Score=327.30  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=224.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.+.+.||+|.|+.|+.+.+..||+.+|+|.+.....+....+++.+|+.+-+.|+||||+++.+.+...     ...|
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~~y   86 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHY   86 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ceeE
Confidence            37788999999999999999999999999999976655666889999999999999999999999999887     6689


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~  157 (336)
                      +|+|.+.| +|...|-.+--+++-.+-..++||+++|+|+|.+||+|||+||+|+++-.   ..-+||+|||++...+..
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999986 88877766566789999999999999999999999999999999999943   345999999999988866


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ..-....|++.|+|||++.. .+++.++|||+.|+++|-||.|++||.+.+.....+.|....-..              
T Consensus       167 ~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~--------------  231 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY--------------  231 (355)
T ss_pred             cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC--------------
Confidence            66667789999999999987 899999999999999999999999999977666666665421111              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                   ..+.++.+++++++|+++||..||.+|.|+.|+|+|||+.+
T Consensus       232 -------------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  232 -------------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             -------------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                         12345788999999999999999999999999999999876

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-49  Score=350.88  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=216.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++++...     ...
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   93 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----NRV   93 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----CEE
Confidence            4889999999999999999999999999999986532 2334456788999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||+. |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            99999997 5999999988899999999999999999999999999999999999999999999999999987664432 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                       ....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                   
T Consensus       173 -~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-------------------  231 (329)
T PTZ00263        173 -FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-------------------  231 (329)
T ss_pred             -ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence             24578899999999987 678899999999999999999999998876554444332210                   


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~  292 (336)
                                  ......++..+.+||++||+.||.+|++     ++++++||||.+.
T Consensus       232 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        232 ------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             ------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                        0111236788999999999999999996     7999999999874

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-49  Score=350.62  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=212.7

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||+|+||.||+|.+..+|+.||+|++.... ..........+|+.++++++||||+++++++...     ...|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence            46999999999999999999999999996543 2334556778899999999999999999999877     67999999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccce
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY  163 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~  163 (336)
                      |++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.... .......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            997 59999998888999999999999999999999999999999999999999999999999999875322 2223445


Q ss_pred             eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      .|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....                       
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----------------------  211 (323)
T cd05571         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-----------------------  211 (323)
T ss_pred             ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-----------------------
Confidence            78999999999987 778999999999999999999999998876555444332210                       


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                              ......++.++.+||++||+.||++||     ++.++++||||.++
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         212 --------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                    011235688999999999999999999     89999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.3e-49  Score=341.01  Aligned_cols=259  Identities=21%  Similarity=0.312  Sum_probs=213.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++.+.||+|+||.||++.+..+|+.||+|.+..... .......+.+|+.+++.++|+|++++++++...     ...
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeE
Confidence            48899999999999999999999999999999865432 223345567899999999999999999999877     669


Q ss_pred             EEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +++|||++ |+|.+.+..  ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999997 588877754  346899999999999999999999999999999999999999999999999998765444


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......              
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  220 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--------------  220 (285)
T ss_pred             CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--------------
Confidence            33344578999999999987 788999999999999999999999998765432222222211110              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                   ........+.++.+||++||+.||++||+     ++++++||||.++.
T Consensus       221 -------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         221 -------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             -------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence                         01122457889999999999999999996     99999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-48  Score=344.58  Aligned_cols=327  Identities=43%  Similarity=0.780  Sum_probs=266.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+............+..|+.+++.++||||+++++++...... .....
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            68999999999999999999999999999999866544555566788999999999999999999998765321 22457


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++|||+++++|.+++.. ..+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+......  .
T Consensus        96 ~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~  172 (343)
T cd07880          96 YLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--M  172 (343)
T ss_pred             EEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--c
Confidence            99999998899888865 57999999999999999999999999999999999999999999999999998765433  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+......++..............+.
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07880         173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV  252 (343)
T ss_pred             cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHH
Confidence            23456788999999876456889999999999999999999999988877777666665555444333333333334444


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..+............+..++.+.++|.+||+.||++|||+.+++.||||+........+.. .++..+++..+.+-++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  331 (343)
T cd07880         253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEA-PPYDDSFDEVDQSLEEWK  331 (343)
T ss_pred             HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCC-CCccccHHhhccchHHHH
Confidence            4444444444445556789999999999999999999999999999999998665544433 367778889999999999


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      .+.+-|.+.|.|
T Consensus       332 ~~~~~~~~~~~~  343 (343)
T cd07880         332 RLTFTEILSFQP  343 (343)
T ss_pred             HHHHHHHHhcCC
Confidence            999999999976

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4e-48  Score=342.73  Aligned_cols=322  Identities=54%  Similarity=0.901  Sum_probs=261.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCC--CceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||.|+||.||++.+..+  ++.||+|.+............+.+|+.+++++ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            589999999999999999999888  89999999875444444556778899999999 5999999998754321 1224


Q ss_pred             eEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           79 DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ..|+++++++++|.+++....++++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            58999999999999999888899999999999999999999999999999999999999999999999999987644321


Q ss_pred             c-----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          159 F-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       159 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .     .....++..|+|||++.+...++.++|+||+|+++|+|++|..||...+.......+....+.++.........
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence            1     22346788899999886645788999999999999999999999999988888888888888776655444333


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS  313 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~  313 (336)
                      .....+................+..+..+.+++.+||+.||++|||+.+++.||||+..++....+.|..+.+++|....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED  319 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccc
Confidence            33333444444333344445556778999999999999999999999999999999999999899999999888877543


Q ss_pred             CCHHHHHHHHHH
Q 019728          314 CTEDHIRELIWR  325 (336)
Q Consensus       314 ~~~~~~~~~~~~  325 (336)
                       +-+.+++.|.+
T Consensus       320 -~~~~~~~~~~~  330 (332)
T cd07857         320 -SMEELRDMIIE  330 (332)
T ss_pred             -cHHHHHHHHhh
Confidence             33445555543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=344.68  Aligned_cols=259  Identities=32%  Similarity=0.479  Sum_probs=228.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+.+.||.|.||.||.++++.+|+.+|+|++.+... +......+.+|+.+|+++. ||||+.+++.|...     ..
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-----~~  110 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-----DS  110 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-----Ce
Confidence            48899999999999999999999999999999976543 3346678889999999998 99999999999998     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC----CCEEEEeccCCccc
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTT  154 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~----~~~kl~dfg~~~~~  154 (336)
                      +++|||+|. |.|.+.+... .+++..+..++.||+.+++|||+.|++||||||+|+|+...    +.++++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999998 5999999776 49999999999999999999999999999999999999543    57999999999988


Q ss_pred             CCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .........+||+.|+|||++.. ..++...||||+|+++|.|++|..||.+.........+....-             
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------------  255 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------------  255 (382)
T ss_pred             cCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------------
Confidence            88767788899999999999987 7999999999999999999999999999887666654443211             


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                    ....+.++.++..+.+||+.||..||.+|+|+.++|.|||+++...
T Consensus       256 --------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  256 --------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             --------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                          2223456788999999999999999999999999999999887643

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-48  Score=340.41  Aligned_cols=286  Identities=35%  Similarity=0.631  Sum_probs=229.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.++||.|++|.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~   80 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT   80 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeEE
Confidence            58999999999999999999999999999999864432 22234567899999999999999999999877     6699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            99999999999988653 568999999999999999999999999999999999999999999999999987644322 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+....+....+.+....+......... .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-K  239 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc-c
Confidence            233456889999999876567888999999999999999999999998888888888887777665443322111000 0


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      ................+.+++.+.+||.+||+.||.+|||++|+++||||+.+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            0001111111112233567889999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.8e-48  Score=344.01  Aligned_cols=319  Identities=42%  Similarity=0.723  Sum_probs=243.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+.....+......+.+|+.++++++||||+++++++..... ......
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   96 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV   96 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence            5889999999999999999999999999999987655555666778899999999999999999998875532 123468


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|.+.+...  +++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus        97 ~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  174 (353)
T cd07850          97 YLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  174 (353)
T ss_pred             EEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCC
Confidence            999999999999988653  899999999999999999999999999999999999999999999999999876554444


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+.++......... ....+.
T Consensus       175 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  252 (353)
T cd07850         175 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-TVRNYV  252 (353)
T ss_pred             CCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh-hhhHHh
Confidence            44567889999999987 7889999999999999999999999999888888888877777765543322211 111111


Q ss_pred             HhCCcccccccccc-------------CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCC-CCCCCCCC
Q 019728          241 RQLPRCRKQQFATR-------------FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE-PVCPRPFH  306 (336)
Q Consensus       241 ~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~-~~~~~~~~  306 (336)
                      ..........+...             ....+..+.++|.+||+.||++|||+.|+|.||||+..-...+. ...+...+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~~~~  332 (353)
T cd07850         253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYD  332 (353)
T ss_pred             hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCCCCccc
Confidence            11111111000000             12346678999999999999999999999999999865433222 22333333


Q ss_pred             CCcCCCcCCHHHHHHHHH
Q 019728          307 FDFEHSSCTEDHIRELIW  324 (336)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~  324 (336)
                      ...+.....-+.+++.+.
T Consensus       333 ~~~~~~~~~~~~~~~~~~  350 (353)
T cd07850         333 HSIDEREHTVEEWKELIY  350 (353)
T ss_pred             cccccccccHHHHHHHHH
Confidence            333344444455555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-48  Score=342.05  Aligned_cols=326  Identities=44%  Similarity=0.777  Sum_probs=258.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++..... ......
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            5889999999999999999999999999999987654444445667899999999999999999999875432 122457


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+++||+.++|.+.+  ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......  .
T Consensus        96 ~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~  171 (342)
T cd07879          96 YLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--M  171 (342)
T ss_pred             EEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--C
Confidence            999999998887765  346899999999999999999999999999999999999999999999999998765432  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+.......+....+.+.+.............+.
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (342)
T cd07879         172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI  251 (342)
T ss_pred             CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHH
Confidence            33467888999999876456889999999999999999999999998877777777777666555444333333333333


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..............++..+..+.+||++||+.||++||++++++.||||+...... ...++.+++..........+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  330 (342)
T cd07879         252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD-EETEQQPYDDSLENEKLSVDEWK  330 (342)
T ss_pred             hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc-ccCCCCcccchhhhhhCCHHHHH
Confidence            33333333334444567788999999999999999999999999999999987543 33345555555555567778888


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      ..+..|..+|-|
T Consensus       331 ~~~~~~~~~~~~  342 (342)
T cd07879         331 KHIYKEVKSFSP  342 (342)
T ss_pred             HHhhhhhhccCC
Confidence            888888777765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=353.13  Aligned_cols=255  Identities=23%  Similarity=0.358  Sum_probs=226.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|++++.||.|+||+|+++..+.+++.||||++++.. ......+..+.|-.+++... ||.++.++.+|+..     .+
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-----~~  443 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-----EH  443 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-----Ce
Confidence            3789999999999999999999999999999998764 56667788889999998885 99999999999998     78


Q ss_pred             EEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CCC
Q 019728           80 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETD  158 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~~  158 (336)
                      +|+||||++|+-...++..+.|++..++.++..|+.||.|||++||+|||||.+|||+|.+|.+||+|||+++... ...
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            9999999986334444555889999999999999999999999999999999999999999999999999998755 445


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ...+++||+.|+|||++.+ ..|+.+.|.|+|||++||||.|..||.+.+..+....|.....                 
T Consensus       524 ~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-----------------  585 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-----------------  585 (694)
T ss_pred             ccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------------
Confidence            6678899999999999998 8999999999999999999999999999998888887765211                 


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                    .....+|.++.++++++|..+|++|..     +++|..||||+++.
T Consensus       586 --------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  586 --------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             --------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence                          122467999999999999999999993     68999999999985

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-48  Score=346.45  Aligned_cols=260  Identities=23%  Similarity=0.394  Sum_probs=220.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|++..... .......+..|+.++..++||||+++++++...     ...
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CEE
Confidence            58999999999999999999999999999999965432 233456678899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....  .
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence            99999997 59999998888899999999999999999999999999999999999999999999999999876544  2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+..........             
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------  220 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP-------------  220 (333)
T ss_pred             cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC-------------
Confidence            334578899999999987 688999999999999999999999998887666555544321111000             


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                ........++.++.+||.+||..+|.+||+++++++||||..+
T Consensus       221 ----------~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         221 ----------VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             ----------CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence                      0000113568899999999999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.5e-49  Score=347.11  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=215.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-ceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-EEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+.+.||.|+||.||+|.+..++ ..||+|++.... ........+..|+.+++.++||||+++++++...     ..
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~  105 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-----SY  105 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----CE
Confidence            4889999999999999999976554 689999986532 2334456778899999999999999999999877     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      .|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++...... 
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            999999997 599999998889999999999999999999999999999999999999999999999999998765433 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                       .....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....                  
T Consensus       185 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------------------  244 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------------------  244 (340)
T ss_pred             -cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------------------
Confidence             234578899999999987 678899999999999999999999998877655544443211                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                   .......+..+.++|++||+.||++|+     +++++++||||.++.
T Consensus       245 -------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        245 -------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                         011235688899999999999999995     899999999998763

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-49  Score=350.27  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=218.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|+||+|.+..+++.||||++..... .......+..|+.++..++||||+++++++...     ...
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----CeE
Confidence            68999999999999999999999999999999965432 224456678899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999997 5999999888889999999999999999999999999999999999999999999999999987654432 


Q ss_pred             -----------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 019728          159 -----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  209 (336)
Q Consensus       159 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  209 (336)
                                                   ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                         2234568899999999987 6889999999999999999999999988876


Q ss_pred             HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHHcCcc
Q 019728          210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPY  288 (336)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~ell~h~~  288 (336)
                      ......+.......                           ..+....+++.+.+||.+||. ||.+||+ ++++++|||
T Consensus       236 ~~~~~~i~~~~~~~---------------------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         236 QETYNKIINWKESL---------------------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             HHHHHHHhccCCcc---------------------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            55554443311110                           011123368999999999997 9999999 999999999


Q ss_pred             cccCc
Q 019728          289 LQSLH  293 (336)
Q Consensus       289 f~~~~  293 (336)
                      |+.+.
T Consensus       288 ~~~~~  292 (350)
T cd05573         288 FKGID  292 (350)
T ss_pred             cCCCC
Confidence            98763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=313.59  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=226.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+++.||.|.||.||+|+.+.++-.||+|++.++. .......++.+|+++...|+||||+++|++|.+.     ..+
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~ri   97 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----KRI   97 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----cee
Confidence            4789999999999999999999999999999986543 3445557788999999999999999999999998     669


Q ss_pred             EEEEecCC-ccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      |+++||.+ |++...++  ..+++++...+.++.|++.|+.|+|..+++||||||+|+|++.++.+|++|||.+.... .
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence            99999997 79999998  66789999999999999999999999999999999999999999999999999997766 3


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......+||..|.|||...+ ...+...|+|++|++.||++.|..||......+..++|.+..-..+             
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p-------------  242 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP-------------  242 (281)
T ss_pred             CCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-------------
Confidence            34567799999999999988 8899999999999999999999999999888888888876432222             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                        ..++..+.++|.+||..+|.+|.+..|++.|||....
T Consensus       243 ------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  243 ------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                              4678999999999999999999999999999998753

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-48  Score=347.75  Aligned_cols=257  Identities=21%  Similarity=0.291  Sum_probs=213.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++.+.||.|+||+||+|.+..+++.||+|++.... ........+..|+.++..++||||+++++.+.+.     ..+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CeE
Confidence            5889999999999999999999999999999996532 2334456677899999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999997 5999999888899999999999999999999999999999999999999999999999999986533210 


Q ss_pred             -----------------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC
Q 019728          159 -----------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  203 (336)
Q Consensus       159 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  203 (336)
                                                         ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123468999999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCC---CCCCH
Q 019728          204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN---KRITV  280 (336)
Q Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~Rpt~  280 (336)
                      |.+.+..+....+........                           .+....++.++.++|.+|+. +|.   .||++
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~---------------------------~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~  287 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLI---------------------------FPPEVPISEKAKDLILRFCC-EWEHRIGAPGV  287 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCccc---------------------------CCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH
Confidence            988776666555543211100                           01112468899999999775 444   46899


Q ss_pred             HHHHcCcccccC
Q 019728          281 EEALRHPYLQSL  292 (336)
Q Consensus       281 ~ell~h~~f~~~  292 (336)
                      +|+++||||+++
T Consensus       288 ~ei~~hp~f~~~  299 (363)
T cd05628         288 EEIKTNPFFEGV  299 (363)
T ss_pred             HHHhCCCCCCCC
Confidence            999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-47  Score=338.81  Aligned_cols=327  Identities=48%  Similarity=0.826  Sum_probs=261.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      +|.+.+.||+|++|.||++.+..+++.||+|++.....+......+.+|+.++++++||||+++++++...... .....
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   97 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence            68899999999999999999999999999999976554555567788999999999999999999988654321 22457


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+++++++++|.+++.. ..+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||++......  .
T Consensus        98 ~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~  174 (345)
T cd07877          98 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--M  174 (345)
T ss_pred             EEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--c
Confidence            89999998899888765 46999999999999999999999999999999999999999999999999998765432  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+....+.+++.............+.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (345)
T cd07877         175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI  254 (345)
T ss_pred             cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHH
Confidence            34467888999999876557888999999999999999999999888877777777777776666655555444444444


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..........+.......++.+.++|.+||+.||.+||++.++++||||++...+...+... +++..+.-...-.+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  333 (345)
T cd07877         255 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK  333 (345)
T ss_pred             HHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC-CccCcchhcccCHHHHH
Confidence            44443333333333446788999999999999999999999999999999987766555443 34443333445558888


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      +...++...|-|
T Consensus       334 ~~~~~~~~~~~~  345 (345)
T cd07877         334 SLTYDEVISFVP  345 (345)
T ss_pred             HHHHHHHHhcCC
Confidence            888888888765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8e-48  Score=333.73  Aligned_cols=281  Identities=35%  Similarity=0.628  Sum_probs=227.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||+|.+..++..||+|.+............+.+|+.++++++|||++++++++..+     ...|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence            48899999999999999999999999999999866544444456778899999999999999999999876     6699


Q ss_pred             EEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+.++|.+++...   ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            99999999999888643   568999999999999999999999999999999999999999999999999987544321


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+....+....+....+.+....+.....  ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh--hH
Confidence             222335678899999987656678999999999999999999999998877777666666665544333322111  11


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      .+..................+++++.++|++||+.||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            1222222222233334455689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-48  Score=349.46  Aligned_cols=257  Identities=22%  Similarity=0.353  Sum_probs=215.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++.+.||.|+||+||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...     ..+
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CeE
Confidence            5899999999999999999999999999999996532 2334456677899999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||+. |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999997 5999999888889999999999999999999999999999999999999999999999999886432211 


Q ss_pred             --------------------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC
Q 019728          159 --------------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  200 (336)
Q Consensus       159 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  200 (336)
                                                            ......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence                                                  0012358999999999877 7789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-
Q 019728          201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-  279 (336)
Q Consensus       201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-  279 (336)
                      ..||...+..+....+.......                           ..+....+++++.+||++||. +|.+|++ 
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~  287 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETL---------------------------QFPDEVPLSPEAKDLIKRLCC-EAERRLGN  287 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCcc---------------------------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence            99998877655544443211100                           001112468899999999997 9999998 


Q ss_pred             --HHHHHcCcccccC
Q 019728          280 --VEEALRHPYLQSL  292 (336)
Q Consensus       280 --~~ell~h~~f~~~  292 (336)
                        +.+++.||||+..
T Consensus       288 ~~~~~ll~h~~~~~~  302 (364)
T cd05599         288 NGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCHHHHhcCCCcCCC
Confidence              9999999999876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-48  Score=341.08  Aligned_cols=247  Identities=27%  Similarity=0.432  Sum_probs=210.4

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||+|+||.||+|.+..+++.||+|++.... ........+..|+.++++++||||+++++++...     ...|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence            799999999999999999999999986532 2344556778899999999999999999999876     6799999999


Q ss_pred             C-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccceee
Q 019728           88 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVV  165 (336)
Q Consensus        88 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~  165 (336)
                      + |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .......|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            7 599999988888999999999999999999999999999999999999999999999999998754322 22334568


Q ss_pred             eecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCc
Q 019728          166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR  245 (336)
Q Consensus       166 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (336)
                      ++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...   +                      
T Consensus       156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~----------------------  209 (312)
T cd05585         156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---P----------------------  209 (312)
T ss_pred             CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---C----------------------
Confidence            999999999987 77899999999999999999999999887655544433221   0                      


Q ss_pred             cccccccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHHcCcccccC
Q 019728          246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSL  292 (336)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~ell~h~~f~~~  292 (336)
                            ......+++.+.++|.+||+.||.+||   ++.++++||||...
T Consensus       210 ------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         210 ------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence                  111235688999999999999999997   68999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.2e-48  Score=357.10  Aligned_cols=281  Identities=24%  Similarity=0.359  Sum_probs=219.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC------CCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME------HENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||+||+|.+..+++.||||++....   ........|+.+++.++      |++++++++++....  
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~--  204 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET--  204 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC--
Confidence            5889999999999999999999999999999985421   22333455666666665      455888888886542  


Q ss_pred             CcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCC-------------
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASC-------------  141 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~-------------  141 (336)
                        .++|+||++++++|.+++...+.+++..++.|+.||+.||+|||+ .||+||||||+|||++.++             
T Consensus       205 --~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        205 --GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             --ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence              468999999999999999888899999999999999999999998 5999999999999998765             


Q ss_pred             ---CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 019728          142 ---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  218 (336)
Q Consensus       142 ---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  218 (336)
                         .+||+|||.+......  .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       283 ~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCceEEECCCCccccCccc--cccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence               4999999987543322  345578999999999987 7889999999999999999999999999998888888888


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCcccccccc-----------ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA-----------TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                      .++.++..............+.............           ......++.+.+||.+||+.||++|||++|+|+||
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            8887765543322222222222221111000000           00001246688999999999999999999999999


Q ss_pred             ccccC
Q 019728          288 YLQSL  292 (336)
Q Consensus       288 ~f~~~  292 (336)
                      ||...
T Consensus       440 ~~~~~  444 (467)
T PTZ00284        440 YVLKY  444 (467)
T ss_pred             ccccc
Confidence            99875

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.1e-48  Score=342.41  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+...     ...|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence            46899999999999999999999999996543 2344556778899999999999999999999877     67999999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccce
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEY  163 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~  163 (336)
                      |++ |+|...+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            997 599999988888999999999999999999999999999999999999999999999999998753322 223345


Q ss_pred             eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      .|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...                        
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~------------------------  210 (328)
T cd05593         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------------  210 (328)
T ss_pred             cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC------------------------
Confidence            68999999999977 67899999999999999999999999877655444333210                        


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                             .......++.++.+||++||+.||++|+     ++.++++||||.+.
T Consensus       211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         211 -------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             -------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                   0111245688999999999999999997     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-48  Score=342.43  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=211.9

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||+|+||.||++.+..+|+.||+|++.... ........+..|+.+++.++||||+++++.+...     ...|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence            47999999999999999999999999996542 2334556677899999999999999999999877     67999999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccce
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEY  163 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~  163 (336)
                      |++ |+|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            997 599999888888999999999999999999999999999999999999999999999999988753322 222345


Q ss_pred             eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      .|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....                       
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----------------------  211 (323)
T cd05595         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----------------------  211 (323)
T ss_pred             cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------------
Confidence            68899999999977 678999999999999999999999998876655444332210                       


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                              ......+++++.++|++||+.||.+|+     ++.++++||||.+..
T Consensus       212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         212 --------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                    011235688999999999999999998     999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.5e-47  Score=336.69  Aligned_cols=316  Identities=48%  Similarity=0.828  Sum_probs=261.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+............+..|+.+++.++|||++++++++....    ...|
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~~   86 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----EDIY   86 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----CcEE
Confidence            688999999999999999999999999999988655444445677789999999999999999999886532    4589


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  161 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (336)
                      ++|||++++|.+++.. .++++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......  ..
T Consensus        87 lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~  163 (328)
T cd07856          87 FVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MT  163 (328)
T ss_pred             EEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cC
Confidence            9999999899888765 56889999999999999999999999999999999999999999999999998754332  23


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      ...++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+.+..+.++..........+...+..
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            34567889999987654678899999999999999999999999988877777788877777665544443333444444


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHHH
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRE  321 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (336)
                      ..............+..+..+.++|++||+.+|++||++++++.||||...+.+..++.....++|.++.-..--+-++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKV  323 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhcccCCHHHHHH
Confidence            44333333333445678899999999999999999999999999999999999999999989999988887777777776


Q ss_pred             HHH
Q 019728          322 LIW  324 (336)
Q Consensus       322 ~~~  324 (336)
                      ++.
T Consensus       324 ~~~  326 (328)
T cd07856         324 MMY  326 (328)
T ss_pred             Hhc
Confidence            653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.2e-48  Score=348.48  Aligned_cols=259  Identities=22%  Similarity=0.304  Sum_probs=213.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||+||+|.+..+++.||+|++.... .+......+..|+.+++.++||||+++++++.+.     ..+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEE
Confidence            4889999999999999999999999999999996543 3344566788999999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999997 599999988888999999999999999999999999999999999999999999999999987532100  


Q ss_pred             ----------------------------------------------CcccceeeeecccCchhcccCCCCCccchHHHHH
Q 019728          158 ----------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  191 (336)
Q Consensus       158 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (336)
                                                                    .......||..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVG  235 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehh
Confidence                                                          00123468999999999977 6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcC
Q 019728          192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  271 (336)
Q Consensus       192 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  271 (336)
                      |++|+|++|..||...+..+....+.......                           ..+....+++++.+||.+|+.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~dli~~ll~  288 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------------------HIPPQVKLSPEAVDLITKLCC  288 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------------------CCCCCCCCCHHHHHHHHHHcc
Confidence            99999999999998877655444333211100                           011123568999999999664


Q ss_pred             --CCCCCCCCHHHHHcCcccccCc
Q 019728          272 --FDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       272 --~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                        .+|..|++++++++||||+.+.
T Consensus       289 ~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         289 SAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             CcccccCCCCHHHHhcCcccCCCC
Confidence              4555699999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.1e-48  Score=334.79  Aligned_cols=280  Identities=35%  Similarity=0.603  Sum_probs=220.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+............+.+|+.++++++|||++++++++.+.     ...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence            68999999999999999999999999999999865433333445677899999999999999999999876     6699


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +++||++++|.+++.+ .+.+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            9999999999998865 5679999999999999999999999999999999999999999999999999987654321 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||.+.+...++.++|+|||||++|+|++|..|+ .+.+..+.+..+.+..+.+....+........  
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  233 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD--  233 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc--
Confidence            233456788999999877556789999999999999999998875 55555666666666655544332211000000  


Q ss_pred             HHHhCCcc-ccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRC-RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      + ...... .........+.++.++.++|++||+.||.+|||+++++.||||
T Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 Y-KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             c-cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0 000000 0001122345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-48  Score=336.45  Aligned_cols=247  Identities=25%  Similarity=0.312  Sum_probs=210.3

Q ss_pred             ceeeeecccceEEEEEEEeCCCCce-EEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREE-VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      .+.+.||.|+||+||.+.+.  |.. ||+|++.....+......+.+|+.+|.+++|||||+++|++..+..    ..++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~i  117 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCI  117 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEE
Confidence            45667999999999999995  455 9999998766555558899999999999999999999999998721    5899


Q ss_pred             EEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCCCCeEEccCC-CEEEEeccCCcccCCC
Q 019728           83 VYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASC-DLKIGDFGLARTTSET  157 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  157 (336)
                      ||||++ |+|..++..  .+.++...+..|+.||+.|+.|||+++ |+||||||+|||++.++ ++||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999997 699999977  678999999999999999999999999 99999999999999998 9999999999876654


Q ss_pred             -CcccceeeeecccCchhccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          158 -DFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                       .......||+.|||||++.+ ...++.++||||+|+++|||+||..||.+.........+.....              
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~--------------  263 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL--------------  263 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC--------------
Confidence             33444688999999999985 26899999999999999999999999999887444444433111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     .+......++.+..++..||+.||.+||++.+++.
T Consensus       264 ---------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  264 ---------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ---------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                           11222347889999999999999999999999974

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-49  Score=321.87  Aligned_cols=325  Identities=42%  Similarity=0.707  Sum_probs=269.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      ||.-++.+|.|.. .|..|.|..+++.||+|+...++.+...+.+..+|...+..++|+|+++++.+|...... .+...
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            6777889999999 888999999999999999988888888889999999999999999999999999876432 34568


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+|||++.++|.+.+.  -.+....+..|+.|++.|+.|||+.||.||||||+||++..+..+||.|||++......-..
T Consensus        97 y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~m  174 (369)
T KOG0665|consen   97 YLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMM  174 (369)
T ss_pred             HHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccccc
Confidence            9999999999999997  45778899999999999999999999999999999999999999999999999877766566


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      +.+..+.+|+|||++.+ ..+....||||+||++.||++|+..|.+.+..++..++.+.++.+.+..+..+.. ..+.+.
T Consensus       175 tpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~-~~r~yv  252 (369)
T KOG0665|consen  175 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP-TVRNYV  252 (369)
T ss_pred             CchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH-HHHHHh
Confidence            77889999999999998 4599999999999999999999999999999999999999999998876544322 222223


Q ss_pred             HhCCccccccccccCC------------CCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc---cCcCCCCCCCCCCCC
Q 019728          241 RQLPRCRKQQFATRFP------------NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ---SLHDLNDEPVCPRPF  305 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~---~~~~~~~~~~~~~~~  305 (336)
                      ...++.....+.+.++            .-+..+++++.+||..||++|.+++++|+||||+   .-.+....++.  +.
T Consensus       253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe--~~  330 (369)
T KOG0665|consen  253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE--IY  330 (369)
T ss_pred             hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc--hh
Confidence            2222222222222222            2345689999999999999999999999999998   33333222222  44


Q ss_pred             CCCcCCCcCCHHHHHHHHHHHHhhcCCC
Q 019728          306 HFDFEHSSCTEDHIRELIWRESVKFNPD  333 (336)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (336)
                      +-.++....+.++|+++|++|..+|++.
T Consensus       331 d~~~d~~~~t~~e~ke~If~ev~~f~~~  358 (369)
T KOG0665|consen  331 DKQLDEREHTIEEWKELIFKEVQRFEEF  358 (369)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHhhccc
Confidence            4555566777999999999999999984

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=295.67  Aligned_cols=284  Identities=35%  Similarity=0.588  Sum_probs=241.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.-.++||+|.+|+||++++.++++.||+|.+.....++..-...++|+.+++.++|.|||+++++...+     ..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence            46667899999999999999999999999999988777777778899999999999999999999999887     5699


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +|+|||..+|..+..+ ++.+..+.++.++.|++.|+.+.|++++.|||+||+|.+++.+|++||.|||+++..+-.- -
T Consensus        78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            9999999999999865 5779999999999999999999999999999999999999999999999999998876553 3


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......|.+|++|.++.+-+-++.+.|+||.|||+.|+.. |.+.|++.+..+++.+|...++.+.+.++..+..-....
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            4455779999999999997889999999999999999986 888899999999999999999999988765432211000


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ..  -............+.++..-+++++++|.-+|.+|.+++++++||||...
T Consensus       238 ~y--p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PY--PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cc--CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            00  00000111122334567778999999999999999999999999999864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=341.80  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=219.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|+..+.||.|+||.||+|.+..+++.||||++.... .......+.+|+.++.+++++||.++|+.|..+     ..++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lw   87 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLW   87 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHH
Confidence            5778899999999999999999999999999996543 344567788999999999999999999999988     6699


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      ++||||+ |++.+.++..+.+.+.++..++++++.|+.|||..+.+|||||+.||++..+|.+||+|||.+....... .
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999998 5999999998888999999999999999999999999999999999999999999999999987655443 3


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ...+.||+.|||||++.+ ..|+.++||||||++.+||++|.+|+....++..+..|                       
T Consensus       168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-----------------------  223 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-----------------------  223 (467)
T ss_pred             cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-----------------------
Confidence            377899999999999996 89999999999999999999999999877652222111                       


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                             .+...+......|+.+++|+..||..||+.||+|.++|.|+|++..
T Consensus       224 -------pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  224 -------PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             -------cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                   1111122223679999999999999999999999999999999773

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-48  Score=348.52  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=213.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+++.||+|+||.||+|.+..+++.||+|++.... ........+..|+.++++++||||+++++.+...     ..+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence            5889999999999999999999999999999986532 2334456778899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......  
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999997 599999988888999999999999999999999999999999999999999999999999986422100  


Q ss_pred             ----------------------------------------------CcccceeeeecccCchhcccCCCCCccchHHHHH
Q 019728          158 ----------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  191 (336)
Q Consensus       158 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (336)
                                                                    .......||+.|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG  235 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence                                                          00112468899999999987 6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcC
Q 019728          192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  271 (336)
Q Consensus       192 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  271 (336)
                      |++|+|++|..||...+..+....+.......                           ..+....+++++.++|.+|+ 
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~s~~~~~li~~l~-  287 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------------------HIPPQAKLSPEASDLIIKLC-  287 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------------------CCCCcccCCHHHHHHHHHHc-
Confidence            99999999999998877655444443211110                           01112456899999999987 


Q ss_pred             CCCCCCCC---HHHHHcCcccccCc
Q 019728          272 FDPNKRIT---VEEALRHPYLQSLH  293 (336)
Q Consensus       272 ~dp~~Rpt---~~ell~h~~f~~~~  293 (336)
                      .+|.+|++   ++++++||||+.+.
T Consensus       288 ~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         288 RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            59999997   99999999998863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-47  Score=335.57  Aligned_cols=292  Identities=36%  Similarity=0.599  Sum_probs=229.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+|+.||+|.+..............+|+.++++++|+|++++++++.....   ...+
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~   84 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL---DSIF   84 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC---CeEE
Confidence            5889999999999999999999999999999986543333333455689999999999999999999876532   4589


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++++|.+++.. ...+++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            9999999999998875 3678999999999999999999999999999999999999999999999999987655432 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+....+....+.+....+...........
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK  244 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence            22334577899999987656788999999999999999999999999998888888888776655443221111000000


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND  297 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~  297 (336)
                      . .................++.+.++|++||+.||++|||+++++.||||+...-+..
T Consensus       245 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~  301 (309)
T cd07845         245 F-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE  301 (309)
T ss_pred             c-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence            0 00000001111223446889999999999999999999999999999997655433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-48  Score=347.89  Aligned_cols=257  Identities=20%  Similarity=0.302  Sum_probs=212.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+++.||.|+||.||++.+..+++.||||++.+.. ........+..|+.+++.++||||+++++++...     ...
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Cee
Confidence            5889999999999999999999999999999986532 2334456677899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++ |+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++...... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999997 5999999888889999999999999999999999999999999999999999999999999885321100 


Q ss_pred             -----------------------------------------------cccceeeeecccCchhcccCCCCCccchHHHHH
Q 019728          159 -----------------------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  191 (336)
Q Consensus       159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (336)
                                                                     ......|++.|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence                                                           0012358899999999977 6789999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcC
Q 019728          192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  271 (336)
Q Consensus       192 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  271 (336)
                      |++|+|++|..||......+....+........                           .+....++.++.+||++||.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~p~~~~~s~~~~dli~~lL~  288 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLY---------------------------FPDDIHLSVEAEDLIRRLIT  288 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC---------------------------CCCCCCCCHHHHHHHHHHhc
Confidence            999999999999988776555544433111000                           01112468899999999998


Q ss_pred             CCCCCC---CCHHHHHcCcccccC
Q 019728          272 FDPNKR---ITVEEALRHPYLQSL  292 (336)
Q Consensus       272 ~dp~~R---pt~~ell~h~~f~~~  292 (336)
                       +|.+|   +++.+++.||||++.
T Consensus       289 -~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         289 -NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             -CHhhcCCCCCHHHHhcCCCcCCC
Confidence             77765   599999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6e-48  Score=339.59  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=211.4

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||+|+||+||+|.+..+++.||+|++.... ...........|..++..+ +||||+++++++...     ..+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence            47999999999999999999999999986542 2334456677888888877 699999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||++ |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9998 59999998888999999999999999999999999999999999999999999999999999875332 222344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------------  212 (320)
T cd05590         156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------------  212 (320)
T ss_pred             cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------------
Confidence            578999999999976 778999999999999999999999999887666555443210                      


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~ell~h~~f~~~~  293 (336)
                               ......++.++.++|++||+.||.+||++      +++++||||+.+.
T Consensus       213 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         213 ---------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence                     01123468899999999999999999998      9999999998763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-47  Score=336.41  Aligned_cols=281  Identities=19%  Similarity=0.288  Sum_probs=217.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..++..||+|.+.... .......+.+|++++++++||||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   79 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS   79 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEE
Confidence            5889999999999999999999999999999986542 334557788999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++| +|.+++...+.+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            99999985 9999998888899999999999999999999986 6999999999999999999999999998765433 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc-----------
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-----------  228 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------  228 (336)
                      .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+............           
T Consensus       159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            334568899999999987 67899999999999999999999999877654433222111000000000           


Q ss_pred             --------cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          229 --------GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       229 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                              ...+..........+......  ......+++++.+||.+||+.||++|||++++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPP--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCc--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                    000000011111111110000  01112468899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.3e-47  Score=337.63  Aligned_cols=301  Identities=47%  Similarity=0.851  Sum_probs=246.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|.||++.+..+++.+|+|++.....+......+.+|+.+++++ +||||+++++++.....   ...
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~~~   84 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---KDI   84 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---ceE
Confidence            58899999999999999999998999999999866544555566777899999999 99999999998866432   458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      |+||||++++|.+++... .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        85 ~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          85 YLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            999999999999998775 78999999999999999999999999999999999999999999999999987554322  


Q ss_pred             ----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 ----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                          ......++..|+|||.+.+....+.++|+||||+++|+|++|..||.+....+....+....+.+.......+...
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence                1223467888999998876567889999999999999999999999988888888887777766655443333333


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFH  306 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~  306 (336)
                      .....................+..+.++.++|.+||+.||.+|||+.++++||||+........+..+.++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~  315 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPIT  315 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCcc
Confidence            333334444444444445555668999999999999999999999999999999999877766666655544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.8e-48  Score=347.84  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=212.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+...     ..+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CEE
Confidence            4899999999999999999999999999999986532 2233456677899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......  
T Consensus        77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999997 599999988888999999999999999999999999999999999999999999999999987422100  


Q ss_pred             ------------------------------------------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHH
Q 019728          158 ------------------------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  195 (336)
Q Consensus       158 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  195 (336)
                                                                .......|++.|+|||++.+ ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence                                                      00112468899999999977 77899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCC
Q 019728          196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  275 (336)
Q Consensus       196 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  275 (336)
                      +|++|..||.+.+..+....+.......                           ..+....+++.+.++|.+|+ .+|.
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~l~-~~p~  287 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTL---------------------------HIPSQAKLSREASDLILRLC-CGAE  287 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccc---------------------------cCCCCCCCCHHHHHHHHHHh-cCHh
Confidence            9999999998877655544332211000                           01112356889999999987 5999


Q ss_pred             CCC---CHHHHHcCcccccC
Q 019728          276 KRI---TVEEALRHPYLQSL  292 (336)
Q Consensus       276 ~Rp---t~~ell~h~~f~~~  292 (336)
                      +|+   ++.++++||||+.+
T Consensus       288 ~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         288 DRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hcCCCCCHHHHhCCCCcCCC
Confidence            999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=335.16  Aligned_cols=256  Identities=28%  Similarity=0.440  Sum_probs=233.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||.|.|..|-+|++--||+.||+|++.+...+......+++|+..|+.++|||||++|++....     ..+|+
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKlyL   94 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKLYL   94 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceEEE
Confidence            6678899999999999999999999999999998888888889999999999999999999999999877     66999


Q ss_pred             EEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE-ccCCCEEEEeccCCcccCCCCc
Q 019728           83 VYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-NASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~-~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |.|+-+ |+|+++|... ..++++.++.++.||+.|+.|+|+..+|||||||+||++ ..-|-+||+|||++....+...
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            999997 5999999764 679999999999999999999999999999999999976 5678999999999999888888


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ....+|+..|-|||.+.+..+..++.||||||+|+|-|++|+.||...++.+.+-.|+.-.                   
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-------------------  235 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-------------------  235 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-------------------
Confidence            8889999999999999998888899999999999999999999999999888887776521                   


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                  ......++.++++||..||..||++|.+.+|+.+++|++.+..
T Consensus       236 ------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  236 ------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                        1233467999999999999999999999999999999998754

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-47  Score=336.70  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=214.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCC-CceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|++.+.||.|+||.||+|.+..+++.||+|++.... ........+..|..++..++| ++|+++++++...     ..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence            4889999999999999999999999999999986542 233455667789999999976 5688899988876     66


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-C
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-T  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~  157 (336)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... .
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999997 59999998888899999999999999999999999999999999999999999999999999865322 2


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------  217 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------  217 (324)
T ss_pred             CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            22334568999999999987 678999999999999999999999998877665555443211                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~f~~~  292 (336)
                                    ......++..+.+++++||..||.+|++.     +++++||||+.+
T Consensus       218 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         218 --------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                          11123568899999999999999999976     899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.1e-48  Score=316.41  Aligned_cols=288  Identities=37%  Similarity=0.600  Sum_probs=234.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|.+|.||+|..+.++.    .+|||+++.+...........+|+.+++.++|||++.+..++...+    
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d----  100 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD----  100 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC----
Confidence            58899999999999999997655543    6999999766444455567789999999999999999999998852    


Q ss_pred             ceEEEEEecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC----CCEEEEec
Q 019728           78 NDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGDF  148 (336)
Q Consensus        78 ~~~~iv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~----~~~kl~df  148 (336)
                      ..+++++||++.+|...|+-     .+.++...++.|++||+.|++|||++.+.||||||.|||+..+    |.+||+|+
T Consensus       101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            56999999999999999952     2568999999999999999999999999999999999999877    89999999


Q ss_pred             cCCcccCCCC----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHH
Q 019728          149 GLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVHQLRL  215 (336)
Q Consensus       149 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~~  215 (336)
                      |+++.....-    .....+.|.+|+|||++.+...|+++.|+|++|||+.||++.++.|.+..         ..+++.+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9998765442    23455779999999999998899999999999999999999998885542         4578899


Q ss_pred             HHHHhCCCCcccccccccchHH-HHHHhCC-----ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          216 ITELIGSPDDASLGFLRSDNAR-RYVRQLP-----RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      |.++++.|.+..|..+..-.-. ..+..++     .............-++...+|+.+||+.||.+|.|++++|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            9999999999887665442211 1122221     111111122233456779999999999999999999999999999


Q ss_pred             ccCc
Q 019728          290 QSLH  293 (336)
Q Consensus       290 ~~~~  293 (336)
                      +...
T Consensus       341 ~~d~  344 (438)
T KOG0666|consen  341 TEDP  344 (438)
T ss_pred             ccCC
Confidence            9864

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-47  Score=328.40  Aligned_cols=258  Identities=22%  Similarity=0.326  Sum_probs=213.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++.+.||+|++|+||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+...     ...
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence            48899999999999999999999999999999865332 223345567899999999999999999999877     669


Q ss_pred             EEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ++||||+. |+|.+.+...  .++++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999997 5898887543  46899999999999999999999999999999999999999999999999998765444


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+...+....             
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  221 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------  221 (285)
T ss_pred             CccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-------------
Confidence            33334577899999999976 6788999999999999999999999987654433333322211100             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                                    ......++..+.+||.+||+.||++||     +++++++||||...
T Consensus       222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         222 --------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             --------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence                          111235688999999999999999999     99999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-48  Score=338.70  Aligned_cols=254  Identities=28%  Similarity=0.414  Sum_probs=231.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce-E
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND-V   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~-~   80 (336)
                      .|..++.+|.|+||.+++++++..++.|++|.+.....+........+|+.++++++|||||.+.+++..+     +. +
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-----~~~l   79 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-----GQLL   79 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-----CceE
Confidence            47889999999999999999999999999999988777777778899999999999999999999999987     45 8


Q ss_pred             EEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +|+|+||+| ++.+.|...  ..|+++.+..|+.|++.|+.|||+++|.|||||+.||+++.++.++|+|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999985 999998654  45899999999999999999999999999999999999999999999999999998888


Q ss_pred             C-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      . ...+..||++|++||.+.+ .+|+.++|||||||++|||++-+.+|...+......++......              
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~--------------  224 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS--------------  224 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC--------------
Confidence            6 6778899999999999998 89999999999999999999999999999988888777765432              


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                      +....++.+++.+|+.||..+|..||++.++|.+|.+..
T Consensus       225 ----------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  225 ----------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ----------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                            233466999999999999999999999999999998863

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.6e-47  Score=327.86  Aligned_cols=281  Identities=38%  Similarity=0.654  Sum_probs=227.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||+|.+..+++.||||.+............+.+|++++++++||||+++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence            38899999999999999999999999999999865544444456788999999999999999999998876     5689


Q ss_pred             EEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      ++|||+.++|.+++..  ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            9999999899998865  3568999999999999999999999999999999999999999999999999987554322 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+....+...  .....
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  233 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV--TSLPD  233 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh--hHHHH
Confidence            1223355788999999876555788999999999999999999999988887777777776665544322211  11111


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ....+............+.++.++.++|.+||+.||++|||+++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            222222222333334455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.1e-48  Score=340.04  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=210.5

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||+|+||.||++.+..+|+.||+|++.... ...........|+.++..++||||+++++.+...     ..+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence            46999999999999999999999999996543 2334456677899999999999999999999877     67999999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      |++ |+|...+...+.+++..++.++.||+.||+|||+ .|++||||||+||+++.++.++|+|||++..... ......
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            997 5899998888889999999999999999999997 7999999999999999999999999999865322 222334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~----------------------  212 (325)
T cd05594         156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------------------  212 (325)
T ss_pred             ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC----------------------
Confidence            568999999999977 678999999999999999999999998876554444332210                      


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                               ......+++++.+||++||+.||++|+     ++.++++||||.+.
T Consensus       213 ---------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         213 ---------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence                     011235688999999999999999997     99999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.5e-47  Score=333.48  Aligned_cols=277  Identities=34%  Similarity=0.576  Sum_probs=208.9

Q ss_pred             eeeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      +++||+|+||.||+|.+.  .+++.||+|.+.....    .....+|+.++++++||||+++++++.....   ..+|++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEE
Confidence            568999999999999965  4678999999864322    2346789999999999999999999865433   568999


Q ss_pred             EecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE----ccCCCEEEEeccC
Q 019728           84 YELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGL  150 (336)
Q Consensus        84 ~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~  150 (336)
                      |||++++|.+++...         ..+++..++.++.||+.||+|||+.||+||||||+|||+    +.++.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999998887532         258999999999999999999999999999999999999    4567899999999


Q ss_pred             CcccCCCC----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 019728          151 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---------VHQLRLIT  217 (336)
Q Consensus       151 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~~~  217 (336)
                      +.......    ......+++.|+|||++.+...++.++|+||+||++|+|++|..||...+.         ...+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654321    123456788999999988756789999999999999999999999975442         34556666


Q ss_pred             HHhCCCCcccccccccc-hHHHHHHhCCc-----cccc-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          218 ELIGSPDDASLGFLRSD-NARRYVRQLPR-----CRKQ-QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ...+.+....+...... ...........     .... .........+..+.+||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            66666555433221110 00000111000     0000 0011112346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.5e-47  Score=329.13  Aligned_cols=287  Identities=37%  Similarity=0.618  Sum_probs=228.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC---hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+......   ......+..|+.++++++|+||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----S   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----C
Confidence            688999999999999999999999999999999654332   33445667899999999999999999999886     6


Q ss_pred             eEEEEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++||||+.|+|.+++.... .+++..++.++.||++||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            799999999889999998766 7999999999999999999999999999999999999999999999999998765443


Q ss_pred             C-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      . ......++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+....+....+.+....+....... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc-
Confidence            2 22233457789999998765678899999999999999999988888887777777666655544333221110000 


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                       . ...............+...+..+.++|.+||+.||++|||+.|++.|+||++...+.
T Consensus       235 -~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 -D-YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             -c-cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence             0 000001111112233456688999999999999999999999999999999976554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-47  Score=338.42  Aligned_cols=259  Identities=19%  Similarity=0.290  Sum_probs=210.2

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      .|++.+.||+|+||.||++.+.   .+++.||+|++.+..  ...........|+.+++.+ +||||+++++++...   
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE---   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence            4899999999999999999874   578999999986432  2233456677899999999 599999999998877   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ..+++||||++ |+|.+++...+.+++.+++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++...
T Consensus        78 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          78 --AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence              66999999997 599999988888999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC--cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          155 SETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ....  ......|+..|+|||++.+...++.++|||||||++|+|++|..||...........+...+..          
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------  225 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----------  225 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----------
Confidence            3322  2234568999999999987456788999999999999999999999654321111111110000          


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                                       ........++..+.++|.+||+.||++||     +++++++||||+..
T Consensus       226 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         226 -----------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                             00112245788999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.2e-47  Score=327.51  Aligned_cols=283  Identities=37%  Similarity=0.651  Sum_probs=228.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+............+.+|+.++++++|||++++++++...     ...|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeE
Confidence            68999999999999999999999999999999976544445567788999999999999999999999876     6689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      +||||++++|.+++.. ..++++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9999997799999864 4678999999999999999999999999999999999999999999999999987665432  


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||.+.+...++.++||||||+++++|++|..||.+.........+....+.+....+..........
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            12344678899999998765667899999999999999999999998888777777777766655443322111100000


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                      . ...............+..+..+.++|++||+.||.+|||++++++||||.
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 K-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             c-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            0 00111111112234456789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9e-48  Score=340.23  Aligned_cols=259  Identities=22%  Similarity=0.302  Sum_probs=215.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||.|+||+||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeE
Confidence            58899999999999999999999999999999975432 333456677899999999999999999998876     679


Q ss_pred             EEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||++ |+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            99999997 5999999775 679999999999999999999999999999999999999999999999999987654332


Q ss_pred             c--ccceeeeecccCchhccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          159 F--MTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .  .....+++.|+|||++..     ...++.++|||||||++|+|++|..||...........+.......        
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------  228 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--------  228 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--------
Confidence            2  223467899999999863     2567889999999999999999999998877655554443321100        


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                         ..+..+.++..+.+||++||+ +|.+||++++++.||||+.+.
T Consensus       229 -------------------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         229 -------------------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence                               011124578899999999998 999999999999999998764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-47  Score=336.20  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=210.8

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||+|.+..+++.||+|++.... ...........|..++..+ +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence            46999999999999999999999999986532 2334456677888888876 799999999999887     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~  162 (336)
                      ||++ |+|...+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .....
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9997 599999988888999999999999999999999999999999999999999999999999998754322 22334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.....                     
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------------------  213 (321)
T cd05591         156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------------------  213 (321)
T ss_pred             cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            568999999999877 6789999999999999999999999998876666554433110                     


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-------CHHHHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-------TVEEALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-------t~~ell~h~~f~~~  292 (336)
                                .....++.++.++|++||+.||++|+       +++++++||||..+
T Consensus       214 ----------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         214 ----------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                      11124588999999999999999999       99999999999775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-47  Score=338.40  Aligned_cols=257  Identities=20%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||++.+..+++.||+|+++... ........+..|..+++.+ +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence            46999999999999999999999999997643 2334456677899999998 699999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CCCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~  162 (336)
                      ||++ |+|.+++...+++++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9997 5999999888899999999999999999999999999999999999999999999999999987532 2223344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH-HHH
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR-YVR  241 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  241 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||......+.          +         ...... ...
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~---------~~~~~~~~~~  215 (329)
T cd05588         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------P---------DQNTEDYLFQ  215 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccccccccc----------c---------cccchHHHHH
Confidence            578999999999987 7788999999999999999999999964221000          0         000000 000


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHHcCcccccC
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYLQSL  292 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~ell~h~~f~~~  292 (336)
                      .+..    ........++..+.++|++||+.||.+|++      ++++++||||..+
T Consensus       216 ~~~~----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         216 VILE----KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHc----CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            0000    001122457889999999999999999987      7999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7e-47  Score=327.95  Aligned_cols=283  Identities=30%  Similarity=0.578  Sum_probs=219.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|.+............+.+|+.++++++|||++++++++...     ...+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEEE
Confidence            58999999999999999999999999999998865433333445677899999999999999999999876     6689


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      ++|||+++ .|..++.....+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            99999986 555555566679999999999999999999999999999999999999999999999999987665443 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+....+....+....+.........+........
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            22345678899999987656678999999999999999999999998887776666665444322211111000000000


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ................+.++..+.+|+.+||+.||++||++.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000000011112245678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-48  Score=328.89  Aligned_cols=258  Identities=32%  Similarity=0.511  Sum_probs=216.7

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++++.||+|++|+||++.+..+++.||+|.+..............+|+.++++++||||+++++++...     ...++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----ccccc
Confidence            7899999999999999999999999999999977655555555556799999999999999999999886     67999


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc-CCCCcc
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFM  160 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~-~~~~~~  160 (336)
                      +||++.+ +|.+++...+.++..+++.++.||+.||++||+.|++|+||||+||+++.++.++|+|||.+... ......
T Consensus        76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999997 99999987788999999999999999999999999999999999999999999999999998753 333344


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++......+.++|+||||+++++|++|..||...........+.............           
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  224 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----------  224 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----------
Confidence            456778899999998833789999999999999999999999999885555554444432211111100           


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                   .....+..+.++|++||+.||++||++.++++||||
T Consensus       225 -------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                         001123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-47  Score=335.13  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=209.7

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHH---hhCCCCceeeecceecCCCCCCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLL---RHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l---~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      |++.+.||.|++|.||++.+..+++.||||++.... ........+..|..++   +.++||||+++++++...     .
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence            789999999999999999999999999999996543 2223345556665554   566799999999999877     6


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-  156 (336)
                      ..|+||||++| +|...+.. +.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..... 
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            79999999985 88877754 5799999999999999999999999999999999999999999999999998865332 


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....                
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------  217 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------------  217 (324)
T ss_pred             CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            222334578999999999987 678999999999999999999999998877665554443310                


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                     ......++..+.++|++||+.||.+||     ++.++++||||+.+.
T Consensus       218 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         218 ---------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                           011235688999999999999999999     799999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-47  Score=341.13  Aligned_cols=258  Identities=22%  Similarity=0.296  Sum_probs=213.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|+||.||++.+..+++.||+|++.... ........+..|+.+++.++||||+++++++...     ...
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-----~~~  118 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-----KYL  118 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CEE
Confidence            4889999999999999999999999999999996432 2233445567899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||.+....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999997 589988865 468999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccceeeeecccCchhcccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 -FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                       ......|++.|+|||++.+.   ..++.++|+|||||++|+|++|..||...+.......+.......           
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  266 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-----------  266 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC-----------
Confidence             12345689999999998652   347889999999999999999999998877655554443211100           


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSL  292 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~  292 (336)
                                      ..+....+|.++.+||++||+.+|.+  |++++++++||||+..
T Consensus       267 ----------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         267 ----------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             ----------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence                            01112356899999999999999988  9999999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-47  Score=335.31  Aligned_cols=250  Identities=23%  Similarity=0.389  Sum_probs=209.9

Q ss_pred             eeeecccceEEEEEEEeC---CCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            6 RGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      ++.||+|+||.||++.+.   .+++.||+|++....  .+......+..|+.+++.++||||+++++.+...     ...
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence            368999999999999874   578899999986532  2233445667899999999999999999999877     669


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~  158 (336)
                      |+||||+.| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999985 9999998888899999999999999999999999999999999999999999999999999864332 22


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....                  
T Consensus       156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~------------------  216 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK------------------  216 (323)
T ss_pred             cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            2334568999999999977 678899999999999999999999998877655444433210                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                                   ....+.+++.+.++|++||+.||++||     +++++++||||...
T Consensus       217 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         217 -------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                         112245688999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-48  Score=338.79  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=211.4

Q ss_pred             eeeecccceEEEEEEEe---CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            6 RGEYDDIIFFIFSAAVN---SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      ++.||+|+||.||++.+   ..+|+.||+|++...............|+.++++++||||+++++++..+     ...|+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEE
Confidence            36899999999999987   35789999999976443444456677899999999999999999999877     67999


Q ss_pred             EEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccc
Q 019728           83 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM  160 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~  160 (336)
                      ||||++ |+|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999997 599999988888999999999999999999999999999999999999999999999999998765443 223


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....                    
T Consensus       156 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------------  214 (318)
T cd05582         156 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------------  214 (318)
T ss_pred             ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            34568899999999877 677899999999999999999999998877655544432210                    


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  292 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~  292 (336)
                                 ......++..+.++|++||+.||++||+     ++++++||||+.+
T Consensus       215 -----------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         215 -----------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence                       1112356889999999999999999999     7889999999875

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-46  Score=335.68  Aligned_cols=277  Identities=24%  Similarity=0.292  Sum_probs=209.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|+||.||+|.+..+++.||+|+....        ....|+.++++++||||+++++++...     ...+
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  133 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITC  133 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----CeeE
Confidence            489999999999999999999999999999975332        224689999999999999999999877     6689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +|||++.++|.+++.. ..++++.+++.|+.||+.||+|||++||+||||||+||+++.++.++|+|||.+.........
T Consensus       134 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        134 MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999999999998865 467999999999999999999999999999999999999999999999999998754433333


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCCh---------HHHHHHHHHHhCCCCcccccc
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDY---------VHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~---------~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ....++..|+|||++.+ ..++.++|+|||||++|+|+++..+ |.....         ...+..+....+..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            44568899999999987 6789999999999999999986544 433221         122223333333222211111


Q ss_pred             cccchHHHHHHhCCccccc--cc-cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          231 LRSDNARRYVRQLPRCRKQ--QF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ........+.......+..  .. .......+.++.+||++||+.||++|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            1111111121111111000  00 01122567888999999999999999999999999999874

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.4e-47  Score=333.51  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=207.5

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||+|.+..+|+.||+|.+..... ..........|..++... +||||+++++++...     ..+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence            479999999999999999999999999965421 123345566777777755 899999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||+. |+|...+...+.+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9997 59999998888899999999999999999999999999999999999999999999999998864322 222334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~----------------------  212 (316)
T cd05620         156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT----------------------  212 (316)
T ss_pred             cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Confidence            568999999999987 778999999999999999999999998877655444432210                      


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-EEALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-~ell~h~~f~~~~  293 (336)
                               ......++.++.++|++||+.||++|+++ +++++||||..+.
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         213 ---------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                     01112468899999999999999999997 5889999998863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-47  Score=341.29  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=214.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||+||++.+..+++.||+|++.... ........+..|+.++..++||||+++++.+...     ..+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEE
Confidence            5889999999999999999999999999999996432 2334456777899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... 
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999997 5999999888899999999999999999999999999999999999999999999999999876432110 


Q ss_pred             -----------------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC
Q 019728          159 -----------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  203 (336)
Q Consensus       159 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  203 (336)
                                                         ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0113468899999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC---CH
Q 019728          204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TV  280 (336)
Q Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~  280 (336)
                      |...........+.......                          . .+....++.++.+||.+|+. ||.+|+   ++
T Consensus       236 f~~~~~~~~~~~i~~~~~~~--------------------------~-~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~  287 (360)
T cd05627         236 FCSETPQETYRKVMNWKETL--------------------------V-FPPEVPISEKAKDLILRFCT-DSENRIGSNGV  287 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCce--------------------------e-cCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCH
Confidence            98877665554443211000                          0 01112468899999999874 999998   58


Q ss_pred             HHHHcCcccccCc
Q 019728          281 EEALRHPYLQSLH  293 (336)
Q Consensus       281 ~ell~h~~f~~~~  293 (336)
                      +++++||||+++.
T Consensus       288 ~ei~~hp~f~~~~  300 (360)
T cd05627         288 EEIKSHPFFEGVD  300 (360)
T ss_pred             HHHhcCCCCCCCC
Confidence            9999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.7e-47  Score=333.73  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=210.1

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||+||++.+..+++.||+|++.+.. ...........|..+++.+ +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            47999999999999999999999999996542 2334456667888888888 699999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||++ |+|...+...+.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9997 59999998888899999999999999999999999999999999999999999999999998865322 222334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                      
T Consensus       156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~----------------------  212 (318)
T cd05570         156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE----------------------  212 (318)
T ss_pred             eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            568899999999987 778999999999999999999999998877555444332210                      


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~f~~~  292 (336)
                               ......++..+.+||++||+.||++||++     .+++.||||+..
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         213 ---------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                     01123468899999999999999999999     999999999885

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=315.08  Aligned_cols=263  Identities=26%  Similarity=0.411  Sum_probs=215.2

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||-|-.|.|..+.++.||+++|+|++..       ..+..+|+++--.. .|||||.++++|...-. +-..+.+|||
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~-~rkcLLiVmE  139 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQ-GRKCLLIVME  139 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc-CceeeEeeee
Confidence            579999999999999999999999998843       35567888887666 59999999999875432 2245889999


Q ss_pred             cCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCcccCCCCc
Q 019728           86 LMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~~~  159 (336)
                      .++ |.|++.+++++.  |++.++..|++||..|+.|||+.+|+||||||+|+|++.   +..+||+|||+++....+..
T Consensus       140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~  219 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD  219 (400)
T ss_pred             cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCcc
Confidence            998 599999988765  999999999999999999999999999999999999965   44599999999999887777


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ..+.+.|++|.|||++.. .+++.+.|+||+|+++|-||+|++||...........+..-+.                  
T Consensus       220 L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~------------------  280 (400)
T KOG0604|consen  220 LMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR------------------  280 (400)
T ss_pred             ccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh------------------
Confidence            778899999999999976 7899999999999999999999999977654322222211111                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC  301 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~  301 (336)
                           ...-....+.|..+|...+++|+++|..+|++|.|++++++|||+.+......-+.+
T Consensus       281 -----~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  281 -----TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             -----ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence                 000111123445679999999999999999999999999999999987655444444

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-47  Score=335.05  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=207.6

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHH-HHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||+||+|.+..+|+.||+|++.... ........+..|.. +++.++||||+++++.+...     ...|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence            47999999999999999999999999986532 12233344555554 56788999999999999876     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||++ |+|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9997 59999998888899999999999999999999999999999999999999999999999999875332 222334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------------  211 (323)
T cd05575         156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----------------------  211 (323)
T ss_pred             ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            568999999999877 77899999999999999999999999887765544443221                       


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~ell~h~~f~~~~  293 (336)
                              .....+.++..+.++|++||+.||.+||++    .++++||||.++.
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         212 --------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                    011234568899999999999999999987    6999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.5e-47  Score=332.44  Aligned_cols=250  Identities=25%  Similarity=0.371  Sum_probs=207.3

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||+|+||.||+|.+..+++.||+|+++.... ..........|..++... +||||+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            469999999999999999999999999965431 223344556677676654 799999999999876     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~  162 (336)
                      ||++ |+|..++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...... .....
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9997 599999988888999999999999999999999999999999999999999999999999998754322 23344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------------  212 (316)
T cd05592         156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------------  212 (316)
T ss_pred             ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            578999999999987 678999999999999999999999999877655544432210                      


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-EEALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-~ell~h~~f~~~~  293 (336)
                               ......++.++.++|++||+.||++||++ .+++.||||..+.
T Consensus       213 ---------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         213 ---------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                     11123468889999999999999999986 5888999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.1e-47  Score=333.03  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=214.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++.+... ..........|..++..+ +||+|+++++++...     ..
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence            48899999999999999999999999999999865432 233445566788888777 589999999999877     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  157 (336)
                      .|+||||++ |+|.+.+...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... 
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999997 599999988888999999999999999999999999999999999999999999999999998754322 


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.....                
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------------  218 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------------  218 (323)
T ss_pred             CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            22334568999999999987 7789999999999999999999999998876665554433110                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                     .....++.++.+++.+||+.||.+|++     ..++++||||+.+.
T Consensus       219 ---------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         219 ---------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             ---------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                           112356889999999999999999997     58999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.2e-47  Score=338.82  Aligned_cols=258  Identities=22%  Similarity=0.291  Sum_probs=211.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||++.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...     ...
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~  118 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-----KYL  118 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEE
Confidence            5889999999999999999999999999999986432 2333445567899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            99999997 599998865 4689999999999999999999999999999999999999999999999999876543321


Q ss_pred             --ccceeeeecccCchhcccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          160 --MTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                        .....|++.|+|||++.+.   ..++.++|+|||||++|+|++|..||...+.......+........          
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------  267 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN----------  267 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC----------
Confidence              2345789999999998652   2378899999999999999999999988776655554433111000          


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSL  292 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~  292 (336)
                                       .+....++..+.+++..||..++.+  |+++.|+++||||+..
T Consensus       268 -----------------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         268 -----------------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             -----------------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                             0111356889999999999865544  8899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-46  Score=327.54  Aligned_cols=284  Identities=37%  Similarity=0.635  Sum_probs=225.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.++...........+.+|+.++++++||||+++++++.....   ...|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~~   82 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL---DKIY   82 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcEE
Confidence            4788999999999999999999999999999997554333344556789999999999999999998876532   5689


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      ++|||++++|.+++... ..+++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus        83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            99999999999998764 35899999999999999999999999999999999999999999999999998766544 22


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+....+.++|+||||+++++|++|..||......+....+....+.+.+..+.....-.....
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            33345678899999987655678999999999999999999999999888888888877776665543322110000000


Q ss_pred             HHhCCccccccccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                       ..............++.  +++.+.++|++||+.||++|||+.|++.||||
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         243 -KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             -cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             00001111111223333  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-46  Score=325.06  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=204.4

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||.|+||+||++.+..+++.||+|++..... .......+..|+.+++.++||||+++.+++...     ...|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence            7999999999999999999999999865322 223345667899999999999999999998877     6699999999


Q ss_pred             C-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-cc
Q 019728           88 D-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MT  161 (336)
Q Consensus        88 ~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-~~  161 (336)
                      + |+|...+.    ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........ ..
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            7 58887763    345689999999999999999999999999999999999999999999999999876543322 23


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      ...++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+......                   
T Consensus       156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  215 (280)
T cd05608         156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-------------------  215 (280)
T ss_pred             ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-------------------
Confidence            3467889999999987 77889999999999999999999999765432211111111000                   


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                              ........++..+.+++.+||+.||++||     +++++++||||++..
T Consensus       216 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         216 --------DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             --------cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence                    00111245788999999999999999999     889999999998853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-47  Score=334.97  Aligned_cols=253  Identities=19%  Similarity=0.347  Sum_probs=205.6

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||+|+||.||+|.+..+++.||+|++.+.. ........+..|..++.++ +||||+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence            47999999999999999999999999997643 2334556677888888877 799999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||++ |+|...+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9998 59999988888899999999999999999999999999999999999999999999999999875322 222334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCcccccccccchHH
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-----HQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||......     .....+.+                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-------------------  215 (329)
T cd05618         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------------------  215 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH-------------------
Confidence            578999999999987 77899999999999999999999999532110     00000000                   


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~ell~h~~f~~~  292 (336)
                          ...    ..........+..+.++|++||+.||++||+      +.++++||||+++
T Consensus       216 ----~i~----~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         216 ----VIL----EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             ----HHh----cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence                000    0001223467889999999999999999998      5899999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-46  Score=322.53  Aligned_cols=280  Identities=39%  Similarity=0.678  Sum_probs=226.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++.+.||.|++|.||++.+..+|+.||+|++............+.+|+.+++.++|||++++++++...     ...|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence            6789999999999999999999999999999875543334445677899999999999999999999876     66999


Q ss_pred             EEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           83 VYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        83 v~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +|||++++|.+++....  .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            99999989999997765  78999999999999999999999999999999999999999999999999987554321 1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+...++.++|+||||+++|+|++|..||...+.......+.+..+.+....+...  .....+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV--TSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh--hhchhh
Confidence            223355788999998876456788999999999999999999999988887777777666555544332111  111112


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ...+............+.++..+.++|.+||+.||.+|||++|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            22222222223334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-46  Score=323.65  Aligned_cols=280  Identities=36%  Similarity=0.659  Sum_probs=221.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |++.++||.|++|.||++.+..+++.||+|.++....... .....+|+.+++++. |||++++++++.+...   ...+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEE
Confidence            6889999999999999999999999999999865433322 234457888999885 9999999999886532   4589


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +||||++++|.+.+... ..+++.+++.++.||+.||+|||+.|++|+||+|+||+++. +.++|+|||.+.........
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            99999999999988764 57899999999999999999999999999999999999999 99999999999876554444


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+......+.++|+|||||++|+|++|..||.+.+..+....+....+.+...............+ 
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY-  234 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc-
Confidence            4456788999999876546678899999999999999999999999888887777777666555432211111100000 


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                       ..............+..+..+.++|.+||+.+|++||++++++.||||
T Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 -NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             -cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence             000000111112234678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-46  Score=329.89  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=207.5

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||+|+||.||+|.+..+++.||+|++..... ..........|..++... +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence            479999999999999999999999999965421 223345566677777764 899999999999877     6699999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~  162 (336)
                      ||++ |+|.+++.....+++.++..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++...... .....
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9997 599999988788999999999999999999999999999999999999999999999999998753222 22334


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------------  212 (316)
T cd05619         156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN----------------------  212 (316)
T ss_pred             ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Confidence            567899999999987 678999999999999999999999998877655444432210                      


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-ell~h~~f~~~~  293 (336)
                               ......++.++.++|.+||+.||++||++. ++++||||+.+.
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         213 ---------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             ---------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence                     001124578899999999999999999996 899999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-46  Score=337.26  Aligned_cols=278  Identities=23%  Similarity=0.282  Sum_probs=215.9

Q ss_pred             ccceeeeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+++.||.|++|.||++...  .+++.||+|.+...       ....+|+.+++.++||||+++++++...     ..
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~  160 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK-----ST  160 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC-----CE
Confidence            6999999999999999999764  45678999988542       2245799999999999999999998876     67


Q ss_pred             EEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           80 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      .|++||++.++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus       161 ~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        161 VCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99999999999999997778899999999999999999999999999999999999999999999999999876543322


Q ss_pred             ---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCccccccccc
Q 019728          160 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---VHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                         .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+...   ...+..+.+.++..+...... ..
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~-~~  318 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN-GS  318 (392)
T ss_pred             cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc-cc
Confidence               223468999999999977 6789999999999999999999999976543   445555555554333221111 11


Q ss_pred             chHHHHHHhCCcc-ccc-ccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          234 DNARRYVRQLPRC-RKQ-QFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~~~~~-~~~-~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ............. +.. ..+..  ....+.++.++|++||..||++|||+.|+|.||||+..+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            1111111111111 111 01111  124577899999999999999999999999999998743

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-46  Score=329.46  Aligned_cols=281  Identities=19%  Similarity=0.285  Sum_probs=214.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.++||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   79 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS   79 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEEE
Confidence            5899999999999999999999999999999886542 334556788999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||+. |+|.+++...+.+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            9999997 59999998888899999999999999999999985 7999999999999999999999999998654332 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCcccccccc------
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-PDDASLGFLR------  232 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------  232 (336)
                      .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+...... +.........      
T Consensus       159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            233467889999999977 67889999999999999999999999876543332221110000 0000000000      


Q ss_pred             ----------cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 ----------SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                ..................  ......+.++.+||.+||+.||++|||+.|++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPK--LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCcc--CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                      000000011110000000  0012357889999999999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.7e-46  Score=330.09  Aligned_cols=301  Identities=40%  Similarity=0.675  Sum_probs=228.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC-----
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT-----   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~-----   76 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++.+.......     
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            7899999999999999999999999999999985542  244567788999999999999999998877653211     


Q ss_pred             ----cceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCC
Q 019728           77 ----FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLA  151 (336)
Q Consensus        77 ----~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~  151 (336)
                          ....|++|||++++|.+++.. +++++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||.+
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~  162 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA  162 (342)
T ss_pred             cccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence                135799999999999888865 57899999999999999999999999999999999999974 557899999998


Q ss_pred             cccCCCC----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          152 RTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       152 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      .......    ......++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+....+...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07854         163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED  242 (342)
T ss_pred             eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7543221    112235677899999876546788999999999999999999999988887766666555433322211


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFH  306 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~  306 (336)
                      ...... .....................+..+.++.+||++||+.||.+|||+++++.||||+.+..+...+....++.
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~  320 (342)
T cd07854         243 RNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH  320 (342)
T ss_pred             hhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCCCCcc
Confidence            111100 000111111111112222334578899999999999999999999999999999998776666666655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.6e-46  Score=323.51  Aligned_cols=283  Identities=33%  Similarity=0.593  Sum_probs=221.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++...     ...|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeEE
Confidence            58899999999999999999998999999999866544444556677899999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||+++ .|..+......+++.+++.++.||+.|++|||+.|++|+||+|+||++++++.++|+|||++....... .
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            99999986 666666566679999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+...++.++|+||||+++++|++|..||......+....+....+..................
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            23346788999999987656678899999999999999999999988777666666666555433221111110000000


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ................+.++..+.+|+++||+.+|.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00000000111122345788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-46  Score=330.27  Aligned_cols=260  Identities=20%  Similarity=0.313  Sum_probs=212.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|..++..++||||+++++++...     .++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----CeE
Confidence            5899999999999999999999999999999986422 2333455677899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999997 599999976 4679999999999999999999999999999999999999999999999999986554332


Q ss_pred             c--ccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          159 F--MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .  .....|++.|+|||++..    ...++.++|+|||||++|+|++|..||...+..+....+.....           
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-----------  225 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----------  225 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            2  223468999999999863    24578899999999999999999999988766555444432110           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~  292 (336)
                                     ....+...+.++..++++|++||..++++  |++++++++||||.+.
T Consensus       226 ---------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         226 ---------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             ---------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence                           01112223457899999999999764444  7899999999999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.1e-46  Score=322.30  Aligned_cols=285  Identities=37%  Similarity=0.658  Sum_probs=227.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|+||++.+..+++.||+|.+............+.+|+.++++++|||++++++++...     ...|
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRLY   77 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeEE
Confidence            58899999999999999999999999999999865543444456677899999999999999999999876     6799


Q ss_pred             EEEecCCccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCcccCCC-
Q 019728           82 IVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~-  157 (336)
                      +||||++++|.+.+.....  +++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+...... 
T Consensus        78 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999999999988866443  578889999999999999999999999999999999985 456999999998754432 


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..||......+....+....+.+....+.....  ..
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  235 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LP  235 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc--ch
Confidence            1223345688999999987655688999999999999999999999998887777777777666655444322111  11


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .+................+..+..+.+++.+||+.||++||++.+++.||||+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            11111222122222233467789999999999999999999999999999999864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.9e-46  Score=322.85  Aligned_cols=286  Identities=35%  Similarity=0.600  Sum_probs=225.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|.+............+.+|+.+++.+. |||++++++++......+....
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            589999999999999999999999999999998665444444567788999999995 6999999999877644333448


Q ss_pred             EEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~  154 (336)
                      |++|||++++|.+++...     ..+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            999999999999988642     35799999999999999999999999999999999999998 889999999998754


Q ss_pred             CCC-CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          155 SET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+..........
T Consensus       162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T cd07837         162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK  241 (295)
T ss_pred             CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence            332 1122335577899999887646678999999999999999999999998888777777777665544433211100


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                      ...   ................+.++..+.+||.+||+.||.+||++.|++.||||+
T Consensus       242 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         242 LRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             ccc---hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            000   001111122222333456899999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=331.28  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=210.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ++++.++||+|.||.||++.+. ....||+|.++...   .....+.+|+++|++|+|++||++++++..+     ..+|
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piy  277 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIY  277 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceE
Confidence            3578899999999999999994 34479999997642   3346677999999999999999999999987     4599


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |||||+. |+|.++++.  ++.++..+...++.||++|++||++++++||||-..||||+++..+||+|||+++......
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999997 899999987  4678999999999999999999999999999999999999999999999999999666554


Q ss_pred             cccce--eeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FMTEY--VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~~~~--~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .....  -.+..|+|||++.. ..++.+|||||||++++||+| |+.||.+....+.+..+.+....|.           
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-----------  425 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-----------  425 (468)
T ss_pred             eeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-----------
Confidence            43332  23567999999987 889999999999999999998 9999999999988888876443332           


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         +...|+++.+++..||+.+|++|||++.+..
T Consensus       426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                               3456999999999999999999999997753

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.8e-46  Score=334.87  Aligned_cols=259  Identities=23%  Similarity=0.277  Sum_probs=211.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||++.+..+++.||+|++.... ........+.+|..+++.++||||+++++.+...     ...
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~  118 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----RYL  118 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEE
Confidence            5889999999999999999999999999999986432 2333445567899999999999999999999876     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            99999997 589888865 468999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccceeeeecccCchhcccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 -FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                       ......|++.|+|||++.+.   ..++.++|+|||||++|+|++|..||...+.......+........          
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------  267 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------  267 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence             12345789999999998752   2378899999999999999999999998876655554433111000          


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~~  293 (336)
                                       .+....++..+.++|.+||..++.+  |++++++++||||++.+
T Consensus       268 -----------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         268 -----------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             -----------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                             1122467899999999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-47  Score=335.12  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=205.7

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCcceEEEEE
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ||.|+||+||+|.+..+++.||+|++.... ...........|..++...   .||||+++++.+...     ...|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence            799999999999999999999999986432 2233444556677777665   699999999999887     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~  162 (336)
                      ||+. |+|...+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .....
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9997 599999988889999999999999999999999999999999999999999999999999998754322 22344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+...++.++|||||||++|+|++|..||...+.......+......                    
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------  215 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--------------------  215 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            578999999999876456899999999999999999999999887655544433221000                    


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCC----CHHHHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----t~~ell~h~~f~~~  292 (336)
                                .....++.++.+||++||+.||.+||    +++++++||||...
T Consensus       216 ----------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         216 ----------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence                      00123588999999999999999998    79999999999875

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.7e-46  Score=328.00  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=213.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+.+.||.|+||.||+|.+..+|+.||+|++.+... ..........|..++..+. |++|+++++++...     ..
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence            47889999999999999999999999999999865422 2334456778888888885 57788899988876     66


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999997 5999999888889999999999999999999999999999999999999999999999999987543222


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------  217 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------  217 (323)
T ss_pred             ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence             2234568899999999877 678999999999999999999999998877655554443311                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                    ......++.++.+++.+||+.||.+|++     .+++++||||+.+.
T Consensus       218 --------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         218 --------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             --------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                          0112356888999999999999999997     58999999999863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=316.68  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=211.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC---hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN---IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|.+.+.||.|++|.||.+.+..+++.||+|.+......   ......+.+|+.++++++||||+++++++...     .
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----E   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----C
Confidence            478899999999999999999999999999998654322   22345677899999999999999999999887     5


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++++||++| +|.+++...+.+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            79999999974 99999988888999999999999999999999999999999999999999999999999998754332


Q ss_pred             Ccc----cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 DFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...    ....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.......+...              
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------------  222 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--------------  222 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc--------------
Confidence            111    23456788999999987 66889999999999999999999999776544433322111              


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                     ..........+..+.++|++||..+|.+|||+.+++.||||
T Consensus       223 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         223 ---------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                           00111224568899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-46  Score=331.54  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=207.0

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHH-HHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||+|.+..+|+.||+|++.... ........+..|.. +++.++||||+++++.+...     ...|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence            46999999999999999999999999986542 22333445555554 46778999999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||+. |+|...+...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9997 58999998888999999999999999999999999999999999999999999999999999875322 223345


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------------  211 (325)
T cd05604         156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------------  211 (325)
T ss_pred             ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            578999999999987 77889999999999999999999999887655544433221                       


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~ell~h~~f~~~  292 (336)
                              .....+..+..+.++|++||+.||.+||++    .+++.||||.+.
T Consensus       212 --------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         212 --------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             --------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence                    011224578899999999999999999976    599999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.8e-46  Score=321.90  Aligned_cols=280  Identities=36%  Similarity=0.663  Sum_probs=224.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.++||.|++|.||+|.+..+|+.||+|.+..... ......+.+|+.++++++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEE
Confidence            48899999999999999999999999999999865432 23345667899999999999999999999887     5689


Q ss_pred             EEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++++|.+++...   .++++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            99999999999988654   358999999999999999999999999999999999999999999999999887543321


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+......+....+..+..  ..
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LP  232 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cc
Confidence             122345678899999987655678999999999999999999999999888887777777666555443322210  01


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      .+................+..+..+.+++.+||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1111111111112222334668899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.9e-46  Score=322.39  Aligned_cols=258  Identities=23%  Similarity=0.329  Sum_probs=210.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||++.+..+++.||+|.+..... .......+..|+.++++++|++++.+++.+...     ...
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence            47889999999999999999999999999999865432 233345567899999999999999999998876     679


Q ss_pred             EEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      |++|||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999997 5898888543  35899999999999999999999999999999999999999999999999998765443


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||...................              
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------  220 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------------  220 (285)
T ss_pred             ccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--------------
Confidence            33334467899999999977 678999999999999999999999997653211111111110000              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~  292 (336)
                                   ........++++.+|+++||+.||++|||     ++|+++||||..+
T Consensus       221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         221 -------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             -------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence                         00112356888999999999999999999     9999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-46  Score=321.84  Aligned_cols=282  Identities=36%  Similarity=0.659  Sum_probs=223.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+............+.+|++++++++|+||+++++++...     ...+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEE
Confidence            68999999999999999999999999999999876555555667888999999999999999999999876     6699


Q ss_pred             EEEecCCccHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           82 IVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        82 iv~e~~~g~L~~~-l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      ++|||+++++.+. ......+++.+++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9999999755544 4555679999999999999999999999999999999999999999999999999987655443  


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||++.+...++.++|+||||+++|+|++|..||......+.+..+....+..++.....+.......
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            23345678889999999874488999999999999999999999999888777777776666554443221111100000


Q ss_pred             HHHhCCc-cccccccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPR-CRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      -. .... .........++ .++..+.+||++||..+|++||++++++.||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GV-AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cc-ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00 0000 00001111222 348899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-46  Score=321.64  Aligned_cols=281  Identities=35%  Similarity=0.607  Sum_probs=216.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+...... .......+|+.+++.++||||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK-----KTLT   79 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeEE
Confidence            488999999999999999999989999999998654322 1223456899999999999999999999876     6799


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          80 LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            99999999999988654 468999999999999999999999999999999999999999999999999986543221 1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||++.+...++.++|+||+|+++|+|++|..||.... ..+....+...++.+....+........ .
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE-F  238 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc-c
Confidence            1223457789999998765668899999999999999999999997765 4556666666655544333211110000 0


Q ss_pred             HHHhCCccccccccccCCCCC--hhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKS--SGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      .................+.++  ..+.+++.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000001111122223344  789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.7e-46  Score=319.57  Aligned_cols=253  Identities=20%  Similarity=0.293  Sum_probs=202.8

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCcccC-hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||.|+||.||++.+..+|+.||+|.+...... .........|+++++.++||||+++++++...     ...|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence            79999999999999999999999998653322 22334456799999999999999999999876     6799999999


Q ss_pred             C-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccccee
Q 019728           88 D-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  164 (336)
Q Consensus        88 ~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (336)
                      + ++|.+++...  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.............
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            7 5898887543  358889999999999999999999999999999999999999999999999987665443334456


Q ss_pred             eeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCC
Q 019728          165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  244 (336)
Q Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
                      ++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.....                       
T Consensus       156 ~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  211 (277)
T cd05607         156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-----------------------  211 (277)
T ss_pred             CCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-----------------------
Confidence            7889999999987 5689999999999999999999999976432211111111000                       


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHHcCcccccCc
Q 019728          245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  293 (336)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~ell~h~~f~~~~  293 (336)
                         ..........++.++.++|++||+.||++||++    ++++.||||+.+.
T Consensus       212 ---~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         212 ---EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             ---ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence               000011123568899999999999999999999    6788999998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.9e-46  Score=341.75  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=217.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC---Ccc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---~~~   78 (336)
                      +|.+.+.||.|+||+||+|.+..+++.||||++.....+......+.+|+..+..++|+|++++++.+......   ...
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            69999999999999999999999999999999976655666677788999999999999999998877544321   112


Q ss_pred             eEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           79 DVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      .+++||||++ |+|.+++..    ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~  192 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM  192 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence            4789999998 599998864    34689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCC---CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          154 TSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       154 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ....   .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...           
T Consensus       193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~-----------  260 (496)
T PTZ00283        193 YAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG-----------  260 (496)
T ss_pred             ccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----------
Confidence            4432   22334578999999999987 77899999999999999999999999887655444333221           


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                         ...+..+.+++++.+++.+||+.||.+||++.++++|||++...
T Consensus       261 -------------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        261 -------------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                               01122356788999999999999999999999999999988653

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.7e-46  Score=328.01  Aligned_cols=254  Identities=19%  Similarity=0.319  Sum_probs=207.0

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||++.+..+++.||+|++.... ........+..|..++.++ +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence            47999999999999999999999999997643 2334556677899999888 699999999999877     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CCCcccc
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTE  162 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~  162 (336)
                      ||++ |+|...+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9997 5999998888889999999999999999999999999999999999999999999999999987532 2223344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCcccccccccchHHHH
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---QLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.......   ....+.....                  
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  216 (327)
T cd05617         156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------------  216 (327)
T ss_pred             ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------------
Confidence            578999999999987 788999999999999999999999996432110   0000101000                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~ell~h~~f~~~~  293 (336)
                               .........++..+.++|++||+.||++|++      ++++++||||..+.
T Consensus       217 ---------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         217 ---------EKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             ---------hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                     0001122456889999999999999999997      57999999998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.9e-46  Score=330.26  Aligned_cols=256  Identities=25%  Similarity=0.303  Sum_probs=204.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+++.||.|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...     ..+|
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  148 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GEIQ  148 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----CeEE
Confidence            4678899999999999999999999999999985432 334456788999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||+.+ +|.+    ....++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus       149 lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        149 VLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            99999985 6643    2346788889999999999999999999999999999999999999999999987654321 2


Q ss_pred             ccceeeeecccCchhcccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 MTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .....|+..|+|||++...    ...+.++|||||||++|+|++|+.||......+....+.....              
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--------------  290 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM--------------  290 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc--------------
Confidence            2345788999999987431    3345689999999999999999999974332221111111100              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                   ..........+.++.+||.+||+.||++|||+.|+++||||..-+.
T Consensus       291 -------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        291 -------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             -------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                         0111223456889999999999999999999999999999998643

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-45  Score=323.78  Aligned_cols=277  Identities=35%  Similarity=0.562  Sum_probs=205.6

Q ss_pred             eeeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      ..+||+|+||.||+|.+.  .+++.||+|.+....    ....+.+|+.+++.++||||+++++++.....   ...+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEE
Confidence            468999999999999965  366889999886432    22356789999999999999999999865433   568999


Q ss_pred             EecCCccHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE----ccCCCEEEEeccC
Q 019728           84 YELMDTDLHQIIRS---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGL  150 (336)
Q Consensus        84 ~e~~~g~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~  150 (336)
                      |||++++|.+++..         ...+++..++.++.||+.||+|||+.|++|+||||+||++    +.++.++|+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99999999888752         1248899999999999999999999999999999999999    5667899999999


Q ss_pred             CcccCCCC----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH
Q 019728          151 ARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---------VHQLRLIT  217 (336)
Q Consensus       151 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~~~  217 (336)
                      ++......    ......++..|+|||++.+...++.++|||||||++|+|++|..||...+.         ......+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            97654332    123456788999999987756689999999999999999999999975432         23445555


Q ss_pred             HHhCCCCcccccccccch-HHHHHHhCCcc---c---cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          218 ELIGSPDDASLGFLRSDN-ARRYVRQLPRC---R---KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ..++.+....+....... ...........   .   ...........+..+.+||.+||+.||.+|||++|+|.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            555544443322111000 00000000000   0   000011122346679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.8e-46  Score=327.89  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHH-HHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||+|.+..+++.||+|++.... ........+..|.. +++.++||||+++++.+...     ...|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence            47999999999999999999999999986532 12233344555554 67888999999999998877     6799999


Q ss_pred             ecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||++| +|...+...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99984 9998888888899999999999999999999999999999999999999999999999999875322 222344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..   .+                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~-------------------  212 (321)
T cd05603         156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---KP-------------------  212 (321)
T ss_pred             ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---CC-------------------
Confidence            578899999999877 6789999999999999999999999988765544433322   10                   


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~ell~h~~f~~~  292 (336)
                               ....+..+..+.++|.+||+.||.+|+++    .++++|+||..+
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         213 ---------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence                     11224568889999999999999999865    599999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-45  Score=322.51  Aligned_cols=287  Identities=34%  Similarity=0.532  Sum_probs=219.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC---Ccc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---~~~   78 (336)
                      +|++.++||.|++|.||+|.+..+++.||+|.+..............+|+.++++++||||+++++++......   ...
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            48899999999999999999999999999998865433333344566899999999999999999987665321   124


Q ss_pred             eEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++||||++++|.+.+... ..+++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        93 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  172 (310)
T cd07865          93 SFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS  172 (310)
T ss_pred             eEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCC
Confidence            57999999999998888664 36899999999999999999999999999999999999999999999999998755432


Q ss_pred             Cc-----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 DF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ..     .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+..+........
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (310)
T cd07865         173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD  252 (310)
T ss_pred             cccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence            21     1223567789999998764567889999999999999999999999888777777777766655443322211


Q ss_pred             cchHHHHHHhCCcccccccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          233 SDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ......... ............  ....+..+.++|.+||..||.+|||++++++||||
T Consensus       253 ~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         253 KLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             chhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            111100000 000000000000  11246778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-45  Score=336.09  Aligned_cols=276  Identities=24%  Similarity=0.295  Sum_probs=207.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.+.+.||.|+||.||++.+..+++.||||....        ....+|+.++++++||||+++++++...     ...+
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~  236 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTC  236 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence            58999999999999999999999999999996421        2346899999999999999999998776     5689


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      ++||++.++|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||+++......  
T Consensus       237 lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            99999999999988654 569999999999999999999999999999999999999999999999999987643321  


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCcccccc
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-------YVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                       ......|+..|+|||++.+ ..++.++|||||||++|+|++|..++....       ....+..+..............
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence             1223468999999999987 678999999999999999999876543221       1223333333322211111111


Q ss_pred             cccchHHHHHHhCCccccc----cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          231 LRSDNARRYVRQLPRCRKQ----QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                      ........+..........    ..-..+...+..+.+||++||+.||.+|||+.|+|+||||++
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            1111111111111100000    001112246778999999999999999999999999999975

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.7e-46  Score=328.46  Aligned_cols=249  Identities=22%  Similarity=0.387  Sum_probs=206.2

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHH-HHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREI-KLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||+|+||+||+|.+..+++.||+|++..... .......+..|. .+++.++||||+++++++...     ...|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence            479999999999999999999999999865321 122233444444 456788999999999999877     6699999


Q ss_pred             ecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCcccc
Q 019728           85 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTE  162 (336)
Q Consensus        85 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  162 (336)
                      ||+.| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            99985 9999998888899999999999999999999999999999999999999999999999999875332 222344


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...   +                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------------  212 (325)
T cd05602         156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P-------------------  212 (325)
T ss_pred             ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------------
Confidence            578999999999987 77899999999999999999999999887766555444321   0                   


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH----HHHcCcccccC
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE----EALRHPYLQSL  292 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~----ell~h~~f~~~  292 (336)
                               ....+.++..+.++|++||+.||.+|+++.    ++++|+||..+
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         213 ---------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             ---------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence                     112246788999999999999999999765    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-45  Score=317.87  Aligned_cols=259  Identities=23%  Similarity=0.352  Sum_probs=214.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|+..+.||.|+||+||++.+..+++.||+|.+..... .......+.+|+.+++.++|+|++.+++.+...     ...
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEE
Confidence            47889999999999999999999999999999865432 223345567899999999999999999998877     669


Q ss_pred             EEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +++|||+.+ +|.+.+...  .++++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            999999985 888887543  46999999999999999999999999999999999999999999999999988765443


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+........             
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------------  221 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-------------  221 (285)
T ss_pred             CcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-------------
Confidence            33334577899999999976 6789999999999999999999999987765444443333221111             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                    .......+..+.+|+..||+.||++||+     +.+++.|+||.+..
T Consensus       222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         222 --------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             --------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence                          0112456888999999999999999999     89999999998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-45  Score=339.04  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=212.1

Q ss_pred             cceeeeecccceEEEEEEEeCCC-CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.+.+.||.|++|.||+|.+..+ +..||+|.+...  .......+..|+.+++.++||||+++++++...     ...|
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~  141 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLL  141 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEE
Confidence            88999999999999999999877 788999977433  344456677899999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++ |+|.+.+..    ..++++.++..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999997 599887743    45789999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ..   ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....            
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------------  288 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY------------  288 (478)
T ss_pred             ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            32   2334568999999999987 7789999999999999999999999988776555444332100            


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                        .+....++..+.++|.+||+.||++||++.+++.|+|++.+
T Consensus       289 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        289 ------------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                              11123568899999999999999999999999999998754

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-45  Score=350.79  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=214.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+++.||.|+||+||+|.+..+++.||+|.+............+..|+.+++.++||||+++++++.....   ..+|
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~~ly   90 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN---QKLY   90 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---CEEE
Confidence            6899999999999999999999999999999997665556667788899999999999999999998865433   5689


Q ss_pred             EEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CeeccCCCCCCeEEcc----------
Q 019728           82 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-------SVLHRDLKPSNLLLNA----------  139 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-------~i~H~dlkp~nil~~~----------  139 (336)
                      +||||++ |+|.++|..    ...+++..++.|+.||+.||+|||+.       +|+|+||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999998 599998864    35799999999999999999999995       4999999999999964          


Q ss_pred             -------CCCEEEEeccCCcccCCCCcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 019728          140 -------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  211 (336)
Q Consensus       140 -------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  211 (336)
                             .+.++|+|||++.............+++.|+|||++.+. ..++.++|||||||++|+|++|..||...+...
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~  250 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS  250 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence                   234899999999876554444556789999999998642 457899999999999999999999997655433


Q ss_pred             HHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          212 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                      .+.....  ..+                            .......+.++.+||..||+.+|.+||++.++|.|||++.
T Consensus       251 qli~~lk--~~p----------------------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        251 QLISELK--RGP----------------------------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             HHHHHHh--cCC----------------------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            3222111  000                            0111345889999999999999999999999999999987


Q ss_pred             CcC
Q 019728          292 LHD  294 (336)
Q Consensus       292 ~~~  294 (336)
                      +..
T Consensus       301 i~~  303 (1021)
T PTZ00266        301 VGP  303 (1021)
T ss_pred             cCC
Confidence            643

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-45  Score=325.53  Aligned_cols=261  Identities=20%  Similarity=0.329  Sum_probs=212.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||++.+..+++.||+|++.+.. ........+..|..++..++|++|+++++.+...     ...
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CEE
Confidence            5899999999999999999999999999999986432 2233344567899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||+. |+|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999997 699999976 4678999999999999999999999999999999999999999999999999986543322


Q ss_pred             c--ccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          159 F--MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .  .....|++.|+|||++..    ...++.++|+|||||++|+|++|+.||...+..+....+.....           
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------  225 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----------  225 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----------
Confidence            1  223468999999999862    24678899999999999999999999988776665554432110           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccCc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  293 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~~  293 (336)
                                     ....+.....++.++.+||++||..++.+  |++++++++||||+++.
T Consensus       226 ---------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         226 ---------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             ---------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence                           00112223457899999999999765544  68999999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-45  Score=316.77  Aligned_cols=283  Identities=37%  Similarity=0.613  Sum_probs=226.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+............+.+|+.+++.++|||++++++++.....   ...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK---GSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCC---CcEEE
Confidence            678999999999999999999999999999997654444555677889999999999999999999876521   45899


Q ss_pred             EEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--c
Q 019728           83 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--F  159 (336)
Q Consensus        83 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (336)
                      ||||++++|.+++... ..+++..++.++.||+.|+++||+.|++|+||+|+||++++++.++|+|||.+.......  .
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            9999999999998765 579999999999999999999999999999999999999999999999999987665443  1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+...++.++|+||||+++++|++|+.||...+.......+....+.+....+...........
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23335577899999887656788999999999999999999999999888888888877766665544332211100000


Q ss_pred             HHhCCccccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      .... ............. .+..+.+++++||+.+|.+||++++++.||||
T Consensus       238 ~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPK-KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccc-ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            0000 0001111122233 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-45  Score=316.11  Aligned_cols=281  Identities=45%  Similarity=0.746  Sum_probs=228.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||.|++|.||++.+..+++.+++|.+............+..|+.++++++|||++++++++...     ...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence            6788999999999999999999999999999876554545667888999999999999999999998877     66999


Q ss_pred             EEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-cc
Q 019728           83 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  160 (336)
Q Consensus        83 v~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~  160 (336)
                      ++||++++|.+.+.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            999999999988876 3678999999999999999999999999999999999999999999999999887665443 22


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+....+.+....+...... .....
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-ARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-hhhhh
Confidence            23456788999999877447899999999999999999999999998888888877776665544333222110 00011


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ...............+..+..+.++|.+||+.||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1111111222233345678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-44  Score=309.07  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=210.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|.+............+..|+.++++++|||++++++.+....    ..+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEE
Confidence            589999999999999999999999999999999765545556677889999999999999999998875431    4589


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  157 (336)
                      ++|||++ ++|.+++..  ...+++.+++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999997 589998875  345899999999999999999999999999999999999999999999999998765432 


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||++.+ ..++.++|+||||+++++|++|..||...+.......+....                 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----------------  218 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-----------------  218 (257)
T ss_pred             CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------
Confidence            22234467888999999877 678899999999999999999999998766544333322210                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                   ........++.+.+++.+||+.||.+||++.+++.||||
T Consensus       219 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 -------------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         011123568889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.4e-45  Score=316.77  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=216.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|++.... ........+.+|++++++++||||+++++++...     ...
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CeE
Confidence            5889999999999999999999999999999986532 2334567788999999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |++|||++ ++|.+++...+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999995 699999988889999999999999999999999999999999999999999999999999998776544  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+...   .                
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~----------------  214 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG---K----------------  214 (290)
T ss_pred             CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C----------------
Confidence            234467889999999876 67889999999999999999999999877644433333210   0                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                  .......+..+.++|++||..||.+|+     +++|+++||||+.+.
T Consensus       215 ------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         215 ------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             ------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                        011234588899999999999999999     999999999998865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-45  Score=323.10  Aligned_cols=285  Identities=34%  Similarity=0.567  Sum_probs=225.7

Q ss_pred             ccc-eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChh------------HHHHHHHHHHHHhhCCCCceeeecce
Q 019728            2 SVK-LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNII------------DARRTLREIKLLRHMEHENVIAIKDI   68 (336)
Q Consensus         2 ~~~-i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~hp~iv~~~~~   68 (336)
                      ||. +.+.||.|++|+||+|.+..+++.||+|++........            ....+.+|+.++++++||||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            454 45779999999999999999999999999865422210            01246789999999999999999999


Q ss_pred             ecCCCCCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEec
Q 019728           69 IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  148 (336)
Q Consensus        69 ~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (336)
                      +...     ...+++|||++|+|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+||
T Consensus        89 ~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         89 YVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            9876     66999999999999999988888999999999999999999999999999999999999999999999999


Q ss_pred             cCCcccCCC---------------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019728          149 GLARTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  213 (336)
Q Consensus       149 g~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  213 (336)
                      |.+......               .......++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+.+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            988765411               11122345778999999877556789999999999999999999999999888888


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ..+....+.+....+.......   .................+..+..+.++|.+||+.||++|||++|++.||||++..
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLP---LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcc---cccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            8888877766554322110000   0000011111222233456688999999999999999999999999999999764


Q ss_pred             C
Q 019728          294 D  294 (336)
Q Consensus       294 ~  294 (336)
                      .
T Consensus       321 ~  321 (335)
T PTZ00024        321 L  321 (335)
T ss_pred             C
Confidence            3

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=316.45  Aligned_cols=280  Identities=38%  Similarity=0.657  Sum_probs=228.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++.+.||.|++|.||.+.+..+++.||+|.+...............|+.++++++|||++++++++...     ...++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            6788999999999999999999999999999976543444556777899999999999999999999877     56999


Q ss_pred             EEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-cc
Q 019728           83 VYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  160 (336)
Q Consensus        83 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~  160 (336)
                      +||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            9999999999999876 579999999999999999999999999999999999999999999999999987654432 22


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      .....+..|+|||.+.+...++.++|+|||||++++|++|..||...........+....+.+....+.......  .+-
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYK  233 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--ccc
Confidence            233456789999998774588999999999999999999999999988888888888777766554332211111  000


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ...............+..+..+.++|++||..||++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1111111122223345668899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-46  Score=329.00  Aligned_cols=257  Identities=23%  Similarity=0.357  Sum_probs=231.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||+|.|++|.++++..|+..||||.+.+...+.....++.+|+++|+.++|||||+++.+....     ..+|+
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~~lyl  132 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----ATLYL  132 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----ceeEE
Confidence            7899999999999999999999999999999999888888888899999999999999999999999887     67999


Q ss_pred             EEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc
Q 019728           83 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  161 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (336)
                      ||||+. |.+++++...++..+.+++.++.|+++|++|+|+++|||||||.+|++++.+.++||+|||++..........
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            999997 6999999999999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      ..+|++.|+|||++.+....++..|+||+|+++|.|+.|..||.+..-.......                         
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-------------------------  267 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-------------------------  267 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh-------------------------
Confidence            9999999999999999778899999999999999999999999987533221111                         


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                            ......+.-.++.++.++|+++|..+|.+|++.++++.|.|.......
T Consensus       268 ------l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  268 ------LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ------eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                  111122334568899999999999999999999999999998876544

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.4e-45  Score=320.43  Aligned_cols=287  Identities=36%  Similarity=0.589  Sum_probs=223.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC---Ccc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---~~~   78 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+..............+|+++++.++||||+++++++......   ...
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            58999999999999999999999999999999865433333334567899999999999999999987654321   124


Q ss_pred             eEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .++++|||++++|...+.. ...+++..++.++.||++||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        89 ~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  168 (311)
T cd07866          89 SVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGP  168 (311)
T ss_pred             eEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCC
Confidence            5799999999988888765 357999999999999999999999999999999999999999999999999988754332


Q ss_pred             Cc------------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 019728          158 DF------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       158 ~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                      ..            .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+.......+....+.+.+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  248 (311)
T cd07866         169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE  248 (311)
T ss_pred             CcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            11            122345778999999876566889999999999999999999999998888888887777666554


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ..+..+..-...... .............+...+..+.++|.+||+.||++|||+.++++||||
T Consensus       249 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         249 ETWPGWRSLPGCEGV-HSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hhchhhhhccccccc-ccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            433211100000000 000001111222344567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.1e-45  Score=317.21  Aligned_cols=287  Identities=37%  Similarity=0.605  Sum_probs=224.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-----CC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-----DT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-----~~   76 (336)
                      +|.+.+.||.|++|.||++.+..+|+.||+|.+............+.+|+.++++++|||++++++++.....     ..
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            5889999999999999999999999999999986544333344566789999999999999999999876531     11


Q ss_pred             cceEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           77 FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        77 ~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...+++++||+++++...+.+. ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        88 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  167 (302)
T cd07864          88 KGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN  167 (302)
T ss_pred             CCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccccc
Confidence            1368999999999888888764 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          156 ETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...  ......++..|+|||.+.+....+.++|+|||||++++|++|+.||...+....+..+.+..+.+....+.....
T Consensus       168 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (302)
T cd07864         168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIK  247 (302)
T ss_pred             CCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccc
Confidence            332  112234577899999887645678899999999999999999999998888888888888776655443221111


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      .......+... .........+..++..+.+++.+||+.||.+||++++++.||||
T Consensus       248 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         248 LPYFNTMKPKK-QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccc-ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00000000000 00011122334578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-44  Score=316.88  Aligned_cols=281  Identities=22%  Similarity=0.312  Sum_probs=215.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||++.+..++..||+|.+.... ......++.+|++++++++||||+++++++...     ...+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS   75 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence            5899999999999999999999999999999986532 344556788999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|||++ ++|.+++...+++++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  154 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  154 (308)
T ss_pred             EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-c
Confidence            9999997 4999999888889999999999999999999997 59999999999999999999999999988654332 1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc----c--ccc-
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL----G--FLR-  232 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~-  232 (336)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+............    .  ... 
T Consensus       155 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            234467889999999876 67889999999999999999999999776533322222111111000000    0  000 


Q ss_pred             --cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 --SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                        ........+.......  .......++.++.+|+.+||..||++|||+.+++.||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence              0000011111100000  000111367889999999999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-45  Score=324.09  Aligned_cols=260  Identities=19%  Similarity=0.317  Sum_probs=212.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||+|+||.||++.+..+++.||+|++.+.. ........+..|..++..++|+||+++++++...     ...
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEE
Confidence            5899999999999999999999999999999986532 2333445567889999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999997 599999976 4679999999999999999999999999999999999999999999999999987654332


Q ss_pred             c--ccceeeeecccCchhcccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          159 F--MTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .  .....|++.|+|||++.+.    ..++.++|+|||||++|+|++|..||...+..+....+.....           
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------  225 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-----------  225 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-----------
Confidence            2  1234689999999998642    3578899999999999999999999988776555444432110           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~  292 (336)
                                     ....+.....++.++.++|.+||..++.+  |+++++++.||||+.+
T Consensus       226 ---------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         226 ---------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             ---------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence                           01112223456889999999999876654  4699999999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-45  Score=320.68  Aligned_cols=285  Identities=36%  Similarity=0.606  Sum_probs=215.2

Q ss_pred             ccceeeeecccceEEEEEEEeCC--CCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE--TREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||+|++|.||+|.+..  +++.||+|.+.... ..........+|+.+++.++||||+++++++.....   .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---K   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---c
Confidence            68999999999999999999988  89999999997633 223334667789999999999999999999987633   4


Q ss_pred             eEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc----CCCEEEEecc
Q 019728           79 DVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA----SCDLKIGDFG  149 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~----~~~~kl~dfg  149 (336)
                      .+++||||++++|.+.+...     ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.    ++.++|+|||
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            58999999999888877532     36899999999999999999999999999999999999999    8999999999


Q ss_pred             CCcccCCCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHH
Q 019728          150 LARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---------HQLRLI  216 (336)
Q Consensus       150 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~  216 (336)
                      ++........    .....++..|+|||++.+...++.++|+|||||++++|++|..||.+....         ..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9876543321    223456788999999877567889999999999999999999999765432         234444


Q ss_pred             HHHhCCCCccccccccc-chHHHHHHhCCccc-----cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          217 TELIGSPDDASLGFLRS-DNARRYVRQLPRCR-----KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       217 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ...++.+....+..... ..............     .....+.....+..+.+++.+||+.||++|||+.|++.||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            44444333322211100 00000000000000     000011112678889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.6e-45  Score=321.94  Aligned_cols=283  Identities=17%  Similarity=0.213  Sum_probs=207.8

Q ss_pred             ceeeeeccc--ceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            4 KLRGEYDDI--IFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         4 ~i~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +++++||.|  ++++||++.+..+|+.||+|.+............+..|+.+++.++||||+++++++..+     ...+
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~   75 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELW   75 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEE
Confidence            367889999  788999999999999999999976554455556677899999999999999999999877     6699


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ |+|.+++..  .+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++++||+.........
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999998 599999865  3468999999999999999999999999999999999999999999999997643321110


Q ss_pred             --------cccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc-c
Q 019728          159 --------FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS-L  228 (336)
Q Consensus       159 --------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  228 (336)
                              ......++..|+|||++.+. ..++.++|||||||++|+|++|..||..............  +..+... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~  233 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccc
Confidence                    11223456779999998753 4588999999999999999999999987554332222111  1111000 0


Q ss_pred             cccccchH-------------HHHHH---hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          229 GFLRSDNA-------------RRYVR---QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       229 ~~~~~~~~-------------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ...+....             .....   .................++.+.+||++||+.||++|||++++++||||+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            00000000             00000   000000000011223457889999999999999999999999999999876


Q ss_pred             c
Q 019728          293 H  293 (336)
Q Consensus       293 ~  293 (336)
                      .
T Consensus       314 ~  314 (327)
T cd08227         314 K  314 (327)
T ss_pred             c
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.7e-44  Score=307.99  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=213.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.+.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.++|||++++++++...     ...|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence            47889999999999999999999999999999876544566677888999999999999999999999877     6699


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||+. ++|.+++...  ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999997 5999998764  578999999999999999999999999999999999999999999999999887654432


Q ss_pred             c-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      . .....++..|+|||++.+ ..++.++|+||||+++++|++|..||...+.......+...                  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08529         156 NFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG------------------  216 (256)
T ss_pred             chhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------------
Confidence            2 233457788999999987 67889999999999999999999999887754444333221                  


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                  ........++..+.+++++||+.+|++||++.+++.|||+
T Consensus       217 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         217 ------------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                        0111112567889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=314.54  Aligned_cols=253  Identities=23%  Similarity=0.379  Sum_probs=217.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.++++||+|++|.||+|.++++|..+|||++..    ..+.+.+.+|+.++.++..|++|++|+.|...     ..+||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWI  105 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWI  105 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceEe
Confidence            5678999999999999999999999999999855    45688899999999999999999999998877     66999


Q ss_pred             EEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCc
Q 019728           83 VYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDF  159 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~  159 (336)
                      |||||+ |+..+.++. +++++++++..+++..+.||+|||...-+|||||..|||++.+|..||.|||.+..... ...
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            999998 799998864 57899999999999999999999999999999999999999999999999999876443 344


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|||||++.. -.|+..+||||||+...||..|++||....+..   .|.-+...|++..            
T Consensus       186 RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF------------  249 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTF------------  249 (502)
T ss_pred             hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCC------------
Confidence            566789999999999987 788999999999999999999999997765432   2222222222221            


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ......|+++.+|+++||-..|++|.|+.++++|||+++.+
T Consensus       250 -------------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  250 -------------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             -------------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence                         11124588999999999999999999999999999998865

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=313.21  Aligned_cols=282  Identities=37%  Similarity=0.595  Sum_probs=221.6

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      |++.+.||.|++|.||++.+..+++.||+|.+............+.+|+.+++++   +|||++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6889999999999999999998899999999975443333344556777777666   5999999999998764333345


Q ss_pred             EEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           80 VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .+++|||++++|.+++....  .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            89999999999999887643  5899999999999999999999999999999999999999999999999998776555


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||......+....+......+....+........ 
T Consensus       161 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (287)
T cd07838         161 MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR-  238 (287)
T ss_pred             cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch-
Confidence            44444567888999999987 6788999999999999999999999998888877777766555433222111000000 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                         ...............+..+..+.++|++||+.||.+||++++++.||||
T Consensus       239 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 ---SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ---hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence               0001111111223334567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=318.11  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=213.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC-hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN-IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|++|+||+|.+..+++.||+|.+...... ......+..|+++++.++||||+++++.+...     ...
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CEE
Confidence            589999999999999999999999999999999765332 34566788999999999999999999998876     679


Q ss_pred             EEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      |++|||+.| +|.+++...  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999975 999998754  56899999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc------------------------------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 019728          158 DF------------------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  207 (336)
Q Consensus       158 ~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  207 (336)
                      ..                              .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            11                              112356778999999977 67889999999999999999999999887


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC----HHHH
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT----VEEA  283 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~el  283 (336)
                      +.......+...   ..                          ..+.....+..+.++|.+||..||++|||    ++++
T Consensus       236 ~~~~~~~~~~~~---~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         236 NRDETFSNILKK---EV--------------------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             chHHHHHHHhcC---Cc--------------------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            765544333210   00                          00111236889999999999999999999    9999


Q ss_pred             HcCcccccCc
Q 019728          284 LRHPYLQSLH  293 (336)
Q Consensus       284 l~h~~f~~~~  293 (336)
                      +.||||++..
T Consensus       287 l~~~~~~~~~  296 (316)
T cd05574         287 KQHPFFRGVN  296 (316)
T ss_pred             HcCchhhcCC
Confidence            9999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-44  Score=310.94  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=209.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh-------hHHHHHHHHHHHHhhCCCCceeeecceecCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI-------IDARRTLREIKLLRHMEHENVIAIKDIIRPPKK   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   74 (336)
                      +|.+.+.||.|++|.||.|.+..+++.||+|.+.......       .....+.+|+.++++++||||+++++++...  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence            5889999999999999999999899999999886543221       2335677899999999999999999998876  


Q ss_pred             CCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           75 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        75 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                         ...+++|||+++ +|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          79 ---DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             ---CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence               568999999975 9999998888899999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCCc-------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          154 TSETDF-------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       154 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                      ......       .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+...       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-------  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-------
Confidence            542211       112346788999999876 67888999999999999999999999876544333222110       


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                             .........+..+.++|++||+.||.+||++.++++||||
T Consensus       228 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 -----------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                   0011223568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.9e-45  Score=311.21  Aligned_cols=254  Identities=23%  Similarity=0.391  Sum_probs=213.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||.|++|.||++.+..+++.||+|.+.+... .......+.+|++++++++||||+++++++...     ...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeE
Confidence            48899999999999999999999999999999975432 335667888999999999999999999999876     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|+||+.| +|.+.+....++++..+..++.||++||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            999999975 9999998877899999999999999999999999999999999999999999999999999877655433


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... +......                 
T Consensus       156 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~-----------------  216 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQET-----------------  216 (258)
T ss_pred             ccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-HHHHhcc-----------------
Confidence            444567888999999877 668999999999999999999999998766421111 1111100                 


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH--HHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV--EEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--~ell~h~~f  289 (336)
                                .........+..+.++|++||+.||.+||++  .|+++||||
T Consensus       217 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                      0111223567899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-44  Score=312.98  Aligned_cols=258  Identities=27%  Similarity=0.381  Sum_probs=210.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.++||.|++|.||++.+..+++.|++|.+...  +......+.+|+.+++.++|||++++++.+...     ...|
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   85 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLW   85 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEE
Confidence            388999999999999999999999999999998643  445567788899999999999999999998876     6699


Q ss_pred             EEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           82 IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      +||||++| +|...+.+ ...+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            99999985 77777654 457899999999999999999999999999999999999999999999999987654322 1


Q ss_pred             cccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      ......++..|+|||++.+    ...++.++|+|||||++|+|++|..||...+.......+..   ....         
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPP---------  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCc---------
Confidence            1234456788999998852    24567899999999999999999999977654333322211   1100         


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                      .......++.++.++|++||+.||++||+++++++||||.++..
T Consensus       234 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         234 ----------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             ----------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                            00112356788999999999999999999999999999988753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-44  Score=321.67  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=197.0

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||.||+|.+     ..+++.||+|++... ........+.+|+.+++.+ +||||+++++++....  
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--   84 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN--   84 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC--
Confidence            588999999999999999985     244578999998643 2334456788999999999 8999999999876542  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC--------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------------   98 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------------------------   98 (336)
                        ..++++|||++ |+|.+++...                                                        
T Consensus        85 --~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          85 --GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence              35899999997 5999988642                                                        


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecc
Q 019728           99 ------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWY  169 (336)
Q Consensus        99 ------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y  169 (336)
                            .++++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++.......   .....++..|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  2477888999999999999999999999999999999999999999999999876432211   1223345789


Q ss_pred             cCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCcccc
Q 019728          170 RAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK  248 (336)
Q Consensus       170 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (336)
                      +|||++.+ ..++.++|||||||++|+|++ |..||......+........  .                          
T Consensus       243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~--------------------------  293 (338)
T cd05102         243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--G--------------------------  293 (338)
T ss_pred             cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc--C--------------------------
Confidence            99999876 678999999999999999997 99999876533222211110  0                          


Q ss_pred             ccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       249 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                       .........++.+.+++.+||+.||.+|||+.+++.
T Consensus       294 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         294 -TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             001112356788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-44  Score=309.03  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=207.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc---ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|.+.+.||.|++|.||++.+..+++.|++|.+.....   .......+.+|+.++++++||||+++++++.....   .
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---K   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---C
Confidence            58899999999999999999999999999998865432   22345667789999999999999999998875432   4


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++++||+++ +|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            68999999974 99999988788999999999999999999999999999999999999999999999999998754321


Q ss_pred             C----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .    ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+..   ...         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~---------  226 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT---------  226 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC---------
Confidence            1    1122346788999999877 6788999999999999999999999987654433322211   100         


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                       .+......+..+.+++ +||..+|++||+++|+++||||+
T Consensus       227 -----------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 -----------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             -----------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                             0111234577889999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=312.81  Aligned_cols=256  Identities=29%  Similarity=0.400  Sum_probs=212.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+...  .......+..|+.++++++|||++++++.+...     ...|
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLW   78 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEE
Confidence            588999999999999999999989999999998543  445566788999999999999999999999876     6699


Q ss_pred             EEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           82 IVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      +||||+++ +|.+++... ..+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999985 898888663 57999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      ......++..|+|||.+..    ...++.++|+||||+++|+|++|..||...+.......+..   ....         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPP---------  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCC---------
Confidence            2234467888999999752    24577899999999999999999999987765444333321   1000         


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                      .......++.++.++|.+||+.||.+||+++++++||||.+.
T Consensus       227 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 ----------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ----------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                            001123467899999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=311.72  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=213.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+.... .......+.+|+.+++.++|||++++++++...     ...|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW   75 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence            6889999999999999999999999999999986543 234456678899999999999999999998876     6699


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +++||+++ +|.+++... ++++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            99999975 999998765 8899999999999999999999999999999999999999999999999998776543 22


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....   .               
T Consensus       155 ~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~---------------  215 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---P---------------  215 (274)
T ss_pred             cccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---C---------------
Confidence            234467788999999987 568999999999999999999999998765443332222110   0               


Q ss_pred             HHhCCccccccccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                  ..... .++..+.+++.+||..||++|||++++++||||+...
T Consensus       216 ------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         216 ------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             ------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                        00111 2688899999999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.9e-44  Score=312.36  Aligned_cols=280  Identities=34%  Similarity=0.576  Sum_probs=211.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|.+..... ........+|+.+++.++|+||+++++++...     ...|
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~   79 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLT   79 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CeEE
Confidence            58999999999999999999999999999999865432 22234567899999999999999999999876     5689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++++|.+.+.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....... .
T Consensus        80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          80 FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             EEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            9999999888887754 3567889999999999999999999999999999999999999999999999887543321 1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCccccccccc-chHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSPDDASLGFLRS-DNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  237 (336)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|..||..... .+.+..+....+.+.......... ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            23335688899999987645678899999999999999999999976553 344444444444443322111100 0000


Q ss_pred             HHHHhCCccccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ...  ..............  ..+..+.+++.+||..||++|||++|++.||||
T Consensus       240 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEW--FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chh--ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            000  00000000111111  236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.3e-44  Score=307.48  Aligned_cols=254  Identities=29%  Similarity=0.456  Sum_probs=214.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..++..||+|.+............+..|+++++.++|||++++++++.....   ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEE
Confidence            5889999999999999999999999999999987655566667788899999999999999999998765433   5689


Q ss_pred             EEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           82 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVH-----SASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ++|||++ ++|.+++..    ..++++..++.++.||+.||++||     +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999997 599998865    367899999999999999999999     899999999999999999999999999998


Q ss_pred             cccCCCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          152 RTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       152 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+...           
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------  225 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-----------  225 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-----------
Confidence            87665443 334567889999999877 66889999999999999999999999887644433332211           


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                         .........+..+.+++.+||+.+|++||++++++.|||+
T Consensus       226 -------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 -------------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                               1112223568899999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-44  Score=311.95  Aligned_cols=258  Identities=22%  Similarity=0.379  Sum_probs=211.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++++.||.|++|.||++.+..+++.||+|.+.... +......+.+|+.++++++||||+++++.+...     ...|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEE
Confidence            5889999999999999999999999999999886532 344457788999999999999999999998876     6799


Q ss_pred             EEEecCCc-cHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++| +|..++...   ..+++..+..++.||+.|+.|||+ .|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            99999985 888888663   378999999999999999999997 5999999999999999999999999999876533


Q ss_pred             CCcccceeeeecccCchhcccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .. .....++..|+|||.+.+.     ..++.++|+|||||++|+|++|..||...........+.......+       
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  227 (286)
T cd06622         156 SL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-------  227 (286)
T ss_pred             Cc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence            32 2334567789999998542     2357899999999999999999999976554333333322221111       


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                          ....+.++.++.+||.+||+.+|.+||+++++++||||....
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence                                122345788999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.2e-44  Score=306.29  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=212.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.+|.+.+..+++.||+|.+............+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEE
Confidence            68999999999999999999999999999999865444455567788999999999999999999999876     6799


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+. ++|.+.+...  ..+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999997 5999988654  357899999999999999999999999999999999999999999999999987654432


Q ss_pred             c-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      . .....++..|+|||++.+ ...+.++|+|||||++++|++|..||...+..+....+...  .               
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~---------------  217 (256)
T cd08218         156 ELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--S---------------  217 (256)
T ss_pred             hhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--C---------------
Confidence            2 223456788999999877 67888999999999999999999999876655444333211  0               


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                   ........+.++.++|.+||+.+|.+||++.+++.||||
T Consensus       218 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 -------------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                         111223568889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.5e-44  Score=307.67  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=209.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc----cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF----DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||.|+||.||++.+ .+++.+|+|.+....    ........+.+|+.++++++|+||+++++++...     
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence            588999999999999999987 478999999886432    1233446677899999999999999999999877     


Q ss_pred             ceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           78 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ...+++|||+.| +|.+++.+..++++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            669999999975 9999998878899999999999999999999999999999999999999999999999998865432


Q ss_pred             C-------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          157 T-------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       157 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      .       .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  225 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--------  225 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--------
Confidence            1       11123456788999999877 6788999999999999999999999987654433322222100        


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                          ..+.....++.++.++|++||+.+|.+||++.++++||||
T Consensus       226 --------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 --------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                1112234568899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=329.97  Aligned_cols=256  Identities=28%  Similarity=0.410  Sum_probs=219.9

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.|++.||.|+||.||+|.++.++-.-|.|++  ...+.......+-|+.||..+.||+||++++.|...     +.+||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvI--etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwi  106 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVI--ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWI  106 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhh--cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEE
Confidence            67899999999999999999999999999988  444677888999999999999999999999988877     67999


Q ss_pred             EEecCCccHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc-CCCCc
Q 019728           83 VYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF  159 (336)
Q Consensus        83 v~e~~~g~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~-~~~~~  159 (336)
                      +.|+|+|+-.+.+  .-...++++++..+++|++.||.|||+++|+|||||..|||++-+|.++|.|||.+... .....
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999997544443  34678999999999999999999999999999999999999999999999999987543 33345


Q ss_pred             ccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..++.||++|||||+...    ..+|+.++||||||+++.+|..+.+|-...++...+-+|.+-   .|+...       
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLl-------  256 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLL-------  256 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCccc-------
Confidence            677899999999999753    378999999999999999999999999998887777666552   222111       


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                        ....++..+.+|+..||..||..||++.++|.||||+++.
T Consensus       257 ------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  257 ------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             ------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                              1124588899999999999999999999999999999864

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=325.41  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=220.8

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEec
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL   86 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~   86 (336)
                      +.||+|.||+||-++++.+|+.||||++.+.........++..|+++|+.+.||.||.+--.++..     +.+++|||.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVMEK  644 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVMEK  644 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEehh
Confidence            679999999999999999999999999987655555568888999999999999999999999888     669999999


Q ss_pred             CCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC---CCEEEEeccCCcccCCCCccc
Q 019728           87 MDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMT  161 (336)
Q Consensus        87 ~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~~~~  161 (336)
                      +.|+..+.|.+  .+++++...+.++.||+.||.|||-+||+|.||||+|||+...   .++||||||+++..+...+..
T Consensus       645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            99999888865  3789999999999999999999999999999999999999653   459999999999999998888


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      +..||+.|.|||++.+ +.|+.+-|+||+|+|+|--|+|..||....+  ....|+....-.+                 
T Consensus       725 sVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyP-----------------  784 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYP-----------------  784 (888)
T ss_pred             hhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccC-----------------
Confidence            9999999999999998 8999999999999999999999999976543  2223332222112                 


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                +..|..++..+.+||..+|+..-.+|.|.+..|+|||+++.+
T Consensus       785 ----------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  785 ----------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             ----------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence                      233467899999999999999999999999999999999876

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=311.47  Aligned_cols=279  Identities=38%  Similarity=0.665  Sum_probs=223.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.+.+.||.|++|+||+|.+..+++.|+||.+...... .......+|+..+++++ |||++++++++...     ...+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEE
Confidence            67899999999999999999999999999998654332 22334557899999998 99999999999886     6799


Q ss_pred             EEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++|+|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            999999889999987754  789999999999999999999999999999999999999999999999999887655444


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH-H
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR-R  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (336)
                      .....++..|+|||++.....++.++|+||||+++++|++|+.||......+....+....+.+....+...  .... .
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  232 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG--YKLASK  232 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH--hhhhcc
Confidence            444567888999999866567889999999999999999999999998888888877777666554321100  0000 0


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ....+............+..+..+.++|++||+.||.+|||++|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            000011111111122233457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-44  Score=312.25  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=213.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+....  ......+.+|+.+++.++|||++++++.+...     ...|
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   92 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELF   92 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEE
Confidence            4889999999999999999999999999999986432  23456678899999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      +|+||+.| +|.+++.. ..+++.++..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999975 88887765 4689999999999999999999999999999999999999999999999998876543322 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.... .+.               
T Consensus       172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~---------------  234 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE---------------  234 (296)
T ss_pred             CCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Ccc---------------
Confidence            223467788999999876 678899999999999999999999998877654443332210 000               


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                  ......+++.+.++|++||..||.+||++.+++.||||+.....
T Consensus       235 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~  278 (296)
T cd06655         235 ------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL  278 (296)
T ss_pred             ------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence                        01123568889999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.6e-44  Score=305.27  Aligned_cols=252  Identities=27%  Similarity=0.345  Sum_probs=212.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.+|+|.+.....+......+..|+.++++++|||++++++.+...     ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence            58999999999999999999999999999999976554555677888999999999999999999998766     6699


Q ss_pred             EEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  157 (336)
                      +||||++| +|.+++...  ..+++..++.++.|++.|++|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999975 999999763  3589999999999999999999999999999999999998654 5799999999876655


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+.......+....                 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-----------------  217 (256)
T cd08220         156 SKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-----------------  217 (256)
T ss_pred             ccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-----------------
Confidence            44444567889999999876 678899999999999999999999998766544333332210                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                   ........+..+.+++.+||+.||.+|||+.|++.||||
T Consensus       218 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 -------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                         011123468889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.8e-44  Score=304.71  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=215.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||.+.+..+++.+++|.+.....+......+.+|++++++++|+||+++++++...     ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence            58999999999999999999999999999999876655666677888999999999999999999999887     6699


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++...  ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999997 5999999764  468999999999999999999999999999999999999999999999999987654433


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+...  .               
T Consensus       156 ~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~---------------  217 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--N---------------  217 (256)
T ss_pred             ccccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--C---------------
Confidence             2334567889999999877 56888999999999999999999999876655544443221  0               


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                   ........+..+.+++.+||+.+|.+||++++++.|+|+
T Consensus       218 -------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 -------------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                         011124568889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-45  Score=318.77  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=209.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.++++||+||.+.||++... ....||+|++.....+......+..|+..|.+|+ |.+|+.+++|-..+     +.+
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~~l  435 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----GYL  435 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----ceE
Confidence            5889999999999999999985 4567888888777778899999999999999996 99999999998876     679


Q ss_pred             EEEEecCCccHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||-+.+|..+|++.... +.-.++.++.|++.|+.+.|+.||||.||||.|+|+- .|.+||+|||+|........
T Consensus       436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            999999999999999876543 3358899999999999999999999999999999874 56899999999987765543


Q ss_pred             ---ccceeeeecccCchhcccC----------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          160 ---MTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                         ..+.+||..|||||++...          .+.+.++||||||||+|+|+.|+.||....  ..++++..+...-.  
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~--  590 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNH--  590 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCc--
Confidence               4567999999999998531          236789999999999999999999996532  23333333222111  


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCC--ChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                               ...++.+  ..++.++++.||..||++||++.|||+|||++..+
T Consensus       591 -------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  591 -------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             -------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence                                     1112322  22389999999999999999999999999998743

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-44  Score=309.43  Aligned_cols=254  Identities=26%  Similarity=0.326  Sum_probs=207.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.++...  ......+.+|+.+++.++||||+++++.+...     ...|
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~   82 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLW   82 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Confidence            4788999999999999999999999999999986542  33445677899999999999999999998876     6699


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      ++|||++ ++|.+++...+.+++.+++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            9999998 5999999888899999999999999999999999999999999999999999999999999986544321 1


Q ss_pred             ccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .....++..|+|||++..  ...++.++|+|||||++|+|++|..||..................++             
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------  229 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-------------  229 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC-------------
Confidence            234467889999998742  24678899999999999999999999866543332222111000000             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                                   .......++..+.++|.+||+.||++||++++++.|||
T Consensus       230 -------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 -------------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -------------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                         00011245778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=289.91  Aligned_cols=256  Identities=27%  Similarity=0.323  Sum_probs=207.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ||+|.+.||.|||+.||++++..+++.||+|++...  +....+..++|++..++++|||+++++++......++....|
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            799999999999999999999999999999999765  467788899999999999999999999998887776767899


Q ss_pred             EEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           82 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      ++++|.. |+|.+.++.    +..+++.++..|+.+|++||.+||+..  ++||||||.||++++.+.++|.|||.+...
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            9999997 899999864    236899999999999999999999999  999999999999999999999999987653


Q ss_pred             CCCCc----------ccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 019728          155 SETDF----------MTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  222 (336)
Q Consensus       155 ~~~~~----------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  222 (336)
                      .-.-.          ......|..|+|||.+.-.  .-.+.++|||||||++|.|+.|..||...-         + .+ 
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~-~G-  248 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------Q-QG-  248 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------h-cC-
Confidence            32111          1234568889999998642  346889999999999999999999995321         0 00 


Q ss_pred             CCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                         .+...             .....+...+....+|..+.++|+.||++||.+||++.+++++
T Consensus       249 ---gSlaL-------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 ---GSLAL-------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ---CeEEE-------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence               00000             0000001111223479999999999999999999999999874

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-44  Score=305.75  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=212.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc---cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      ||+..+.||.|++|.||+|.+..+++.|++|.+....   ........+..|+.+++.++|||++++++++...     .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence            6889999999999999999999899999999885432   2234567788999999999999999999998776     5


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++++||++| +|.+++.+.+.+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            68999999975 99999988888999999999999999999999999999999999999999999999999988765544


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||.+.....++.++|+||||+++|+|++|..||...........+...                  
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------------  217 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------------  217 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc------------------
Confidence            33344567888999999876334889999999999999999999999776543333222210                  


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                 .........++..+.+++++||+.+|.+||++.+++.|||+
T Consensus       218 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         218 -----------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -----------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                       01112224568899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-44  Score=307.83  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=210.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc----ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|+..+.||.|++|.||++.+..+++.||+|.+.....    .......+..|+.++++++|||++++++++...     
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence            48889999999999999999999999999999864321    122456788999999999999999999999877     


Q ss_pred             ceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (336)
                      ...++||||+.| +|.+++...+++++..++.++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            679999999985 9999998888899999999999999999999999999999999999998776 59999999986654


Q ss_pred             CCC-----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ...     ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+......        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc--------
Confidence            321     1223456788999999876 67889999999999999999999999755432222222211100        


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                        .........+++.+.+++.+||..+|.+||++.+++.||||+
T Consensus       227 ------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                              001122235688999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.1e-44  Score=307.39  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=211.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|+||++.+..++..+++|++....... ....+.+|+.+++.++|+|++++++.+...     ...|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELW   75 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEE
Confidence            5889999999999999999998899999999986544333 667888999999999999999999998776     6799


Q ss_pred             EEEecCCc-cHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ++||+++| +|.+++...   ..+++..++.++.||+.|+++||+.|++|+||+|+||++++++.++|+|||.+......
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            99999975 999998764   45899999999999999999999999999999999999999999999999988655433


Q ss_pred             Cc-----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 DF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ..     .....++..|+|||.+.....++.++|+||||+++++|++|+.||...+..........   ..+...     
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~-----  227 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDPPSL-----  227 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCCCCc-----
Confidence            21     23345788899999987744789999999999999999999999977654433322221   110000     


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                       ........++..+.+++.+||+.||.+||++++++.||||
T Consensus       228 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         228 -----------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -----------------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                             0001124668899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.5e-44  Score=311.81  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=210.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+....  ......+.+|+.+++.+.|||++++++.+...     ...|
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~   93 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEE
Confidence            6889999999999999999999999999999986543  23356678899999999999999999998876     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||+. ++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999997 589998865 468999999999999999999999999999999999999999999999999887544322 1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... ..+                
T Consensus       173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----------------  234 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP----------------  234 (296)
T ss_pred             cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC----------------
Confidence            233467889999999876 67889999999999999999999999776543322211110 000                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                 .......++..+.+++.+||..||.+||++.+++.||||....
T Consensus       235 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         235 -----------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             -----------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                       0011235678899999999999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=304.17  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=224.1

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |..++.||+|.||+|.+++.+.+++.||||++++.. -.....+.-+.|-.+|+..+||.+..+...|+..     ..+|
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----drlC  244 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----DRLC  244 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----ceEE
Confidence            567899999999999999999999999999997754 3445567777899999999999999999999988     6699


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc-CCCCc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~-~~~~~  159 (336)
                      +||||.+| .|.-.+...+.|++...+.+...|+.||.|||+++||+||||.+|.|+|.+|.+||+|||+++.. ...+.
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            99999984 88888888889999999999999999999999999999999999999999999999999998763 33445


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ...++||+.|.|||++.. ..|+.+.|.|.+|+++|||++|+.||...+.......|.-..-                  
T Consensus       325 ~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~------------------  385 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL------------------  385 (516)
T ss_pred             eccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc------------------
Confidence            678899999999999987 8999999999999999999999999999887766665543211                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                   .-...++++++.|+..+|..||++|.     .+.|+.+|+||.++.
T Consensus       386 -------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  386 -------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             -------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence                         11246799999999999999999998     789999999999875

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5e-44  Score=309.64  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=204.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHH-HhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL-LRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||+|+||.||++.+..+|+.||||.+........ ......|+.. ++.++|||++++++++...     ...
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~   75 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV   75 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence            48899999999999999999999999999999866533322 3445556654 6667899999999999876     569


Q ss_pred             EEEEecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      |++|||++|+|.+++..    ...+++..++.++.||+.|++|||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus        76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999998887754    34689999999999999999999997 99999999999999999999999999987654


Q ss_pred             CCCcccceeeeecccCchhcccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .........++..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.... ..+.+..+..   .....     
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-----  227 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPSPQ-----  227 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---cCCCC-----
Confidence            33323334567889999988642   346789999999999999999999996532 2222222111   00000     


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                           .....+|.++.++|.+||..+|.+||++++++.||||+...
T Consensus       228 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         228 ---------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ---------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                                 00123688999999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.3e-44  Score=308.48  Aligned_cols=255  Identities=26%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++.+.||.|++|.||++.+..++..+++|.+...  .......+..|+.+++.++|||++++++++...     ...|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~   79 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI   79 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence            57889999999999999999999999999998543  344566778899999999999999999998876     66899


Q ss_pred             EEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           83 VYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +|||+++ +|...+.. ..++++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            9999985 77777654 467999999999999999999999999999999999999999999999999998654332 12


Q ss_pred             ccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .....++..|+|||++..    ...++.++|+||+||++|+|++|..||...+.......+.......            
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------  227 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------  227 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC------------
Confidence            233467889999999742    2457789999999999999999999998766544443332211000            


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                      ......++..+.++|.+||+.||.+||++++++.||||+..
T Consensus       228 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 ----------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                            01123457889999999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.7e-44  Score=306.33  Aligned_cols=249  Identities=21%  Similarity=0.348  Sum_probs=208.6

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||.|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+...     ...|++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence            6999999999999999999999999965432 334556788999999999999999999998876     5689999999


Q ss_pred             C-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceeee
Q 019728           88 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT  166 (336)
Q Consensus        88 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  166 (336)
                      + ++|.+++.+...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.............++
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            7 599999988888999999999999999999999999999999999999999999999999998876554333344678


Q ss_pred             ecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCC
Q 019728          167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  244 (336)
Q Consensus       167 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
                      ..|+|||.+.+ ..++.++|+||||+++|+|++|..||....  .......+....                        
T Consensus       156 ~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------  210 (262)
T cd05572         156 PEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN------------------------  210 (262)
T ss_pred             cCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC------------------------
Confidence            88999999876 678899999999999999999999998765  322222222100                        


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 019728          245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  292 (336)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~  292 (336)
                           .........+.++.++|.+||+.||.+||+     ++|+++||||++.
T Consensus       211 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         211 -----GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence                 001111234788999999999999999999     9999999999975

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-44  Score=305.65  Aligned_cols=254  Identities=27%  Similarity=0.343  Sum_probs=209.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+....  ......+.+|+.++++++|||++++++++...     ..+|
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   76 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLW   76 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEE
Confidence            5889999999999999999999999999999996542  23567788999999999999999999998876     6699


Q ss_pred             EEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      ++|||+++ +|.+++... .++++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            99999985 999888776 789999999999999999999999999999999999999999999999999887654332 


Q ss_pred             cccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ......++..|+|||.+.+.  ..++.++|+||||+++|+|++|..||...........+....-.++ .          
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-~----------  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-K----------  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-c----------
Confidence            22334667889999998762  2678899999999999999999999987765444333222100000 0          


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                                     .......+.++.+++++||..+|.+|||+.+++.|+|
T Consensus       226 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 ---------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                           0011234678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-46  Score=325.19  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=217.1

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      .=++.||+|+||.||.|+|..+.+.||||++..+ ..+......+++|+..|++++|||.+.+.++|...     ...|+
T Consensus        29 ~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~TaWL  103 (948)
T KOG0577|consen   29 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAWL  103 (948)
T ss_pred             HHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chHHH
Confidence            3467899999999999999999999999999754 36778889999999999999999999999999987     66899


Q ss_pred             EEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc
Q 019728           83 VYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  161 (336)
Q Consensus        83 v~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (336)
                      |||||=|+-.+++.- .+++.+.++..|+.+.+.||+|||+.+.+|||||..|||+++.|.|||+|||.+....+   ..
T Consensus       104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An  180 (948)
T KOG0577|consen  104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN  180 (948)
T ss_pred             HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence            999998877777654 36899999999999999999999999999999999999999999999999998876654   35


Q ss_pred             ceeeeecccCchhcc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          162 EYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      +++||++|||||++.  ..+.|+-+.||||||++-.+|...++|+.+.+....+..|.....   +..            
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes---PtL------------  245 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---PTL------------  245 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC---CCC------------
Confidence            779999999999974  347899999999999999999999999988776665555544211   111            


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                    ..+.+|..++.|+..||+.-|.+|||.+++|.|+|+.-
T Consensus       246 --------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  246 --------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             --------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                          01355889999999999999999999999999999764

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.4e-44  Score=305.29  Aligned_cols=258  Identities=28%  Similarity=0.387  Sum_probs=216.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||+|.+..+++.|++|++...... .....+..|+..+.+++|||++++++++...     ...+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS   75 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence            578999999999999999999999999999998664322 5567788999999999999999999999877     6699


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|||++ ++|.+++....++++..++.++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999998 5999999887889999999999999999999999 9999999999999999999999999999876654433


Q ss_pred             c-cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 M-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      . ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....................              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------  220 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--------------  220 (264)
T ss_pred             cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--------------
Confidence            2 24567888999999877 6888999999999999999999999977642111111211111110              


Q ss_pred             HHHhCCccccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ...... ++..+.++|++||..+|++||++.++++||||+...
T Consensus       221 -------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 -------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                         111123 688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-44  Score=308.66  Aligned_cols=254  Identities=25%  Similarity=0.295  Sum_probs=205.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|++....  ......+.+|+.++++++||||+++++++...     ...|
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~   82 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW   82 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence            5889999999999999999999999999999986432  23345677899999999999999999999876     6689


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++ ++|.+++...+++++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            9999998 5999999887889999999999999999999999999999999999999999999999999987654322 1


Q ss_pred             ccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .....++..|+|||.+..  ...++.++|+||+||++|+|++|..||...........+....  .              
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~--~--------------  226 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN--F--------------  226 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC--C--------------
Confidence            233467888999998742  2457789999999999999999999996554322211111100  0              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                                ..........++..+.+||++||+.||++||+++++++|+|
T Consensus       227 ----------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         227 ----------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                      00000111346789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-44  Score=312.42  Aligned_cols=257  Identities=24%  Similarity=0.384  Sum_probs=211.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+....  ......+.+|+.+++.++|||++++++++...     ...|
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   92 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   92 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEE
Confidence            6889999999999999999999999999999986532  23346678899999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      +||||++| +|.+++.. ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999974 89888865 5689999999999999999999999999999999999999999999999998876543322 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. .+.+                
T Consensus       172 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~----------------  233 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------------  233 (297)
T ss_pred             cCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC----------------
Confidence            233467888999999877 7788999999999999999999999977553222111100 0000                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                 .......++..+.+|+.+||+.||.+||++++++.||||+.....
T Consensus       234 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         234 -----------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             -----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence                       001123467889999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-44  Score=310.40  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||++.+..+++.||+|.+.... .......+.+|+.++++++|||++++++.+...     ...+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence            5788999999999999999999999999999986542 334456788999999999999999999999887     6689


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++|||+++ +|..+    ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        76 lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~  150 (279)
T cd06619          76 ICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IA  150 (279)
T ss_pred             EEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cc
Confidence            99999986 55433    35788999999999999999999999999999999999999999999999998765433 22


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCcccccccccchHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL---RLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........   ..........              
T Consensus       151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  215 (279)
T cd06619         151 KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------------  215 (279)
T ss_pred             cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------------
Confidence            34577889999999987 67899999999999999999999999653211100   0000000000              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                 ..........+.++.+++.+||+.||.+||+++|++.||||+...
T Consensus       216 -----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         216 -----------DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             -----------CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence                       000011234678899999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=296.80  Aligned_cols=265  Identities=23%  Similarity=0.390  Sum_probs=215.9

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||+|+++.|-.+....+|..||+|++.+.  ......++++|++++.+++ |+||+.++++|.++     ..+|+|||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVfE  156 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVFE  156 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEEe
Confidence            5799999999999999999999999999665  4556788999999999996 99999999999998     67999999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccCCcccCCC----
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSET----  157 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~----  157 (336)
                      .+. |.|.+.|+.++.|++.++.+++++|+.||.+||.+||.|||+||+|||......   +|||||.+.......    
T Consensus       157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            997 599999999999999999999999999999999999999999999999865443   899999875432111    


Q ss_pred             ----CcccceeeeecccCchhcc---c-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          158 ----DFMTEYVVTRWYRAPELLL---N-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       158 ----~~~~~~~~~~~y~aPE~~~---~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                          ....+.+|+-.|||||+..   + ...|+.+.|.||||+|+|-||+|+.||.+....                ..+
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~----------------dCG  300 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA----------------DCG  300 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC----------------cCC
Confidence                1123457888899999853   2 257899999999999999999999999776421                112


Q ss_pred             ccccch----HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          230 FLRSDN----ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       230 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      |..+..    ....+.++..-.-......|..+|.+.+++++.+|..|+.+|.++.++++|||++....
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            222221    22233333333333344556789999999999999999999999999999999987643

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-43  Score=310.65  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=212.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||.|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+...     ...
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CEE
Confidence            48899999999999999999999999999998865432 233456777899999999999999999998876     678


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +++|||++| +|.+++...+.+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.++...... 
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999985 999999888889999999999999999999999999999999999999999999999999876421110 


Q ss_pred             ---------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 019728          159 ---------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       159 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                                     ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+....+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                           0112345778999999876 678999999999999999999999998776554444332211000


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHHcCcccccC
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSL  292 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~ell~h~~f~~~  292 (336)
                                                  +......+.++.++|++||+.||++||+   +.++++||||.+.
T Consensus       236 ----------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         236 ----------------------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             ----------------------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence                                        0111246888999999999999999997   8999999999774

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.2e-44  Score=304.95  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=208.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+....    ....+.+|+.++++++|||++++++++...     ...|
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~   74 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLW   74 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEE
Confidence            5889999999999999999999889999999985432    267788999999999999999999999887     6699


Q ss_pred             EEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +++||+++ +|.+++.. ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999985 99999875 4578999999999999999999999999999999999999999999999999987655432 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+..   ..               
T Consensus       155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---------------  215 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP---------------  215 (256)
T ss_pred             ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CC---------------
Confidence            2233456788999999877 6788999999999999999999999987654332211110   00               


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                .........++..+.++|.+||+.||++|||+.+++.||||
T Consensus       216 ----------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 ----------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ----------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                      00001123467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4e-44  Score=309.28  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=205.9

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||.|+||+||+|.+..+|+.||+|.+..... .......+..|+.++++++|||++++++.+...     ...|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence            6999999999999999999999999865432 223345567899999999999999999999876     6699999999


Q ss_pred             C-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccccee
Q 019728           88 D-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  164 (336)
Q Consensus        88 ~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (336)
                      + ++|.+++...+  .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            8 59999987655  79999999999999999999999999999999999999999999999999887654433333446


Q ss_pred             eeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCC
Q 019728          165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  244 (336)
Q Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
                      ++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....                        
T Consensus       156 ~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------  210 (277)
T cd05577         156 GTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------------------------  210 (277)
T ss_pred             CCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc------------------------
Confidence            6788999999877 568899999999999999999999997765322111111110                        


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                         ...........++.+.++|++||+.||.+||     ++.++++||||..+.
T Consensus       211 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         211 ---LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             ---ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence               0011122345688999999999999999999     899999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-43  Score=303.38  Aligned_cols=256  Identities=28%  Similarity=0.409  Sum_probs=211.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ||.+.+.||.|++|.||++.+..+++.|++|.+............+..|+.+++.++|+||+++++.....     ...+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence            68999999999999999999998999999999976655556778889999999999999999999998766     6699


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +++||++ ++|.+++.....+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999998 599999988777999999999999999999999999999999999999999999999999998765443221


Q ss_pred             -----cceeeeecccCchhcccCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          161 -----TEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       161 -----~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                           ....++..|+|||.+.+..  ..+.++|+||||+++++|++|..||...+........... ...+         
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------  225 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---------  225 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---------
Confidence                 1235678899999987632  3788999999999999999999999765432222111110 0000         


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                       ..+.....+..+.++|++||+.+|.+||++.+++.|||+
T Consensus       226 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                             001122457889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-44  Score=307.78  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=211.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+..... ......+.+|++++++++||||+++++.+...     ...+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence            47888999999999999999999999999999866432 35567788999999999999999999998877     6799


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +++||++ ++|.+++... ..+++..++.++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999998 5999999776 789999999999999999999999 999999999999999999999999999886554322


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .. ...++..|+|||.+.+ ..++.++|+||||+++++|++|..||.....  ......+........            
T Consensus       156 ~~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------  221 (265)
T cd06605         156 AK-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------------  221 (265)
T ss_pred             hh-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------------
Confidence            21 2567788999999877 6889999999999999999999999966421  111111111111110            


Q ss_pred             HHHHHhCCccccccccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          237 RRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                     ...... ++..+.++|.+||..||++|||+.+++.||||+..
T Consensus       222 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 ---------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ---------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                           011111 68889999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.6e-43  Score=303.52  Aligned_cols=255  Identities=25%  Similarity=0.430  Sum_probs=208.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc---cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|++.+.||.|++|.||.+.+..+++.||+|.+....   ........+.+|+.++++++||||+++++++.+...   .
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---R   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---c
Confidence            5889999999999999999999999999999885432   123345677889999999999999999998876432   4


Q ss_pred             eEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .++++|||++ ++|.+++.+.+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            5789999997 599999988788999999999999999999999999999999999999999999999999988754321


Q ss_pred             C----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .    ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+.   ..+.         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~---------  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPT---------  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCC---------
Confidence            1    1123356788999999877 678899999999999999999999997664443332221   1110         


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                       .....+..+..+.++|++||. +|++||++++++.|||+.
T Consensus       227 -----------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 -----------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             -----------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                             011223567889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.8e-44  Score=306.32  Aligned_cols=256  Identities=22%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCC-cce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT-FND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~-~~~   79 (336)
                      .|.+.+.||.|++|.||++.+..+++.||+|.+....   .....+..|+.+++++ +|||++++++++......+ ...
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            4788999999999999999999999999999986532   2345677899999998 6999999999987653322 246


Q ss_pred             EEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           80 VYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .|++|||++ ++|.+++...  ..+++..++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            899999998 5999988763  4689999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CcccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 T-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      . .......++..|+|||++.+    ...++.++|+||+||++|+|++|..||...........+..   .         
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~---------  231 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---N---------  231 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---C---------
Confidence            2 12234567888999999863    23578899999999999999999999976543322221111   0         


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                       ..........+..+.+|+.+||+.||.+|||+.+++.||||
T Consensus       232 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 -----------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -----------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                             00011123567899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-43  Score=304.98  Aligned_cols=259  Identities=24%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             CccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC--------hhHHHHHHHHHHHHhhCCCCceeeecceecCC
Q 019728            1 MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN--------IIDARRTLREIKLLRHMEHENVIAIKDIIRPP   72 (336)
Q Consensus         1 ~~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   72 (336)
                      .+|.+.+.||.|++|.||++.+..+|+.||+|.+......        ....+.+..|+.+++.++|||++++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   80 (272)
T cd06629           1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE   80 (272)
T ss_pred             CceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence            3789999999999999999999999999999988542111        11234567899999999999999999998876


Q ss_pred             CCCCcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           73 KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        73 ~~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                           ...++||||+. ++|.+++...+++++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          81 -----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             -----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence                 66899999997 599999988888999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC---cccceeeeecccCchhcccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          152 RTTSETD---FMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      .......   ......++..|+|||.+.... .++.++|+||||+++++|++|..||...+.......+..   ...   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~---  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRS---  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---ccc---
Confidence            7543221   122345678899999987633 478899999999999999999999976544332221111   000   


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                         .........+.++..+.++|.+||..||.+||+++++++||||
T Consensus       230 -------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 -------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                               0000112234578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.8e-44  Score=309.60  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=209.9

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      .....||.|++|.||++.+..+++.||||.+...  .......+.+|+.+++.++|||++++++.+...     ...|++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv   97 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVV   97 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEE
Confidence            3456799999999999999999999999998543  334556688999999999999999999998876     668999


Q ss_pred             EecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-ccc
Q 019728           84 YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMT  161 (336)
Q Consensus        84 ~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~  161 (336)
                      |||+++ +|.+++.. +.+++.+++.++.||+.|++|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658          98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence            999985 78777754 578999999999999999999999999999999999999999999999999886543221 123


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      ...++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+........                 
T Consensus       177 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  238 (292)
T cd06658         177 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-----------------  238 (292)
T ss_pred             eeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-----------------
Confidence            3467889999999876 6788999999999999999999999987765544443322111100                 


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                 ......+..+.+++.+||..||.+|||+++++.||||.....+
T Consensus       239 -----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         239 -----------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             -----------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence                       1112457889999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=301.63  Aligned_cols=295  Identities=43%  Similarity=0.742  Sum_probs=250.5

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      --+.||.|+||.||.+.|..+|+.||+|++..-+.+-.....+++|++++.-++|.|++..+++......+-+..+|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            45789999999999999999999999999987777888889999999999999999999999999888777777899999


Q ss_pred             ecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--cccc
Q 019728           85 ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTE  162 (336)
Q Consensus        85 e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~  162 (336)
                      |.+..+|+..|-+...++.+.++-+++||++||.|||+.||.||||||.|.|++.+..+||||||+++.....+  ..+.
T Consensus       137 ELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTq  216 (449)
T KOG0664|consen  137 ELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTH  216 (449)
T ss_pred             HHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHH
Confidence            99999999999998999999999999999999999999999999999999999999999999999998765443  3455


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ...|.+|+|||.+++...|+.+.||||+|||+.||+..+..|...++.+++..|..+++.|..+.+..-....-...++.
T Consensus       217 EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~  296 (449)
T KOG0664|consen  217 EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRA  296 (449)
T ss_pred             HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhcc
Confidence            67799999999999989999999999999999999999999999999999999999999998876654333322222222


Q ss_pred             CCccccccccccC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCC
Q 019728          243 LPRCRKQQFATRF-----PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC  301 (336)
Q Consensus       243 ~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~  301 (336)
                      -.+.  ....-.+     ..-..+...++.++|..||.+|.+.++++.|++.....-......|
T Consensus       297 ~~k~--Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sCmC  358 (449)
T KOG0664|consen  297 GLRA--PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSCMC  358 (449)
T ss_pred             CCCC--CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeeeeE
Confidence            2211  1111111     1334568899999999999999999999999999876544444444

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-46  Score=294.77  Aligned_cols=291  Identities=34%  Similarity=0.531  Sum_probs=238.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC---cce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT---FND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~---~~~   79 (336)
                      |.-+.+||+|.||.||+|+.+.+|+.||+|++-........-...++|+.+|..++|+|++.+++++.......   -..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            55678899999999999999999999999987554334445567789999999999999999999886643221   135


Q ss_pred             EEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|+||.+|+.+|.-++.+. -+++..+++.++++++.||.|+|+..|.|||+|+.|+||+.+|.++|.|||+++..+.++
T Consensus        99 ~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~  178 (376)
T KOG0669|consen   99 FYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSK  178 (376)
T ss_pred             eeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence            8999999999999998765 579999999999999999999999999999999999999999999999999997655443


Q ss_pred             cc-----cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          159 FM-----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       159 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ..     +..+.|.+|++||.+.+...++++.|+|..|||+.+|.++.+.+.+...-.++..|..+.+.....-|..+..
T Consensus       179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~  258 (376)
T KOG0669|consen  179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDN  258 (376)
T ss_pred             ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCccc
Confidence            21     2335599999999999989999999999999999999999999999999999999999999888776655544


Q ss_pred             chHHHHHHh--CCccccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          234 DNARRYVRQ--LPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      -...+....  +.....+.......  .-.+++.+|+.+||..||.+|++++++++|.||..-+
T Consensus       259 lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  259 LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            333332211  22222222222222  2366899999999999999999999999999998754

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=306.80  Aligned_cols=278  Identities=30%  Similarity=0.496  Sum_probs=221.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC--CC----ceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HE----NVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hp----~iv~~~~~~~~~~~~   75 (336)
                      ||.|.+.+|+|.||.|-.+.|..++..||||+++.-   ....+...-|++++.++.  .|    -++.+.++|...   
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr---  163 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR---  163 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc---
Confidence            789999999999999999999999999999998643   334455667999999994  23    367787888777   


Q ss_pred             CcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc--------------
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--------------  139 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~--------------  139 (336)
                        ++.|||+|.++-++.+++..+  .+++...++.+.+|+++++++||+.+++|.||||+||++..              
T Consensus       164 --ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  164 --GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             --CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence              789999999999999999876  46899999999999999999999999999999999999831              


Q ss_pred             ------CCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019728          140 ------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  213 (336)
Q Consensus       140 ------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  213 (336)
                            +..++|+|||.|.......  ...+.|..|+|||++.+ .+++.++||||+|||++|+.+|...|+..+..+.+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                  3348999999987655443  56678999999999999 89999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhC----------------C-cccccccccc-CCCCChhHHHHHHHhcCCCCC
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQL----------------P-RCRKQQFATR-FPNKSSGAVDLLEKMLVFDPN  275 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~-~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~  275 (336)
                      ..++.++++.|......-.   ...+...-                . .++....... ....-..+.+||++||..||.
T Consensus       319 aMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            9999999976654332210   11111100                0 0000000000 001233588999999999999


Q ss_pred             CCCCHHHHHcCcccccCc
Q 019728          276 KRITVEEALRHPYLQSLH  293 (336)
Q Consensus       276 ~Rpt~~ell~h~~f~~~~  293 (336)
                      +|+|+.|+|.||||..+.
T Consensus       396 ~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccHHHHhcCHHhhcCC
Confidence            999999999999998753

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=311.93  Aligned_cols=270  Identities=24%  Similarity=0.342  Sum_probs=227.7

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |+.-+.||.|+||.||.++-+.||+-||+|++.+.. .........+.|-++|++++.+.||.+-+.|...     ..++
T Consensus       187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----d~LC  261 (591)
T KOG0986|consen  187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-----DALC  261 (591)
T ss_pred             eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----CceE
Confidence            677899999999999999999999999999885432 2334446677899999999999999999999887     6699


Q ss_pred             EEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|+..|+| +|.-.|.+.+  .|++..+..++.+|+.||.+||+.+||+||+||+|||+|+.|+++|+|+|+|.......
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            99999985 9988886654  79999999999999999999999999999999999999999999999999999888877


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......||..|||||++.+ ..|+.+.|.|||||++|+|+.|+.||...........+.+..-                 
T Consensus       342 ~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-----------------  403 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-----------------  403 (591)
T ss_pred             ccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-----------------
Confidence            7666799999999999998 6699999999999999999999999977654333322222111                 


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc------CCCCCCCCCCCC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH------DLNDEPVCPRPF  305 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~------~~~~~~~~~~~~  305 (336)
                                ....+.....|+++++|.+.+|+.||++|.     ++.++-.||||++++      ..-..|.+|.+.
T Consensus       404 ----------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~  471 (591)
T KOG0986|consen  404 ----------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG  471 (591)
T ss_pred             ----------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence                      111122246799999999999999999998     788999999999986      455667777663

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.4e-43  Score=305.66  Aligned_cols=258  Identities=22%  Similarity=0.336  Sum_probs=206.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|.||++.+..+++.+|+|.+...   ......+..|+.+++++ +|||++++++++...........
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            488999999999999999999999999999998543   22345566889999999 79999999999876543333568


Q ss_pred             EEEEecCCc-cHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      |+||||++| +|.+++.    ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999975 8988875    34578999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-cccceeeeecccCchhcccCC----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETD-FMTEYVVTRWYRAPELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ... ......++..|+|||.+....    .++.++|+|||||++|+|++|..||...........+..   .....    
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~----  252 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPT----  252 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCC----
Confidence            332 122345678899999976422    367899999999999999999999987655443332211   11000    


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                           .......+..+.++|.+||+.+|.+||++.++++||||+
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 ---------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                 001123567899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-43  Score=300.06  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=215.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+............+..|+++++.++|||++++++.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            58999999999999999999998999999999976655556777888999999999999999999998877     6699


Q ss_pred             EEEecCCc-cHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +++|++++ +|.+.+...    ..+++..+..++.+++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            99999985 999998763    6799999999999999999999999999999999999999999999999999876554


Q ss_pred             CC-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          157 TD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .. ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+...........                
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----------------  218 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG----------------  218 (258)
T ss_pred             CcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC----------------
Confidence            43 2334577889999999876 67889999999999999999999999877644333332210                


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                    .........+..+.+++++||..+|++|||+.+++.||||
T Consensus       219 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         219 --------------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                          0111223568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-43  Score=305.86  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             eecccceEEEEEEEeCCCCceEEEEEecCcccChh-HHHHHHHHHHH---HhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            8 EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKL---LRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~---l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      .||+|+||.||++.+..+++.||+|.+........ .......|..+   +....|||++.+++.+...     ...++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence            48999999999999999999999998865432222 12223344433   3344799999999999876     568999


Q ss_pred             EecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccc
Q 019728           84 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  162 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (336)
                      |||++ |+|.+++...+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence            99998 5999999888889999999999999999999999999999999999999999999999999986554332 223


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....                     
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------------  212 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------------  212 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------------
Confidence            467889999999865356889999999999999999999999754321111 1111000                     


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                            ..........+..+.++|++||+.||++|+     ++.|+++||||+.+.
T Consensus       213 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         213 ------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             ------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence                  000112345688999999999999999999     699999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-43  Score=307.33  Aligned_cols=260  Identities=22%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |...+.||.|++|.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++...     ...+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            45678899999999999999999999999998654322 44567788999999996 99999999988776     5689


Q ss_pred             EEEecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           82 IVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        82 iv~e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ++||++++++.++..     ....+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            999999876655432     246799999999999999999999975 99999999999999999999999999987654


Q ss_pred             CCCcccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .........++..|+|||++.+.  ..++.++|+||+||++|+|++|..||....  .....+.......++..      
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~------  231 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL------  231 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC------
Confidence            44333444678889999998764  368899999999999999999999997654  12222222111110000      


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                       .......++.++.+||++||+.||++|||+++++.||||+...
T Consensus       232 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         232 -----------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             -----------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                             0011134688999999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4e-43  Score=307.50  Aligned_cols=254  Identities=25%  Similarity=0.338  Sum_probs=210.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|+||++.+..+++.||+|.+.... ........+.+|+.+++.++|||++++++++...     ...
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~   90 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTA   90 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeE
Confidence            5888999999999999999999999999999986432 3344556788999999999999999999999876     568


Q ss_pred             EEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||+.|++.+.+.. ..++++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            99999999998888764 457899999999999999999999999999999999999999999999999988655433  


Q ss_pred             ccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ....++..|+|||++.+  ...++.++||||||+++|+|++|..||...+.......+...   ....           
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~-----------  233 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPT-----------  233 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---CCCC-----------
Confidence             23456778999998752  256788999999999999999999999877654433322110   0000           


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                     ......+..+.++|.+||+.||.+||++.+++.||||..-
T Consensus       234 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         234 ---------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             ---------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                           0012357789999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-43  Score=300.54  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHH-hhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLL-RHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|++|.||+|.+..+++.||+|.+..... ..........|..++ ...+|||++++++++...     ...|+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence            679999999999999999999999999865422 222233444555444 455899999999999876     6799999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccce
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY  163 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (336)
                      ||++ ++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....   ....
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            9997 49999998888899999999999999999999999999999999999999999999999998875443   2233


Q ss_pred             eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      .++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......                     
T Consensus       154 ~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  211 (260)
T cd05611         154 VGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---------------------  211 (260)
T ss_pred             CCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC---------------------
Confidence            56788999999887 55889999999999999999999999887665544433221100                     


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHHcCcccccCc
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  293 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~ell~h~~f~~~~  293 (336)
                            ........++..+.+++++||+.||++||   +++|+++||||+.++
T Consensus       212 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         212 ------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                  00112235689999999999999999999   558999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-43  Score=303.78  Aligned_cols=245  Identities=20%  Similarity=0.174  Sum_probs=201.0

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccCh-hHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      ..||+|++|.||++..  +|+.||+|.+....... .....+.+|+.++++++||||+++++++.+... .....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~-~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD-DLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc-CCCceEEEEE
Confidence            5789999999999998  68999999997653322 334677799999999999999999999876111 1145899999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccce
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY  163 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (336)
                      |++ |+|.+++...+.++......++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~  180 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKN  180 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccc
Confidence            998 59999998888899999999999999999999984 99999999999999999999999999987654332  234


Q ss_pred             eeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          164 VVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      .++..|+|||++.+. ..++.++|||||||++|+|++|..||...+..+....+......                    
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------------------  240 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS--------------------  240 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC--------------------
Confidence            678899999998652 57899999999999999999999999887765544443321110                    


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                               .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       241 ---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 ---------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ---------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                     0111256889999999999999999999999986

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.3e-43  Score=302.62  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=204.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC-Ccce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD-TFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~-~~~~   79 (336)
                      .|++.+.||.|+||.||++.+..+++.||+|.+...   ......+..|+.+++++ +|||++++++++...... ....
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            478889999999999999999999999999988543   23445677899999998 699999999998653221 2256


Q ss_pred             EEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           80 VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .|++|||+++ +|.+++...  ..+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            8999999985 999988653  4588889999999999999999999999999999999999999999999998875432


Q ss_pred             C-CcccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 T-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      . .......++..|+|||++..    ...++.++|+|||||++|+|++|..||...........+..   ..        
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~--------  242 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP--------  242 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CC--------
Confidence            2 12234567889999998753    24577899999999999999999999976554333221111   00        


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                        ........++..+.+||++||+.||.+||++.|++.||||
T Consensus       243 ------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 ------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                              0001123568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.8e-43  Score=299.14  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=209.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+|..||+|.+............+.+|+.+++.++|+|++++++.+...     ...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence            58899999999999999999999999999999866433344556777999999999999999999998876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC-EEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~  157 (336)
                      +++||+.+ +|.+++....  .+++..+..++.|++.|++|||+.+++|+||+|+||++++++. ++|+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999974 9999886543  4789999999999999999999999999999999999988864 699999988765443


Q ss_pred             Cc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 DF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+..                  
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------  216 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ------------------  216 (257)
T ss_pred             cccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------------------
Confidence            21 223457888999999876 6788999999999999999999999987664443322211                  


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                  .......+..+.++.++|++||..+|++|||+.+++.||||
T Consensus       217 ------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         217 ------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                        00112234568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-42  Score=301.64  Aligned_cols=255  Identities=23%  Similarity=0.419  Sum_probs=210.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.-.+.||.|++|.||++.+..+++.+++|.+...  .......+.+|+.+++.++|||++++++++...     ...++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~   93 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWV   93 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEE
Confidence            34467999999999999999989999999988543  333456678999999999999999999998876     66899


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-c
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-M  160 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (336)
                      ++||+.| +|.+++.. +++++.++..++.|++.|+++||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          94 VMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             EEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence            9999974 99998877 6799999999999999999999999999999999999999999999999998765433211 2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+....   +..              
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~---~~~--------------  234 (285)
T cd06648         173 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL---PPK--------------  234 (285)
T ss_pred             ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC---CCC--------------
Confidence            23457888999999876 678899999999999999999999998766554444333210   000              


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                 ......++..+.+++++||+.+|++||++.++++||||+....
T Consensus       235 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         235 -----------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             -----------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                       0111236788999999999999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-43  Score=301.97  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=206.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCC-CCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK-DTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~-~~~~~   79 (336)
                      +|.+.+.||.|++|.||+|.+..+++.+++|.+....   .....+.+|+.+++++ .||||+++++++..... .....
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            6899999999999999999999899999999986542   2346678999999999 69999999999876542 22256


Q ss_pred             EEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           80 VYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      .|++|||+++ +|.+++..    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            8999999985 88888754    357899999999999999999999999999999999999999999999999988654


Q ss_pred             CCCC-cccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          155 SETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      .... ......++..|+|||++..    ...++.++|+||||+++|+|++|..||...........+..   .+...   
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~---  237 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT---  237 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC---
Confidence            4322 2234467888999998753    23467889999999999999999999976554433332221   11100   


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                            .......+..+.++|++||..||++|||+.+++.|||+
T Consensus       238 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 ----------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                  00112357889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.1e-43  Score=300.60  Aligned_cols=247  Identities=20%  Similarity=0.251  Sum_probs=202.0

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||.||++.+.   ..+..||+|.++... +......+.+|+.++++++||||+++++++...     .
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   79 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-----N   79 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----C
Confidence            4789999999999999999875   445689999986542 334456788999999999999999999998876     5


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..++||||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            68999999985 888888764 5789999999999999999999999999999999999999999999999998765432


Q ss_pred             CCccc--ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .....  ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||......+....+.....            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------------  226 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR------------  226 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC------------
Confidence            22111  2234567999999877 788999999999999999775 9999988776655544432111            


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        .+.....+..+.+++.+||+.+|.+||+++++++
T Consensus       227 ------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 ------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                              1122456888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.6e-43  Score=304.99  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             ccceeeeecccceEEEEEEEeCC----------------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE----------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI   65 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~   65 (336)
                      +|++.++||+|+||.||+|.+..                ++..||+|.+.... .......+.+|+.++++++||||+++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            58899999999999999998632                34479999886532 33455678899999999999999999


Q ss_pred             cceecCCCCCCcceEEEEEecCC-ccHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCe
Q 019728           66 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------------QQLTDDHCQYFLYQLLRGLKYVHSASV  125 (336)
Q Consensus        66 ~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i  125 (336)
                      ++++...     ...+++|||+. |+|.+++...                   ..++...++.++.||+.||+|||+.|+
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999876     55899999997 5999988542                   136778899999999999999999999


Q ss_pred             eccCCCCCCeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh--C
Q 019728          126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--R  200 (336)
Q Consensus       126 ~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g  200 (336)
                      +|+||||+||+++.++.++|+|||++........   .....++..|+|||++.+ ..++.++|+|||||++|+|++  +
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999876543321   122344678999999876 678999999999999999986  5


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 019728          201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  280 (336)
Q Consensus       201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  280 (336)
                      ..||......+....+........                       ........+..+..+.+++.+||+.||++|||+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQG-----------------------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhcc-----------------------ccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            678877665555444333211100                       000111234568899999999999999999999


Q ss_pred             HHHH
Q 019728          281 EEAL  284 (336)
Q Consensus       281 ~ell  284 (336)
                      .++.
T Consensus       296 ~~i~  299 (304)
T cd05096         296 SDIH  299 (304)
T ss_pred             HHHH
Confidence            9994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.7e-43  Score=302.63  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=210.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|...++||.|++|.||.|.+..+++.||+|.+.... .......+.+|+.+++.+.|||++++++++...     ...|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLW   78 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence            3678899999999999999999999999999986532 234567788999999999999999999999877     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      +||||++| +|.+++.. +++++.++..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        79 lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          79 IIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            99999975 99988865 5789999999999999999999999999999999999999999999999999876544322 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..                     
T Consensus       158 ~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---------------------  215 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK---------------------  215 (277)
T ss_pred             cccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---------------------
Confidence            223356778999999876 6789999999999999999999999977654333222110                     


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                               ...+......+..+.+++.+||+.+|++||++.+++.|+||....
T Consensus       216 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         216 ---------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ---------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                     001112234578899999999999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.4e-43  Score=301.12  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=199.5

Q ss_pred             eecccceEEEEEEEeCCCCceEEEEEecCcccCh-hHHHHHHHH---HHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            8 EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI-IDARRTLRE---IKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e---~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      .||+|++|.||+|.+..+++.||+|.+....... ........|   ...++...||+++++++++...     ...++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence            4899999999999999999999999986543221 111222333   3445556799999999999877     669999


Q ss_pred             EecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccc
Q 019728           84 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE  162 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (336)
                      |||+. |+|.+++...+.+++..++.++.|++.|++|||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~  154 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA  154 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcC
Confidence            99997 4899999888889999999999999999999999999999999999999999999999999987554332 223


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHh
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ  242 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
                      ..++..|+|||.+.+...++.++|+||+|+++|+|++|..||.................                     
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------  213 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------------  213 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------------------
Confidence            46789999999987645688999999999999999999999977532211111000000                     


Q ss_pred             CCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                             .........+..+.+++.+||..+|.+||     ++.++++||||+...
T Consensus       214 -------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         214 -------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             -------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence                   00112234588999999999999999999     999999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-42  Score=301.63  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=207.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|...+.||.|++|.||++.+..+++.+|+|.+.... .......+.+|++++++++||||+++++++.....   ..+|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~   77 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIG   77 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEE
Confidence            6889999999999999999999999999999986542 23456778899999999999999999999876533   4689


Q ss_pred             EEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++| +|.+++..    ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999975 88877642    35689999999999999999999999999999999999999999999999999865443


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCcccccccccc
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....  .................        
T Consensus       158 ~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  227 (287)
T cd06621         158 SL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE--------  227 (287)
T ss_pred             cc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh--------
Confidence            32 123456778999999876 6788999999999999999999999976521  01111111111100000        


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ...........++.+.++|.+||..+|.+|||+.|++.||||+...
T Consensus       228 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         228 -------------LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -------------hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                         0000011123467899999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=295.58  Aligned_cols=252  Identities=28%  Similarity=0.449  Sum_probs=214.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+............+.+|++++++++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence            58899999999999999999999999999999977655556678889999999999999999999998876     6689


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      ++||++++ +|.+++.....+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999985 9999998888899999999999999999999999999999999999999999999999999876654432 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||...+ ...+.++|+|+||+++++|++|..||...+.......+..                     
T Consensus       156 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------  213 (254)
T cd06627         156 DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---------------------  213 (254)
T ss_pred             ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------------
Confidence            233466888999999876 5588999999999999999999999977654333222211                     


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                               ..........+..+.+++.+||..+|++|||+.+++.||||
T Consensus       214 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 ---------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                     01112224568899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=321.04  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=210.7

Q ss_pred             eecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            8 EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      .||+|.+|+||.|+|..|+..+|||-+...  +....+.+..|+.+-++|+|.|||+++|.+..+     +++-|.||..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecC
Confidence            589999999999999999999999999543  455667788999999999999999999998887     6789999999


Q ss_pred             C-ccHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCcccCCCCc-cc
Q 019728           88 D-TDLHQIIRSD-QQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDF-MT  161 (336)
Q Consensus        88 ~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~-~~  161 (336)
                      + |+|.+++++. +++  +++.+-.+.+||++||.|||++.|||||||.+|||++. .|.+||+|||.++....-.. ..
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            8 5999999864 777  88999999999999999999999999999999999964 78899999999988665443 45


Q ss_pred             ceeeeecccCchhcc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          162 EYVVTRWYRAPELLL-NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      .+.||.-|||||++. |...|+.++|||||||++.||.||++||.........  +.+.       ++            
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-------Gm------------  793 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-------GM------------  793 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-------cc------------
Confidence            678999999999986 4467999999999999999999999999765432211  1110       00            


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                             -...+++...++.+++.||.+|+.+||.+||++.++|.+||++.-+
T Consensus       794 -------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  794 -------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             -------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence                   0111333446688899999999999999999999999999998764

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-43  Score=302.85  Aligned_cols=265  Identities=19%  Similarity=0.256  Sum_probs=209.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|+||++.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...     ...+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNIC   79 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEE
Confidence            5889999999999999999999999999999886432 334567788999999999999999999999887     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||+++ +|.+++...+++++..+..++.+++.|+.|||+ .|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            99999984 898988887889999999999999999999997 599999999999999999999999999876543221 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||............                .......
T Consensus       159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~----------------~~~~~~~  221 (284)
T cd06620         159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD----------------PMGILDL  221 (284)
T ss_pred             cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh----------------hhHHHHH
Confidence            223467889999999876 67889999999999999999999999865432110000                0000000


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ...........  ......+..+.+|+++||+.||.+|||++|+++|+||..-
T Consensus       222 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         222 LQQIVQEPPPR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHhhccCCC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            00000000000  0011357789999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.4e-43  Score=302.42  Aligned_cols=257  Identities=22%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|.||++.+..+++.+|+|++....   .....+..|+.+++.+ +|||++++++++...........
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            5889999999999999999999999999999875421   2234566899999999 69999999998854332223568


Q ss_pred             EEEEecCCc-cHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      +++|||++| +|.+++.    ....+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999974 8888764    33568899999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-cccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ... ......++..|+|||++..    ...++.++|+|||||++|+|++|..||...........+...   ...     
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~-----  247 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---PPP-----  247 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---CCC-----
Confidence            322 2233467888999998753    145788999999999999999999999776543322211110   000     


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                          ........+..+.++|.+||+.||.+|||+.|++.|+||
T Consensus       248 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 --------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                000112346789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-43  Score=327.32  Aligned_cols=283  Identities=23%  Similarity=0.291  Sum_probs=201.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCce-EEEEE--------------ecC-cccChhHHHHHHHHHHHHhhCCCCceeee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREE-VAIKK--------------IGN-AFDNIIDARRTLREIKLLRHMEHENVIAI   65 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~-vaiK~--------------~~~-~~~~~~~~~~~~~e~~~l~~l~hp~iv~~   65 (336)
                      +|++++.||+|+||+||++..+..... .+.|.              +.+ ..........+.+|+.++++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            589999999999999999876433221 22221              111 11122344567789999999999999999


Q ss_pred             cceecCCCCCCcceEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC
Q 019728           66 KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  140 (336)
Q Consensus        66 ~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~  140 (336)
                      ++++...     ...|++++++.++|.+++...     ......+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       229 ~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            9999877     568999999999998887542     234466788899999999999999999999999999999999


Q ss_pred             CCEEEEeccCCcccCCCC--cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC-CCCC--ChHHHHHH
Q 019728          141 CDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGK--DYVHQLRL  215 (336)
Q Consensus       141 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~--~~~~~~~~  215 (336)
                      +.+||+|||++.......  ......|+..|+|||++.+ ..++.++|||||||++|+|++|..+ +...  .....+..
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            999999999997654332  2234578999999999987 6789999999999999999998754 4332  23344444


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccc-ccccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCR-KQQFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      +...+.........  .......+........ .......  ...++..+.++|.+||+.||.+|||+.|+|.||||...
T Consensus       383 ~~~~~~~~~~~~p~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        383 IIDSLSVCDEEFPD--PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHhcccChhhcCC--cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            44433322211100  0001111111111000 0011111  12457788999999999999999999999999999874

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.1e-43  Score=299.22  Aligned_cols=249  Identities=28%  Similarity=0.426  Sum_probs=207.6

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||.|++|.||++.+..+|+.|++|.+.... ........+.+|+.++++++|||++++++.+...     ...|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence            689999999999999999999999986543 2335567788899999999999999999998776     6699999999


Q ss_pred             Cc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--------
Q 019728           88 DT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--------  158 (336)
Q Consensus        88 ~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--------  158 (336)
                      .| +|.+++.+.+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.......        
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            74 999999887789999999999999999999999999999999999999999999999999887544331        


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||.... ...+.++|+||||+++|+|++|..||...........+....  ..             
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------  219 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IE-------------  219 (265)
T ss_pred             ccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cC-------------
Confidence             1223456778999999876 568899999999999999999999998777555443332200  00             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV---EEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~---~ell~h~~f~~~  292 (336)
                                    .+.....+..+.+++++||+.+|++|||+   .++++||||+++
T Consensus       220 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         220 --------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             --------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                          00011248899999999999999999999   999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-42  Score=296.23  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=213.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++||||+++++++...     ...|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            58999999999999999999999999999999976554556667788999999999999999999999877     6699


Q ss_pred             EEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ++|||+++ +|.+++..    ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            99999975 99998865    35689999999999999999999999999999999999999999999999999877655


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      . ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..                  
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------  215 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------------  215 (256)
T ss_pred             C-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence            4 2233457888999999877 7788899999999999999999999988765443332221                  


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                  ..........+.++.+++.+||+.+|.+||++.+++.||++
T Consensus       216 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         216 ------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                        01111223567889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-42  Score=295.88  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=215.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.|++|++............+.+|+.++++++||||+++++.+.....   ...+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK---NTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC---CeEE
Confidence            5889999999999999999999999999999997655445667888899999999999999999999887632   4589


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      +++|+++ ++|.+++.+...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999996 59999998877999999999999999999999999999999999999999999999999999887665543 


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||.....  ....+.....                
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~----------------  218 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS----------------  218 (260)
T ss_pred             ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc----------------
Confidence              344567888999999876 5689999999999999999999999987651  1111111110                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                ...........+..+.++|.+||+.||.+||++.+++.||||
T Consensus       219 ----------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 ----------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ----------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                      011112234558899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.7e-43  Score=305.45  Aligned_cols=254  Identities=24%  Similarity=0.400  Sum_probs=208.9

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.....||.|+||.||++.+..+++.||+|.+....  ......+.+|+.+++.++|||++++++++...     ...|+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~i   95 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWV   95 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEE
Confidence            445568999999999999999999999999985432  23456678899999999999999999998876     66999


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-cc
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  160 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~  160 (336)
                      +|||+++ +|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            9999985 88776654 578999999999999999999999999999999999999999999999999886543321 12


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+...   +..               
T Consensus       175 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~---------------  235 (297)
T cd06659         175 KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP---------------  235 (297)
T ss_pred             cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------------
Confidence            34567889999999977 67899999999999999999999999876655444333211   000               


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                ........+..+.++|++||+.+|.+||+++++++||||....
T Consensus       236 ----------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         236 ----------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             ----------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                      0111235678899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-44  Score=326.87  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=203.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecce-ecCCCCCC-cc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDI-IRPPKKDT-FN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~-~~~~~~~~-~~   78 (336)
                      +++|.+-|.+|||+.||+|.+...|..||+|.+-..  +......+.+|+++|++|+ |+|||.+++. .......+ .-
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            578999999999999999999888899999988554  6778888899999999997 9999999993 33332222 34


Q ss_pred             eEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           79 DVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      .++++||||. |+|.++|..  ..+|++.++++|+.|+++||++||...  |+|||||-+|||++.+|..||||||.+.-
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            5889999998 699999974  355999999999999999999999998  99999999999999999999999998864


Q ss_pred             cCCCCcc----------cceeeeecccCchhcc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 019728          154 TSETDFM----------TEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       154 ~~~~~~~----------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      .......          -....|+.|+|||.+.  ...+.+.++|||+|||+||.|+....||........+.       
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln-------  268 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN-------  268 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe-------
Confidence            3322111          1224588899999853  33788999999999999999999999998764222211       


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                -..-.+.++.++..+.+||+.||+.||.+||++-+++.
T Consensus       269 --------------------------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  269 --------------------------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             --------------------------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                                      00112334678999999999999999999999999885

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.2e-42  Score=302.43  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=209.2

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |...++||.|++|+||++.+..+++.|++|++.... ........+..|+.+++.++|||++++++++...     ...|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            455678999999999999999999999999986533 2334456778899999999999999999999877     6689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++|||+.|++.+++.. ..++++.++..++.||+.|++|||++|++|+||+|+||+++.++.++|+|||.+.....   .
T Consensus        98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~  174 (313)
T cd06633          98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---A  174 (313)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---C
Confidence            9999999998888865 45689999999999999999999999999999999999999999999999998765432   2


Q ss_pred             cceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          161 TEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ....++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+....  .+              
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~--------------  238 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SP--------------  238 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC--------------
Confidence            23467888999999852  2567889999999999999999999998776554444332210  00              


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   ......++..+.+|+.+||+.+|.+||++.+++.||||+..
T Consensus       239 -------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 -------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                         01123457789999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=295.87  Aligned_cols=254  Identities=24%  Similarity=0.424  Sum_probs=209.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc---cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|++.+.||.|++|.||++.+..+++.||+|.+....   ........+.+|+.++++++||||+++++++.....   .
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---K   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---C
Confidence            5899999999999999999999999999999875322   233455677889999999999999999999866533   4


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .+++++||+++ +|.+.+.+.+.+++..++.++.||+.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            58899999974 99999988788999999999999999999999999999999999999999999999999998764321


Q ss_pred             C----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 D----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .    ......++..|+|||.+.+ ..++.++|+|||||++++|++|..||...........+   ...+.         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~---------  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPT---------  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCC---------
Confidence            1    1123457888999999887 67889999999999999999999999876544333222   11111         


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                       .......+++.+.++|++||+ +|..||++.++++|||.
T Consensus       227 -----------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 -----------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             -----------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                             112234678899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=287.08  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=215.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .++++.||+|..|+||+++.+.+|...|+|.+... .+.+...+++..+.++...+ +|+||+.+|+|..+     ..++
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~  167 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVF  167 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHH
Confidence            45678999999999999999999999999999664 35667788888888877775 99999999999988     6689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |.||.|..-+..+++. .++++|..+-.+...++.||.||.++ ||+|||+||+|||+|+.|++||||||++.....+..
T Consensus       168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            9999998666555543 46799999999999999999999975 899999999999999999999999999988877777


Q ss_pred             ccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 MTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .+...|-+.|||||.+...  ..|+..+||||||+.++||.||..||.+.+ +.+.+.++.....   +..         
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---P~L---------  315 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---PLL---------  315 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---CCC---------
Confidence            7777888999999998642  568889999999999999999999998854 3455555544211   110         


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                      ....+.|+.+.+|+..||+.|+.+||...++|.|||+....
T Consensus       316 ----------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  316 ----------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ----------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                            11124799999999999999999999999999999987653

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.9e-43  Score=303.51  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=209.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.|++|.+...  .......+..|+.+++.++|||++++++++...     ...|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~   92 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW   92 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence            688999999999999999999889999999998543  233456678899999999999999999998876     5689


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +|+||++ ++|.+++.+ ..+++.++..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            9999997 599998865 468899999999999999999999999999999999999999999999999876544332 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.. ..++.++|+||||+++|++++|..||...+.......+.. .+.+                
T Consensus       172 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~----------------  233 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------------  233 (293)
T ss_pred             cccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------------
Confidence            223457788999999876 6788999999999999999999999987654332211110 0000                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                 .......++..+.++|++||..+|.+||++.+++.|+||+....
T Consensus       234 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         234 -----------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             -----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                       00112245778999999999999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8e-43  Score=313.18  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=197.2

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||.||+|.+     ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~---  111 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG---  111 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC---
Confidence            478899999999999999974     3567789999986432 233456788999999999 899999999999877   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC-------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ-------------------------------------------------------   99 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~-------------------------------------------------------   99 (336)
                        ...++||||++ |+|.+++....                                                       
T Consensus       112 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         112 --GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             --CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence              56899999997 59998886421                                                       


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728          100 --------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus       100 --------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                                          .+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                                467888999999999999999999999999999999999999999999999876543321


Q ss_pred             ---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                         .....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||................               
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---------------  333 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---------------  333 (375)
T ss_pred             ccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC---------------
Confidence               112233567999999977 778999999999999999998 889997654332222221100               


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                    .........+.++.+++.+||+.||++||++.++++.
T Consensus       334 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 --------------YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             --------------ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                          0001112347789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-43  Score=300.67  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=208.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC---CCceeeecceecCCCCCCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      |.+.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.++++++   |||++++++++...     ..
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~   76 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----PR   76 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CE
Confidence            778899999999999999999999999999986542 2334566778999999996   99999999998776     66


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      .+++|||+.| +|.+++.. +.+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            8999999975 89888866 478999999999999999999999999999999999999999999999999987655432


Q ss_pred             c-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      . .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+..   .               
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~---------------  217 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---S---------------  217 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---C---------------
Confidence            2 23346788899999987645678999999999999999999999977653322211100   0               


Q ss_pred             HHHHhCCccccccccccC-CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                  ...... ...+.++.+++.+||+.||++||++.+++.|+||+...
T Consensus       218 ------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 ------------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ------------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                        000011 12678899999999999999999999999999998753

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-42  Score=298.33  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             cceeeee--cccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            3 VKLRGEY--DDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~l--g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      |.+.+.+  |.|+||.||++.+..+++.+|+|.+.......       .|......+ +|||++++++.+...     ..
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~-----~~   83 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL-----KG   83 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----Ce
Confidence            4566666  99999999999999999999999986532211       122222222 699999999999887     56


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSET  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  157 (336)
                      .|+||||++ ++|.+++....++++.+++.++.||+.|++|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            999999997 59999998878999999999999999999999999999999999999999998 9999999988765433


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCcccccccccchH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ-LRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .   ...++..|+|||++.+ ..++.++|+||+|+++|+|++|..||........ ...+....                
T Consensus       164 ~---~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  223 (267)
T PHA03390        164 S---CYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ----------------  223 (267)
T ss_pred             c---cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh----------------
Confidence            2   2356888999999977 6788999999999999999999999975543221 11111110                


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHHcCccccc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQS  291 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~ell~h~~f~~  291 (336)
                                  .......+..+..+.+||.+||+.||.+||+ ++++|+||||++
T Consensus       224 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        224 ------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                        0011222467899999999999999999996 699999999974

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.1e-43  Score=303.01  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=208.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||.|++|.||++.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...     ...|+
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   79 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWI   79 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEE
Confidence            677889999999999999999999999999986443 233556788999999999999999999999876     66999


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-c
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-M  160 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (336)
                      ||||+++ +|.+++.. ..+++..++.++.||+.|++|||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            9999985 88888765 5789999999999999999999999999999999999999999999999999876544321 2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+ ..++.++|+|||||++++|++|..||...........+..                      
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------------------  215 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK----------------------  215 (277)
T ss_pred             hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc----------------------
Confidence            23356788999999877 6788999999999999999999999876543322211100                      


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                              ..........+.++.++|.+||+.+|.+||++.+++.||||....
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         216 --------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             --------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                    000111234578899999999999999999999999999998643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-42  Score=296.29  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+.... .....+....|+.+++.++|||++++++.+...     ..+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence            5889999999999999999999999999999986432 234567778899999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++..  ...++++.++.++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999997 599998864  3458999999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+...                  
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~------------------  215 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG------------------  215 (255)
T ss_pred             cccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC------------------
Confidence             2234567888999999877 67899999999999999999999999877654443333221                  


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                                  ........++..+.++|++||+.||.+||++.++++..
T Consensus       216 ------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         216 ------------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             ------------CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                        01112234678899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-42  Score=300.91  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=203.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-----ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|++.+.||+|++|.||++.+...+     ..||+|.+.... .......+.+|+.++++++||||+++++++...    
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----   80 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE----   80 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence            3789999999999999999986555     679999886432 334456678999999999999999999998876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                       ...+++|||++ ++|.+++...                ..+++.+++.++.||+.||+|||++|++|+||||+||+++.
T Consensus        81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence             55899999997 5999998754                45788999999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019728          140 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  215 (336)
Q Consensus       140 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  215 (336)
                      ++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999987643322   1223355778999999876 678999999999999999998 9999988766554443


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +...                              .........+.++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~------------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSR------------------------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcC------------------------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3221                              0111224678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-42  Score=300.69  Aligned_cols=251  Identities=30%  Similarity=0.486  Sum_probs=212.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|++.... ........+..|..++++++ ||||+++++++...     ..
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----EN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----ce
Confidence            5899999999999999999999999999999986643 23344567788999999998 99999999998876     56


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      .+++||++. ++|.+++...+.+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999995 6999999988899999999999999999999999999999999999999999999999999987654332


Q ss_pred             c---------------------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 019728          159 F---------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  217 (336)
Q Consensus       159 ~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  217 (336)
                      .                     .....++..|+|||+..+ ...+.++|+||||++++++++|..||...........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            1                     122345778999999876 668899999999999999999999998876544433332


Q ss_pred             HHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHHcCccc
Q 019728          218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYL  289 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~ell~h~~f  289 (336)
                      ...                               ......++..+.++|++||+.||.+||++    +++++||||
T Consensus       236 ~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 KLE-------------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             hcC-------------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            110                               01123558889999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.6e-42  Score=296.53  Aligned_cols=249  Identities=27%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      ...||+|++|.||++.+..++..|++|.+...  .......+.+|+.+++.++|+||+++++++..+     ...++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   85 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFME   85 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEe
Confidence            45799999999999999999999999988643  334556788999999999999999999998877     67999999


Q ss_pred             cCC-ccHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCcccCCCC-c
Q 019728           86 LMD-TDLHQIIRSD-QQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        86 ~~~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      |++ ++|.+++... ..+  ++..+..++.||+.|++|||+.|++|+||+|+||+++. ++.++|+|||.+....... .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            997 5999998764 445  88889999999999999999999999999999999976 6789999999887554322 2


Q ss_pred             ccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...............                   
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-------------------  226 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-------------------  226 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-------------------
Confidence            2234568889999998652 34788999999999999999999999764322111100000                   


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                               ...........++++.+++++||+.+|.+|||+.+++.||||
T Consensus       227 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         227 ---------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ---------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                     001112224568889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.9e-43  Score=312.93  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=196.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-----CceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+.+.||.|+||.||+|.+...     ++.||+|++.... .......+.+|+.+++.+ +||||+++++.+...   
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~---  114 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG---  114 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC---
Confidence            478999999999999999986443     3579999996543 233456788999999999 899999999998877   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC--------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------------   98 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------------------------   98 (336)
                        ...++||||+. |+|.+++...                                                        
T Consensus       115 --~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         115 --GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             --CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence              56899999997 5999888532                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc---c
Q 019728           99 --------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---T  161 (336)
Q Consensus        99 --------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~  161 (336)
                                    .++++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........   .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                          24788889999999999999999999999999999999999999999999998765432211   1


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....                   
T Consensus       273 ~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-------------------  332 (374)
T cd05106         273 NARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-------------------  332 (374)
T ss_pred             CCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-------------------
Confidence            1233567999999876 678999999999999999997 9999976543332222211000                   


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                ........++++.+++.+||+.||.+|||+.++++
T Consensus       333 ----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 ----------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ----------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      00111235789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.7e-42  Score=290.85  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=210.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.+.+.||.|++|.||++.+..+++.+++|++.....  .....+.+|+.+++.++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            37889999999999999999998999999999965432  4567788999999999999999999999877     5689


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +++||++ ++|.+++... +.+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999998 5999998776 6799999999999999999999999999999999999999999999999999877665433


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+..........  ...+..             
T Consensus       154 ~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~-------------  217 (253)
T cd05122         154 RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGL-------------  217 (253)
T ss_pred             ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCc-------------
Confidence            345567888999999876 5688999999999999999999999987654433332222  000000             


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                                   .....++..+.++|++||+.||++|||+.+++.|||
T Consensus       218 -------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 -------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                         001124788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7e-42  Score=300.88  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=210.1

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |...+.||+|+||.||++.+..++..||+|.+.... ........+..|+.+++.++|||++++++++...     ...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEE
Confidence            678889999999999999999999999999986542 3344556788999999999999999999999876     5689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +||||+.|+|.+.+.. ..++++.++..++.||+.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus       102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9999999988888754 466899999999999999999999999999999999999999999999999987654432   


Q ss_pred             cceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          161 TEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ....++..|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+......                
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------  242 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------------  242 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC----------------
Confidence            23456788999999742  256788999999999999999999999876655544444331110                


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   .......+..+.+++.+||+.+|.+||++.++++|+|+...
T Consensus       243 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         243 -------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             -------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                         01112457789999999999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.6e-42  Score=306.30  Aligned_cols=284  Identities=16%  Similarity=0.176  Sum_probs=206.0

Q ss_pred             eeeeccc--ceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            6 RGEYDDI--IFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         6 ~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      ...||.|  ++|+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++...     ...+++
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v   77 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVI   77 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEE
Confidence            3456666  999999999999999999999876554555667888999999999999999999999887     568999


Q ss_pred             EecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           84 YELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      |||+. ++|.+++...  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++++||+.+........ 
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99998 4999988764  3589999999999999999999999999999999999999999999999975432211100 


Q ss_pred             -------ccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          160 -------MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       160 -------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                             .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||...................+. .....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  236 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL-DITTF  236 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc-ccccc
Confidence                   0111235569999998753 34789999999999999999999999876544333222221110000 00000


Q ss_pred             ccch------HHHHHHhCC----------ccc-cccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          232 RSDN------ARRYVRQLP----------RCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       232 ~~~~------~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      +...      .........          ... ...........+..+.+||++||+.||++|||++|+++||||..+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            0000      000000000          000 00001112346778999999999999999999999999999998754


Q ss_pred             C
Q 019728          295 L  295 (336)
Q Consensus       295 ~  295 (336)
                      .
T Consensus       317 ~  317 (328)
T cd08226         317 Q  317 (328)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.9e-42  Score=294.64  Aligned_cols=245  Identities=20%  Similarity=0.358  Sum_probs=202.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+..+++.||+|.+...   ......+.+|+.++++++|||++++++++...     ...+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY   78 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcE
Confidence            477889999999999999999999999999998643   33456788999999999999999999998876     5689


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999997 5999998653  358899999999999999999999999999999999999999999999999987655432


Q ss_pred             ccc--ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ...  ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+.....              
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------  223 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR--------------  223 (263)
T ss_pred             eeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--------------
Confidence            211  1223457999998876 778899999999999999998 9999987765544433322110              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .......+.++.+++.+||+.||++||++.++++
T Consensus       224 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ----------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                            1122456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-42  Score=298.55  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=202.7

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|.+.+.||.|++|.||+|.+.     .+++.||+|.+.... .......+.+|+++++.++|||++++++++...    
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   80 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG----   80 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence            5788999999999999999874     346789999986542 233457788999999999999999999999887    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD--------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                       ...+++|||++ ++|.+++...              ..+++..+..++.||+.|+++||++|++|+||+|+||+++.++
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence             56999999997 5999999754              2478889999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 019728          142 DLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  217 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~  217 (336)
                      .++|+|||.+.......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999987543322   1223344678999999987 778999999999999999998 999998776655444433


Q ss_pred             HHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ...                              ........+..+.+++++||+.||.+||++.|+++
T Consensus       239 ~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGR------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            110                              01112356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-42  Score=306.48  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||.||+|.+.     .+++.||+|++.... .......+.+|+.+++++ +||||+++++++....  
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~--   84 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG--   84 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC--
Confidence            6899999999999999999753     345789999986432 233456678899999999 7999999999876542  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC--------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------------   98 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------------------------   98 (336)
                        ..++++|||+. ++|.+++...                                                        
T Consensus        85 --~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          85 --GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             --CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence              45899999998 4998888542                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc---ccceeeeeccc
Q 019728           99 -----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYR  170 (336)
Q Consensus        99 -----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~  170 (336)
                           .++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........   .....++..|+
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 2578899999999999999999999999999999999999999999999999876533211   12234456799


Q ss_pred             CchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccc
Q 019728          171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ  249 (336)
Q Consensus       171 aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (336)
                      |||++.+ ..++.++|||||||++|+|++ |..||.+....+.........                             
T Consensus       243 aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------  292 (337)
T cd05054         243 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-----------------------------  292 (337)
T ss_pred             CcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-----------------------------
Confidence            9999887 788999999999999999998 999997754333222111100                             


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       250 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .........+.++.+++.+||+.+|++||+++|+++|
T Consensus       293 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0001123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.8e-42  Score=293.72  Aligned_cols=242  Identities=19%  Similarity=0.297  Sum_probs=199.4

Q ss_pred             eeecccceEEEEEEEe--CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ++||+|+||.||+|.+  ..+++.+|+|++.....+......+..|+.+++.++||||+++++++..      ...+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~   74 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVM   74 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEE
Confidence            3699999999999965  4567889999987655555667788899999999999999999998754      3468999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc---
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---  160 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---  160 (336)
                      ||++ |+|.+++...+.+++..+..++.|++.|++|||++|++|+||||.||+++.++.++|+|||.+.........   
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9998 589999988788999999999999999999999999999999999999999999999999998765443221   


Q ss_pred             -cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          161 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       161 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                       ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||......+....+.+..                  
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~------------------  215 (257)
T cd05116         155 KTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE------------------  215 (257)
T ss_pred             cCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------------------
Confidence             11223468999998865 678889999999999999998 999998776555444432210                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                  ........+.++.++|++||+.||.+||++.+|..
T Consensus       216 ------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 ------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                        01122457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.1e-42  Score=292.65  Aligned_cols=242  Identities=21%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEec
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL   86 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~   86 (336)
                      +.||+|++|.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++...     ...++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence            47999999999999999999999999875432 344556788999999999999999999999876     568999999


Q ss_pred             CC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc---
Q 019728           87 MD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---  161 (336)
Q Consensus        87 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---  161 (336)
                      +. ++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..........   
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            97 5999998764 458999999999999999999999999999999999999999999999999987544321111   


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....                   
T Consensus       155 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-------------------  214 (252)
T cd05084         155 MKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-------------------  214 (252)
T ss_pred             CCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------------------
Confidence            1122456999999876 678899999999999999997 8889976654433332222100                   


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                 .......+..+.+++.+||+.||++|||+.+++.
T Consensus       215 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -----------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0112345788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=312.07  Aligned_cols=236  Identities=24%  Similarity=0.325  Sum_probs=203.7

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      ++.||+|+.|.||+++.  .++.||||+++..         -..+++.|++|+||||+.+.+++...     .-+|||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME  192 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME  192 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence            57799999999999998  4789999998431         22578899999999999999999887     66999999


Q ss_pred             cCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccccee
Q 019728           86 LMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV  164 (336)
Q Consensus        86 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (336)
                      ||. |-|.+.++...+++......|.++|+.|+.|||.+.|+|||||.-||||+.+..+||+|||.++........-.+.
T Consensus       193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence            997 8999999999999999999999999999999999999999999999999999999999999999877766666789


Q ss_pred             eeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCC
Q 019728          165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  244 (336)
Q Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
                      ||..|||||++++ .+.+.+.||||+||++||||||..||...+....+-.+    +                       
T Consensus       273 GTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----G-----------------------  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----G-----------------------  324 (904)
T ss_pred             hhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEec----c-----------------------
Confidence            9999999999998 89999999999999999999999999876543322100    0                       


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                        ......++....++.++-||++||+..|..||++.+++.|-
T Consensus       325 --sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  325 --SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             --CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence              00011233446788899999999999999999999999883

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-42  Score=296.64  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=209.0

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++.+.||.|+||.||++.+..+++.||+|.+.... .......+.+|+.++++++|||++++++.+...     ...|+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   79 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI   79 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence            678899999999999999999899999999885432 233456778899999999999999999999877     66999


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-c
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-M  160 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (336)
                      ||||+++ +|.+++.+ ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            9999985 88888765 5689999999999999999999999999999999999999999999999998865543321 2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||.+.+ ...+.++|+|||||++++|++|..||...........+..   .                  
T Consensus       159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~------------------  216 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---N------------------  216 (277)
T ss_pred             ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc---C------------------
Confidence            23456788999999876 6788899999999999999999999977654333322211   0                  


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                               ........++.++.+++.+||+.+|.+||++.+++.||||...
T Consensus       217 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         217 ---------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                     0011123568889999999999999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.3e-43  Score=298.33  Aligned_cols=245  Identities=26%  Similarity=0.381  Sum_probs=198.3

Q ss_pred             ceeeeecccceEEEEEEEeC----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            4 KLRGEYDDIIFFIFSAAVNS----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      ++.+.||.|.||.||.|...    ..+..|+||.++. .........+.+|++.+++++||||+++++++...     ..
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~   75 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP   75 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence            67899999999999999997    4567799999954 34455688899999999999999999999999955     45


Q ss_pred             EEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           80 VYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .++||||+. |+|.+++...  ..++...+..|+.||+.||+|||+++++|++|+++||+++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            899999998 6999999886  6799999999999999999999999999999999999999999999999999877632


Q ss_pred             CC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          157 TD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ..   ..........|+|||.+.. ..++.++||||||+++|||++ |..||...+..+....+.+..            
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~------------  222 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ------------  222 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE------------
T ss_pred             cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc------------
Confidence            21   1233456778999999887 668999999999999999999 789998887666555552211            


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        ........+..+.++|.+||..||.+|||+.++++
T Consensus       223 ------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 ------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                              11222456889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.9e-42  Score=298.24  Aligned_cols=252  Identities=24%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      ..+||.|++|.||++.+..+++.||+|++...  .......+.+|+.+++.++|||++++++.+...     ...+++||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   97 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVME   97 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEe
Confidence            45799999999999999999999999988543  334566788999999999999999999999877     67999999


Q ss_pred             cCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-cccce
Q 019728           86 LMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEY  163 (336)
Q Consensus        86 ~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~  163 (336)
                      |+++ +|.+++.. .++++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            9985 78777654 578999999999999999999999999999999999999999999999999876544321 12234


Q ss_pred             eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      .++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+......                     
T Consensus       177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------------  234 (292)
T cd06657         177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---------------------  234 (292)
T ss_pred             ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc---------------------
Confidence            56788999998876 67889999999999999999999999877655444433221110                     


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                             .......++..+.+++.+||+.||.+||++.+++.||||.....
T Consensus       235 -------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 -------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                   01112356888999999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.2e-42  Score=298.09  Aligned_cols=252  Identities=30%  Similarity=0.457  Sum_probs=210.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||.|++|.||++.+..+++.|++|++.....   ....+..|+.+++.++|+|++++++++...     ...|+
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            6778899999999999999998999999999865422   566778999999999999999999999887     66999


Q ss_pred             EEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           83 VYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      ++||++ ++|.+++...+ .++...+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            999998 59999998876 89999999999999999999999999999999999999999999999999876544322 1


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.... .+.               
T Consensus       173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------  235 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP---------------  235 (286)
T ss_pred             hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC---------------
Confidence            223346778999999876 678999999999999999999999998766544333322110 000               


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                  ......++..+.++|++||+.+|.+||++.+++.|+||+.
T Consensus       236 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         236 ------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             ------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                        0111236788999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-42  Score=297.27  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=201.2

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|.+.+.||.|+||.||++.+     ..++..+|+|.+...  .......+.+|+.++++++||||+++++++...    
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   79 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----   79 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence            478999999999999999986     234567999988543  344566788999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ-------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  142 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~  142 (336)
                       ...+++|||++ ++|.+++...+             .+++..++.++.||+.||+|||++|++||||||+||++++++.
T Consensus        80 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          80 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             -CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence             56899999997 59999987543             4899999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019728          143 LKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  218 (336)
Q Consensus       143 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~  218 (336)
                      ++|+|||.+........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+..
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999875543221   122334678999999877 678999999999999999998 9999987765554444322


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ..                              ........+.++.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GR------------------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CC------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            10                              01112346788999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.5e-42  Score=292.08  Aligned_cols=245  Identities=19%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|+||.+.+.. +..+|+|.+....   .....+.+|+.++++++||||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIY   75 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcE
Confidence            47899999999999999998753 4569999886432   2245678999999999999999999998776     4589


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|||+. |+|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999997 5899998764 4689999999999999999999999999999999999999999999999998876543322


Q ss_pred             cc--ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 MT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ..  ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+.....               
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------  219 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR---------------  219 (256)
T ss_pred             eecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC---------------
Confidence            11  1234567999999976 678899999999999999998 9999987765544443322111               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     .......+..+.+++.+||+.||.+||++.+++.+
T Consensus       220 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         220 ---------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                           01112347889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=311.73  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=204.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ++.+...||.|.||+||++.+..   .||||+++....+....+.+..|+.++++-+|.||+-+.|++..+     . +.
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----~-~A  463 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----P-LA  463 (678)
T ss_pred             Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----c-ee
Confidence            35788999999999999999965   599999999888888999999999999999999999999999876     3 49


Q ss_pred             EEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           82 IVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      ||+-+|+| +|...++.. ..|.....+.|++||++|+.|||.++|+|+|||..||++.+++.|||+|||++.....-  
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            99999998 999999754 46899999999999999999999999999999999999999999999999998654322  


Q ss_pred             -CcccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          158 -DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                       .......+...|||||+++.  ..+++..+||||+||++|||++|..||...+....+-.+-+          ++.   
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr----------G~l---  610 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR----------GYL---  610 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc----------ccc---
Confidence             12233466788999999863  36899999999999999999999999984432222111100          000   


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                   ..+........+.++++|+..||..++++||.+.+||.
T Consensus       611 -------------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  611 -------------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -------------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                         00111222355779999999999999999999999987

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8e-42  Score=297.74  Aligned_cols=258  Identities=22%  Similarity=0.322  Sum_probs=204.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||.|++|.||++.+..+++.||+|.+..... ......+..|+.++.... ||||+++++++...     ...
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   89 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SDV   89 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----CeE
Confidence            47899999999999999999998899999999865432 233455666777666664 99999999999876     669


Q ss_pred             EEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |++|||+++.+.+++.. ...+++..+..++.||+.|++|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99999999888887755 4578999999999999999999997 599999999999999999999999999987654433


Q ss_pred             cccceeeeecccCchhcccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccccc
Q 019728          159 FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      ......++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...... +.+..+   .......        
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~--------  238 (296)
T cd06618         170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI---LQEEPPS--------  238 (296)
T ss_pred             cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH---hcCCCCC--------
Confidence            33334567789999998652   24788999999999999999999999764321 222211   1110000        


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                       .+....++.++.+|+.+||+.||.+||++++++.||||+...
T Consensus       239 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         239 -----------------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                             001124678899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=330.26  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=223.1

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.|++.||.|+||.|.+++.+.|++.||+|++++- .........+..|-.+|.--+.+=|+.++..|.++     .++|
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-----~~LY  151 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-----RYLY  151 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-----cceE
Confidence            78999999999999999999999999999999662 23445567788899999888999999999999998     7799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      +||||++ |+|..++.+..++++..++.++..|+.||..+|+.|+|||||||+|||+|..|++||.|||.+-......  
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999997 5999999988899999999999999999999999999999999999999999999999999876655332  


Q ss_pred             cccceeeeecccCchhccc---C-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 FMTEYVVTRWYRAPELLLN---C-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~---~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .....+|||-|.|||++..   . +.|+...|.|||||++|||+.|..||...+-.++..+|+.-.....          
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~----------  301 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS----------  301 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC----------
Confidence            3455689999999999863   2 5789999999999999999999999999888888888766321111          


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~ell~h~~f~~~~  293 (336)
                                      ++ ....+|.++++||++++. +|+.|..   ++++-+||||.++.
T Consensus       302 ----------------FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  302 ----------------FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ----------------CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence                            11 123579999999999985 7899997   99999999999975

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.9e-42  Score=293.36  Aligned_cols=249  Identities=28%  Similarity=0.410  Sum_probs=202.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||.|++|.||+|.+..+++.||||.+... .........+..|+.+++.++|||++++++++...     ...
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NEL   77 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeE
Confidence            588999999999999999999999999999988643 23445566788899999999999999999998876     668


Q ss_pred             EEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ++++||+++ +|.+++..    ...+++..+..++.||+.|++|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999984 88888752    3458999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCcccccccc
Q 019728          156 ETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.....  ......+ .....++        
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--------  227 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPP--------  227 (267)
T ss_pred             chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCC--------
Confidence            3322 223457788999999877 6788999999999999999999999865432  1111111 1101000        


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          ......+..+.+++++||+.+|++||++.++++
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                011245778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.9e-42  Score=294.16  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=202.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCc--eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~   79 (336)
                      |.+.+.||+|++|.||++.+..++.  .||+|.++....+......+..|+.+++.++||||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999977765  69999887665566667888899999999999999999997654322 12245


Q ss_pred             EEEEEecCC-ccHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           80 VYIVYELMD-TDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      .+++|||+. |+|.+++..      ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            799999997 599888742      2347899999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          153 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       153 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      .......   ......+..|+|||...+ ..++.++|+|||||++|+|++ |..||...........+...         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---------  230 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG---------  230 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---------
Confidence            6543321   112234567999999877 778999999999999999999 88999876654433332210         


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                           ......+..+..+.++|.+||+.||.+|||+.+++.+
T Consensus       231 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         231 ---------------------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                 0011124567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-42  Score=294.13  Aligned_cols=253  Identities=20%  Similarity=0.292  Sum_probs=203.4

Q ss_pred             cceeeeecccceEEEEEEEeCC---CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~   78 (336)
                      |.+.+.||+|+||.||.|....   ++..||+|.++...........+..|+..++.++|||++++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6789999999999999998754   44789999997655555666788899999999999999999998776533 2224


Q ss_pred             eEEEEEecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ..+++|||+. |+|..++...      ..+++..++.++.|++.||+|||+.|++|+||||+||++++++.++|+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            4799999998 5998887432      35899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          152 RTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       152 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      +........   .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+...        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--------  231 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--------  231 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence            765433211   11233567999999876 778999999999999999999 89999876655443333221        


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                            .........+..+.+++.+||+.||++|||+.|++.+
T Consensus       232 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         232 ----------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  0111224568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.9e-42  Score=291.26  Aligned_cols=244  Identities=22%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|+||.||++..+ .+..+|+|.+....   .....+.+|+.++++++||||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLY   75 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEE
Confidence            4788999999999999999885 45689999875432   2245678899999999999999999999876     5689


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|||++ |+|.+++... +.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            9999997 5999998753 4689999999999999999999999999999999999999999999999998876543322


Q ss_pred             cc--ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 MT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ..  ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+....+.....               
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~---------------  219 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR---------------  219 (256)
T ss_pred             eccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---------------
Confidence            21  2234567999999876 678899999999999999999 8999988776555544433110               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     .......+..+.+++.+||+.||.+||+++++++
T Consensus       220 ---------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ---------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                           0111234678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.8e-42  Score=294.69  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=199.0

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||.|++|.||.+.+.     .++..||+|++.... .......+.+|+.+++.++||||+++++++...    
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~----   81 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG----   81 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----
Confidence            5889999999999999999874     245679999885432 234456678999999999999999999998776    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                       ...++||||++ |+|.+++.+..          .++...+..++.|++.|++|||+.|++|+||||+||+++.++.++|
T Consensus        82 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          82 -QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             -CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence             56899999998 59999986532          3567788999999999999999999999999999999999999999


Q ss_pred             EeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||++.........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+.... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-  238 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-  238 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence            999998754433221   12234667999999876 678999999999999999998 788998776554443332210 


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                   ........+..+.+++.+||+.||++|||+.|++++
T Consensus       239 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 -----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                         011123457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-41  Score=295.28  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|.+.+.||.|++|.||+|.+.     ..+..||+|.+.... .......+.+|+.+++.++||||+++++++...    
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   81 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG----   81 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----
Confidence            5899999999999999999764     235579999886442 233445677899999999999999999998876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                       ...|++|||+. |+|.+++...          ...+...+..++.||+.||+|||++|++|+||||+||+++.++.++|
T Consensus        82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence             55899999997 6999999642          23466788899999999999999999999999999999999999999


Q ss_pred             EeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||.++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+...  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--  237 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--  237 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence            999998754332211   12234567999999876 678899999999999999998 78899877655444333210  


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc------CcccccC
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR------HPYLQSL  292 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~------h~~f~~~  292 (336)
                                                  .........+..+.+++++||+.||++|||+.++++      ||||.++
T Consensus       238 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         238 ----------------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             ----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence                                        001111345788999999999999999999999986      8998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.3e-42  Score=299.21  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=208.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|...+.||.|++|.||++.+..+++.+|+|.+... .........+.+|+.+++.++|+|++++++++...     ...
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Cee
Confidence            466788999999999999999999999999988643 22344556778999999999999999999998876     568


Q ss_pred             EEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++||||+.|++.+.+.. ..++++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            99999999988887754 456899999999999999999999999999999999999999999999999988765432  


Q ss_pred             ccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ....++..|+|||.+.+  ....+.++|||||||++|+|++|..||...+.......+.....                
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------  231 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------------  231 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC----------------
Confidence             23456788999999752  24578899999999999999999999977654433332221100                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   ........+..+.++|++||+.+|.+||++++++.|||+...
T Consensus       232 -------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         232 -------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                         001113567889999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=295.24  Aligned_cols=285  Identities=29%  Similarity=0.460  Sum_probs=219.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-----C---CceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----H---ENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---p~iv~~~~~~~~~~   73 (336)
                      ||.+.++||.|.|++||+|.|..+.+.||+|+++..   ....+..+.|+.+|++++     |   .+||++++.|....
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            799999999999999999999999999999998653   445567789999999994     2   47999999999887


Q ss_pred             CCCcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccC----------
Q 019728           74 KDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS----------  140 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~----------  140 (336)
                      .++ .|+++|+|+++.+|+.+|...  +.++...++.|++||+.||.|||+. ||+|.||||+|||+..+          
T Consensus       156 pNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~  234 (590)
T KOG1290|consen  156 PNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE  234 (590)
T ss_pred             CCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence            766 789999999999999999754  6799999999999999999999975 99999999999998310          


Q ss_pred             -C------------------------------------------------------------------------------
Q 019728          141 -C------------------------------------------------------------------------------  141 (336)
Q Consensus       141 -~------------------------------------------------------------------------------  141 (336)
                       +                                                                              
T Consensus       235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~  314 (590)
T KOG1290|consen  235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES  314 (590)
T ss_pred             hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence             0                                                                              


Q ss_pred             -----------------------------------------------------------------------------CEE
Q 019728          142 -----------------------------------------------------------------------------DLK  144 (336)
Q Consensus       142 -----------------------------------------------------------------------------~~k  144 (336)
                                                                                                   ++|
T Consensus       315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK  394 (590)
T KOG1290|consen  315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK  394 (590)
T ss_pred             chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence                                                                                         012


Q ss_pred             EEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHH
Q 019728          145 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK------DYVHQLRLITE  218 (336)
Q Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~~~~  218 (336)
                      |.|||.++-....  ++.-..|..|+|||++.+ ..|+..+||||++|+++||+||...|...      .+.+.++.|.+
T Consensus       395 IaDlGNACW~~kh--FT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E  471 (590)
T KOG1290|consen  395 IADLGNACWVHKH--FTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME  471 (590)
T ss_pred             Eeeccchhhhhhh--hchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence            2222222211111  111233566999999999 89999999999999999999999988543      36789999999


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCccccccccccCC-------------CCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-------------NKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      +++..|....  ..+...+.|+......+.......++             ....++.+||.-||+.+|++||||.++|+
T Consensus       472 LLG~iPr~ia--~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  472 LLGKIPRKIA--LGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHhhccHHHH--hcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            9998877542  12233344444333322222111111             23556889999999999999999999999


Q ss_pred             CcccccCcCC
Q 019728          286 HPYLQSLHDL  295 (336)
Q Consensus       286 h~~f~~~~~~  295 (336)
                      |||+..+..+
T Consensus       550 hPwLn~~~~~  559 (590)
T KOG1290|consen  550 HPWLNPVAGP  559 (590)
T ss_pred             CccccCCCCC
Confidence            9999988765

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=291.40  Aligned_cols=243  Identities=25%  Similarity=0.373  Sum_probs=204.6

Q ss_pred             eeecccceEEEEEEEeCCC---CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      +.||.|++|.||+|.+...   +..|++|.+....... ....+.+|+..++.++|+|++++++++...     ...+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEE
Confidence            4799999999999999866   8999999997654333 567888999999999999999999999875     669999


Q ss_pred             EecCC-ccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           84 YELMD-TDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      |||++ ++|.+++...         ..+++.+++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            99995 6999999875         7799999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          154 TSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       154 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      .....   ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------  224 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---------  224 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence            65432   1233456778999999887 578999999999999999999 699998876655544443210         


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                           ........+.++.+++.+||..+|++|||+.+++++
T Consensus       225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 ---------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ---------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                 011223558899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.1e-42  Score=300.75  Aligned_cols=247  Identities=21%  Similarity=0.264  Sum_probs=199.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCce----EEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.+..+++.    ||+|++... ........+..|+.+++.++||||+++++++...     
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            588999999999999999998666654    899988643 2344556788999999999999999999988754     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..+++++|+. |+|.+++... ..++...+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             3578999997 6999999764 458899999999999999999999999999999999999999999999999998665


Q ss_pred             CCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .....   .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+....+....           
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  228 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----------  228 (316)
T ss_pred             CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-----------
Confidence            43221   11233567999999877 778999999999999999997 999998765444322221100           


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                         ..+..+..+.++.+++.+||..||.+||++.+++.+
T Consensus       229 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 -------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                               011123457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9e-42  Score=297.53  Aligned_cols=248  Identities=22%  Similarity=0.283  Sum_probs=198.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc--eEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||.|+||.||+|.+..++.  .+++|.++. .........+.+|+.++.++ +||||+++++++...     .
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~   76 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G   76 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence            58899999999999999999877665  468887753 22334456788999999999 799999999998876     5


Q ss_pred             eEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ..|++|||++ ++|.+++....                .+++..++.++.||+.||+|||++|++|+||||+||+++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            5899999997 59999996532                478899999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 019728          142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  220 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~  220 (336)
                      .++|+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            999999998864322211111223456999999876 678999999999999999997 999998776554443322110


Q ss_pred             CCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                    .......++..+.+|+.+||+.+|.+||++++++..
T Consensus       236 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 ------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                          011223568899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-41  Score=291.00  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.++||+|++|.||+|.+. .+..||+|.+...   ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIY   77 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcE
Confidence            4889999999999999999974 5677999987543   23456788999999999999999999998776     5689


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||+. ++|.+++..  ...++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999997 599999865  3568889999999999999999999999999999999999999999999999987654332


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+.....              
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------  222 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--------------  222 (261)
T ss_pred             eeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            1  112234567999999876 678889999999999999998 9999987665544443322110              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .+.....+.++.+++.+||..+|++||+++++++
T Consensus       223 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 ----------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            1122356889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.8e-42  Score=299.51  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=197.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCce--EEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|.+.+.||.|+||.||+|.+..++..  +++|.+... ........+.+|+.++.++ +||||+++++++...     .
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----~   81 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   81 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----C
Confidence            478899999999999999999877765  577766432 2334556778899999999 899999999999876     5


Q ss_pred             eEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ..|++|||++ ++|.+++...+                .+++..++.++.||+.|++|||++|++||||||+||+++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            6899999997 59999986432                578999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 019728          142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  220 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~  220 (336)
                      .++|+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+..  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--  238 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--  238 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence            999999999864322111112223567999998876 678899999999999999998 9999977655443322211  


Q ss_pred             CCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                       ..                           ........+..+.+++.+||+.+|++||++++++.+
T Consensus       239 -~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 -GY---------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -CC---------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             00                           001112457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-41  Score=293.80  Aligned_cols=248  Identities=21%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCC-----CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|.+.+.||.|++|.||+|.+..     ++..|++|.+.... .......+..|+.+++.++||||+++++++...    
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   81 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER----   81 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC----
Confidence            47899999999999999999977     77889999885432 333446688899999999999999999988776    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl  145 (336)
                       ...+++|||+. ++|.+++...+       .+++..+..++.||+.|++|||++|++|+||+|+||+++.++   .++|
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence             55799999997 59999987643       488999999999999999999999999999999999998765   5999


Q ss_pred             EeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||.+.........   .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence            999998765332211   12223467999999976 678999999999999999997 999998776554433322110 


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                   ........+..+.+++.+||+.+|++||++.++++|
T Consensus       239 -----------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 -----------------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -----------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                         001124568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.8e-42  Score=324.93  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=199.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.++||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.++++++||||+++++++...     ...
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~l   77 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DPV   77 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CEE
Confidence            6899999999999999999999999999999997543 2344556788999999999999999999999876     668


Q ss_pred             EEEEecCCc-cHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEec
Q 019728           81 YIVYELMDT-DLHQIIRSD-----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  148 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (336)
                      |++|||++| +|.+++.+.           ...+...+..++.||+.||+|||+.||+||||||+||+++.++.++|+||
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence            999999985 999988641           23556778899999999999999999999999999999999999999999


Q ss_pred             cCCcccCCC-------------------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 019728          149 GLARTTSET-------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  209 (336)
Q Consensus       149 g~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  209 (336)
                      |++......                   .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.....
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            998755111                   01122468999999999877 7789999999999999999999999977543


Q ss_pred             HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ......  .....+.                          .......+++.+.+++.+||+.||++|++..+.+.
T Consensus       237 ~ki~~~--~~i~~P~--------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        237 RKISYR--DVILSPI--------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhh--hhccChh--------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            221111  0000000                          00112467889999999999999999987655553

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-43  Score=310.13  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=215.6

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEec--CcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +.-..||+|+|-+||+|.|..+|..||--.++  .-..++...+++..|+.+|+.|+||||+++|++..+...   ..+-
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            45678999999999999999999999965443  334677888999999999999999999999999988754   4588


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEcc-CCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~  157 (336)
                      +|+|.+. |+|..+++..+.++...++.|++||+.||.|||++.  |+|||||-+||+|+. .|.+||+|+|+|......
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999997 899999999999999999999999999999999996  999999999999976 588999999999877655


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .. ....||+.|||||.+.  ..|+...||||||+++.||+|+..||..-...+++.+-+.  ....+...         
T Consensus       200 ~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~--SGiKP~sl---------  265 (632)
T KOG0584|consen  200 HA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT--SGIKPAAL---------  265 (632)
T ss_pred             cc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH--cCCCHHHh---------
Confidence            33 3479999999999997  5899999999999999999999999988766555443322  22221111         


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                       ..--.+++++||.+||.. .++|+|+.|||.||||..-
T Consensus       266 -----------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  266 -----------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                             122377899999999999 9999999999999999874

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-42  Score=291.06  Aligned_cols=245  Identities=18%  Similarity=0.278  Sum_probs=200.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+. ++..+|+|.+.....   ....+.+|+.+++.++||||+++++++...     ...|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIF   75 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceE
Confidence            6889999999999999999985 567899998864322   234577899999999999999999998776     5689


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|||++ ++|.+++... ..+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.++.......
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            9999997 5999998753 4689999999999999999999999999999999999999999999999998876543322


Q ss_pred             cc--ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 MT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ..  ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.....               
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------  219 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---------------  219 (256)
T ss_pred             cccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---------------
Confidence            11  1123457999999887 678899999999999999998 8999987665544443322110               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     .......+..+.+++.+||..+|++|||+.++++.
T Consensus       220 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ---------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                           11123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=289.91  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+. .++.||+|.+....   .....+.+|+.++++++|||++++++++...     ...|
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIY   77 (261)
T ss_pred             heeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCee
Confidence            4789999999999999999975 45789999986532   2345678899999999999999999998776     5689


Q ss_pred             EEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++....  .++...+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999995 69999997654  68999999999999999999999999999999999999999999999999987665332


Q ss_pred             cccc--eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ....  ...+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.........+.....              
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------  222 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------------  222 (261)
T ss_pred             ccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            2111  122357999999876 678999999999999999999 9999988765554444332111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .......+..+.+++.+||+.||.+||++.+++.
T Consensus       223 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 ----------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                            0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1e-41  Score=291.70  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+.. ++.+++|.+...  .......+..|+.+++.++|||++++++++...     ...+
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   78 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVY   78 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeE
Confidence            57899999999999999999977 899999998654  233456788899999999999999999998877     5689


Q ss_pred             EEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||+++ +|.+++.+.  ..++...++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999985 999999753  468999999999999999999999999999999999999999999999999987654322


Q ss_pred             c-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      . .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.....               
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------  222 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---------------  222 (261)
T ss_pred             ccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---------------
Confidence            1 122234567999999876 678899999999999999998 8999988775555544432110               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     .+.....+..+.+++.+||+.||.+|||+.++++
T Consensus       223 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 ---------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                           1122466889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=290.50  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=202.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCC---CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|++.+.||.|+||+||+|.+..+   ...||+|.+.... .......+..|+.++++++||||+++++++...     .
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   78 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-----R   78 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----C
Confidence            488999999999999999998654   4579999886543 344556778899999999999999999998776     5


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+++|||+++ +|.+++... +.+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            68999999974 999998664 4689999999999999999999999999999999999999999999999999887642


Q ss_pred             CCc--c-cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          157 TDF--M-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       157 ~~~--~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ...  . ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......          
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----------  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            211  1 11233567999999876 678999999999999999998 99999776655444433221110          


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                          +.....+..+.+++.+||+.+|++||++.+++++
T Consensus       228 --------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 --------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                1123568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.8e-41  Score=294.71  Aligned_cols=260  Identities=19%  Similarity=0.320  Sum_probs=208.7

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      .|++.+.||.|++|.||.|.+.   .+|+.||+|.+....  ........+..|+.+++++ +||||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD---   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence            3789999999999999999985   478999999986532  1223446677899999999 599999999998876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ...|+||||++ ++|.+++....++++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          78 --TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             --CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence              56899999998 499999988888999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--cccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          155 SETD--FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....  ......++..|+|||.+.+. ...+.++|+||||+++|+|++|..||...........+.......        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--------  227 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--------
Confidence            4322  12234578889999998652 346789999999999999999999996543222222221111000        


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                         ..+....++..+.+++++||+.||++||     ++++++.||||+...
T Consensus       228 -------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         228 -------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence                               0111234688899999999999999997     899999999998864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.5e-42  Score=299.78  Aligned_cols=281  Identities=20%  Similarity=0.270  Sum_probs=203.2

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      .+.+.+|.|  |.||.+++..+++.||+|++............+.+|+.+++.++||||+++++++...     ...+++
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~   77 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVV   77 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEE
Confidence            344444444  5667777777999999999976545566778899999999999999999999999877     668999


Q ss_pred             EecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           84 YELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      |||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+||+.+.......  
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99998 5898988753  468999999999999999999999999999999999999999999999999876443221  


Q ss_pred             ------cccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc-cc
Q 019728          159 ------FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GF  230 (336)
Q Consensus       159 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  230 (336)
                            ......++..|+|||++... ..++.++|+||+||++++|++|..||..........  ....+..+.... ..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~  235 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLLDKST  235 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccccccCc
Confidence                  11223456789999998653 357889999999999999999999998765443221  111111111000 00


Q ss_pred             cccc--hHHH--HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          231 LRSD--NARR--YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .+..  ....  ...................++.++.+|+++||+.||++|||++++|+||||+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            0000  0000  0000000000011111224467899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=288.32  Aligned_cols=244  Identities=27%  Similarity=0.422  Sum_probs=206.2

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      ||.|++|.||.+.+..+++.|++|.+.... ........+..|+.++++++|||++++++.+...     ...+++||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence            699999999999998889999999986543 2334566788899999999999999999998876     6699999999


Q ss_pred             C-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccccceee
Q 019728           88 D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVV  165 (336)
Q Consensus        88 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~  165 (336)
                      + ++|.+++.....+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            5 699999988888999999999999999999999999999999999999999999999999998765543 22334466


Q ss_pred             eecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCc
Q 019728          166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR  245 (336)
Q Consensus       166 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (336)
                      +..|+|||...+ ...+.++|+||||+++|+|++|..||...+.......+...                          
T Consensus       156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------------------  208 (250)
T cd05123         156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--------------------------  208 (250)
T ss_pred             CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--------------------------
Confidence            788999999876 66788999999999999999999999877654333333220                          


Q ss_pred             cccccccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHHcCccc
Q 019728          246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV---EEALRHPYL  289 (336)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~---~ell~h~~f  289 (336)
                           ........+..+.+++++||..||.+||++   +++++||||
T Consensus       209 -----~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 -----PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                 011223448889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=339.34  Aligned_cols=258  Identities=26%  Similarity=0.343  Sum_probs=219.3

Q ss_pred             CccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            1 MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         1 ~~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      |||.-+..||.|.||.||.|.+..+|+..|+|-++...........+.+|..+++.++|||+|++|++-...     +.+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKV 1309 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHH
Confidence            467778899999999999999999999999998876655566778888999999999999999999998887     569


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +|.||||. |+|.+.++..+-..+...+.+..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|.....+. 
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            99999997 6999999887778888888899999999999999999999999999999999999999999998765542 


Q ss_pred             ----cccceeeeecccCchhcccCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          159 ----FMTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ----~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                          ......||+.|||||++.+..  ....++|||||||+..||+||+.||...+..-.+..-+..-..          
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~---------- 1459 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK---------- 1459 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC----------
Confidence                234568999999999998743  4677999999999999999999999887654443322222111          


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                         +..+..+|.+.++||..||..||++|.++.|+++|.|-+.-
T Consensus      1460 -------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1460 -------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             -------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence                               22223479999999999999999999999999999986653

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-41  Score=290.95  Aligned_cols=249  Identities=27%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|++|.||++.+..+++.|++|.+.... ........+.+|+.+++.++||||+++++++...     ...
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----CeE
Confidence            5889999999999999999999999999999886532 3444556788999999999999999999999876     668


Q ss_pred             EEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      +++|||++| +|.+++..    ...+++..++.++.||+.|++|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            999999985 89888763    3568999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCcccccccc
Q 019728          156 ETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV--HQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.+....  .....+... ..          
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----------  225 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DY----------  225 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CC----------
Confidence            3322 223467888999999876 67889999999999999999999999754321  111111100 00          


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        ........+..+.+++.+||..||++|||+.+++.
T Consensus       226 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 ------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                              00011246788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-42  Score=317.74  Aligned_cols=245  Identities=24%  Similarity=0.390  Sum_probs=212.2

Q ss_pred             cceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      ++..++||+|.||.||+|...     .....||||.++.. .+.....++.+|++++..|+|||||+++|++...     
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-----  561 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREG-----  561 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----
Confidence            467899999999999999873     33456999998653 3445778899999999999999999999999998     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD--------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  142 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~  142 (336)
                      ...|+|+|||. |+|.++|+.+              .+++..+...|+.||+.|+.||-++.+|||||-+.|+||.++..
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            56999999998 8999999742              23889999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019728          143 LKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  218 (336)
Q Consensus       143 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~  218 (336)
                      |||+|||+++..-..++.   ....-..+|||||.+.- ++++.+|||||+||++||+++ |..||.+....+.++.+..
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999987665542   23355788999999987 899999999999999999998 9999999998888887755


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHH
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  284 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell  284 (336)
                                                    ...-+.....|.++.+|+..||+..|++||++.||=
T Consensus       721 ------------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  721 ------------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             ------------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence                                          112344467899999999999999999999999983

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-41  Score=287.82  Aligned_cols=241  Identities=19%  Similarity=0.255  Sum_probs=196.8

Q ss_pred             eeecccceEEEEEEEeCCCC---ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      ++||.|++|.||+|.+..++   ..||+|.+...... .....+..|+.+++.+.|||++++++++..      ...+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence            57999999999999876554   78999998654332 455678899999999999999999998754      347999


Q ss_pred             EecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc-
Q 019728           84 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-  161 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-  161 (336)
                      |||+. |+|.+++.....+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99997 5999999888889999999999999999999999999999999999999999999999999987654332211 


Q ss_pred             ---ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          162 ---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       162 ---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                         ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+....                 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-----------------  215 (257)
T ss_pred             cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-----------------
Confidence               1122357999999876 678999999999999999998 999998776544433332210                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                   ..+.....+..+.++|.+||..+|++||++.+++.
T Consensus       216 -------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 -------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         01122456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.8e-41  Score=293.60  Aligned_cols=246  Identities=24%  Similarity=0.378  Sum_probs=200.1

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|.+.+.||.|++|.||++.+.     .++..+++|.+...  .......+.+|+.++++++||||+++++++...    
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   79 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----   79 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC----
Confidence            5788999999999999999864     34566899988543  334446678899999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                       ...++||||++ ++|.+++...+                .+++..++.++.||+.|++|||++|++|+||||+||+++.
T Consensus        80 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 -DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence             56899999997 59999996532                3788999999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019728          140 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  215 (336)
Q Consensus       140 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  215 (336)
                      ++.++|+|||.+........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999876543321   223345778999999877 678889999999999999998 9999987765554433


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      +...                              .........+..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQG------------------------------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCC------------------------------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2210                              001112345788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3e-41  Score=292.27  Aligned_cols=248  Identities=19%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             ccceeeeecccceEEEEEEEe----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++.+.||+|+||+||+|.+    ..++..|++|.+.... .......+.+|+.+++.++||||+++++++...     
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----   79 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-----   79 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence            478999999999999999985    3456789999986432 334456778899999999999999999998877     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                      ...|++|||++ ++|.+++...                 ..+++..+..++.|++.||+|||++|++|+||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            56899999998 5999988532                 24788889999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019728          140 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  215 (336)
Q Consensus       140 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  215 (336)
                      ++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999876543321   122334567999999876 678999999999999999998 9999987665444333


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +....                              ........+..+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQ------------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            32210                              011223568889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-41  Score=294.26  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC----------------ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR----------------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI   65 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~   65 (336)
                      +|++++.||.|+||.||+|.+..++                ..||+|++.... .......+.+|+.++++++|||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            5899999999999999999886544                457999986543 23456778899999999999999999


Q ss_pred             cceecCCCCCCcceEEEEEecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCC
Q 019728           66 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS  133 (336)
Q Consensus        66 ~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~  133 (336)
                      ++++...     ...+++||++. ++|.+++....           .+++..++.++.|++.||+|||+.|++|+||||+
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          85 LGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             EEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            9999876     56899999997 59999987655           6899999999999999999999999999999999


Q ss_pred             CeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCC
Q 019728          134 NLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD  208 (336)
Q Consensus       134 nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~  208 (336)
                      ||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.++|||||||++|+|++  +..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999876443321   223344678999999876 678999999999999999998  678887766


Q ss_pred             hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ....+..........                       .........+..+.++.+++.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDD-----------------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccc-----------------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            555444443221100                       000111122356789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.3e-42  Score=272.20  Aligned_cols=282  Identities=27%  Similarity=0.532  Sum_probs=226.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.|.+++|.|.+|.||.+.+..+++.++||+++     +....++.+|+.+|+.|. ||||++++++..++..   ...
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---ktp  110 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KTP  110 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cCc
Confidence            3789999999999999999999999999999984     456688999999999997 9999999999998865   457


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccCCCC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~  158 (336)
                      .+|+||.+. +...+.   ..++.-.++.++.+++.||.|+|++||.|||+||.|++++... .++|+|||++....+..
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            899999986 666665   4688899999999999999999999999999999999998654 59999999998876665


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCcccc----ccccc
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASL----GFLRS  233 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  233 (336)
                      ...-...+.+|-.||++..-..++.+-|+|||||++..|+..+.|| .+.+..+++-+|.+.++...-...    ...-.
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            4444577899999999988788999999999999999999987775 777888999999998885433210    00001


Q ss_pred             chHHHHHHhCCccccccc-cccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          234 DNARRYVRQLPRCRKQQF-ATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      ......+....+.+...+ .+... -.++++.+|+.++|..|..+|+|+.|++.||||..+.+
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence            112222222222222222 12222 34699999999999999999999999999999987654

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-41  Score=288.65  Aligned_cols=243  Identities=24%  Similarity=0.351  Sum_probs=197.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.++||+|++|.||+|.+..+ ..||+|++.....   ....+.+|+++++.++||||+++++.+..      ...+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   76 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence            689999999999999999998655 4599999865332   23567889999999999999999998754      3479


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ |+|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999998 5999999753  457899999999999999999999999999999999999999999999999987654332


Q ss_pred             cc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..  ....++..|+|||...+ ..++.++|+|||||++|+|++ |..||...........+.....              
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------  221 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------------  221 (262)
T ss_pred             cccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--------------
Confidence            21  12344667999998876 678999999999999999999 8889987665444433321100              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .......+..+.+++.+||+.||.+||++.+++.
T Consensus       222 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 ----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                            0112356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-41  Score=294.93  Aligned_cols=248  Identities=25%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-----CceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|++|.||++.+...     ...+|+|.+.... .......+.+|+.+++++ +||||+++++++...   
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---   88 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE---   88 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC---
Confidence            578899999999999999998643     3679999886543 334556788999999999 799999999998876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                        ..++++|||+. |+|.+++..                .+.+++..+..++.||+.||+|||+.|++|+||||+||+++
T Consensus        89 --~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          89 --GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             --CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence              56899999997 599999854                24688999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019728          139 ASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  214 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  214 (336)
                      .++.++|+|||.+.........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+...
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999998765443211   11223567999999876 778999999999999999997 999998776555444


Q ss_pred             HHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .+....                              ........+..+.+|+.+||..||++|||+.+++.+
T Consensus       246 ~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGY------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            332210                              011123457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-41  Score=303.93  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=195.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-----CceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+++.||.|+||.||+|.+...     +..||+|++... ......+.+.+|+.+++++. ||||+++++++...   
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~---  113 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS---  113 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC---
Confidence            477899999999999999987433     356999998653 23344567889999999996 99999999999876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC--------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------------   98 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------------------------   98 (336)
                        ...|+|||||. |+|.+++..+                                                        
T Consensus       114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         114 --GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             --CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence              66999999997 5998887532                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           99 ----------------------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        99 ----------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                                                              ..+++..+..++.||+.||+|||+.|++|+||||+||+++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    2477888899999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019728          139 ASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  214 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  214 (336)
                      .++.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999875433211   122345677999999876 678999999999999999997 999997654322221


Q ss_pred             HHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      .....  .                           .........+..+.+++.+||+.||++||++.++.+
T Consensus       351 ~~~~~--~---------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKS--G---------------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhc--C---------------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            11110  0                           001112356889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-41  Score=292.83  Aligned_cols=248  Identities=18%  Similarity=0.287  Sum_probs=200.3

Q ss_pred             ccceeeeecccceEEEEEEEeCC-----CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|++.+.||.|+||.||++.+..     .++.||+|.+.... .......+..|+.++..++||||+++++++...    
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~----   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE----   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence            47889999999999999998754     35789999986442 233456677899999999999999999999877    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                       ...++++||+. ++|.+++...                ..++...+..++.|++.||+|||++|++||||||+||++++
T Consensus        81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence             55899999997 5898888531                34788889999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019728          140 SCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  215 (336)
Q Consensus       140 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  215 (336)
                      ++.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999876543321   122344678999999876 678999999999999999998 8889987765544443


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +....                              ........+..+.+++.+||+.+|.+||++.+++..
T Consensus       239 i~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQ------------------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCC------------------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            33211                              011124568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=290.26  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=200.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-----CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|.+.+.||.|++|.||++.+...     +..||+|.+.... .......+.+|+.+++.++||||+++++++...    
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG----   81 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC----
Confidence            578999999999999999998643     4789999985432 334456678899999999999999999999877    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                       ...+++|||++ |+|.+++...          ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|
T Consensus        82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence             56899999997 6999998643          23677899999999999999999999999999999999999999999


Q ss_pred             EeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||.++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+...  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--  237 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG--  237 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC--
Confidence            99999876543321   122345678999999876 678999999999999999998 99999877655544433210  


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                  .........+..+.+++.+||+.+|++|||+.++++
T Consensus       238 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 ----------------------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                        001112345889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.2e-41  Score=290.89  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|.+.++||.|+||.||++..     ..++..+|+|.+...  .......+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   79 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG----   79 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC----
Confidence            467899999999999999974     345678999987543  345566788999999999999999999998876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ---------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  140 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~  140 (336)
                       ...+++|||+. ++|.+++...+               .+++..+..++.||+.|++|||+.|++|+||||+||+++++
T Consensus        80 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 -RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             -CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence             55899999997 59999987643               47889999999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 019728          141 CDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  216 (336)
Q Consensus       141 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~  216 (336)
                      +.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            9999999999865433221   122234577999999877 678999999999999999998 99999776655444333


Q ss_pred             HHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ....                              .......+++.+.++|.+||+.||.+||++++++.
T Consensus       238 ~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGR------------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCc------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2210                              01112356888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9e-41  Score=286.70  Aligned_cols=248  Identities=28%  Similarity=0.419  Sum_probs=202.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.++... ........+.+|+.++++++|+|++++++.+...     ...
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~~   77 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NEL   77 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeE
Confidence            5899999999999999999999999999999886432 3344467788999999999999999999999876     568


Q ss_pred             EEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      +++|||++ ++|.+++..    ...+++..++.++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999998 499988853    3458999999999999999999999999999999999999999999999999887554


Q ss_pred             CCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCcccccccc
Q 019728          156 ETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV--HQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  .....+..              
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  222 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--------------  222 (267)
T ss_pred             CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--------------
Confidence            3321 223457788999999876 67889999999999999999999999654311  11111110              


Q ss_pred             cchHHHHHHhCCccccccccccC-CCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      ....+.. ...+..+.++|.+||..+|++|||+.++++
T Consensus       223 ----------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         223 ----------------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ----------------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                            0011111 256778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-41  Score=295.21  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=199.7

Q ss_pred             ccceeeeecccceEEEEEEEeCC-------CCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|.+.+.||+|+||.||++.+..       +...+|+|.+.... .......+..|+.+++.+ +||||+++++++... 
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-   96 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-   96 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence            57899999999999999998743       23569999986532 344556788899999999 799999999999877 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ...|+||||++ |+|.+++...+                .++..+++.++.||+.||+|||+.|++|+||||+||+
T Consensus        97 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          97 ----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence                56899999997 59999997532                4788899999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++|+|||.+.........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999998765432211   11223467999999877 678999999999999999998 8899977665443


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+....                              ........+.++.+++.+||..+|.+|||+.+++.+
T Consensus       252 ~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcCC------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33332110                              011223568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-41  Score=285.99  Aligned_cols=241  Identities=22%  Similarity=0.313  Sum_probs=200.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||++..  .|+.||+|.+.....   ...++..|+.+++.++|+|++++++++...     ...+
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLY   76 (256)
T ss_pred             hccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeE
Confidence            478899999999999999988  478999999965422   567788999999999999999999998875     5689


Q ss_pred             EEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ ++|.+++....  .+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999998 59999997655  68999999999999999999999999999999999999999999999999987764332


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .  ....+..|+|||.+.+ ..++.++|+||||+++++|++ |..||......+....+....                 
T Consensus       157 ~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------  216 (256)
T cd05039         157 D--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-----------------  216 (256)
T ss_pred             c--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence            2  2234567999999876 678889999999999999997 999998776544433332100                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                   ........++.+.++|++||..+|++||++++++.
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         01112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=304.02  Aligned_cols=240  Identities=31%  Similarity=0.470  Sum_probs=202.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+...+|.|+||.|-.+.+..+++..++|++.+.      ..+..+|+.++... +|||+++.++.+.+.     .+.
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~  391 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEI  391 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCC-----cee
Confidence            477888899999999999999999999999999665      22334667566555 699999999999988     779


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE-ccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-NASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~-~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+|||.+.| -+.+.+...+.+. .++..|+.+|+.|+.|||++|++||||||+|||+ +..++++|+|||.++..... 
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999999985 7777777765555 8888999999999999999999999999999999 68999999999998876655 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ....+-|..|.|||++.. ..++.++|+||||+++|+||+|+.||...... +....+    +.++             
T Consensus       470 -~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~-------------  530 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPK-------------  530 (612)
T ss_pred             -hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCc-------------
Confidence             444567888999999985 89999999999999999999999999776544 222111    1111             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                      ....+|.++++||++||+.||.+||++.+++.||||
T Consensus       531 ----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                            114579999999999999999999999999999999

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.1e-41  Score=289.76  Aligned_cols=246  Identities=22%  Similarity=0.256  Sum_probs=199.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||.|++|+||+|.+..+++    .||+|++.... .......+.+|+.+++.++||||+++++++...     
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   81 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----   81 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence            57899999999999999999877776    48999886432 334456778899999999999999999988653     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..+++++|++ |+|.+++... +.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             3689999997 6999999764 568999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .....   ....++..|+|||...+ ..++.++|||||||++|+|++ |..||...........+...            
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------  227 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG------------  227 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC------------
Confidence            33221   11234567999999876 678999999999999999998 89999776543333222210            


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        ...+.....+..+.+++.+||+.||++||++.++++
T Consensus       228 ------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         228 ------------------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ------------------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              001112356888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-41  Score=291.68  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=200.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC--------------ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR--------------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD   67 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~   67 (336)
                      +|++.+.||+|+||.||++.+..++              ..||+|++.... .......+.+|++++++++|||++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5889999999999999999885432              358999986432 3445567889999999999999999999


Q ss_pred             eecCCCCCCcceEEEEEecCC-ccHHHHHHcCC------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCC
Q 019728           68 IIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN  134 (336)
Q Consensus        68 ~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~n  134 (336)
                      ++...     ...++||||+. ++|.+++....            .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        85 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          85 VCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             EEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            99876     56899999998 49999885431            36788899999999999999999999999999999


Q ss_pred             eEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCh
Q 019728          135 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDY  209 (336)
Q Consensus       135 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~  209 (336)
                      |+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++  |..||.....
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999999875433221   122234678999999876 678999999999999999988  6678877665


Q ss_pred             HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      .+....+........                       ........+..+..+.+|+.+||+.||++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQG-----------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhcc-----------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            555444333211000                       00111223456889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.2e-41  Score=291.72  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=199.1

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+.+.||.|+||.||++.+     ..++..||+|++.... .......+.+|+.+++++ +||||+++++++...   
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---  111 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG---  111 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC---
Confidence            478899999999999999986     3345689999886542 234456788999999999 799999999998876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                        ...|++|||+. |+|.+++....  .+++.++..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus       112 --~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         112 --GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             --CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence              56899999997 69999997543  38999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          153 TTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       153 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      .......   .....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||......+.........  .     
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--~-----  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--Y-----  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--C-----
Confidence            6543321   112234677999999877 678899999999999999998 999997765443332221100  0     


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                            ........+..+.+++.+||+.+|++|||+.+++.
T Consensus       262 ----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 ----------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ----------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  00112345788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.9e-41  Score=287.49  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=201.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc---eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|++.+.||.|++|.||+|.+..+++   .||+|.+.... .......+..|+.+++.++||||+++++++...     .
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~   78 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----R   78 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----C
Confidence            47899999999999999999977665   59999986542 344567788999999999999999999998776     5


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+++|||+++ +|.+++... +.++..+++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            68999999985 899988753 5689999999999999999999999999999999999999999999999998865433


Q ss_pred             CCcccc----e--eeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          157 TDFMTE----Y--VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       157 ~~~~~~----~--~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      ......    .  ..+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+.....        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~--------  229 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--------  229 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--------
Confidence            221111    1  11357999999876 678999999999999999886 9999987765554444422111        


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                            .+.....+..+.+++.+||+.+|.+||++.+++.
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 ----------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ----------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0112356788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.9e-41  Score=289.65  Aligned_cols=261  Identities=23%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             ceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            4 KLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      ++.+.||.|+||+||++.    ...+++.||+|.+.... .......+.+|+.+++.++||||+++++++.....   ..
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~   82 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG---KG   82 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---ce
Confidence            889999999999998765    34578889999986542 23345677889999999999999999998765432   45


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      .+++|||++ ++|.+++.. ..+++.+++.++.|++.|++|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            899999998 489888876 469999999999999999999999999999999999999999999999999987654321


Q ss_pred             c----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 F----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......     ..........    .....
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-----~~~~~~~~~~----~~~~~  231 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-----FEEMIGPKQG----QMTVV  231 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch-----hhhhhccccc----ccchh
Confidence            1    112234567999999876 67889999999999999999999998654321     0011100000    00000


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ...   ....   .....+.....+..+.+++.+||+.||++|||++++++
T Consensus       232 ~~~---~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 RLI---ELLE---RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhh---hhhh---cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000   0000   00111223467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.9e-41  Score=287.95  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=202.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCc---ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      ||.+.++||.|++|.||++.+..++..+++|+++..   .........+..|+.+++.++|||++++++++...     .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence            699999999999999999999888777777766432   22333445566899999999999999999998876     5


Q ss_pred             eEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           79 DVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      ..+++|||+.+ +|.+++..    ...+++.+++.++.|++.|++|||+.|++|+||+|+||+++. +.++|+|||.+..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence            68999999985 88887753    457899999999999999999999999999999999999975 5699999998876


Q ss_pred             cCCC-CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          154 TSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .... .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+..   ..         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~---------  221 (260)
T cd08222         155 LMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GP---------  221 (260)
T ss_pred             cCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CC---------
Confidence            5332 22233456788999999866 6678899999999999999999999976654433332211   11         


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                        ........+.++.++|.+||..||.+||++.+++.||||
T Consensus       222 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                              011123567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=283.60  Aligned_cols=241  Identities=24%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEec
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL   86 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~   86 (336)
                      ++||.|++|.||++.+.. ++.|++|.+...... .....+.+|++++++++||||+++++++...     ...+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence            479999999999999977 999999988654332 4567788999999999999999999998877     568999999


Q ss_pred             CC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc---c
Q 019728           87 MD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---T  161 (336)
Q Consensus        87 ~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---~  161 (336)
                      ++ ++|.+++.. ...++...+..++.+++.|++|||++|++|+||+|+||+++.++.++|+|||.+.........   .
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            97 589999865 356889999999999999999999999999999999999999999999999998765422111   1


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....                   
T Consensus       154 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-------------------  213 (251)
T cd05041         154 LKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-------------------  213 (251)
T ss_pred             cCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-------------------
Confidence            1223566999999876 678999999999999999998 8899977665443333322100                   


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                 .......+..+.+++.+||..+|.+|||+.|+++
T Consensus       214 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -----------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                       0112345789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.8e-41  Score=286.09  Aligned_cols=243  Identities=23%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.++||.|++|.||+|.+. +++.||+|.+.....   ....+.+|+.++++++|||++++++++..      ...+
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   76 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY   76 (260)
T ss_pred             HceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence            4889999999999999999975 578899999865432   34567889999999999999999998743      3479


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||+. ++|.+++...  ..++..++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999997 5999998653  468999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..  ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+....+.....              
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------  221 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--------------  221 (260)
T ss_pred             cccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--------------
Confidence            11  12234567999999876 678899999999999999998 9999987765555444322111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .+.....+.++.+++++||..+|++||+++++++
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 ----------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                            1112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.7e-41  Score=291.25  Aligned_cols=260  Identities=19%  Similarity=0.291  Sum_probs=205.8

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCccc--ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      .|.+.+.||.|++|.||++.+.   .+++.||+|.+.+...  .......+..|+.++.++ +||||+++++.+...   
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~---   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD---   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence            4889999999999999999864   4678899999864321  223445677899999999 599999999998776   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ...|+||||+. |+|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          78 --TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             --CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence              56899999997 599999987788999999999999999999999999999999999999999999999999988764


Q ss_pred             CCCCc--ccceeeeecccCchhcccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          155 SETDF--MTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       155 ~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .....  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+...          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~----------  225 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL----------  225 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----------
Confidence            43321  12235688899999986522 368899999999999999999999964332211111111100          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~ell~h~~f~~~~  293 (336)
                                       .........++..+.++|.+||+.||++|||   +.++++||||+.+.
T Consensus       226 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         226 -----------------KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             -----------------ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence                             0001122346788999999999999999998   56779999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.5e-41  Score=287.01  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc---eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||.|+||.||+|.+..++.   .+|+|.+.... .......+..|+.++++++||||+++++++...     .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   78 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----K   78 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----C
Confidence            58899999999999999999865544   69999886543 234456788899999999999999999998766     5


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|++|||++ ++|.+++... +.++..++..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            6899999997 5999998764 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcc----cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....    ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+....+.+...          
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----------  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----------
Confidence            3211    11122457999999976 678999999999999999886 9999987765544443332110          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          .+.....+..+.+++.+||+.+|.+||++.+++.
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 --------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                1112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1e-40  Score=284.72  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=204.2

Q ss_pred             cceeeeecccceEEEEEEEeCCCC----ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +.+.+.||.|++|.||.+.+...+    ..||+|++.... .......+..|+.+++.++|+|++++++++...     .
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence            467899999999999999998766    889999985442 222567888999999999999999999999887     5


Q ss_pred             eEEEEEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ..+++||++. ++|.+++.....  +++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            6999999997 499999976554  9999999999999999999999999999999999999999999999999987665


Q ss_pred             CCCccc--ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          156 ETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       156 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ......  ...++..|+|||.+.+ ..++.++|+||||+++++|++ |..||...+.......+.....           
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-----------  222 (258)
T ss_pred             cccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------
Confidence            442221  1235678999999865 778999999999999999998 8899987665555544432111           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         .......+.++.+++.+||..||++|||+.++++
T Consensus       223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                               1112346889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-40  Score=292.34  Aligned_cols=247  Identities=25%  Similarity=0.382  Sum_probs=198.9

Q ss_pred             ccceeeeecccceEEEEEEEeCC-------CCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|.+.+.||.|++|.||++.+..       ....+|+|.+.... .......+..|+.+++++ +||||+++++++... 
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-   90 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-   90 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence            57899999999999999998632       34569999886432 334566788999999999 699999999998876 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ...|++|||+. |+|.+++...                ..++..++..++.||+.||+|||++|++|+||||+||+
T Consensus        91 ----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          91 ----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence                56899999997 5999999653                34788899999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++|+|||.++.......   .....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||......+.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999876543221   111223457999999877 778999999999999999999 8999987765544


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ...+....                              ........+.++.+++.+||+.||++|||+.+++.
T Consensus       246 ~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREGH------------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            44332210                              01112355788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=285.24  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=200.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||+|.+. .+..||+|.+....   .....+..|+.++++++|||++++++++...     ...+
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPIY   77 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----CceE
Confidence            5889999999999999999985 45779999986533   2346688999999999999999999998776     5589


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++||+++ ++|.+++...  ..++...+..++.||+.|++|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999997 5999999764  368999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..  .....+..|+|||.+.+ ...+.++|+||||+++++|++ |..||.+.........+......             
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  223 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------------  223 (261)
T ss_pred             hhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            11  11223467999999876 678999999999999999998 99999887765555544331110             


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                       ......+.++.+++.+||+.+|.+||+++++++
T Consensus       224 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 -----------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                             112344788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-40  Score=287.54  Aligned_cols=246  Identities=20%  Similarity=0.264  Sum_probs=195.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||.|+||+||+|.+..+++    .+++|.+... ........+..|+..++++.||||+++++++..      
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            57889999999999999999977776    4677776432 223344667788889999999999999998753      


Q ss_pred             ceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...++++||+. |+|.+++.. .+.+++..+..++.||+.|++|||+.|++|+||||+||+++.++.++|+|||.++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            33688999997 699999975 4578999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...   ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+... ..         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~---------  229 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ER---------  229 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-Cc---------
Confidence            322   1122345678999999876 678999999999999999998 99999876544332222110 00         


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          .......+.++.+++.+||..||.+|||+.|+++
T Consensus       230 --------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 --------------------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                0111234667899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-40  Score=283.75  Aligned_cols=241  Identities=23%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.+.+.||.|++|.||++..  .|..||+|.+...    .....+..|+.++++++|+|++++++++....    ...+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   76 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceE
Confidence            478999999999999999987  4788999988542    23456788999999999999999999764431    4589


Q ss_pred             EEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++...+  .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999997 59999987643  47899999999999999999999999999999999999999999999999987654332


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        .....+..|+|||++.+ ..++.++|+|||||++|+|++ |..||...+.......+....                 
T Consensus       157 --~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------  216 (256)
T cd05082         157 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------------  216 (256)
T ss_pred             --CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence              22234567999999876 678899999999999999997 999998766544433332210                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                   ........++.+.+++.+||+.||++|||+.++++
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 -------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         01122456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-40  Score=284.80  Aligned_cols=243  Identities=22%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.++||.|++|.||+|.+. .+..+|+|.+......   ...+.+|+.++++++|||++++++++..      ...|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY   76 (260)
T ss_pred             HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence            5889999999999999999875 5677999998654332   3567899999999999999999998753      3479


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999997 5999998753  458999999999999999999999999999999999999999999999999987654332


Q ss_pred             cc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+.....              
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  221 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR--------------  221 (260)
T ss_pred             cccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            11  12234567999999876 678899999999999999999 8999987665554443322100              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .+.....+..+.+++.+||..||.+|||+.++.+
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 ----------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                            1112356788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-40  Score=289.65  Aligned_cols=247  Identities=26%  Similarity=0.358  Sum_probs=198.3

Q ss_pred             ccceeeeecccceEEEEEEEeCC-----CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|++.+.||+|+||.||+|.+..     ....+++|.+.... .......+.+|+.+++.++||||+++++.+...    
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD----   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC----
Confidence            47889999999999999999753     23568888886432 234456788999999999999999999998876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                       ...++++||+. ++|.+++...                        .++++..++.++.|++.||+|||+.|++|+||+
T Consensus        76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          76 -GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             -CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence             55899999998 5999987542                        247888999999999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  207 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  207 (336)
                      |+||++++++.++|+|||++........   .....++..|+|||.+.+ ..++.++||||||+++++|++ |..||.+.
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999875433211   112234567999999876 678999999999999999998 99999877


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ........+.....                              .......+.++.+++..||+.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKTGYR------------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhCCCC------------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            65544433322110                              1112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=286.58  Aligned_cols=242  Identities=22%  Similarity=0.274  Sum_probs=192.4

Q ss_pred             eeecccceEEEEEEEeCCCCce--EEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      +.||.|++|.||++.+..++..  +++|.+... ........+..|+.++.++ +||||+++++++...     ...|++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence            4689999999999999877764  688877532 2334456778999999999 799999999999876     558999


Q ss_pred             EecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEE
Q 019728           84 YELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  146 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~  146 (336)
                      |||+. |+|.+++....                .+++..++.++.|++.|++|||+.|++|+||||+||+++.++.++|+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99997 69999986532                47889999999999999999999999999999999999999999999


Q ss_pred             eccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 019728          147 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                      |||++..............+..|+|||++.. ..++.++|+||||+++|+|++ |..||...+..+....+....     
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----  228 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----  228 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence            9998853322111112223557999999876 778999999999999999997 999997765444333321100     


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                               ........+.++.+++.+||..||.+|||+.+++.
T Consensus       229 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 -------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                     00112345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-40  Score=295.03  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-------CceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-------REEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|++++.||.|+||.||+|.+...       +..||+|.+... ........+.+|+.+++++ +||||+++++++... 
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-   90 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-   90 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence            588999999999999999986432       236899987643 2345567888999999999 799999999999876 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ...+++|||++ |+|.+++....                .++...+..++.||+.||+|||++|++|+||||+||+
T Consensus        91 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          91 ----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence                56899999997 59999986532                3677888999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++|+|||.++........   ....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||......+.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999998765432211   11223457999999977 778899999999999999998 8899987765554


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+....                              ........+..+.+++.+||+.+|.+||++.+++.+
T Consensus       246 ~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLKEGH------------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44332210                              011123557889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.7e-40  Score=316.79  Aligned_cols=146  Identities=20%  Similarity=0.307  Sum_probs=132.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.++||.|+||+||+|.+..+++.||||++.... ........+..|+.++..++||||+++++.+...     ..+
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~   79 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NNV   79 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CEE
Confidence            5899999999999999999999999999999996532 3444557788899999999999999999988776     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      |+||||+. ++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999996 5999999887889999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.2e-40  Score=282.79  Aligned_cols=240  Identities=18%  Similarity=0.268  Sum_probs=192.9

Q ss_pred             eecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEe
Q 019728            8 EYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      .||.|+||.||++.+.  ..+..||+|++.... .......+.+|+.++++++||||+++++++..      ...++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e   74 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME   74 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence            4899999999999875  445679999886542 34445678899999999999999999998753      34799999


Q ss_pred             cCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc---
Q 019728           86 LMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---  160 (336)
Q Consensus        86 ~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---  160 (336)
                      |++ ++|.+++.. ...+++..++.++.||+.|++|||++|++|+||||+||+++.++.++|+|||.+.........   
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            997 599998875 457899999999999999999999999999999999999999999999999998754432211   


Q ss_pred             -cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          161 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       161 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                       ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+....                  
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------  215 (257)
T cd05115         155 RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK------------------  215 (257)
T ss_pred             cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------------
Confidence             11122467999999876 678899999999999999996 999998876555443332211                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                  ........++++.++|.+||..||++||++.++.+
T Consensus       216 ------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 ------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        01112355889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-40  Score=283.73  Aligned_cols=243  Identities=23%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+ ..+|+|.+....   .....+.+|+.+++.++|||++++++++..      ...+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   76 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIY   76 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcE
Confidence            578999999999999999998654 469999875432   233567789999999999999999998753      3478


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||+. ++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999998 4999999753  347899999999999999999999999999999999999999999999999987654332


Q ss_pred             cc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..  ....++..|+|||...+ ...+.++|+||||+++|+|++ |..||.+....+....+.....              
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------  221 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR--------------  221 (260)
T ss_pred             ccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            11  12244667999998876 678999999999999999999 9999988765544443322110              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .......+..+.+++++||..||.+||+++++++
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 ----------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            0112356788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.5e-41  Score=318.05  Aligned_cols=259  Identities=29%  Similarity=0.390  Sum_probs=200.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCC--------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK--------   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--------   73 (336)
                      .|+.++.||+||||.||+++++-.|..||||++.... +.....++.+|+..+.+|+|||||++|....+..        
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            3667889999999999999999999999999998766 7788889999999999999999999876532211        


Q ss_pred             ---------------------------------------------C----------------------------------
Q 019728           74 ---------------------------------------------K----------------------------------   74 (336)
Q Consensus        74 ---------------------------------------------~----------------------------------   74 (336)
                                                                   .                                  
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                         0                                  


Q ss_pred             ------------------CC-c--------ceEEEEEecCCccHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCe
Q 019728           75 ------------------DT-F--------NDVYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASV  125 (336)
Q Consensus        75 ------------------~~-~--------~~~~iv~e~~~g~L~~~l~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~i  125 (336)
                                        +. .        ..+||-||||+.++...+...+.+  ..+++|+++++|++||+|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                              00 0        237899999997555555444444  488999999999999999999999


Q ss_pred             eccCCCCCCeEEccCCCEEEEeccCCcccC------------------CCC-cccceeeeecccCchhcccCC--CCCcc
Q 019728          126 LHRDLKPSNLLLNASCDLKIGDFGLARTTS------------------ETD-FMTEYVVTRWYRAPELLLNCT--EYTAA  184 (336)
Q Consensus       126 ~H~dlkp~nil~~~~~~~kl~dfg~~~~~~------------------~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~  184 (336)
                      +||||||.||++++++.|||+|||++....                  .+. ..+...||..|+|||++.+..  +|+.+
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999987511                  111 235568899999999998755  69999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHH
Q 019728          185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD  264 (336)
Q Consensus       185 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (336)
                      .|+||||++++||+.   ||...  ++....+..+-...-+..                        ...+...-+.-..
T Consensus       799 iDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~------------------------~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEP------------------------ADFFDPEHPEEAS  849 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCC------------------------cccccccchHHHH
Confidence            999999999999985   45443  333333333221100000                        0012223445679


Q ss_pred             HHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          265 LLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       265 li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                      +|+.||+.||.+||||.|+|++.||-
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhccCCC
Confidence            99999999999999999999999987

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-40  Score=295.76  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=194.8

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||.||+|.+     ..+++.||||++.... .......+.+|+.++.++ +||||+++++++....  
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--   84 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   84 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence            589999999999999999985     3567889999986532 233456788999999999 6899999999876542  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC--------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD--------------------------------------------------------   98 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------------------------   98 (336)
                        ...+++|||++ |+|.+++...                                                        
T Consensus        85 --~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          85 --GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             --CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence              35799999998 5999988642                                                        


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc---cccee
Q 019728           99 -----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYV  164 (336)
Q Consensus        99 -----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~  164 (336)
                                 ..++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........   .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                       1357778888999999999999999999999999999999999999999999876432211   11223


Q ss_pred             eeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      ++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||................                       
T Consensus       243 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------------  298 (343)
T cd05103         243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-----------------------  298 (343)
T ss_pred             CCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-----------------------
Confidence            4567999999876 678899999999999999997 999997654322221111100                       


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                            .........++.+.+++..||+.||++|||+.++++|
T Consensus       299 ------~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         299 ------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  0001112346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3e-40  Score=283.70  Aligned_cols=247  Identities=21%  Similarity=0.313  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc---eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|...+.||.|++|.||+|.+..+++   .+++|.+.... .......+..|+.+++.++|||++++++++...     .
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   79 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----K   79 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----C
Confidence            46788999999999999999876655   69999885432 334456788999999999999999999999876     5


Q ss_pred             eEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|++|||+++ +|.+++.. .+.+++.++..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            68999999985 99988865 35789999999999999999999999999999999999999999999999999876543


Q ss_pred             CCccc----ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .....    ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+.....          
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~----------  228 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR----------  228 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC----------
Confidence            22111    1122356999999876 678899999999999999997 9999987765554444432110          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          .+.....+..+.+++.+||+.+|.+||++.++++
T Consensus       229 --------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         229 --------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                0112245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=300.59  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=229.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ++++..||.|+||.|=++........+|+|++++.+ -+..+.+.+..|-.+|..++.|.||++|..|.+.     ..+|
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----kyvY  496 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KYVY  496 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hhhh
Confidence            466788999999999999887666669999987654 3556667888999999999999999999999998     6699


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++||.|- |.|...++.++.|.+..++.++..+++|++|||++||++|||||+|++++.+|.+||.|||+++..+.....
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            9999995 699999999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      -.++||+.|.|||++.+ +..+.+.|.|+||+++|||++|.+||.+.++......|.+-+...                 
T Consensus       577 wTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-----------------  638 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-----------------  638 (732)
T ss_pred             eeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----------------
Confidence            89999999999999998 888999999999999999999999999999988888887644311                 


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                  ..+..++..+.+||+++...+|.+|.     .+.++-.|.||.+..
T Consensus       639 ------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  639 ------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             ------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence                        12246788999999999999999998     489999999998764

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.8e-40  Score=288.20  Aligned_cols=247  Identities=20%  Similarity=0.287  Sum_probs=199.5

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||.|+||.||+|.+.     .++..||+|++.... .......+.+|+.+++.++|||++++++++...    
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~----   80 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG----   80 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC----
Confidence            5789999999999999999974     367889999986532 334456688899999999999999999998876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS  133 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~  133 (336)
                       ...+++|||++ |+|.+++...                      ..+++.+++.++.||+.||+|||++|++|+||+|+
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          81 -KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             -CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence             55899999998 5999998642                      24678889999999999999999999999999999


Q ss_pred             CeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 019728          134 NLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  209 (336)
Q Consensus       134 nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  209 (336)
                      ||+++.++.++|+|||.+........   ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+...
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999875433321   112233567999999876 678999999999999999997 8889977765


Q ss_pred             HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      .+....+....                              ........+..+.+|+.+||+.||.+|||+.|++.
T Consensus       239 ~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGN------------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            55443332210                              00112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3e-40  Score=287.88  Aligned_cols=254  Identities=20%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             ccceeeeecccceEEEEEEEeCC----------------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE----------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI   65 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~   65 (336)
                      +|++.++||.|+||.||++.+..                ++..||+|++... ........+.+|+.+++.++||||+++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            58899999999999999986532                3456999988643 234455678899999999999999999


Q ss_pred             cceecCCCCCCcceEEEEEecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCC
Q 019728           66 KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS  133 (336)
Q Consensus        66 ~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~  133 (336)
                      ++++...     ...+++|||+. |+|.+++....           .+++..+..++.||+.|++|||+.|++|+||||+
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~  159 (296)
T cd05095          85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR  159 (296)
T ss_pred             EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence            9999877     55899999997 59999987532           3667789999999999999999999999999999


Q ss_pred             CeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCC
Q 019728          134 NLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD  208 (336)
Q Consensus       134 nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~  208 (336)
                      ||+++.++.++|+|||.+........   ......+..|++||...+ ..++.++|+|||||++|+|++  |..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999999876543321   122233567999998776 678999999999999999998  778887765


Q ss_pred             hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ..+..........                    ..   ......+.....+..+.+|+.+||+.||.+||++.+++.
T Consensus       239 ~~~~~~~~~~~~~--------------------~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DEQVIENTGEFFR--------------------DQ---GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hHHHHHHHHHHHh--------------------hc---cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5444432222110                    00   000111222456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-40  Score=285.26  Aligned_cols=264  Identities=22%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             ccceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||.+.    +..+++.||+|.+...  .......+.+|++++++++|||++++++++.....   
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---   79 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---   79 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC---
Confidence            47899999999999999997    4567889999998643  34456678899999999999999999998765432   


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...+++|||++ |+|.+++... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            45899999997 5999998654 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc----cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .....    ....++..|+|||.+.+ ..++.++|+||||+++++|++|..++...... ....    .+......    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~~----  229 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQGQ----  229 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----cccccccc----
Confidence            32211    11223456999999876 67889999999999999999988766443211 1110    00000000    


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                        ...........   .....+.....+..+.+|+.+||..+|++|||+.|++.
T Consensus       230 --~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         230 --MIVYHLIELLK---NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             --cchHHHHHHHh---cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              00000000000   01111223567889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.2e-40  Score=281.79  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=198.0

Q ss_pred             eeecccceEEEEEEEeCC-CCc--eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSE-TRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      +.||.|++|.||++.+.. .++  .||+|.+...... .....+..|+.++++++||||+++++.+..      ...+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence            468999999999999865 333  6999999765433 566788899999999999999999999876      348999


Q ss_pred             EecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           84 YELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      |||++ ++|.+++.+..  .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99997 69999997754  689999999999999999999999999999999999999999999999999876544211 


Q ss_pred             ---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                         .....++..|+|||.+.+ ..++.++|+|||||++++|++ |..||......+....+......             
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------  219 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-------------  219 (257)
T ss_pred             eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-------------
Confidence               112345678999999876 678899999999999999998 99999877666555444331100             


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .......+..+.+++.+||+.+|++||++.++++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 ----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                            0112345788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-40  Score=286.18  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=199.1

Q ss_pred             cceeeeecccceEEEEEEEe----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAVN----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      |++++.||+|++|.||++..    ..+++.||+|.+.... .......+.+|+.+++.++|||++++++++.....   .
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~   81 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---N   81 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---C
Confidence            68899999999999999984    4678899999986432 34445678899999999999999999998876533   4


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+++|||++ ++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            5899999997 5999998664 4589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          157 TDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       157 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ...    .....++..|+|||.+.+ ..++.++|+|||||++|+|+++..|......     ......+.....    ..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~----~~  231 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQ----MT  231 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccc----cc
Confidence            321    122345667999999876 6788999999999999999998766533211     001111100000    00


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                         .........   .....+.....+..+.+|+.+||+.||.+|||+++++..
T Consensus       232 ---~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         232 ---VTRLVRVLE---EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ---HHHHHHHHH---cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               000011000   011122335678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-40  Score=289.74  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             ccceeeeecccceEEEEEEEeC-------CCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|.+.+.||.|+||.||+|.+.       ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++++... 
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   93 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-   93 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC-
Confidence            4789999999999999999852       234579999886432 344557788999999999 799999999999876 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ...|++|||+. |+|.+++.+.                ..++...+..++.||+.||+|||++|++|+||||+||+
T Consensus        94 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          94 ----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence                56899999997 5999998753                24677889999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++|+|||.+........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999876543321   112234567999999877 678999999999999999998 7889987765554


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+....                              ........+..+.+++.+||+.+|.+||++.+++..
T Consensus       249 ~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            44332210                              001123568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-40  Score=297.49  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=197.4

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+.+.||.|+||.||+|.+.     .+++.||+|++.... .......+.+|+.++.++. ||||+++++++...   
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~---  113 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG---  113 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC---
Confidence            3678899999999999999964     455789999997543 2334457889999999997 99999999999876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC-------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ-------------------------------------------------------   99 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~-------------------------------------------------------   99 (336)
                        ...++||||+. |+|.+++...+                                                       
T Consensus       114 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         114 --GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             --CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence              56899999998 59999885421                                                       


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728          100 -------------------------------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus       100 -------------------------------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                                                                 .++...+..++.||+.||+|||+.|++|+||||+||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2566778889999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+.
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            9999999999999987543221   1122345678999999877 678899999999999999998 8899977554333


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .......  .                           .........+.++.+++.+||..+|.+||++.+++..
T Consensus       351 ~~~~~~~--~---------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         351 FYNAIKR--G---------------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHc--C---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2222110  0                           0011123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=299.58  Aligned_cols=247  Identities=22%  Similarity=0.309  Sum_probs=209.2

Q ss_pred             cceeeeecccceEEEEEEEeCCCCc---e-EEEEEecC-cccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETRE---E-VAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~---~-vaiK~~~~-~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +.+.++||+|+||.||++.....+.   . ||+|..+. ..........++.|..++++++|||||++||+....     
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-----  233 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-----  233 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----
Confidence            4566999999999999999865432   3 89998875 346778889999999999999999999999999988     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ..+++|||+|. |+|.++|+..+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++...
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            56999999998 59999999876 49999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCccc-ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH-HhCCCCcccccccc
Q 019728          156 ETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE-LIGSPDDASLGFLR  232 (336)
Q Consensus       156 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  232 (336)
                      ...... ..-.+..|+|||.+.. ..++.++||||+||++||+.+ |..||.+....+....+.. ....          
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~----------  382 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM----------  382 (474)
T ss_pred             ceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC----------
Confidence            222222 2234678999999987 699999999999999999998 8889999998877777743 2111          


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          ......+..+..++.+|+..||++||++.++.+
T Consensus       383 --------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  383 --------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                112245778999999999999999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.1e-40  Score=280.95  Aligned_cols=245  Identities=18%  Similarity=0.330  Sum_probs=199.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|++|.||++.+. .+..+|+|.+......   ...+..|++++++++|||++++++++...     ...+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPIC   75 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceE
Confidence            5789999999999999999885 4778999988654322   34677899999999999999999998876     5689


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++|||+. ++|.+++... +.+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            9999998 4899888764 4689999999999999999999999999999999999999999999999998875543322


Q ss_pred             c--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 M--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.....               
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------  219 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---------------  219 (256)
T ss_pred             cccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC---------------
Confidence            1  12234567999999876 678899999999999999998 9999987765544443322100               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 ---------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ---------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           01112357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.7e-40  Score=281.93  Aligned_cols=249  Identities=19%  Similarity=0.279  Sum_probs=200.6

Q ss_pred             ccceeeeecccceEEEEEEEeCC-----CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|++.+.||.|+||.||+|+...     +.+.|++|.+.... .......+..|+.++++++|||++++++++...    
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   80 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA----   80 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence            47899999999999999999754     34679999875431 223456788999999999999999999998776    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  146 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~  146 (336)
                       ...+++|||++ |+|.+++....         .+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++++
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence             55899999998 69999997655         68999999999999999999999999999999999999999999999


Q ss_pred             eccCCcccCCCC--cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 019728          147 DFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       147 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                      |||.+.......  ......++..|+|||.+.+ ...+.++|+||||+++|+|++ |..||...........+....   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~---  235 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK---  235 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC---
Confidence            999886543222  1223355778999999876 667899999999999999998 888997665444333322100   


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                .........+..+.+++.+||+.||.+||++.+++..
T Consensus       236 --------------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 --------------------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                      0001123567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.1e-40  Score=284.12  Aligned_cols=248  Identities=22%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             ccceeeeecccceEEEEEEEeCC----CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|.+.+.||+|+||.||.|.+..    ++..|++|.+... .+......+.+|+.++++++|||++++++++....    
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----   81 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG----   81 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----
Confidence            58899999999999999999875    3578999987533 34556677889999999999999999999876542    


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEec
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD--------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  148 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (336)
                      ...+++++|++ ++|.+++...        ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            44799999997 6999988653        35889999999999999999999999999999999999999999999999


Q ss_pred             cCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 019728          149 GLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPD  224 (336)
Q Consensus       149 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  224 (336)
                      |+++.......   .....++..|+|||++.+ ..++.++|||||||++|++++ |..||...+..+....+....    
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY----  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC----
Confidence            99876543221   122344667999999876 678999999999999999998 999998766544333222110    


Q ss_pred             cccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                ........++++.+++.+||..||++|||+.++++
T Consensus       237 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 --------------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                      00112345788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-40  Score=283.16  Aligned_cols=246  Identities=23%  Similarity=0.277  Sum_probs=199.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||+||+|.+..+|+    .||+|...... .......+.+|+.++++++|||++++++++..      
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            58899999999999999999876665    58999875542 34456778899999999999999999998875      


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...+++|||+. |+|.+++.+. ..+++..+..++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            34799999997 5999998764 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccc---ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ......   ...++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+....+....           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-----------  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-----------
Confidence            332111   1123467999998876 678899999999999999998 999998876544433332210           


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         ..+.....+..+.+++.+||..||.+||++.++++
T Consensus       229 -------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 -------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                               01112345778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.4e-40  Score=277.74  Aligned_cols=241  Identities=21%  Similarity=0.320  Sum_probs=195.0

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEec
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL   86 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~   86 (336)
                      +.||.|++|.||++... ++..||+|.+.... .......+.+|+.+++.++|||++++++++...     ...++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence            47899999999999864 68899999886543 233445678899999999999999999998876     568999999


Q ss_pred             CC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc--cc
Q 019728           87 MD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TE  162 (336)
Q Consensus        87 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~  162 (336)
                      ++ ++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.........  ..
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            97 5999988653 46789999999999999999999999999999999999999999999999988654332211  11


Q ss_pred             eeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      ..++..|+|||++.+ ..++.++|+||||+++|++++ |..||...........+....                     
T Consensus       154 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---------------------  211 (250)
T cd05085         154 KQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---------------------  211 (250)
T ss_pred             CCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence            233567999999876 678899999999999999998 999998776554443332210                     


Q ss_pred             hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                               ........+..+.+++.+||+.+|++||++.+++.
T Consensus       212 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 ---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                     00112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.9e-40  Score=281.41  Aligned_cols=238  Identities=19%  Similarity=0.236  Sum_probs=186.1

Q ss_pred             eeecccceEEEEEEEeCC------------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC
Q 019728            7 GEYDDIIFFIFSAAVNSE------------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK   74 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   74 (336)
                      +.||.|++|.||++....            ....|++|.+...  .......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            468999999999998532            2235888887543  233445677889999999999999999998876  


Q ss_pred             CCcceEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC-------EEE
Q 019728           75 DTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-------LKI  145 (336)
Q Consensus        75 ~~~~~~~iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~-------~kl  145 (336)
                         ...+++|||+++ +|..++.. ...+++..++.++.||+.|++|||++|++|+||||+||+++.++.       +++
T Consensus        77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence               557999999985 77777764 356899999999999999999999999999999999999987664       899


Q ss_pred             EeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCC
Q 019728          146 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQLRLITELIGSPD  224 (336)
Q Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (336)
                      +|||.+......   ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+.......    . 
T Consensus       154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~-  225 (262)
T cd05077         154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG----Q-  225 (262)
T ss_pred             CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc----C-
Confidence            999988654322   23356778999998875477899999999999999998 58888876543322111100    0 


Q ss_pred             cccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                 .......+.++.++|.+||+.||.+||++.+++++
T Consensus       226 ---------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 ---------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ---------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                       00112335679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.7e-40  Score=279.95  Aligned_cols=228  Identities=21%  Similarity=0.314  Sum_probs=185.4

Q ss_pred             cceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCC-cc
Q 019728           12 IIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TD   90 (336)
Q Consensus        12 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~-g~   90 (336)
                      |.+|.||++.+..+++.||+|.+....       ....|...+....|||++++++++...     ...+++|||++ |+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCC
Confidence            889999999999999999999996532       122344445556799999999998876     66999999998 59


Q ss_pred             HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceeeeeccc
Q 019728           91 LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR  170 (336)
Q Consensus        91 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~  170 (336)
                      |.+++....++++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+......  .....++..|+
T Consensus        72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            9999988778999999999999999999999999999999999999999999999999987655432  12234566799


Q ss_pred             CchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCcccccc
Q 019728          171 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ  250 (336)
Q Consensus       171 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (336)
                      |||...+ ..++.++|+||+|+++|+|++|..|+......     +..                              ..
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~------------------------------~~  193 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT------------------------------HT  193 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc------------------------------cc
Confidence            9998866 67788999999999999999999877432110     000                              00


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHHcCccc
Q 019728          251 FATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYL  289 (336)
Q Consensus       251 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~f  289 (336)
                      .......++..+.++|.+||+.||++||++     +++++||||
T Consensus       194 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         194 TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            001123468889999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.2e-40  Score=280.86  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=203.4

Q ss_pred             ccceeeeecccceEEEEEEEeCC-CCceEEEEEecCcc--------cChhHHHHHHHHHHHHhh-CCCCceeeecceecC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-TREEVAIKKIGNAF--------DNIIDARRTLREIKLLRH-MEHENVIAIKDIIRP   71 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~   71 (336)
                      .|.+.+.||.|++|.||++.+.. +++.+|+|.+....        ........+..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47899999999999999999987 68899999885321        233445667788888875 699999999999987


Q ss_pred             CCCCCcceEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEE
Q 019728           72 PKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        72 ~~~~~~~~~~iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                      .     ...+++|||++| +|.+++..    ...+++..++.++.|++.|+.|||+ .|++|+||+|+||+++.++.++|
T Consensus        81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          81 N-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             C-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence            7     679999999975 88887742    3568999999999999999999996 78999999999999999999999


Q ss_pred             EeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 019728          146 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                      +|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......+  
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  232 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--  232 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--
Confidence            99999877655543345567888999999986 678999999999999999999999998776554443332211100  


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                 ......+..+.++|++||+.||++||++.|+..+
T Consensus       233 ---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 ---------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                       0112457889999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9e-40  Score=281.08  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCC---CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||.|++|.||+|.+...   ...|++|...... .....+.+.+|+.+++.++|||++++++++...      
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   79 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------   79 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------
Confidence            478899999999999999997544   3468999885432 244566788999999999999999999988753      


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|++|||++ |+|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            3689999997 5999999764 3589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ....  ....++..|+|||.+.. ..++.++|+||||+++++|++ |..||......+....+...              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~--------------  224 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG--------------  224 (270)
T ss_pred             ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--------------
Confidence            3221  12223457999998876 678899999999999999986 99999887655444333211              


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                      .........+..+.+++.+||..+|.+|||+.+++..
T Consensus       225 ----------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         225 ----------------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ----------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            0112234668899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-40  Score=283.81  Aligned_cols=238  Identities=16%  Similarity=0.240  Sum_probs=188.9

Q ss_pred             eeecccceEEEEEEEeCCCCc-------eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            7 GEYDDIIFFIFSAAVNSETRE-------EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +.||.|+||.||++.+...+.       .|++|.+...  .....+.+..|..+++.++|||++++++++...     ..
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence            469999999999999865543       4888877432  234456778899999999999999999999876     55


Q ss_pred             EEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC--------EEEEecc
Q 019728           80 VYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--------LKIGDFG  149 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~--------~kl~dfg  149 (336)
                      .++||||++ |+|.+++...+ .+++..+..++.||+.|++|||++|++|+||||+||+++.++.        ++++|||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            899999997 58999997654 5899999999999999999999999999999999999987765        6999999


Q ss_pred             CCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          150 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      .+......   ....++..|+|||++.+...++.++|+||||+++|+|++| ..||..............          
T Consensus       154 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~----------  220 (258)
T cd05078         154 ISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----------  220 (258)
T ss_pred             cccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----------
Confidence            88655432   2345677899999997645678999999999999999998 466665543332221111          


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                            ........+.++.+++.+||+.||++|||+++++..
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                  001112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-39  Score=278.25  Aligned_cols=243  Identities=24%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.++||.|++|.||++.+. .+..+++|.+...   ......+.+|+.++++++|+|++++++++..      ...+
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            5889999999999999999864 5567999988643   3345678889999999999999999999876      2379


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||++ ++|.+++...  ..++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999997 5999999763  457888999999999999999999999999999999999999999999999886543322


Q ss_pred             cc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 FM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..  ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||...+..+....+....               
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------  220 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------------  220 (260)
T ss_pred             cccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------------
Confidence            11  12234567999999876 678889999999999999998 999998776554443332210               


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     ..+.....+.++.+++.+||+.+|++||++.+++.
T Consensus       221 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ---------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                           01122456889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-39  Score=280.52  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=200.4

Q ss_pred             cceeeeecccceEEEEEEEeC---CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC-cc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT-FN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~-~~   78 (336)
                      |++.+.||.|++|.||+|.+.   .+++.||||.+..........+.+.+|+.++++++|||++++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   46788999999766656666778889999999999999999999887653322 12


Q ss_pred             eEEEEEecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ..+++++|+. |+|.+++...      ..++...++.++.||+.|++|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            3578899997 6888877432      24788999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          152 RTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       152 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ........   .....++..|++||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  232 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-------  232 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            76543221   122234567999999876 678889999999999999999 889997765443333222100       


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                             .....+..+..+.+++.+||+.+|++||++.+++..
T Consensus       233 -----------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 -----------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   001123567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-40  Score=281.47  Aligned_cols=237  Identities=18%  Similarity=0.189  Sum_probs=185.4

Q ss_pred             eecccceEEEEEEEeCCC------------------------CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCcee
Q 019728            8 EYDDIIFFIFSAAVNSET------------------------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI   63 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv   63 (336)
                      .||+|+||.||++....+                        ...|++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            699999999999875321                        235888888543  233445677889999999999999


Q ss_pred             eecceecCCCCCCcceEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           64 AIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ++++++...     ...++||||+++ +|..++.. .+.+++..+..++.||+.||+|||++|++||||||+||+++..+
T Consensus        80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            999999876     568999999984 88888865 46789999999999999999999999999999999999997644


Q ss_pred             -------CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q 019728          142 -------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQL  213 (336)
Q Consensus       142 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~  213 (336)
                             .++++|||.+......   ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||......+..
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             cccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                   3899999987544322   12345677999998876567899999999999999995 699999776543332


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .......                                ......++.+.++|.+||+.+|++|||+.+++++
T Consensus       232 ~~~~~~~--------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYEKKH--------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHhcc--------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2111100                                0112235679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=278.16  Aligned_cols=239  Identities=23%  Similarity=0.342  Sum_probs=195.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||.|++|.||.+..  +++.||+|.+....    ....+.+|+.+++.++|||++++++++...      ..+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~   74 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLY   74 (254)
T ss_pred             HceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcE
Confidence            478999999999999999865  78889999985432    345678899999999999999999998654      369


Q ss_pred             EEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||+. ++|.+++....  .+++..+..++.|++.|++|||+.|++||||+|+||+++.++.++|+|||.+...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999997 59999997643  4789999999999999999999999999999999999999999999999988654322 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.+...                
T Consensus       154 -~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------  215 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR----------------  215 (254)
T ss_pred             -CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC----------------
Confidence             122233567999999876 678899999999999999997 9999987765444333322100                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                    .......+..+.+++++||+.+|.+||++++++.
T Consensus       216 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 --------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             --------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2e-39  Score=278.78  Aligned_cols=247  Identities=23%  Similarity=0.279  Sum_probs=188.9

Q ss_pred             eeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ++||.|+||.||++...  .....+++|.+.... .......+.+|+.+++.++||||+++++.+...     ...|+||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~   74 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL   74 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence            46999999999999653  244568888775432 334456678899999999999999999998876     5689999


Q ss_pred             ecCC-ccHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           85 ELMD-TDLHQIIRSDQ-----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ||++ |+|.+++....     ..++..+..++.||+.|++|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9998 59999987643     24677888999999999999999999999999999999999999999999986543321


Q ss_pred             c---ccceeeeecccCchhccc------CCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          159 F---MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       159 ~---~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      .   .....++..|+|||++..      ...++.++|+|||||++|+|++ |..||......+.+...........    
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----  230 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL----  230 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC----
Confidence            1   122234567999998743      2456889999999999999999 7889987765544433322111000    


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                           ..+......+..+.+++..|+ .||++|||++++++
T Consensus       231 ---------------------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 ---------------------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---------------------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                 001112356788899999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-39  Score=279.93  Aligned_cols=242  Identities=25%  Similarity=0.370  Sum_probs=194.0

Q ss_pred             eeecccceEEEEEEEeCCCC------ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            7 GEYDDIIFFIFSAAVNSETR------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +.||.|++|.||++.+....      +.+|+|.+.... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   74 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ   74 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence            46899999999999986443      679999885432 234456788899999999999999999998776     558


Q ss_pred             EEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-----CEEEEe
Q 019728           81 YIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGD  147 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-----~~kl~d  147 (336)
                      +++|||++ ++|.+++...       ..+++..+..++.||+.|++|||+.+++|+||+|+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999997 5999998642       3478899999999999999999999999999999999999877     899999


Q ss_pred             ccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 019728          148 FGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       148 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                      ||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+...    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----  229 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG----  229 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----
Confidence            999875543321   112234577999999877 678999999999999999998 99999876655444333210    


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                .........+..+.++|.+||..+|.+||++.++++
T Consensus       230 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 --------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                      001122356788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.6e-39  Score=276.52  Aligned_cols=247  Identities=21%  Similarity=0.247  Sum_probs=189.1

Q ss_pred             eeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||+|+||.||++...  .++..+|+|.+..... ......+.+|+.+++.++||||+++++++...     ...++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~   74 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM   74 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence            46999999999999864  4567799998865432 23345678899999999999999999998776     5589999


Q ss_pred             ecCC-ccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           85 ELMD-TDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        85 e~~~-g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ||++ |+|.+++...     ...+...+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9998 6999998653     235677888899999999999999999999999999999999999999999986543332


Q ss_pred             c---ccceeeeecccCchhcccC------CCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          159 F---MTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       159 ~---~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      .   .....++..|+|||++.+.      ..++.++|+||||+++|+|++ |..||......+...........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------  228 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL------  228 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC------
Confidence            1   1223456789999998642      135789999999999999996 99999876554433222111000      


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         ....+......+..+.++++.|+ .+|.+|||++||+.
T Consensus       229 -------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -------------------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -------------------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                               00001112345778999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-39  Score=276.87  Aligned_cols=244  Identities=23%  Similarity=0.334  Sum_probs=189.1

Q ss_pred             eeecccceEEEEEEEeCC---CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      +.||.|+||.||+|.+..   .+..||+|.+... ........+.+|+.+++.++|||++++++++....    ...+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence            468999999999998743   3457999987532 23445677889999999999999999999765432    347899


Q ss_pred             EecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc--
Q 019728           84 YELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--  159 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (336)
                      |||+. |+|.+++... ...+...+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99997 5999998764 3467778888999999999999999999999999999999999999999999875432211  


Q ss_pred             ---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 ---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                         .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+....               
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~---------------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR---------------  219 (262)
T ss_pred             ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence               112234567999999876 678999999999999999999 466776655443332221100               


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     ........+..+.+++.+||+.+|++||++.+++..
T Consensus       220 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 ---------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                           001112457889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-39  Score=283.35  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=196.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++.+.||+|++|.||++.+..+++    .||+|.+.... .......+.+|+.+++.++||||+++++++...     
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            47889999999999999999977776    47888875432 233445678899999999999999999988653     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..++++||++ |+|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+....
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             3578999997 69999987643 58999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+...            
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------  227 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG------------  227 (303)
T ss_pred             CcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC------------
Confidence            3221   112234668999999876 778999999999999999997 89999776543332222110            


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                        ......+..+..+.+++..||..+|.+||++.+++..
T Consensus       228 ------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         228 ------------------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              0011123457789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=310.50  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=210.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc-----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .+.+.+.||+|+||.||.+.......     .||||.+.+ ..+.....++++|..+|+.++|||||++.|++.+.    
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~----  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS----  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC----
Confidence            35688999999999999999864433     389998854 34678889999999999999999999999999986    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEec
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF  148 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (336)
                       ...+|++|||. |+|..+|+..       ..++..+...++.||+.|+.||+++++|||||...|+|++....+||+||
T Consensus       768 -~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  768 -GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             -CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence             56899999997 6999999865       35899999999999999999999999999999999999999999999999


Q ss_pred             cCCcccCCCCccc---ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 019728          149 GLARTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPD  224 (336)
Q Consensus       149 g~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  224 (336)
                      |+|+.....+...   .......|||||.+.. ..++.++|||||||++||+++ |..||...+..+.+......-.   
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR---  922 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR---  922 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc---
Confidence            9999554443321   1233568999999998 899999999999999999998 8999999987777664444211   


Q ss_pred             cccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                 -......+..+.+++.+||+.+|++||++..+++
T Consensus       923 ---------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 ---------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ---------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                       1223467889999999999999999999999986

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=281.19  Aligned_cols=258  Identities=13%  Similarity=0.106  Sum_probs=190.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCC---CceEEEEEecCcccChhH---------HHHHHHHHHHHhhCCCCceeeeccee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET---REEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIAIKDII   69 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~hp~iv~~~~~~   69 (336)
                      +|++.+.||+|+||+||+|.+..+   +..+|+|+..........         ......+...+..+.|+++++++++.
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            689999999999999999999777   667788765332111100         11222344556677899999999876


Q ss_pred             cCCCCCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEecc
Q 019728           70 RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG  149 (336)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg  149 (336)
                      ....... ...+++++++..++.+.+......++..++.++.|++.|++|||+.|++||||||+|||++.++.++|+|||
T Consensus        93 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFG  171 (294)
T PHA02882         93 SFKRCRM-YYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYG  171 (294)
T ss_pred             eEecCCc-eEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcC
Confidence            5442211 235788998887888777665567889999999999999999999999999999999999999999999999


Q ss_pred             CCcccCCCC--------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHh
Q 019728          150 LARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELI  220 (336)
Q Consensus       150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~  220 (336)
                      +++......        ......+++.|+|||++.+ ..++.++|||||||++++|++|..||..... .........  
T Consensus       172 la~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~--  248 (294)
T PHA02882        172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC--  248 (294)
T ss_pred             CceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH--
Confidence            987543211        1123468999999999887 7789999999999999999999999987632 222211111  


Q ss_pred             CCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                       .+...+...     ....+..++.+.++++.|+..+|++||++.++++
T Consensus       249 -----------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 -----------------DFIKRLHEG-----KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             -----------------HHHHHhhhh-----hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                             000011000     0112455788999999999999999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=271.96  Aligned_cols=258  Identities=21%  Similarity=0.319  Sum_probs=207.5

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ++.||.|+||+|++..++.+|+..|+|.+...-. +....+++.|.+...+- ++||||++||....+     +..||.|
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCM  142 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICM  142 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeH
Confidence            4679999999999999999999999999965432 45667777888765555 799999999998877     6689999


Q ss_pred             ecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           85 ELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        85 e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |.|+-+|..+..     ....++|+.+-.|.-..+.||.||.+. +|+|||+||+|||++..|.+||||||.+.....+-
T Consensus       143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            999987766543     346799999999999999999999975 89999999999999999999999999988766654


Q ss_pred             cccceeeeecccCchhcccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ..+...|-..|||||.+.... .++.+||+||||+++||+.||..||..-+.  ....+.......++..          
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l----------  290 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL----------  290 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee----------
Confidence            455567788899999987654 489999999999999999999999876443  3333322222111111          


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                  ......-+.+..+..+|..||.+|-+.||...+++.+||++-..
T Consensus       291 ------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  291 ------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             ------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence                        11112235789999999999999999999999999999998754

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-39  Score=278.97  Aligned_cols=264  Identities=23%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             ccceeeeecccceEEEEEEEeC----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++.+.||.|++|.||++...    .+++.||+|.+...... .....+.+|+.+++.++||||+++++++.....   
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~---   80 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---   80 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC---
Confidence            3678899999999999999864    45889999999754333 456778899999999999999999998876432   


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...+++|||++ ++|.+++.... .++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            56899999997 59999997654 58999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCcc----cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .....    ....++..|+|||.+.+ ..++.++|+||||+++++|++|..|+........     ...+....      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-----~~~~~~~~------  228 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-----RMIGIAQG------  228 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhc-----cccccccc------
Confidence            32111    11233456999999876 6788999999999999999999998865422110     00000000      


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                       .............   ....+.....+.++.+++.+||+.+|.+|||+.|++.
T Consensus       229 -~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         229 -QMIVTRLLELLKE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -cccHHHHHHHHHc---CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             0000000000000   0011122355788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-39  Score=275.54  Aligned_cols=235  Identities=20%  Similarity=0.253  Sum_probs=187.0

Q ss_pred             eeecccceEEEEEEEeCCCC----------ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            7 GEYDDIIFFIFSAAVNSETR----------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +.||.|+||.||++.+..++          ..+++|.+....   .....+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVRD----   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEecC----
Confidence            46899999999999998766          357788764432   1267778899999999999999999988662    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-------CEEEEe
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-------DLKIGD  147 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-------~~kl~d  147 (336)
                        ..++||||++ |+|.+++.... .++...+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|
T Consensus        74 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          74 --ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             --CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence              2689999998 59999987755 789999999999999999999999999999999999999887       799999


Q ss_pred             ccCCcccCCCCcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 019728          148 FGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       148 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                      ||.+......   ....++..|+|||++.+. ..++.++|+||||+++++|++ |..||..............    .. 
T Consensus       152 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~~-  223 (259)
T cd05037         152 PGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----QH-  223 (259)
T ss_pred             CCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----CC-
Confidence            9998765542   223456679999998773 378899999999999999999 5778866543222211110    00 


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                 .........+.+++.+||..+|.+|||+.+++.
T Consensus       224 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 ---------------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---------------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                       000112368999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-40  Score=292.36  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=213.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |..++.||-|+||.|.++....|...||+|.+.+. ......+.....|-+||..-.++-||++|..|.+.     ..+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----dnLY  705 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLY  705 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----CceE
Confidence            56789999999999999999999999999998654 35667778888999999999999999999999988     6699


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-----
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-----  155 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-----  155 (336)
                      +||+|++ |++-++|-..+-|.|+.++.++.++..|+.+.|..|++||||||+|||||.+|.+||+|||++.-..     
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            9999997 5999999888999999999999999999999999999999999999999999999999999974211     


Q ss_pred             ------------CCC--------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHH
Q 019728          156 ------------ETD--------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  197 (336)
Q Consensus       156 ------------~~~--------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  197 (336)
                                  +.+                          .....+||..|+|||++.. ..++...|.||.|+|+|+|
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence                        000                          0133578999999999987 7899999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCC
Q 019728          198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  277 (336)
Q Consensus       198 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  277 (336)
                      +.|+.||....+.+...++........                           ...-..+|.++.++|.++. .+++.|
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~---------------------------~~~~~~ls~e~~~li~kLc-~sad~R  916 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLH---------------------------IPYQGNLSKEALDLIQKLC-CSADSR  916 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccc---------------------------cccccccCHHHHHHHHHHh-cChhhh
Confidence            999999977665444333322111110                           1112467999999998866 467888


Q ss_pred             C---CHHHHHcCcccccCc
Q 019728          278 I---TVEEALRHPYLQSLH  293 (336)
Q Consensus       278 p---t~~ell~h~~f~~~~  293 (336)
                      .   .++++-.||||+.|.
T Consensus       917 LGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  917 LGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hcccchhhhhcCccccccc
Confidence            8   677899999999885

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=284.45  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=193.2

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc-eEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN-DVYI   82 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~-~~~i   82 (336)
                      .-...||.|+||.||++.-.. |..||||.+.......  ..++..|+.++.+++|||+|+++|++.+.     . +.++
T Consensus        78 s~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~-----~~~~~L  149 (361)
T KOG1187|consen   78 SESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEG-----GEHRLL  149 (361)
T ss_pred             chhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecC-----CceEEE
Confidence            344789999999999999954 4899999875533221  45599999999999999999999999987     4 4899


Q ss_pred             EEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           83 VYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS---VLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      |+||+. |+|.+.+....  ++++.....|+.+++.||+|||+..   |+|||||++|||+|++.+.||+|||+++....
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            999997 79999997765  8899999999999999999999964   99999999999999999999999999966554


Q ss_pred             -CCcccce-eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCccccccc
Q 019728          157 -TDFMTEY-VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ---LRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 -~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (336)
                       ....... .||..|+|||.... +..+.++||||+|+++.|+++|+.+.........   .......+...        
T Consensus       230 ~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--------  300 (361)
T KOG1187|consen  230 GDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--------  300 (361)
T ss_pred             cccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--------
Confidence             3222222 78999999999987 7899999999999999999999988765421111   11101111000        


Q ss_pred             ccchHHHHHHhCCcccccccc-ccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFA-TRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                .+...-+.... ..+.  ..-..+..+...|++.+|.+||++.|++.
T Consensus       301 ----------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 ----------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ----------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                      00000000000 0001  11123667888999999999999999855

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=298.86  Aligned_cols=204  Identities=28%  Similarity=0.373  Sum_probs=178.1

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYI   82 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~~i   82 (336)
                      ..-+.||.|+||.||.++++++|+.||||.+.... +....+..-+|++++++++|||||+++++-..... .-.....+
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34578999999999999999999999999986533 55667888899999999999999999998765531 01134689


Q ss_pred             EEecCC-ccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc--cCC--CEEEEeccCCccc
Q 019728           83 VYELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASC--DLKIGDFGLARTT  154 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~--~~~--~~kl~dfg~~~~~  154 (336)
                      +||||. |+|...+++   ..++++.+++.++.++..|+.|||++||+||||||.||++-  .+|  ..||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999997 599999965   46799999999999999999999999999999999999973  334  3799999999999


Q ss_pred             CCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 019728          155 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  208 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  208 (336)
                      +.+....+..||..|.+||++...+.++...|.||+||++|+.+||..||....
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            999999999999999999999865899999999999999999999999996544

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=278.73  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=220.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|..+..||.|+||.|-+|..+.+.+.||||++++.. -...+.+..+.|-.+|... +-|.++.++.+|+.-     ..
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-----DR  424 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-----DR  424 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-----hh
Confidence            3678899999999999999999999999999997653 2233445555677777777 478899999999987     55


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  157 (336)
                      +|+||||++ |+|--.|++-++|.+..+..++.+|+.||-+||++||++||||.+|||++.+|.+||.|||.++..-.. 
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999998 599999999999999999999999999999999999999999999999999999999999998764433 


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .....++||+.|+|||.+.- .+|+.+.|.||+|+++|||+.|+.||.+.+..+..+.|.+---                
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv----------------  567 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV----------------  567 (683)
T ss_pred             cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC----------------
Confidence            34557899999999999876 8999999999999999999999999999999998888866221                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                     .....+|.++.++.+..|...|.+|.     .-.++-.||||+.+.
T Consensus       568 ---------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  568 ---------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             ---------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence                           22356799999999999999999998     346788899998873

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.6e-38  Score=269.21  Aligned_cols=247  Identities=19%  Similarity=0.221  Sum_probs=187.6

Q ss_pred             eeecccceEEEEEEEeCCC--CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ++||.|+||.||++.....  ...+++|.+.... .......+.+|+.+++.++|||++++++.+...     ...|++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~   74 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVF   74 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEE
Confidence            4699999999999976432  3346677664432 234567788999999999999999999998876     5689999


Q ss_pred             ecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           85 ELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        85 e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      ||++ |+|.+++...    ...+...++.++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++....... 
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9998 5999998753    345677888999999999999999999999999999999999999999999876432221 


Q ss_pred             --cccceeeeecccCchhcccC------CCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          159 --FMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                        ......++..|+|||++...      ..++.++|+||||+++|+|++ |..||......+....+.......      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence              12234567889999987531      245778999999999999997 577887766555444432211000      


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         ...+.....+++.+.+++..|| .+|.+||++++++.
T Consensus       229 -------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                               0001112346788999999999 67999999999965

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=286.77  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             cceeeeecccceEEEEEEEeCC--CCc--eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSE--TRE--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +.+.+.||.|.||.||.+....  .|+  .||||..+.. ......+.++.|.-+++.+.||||+++.|++.+.      
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------  463 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------  463 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------
Confidence            4567899999999999998742  344  3888877553 3455689999999999999999999999999874      


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|||||.++ |.|..+++.+ ..++......++.||..||+|||+.++|||||-..|||+....-+||+|||+++....
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            4899999998 8999999875 4688888899999999999999999999999999999999999999999999998887


Q ss_pred             CCccccee--eeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TDFMTEYV--VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ........  .+..|||||.+.- ..++.++|||.||+++||++. |..||.+....+.+..+++               
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn---------------  607 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN---------------  607 (974)
T ss_pred             cchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC---------------
Confidence            76543323  3566999998865 789999999999999999986 9999998766555444332               


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHH
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  284 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell  284 (336)
                                     ....+..+..|+.+..|+.+||..||.+||.+.++.
T Consensus       608 ---------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  608 ---------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ---------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                           333456678899999999999999999999887764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=279.53  Aligned_cols=261  Identities=22%  Similarity=0.367  Sum_probs=211.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecC--ccc---ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGN--AFD---NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~--~~~---~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      ||.++..||.|+|+.||+|.|...++.||+|+-..  .+.   .........+|..+-+.|.||.||++|++|.-+.   
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt---  540 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT---  540 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc---
Confidence            68899999999999999999999999999997643  332   2233456678999999999999999999998764   


Q ss_pred             cceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEc---cCCCEEEEeccC
Q 019728           77 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN---ASCDLKIGDFGL  150 (336)
Q Consensus        77 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~---~~~~~kl~dfg~  150 (336)
                       ..+|-|.|||+| +|.-+++.++-+++.+++.|+.||+.||.||.+..  |+|-||||.|||+-   ..|.+||+|||+
T Consensus       541 -dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  541 -DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             -ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence             347999999998 89889999999999999999999999999999874  99999999999983   467899999999


Q ss_pred             CcccCCCCc--------ccceeeeecccCchhccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 019728          151 ARTTSETDF--------MTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL  219 (336)
Q Consensus       151 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  219 (336)
                      ++..+....        .....||.+|.|||.|.-   ..+.+.+.||||+|+|+|+.+.|+.||.....-..+-....+
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            998765533        244678999999998753   245688999999999999999999999776432222111111


Q ss_pred             hCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          220 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                      +.                        ..... .+.-|.+++++.+||++||+.--++|....++..||+|.-
T Consensus       700 lk------------------------AtEVq-FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  700 LK------------------------ATEVQ-FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hc------------------------ceecc-CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            10                        00111 1233577999999999999999999999999999999975

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=282.24  Aligned_cols=257  Identities=22%  Similarity=0.337  Sum_probs=213.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +..+.++||+|.||.|-++.-. .+..||+|+++... +......+.+|+++|.+|+||||+.+++++..+     ..++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic  611 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC  611 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence            3568899999999999999984 37899999986543 334468899999999999999999999999988     5599


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|+||++ |+|.+++..+  .........+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++..-..+
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999997 8999999876  334556677799999999999999999999999999999999999999999998655443


Q ss_pred             c---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          159 F---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .   ......+.+|||+|.+.. ++++.++|+|++|+++||+++  ...||....+.+............+..       
T Consensus       692 yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~-------  763 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ-------  763 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc-------
Confidence            2   344566889999999887 899999999999999999864  678998887777666655544433322       


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                      ......+-.+..+.+++-.||..|-++||+++++  |.+|++
T Consensus       764 ----------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  764 ----------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             ----------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence                            2234556789999999999999999999999998  555544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.7e-38  Score=293.92  Aligned_cols=272  Identities=19%  Similarity=0.234  Sum_probs=176.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCC----CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~   76 (336)
                      .|.+.+.||+|+||.||+|.+..+    +..||+|++.....    ......+  .++...+.++..+...+..... ..
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            588999999999999999999988    89999998754211    1111111  1222223333333322221111 12


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCe
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQQ--------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL  135 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~ni  135 (336)
                      ....++|+||++ ++|.+++.....                    .....+..++.||+.||+|||+.||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            256899999998 589988865321                    12344678999999999999999999999999999


Q ss_pred             EEcc-CCCEEEEeccCCcccCCC--CcccceeeeecccCchhcccCC---------------------CCCccchHHHHH
Q 019728          136 LLNA-SCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCT---------------------EYTAAIDIWSVG  191 (336)
Q Consensus       136 l~~~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG  191 (336)
                      |++. ++.+||+|||++......  .......+++.|+|||.+....                     .++.++||||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9986 578999999999754322  2234557789999999764311                     133456999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCcccc---ccccccCCCCChhHHHHHHH
Q 019728          192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK---QQFATRFPNKSSGAVDLLEK  268 (336)
Q Consensus       192 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~  268 (336)
                      |++|+|+++..++.  +............+...            ..+.........   ....+.....+....+||.+
T Consensus       367 viL~el~~~~~~~~--~~~~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        367 LIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDL------------VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             HHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcH------------HHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            99999998775543  22222222222111100            000111100000   00011122234567799999


Q ss_pred             hcCCCCCCCCCHHHHHcCcccccCc
Q 019728          269 MLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       269 ~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ||+.||++|||+.++|+||||+...
T Consensus       433 mL~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        433 MMRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             HccCCcccCCCHHHHhCCcCcCCCC
Confidence            9999999999999999999998754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.9e-39  Score=281.12  Aligned_cols=280  Identities=33%  Similarity=0.545  Sum_probs=223.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC------CceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH------ENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------p~iv~~~~~~~~~~~~   75 (336)
                      +|.+..-.|.|-||+|..|.|...|..||||+|...   +.-...-+.|+++|++|+.      -|+++++..|...   
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk---  506 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK---  506 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc---
Confidence            688999999999999999999999999999999653   3344555689999999963      4889999888877   


Q ss_pred             CcceEEEEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCC
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLA  151 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~  151 (336)
                        +|+|+|+|-+.-+|.+++..-   -++....++.++.|++.||..|..+|++|.||||+||||++.. .+||||||.|
T Consensus       507 --nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 --NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             --ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence              889999999999999999753   4588889999999999999999999999999999999998765 5899999999


Q ss_pred             cccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc-
Q 019728          152 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF-  230 (336)
Q Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  230 (336)
                      ...+.+.. +.+..+..|+|||++.| .+|+...|+||+||++|||.||+..|++.....++...+.+.+..+...... 
T Consensus       585 ~~~~enei-tPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASENEI-TPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccccc-cHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            88877754 34566888999999998 8999999999999999999999999999999999999999888777653211 


Q ss_pred             -cccchHHH-------HHHhCCcc---------cc-ccc----------cccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 019728          231 -LRSDNARR-------YVRQLPRC---------RK-QQF----------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  282 (336)
Q Consensus       231 -~~~~~~~~-------~~~~~~~~---------~~-~~~----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  282 (336)
                       +....+..       -.+.+...         .+ ..+          +..-+.+-..+++||.+||..||++|.|..+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence             00000000       00000000         00 000          0001112345889999999999999999999


Q ss_pred             HHcCccccc
Q 019728          283 ALRHPYLQS  291 (336)
Q Consensus       283 ll~h~~f~~  291 (336)
                      +|.||||+.
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999974

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-37  Score=262.64  Aligned_cols=242  Identities=38%  Similarity=0.635  Sum_probs=200.1

Q ss_pred             ceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCCc-cH
Q 019728           13 IFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DL   91 (336)
Q Consensus        13 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L   91 (336)
                      ++|.||++.+..+++.+++|++........ ...+.+|+..+++++|+|++++++++...     ...++++|++++ +|
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence            589999999998999999999865432221 67888999999999999999999998876     568999999986 99


Q ss_pred             HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceeeeecccC
Q 019728           92 HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA  171 (336)
Q Consensus        92 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~a  171 (336)
                      .+++.....++...++.++.+++.++++||+.|++|+||+|.||+++.++.++|+|||.+.............++..|+|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            99998766699999999999999999999999999999999999999999999999999887765544445567888999


Q ss_pred             chhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccccchHHHHHHhCCcccccc
Q 019728          172 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ  250 (336)
Q Consensus       172 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (336)
                      ||.+.+ ...+.++|+|+||+++++|++|..||...... .....+......                            
T Consensus       155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----------------------------  205 (244)
T smart00220      155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----------------------------  205 (244)
T ss_pred             HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----------------------------
Confidence            999876 67788999999999999999999999773322 222222110000                            


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       251 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      .......++..+.+++.+||..+|++||++.++++||||
T Consensus       206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            000011167889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=261.72  Aligned_cols=263  Identities=20%  Similarity=0.327  Sum_probs=215.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+++.||.|++.+|.+++.+.|.+.||+|++++..- ..+..+=...|-.+.++- +||.+|-++.+|...     ..
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-----sr  325 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-----SR  325 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----ce
Confidence            37889999999999999999999999999999987643 344455555677777777 699999999999988     66


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc-CCC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SET  157 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~-~~~  157 (336)
                      +++|.||.+| +|--.+++.+.++++.++.+..+|..||.|||++||++||||.+|||++..|.+||+|+|..+.. .+.
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999999985 88888888899999999999999999999999999999999999999999999999999998764 445


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      +..+.++||+.|.|||.+++ ..|+.+.|.|+||++++||+.|+.||.-....                    .+..+..
T Consensus       406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~--------------------n~d~nte  464 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD--------------------NPDMNTE  464 (593)
T ss_pred             cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCC--------------------Ccccchh
Confidence            56778899999999999998 89999999999999999999999999432100                    0011111


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC------CHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI------TVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------t~~ell~h~~f~~~~  293 (336)
                      .++-++.-.++   ..+.+.+|-.+..+++.-|.+||++|.      .+.++-.|+||+++.
T Consensus       465 dylfqvilekq---iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  465 DYLFQVILEKQ---IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             HHHHHHHhhhc---ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            12221111111   122345677788999999999999997      678999999999863

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=282.05  Aligned_cols=251  Identities=24%  Similarity=0.310  Sum_probs=212.2

Q ss_pred             cceeeeecccceEEEEEEEeCCCC-c--eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETR-E--EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~-~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +++.++||+|+||.|+.+.+...+ +  .||||.+.....+. ....+++|+.+|.+|+|||++++||++.+.      .
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q------p  184 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P  184 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence            467899999999999999996543 3  49999997654443 778899999999999999999999999873      3


Q ss_pred             EEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           80 VYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+|||++. |+|++.++.  ...|.......++.||+.|++||.++++|||||-..|+++-....+||+|||+.+..+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            789999998 799999986  35688889999999999999999999999999999999998888999999999998776


Q ss_pred             CCcccce----eeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDFMTEY----VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~~~~~----~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .+.....    .....|+|||.+.. ..++.++|+|++|+++|||++ |+.||.+......++++.+-            
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------------  331 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------------  331 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc------------
Confidence            6433221    23566999999987 899999999999999999998 88999999988888777531            


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                        ...+..+..+.++.+++..||..+|.+|||+..|...-+...
T Consensus       332 ------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  332 ------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                              122344577999999999999999999999999875544433

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=287.50  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=215.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.|.+.||.|.+|.||++++..++...|+|+.....   ...+.+..|+.+++.. .|||++.+|++|....+.....+|
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            688999999999999999999999999999886543   2335566788999988 599999999999877766667899


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  157 (336)
                      +|||||+ |+..++++.  ..++.+..+..|++.++.|+.+||.+.++|||||-.|||++.++.+||+|||.+...... 
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            9999998 588888865  456889999999999999999999999999999999999999999999999998776544 


Q ss_pred             CcccceeeeecccCchhcccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 DFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .......||+.|||||++...    .-++..+|+||||++..||.-|.+|+....+...   +..+...|++...     
T Consensus       178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRNPPPkLk-----  249 (953)
T KOG0587|consen  178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPPPKLK-----  249 (953)
T ss_pred             ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccCCCCCCcccc-----
Confidence            345677999999999998642    3467789999999999999999999977654433   3333333433321     


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                          .+...+..+.+||..||..|..+||+..++|.|||.+.
T Consensus       250 --------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  250 --------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             --------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                                12355888999999999999999999999999999873

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=274.97  Aligned_cols=242  Identities=20%  Similarity=0.344  Sum_probs=206.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      +....+||.|.||.||.+.++...-.||+|.++.   +....+.++.|..+|+.++|||+|++++++..+     ..+||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYI  340 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYI  340 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEE
Confidence            3456899999999999999999889999999865   356688999999999999999999999999988     56999


Q ss_pred             EEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           83 VYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+|||. |+|.++++...  .++.-...+++.||..|+.||..++++||||-..|+|+.++..+|+.|||+++.+....+
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            999996 89999998643  467778889999999999999999999999999999999999999999999998776654


Q ss_pred             ccce--eeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 MTEY--VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 ~~~~--~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ....  -....|+|||-+.- ..++.++|||+||+++||+.| |..||++.+-......+.+....              
T Consensus       421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM--------------  485 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM--------------  485 (1157)
T ss_pred             ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc--------------
Confidence            3321  23567999998865 788999999999999999998 88999998766655555442211              


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  283 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  283 (336)
                                      ....++++.+.+|++.||++.|.+||++.|+
T Consensus       486 ----------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  486 ----------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ----------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                            1234679999999999999999999999988

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=284.80  Aligned_cols=246  Identities=23%  Similarity=0.336  Sum_probs=215.2

Q ss_pred             cceeeeecccceEEEEEEEeCCCCce---EEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~---vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      ++|.+.||.|-||.|+.++-+..|++   ||||.++.. ..+.....++.|..||-++.||||+++.|+....     ..
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~P  704 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KP  704 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----ce
Confidence            57889999999999999999877754   999988654 4677888999999999999999999999999887     55


Q ss_pred             EEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +.||+|||+ |+|..+|+.+ +.|+..++.-+++.|+.|+.||-+.|+|||||-..|||++.+-.+|++|||+++.....
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            999999997 8999999865 67999999999999999999999999999999999999999999999999999976444


Q ss_pred             Cc--cccee--eeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 DF--MTEYV--VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 ~~--~~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ..  .+...  -+.+|+|||++.- .+++.++||||+|++|||.++ |+.||=....-+.++.|++....|++.      
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm------  857 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM------  857 (996)
T ss_pred             CCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC------
Confidence            21  11111  2578999999976 899999999999999999886 999998888888999988876666544      


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                              +.|..+..|+..||++|-.+||.+.+|++
T Consensus       858 ------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  858 ------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                    45889999999999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-36  Score=272.19  Aligned_cols=271  Identities=18%  Similarity=0.252  Sum_probs=184.2

Q ss_pred             ccceeeeecccceEEEEEEEeC----------------CCCceEEEEEecCcccCh------------hHHHHHHHHHHH
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS----------------ETREEVAIKKIGNAFDNI------------IDARRTLREIKL   53 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~----------------~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~   53 (336)
                      .|++.++||+|+||+||++.+.                ..++.||||.+.......            ...+....|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            5889999999999999999752                345679999986432110            011223346677


Q ss_pred             HhhCCCCce-----eeecceecCCCCCC---cceEEEEEecCC-ccHHHHHHcC------------------------CC
Q 019728           54 LRHMEHENV-----IAIKDIIRPPKKDT---FNDVYIVYELMD-TDLHQIIRSD------------------------QQ  100 (336)
Q Consensus        54 l~~l~hp~i-----v~~~~~~~~~~~~~---~~~~~iv~e~~~-g~L~~~l~~~------------------------~~  100 (336)
                      +.+++|.++     +++++++......+   ....++||||++ ++|.+++...                        ..
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777766544     56667665432211   145899999998 5998887532                        12


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc--ceeeeecccCchhcccC
Q 019728          101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNC  178 (336)
Q Consensus       101 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~  178 (336)
                      ++...++.++.|++.+|+|||+.+++||||||+||+++.++.++|+|||++..........  ...+++.|+|||.+...
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            3566788999999999999999999999999999999999999999999986544322222  12347889999987542


Q ss_pred             CC---------------------CCccchHHHHHHHHHHHHhCCC-CCCCCChHHH-HHHHHHHhCCCCcccccccccch
Q 019728          179 TE---------------------YTAAIDIWSVGCILGEIMTREP-LFPGKDYVHQ-LRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       179 ~~---------------------~~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ..                     .....|+||+||++|+|++|.. ||........ .....                 .
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~-----------------~  448 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD-----------------N  448 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc-----------------c
Confidence            11                     1124699999999999999875 6654321111 00000                 0


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCC---CCCCCHHHHHcCccccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP---NKRITVEEALRHPYLQS  291 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~ell~h~~f~~  291 (336)
                      ....++....  .....+.+...++..++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       449 ~~~~~r~~~~--~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        449 DLNRWRMYKG--QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hHHHHHhhcc--cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0000011100  011112345678999999999999866   68999999999999964

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=284.30  Aligned_cols=243  Identities=29%  Similarity=0.324  Sum_probs=189.2

Q ss_pred             eeeecccceEEE-EEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEE
Q 019728            6 RGEYDDIIFFIF-SAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         6 ~~~lg~G~~g~v-~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      .+.+|.|+.|+| |++..  .|+.||+|.+-.     ....-+.+|++.++.- +||||+++|+.-.+.     ...||.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----qF~YIa  581 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----QFLYIA  581 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCC-----ceEEEE
Confidence            457899999965 88887  678999998833     3445677999999999 599999999987776     779999


Q ss_pred             EecCCccHHHHHHcCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---C--CCEEEEeccCCccc
Q 019728           84 YELMDTDLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---S--CDLKIGDFGLARTT  154 (336)
Q Consensus        84 ~e~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~--~~~kl~dfg~~~~~  154 (336)
                      .|.|..+|.+++.....    ......+.++.|++.||++||+.+||||||||.||||+.   +  .+++|+|||+++..
T Consensus       582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99999999999987411    122445778899999999999999999999999999976   3  45899999999886


Q ss_pred             CCCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          155 SETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      .....    .....||..|+|||++.. ..-+.+.|||||||++|..++| ..||...-.  ...+|..-.  .      
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~--~------  730 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGN--Y------  730 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCc--c------
Confidence            65432    345678999999999987 5667799999999999999986 899976421  111221100  0      


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                          .....-+....++.+||.+||++||..||+|.++|.||+|=.
T Consensus       731 --------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  731 --------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             --------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence                                000011111127999999999999999999999999999943

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=269.91  Aligned_cols=199  Identities=24%  Similarity=0.339  Sum_probs=177.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc------cChhHHHHHHHHHHHHhhCC---CCceeeecceecCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF------DNIIDARRTLREIKLLRHME---HENVIAIKDIIRPP   72 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~   72 (336)
                      .|..++++|.|+||.|++|.++.+...|+||++.++.      -.....-.+-.|+++|..++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4788999999999999999999999999999997642      11122233447999999997   99999999999998


Q ss_pred             CCCCcceEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           73 KKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        73 ~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                           ..+|++||.-+ | +|.++|.....++|.+++.|++||..|+++||+.||+|||||-+||.++.+|-+||+|||.
T Consensus       642 -----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  642 -----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             -----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence                 77999999986 6 9999999999999999999999999999999999999999999999999999999999998


Q ss_pred             CcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 019728          151 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  206 (336)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  206 (336)
                      +...-+. ++..+.||..|+|||++.+....+..-|||+||+++|.++..+.||.+
T Consensus       717 aa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            8655443 567789999999999999977889999999999999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=274.99  Aligned_cols=257  Identities=25%  Similarity=0.330  Sum_probs=215.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|.++..+|+|.+|.||+|+|+.+++..|+|+++....  ....-+.+|+.+++..+||||+.+++.+...     ..+|
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dklw   88 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKLW   88 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhh-----cCcE
Confidence            47899999999999999999999999999999976532  3455667899999999999999999999988     4599


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~~  159 (336)
                      |+||||+ |+|.+...-.+++++.++....+..+.|++|||+.|-.|||||-.||++++.|.+|+.|||.+..... -..
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            9999998 48988888889999999999999999999999999999999999999999999999999998765443 334


Q ss_pred             ccceeeeecccCchhcc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ...+.|+++|||||+..  ....|...+|+|++|+...|+-.-+.|-....+...+..+.+-...++.-.          
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk----------  238 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK----------  238 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc----------
Confidence            56779999999999853  226789999999999999999888877766555544444433222221111          


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                      .....+..+.+|++.+|..+|++||+++.+|.|||...
T Consensus       239 ----------------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  239 ----------------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ----------------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                            11345888999999999999999999999999999865

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.5e-35  Score=251.58  Aligned_cols=281  Identities=29%  Similarity=0.435  Sum_probs=208.0

Q ss_pred             ccceeeeecccceEEEEEEEeCC---CCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~   77 (336)
                      -|+++.+||.|.|++||++.+..   .++.||+|.+...    +...++..|+++|..+. +.||+++.+++..+     
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn-----  107 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN-----  107 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC-----
Confidence            37889999999999999999987   7889999988542    23456889999999995 99999999999988     


Q ss_pred             ceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~  155 (336)
                      ....+|+||++. ...++..   .++..+++.+++.++.||+++|..||+||||||.|++++.. +.-.|+|||++....
T Consensus       108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            669999999985 7777764   47788999999999999999999999999999999999864 568899999986110


Q ss_pred             -----------------C-C-------------Cc--------------ccceeeeecccCchhcccCCCCCccchHHHH
Q 019728          156 -----------------E-T-------------DF--------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSV  190 (336)
Q Consensus       156 -----------------~-~-------------~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  190 (336)
                                       . .             ..              .....||+.|+|||++......+++.||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence                             0 0             00              0112468889999999887888999999999


Q ss_pred             HHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCccccc-------ccccch---HHHHHHhCC-----cccc-----c
Q 019728          191 GCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLG-------FLRSDN---ARRYVRQLP-----RCRK-----Q  249 (336)
Q Consensus       191 G~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~-----~~~~-----~  249 (336)
                      |+|+..++++..||.. .++.+.+..+..+.+...-....       .+..++   .......+.     .+.+     .
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            9999999999999744 34445555554444421111100       011011   111111111     1111     1


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       250 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      ....-....+..+.+|+.+||..||.+|.|++++|.||||...++
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            111222245668999999999999999999999999999996543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=226.45  Aligned_cols=208  Identities=24%  Similarity=0.359  Sum_probs=175.2

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEEEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      -+..||+|++|.|=+.++..+|...|+|.+.... +....++.++|+++..+. .+|.+|.+|+.+...     ..++|.
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gdvwIc  123 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GDVWIC  123 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----ccEEEe
Confidence            3568999999999999999999999999997654 455667788888887776 699999999988877     669999


Q ss_pred             EecCCccHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           84 YELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        84 ~e~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ||.|+.+|..+.    ..++.++|..+-+|+..+..||.|||++ .++|||+||+|||++.+|++|+||||.+....++-
T Consensus       124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            999998887664    4567899999999999999999999986 89999999999999999999999999998776554


Q ss_pred             cccceeeeecccCchhccc---CCCCCccchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 019728          159 FMTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITE  218 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~  218 (336)
                      ..+-..|-..|||||.+..   ...|+.++||||||+.+.||.+++.||.. ..+.++++.+.+
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            3333466778999998753   24788999999999999999999999965 345566655544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=290.53  Aligned_cols=251  Identities=16%  Similarity=0.225  Sum_probs=182.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      +...+.||+|+||.||+|.+..+++.||+|.+.....      ....|++.+++++||||+++++++...     ...|+
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~l  760 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYL  760 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEE
Confidence            3456789999999999999998999999998854321      112458889999999999999999876     55899


Q ss_pred             EEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           83 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH---SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ||||++ |+|.++++   .+++.++..++.||+.|++|||   +.+++||||||+||+++.++..++. ++.......  
T Consensus       761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            999997 59999985   4889999999999999999999   6699999999999999998888775 554433221  


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       .....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...........          ...
T Consensus       835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~  902 (968)
T PLN00113        835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC----------HLD  902 (968)
T ss_pred             -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc----------chh
Confidence             122356789999999876 78899999999999999999999998532110 00100100000000          000


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .+.+.    ..............++.+++.+||+.||++|||+.|+++.
T Consensus       903 ~~~~~----~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        903 MWIDP----SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             heeCc----cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000    0000000001123357789999999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=265.92  Aligned_cols=245  Identities=26%  Similarity=0.423  Sum_probs=201.1

Q ss_pred             ceeeeecccceEEEEEEEeC---C----CCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            4 KLRGEYDDIIFFIFSAAVNS---E----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~---~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      .+.+.||+|.||.|+++.-.   .    ....||+|+.+..... .....+..|+++++.+ +|||++.+.+++...   
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~---  374 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD---  374 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC---
Confidence            46779999999999999743   1    1456999999766545 7788899999999999 599999999999885   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                        +.+++|+||+. |+|.++++..+                .++..+...++.||+.|++||++.+++||||-..|||++
T Consensus       375 --~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  375 --GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             --CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence              66999999998 89999998755                388899999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCcccCCCCccc-c-ee--eeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC-hHHH
Q 019728          139 ASCDLKIGDFGLARTTSETDFMT-E-YV--VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD-YVHQ  212 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~~~~~~-~-~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~  212 (336)
                      .+..+||+|||+++......... . ..  ....|||||.+.. ..++.++||||+|+++||+++ |..||.+.. ..+.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            99999999999998655443322 1 11  3456999999988 899999999999999999998 889998855 3333


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ...+..                              ..........+.++.++++.||+.+|++||++.++..
T Consensus       532 ~~~l~~------------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LEFLKE------------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHhc------------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            332222                              1112233456899999999999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-34  Score=258.45  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=204.0

Q ss_pred             cceeeeecccceEEEEEEEeCCCCce----EEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .+..+.||+|+||+||++.+...|+.    ||||++. +....+....+++|+-+|.++.|||++++++++...      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~-~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------  770 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI-EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------  770 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEee-ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence            45678999999999999999766764    7777663 345666778899999999999999999999998875      


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .+-+|++|++ |.|.++++.+ .++-......|..||++|+.|||.+++|||||-..||||..-..+|+.|||+++....
T Consensus       771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            3688999998 7999999764 5688889999999999999999999999999999999999999999999999988766


Q ss_pred             CCcccce---eeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          157 TDFMTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       157 ~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ....-..   .-...|+|-|.+.. ..++.++||||+||.+||++| |..|+.+....+.-..+..-             
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-------------  916 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-------------  916 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-------------
Confidence            5433222   22566999998887 899999999999999999998 89999988755544333321             


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                       ...+..+..+.++.-++.+||..|+..||+++++..
T Consensus       917 -----------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  917 -----------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -----------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                             112334567889999999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=244.40  Aligned_cols=263  Identities=20%  Similarity=0.207  Sum_probs=192.0

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC--CCCceeeecceecCCCCCCcceE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      ..+.+.||+|.||.||+|.-  +++.||||++     .....+.+..|-++.+..  +|+||+++++.-...... ...+
T Consensus       212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKif-----p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIF-----PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhhc--cCceeEEEec-----CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            35678999999999999998  5699999999     455667778888887766  799999999987665433 2569


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      ++|++|.+ |+|.+++.. ..+++.+..+|+..+++||+|||+-         .|+|||||+.|||+..+++.-|+|||+
T Consensus       284 wLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999997 899999987 4799999999999999999999963         599999999999999999999999999


Q ss_pred             CcccCCCC---cccceeeeecccCchhcccCCCCC-----ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 019728          151 ARTTSETD---FMTEYVVTRWYRAPELLLNCTEYT-----AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  222 (336)
Q Consensus       151 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  222 (336)
                      |.......   .....+||.+|||||++.+.-.+.     .+.||||+|.++|||++....+......+...-.+..++.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            98765432   233468999999999998744444     3689999999999999876544321111111111111111


Q ss_pred             CCcccccccccchHHHHHHhCCcc-ccccccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHH
Q 019728          223 PDDASLGFLRSDNARRYVRQLPRC-RKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEAL  284 (336)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~ell  284 (336)
                      -          ....+....+.+. .+..++..+.  .-...+.+.+.-||..||+.|.|+.=+.
T Consensus       443 h----------Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  443 H----------PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             C----------CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            1          1111111111111 1222222222  2244588999999999999999986553

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=238.47  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=186.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC--CCCceeeecceecCCCCCCcceE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +.+.+.||+|.||.||.+.+  .|+.||||++..     ..-..+.+|.++.+..  +|+||+.+.+.-.... .....+
T Consensus       213 I~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQL  284 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQL  284 (513)
T ss_pred             eEEEEEecCccccceeeccc--cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEE
Confidence            57889999999999999999  589999999943     3446677888888876  8999999988765543 345779


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      |+|++|.+ |+|.+++.. ..++.+.+..++..++.||++||..        .|+|||||+.||||..++.+-|+|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999998 899999987 6899999999999999999999963        3999999999999999999999999998


Q ss_pred             cccCCC-----CcccceeeeecccCchhcccCCC-----CCccchHHHHHHHHHHHHhC----------CCCCCCCChHH
Q 019728          152 RTTSET-----DFMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTR----------EPLFPGKDYVH  211 (336)
Q Consensus       152 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~  211 (336)
                      ......     ...+..+||.+|||||++..+..     .-..+||||||.++||++-.          ..||...    
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~----  439 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV----  439 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC----
Confidence            765443     12456689999999999975322     12368999999999999752          2455332    


Q ss_pred             HHHHHHHHhCCCCcccccccccchHHHHHHhCCcccccc--ccccCCCC--ChhHHHHHHHhcCCCCCCCCCHHHH
Q 019728          212 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ--FATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEA  283 (336)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~li~~~L~~dp~~Rpt~~el  283 (336)
                                         .+.+....-++.+...++..  ++..+...  =..+..+++.||..+|.-|.|+--+
T Consensus       440 -------------------Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  440 -------------------VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             -------------------CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence                               12222222222222111111  11111111  1236688999999999999988655

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=9.6e-32  Score=221.79  Aligned_cols=211  Identities=35%  Similarity=0.570  Sum_probs=182.8

Q ss_pred             ecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCC
Q 019728            9 YDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD   88 (336)
Q Consensus         9 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~   88 (336)
                      ||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++++++++++...     ...++++|+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence            689999999999998889999999986543221 457788999999999999999999999876     56899999999


Q ss_pred             -ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCcccCCCC-ccccee
Q 019728           89 -TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-FMTEYV  164 (336)
Q Consensus        89 -g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~  164 (336)
                       ++|.+++... ..++...++.++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence             6999998765 57899999999999999999999999999999999999999 8999999999887655432 123345


Q ss_pred             eeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCC
Q 019728          165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  244 (336)
Q Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
                      +...|++||.+......+.++|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            677899999987633788999999999999999                                               


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                                     ..+.+++..|++.||++||++.++++++
T Consensus       188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                           1367999999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=227.05  Aligned_cols=257  Identities=19%  Similarity=0.279  Sum_probs=197.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.|.+.||+|.||.+-++.++.++..+++|.+..+   ......+.+|+..---| .|.||+.-|+.-....    ..+
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~Y   97 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAY   97 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceE
Confidence            478999999999999999999999999999999765   44567788888776666 4999999888654432    457


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc--cCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~--~~~~~kl~dfg~~~~~~~~  157 (336)
                      ++++||++ |+|.+-+.. .++.+.-.+.++.|+++|+.|||++++||||||.+||||-  +..++||||||.+...+..
T Consensus        98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            88999998 899998876 4688999999999999999999999999999999999983  2346999999998876643


Q ss_pred             CcccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      -  ........|.+||+...    .....+++|+|+||+++|.+++|+.||......+                      
T Consensus       177 V--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d----------------------  232 (378)
T KOG1345|consen  177 V--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD----------------------  232 (378)
T ss_pred             e--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----------------------
Confidence            1  12233566899998653    2346789999999999999999999997432111                      


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHHcCccccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEALRHPYLQS  291 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~ell~h~~f~~  291 (336)
                      ...+.+..-. .......+..+...++.+..+.++-|..+|++|   .++......-|...
T Consensus       233 ~~Y~~~~~w~-~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  233 KPYWEWEQWL-KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             chHHHHHHHh-cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            1111111111 111224456677889999999999999999999   56666666666644

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-31  Score=221.38  Aligned_cols=198  Identities=33%  Similarity=0.562  Sum_probs=173.6

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..+++++|+|++++++++...     ...++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence            67889999999999999999988999999999654322 2567888999999999999999999998776     56899


Q ss_pred             EEecCCc-cHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC--
Q 019728           83 VYELMDT-DLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--  158 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (336)
                      ++|++++ +|.+++..... +++..++.++.+++.++++||+.+++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999987 99999987666 8999999999999999999999999999999999999999999999999887765442  


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  206 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  206 (336)
                      ......++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334456778899999984336778899999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=5e-32  Score=227.96  Aligned_cols=248  Identities=19%  Similarity=0.260  Sum_probs=206.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-----ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      |+++...+-+|.||.||.+.+++..     +.|.+|.++. ..+..+...++.|.-++..+.|||++.+.++..+..   
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~---  360 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY---  360 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc---
Confidence            5667778889999999999775432     3466776643 457778888999999999999999999999877642   


Q ss_pred             cceEEEEEecCC-ccHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEe
Q 019728           77 FNDVYIVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  147 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~d  147 (336)
                       ...++++++.+ |+|..+++.        ...++..+...++.|++.|++|||+.|++|.||-..|++|++.-++||+|
T Consensus       361 -~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  361 -ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             -CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence             45789999998 899999972        13478888999999999999999999999999999999999999999999


Q ss_pred             ccCCcccCCCCcc---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 019728          148 FGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       148 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                      -.+++...+.++.   .....+..||+||.+.+ ..++.++|+||||+++|||++ |+.||...++.++-..+.+...  
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR--  516 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR--  516 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce--
Confidence            9999887766543   33445678999999998 899999999999999999998 8999999998877666644222  


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                                  ....-+.|+++..++.-||..+|++||+++++..
T Consensus       517 ----------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 ----------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ----------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                                        1223467999999999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.7e-32  Score=264.83  Aligned_cols=205  Identities=16%  Similarity=0.247  Sum_probs=147.9

Q ss_pred             hCCC-CceeeecceecCCCCCCc--ceEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           56 HMEH-ENVIAIKDIIRPPKKDTF--NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        56 ~l~h-p~iv~~~~~~~~~~~~~~--~~~~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                      .++| +||+++++.+......+.  ..++.++|+++++|.+++.. ...+++.+++.++.||+.||+|||++||+|||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            4455 588888888744432221  34788899999999999975 3569999999999999999999999999999999


Q ss_pred             CCCeEEccCCC-------------------EEEEeccCCcccCCCC-----------------cccceeeeecccCchhc
Q 019728          132 PSNLLLNASCD-------------------LKIGDFGLARTTSETD-----------------FMTEYVVTRWYRAPELL  175 (336)
Q Consensus       132 p~nil~~~~~~-------------------~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~  175 (336)
                      |+|||++..+.                   +|++|||+++......                 ......+|++|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999965444                   4555555554321100                 00113467889999998


Q ss_pred             ccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccC
Q 019728          176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF  255 (336)
Q Consensus       176 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
                      .+ ..++.++|||||||++|||++|..|+....  .....+..... +                             +..
T Consensus       188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~-----------------------------~~~  234 (793)
T PLN00181        188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-P-----------------------------PQI  234 (793)
T ss_pred             cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-C-----------------------------hhh
Confidence            87 678999999999999999999888765322  11111111000 0                             000


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       256 ~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ....+...+++.+||++||.+||++.|+++||||....
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            11234567899999999999999999999999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.3e-31  Score=245.91  Aligned_cols=264  Identities=24%  Similarity=0.248  Sum_probs=203.4

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecC---cccChhHH-HHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGN---AFDNIIDA-RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~-~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      ....+|.|++|.|+.+....-.+.++.|....   ........ ..+..|+.+-..++|||++.....+....     ..
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----GI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----cc
Confidence            46789999999888888877677666665531   22222222 33778999999999999988888777663     23


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC---
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  157 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (336)
                      +-.||||+++|.+++.+.+.++..++..+++|++.|++|||+.|+.|||+|++|++++.+|.+||+|||.+......   
T Consensus       397 ~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  397 LQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            44499999999999998888999999999999999999999999999999999999999999999999988653322   


Q ss_pred             --CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          158 --DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                        .......|+..|+|||++.+........||||.|++++.|.+|+.||......+....-        ..         
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--------~~---------  539 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--------NN---------  539 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--------hc---------
Confidence              22345688999999999988455566899999999999999999999766543222100        00         


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                           .................++...+.+|.+||++||.+|.|+++|++++||+++...
T Consensus       540 -----~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  540 -----YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             -----cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence                 0000001112223344678889999999999999999999999999999998643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.5e-29  Score=203.43  Aligned_cols=166  Identities=22%  Similarity=0.276  Sum_probs=128.5

Q ss_pred             ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceeeee
Q 019728           89 TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  167 (336)
Q Consensus        89 g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  167 (336)
                      |+|.+++.. .+++++.+++.|+.||+.||+|||+.+      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            689999986 456999999999999999999999999      999999999999999  99887654432    25789


Q ss_pred             cccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccccchHHHHHHhCCcc
Q 019728          168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC  246 (336)
Q Consensus       168 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (336)
                      .|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+............                  
T Consensus        69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------  129 (176)
T smart00750       69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR------------------  129 (176)
T ss_pred             cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc------------------
Confidence            9999999987 77899999999999999999999999765432 222222221111100000                  


Q ss_pred             ccccccccCCCCCh--hHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          247 RKQQFATRFPNKSS--GAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       247 ~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                            .....++.  .+.+++.+||..||.+||++.+++.|+|+..
T Consensus       130 ------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      130 ------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                  00011223  6999999999999999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=9.8e-28  Score=190.09  Aligned_cols=212  Identities=22%  Similarity=0.248  Sum_probs=176.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|+++++||+|+||.+|++....+|+.||||+-....    ...++..|..+.+.|+ ...|..+..+..+.     .+-
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~yn   86 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEK-----DYN   86 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccc-----ccc
Confidence            5899999999999999999999999999999875432    2346778999999997 56777777777766     557


Q ss_pred             EEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC---CCEEEEeccCCcccCC
Q 019728           81 YIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSE  156 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~  156 (336)
                      .+||+..+.+|.+++. .++.|+...+.-++-|++.-++|+|.++++||||||+|+|+.-.   ..+.|+|||+|+..-.
T Consensus        87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            9999999999988885 35679999999999999999999999999999999999999543   4589999999986443


Q ss_pred             CCc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 019728          157 TDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                      ...        .....||..|++--+..+ ...+...|+=|+|.++..+.-|..||.+.......++.+++.+..
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK  240 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence            321        234578999999888876 677889999999999999999999999988777777777665543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-26  Score=201.35  Aligned_cols=251  Identities=19%  Similarity=0.157  Sum_probs=191.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-ceEEEEEecCcccChhHHHHHHHHHHHHhhCC----CCceeeecceec-CCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHME----HENVIAIKDIIR-PPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~----hp~iv~~~~~~~-~~~~~   75 (336)
                      +|++.++||+|+||.||.+.+..++ +.+|+|..........  ..+..|..++..+.    .+++..+++... ..   
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~---   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE---   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC---
Confidence            6899999999999999999997765 6788998755322211  15667888888886    368888888884 43   


Q ss_pred             CcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-----CCEEEEec
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-----CDLKIGDF  148 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-----~~~kl~df  148 (336)
                        ...|+||+.++.+|.++....  +.++...+..|+.|++.+|.+||+.|++||||||+|+++...     ..+.|.||
T Consensus        94 --~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   94 --DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             --ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence              457999999999999988543  579999999999999999999999999999999999999765     35999999


Q ss_pred             cCCc--ccCCC--------Cc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 019728          149 GLAR--TTSET--------DF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  217 (336)
Q Consensus       149 g~~~--~~~~~--------~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  217 (336)
                      |+++  .....        .. .....||..|+|+.+..+ ...+...|+||++.++.+++.|..||.............
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  31111        11 223458999999999988 889999999999999999999999997766443333332


Q ss_pred             HHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .........                          ......+..+.++...+-..+...+|....+...
T Consensus       251 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLLTD--------------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhccc--------------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            221110000                          0122345677777777777899999988777653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-26  Score=191.78  Aligned_cols=217  Identities=16%  Similarity=0.208  Sum_probs=182.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      -|+++++||+|+||..+.+.+--+++.||||.-..    ...+.++..|+...+.|. .++|..+|.+...+     .+-
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~N   99 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYN   99 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeecccc-----chh
Confidence            58999999999999999999999999999997643    345677788888888884 89999999988877     557


Q ss_pred             EEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-----CEEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-----DLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-----~~kl~dfg~~~~~  154 (336)
                      .+|+|+++.+|.+++. ..++|+...+..++.|++.-++++|++.+++|||||+|+||...+     .+.++|||+++..
T Consensus       100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8999999998888875 356799999999999999999999999999999999999996543     3899999999865


Q ss_pred             CCCCc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          155 SETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       155 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                      .....        ..+..||-+||+--...+ ..-+...|+=+||-++...|-|..||.+......-.+.+++-......
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            54432        234578999999999888 788999999999999999999999999987666666666655544444


Q ss_pred             cc
Q 019728          227 SL  228 (336)
Q Consensus       227 ~~  228 (336)
                      ..
T Consensus       259 ~i  260 (449)
T KOG1165|consen  259 PI  260 (449)
T ss_pred             CH
Confidence            33

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=1.1e-24  Score=192.36  Aligned_cols=263  Identities=30%  Similarity=0.491  Sum_probs=206.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChh-HHHHHHHHHHHHhhCCCC-ceeeecceecCCCCCCcceE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNII-DARRTLREIKLLRHMEHE-NVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~~~~~~   80 (336)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+........ ....+.+|..+++.+.|+ +++++++.+...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            678899999999999999997   8899999977654443 678888999999999988 799999999555     447


Q ss_pred             EEEEecCCc-cHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccC
Q 019728           81 YIVYELMDT-DLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (336)
                      +++++++.+ ++.+.+....   .++...+..++.|++.++.++|+.|++|||+||+||+++..+ .++++|||.+....
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            999999985 8887776654   799999999999999999999999999999999999999988 69999999987544


Q ss_pred             CCC-------cccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCC
Q 019728          156 ETD-------FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY----VHQLRLITELIGS  222 (336)
Q Consensus       156 ~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~~~~  222 (336)
                      ...       ......++..|++||.+.+.  .......|+|++|++++++++|..||.....    ......+... ..
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~  232 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-PT  232 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-CC
Confidence            332       23566889999999999874  4788999999999999999999999877653    2222222221 11


Q ss_pred             C-CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          223 P-DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       223 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                      + .......                      .........+.+++..++..+|..|.+..+...+++........
T Consensus       233 ~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~  285 (384)
T COG0515         233 PSLASPLSP----------------------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE  285 (384)
T ss_pred             cccccccCc----------------------cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence            1 0000000                      00012235789999999999999999999999887776654333

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=3.3e-26  Score=192.35  Aligned_cols=238  Identities=20%  Similarity=0.223  Sum_probs=153.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCC----------CCceeeecceecC
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHME----------HENVIAIKDIIRP   71 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~----------hp~iv~~~~~~~~   71 (336)
                      ++..+.||.|++|.||.+.|..||+.+|+|++.... ......+++.+|.-....+.          |-.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            567889999999999999999999999999885433 23345566666654444432          2234444444332


Q ss_pred             CCCC-------Ccc-----eEEEEEecCCccHHHHHHc---CCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCC
Q 019728           72 PKKD-------TFN-----DVYIVYELMDTDLHQIIRS---DQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  132 (336)
Q Consensus        72 ~~~~-------~~~-----~~~iv~e~~~g~L~~~l~~---~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp  132 (336)
                      ..+.       +..     +.+++|+-+.++|.+++..   ...    +.......+..|++..+++||+.|++|+||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~  173 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP  173 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence            2110       001     3478999999988887642   111    22223345568999999999999999999999


Q ss_pred             CCeEEccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccC-------CCCCccchHHHHHHHHHHHHhCCCCCC
Q 019728          133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFP  205 (336)
Q Consensus       133 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~  205 (336)
                      +|++++.+|.++|+||+.....+.....  ...+..|.|||.....       ..++.+.|.|+||+++|.|.+|..||.
T Consensus       174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~  251 (288)
T PF14531_consen  174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG  251 (288)
T ss_dssp             GGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred             eeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence            9999999999999999877665544322  2335779999976431       246889999999999999999999997


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCC
Q 019728          206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  277 (336)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  277 (336)
                      ........                                  ...+... .++|..+++||+++|+.||.+|
T Consensus       252 ~~~~~~~~----------------------------------~~~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  252 LSSPEADP----------------------------------EWDFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCGGGSTS----------------------------------GGGGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCccccc----------------------------------cccchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            65421100                                  0011111 2779999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-27  Score=210.93  Aligned_cols=239  Identities=21%  Similarity=0.327  Sum_probs=200.8

Q ss_pred             ecccceEEEEEEEe---CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEEEEE
Q 019728            9 YDDIIFFIFSAAVN---SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         9 lg~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +|.|++|.|+++..   ...+..||+|+.++..........-..|..++..++ ||.+++++..+...     ...+++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHhh
Confidence            79999999987765   456788999988765543333335567888999997 99999999999988     6699999


Q ss_pred             ecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccce
Q 019728           85 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY  163 (336)
Q Consensus        85 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (336)
                      ++..| .|...+.....+.+...+.+...++-+++++|+.+++|+|+|++||+++.+|.+++.|||.++..-.....   
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            99975 99999888888999999999999999999999999999999999999999999999999999876554332   


Q ss_pred             eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhC
Q 019728          164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL  243 (336)
Q Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (336)
                      +|+..|||||++.   ....++|.||+|+++++|++|..||.+    +....|.+..                       
T Consensus       154 cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----------------------  203 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----------------------  203 (612)
T ss_pred             ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------------
Confidence            8899999999986   567899999999999999999999988    4444443311                       


Q ss_pred             CccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                              .......+..+++++..++..+|..|.     .+.|+.+|+||+++.
T Consensus       204 --------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  204 --------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             --------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence                    122345678899999999999999998     458999999999874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4.4e-25  Score=193.56  Aligned_cols=171  Identities=18%  Similarity=0.240  Sum_probs=128.3

Q ss_pred             ccceeeeecccceEEEEEEEeCC-CCceEEEEEecCcc---cChhHHHHHHHHHHHHhhCCCCceee-ecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-TREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~iv~-~~~~~~~~~~~~   76 (336)
                      +|.+.+.||+|+||+||+|.+.. ++..||||++....   ........+.+|+.++++++|+|++. +++.        
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--------   90 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--------   90 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--------
Confidence            58999999999999999999876 67778999875321   12334566889999999999999985 4432        


Q ss_pred             cceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC-CCCCeEEccCCCEEEEeccCCccc
Q 019728           77 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        77 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl-kp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                       ...|+||||++| +|. .+..   ..   ...++.|++++|+|||+.||+|||| ||+|||++.++.++|+|||+++..
T Consensus        91 -~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             236999999986 665 3221   11   1467899999999999999999999 999999999999999999999865


Q ss_pred             CCCCcc---------cceeeeecccCchhcccC-----CCCCccchHH
Q 019728          155 SETDFM---------TEYVVTRWYRAPELLLNC-----TEYTAAIDIW  188 (336)
Q Consensus       155 ~~~~~~---------~~~~~~~~y~aPE~~~~~-----~~~~~~~Diw  188 (336)
                      ......         ....++..|++||.+...     ...+..+|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            443211         233456778999987531     2234456665

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-26  Score=212.27  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=186.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      ++...+.||++.|-+|.+|++.+ |. |++|++-+..  .+-....+.+.|++ ....++||.+.+-.....+     ..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HH
Confidence            56778999999999999999954 44 9999886543  34555666677777 6777999999988776655     45


Q ss_pred             EEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC----
Q 019728           80 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----  155 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~----  155 (336)
                      .|+|-+|...+|.+.+..+.-+..-+.+.|+.||+.||.-+|+.||||||||.+|||++.-..+.|+||..-+..-    
T Consensus        96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            7999999999999999887778889999999999999999999999999999999999999999999998765422    


Q ss_pred             CCCcccce----eeeecccCchhcccC---------CC-CCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 019728          156 ETDFMTEY----VVTRWYRAPELLLNC---------TE-YTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  220 (336)
Q Consensus       156 ~~~~~~~~----~~~~~y~aPE~~~~~---------~~-~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~  220 (336)
                      ++.....+    ..-..|.|||.+...         .. .+++.||||+||+++||++ |.+||.-.+    +-....  
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~--  249 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRS--  249 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhc--
Confidence            11111111    223569999988641         12 5778999999999999987 688885322    111110  


Q ss_pred             CCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +          ........+.+++              +..++.+|..|++.||++|.++++.|+.
T Consensus       250 ~----------~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 G----------NADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             c----------CccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0          0111112222222              4468999999999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=8e-25  Score=176.85  Aligned_cols=143  Identities=17%  Similarity=0.190  Sum_probs=111.3

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhH------------------------HHHHHHHHHHHhhCCCC
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIID------------------------ARRTLREIKLLRHMEHE   60 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~hp   60 (336)
                      +.+.||.|++|.||.|.+. +|+.||+|++.........                        ......|+.++.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999997 8999999999654221111                        12233599999999888


Q ss_pred             ceeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeccCCCCCCeEEc
Q 019728           61 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        61 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~i~H~dlkp~nil~~  138 (336)
                      ++.....+...       ..++||||++| ++...+....+++...+..++.|++.+|.++ |+.||+||||||+||+++
T Consensus        80 ~v~~p~~~~~~-------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~  152 (190)
T cd05147          80 GIPCPEPILLK-------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCCCcEEEec-------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence            77544433222       13899999987 5544444457899999999999999999999 799999999999999998


Q ss_pred             cCCCEEEEeccCCcccCC
Q 019728          139 ASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~  156 (336)
                       ++.++|+|||++.....
T Consensus       153 -~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 -DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             -CCcEEEEEccccccCCC
Confidence             47899999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=1.3e-24  Score=177.51  Aligned_cols=174  Identities=13%  Similarity=0.155  Sum_probs=131.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHH-HH------HHHHHHHHhhCCCCceeeecceecCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDA-RR------TLREIKLLRHMEHENVIAIKDIIRPPKK   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~------~~~e~~~l~~l~hp~iv~~~~~~~~~~~   74 (336)
                      +|++.+.||.|+||.||++.+  ++..+|+|.+.......... ..      +.+|+..+.+++||+|..+.+++.....
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            689999999999999999766  47789999997554333222 22      4688899999999999999988765432


Q ss_pred             CC---cceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           75 DT---FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        75 ~~---~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      ..   ....+++|||++| +|.++.    .+++    ....+++.+++.+|+.|++|+|++|.||+++.+| ++|+|||.
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence            11   1457999999998 887763    2333    2456999999999999999999999999999998 99999998


Q ss_pred             CcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHH
Q 019728          151 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM  198 (336)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  198 (336)
                      +...........           .... ..++.++|+|+||+.+..+.
T Consensus       181 ~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            765532211111           2222 45667899999999877654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-24  Score=175.37  Aligned_cols=240  Identities=18%  Similarity=0.204  Sum_probs=188.6

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      ..+..+|.....|..|++++  +|..++.|++............+-.|+-.++-+.||||+.+++.+..+     .++.+
T Consensus       192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~  264 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVI  264 (448)
T ss_pred             hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceE
Confidence            35667888999999999999  567788888876665666667788899999999999999999999887     77999


Q ss_pred             EEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCCEEEE--eccCCcccC
Q 019728           83 VYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIG--DFGLARTTS  155 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~~kl~--dfg~~~~~~  155 (336)
                      +..|++ |+|.+.+.....  ++..++.+++.+|+.|++|||+..  |.--.|...+|++|++.+.+|+  |--++....
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~  344 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV  344 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc
Confidence            999998 799999976543  577889999999999999999985  5555688999999998876664  322221111


Q ss_pred             CCCcccceeeeecccCchhcccCCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                            ....++.|++||.+.....  .-.++|+|||.++++||.|.+.||....+.+.-.++.-               
T Consensus       345 ------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------  403 (448)
T KOG0195|consen  345 ------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------  403 (448)
T ss_pred             ------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------------
Confidence                  1133678999999875222  24589999999999999999999988776654333321               


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHH
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  284 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell  284 (336)
                                    ......+.++++..+..|++-|+..||.+||.++.++
T Consensus       404 --------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 --------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             --------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                          1122355678999999999999999999999887664

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=3.4e-24  Score=200.96  Aligned_cols=219  Identities=26%  Similarity=0.375  Sum_probs=170.1

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |..++.|..|++|.||+++|+.+..++|+| +++.  +           -+++     ||+.    +.+       ..++
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~k-iNkq--~-----------lilR-----nilt----~a~-------npfv  134 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ--N-----------LILR-----NILT----FAG-------NPFV  134 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhc-cccc--c-----------hhhh-----cccc----ccC-------Ccce
Confidence            678999999999999999999999999995 4332  1           1111     1111    111       1334


Q ss_pred             EEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC----
Q 019728           83 VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----  158 (336)
Q Consensus        83 v~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----  158 (336)
                      |     |+-...+...++++.+.        +.+++|||+.||+|+|+||+|.+|+.-|.+|++|||+++......    
T Consensus       135 v-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  135 V-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             e-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence            4     66666666666666544        568999999999999999999999999999999999987644321    


Q ss_pred             -----------cc-cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          159 -----------FM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       159 -----------~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                                 +. ...++|+.|.|||++.. ..|+...|.|++|+|+|+.+.|+.||.+..+.+...........-   
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w---  277 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW---  277 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc---
Confidence                       11 22478999999999877 789999999999999999999999999998888777665532221   


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHHcCcccccCc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  293 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~ell~h~~f~~~~  293 (336)
                                               ++....++++++++|.++|+.+|..|.   .+-++-+|+||+.+.
T Consensus       278 -------------------------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  278 -------------------------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             -------------------------cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence                                     222356789999999999999999997   667788999999874

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.7e-23  Score=169.78  Aligned_cols=143  Identities=17%  Similarity=0.138  Sum_probs=112.7

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChh------------------------HHHHHHHHHHHHhhCCCC
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNII------------------------DARRTLREIKLLRHMEHE   60 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~hp   60 (336)
                      |.+.||+|++|.||+|.+. +|+.||||++........                        .......|+..+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4688999999999999997 899999999865421100                        012234789999999999


Q ss_pred             ceeeecceecCCCCCCcceEEEEEecCCcc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEc
Q 019728           61 NVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN  138 (336)
Q Consensus        61 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~  138 (336)
                      ++.....+....       .|+||||++|. +........+++..++..++.|++.++.++|+ .||+|+||||+||+++
T Consensus        80 ~i~~p~~~~~~~-------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          80 GVPVPEPILLKK-------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCCceEEEecC-------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            876554443322       48999999873 44333344678889999999999999999999 9999999999999999


Q ss_pred             cCCCEEEEeccCCcccCC
Q 019728          139 ASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~  156 (336)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999876654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-23  Score=176.04  Aligned_cols=207  Identities=21%  Similarity=0.283  Sum_probs=150.1

Q ss_pred             CCCceeeecceecCCCC----------------------CCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 019728           58 EHENVIAIKDIIRPPKK----------------------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR  115 (336)
Q Consensus        58 ~hp~iv~~~~~~~~~~~----------------------~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~  115 (336)
                      +|||||++...|.+.-+                      .....+|+||..+..+|+.++-.+ ..+....+-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence            49999999988765321                      112458999999999999999764 4566677778999999


Q ss_pred             HHHHHHhCCeeccCCCCCCeEEc--cCC--CEEEEeccCCcccCCCC-------cccceeeeecccCchhcccCCC----
Q 019728          116 GLKYVHSASVLHRDLKPSNLLLN--ASC--DLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLLNCTE----  180 (336)
Q Consensus       116 ~l~~LH~~~i~H~dlkp~nil~~--~~~--~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~----  180 (336)
                      |+.|||++|+.|||+|.+|||+.  +++  .+.|.|||.+-.-....       ......|.-..||||+...-..    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999983  333  37899999764322211       1223456777899999764211    


Q ss_pred             -CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCC
Q 019728          181 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS  259 (336)
Q Consensus       181 -~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
                       .-.++|.|+.|.+.||++....||...........                             .-+....+......+
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-----------------------------~Yqe~qLPalp~~vp  483 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-----------------------------TYQESQLPALPSRVP  483 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchheechh-----------------------------hhhhhhCCCCcccCC
Confidence             12379999999999999999999987442211100                             011233445556779


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHH---HHc------CcccccCcC
Q 019728          260 SGAVDLLEKMLVFDPNKRITVEE---ALR------HPYLQSLHD  294 (336)
Q Consensus       260 ~~~~~li~~~L~~dp~~Rpt~~e---ll~------h~~f~~~~~  294 (336)
                      +.+++++..+|+.||++|+++.-   +++      |.|++.+.+
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~  527 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMME  527 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcc
Confidence            99999999999999999997643   332      666666543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.1e-21  Score=156.99  Aligned_cols=185  Identities=14%  Similarity=0.034  Sum_probs=136.2

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCccc--ChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      -+...|+.|+||+|+++..  .+.+++.+.+.....  .......+.+|+++|+++. ++++++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            3567899999999997777  577788777754322  1222335678999999995 5889999885         226


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC-CCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl-kp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |++|||+.| +|...+..      . ...++.|++.++.++|++||+|+|| ||+||+++.++.++|+|||++.......
T Consensus        74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999999987 66543311      1 1357789999999999999999999 7999999999999999999998655433


Q ss_pred             cc--------------cceeeeecccCchhcccCCCCC-ccchHHHHHHHHHHHHhCCCCCCC
Q 019728          159 FM--------------TEYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGEIMTREPLFPG  206 (336)
Q Consensus       159 ~~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~  206 (336)
                      ..              .....++.+++|+...-....+ ...+.++.|+-+|.++|+..+.-+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            11              0012355677777654433334 567888999999999999987643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.4e-21  Score=186.38  Aligned_cols=188  Identities=18%  Similarity=0.229  Sum_probs=152.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC---CCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~~~   78 (336)
                      .|.|.+.||.|++|+||.|.+.. |+.||+|+-+....-     .+.==.+++.+|+   -+.|..+...+...     +
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~-----~  767 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQ-----N  767 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccC-----C
Confidence            57899999999999999999987 999999987543211     1122234455555   34555666665555     4


Q ss_pred             eEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-------CCCEEEEeccC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCDLKIGDFGL  150 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-------~~~~kl~dfg~  150 (336)
                      ..++|++|.+ |+|.+++..++..++..+..++.|++..|..||..+|+||||||+|+|+..       ..-++|+|||.
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            5799999998 899999998889999999999999999999999999999999999999932       23499999998


Q ss_pred             CcccC---CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC
Q 019728          151 ARTTS---ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       151 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  201 (336)
                      +-.+.   ....+....++-.+-.+|...| .+|++..|.|.|..+++-||.|+
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence            86532   2234455677888999999988 99999999999999999999998

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=1e-20  Score=154.27  Aligned_cols=137  Identities=18%  Similarity=0.167  Sum_probs=106.6

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-----CCCceeeecceecCCCCCCcce
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      =.+.||+|++|.||.  +..++.. +||++....  ......+.+|+.+++.+     .||||+++++++..+...  ..
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~--g~   78 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT--GY   78 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC--eE
Confidence            357899999999995  7666665 699886532  22456788999999999     579999999999887432  23


Q ss_pred             EE-EEEecCC---ccHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCeeccCCCCCCeEEccC----CCEEEEeccC
Q 019728           80 VY-IVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGL-KYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGL  150 (336)
Q Consensus        80 ~~-iv~e~~~---g~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~i~H~dlkp~nil~~~~----~~~kl~dfg~  150 (336)
                      ++ +|+||++   |+|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+||+++..    +.++|+|++.
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            34 7899954   5999999763 56665  35678888777 89999999999999999999743    3799999543


Q ss_pred             C
Q 019728          151 A  151 (336)
Q Consensus       151 ~  151 (336)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=4.1e-21  Score=160.42  Aligned_cols=144  Identities=14%  Similarity=0.070  Sum_probs=111.9

Q ss_pred             cceeeeecccceEEEEEEE-eCCCCceEEEEEecCcccCh--------------------h--HHHHHHHHHHHHhhCCC
Q 019728            3 VKLRGEYDDIIFFIFSAAV-NSETREEVAIKKIGNAFDNI--------------------I--DARRTLREIKLLRHMEH   59 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~-~~~~~~~vaiK~~~~~~~~~--------------------~--~~~~~~~e~~~l~~l~h   59 (336)
                      |.+.+.||.|++|.||.|. +..+|+.||+|++.......                    .  ....+..|+.+++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6789999999999999999 66789999999986432110                    0  11234579999999975


Q ss_pred             C--ceeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCCCCe
Q 019728           60 E--NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNL  135 (336)
Q Consensus        60 p--~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dlkp~ni  135 (336)
                      .  .+.++++.   .      ..++||||++| +|.........+...++..++.||+.++++||+.| ++|+||||+||
T Consensus       110 ~~i~~p~~~~~---~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW---R------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe---c------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            3  33344432   1      24899999997 56555544556677778899999999999999999 99999999999


Q ss_pred             EEccCCCEEEEeccCCcccCC
Q 019728          136 LLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       136 l~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +++ ++.++|+|||.+...+.
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 88899999998765543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=1.3e-21  Score=171.99  Aligned_cols=175  Identities=27%  Similarity=0.467  Sum_probs=137.2

Q ss_pred             ceEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      ..+||.|++|. .+|.+||..++   ..+...+..++.|+..|+.|   +|.+|+|+||.||++..+..+||+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35899999998 69999997543   35777899999999999999   9999999999999999999999999999876


Q ss_pred             cCCCC-------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCc
Q 019728          154 TSETD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       154 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                      .....       ......||.+||+||.+.+ ..++.++|||+||++++|++.-. .++      +.....         
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~---------  469 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF------ERIATL---------  469 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhh---------
Confidence            55443       3455688999999999998 89999999999999999999722 111      111111         


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                        ...+...+++.+..--+.-..|+.+||.+.|.+||++.+.-.|.|.
T Consensus       470 ------------------~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  470 ------------------TDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ------------------hhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                              1122333333334445556799999999999999988888777774

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=162.85  Aligned_cols=203  Identities=25%  Similarity=0.346  Sum_probs=152.6

Q ss_pred             HhhCCCCceeeecceecCCCCCCcceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCe-eccCC
Q 019728           54 LRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASV-LHRDL  130 (336)
Q Consensus        54 l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i-~H~dl  130 (336)
                      |+.+.|.|+.++++.....     ...++|.+||. |+|.+.+.. .-.++......++++|+.|++|||..-| +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4578899999999999988     66999999998 899999977 3457888888899999999999999866 99999


Q ss_pred             CCCCeEEccCCCEEEEeccCCcccCCC---CcccceeeeecccCchhcccC--CC----CCccchHHHHHHHHHHHHhCC
Q 019728          131 KPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC--TE----YTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       131 kp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~----~~~~~DiwslG~il~~ll~g~  201 (336)
                      ++.|++++....+||+|||+.......   ...........|.|||.+.+.  ..    .+.+.|+||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999988766421   111122235569999998763  11    467899999999999999999


Q ss_pred             CCCCCCChH----HHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCC
Q 019728          202 PLFPGKDYV----HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  277 (336)
Q Consensus       202 ~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  277 (336)
                      .||......    +.+..+.+....+..+.                       ... .....+++..+++.||..+|.+|
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~-----------------------i~~-~~e~~~~l~~l~~~cw~e~P~~r  211 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPS-----------------------IEL-LNELPPELLLLVARCWEEIPEKR  211 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcc-----------------------hhh-hhhcchHHHHHHHHhcccChhhC
Confidence            999764322    22222222000000000                       000 01345579999999999999999


Q ss_pred             CCHHHHHc
Q 019728          278 ITVEEALR  285 (336)
Q Consensus       278 pt~~ell~  285 (336)
                      |+++.+-.
T Consensus       212 Ps~~~i~~  219 (484)
T KOG1023|consen  212 PSIEQIRS  219 (484)
T ss_pred             ccHHHHHh
Confidence            99998854

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=5.6e-19  Score=146.10  Aligned_cols=137  Identities=22%  Similarity=0.183  Sum_probs=110.9

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccC------hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      ++.||.|++|.||++.+  .|..+++|+.......      ........+|+.++..+.|+++..+..++...     ..
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~   73 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN   73 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence            36799999999999988  6788999976533211      11234567899999999999887776665544     44


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      .+++|||++| +|.+++.....    ....++.+++.++++||+.|++|+|++|.||+++ ++.++|+|||.+...
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            7899999986 89888865332    7888999999999999999999999999999999 788999999988653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=4.8e-21  Score=178.90  Aligned_cols=259  Identities=26%  Similarity=0.337  Sum_probs=207.0

Q ss_pred             ccceeeeecccceEEEEEEEeC-CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+.+.||.|+++.|-++... .+...+|.|.+...............|..+...+. |+|++.+++.....     ..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----RS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----cc
Confidence            4788999999999999888874 34455778877655445556666777888888887 99999999998887     66


Q ss_pred             EEEEEecCCc-cHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCCCCeEEccCC-CEEEEeccCCccc
Q 019728           80 VYIVYELMDT-DLHQII-RSDQ-QLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASC-DLKIGDFGLARTT  154 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (336)
                      .++++++..| ++.+-+ .... ..+...+..++.|+..++.|+| ..+++|+|++|+|.+++..+ .+++.|||++...
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            8999999875 888888 5554 6778888899999999999999 99999999999999999999 9999999998765


Q ss_pred             CC-C---Ccccceee-eecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          155 SE-T---DFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       155 ~~-~---~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      .. .   ......+| ++.|+|||...+.....+..|+||+|+++..+++|..|+.........  .             
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~-------------  240 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--Y-------------  240 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--c-------------
Confidence            54 2   22344567 999999999987567788999999999999999999999765432210  0             


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                 ......+.......+..++....+++.+++..+|..|.+.+++-.++|+..
T Consensus       241 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 -----------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----------eeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                       000000111123445677889999999999999999999999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=9.4e-19  Score=143.12  Aligned_cols=138  Identities=18%  Similarity=0.147  Sum_probs=105.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh--------------------hHHHHHHHHHHHHhhCCCCc-
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI--------------------IDARRTLREIKLLRHMEHEN-   61 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~hp~-   61 (336)
                      |.+.+.||.|++|.||++.+. +|+.||||++.......                    ........|+.++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            678899999999999999885 79999999875432110                    01123567888898887774 


Q ss_pred             -eeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           62 -VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        62 -iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                       +..+++.         ...+++|||++| +|......      .....++.+++.++.++|+.|++|+||+|.||++++
T Consensus        96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCceeec---------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence             3333321         235899999987 66554321      345678899999999999999999999999999999


Q ss_pred             CCCEEEEeccCCcccCC
Q 019728          140 SCDLKIGDFGLARTTSE  156 (336)
Q Consensus       140 ~~~~kl~dfg~~~~~~~  156 (336)
                      ++.++|+|||.+.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.7e-18  Score=140.71  Aligned_cols=132  Identities=23%  Similarity=0.228  Sum_probs=102.7

Q ss_pred             eecccceEEEEEEEeCCCCceEEEEEecCcc-cC-----hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            8 EYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DN-----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .||+|++|.||++..  ++..+++|...... ..     ......+.+|+.++..++|+++.....+....     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            489999999999995  67889999864321 11     12235667899999999887655444443333     3368


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      ++|||++| +|.+.+.....       .++.+++.++++||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999986 88887754321       7889999999999999999999999999999 789999999987654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=5.7e-18  Score=137.31  Aligned_cols=139  Identities=19%  Similarity=0.192  Sum_probs=98.0

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHH----------------------HHHHHHHhhCCCCc-
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRT----------------------LREIKLLRHMEHEN-   61 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~hp~-   61 (336)
                      +.+.||+|++|+||.|.+. +++.||||++.............                      ..|...+..+.+.. 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            4678999999999999986 89999999886533222111111                      24555565554332 


Q ss_pred             -eeeecceecCCCCCCcceEEEEEecCCc-cHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEE
Q 019728           62 -VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLL  137 (336)
Q Consensus        62 -iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~-~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~  137 (336)
                       +.++++.         ...+++|||++| ++. ..+... .. ..++..++.+++.++.++|. .|++|+||+|+||++
T Consensus        80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCCceEec---------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence             3333332         225899999987 221 111111 11 16788899999999999999 999999999999999


Q ss_pred             ccCCCEEEEeccCCcccCC
Q 019728          138 NASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       138 ~~~~~~kl~dfg~~~~~~~  156 (336)
                      + ++.++|+|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 88999999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.3e-17  Score=156.36  Aligned_cols=137  Identities=19%  Similarity=0.197  Sum_probs=106.9

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEe-cCccc-----ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKI-GNAFD-----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~-~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      |...+.||+|++|+||++.+.  +..+++|+. .+...     .......+.+|+.+++.++|++++.+..+....    
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~----  408 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP----  408 (535)
T ss_pred             cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC----
Confidence            345789999999999999874  334454433 22111     112345677899999999999998876665554    


Q ss_pred             cceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           77 FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        77 ~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ...++||||++| +|.+++.        ....++.+++.++++||+.|++||||||+||++ .++.++|+|||+++...
T Consensus       409 -~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        409 -EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             -CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence             346899999986 8988875        356788999999999999999999999999999 67789999999987643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.5e-17  Score=149.02  Aligned_cols=251  Identities=25%  Similarity=0.252  Sum_probs=200.2

Q ss_pred             ccceeeeecc--cceEEEEEEEe--CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDD--IIFFIFSAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~--G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~   76 (336)
                      ++.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.....+.....-.+|+...+.++ |++.++.+..+...    
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~----  190 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS----  190 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC----
Confidence            3567788999  99999999999  899999999987666555555666678888888885 99999977777666    


Q ss_pred             cceEEEEEecCCccHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccC
Q 019728           77 FNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR----GLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGL  150 (336)
Q Consensus        77 ~~~~~iv~e~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~----~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~  150 (336)
                       ...++-+|+|+.+|.++...... ++...++..+.+..+    |+.++|+.+++|.|++|+||++..+ ...+++|||+
T Consensus       191 -~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 -GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             -CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence             66899999999999999877655 789999999999999    9999999999999999999999999 8899999999


Q ss_pred             CcccCCCCccc-ce-----eeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCC
Q 019728          151 ARTTSETDFMT-EY-----VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRLITELIGS  222 (336)
Q Consensus       151 ~~~~~~~~~~~-~~-----~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~  222 (336)
                      ....+...... ..     .+...|++||+..+  -++..+|+++||.++.+..++..+....  ..-.++         
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---------  338 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---------  338 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---------
Confidence            87776654322 22     45667999999874  7789999999999999998876555332  110000         


Q ss_pred             CCcccccccccchHHHHHHhCCccccccc-cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          223 PDDASLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                              +...+ .+.....+.++...+.+|++.+|..|++.+.+++|++..+.
T Consensus       339 ------------------------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  339 ------------------------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ------------------------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                    00011 12223567778889999999999999999999999998754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.9e-16  Score=132.55  Aligned_cols=140  Identities=15%  Similarity=0.128  Sum_probs=105.1

Q ss_pred             eeec-ccceEEEEEEEeCCCCceEEEEEecCcc-----------cChhHHHHHHHHHHHHhhCCCCce--eeecceecCC
Q 019728            7 GEYD-DIIFFIFSAAVNSETREEVAIKKIGNAF-----------DNIIDARRTLREIKLLRHMEHENV--IAIKDIIRPP   72 (336)
Q Consensus         7 ~~lg-~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~e~~~l~~l~hp~i--v~~~~~~~~~   72 (336)
                      ..|| .|+.|+||.+...  +..+++|.+....           .+......+.+|+.++..++|+++  ++++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8999999999884  7889999874311           012334567789999999988775  5666654332


Q ss_pred             CCCCcceEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           73 KKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        73 ~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      .. .....++|||+++|  +|.+++.. .++++..    +.+|+.++++||+.||+|+||||.|||++.++.++|+|||.
T Consensus       115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            11 11224699999985  88888765 4555543    56899999999999999999999999999989999999998


Q ss_pred             Cccc
Q 019728          151 ARTT  154 (336)
Q Consensus       151 ~~~~  154 (336)
                      +...
T Consensus       189 ~~~~  192 (239)
T PRK01723        189 GELR  192 (239)
T ss_pred             cccC
Confidence            7654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=4.7e-16  Score=121.38  Aligned_cols=131  Identities=18%  Similarity=0.157  Sum_probs=107.7

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC--CceeeecceecCCCCCCcceEEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      +.+.||.|.++.||++.+..  +.+++|.......    ...+..|+.+++.+++  +++.+++.+....     ...++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL   70 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence            56889999999999999843  7899998855422    4567789999999976  5888888877655     45899


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      +|||++| .+..+       +......++.+++.+++.||..   +++|+|++|.||+++..+.++++||+.+..
T Consensus        71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999987 44332       4566677889999999999985   699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.64  E-value=5.4e-15  Score=134.24  Aligned_cols=169  Identities=18%  Similarity=0.351  Sum_probs=129.9

Q ss_pred             EEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCCccHHHHHHcC
Q 019728           19 AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD   98 (336)
Q Consensus        19 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~   98 (336)
                      .+..+.++.+|.+...+...  ........+.++.++.++||||+++++.+...     ...|+|+|.+. .|..++.. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~-Pl~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVR-PLETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeeccc-cHHHHHHH-
Confidence            45666788999999886543  25567788899999999999999999999887     67999999986 34444433 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-ccceeeeecccCchhcc
Q 019728           99 QQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLL  176 (336)
Q Consensus        99 ~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~  176 (336)
                        +...++...+.||+.||.+|| +.+++|++|..+.|+|+..|..||++|.++........ ......-..|..|+...
T Consensus       101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence              337788888999999999997 67899999999999999999999999987654433221 12222233466776553


Q ss_pred             cCCCCCccchHHHHHHHHHHHHhCC
Q 019728          177 NCTEYTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       177 ~~~~~~~~~DiwslG~il~~ll~g~  201 (336)
                      .   -.-+.|.|.|||++++++.|.
T Consensus       179 ~---s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  179 P---SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c---cccchhhhhHHHHHHHHhCcc
Confidence            3   114579999999999999993

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=5e-16  Score=129.32  Aligned_cols=210  Identities=22%  Similarity=0.246  Sum_probs=149.1

Q ss_pred             HHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019728           50 EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSAS  124 (336)
Q Consensus        50 e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~  124 (336)
                      -+..+-++-|.|||+++.|..+..........++.||+. |++.++|+..    ..+....-++|+.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            345566667999999999988766544466889999997 7999998653    45778888899999999999999985


Q ss_pred             --eeccCCCCCCeEEccCCCEEEEeccCCcc--cCCC---CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHH
Q 019728          125 --VLHRDLKPSNLLLNASCDLKIGDFGLART--TSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  197 (336)
Q Consensus       125 --i~H~dlkp~nil~~~~~~~kl~dfg~~~~--~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  197 (336)
                        |+|+++.-+.|++..+|-+|++.......  ....   .-.....+.+.|.+||.-.. ...+.++|||++|++..+|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence              99999999999999999888864322111  0000   01112244567889986544 5677899999999999999


Q ss_pred             HhCCCCC-CCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC
Q 019728          198 MTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  276 (336)
Q Consensus       198 l~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  276 (336)
                      ..+..-- .+......-..+...+.                                  ....+.-++++.+||+..|..
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~----------------------------------~len~lqr~~i~kcl~~eP~~  321 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVII----------------------------------GLENGLQRGSITKCLEGEPNG  321 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhee----------------------------------eccCccccCcCcccccCCCCC
Confidence            8887432 11111111111111110                                  011222457899999999999


Q ss_pred             CCCHHHHHcCcccccCcC
Q 019728          277 RITVEEALRHPYLQSLHD  294 (336)
Q Consensus       277 Rpt~~ell~h~~f~~~~~  294 (336)
                      ||++.+++.||.+..++-
T Consensus       322 rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  322 RPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             CcchhhhhcCceeeecch
Confidence            999999999999988763

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.59  E-value=1.3e-14  Score=116.35  Aligned_cols=141  Identities=17%  Similarity=0.211  Sum_probs=101.5

Q ss_pred             eeeeecccceEEEEEEEeCC------CCceEEEEEecCcc----------------c----ChhHHHHHH----HHHHHH
Q 019728            5 LRGEYDDIIFFIFSAAVNSE------TREEVAIKKIGNAF----------------D----NIIDARRTL----REIKLL   54 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~----------------~----~~~~~~~~~----~e~~~l   54 (336)
                      +...||.|..+.||.|....      .+..+|||+..-..                .    .......+.    +|+..|
T Consensus         1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            45789999999999998754      35789999773210                0    011222333    799999


Q ss_pred             hhCC--CCceeeecceecCCCCCCcceEEEEEecCCcc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeccCC
Q 019728           55 RHME--HENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDL  130 (336)
Q Consensus        55 ~~l~--hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~i~H~dl  130 (336)
                      +++.  .-++.+++++ .        .-++||||++++ +..-......+++.+...+..+++.++..| |+.|++|+||
T Consensus        81 ~rl~~~Gv~vP~pi~~-~--------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          81 KRMQKAGIPCPEVVVL-K--------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHHHcCCCCCeEEEe-c--------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            9995  3456666654 1        248999999863 322112223456667778889999999988 8999999999


Q ss_pred             CCCCeEEccCCCEEEEeccCCcccC
Q 019728          131 KPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus       131 kp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ++.||+++ ++.+.|+|||.+...+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4679999999886654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.56  E-value=1.1e-15  Score=144.53  Aligned_cols=257  Identities=21%  Similarity=0.224  Sum_probs=192.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +.+.+.+-+|.++.++.+.-..+|...++|...... ...........+-.++-..++|.++.....+...     ...+
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r-----sP~~  880 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR-----SPLP  880 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC-----CCcc
Confidence            456678889999999999998889887877654321 1111223333444444445567777666554433     4589


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC---
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (336)
                      ++++|.+| +|...+++.+..+++-++..+..+..++.+||...+.|+|++|.|.+...+|..++.||+.....+..   
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            99999974 99999998888888889999999999999999999999999999999999999999999732211100   


Q ss_pred             -----------------------------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 019728          158 -----------------------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  208 (336)
Q Consensus       158 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  208 (336)
                                                   .......+++.|.+||...+ ......+|.|++|+++++.++|..||....
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                                         00122356888999999988 778889999999999999999999998876


Q ss_pred             hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH---HHHc
Q 019728          209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE---EALR  285 (336)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---ell~  285 (336)
                      .......+...                            ....+......+.++++++..+|..+|.+|..+.   ++-.
T Consensus      1040 pq~~f~ni~~~----------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~ 1091 (1205)
T KOG0606|consen 1040 PQQIFENILNR----------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKG 1091 (1205)
T ss_pred             hhhhhhccccC----------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCccccccccc
Confidence            55444333221                            1111222335688999999999999999999887   8889


Q ss_pred             CcccccCc
Q 019728          286 HPYLQSLH  293 (336)
Q Consensus       286 h~~f~~~~  293 (336)
                      |+||+...
T Consensus      1092 ~~~~~~~~ 1099 (1205)
T KOG0606|consen 1092 HPFFQDVD 1099 (1205)
T ss_pred             CCccCCCC
Confidence            99999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.5e-14  Score=130.01  Aligned_cols=249  Identities=21%  Similarity=0.187  Sum_probs=183.8

Q ss_pred             ccceeeeecccceEEEEEEEeC-CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.++..||.|.++.|+..... ..+..|++|...+...........+.|+.+...+. |.+++..+..+...     .+
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----r~  340 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----RQ  340 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----cc
Confidence            4678899999999999887765 77889999998777666655666667888877774 89999888777666     45


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCcccCCC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSET  157 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~  157 (336)
                      .|+=-|||.| ++...+.....+.+...+++..|++.++.++|+..++|+|++|+||++..+ +..+++||+........
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            7899999974 544444333457888999999999999999999999999999999999876 77889999987652221


Q ss_pred             Ccccceeeeeccc-CchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 DFMTEYVVTRWYR-APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        .....+..++. .+|.+.....+..+.|+++||.-+.+.+++...-........                        
T Consensus       421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~------------------------  474 (524)
T KOG0601|consen  421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT------------------------  474 (524)
T ss_pred             --cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee------------------------
Confidence              11222333444 356665557889999999999999999998743222111000                        


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                ......+..+.....+..+.+.++..|+..||.+.++..|.=|..
T Consensus       475 ----------i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  475 ----------IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ----------eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                      011112233444578889999999999999999999988765543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=3.5e-13  Score=122.58  Aligned_cols=142  Identities=20%  Similarity=0.225  Sum_probs=95.3

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhH------------------------H--------------HHHH
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIID------------------------A--------------RRTL   48 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~--------------~~~~   48 (336)
                      +.||+|+.|.||+|... +|+.||||+........-.                        .              -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999985 7999999998543111000                        0              0122


Q ss_pred             HHHHHHhhC----CCCceeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 019728           49 REIKLLRHM----EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLR-GLKYVH  121 (336)
Q Consensus        49 ~e~~~l~~l----~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~LH  121 (336)
                      .|...+.++    ++.+-+.+..++...+    ...+++|||++| +|.+..... ....   ...++.+++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            345445554    2333344444443221    236999999987 777665421 1222   2345555555 467899


Q ss_pred             hCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728          122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       122 ~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|++|+|++|.||+++.+++++++|||.+...+.
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            99999999999999999999999999999876653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=8.3e-14  Score=128.15  Aligned_cols=143  Identities=14%  Similarity=0.219  Sum_probs=94.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC---------------------------h-----hHHHHH---
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN---------------------------I-----IDARRT---   47 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------------~-----~~~~~~---   47 (336)
                      |.. +.||+|+.|.||.|..+.+|+.||||+.......                           .     +....+   
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            444 6899999999999999888999999998643100                           0     011112   


Q ss_pred             ---HHHHHHHhhCC----CCceeeecceecCCCCCCcceEEEEEecCCc-cHHHH--HHcCC----CCCHHHHHHHHHHH
Q 019728           48 ---LREIKLLRHME----HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI--IRSDQ----QLTDDHCQYFLYQL  113 (336)
Q Consensus        48 ---~~e~~~l~~l~----hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~--l~~~~----~~~~~~~~~i~~qi  113 (336)
                         .+|...+.+++    +.+.+.+..++.+-+    ...++||||++| .+.+.  +...+    .+.+..+..++.|+
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence               23443444442    344444444443321    336899999987 77653  33322    24444455555555


Q ss_pred             HHHHHHHHhCCeeccCCCCCCeEEccCC----CEEEEeccCCcccCCC
Q 019728          114 LRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSET  157 (336)
Q Consensus       114 ~~~l~~LH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~~~~~~  157 (336)
                      +       ..|++|+|++|.||+++.+|    +++++|||.+...+..
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            4       58999999999999999888    8999999998766543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.3e-13  Score=108.41  Aligned_cols=127  Identities=17%  Similarity=0.112  Sum_probs=92.6

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCce-eeecceecCCCCCCcceEEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ++.|+.|..+.||.+...  ++.|++|.......   .......|+.+++.+.+.++ .+++.....       ..++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEE
Confidence            468899999999999874  78899998754321   12334678888888864443 345444321       247999


Q ss_pred             ecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           85 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV-----LHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        85 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-----~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      |+++| ++...        ......++.+++.+++.||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99997 54332        11123456799999999999985     9999999999999 66799999997753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.44  E-value=8.3e-12  Score=110.56  Aligned_cols=216  Identities=13%  Similarity=0.194  Sum_probs=158.0

Q ss_pred             ceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCCc--c
Q 019728           13 IFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--D   90 (336)
Q Consensus        13 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g--~   90 (336)
                      ...+.|++....+|..|++|.++..  ......+...-+++++++.|+|+|++.+++.... -+...+++|++|.++  +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~--r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGD--RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccc--cccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence            5568899999999999999999432  1122233446678999999999999999998432 233568999999984  8


Q ss_pred             HHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           91 LHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        91 L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      |.+..-.               +...++..+|.++.|+..||.++|+.|+..+-|.|.+|+++.+.+++|+..|......
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            8887522               2347889999999999999999999999999999999999999999999888766554


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      ...           .+|  +.    -..+-|.=.||.++..|.+|..---..+ ..+-.                     
T Consensus       445 ~d~-----------~~~--le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d-~~~~s---------------------  485 (655)
T KOG3741|consen  445 EDP-----------TEP--LE----SQQQNDLRDLGLLLLALATGTENSNRTD-STQSS---------------------  485 (655)
T ss_pred             CCC-----------Ccc--hh----HHhhhhHHHHHHHHHHHhhccccccccc-chHHH---------------------
Confidence            442           111  21    1345689999999999999973211111 11100                     


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                    ......+.++.+++++|.-+...++.+ -++.+++.
T Consensus       486 --------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  486 --------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             --------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                          011223466888899999888888876 77777775

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=3.2e-12  Score=99.11  Aligned_cols=132  Identities=20%  Similarity=0.212  Sum_probs=95.8

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEe-cCcccChhH-----HHHHHHHHHHHhhCCCCc--eeeecceecCCCCCCcc
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKI-GNAFDNIID-----ARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~-~~~~~~~~~-----~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~~~~~   78 (336)
                      ..++.|+-+.++.+..  -|..+++|.= ++....+.-     ..+..+|+.++.+++--.  ...++++...       
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-------   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-------   72 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-------
Confidence            4678999999999866  3455677743 333333332     344557999999886433  3445554443       


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...|+|||.+| .|.+.+...       ...++..+-.-+.-||..||+|+||.++||+++..+ +.++|||++....
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            36899999998 666677664       134667788888999999999999999999998775 9999999987443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=6.4e-12  Score=97.08  Aligned_cols=143  Identities=20%  Similarity=0.207  Sum_probs=105.3

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEe-cCcccC-----hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKI-GNAFDN-----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~-~~~~~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      ....+-+|+.+.|+.+.+  .|+..+||.- .+....     .-...+..+|+.++.++.--.|....-++.+.     .
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence            356788999999999888  6888888843 233222     23345566899999998754555444455444     3


Q ss_pred             eEEEEEecCCc--cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccCC
Q 019728           79 DVYIVYELMDT--DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLA  151 (336)
Q Consensus        79 ~~~iv~e~~~g--~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~  151 (336)
                      .-.++||+++|  ++.+++.+..  .........+++.|-+.+.-||..+|+||||.++||++..++.   +.++|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            35899999998  8899887642  2233333678899999999999999999999999999966553   589999998


Q ss_pred             ccc
Q 019728          152 RTT  154 (336)
Q Consensus       152 ~~~  154 (336)
                      ...
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.36  E-value=5e-11  Score=103.29  Aligned_cols=256  Identities=9%  Similarity=0.024  Sum_probs=161.3

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceee----ecceecCCCCCCcc
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIA----IKDIIRPPKKDTFN   78 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~----~~~~~~~~~~~~~~   78 (336)
                      .+.+.||.|+.+.+|..-.   -..-+.|++..+...    .+ .+.+..|... .||-+..    ........  ++..
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa----~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPA----AQ-AQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGK   83 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCch----HH-HHHHHHhccCCCCcchhhhhcccHHHhhCC--Cccc
Confidence            4578899999999985433   223456877654321    11 1222333333 4554332    11111111  1113


Q ss_pred             eEEEEEecCCc--cHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           79 DVYIVYELMDT--DLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        79 ~~~iv~e~~~g--~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      -+.++|+...|  ....++..      -....++...+..+.++.+.+.||..|.+-||+.++|+|+++++.+.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            37899999976  56665532      23478899999999999999999999999999999999999999999998765


Q ss_pred             CcccCCCCcccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCc
Q 019728          151 ARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                      -....+.....-..+...|++||...-    .-.-+..+|.|.||++++++|.| ..||.+....         ...+++
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~---------~~ap~p  234 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI---------SDAPNP  234 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc---------CCCCCc
Confidence            555555544455578889999997641    13457789999999999999886 8999775310         000000


Q ss_pred             ccccccccchHHHHHHhCC---ccccccccccCCCCChhHHHHHHHhcCC--CCCCCCCHHH
Q 019728          226 ASLGFLRSDNARRYVRQLP---RCRKQQFATRFPNKSSGAVDLLEKMLVF--DPNKRITVEE  282 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~e  282 (336)
                      .. ....   ...|...-.   ..+.......+.-++++++.+..+|+..  ++.-|||++.
T Consensus       235 ~E-~~Ia---~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         235 LE-TDIA---HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             ch-hhhh---cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            00 0000   001111111   1111122223345788999999999984  3568998754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.27  E-value=1.5e-10  Score=98.10  Aligned_cols=136  Identities=13%  Similarity=0.066  Sum_probs=93.3

Q ss_pred             EEEEEEeCCCCceEEEEEecCcccCh---------hHHHHHHHHHHHHhhCCCCce--eeecceecCCCCCCcceEEEEE
Q 019728           16 IFSAAVNSETREEVAIKKIGNAFDNI---------IDARRTLREIKLLRHMEHENV--IAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus        16 ~v~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i--v~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      .|+.+..  .|+.|.||.........         .....+.+|+..+.++..-+|  +.+.++............++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555544  57789999763321110         011136688888888743333  3334444322211124578999


Q ss_pred             ecCCc--cHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-------CCCEEEEeccCCcc
Q 019728           85 ELMDT--DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCDLKIGDFGLART  153 (336)
Q Consensus        85 e~~~g--~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-------~~~~kl~dfg~~~~  153 (336)
                      |+++|  +|.+++..  ..+.+......++.+++..++-||..|++|+|+++.|||++.       +..+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99987  78888854  345667788899999999999999999999999999999975       46799999997753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.27  E-value=6.7e-11  Score=97.32  Aligned_cols=140  Identities=17%  Similarity=0.137  Sum_probs=104.1

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCc------------------ccC--hhHHHHHHHHHHHHhhCCCC--c
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA------------------FDN--IIDARRTLREIKLLRHMEHE--N   61 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~------------------~~~--~~~~~~~~~e~~~l~~l~hp--~   61 (336)
                      .++.+||-|.-|.||.|.+. .|.++|||.=...                  ..+  ........+|+.+|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            57889999999999999995 7999999954111                  111  22334556899999998644  6


Q ss_pred             eeeecceecCCCCCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           62 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        62 iv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      +.++++.         +.-.+|||+++|.....+    +++......++..|++-+..+-..|++|+|+++-||+++++|
T Consensus       173 VP~P~~~---------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW---------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc---------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence            6677665         446899999998332222    223555566777788877777799999999999999999999


Q ss_pred             CEEEEeccCCcccCCC
Q 019728          142 DLKIGDFGLARTTSET  157 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~  157 (336)
                      .+.++||-.+...+.+
T Consensus       240 ~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         240 DIVVIDWPQAVPISHP  255 (304)
T ss_pred             CEEEEeCcccccCCCC
Confidence            9999999877655433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=6.1e-11  Score=98.68  Aligned_cols=143  Identities=16%  Similarity=0.181  Sum_probs=101.7

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC--CceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.|+.|..+.+|++.... |+.+++|........ ........|..+++.+++  .++.+++.+.....  ..+..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence            678999999999998743 688999987543221 234567889999999975  34566666655432  112468999


Q ss_pred             ecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 019728           85 ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-----------------------------------------  122 (336)
Q Consensus        85 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-----------------------------------------  122 (336)
                      |+++| ++.+.+.. ..++......++.+++.+++.||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99987 55444321 345666666667777777777763                                         


Q ss_pred             ---------------CCeeccCCCCCCeEEcc--CCCEEEEeccCCccc
Q 019728          123 ---------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTT  154 (336)
Q Consensus       123 ---------------~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~  154 (336)
                                     ..++|+|+.|.||+++.  ++.+.|+||+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                           24799999999999998  566899999977544

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=1.2e-10  Score=93.11  Aligned_cols=128  Identities=23%  Similarity=0.256  Sum_probs=82.2

Q ss_pred             EEEEEEeCCCCceEEEEEecCcc------------------------cChhHHHHHHHHHHHHhhCCCC--ceeeeccee
Q 019728           16 IFSAAVNSETREEVAIKKIGNAF------------------------DNIIDARRTLREIKLLRHMEHE--NVIAIKDII   69 (336)
Q Consensus        16 ~v~~~~~~~~~~~vaiK~~~~~~------------------------~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~   69 (336)
                      .||.|.. ..|..+|+|+.....                        ..........+|+..|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888888 467899999773210                        0111124445799999999754  566666553


Q ss_pred             cCCCCCCcceEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCeeccCCCCCCeEEccCCCEEEE
Q 019728           70 RPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY-VHSASVLHRDLKPSNLLLNASCDLKIG  146 (336)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~i~H~dlkp~nil~~~~~~~kl~  146 (336)
                      .         -++||||++  |.....+... .++..+...++.+++..+.. +|+.||+||||++.||+++++ .+.++
T Consensus        80 ~---------~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 R---------NVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             T---------TEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred             C---------CEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence            1         389999998  7333333321 12245566778888885554 689999999999999999888 89999


Q ss_pred             eccCCcccC
Q 019728          147 DFGLARTTS  155 (336)
Q Consensus       147 dfg~~~~~~  155 (336)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999876554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=7.5e-12  Score=114.52  Aligned_cols=153  Identities=22%  Similarity=0.324  Sum_probs=110.3

Q ss_pred             HHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Ccc---------cceeeeecccCchhcccCCC
Q 019728          112 QLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFM---------TEYVVTRWYRAPELLLNCTE  180 (336)
Q Consensus       112 qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~~---------~~~~~~~~y~aPE~~~~~~~  180 (336)
                      ++..|+.++|.. ++||++|.|++|.++..+..||+.|+++...... ++.         .-......|.|||.+.+ ..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            344899999975 8999999999999999999999999987554331 111         01122456999999987 78


Q ss_pred             CCccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCC
Q 019728          181 YTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS  259 (336)
Q Consensus       181 ~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
                      .+.++|++|||+++|.+. .|+..+...+..... ..........                          .......++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~--------------------------~~~~s~~~p  238 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAG--------------------------AFGYSNNLP  238 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccc--------------------------cccccccCc
Confidence            899999999999999998 455444433221111 1111000000                          011115679


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          260 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       260 ~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      .++++=+.++|..++.-||++.+++..|||++.
T Consensus       239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             HHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            999999999999999999999999999999873

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=5.5e-10  Score=91.65  Aligned_cols=130  Identities=21%  Similarity=0.235  Sum_probs=94.7

Q ss_pred             CCCceEEEEEecCc-----ccChhHHHHHHHHHHHHhhCC--CCceeeecceecCCCCCCcceEEEEEecCCc--cHHHH
Q 019728           24 ETREEVAIKKIGNA-----FDNIIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQI   94 (336)
Q Consensus        24 ~~~~~vaiK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~   94 (336)
                      ..++.|.+|.....     ...........+|...+..|.  .-...+++++........ ...++|+|+++|  +|.++
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~  108 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDL  108 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHH
Confidence            34566777754221     111133456778888887775  333445555554432222 456899999986  79999


Q ss_pred             HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEEEeccCCccc
Q 019728           95 IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTT  154 (336)
Q Consensus        95 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~  154 (336)
                      +......+......++.+++..++-||+.|++|+|+++.|||++.++   .+.++||+.++..
T Consensus       109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            98755577788889999999999999999999999999999999887   7999999976543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.14  E-value=1.7e-09  Score=87.09  Aligned_cols=142  Identities=13%  Similarity=0.095  Sum_probs=103.7

Q ss_pred             cccceEEEEEEEeCCCCceEEEEEecCc----ccChhHHHHHHHHHHHHhhCCC--CceeeecceecCCCCCCcceEEEE
Q 019728           10 DDIIFFIFSAAVNSETREEVAIKKIGNA----FDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus        10 g~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      |.||-|.|+....  .|+.+-+|.....    ...+.....+.+|+..+.++..  -.+.++. ++........-..++|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4588889988776  3447889977421    1113455677889888888853  2244444 3222222223457899


Q ss_pred             EecCCc--cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC--EEEEeccCCccc
Q 019728           84 YELMDT--DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTT  154 (336)
Q Consensus        84 ~e~~~g--~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~  154 (336)
                      +|-++|  +|.+++...  .+.+..+...++.+++.+++-||+.|+.|+|+.+.||+++.++.  +.++||.-++..
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            998885  999998663  34577888899999999999999999999999999999987777  999999876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.90  E-value=1.4e-08  Score=98.48  Aligned_cols=208  Identities=21%  Similarity=0.247  Sum_probs=148.8

Q ss_pred             HHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019728           45 RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA  123 (336)
Q Consensus        45 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  123 (336)
                      .....|+..+....|+|++.++.+.......+ -...+..++|.+ ++...+..-+.++....+.+..++++|++++|+.
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            33445777788889999999999887664322 123445677875 8889888888999999999999999999999999


Q ss_pred             CeeccCCCCC---CeEEccCCCEEEE--eccCCcccCCCCcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHH
Q 019728          124 SVLHRDLKPS---NLLLNASCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEI  197 (336)
Q Consensus       124 ~i~H~dlkp~---nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l  197 (336)
                      ...|.-+...   +.-++..+.+..+  ||+.++.............+..+.+||..... .......|+|++|.....+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            6666555544   3334555556666  88888877776665555666778888877641 2334457999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCC-hhHHHHHHHhcCCCCCC
Q 019728          198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNK  276 (336)
Q Consensus       198 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dp~~  276 (336)
                      ..|..+-.....      ...                                   ..+..+ ....+++.+|+.-|+++
T Consensus       386 ~~~~~i~~~~~~------~~~-----------------------------------~l~~~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  386 SQGEDISEKSAV------PVS-----------------------------------LLDVLSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             hhcCcccccccc------hhh-----------------------------------hhccccchhhhhhhhhhcchhhhh
Confidence            887643221110      000                                   011112 26788999999999999


Q ss_pred             CCCHHHHHcCcccccCcC
Q 019728          277 RITVEEALRHPYLQSLHD  294 (336)
Q Consensus       277 Rpt~~ell~h~~f~~~~~  294 (336)
                      |+++.+++.|+|.+.-..
T Consensus       425 Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  425 RLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             ccchhhhhhchhcccccc
Confidence            999999999999876443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.90  E-value=3.8e-08  Score=79.60  Aligned_cols=141  Identities=12%  Similarity=0.098  Sum_probs=84.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhH-HHH------HHHHHHHHhhCC---CCceeeecceecC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIID-ARR------TLREIKLLRHME---HENVIAIKDIIRP   71 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~------~~~e~~~l~~l~---hp~iv~~~~~~~~   71 (336)
                      +|++.+.+-......|.+..-  .|+.+++|.........+. ...      ..+++..+.+++   .-..+.++.+...
T Consensus        32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            356667777777666766555  6789999987543321111 111      123333333332   2222232222221


Q ss_pred             CCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           72 PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        72 ~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      ....-....+++|||++| .|.+...    +++    .+...|.+++.-||+.|++|+|.+|.|+++++++ ++++|++.
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~  180 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQG  180 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcc
Confidence            111111335689999998 6655431    222    2445677889999999999999999999998665 99999985


Q ss_pred             Ccc
Q 019728          151 ART  153 (336)
Q Consensus       151 ~~~  153 (336)
                      .+.
T Consensus       181 k~~  183 (229)
T PF06176_consen  181 KRM  183 (229)
T ss_pred             ccc
Confidence            543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.88  E-value=1.2e-08  Score=83.30  Aligned_cols=140  Identities=17%  Similarity=0.143  Sum_probs=95.8

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhH-----------------HHH-----HHHHHHHHhhCCC--C
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIID-----------------ARR-----TLREIKLLRHMEH--E   60 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------~~~-----~~~e~~~l~~l~h--p   60 (336)
                      +...|+.|..+.||+|.. ..+..+|+|++.........                 ..+     ..+|+..|+++..  =
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            455788999999999988 46889999988533211111                 111     1257777777743  3


Q ss_pred             ceeeecceecCCCCCCcceEEEEEecCCcc--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEE
Q 019728           61 NVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLL  137 (336)
Q Consensus        61 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~g~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~  137 (336)
                      .+.+.+.+         .+..+|||+++..  -.-.|.. -++...++..+..++++.+.-|-. .|+||+||+.-|||+
T Consensus       131 rvP~Pi~~---------~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~  200 (268)
T COG1718         131 RVPEPIAF---------RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV  200 (268)
T ss_pred             CCCCceee---------cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence            33334433         3358999999743  1111211 223334778888999999988777 899999999999999


Q ss_pred             ccCCCEEEEeccCCcccCC
Q 019728          138 NASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       138 ~~~~~~kl~dfg~~~~~~~  156 (336)
                      . ++.+.++||+.+.....
T Consensus       201 ~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         201 H-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             E-CCeEEEEECccccccCC
Confidence            9 77899999998876653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.60  E-value=8.6e-07  Score=73.71  Aligned_cols=134  Identities=16%  Similarity=0.099  Sum_probs=81.1

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc--eeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ..||.|..+.||+.    .+..+++|......    ......+|.++++.+..-.  +.+++++....     ...++||
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-----Ceeeeee
Confidence            57899999999973    25568899875422    2344678999999886333  45667666554     4468899


Q ss_pred             ecCCcc--HHHHH---------------------HcC--CCCCHHH-HHHHHHH----------HHH-HHHHHH----hC
Q 019728           85 ELMDTD--LHQII---------------------RSD--QQLTDDH-CQYFLYQ----------LLR-GLKYVH----SA  123 (336)
Q Consensus        85 e~~~g~--L~~~l---------------------~~~--~~~~~~~-~~~i~~q----------i~~-~l~~LH----~~  123 (336)
                      |+++|.  +...+                     ++-  ....... ...+..+          +.. ...+|.    ..
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            999883  22111                     110  0111000 0011000          111 111222    12


Q ss_pred             CeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728          124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      .++|+|+.|.||++++++ +.++||+.+...
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence            479999999999999888 999999977544

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.56  E-value=6.4e-07  Score=69.45  Aligned_cols=131  Identities=20%  Similarity=0.158  Sum_probs=93.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceee-ecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~-~~~~~~~~~~~~~~~~~   81 (336)
                      .+..+.|++|.+|.||++.+  .|..+|+|+-..    +.....+..|.++++.++..++.. +|.+-.         .+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---------~~   88 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---------DF   88 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEech---------hh
Confidence            45678899999999999999  467899997633    334566778999999888666554 444322         35


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-CCCeEEccCCCEEEEeccCCcccC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK-PSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk-p~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      +.|||+.| .|.++-...   .    +.-+..+++..--|-..||-|+.|+ |...++-.++.+.|+||..+....
T Consensus        89 i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          89 IRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            66999998 776665321   1    2234567777777888999999998 444444444489999999887443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=3e-06  Score=70.95  Aligned_cols=80  Identities=14%  Similarity=0.084  Sum_probs=53.9

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCC--ceeeecceecCCCCCCcceEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      ++.|+.|..+.||.+....  ..+++|.....    .....+..|..+++.+...  .+.+++.........  ...+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~--~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN--GFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET--SEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc--ccceEE
Confidence            4689999999999999954  59999987432    4556677888888888522  345565533222211  347999


Q ss_pred             EecCCc-cHHH
Q 019728           84 YELMDT-DLHQ   93 (336)
Q Consensus        84 ~e~~~g-~L~~   93 (336)
                      |++++| .+..
T Consensus        74 ~~~i~g~~~~~   84 (239)
T PF01636_consen   74 MEYIPGRPLDD   84 (239)
T ss_dssp             EEEESSEEHHH
T ss_pred             EEEeccccccc
Confidence            999987 5554

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=2.5e-06  Score=78.65  Aligned_cols=142  Identities=17%  Similarity=0.234  Sum_probs=89.2

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccC---------------------------hh-HH----------HHHH
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN---------------------------II-DA----------RRTL   48 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~-~~----------~~~~   48 (336)
                      ..|+.++-|.||.|..+ +|+.||||+.......                           .. ..          -...
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57889999999999996 5999999987432100                           00 00          0111


Q ss_pred             HHHHHHhhCC----CCceeeecceecCCCCCCcceEEEEEecCCc-cHHHH--HHcCCCCCHHHHHHHHHHHHHH-HHHH
Q 019728           49 REIKLLRHME----HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI--IRSDQQLTDDHCQYFLYQLLRG-LKYV  120 (336)
Q Consensus        49 ~e~~~l~~l~----hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~--l~~~~~~~~~~~~~i~~qi~~~-l~~L  120 (336)
                      +|...+.+++    +..-+++-.++.+-+    +.-.++|||++| .+.+.  +.. ..++...+.   ..++.+ +..+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHH
Confidence            3444444442    233344444443321    235899999998 66555  333 445533332   222221 2334


Q ss_pred             HhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728          121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus       121 H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      -..|+.|.|.+|.||+++.+|.+.+.|||.....+..
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            4589999999999999999999999999988766544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.40  E-value=4.6e-06  Score=70.45  Aligned_cols=134  Identities=11%  Similarity=0.005  Sum_probs=78.1

Q ss_pred             eecccce-EEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEEEEEe
Q 019728            8 EYDDIIF-FIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         8 ~lg~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      .|..|.+ +.||.+...  +..+++|......     .....+|+.+++.+. +--+.+++++....     ...++|||
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEE
Confidence            4455555 788988763  4678888774321     334567888888874 33455666665543     34689999


Q ss_pred             cCCc-cHHHHH-------------------HcC----CCCCHH--H-HHH---H-------------------HHHHHHH
Q 019728           86 LMDT-DLHQII-------------------RSD----QQLTDD--H-CQY---F-------------------LYQLLRG  116 (336)
Q Consensus        86 ~~~g-~L~~~l-------------------~~~----~~~~~~--~-~~~---i-------------------~~qi~~~  116 (336)
                      +++| ++....                   ++-    .++...  . ...   .                   ..++...
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            9987 444321                   110    011100  0 000   0                   1111111


Q ss_pred             HHHH----HhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728          117 LKYV----HSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus       117 l~~L----H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      +...    ....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            1111    123489999999999999977788999997643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=1e-07  Score=87.23  Aligned_cols=239  Identities=17%  Similarity=0.089  Sum_probs=156.6

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc-eeeecceecCCCCCCcceEEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ...+++|+.+++++.+...+...+ .+.+...       ....-++++|.+++||| .+..++-+..+     ...++.+
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E-----~~~~i~~  313 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGE-----DYLWIPM  313 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcc-----cccchhh
Confidence            345778899999988886665555 6666432       34456889999999999 44444433333     5689999


Q ss_pred             ecCCcc--HHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCccc
Q 019728           85 ELMDTD--LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT  161 (336)
Q Consensus        85 e~~~g~--L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (336)
                      +++++.  ....+. +.-.+.+-+...+.+.-+.++++||+.--+|+|    ||+..+ +..+..+|+............
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccc
Confidence            999853  222111 111233444555667777899999999778888    666554 568999999887766554556


Q ss_pred             ceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHH
Q 019728          162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR  241 (336)
Q Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
                      ...+++.++|||+... ..+...-|.|++|.-..+|.-|-.|-..+...  .    ..++..+  +...+..+       
T Consensus       389 t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~----~~~g~~p--~s~~L~~~-------  452 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--L----PMIGNGP--NSPMLTDK-------  452 (829)
T ss_pred             cCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCccc--c----CCCCCCC--Cccccchh-------
Confidence            6688999999998877 67888899999998888888787776542100  0    0000000  00000000       


Q ss_pred             hCCccccccccccCCCCChhHH-HHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          242 QLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~-~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                    ...+.... ++...|+..-|..|+....++-|.+|..-
T Consensus       453 --------------~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  453 --------------SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             --------------hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence                          00011111 57788999999999999999999888753

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.30  E-value=2.7e-05  Score=62.93  Aligned_cols=131  Identities=17%  Similarity=0.197  Sum_probs=90.8

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcc--------------cChhHHHHHHHHHHHHhhCC------CCceeee
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF--------------DNIIDARRTLREIKLLRHME------HENVIAI   65 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------hp~iv~~   65 (336)
                      ...||.|+.-.||.   .......+||+.....              .......+..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            46789999999984   3345567899886543              11122455555555555554      8899999


Q ss_pred             cceecCCCCCCcceEEEEEecC---Cc----cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           66 KDIIRPPKKDTFNDVYIVYELM---DT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        66 ~~~~~~~~~~~~~~~~iv~e~~---~g----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                      +|....+     ....+|+|.+   +|    +|.+++.. +.+++ ...   ..+-+-..+|-+.+|+.+|++|.||++.
T Consensus        83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            9999988     4478888886   23    78888855 45666 433   3444555688999999999999999995


Q ss_pred             cCC----CEEEEe-cc
Q 019728          139 ASC----DLKIGD-FG  149 (336)
Q Consensus       139 ~~~----~~kl~d-fg  149 (336)
                      .+.    .+.|+| ||
T Consensus       153 ~~~~~~~~lvlIDG~G  168 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLG  168 (199)
T ss_pred             ecCCCceEEEEEeCCC
Confidence            432    467776 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=2.6e-05  Score=77.35  Aligned_cols=82  Identities=11%  Similarity=0.090  Sum_probs=55.6

Q ss_pred             eeeecccceEEEEEEEeCCCC--ceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCce--eeecceecCCCCCCcceE
Q 019728            6 RGEYDDIIFFIFSAAVNSETR--EEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENV--IAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i--v~~~~~~~~~~~~~~~~~   80 (336)
                      ++.++.|.+..+|+......+  ..+++|+..... .......+.+|+.+++.+. |+++  .+++.++.+...  .+..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v--~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV--IGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc--CCCc
Confidence            577899999999998775432  468888764321 1123456779999999995 6665  666666654321  1346


Q ss_pred             EEEEecCCcc
Q 019728           81 YIVYELMDTD   90 (336)
Q Consensus        81 ~iv~e~~~g~   90 (336)
                      |+|||+++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            8999999873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.14  E-value=2.6e-05  Score=65.43  Aligned_cols=33  Identities=30%  Similarity=0.388  Sum_probs=26.8

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      .+++|+|+.+.||+++.++...|+||+.+...+
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gD  196 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGD  196 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCcCC
Confidence            358999999999999876656799999775443

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.09  E-value=0.00012  Score=58.91  Aligned_cols=131  Identities=18%  Similarity=0.160  Sum_probs=89.2

Q ss_pred             ccceeeeecccce-EEEEEEEeCCCCceEEEEEecC---c--------cc-Ch-------hHHHHHHHHHHHHhhCC---
Q 019728            2 SVKLRGEYDDIIF-FIFSAAVNSETREEVAIKKIGN---A--------FD-NI-------IDARRTLREIKLLRHME---   58 (336)
Q Consensus         2 ~~~i~~~lg~G~~-g~v~~~~~~~~~~~vaiK~~~~---~--------~~-~~-------~~~~~~~~e~~~l~~l~---   58 (336)
                      .++.++-||+|.. |.||++..  .|+.||+|++..   .        .. ..       .....+..|.....+|+   
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            4678899999999 99999998  678999999321   0        00 00       12234556666666664   


Q ss_pred             CCce--eeecceecCCC-------------CCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019728           59 HENV--IAIKDIIRPPK-------------KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA  123 (336)
Q Consensus        59 hp~i--v~~~~~~~~~~-------------~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  123 (336)
                      +.++  ++++|+..-..             ........||.|+....-        .++...    +.+|++-+..+|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k~  183 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHKL  183 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHHC
Confidence            5566  88888873321             011233578888876432        222322    45777888999999


Q ss_pred             CeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728          124 SVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ||+-+|+++.|..     .-+|+|||.+
T Consensus       184 gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CeeeccCcccccc-----CCEEEecccC
Confidence            9999999999996     3589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.06  E-value=8.8e-05  Score=62.22  Aligned_cols=72  Identities=14%  Similarity=0.216  Sum_probs=45.5

Q ss_pred             eeeecccceEEEEEEEeCC-CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc-eeeecceecCCCCCCcceEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      ++.|..|-...+|++.... .++.|++|........   .....+|+.+++.+.... ..++++... .        .++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--------~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N--------GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C--------cEE
Confidence            4678889899999997643 4678999977542211   122236888888885333 334443321 1        479


Q ss_pred             EecCCc
Q 019728           84 YELMDT   89 (336)
Q Consensus        84 ~e~~~g   89 (336)
                      |||++|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.05  E-value=5.2e-05  Score=70.00  Aligned_cols=141  Identities=18%  Similarity=0.261  Sum_probs=87.6

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccCh--hH---------------------------HH------HHHHHH
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI--ID---------------------------AR------RTLREI   51 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~---------------------------~~------~~~~e~   51 (336)
                      +.||.-+.|.|+.|+-+. |+.||+|+-+......  .+                           ..      .+.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            678999999999999975 9999999875432111  00                           01      112344


Q ss_pred             HHHhhC----CCCc---eeeecceecCCCCCCcceEEEEEecCCc----cHHHHHHcCCCCCHHHHHHHHHHHHHHHH-H
Q 019728           52 KLLRHM----EHEN---VIAIKDIIRPPKKDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLK-Y  119 (336)
Q Consensus        52 ~~l~~l----~hp~---iv~~~~~~~~~~~~~~~~~~iv~e~~~g----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~-~  119 (336)
                      +..+++    +|-+   -|.+-.++.+-.    ..-.++|||++|    ++ +.|.+. .++...   ++..+.++.. -
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~-gi~~~~---i~~~l~~~~~~q  316 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKR-GISPHD---ILNKLVEAYLEQ  316 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHc-CCCHHH---HHHHHHHHHHHH
Confidence            433333    2444   222333333221    236899999987    44 445543 355443   3344444332 3


Q ss_pred             HHhCCeeccCCCCCCeEEcc----CCCEEEEeccCCcccCCC
Q 019728          120 VHSASVLHRDLKPSNLLLNA----SCDLKIGDFGLARTTSET  157 (336)
Q Consensus       120 LH~~~i~H~dlkp~nil~~~----~~~~kl~dfg~~~~~~~~  157 (336)
                      +=..|++|.|=+|-||++..    ++.+.+-|+|+.......
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            34568999999999999984    667999999998766544

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.88  E-value=0.0002  Score=64.31  Aligned_cols=77  Identities=14%  Similarity=0.055  Sum_probs=53.4

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcc----cC-hhHHHHHHHHHHHHhhCC---CCceeeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF----DN-IIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~-~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~~   77 (336)
                      .+.||.|....||.+.+...++.|+||.-....    .+ +....+...|...|+.+.   -.++.+++.+-.       
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-------  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-------  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence            468999999999999996444689999853111    11 234566777888888773   245667777643       


Q ss_pred             ceEEEEEecCCc
Q 019728           78 NDVYIVYELMDT   89 (336)
Q Consensus        78 ~~~~iv~e~~~g   89 (336)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            236899999875

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.88  E-value=2.2e-05  Score=67.05  Aligned_cols=133  Identities=14%  Similarity=0.107  Sum_probs=92.7

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc---c-----------------ChhHHHHHHHHHHHHhhCCC--C
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF---D-----------------NIIDARRTLREIKLLRHMEH--E   60 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~-----------------~~~~~~~~~~e~~~l~~l~h--p   60 (336)
                      +.+++.||-|.-|.||.+-+ ..|...++|.-....   .                 -..+.-...+|+..|+.|..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            45788999999999999999 468888888431110   0                 01112334478888888852  3


Q ss_pred             ceeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           61 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        61 ~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                      -+.+.+++         +.-++|||++.| .|...-+-      ..+..+...+..-+--|-.+|++|+|+.-=||++++
T Consensus       173 pVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            34455554         346899999987 66443211      122334456666677888999999999999999999


Q ss_pred             CCCEEEEeccCC
Q 019728          140 SCDLKIGDFGLA  151 (336)
Q Consensus       140 ~~~~kl~dfg~~  151 (336)
                      ++.++++||-..
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.87  E-value=6.8e-05  Score=67.80  Aligned_cols=175  Identities=22%  Similarity=0.313  Sum_probs=113.4

Q ss_pred             HHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019728           44 ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA  123 (336)
Q Consensus        44 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  123 (336)
                      ..+++--+++++.+.|+|...+.++.....    ....+|||+++-+|.+.+..+. +-...       ++       ..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s-------~~-------~~   86 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDES-------LL-------AH   86 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhh-------hc-------cc
Confidence            345566788999999999999888765432    4488999999999999987654 21111       11       12


Q ss_pred             CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC
Q 019728          124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  203 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  203 (336)
                      |+.|     .|+       +..+| .+.         +.      |  |      .+..+++|||++|.++.++..|...
T Consensus        87 ~~~~-----~~~-------~~~td-~~~---------t~------~--~------~~~~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   87 GVLH-----LNI-------IYITD-HFL---------TK------Y--P------SPIGPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             ccce-----ehh-------hhccc-ccc---------cc------C--C------CCCCcchhhhhHHHHHHHHHHhhHH
Confidence            2211     122       22333 000         00      0  1      1122499999999999999999988


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 019728          204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  283 (336)
Q Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  283 (336)
                      +......+....+.+....+.....-..      ..             ......+.....+..+|+-..|..||...++
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~------e~-------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQELLSTAM------EH-------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchhHHHHHH------HH-------------HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            8877777777777665443332211000      00             1112346667899999999999999999999


Q ss_pred             HcCcccccC
Q 019728          284 LRHPYLQSL  292 (336)
Q Consensus       284 l~h~~f~~~  292 (336)
                      ..++-|...
T Consensus       192 ~k~~i~~ev  200 (725)
T KOG1093|consen  192 SKRCSFTEV  200 (725)
T ss_pred             hcCccHHHH
Confidence            999998764

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.83  E-value=9.7e-05  Score=62.87  Aligned_cols=134  Identities=15%  Similarity=0.138  Sum_probs=75.6

Q ss_pred             eecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCce-eeecceecCCCCCCcceEEEEEec
Q 019728            8 EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVYEL   86 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~~~~~~iv~e~   86 (336)
                      .+..|-.+.+|++..  .++.+++|.........  ......|..+++.+....+ .+++...  .       -++||||
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEe
Confidence            466788889998874  56789999764321111  0123568888888853323 2333332  1       2689999


Q ss_pred             CCc-cHHH--------------HH---HcC----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCee
Q 019728           87 MDT-DLHQ--------------II---RSD----QQLTD-DHCQYFLYQL---------LRGLKYVHS--------ASVL  126 (336)
Q Consensus        87 ~~g-~L~~--------------~l---~~~----~~~~~-~~~~~i~~qi---------~~~l~~LH~--------~~i~  126 (336)
                      ++| .+..              .+   ++-    .+++. ..+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            987 3221              11   111    11221 1112221111         111222221        2589


Q ss_pred             ccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728          127 HRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus       127 H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      |+|+.|.||++++++ +.|+||..+....
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence            999999999999877 7899999876544

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.78  E-value=0.00095  Score=58.77  Aligned_cols=31  Identities=29%  Similarity=0.296  Sum_probs=26.2

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      .++||+|+.|.||+++.+....|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998765568999997643

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.75  E-value=0.0003  Score=61.32  Aligned_cols=142  Identities=19%  Similarity=0.205  Sum_probs=97.7

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCc--------------------c--cChhHHHHH--HHHHHHHhhCCC
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA--------------------F--DNIIDARRT--LREIKLLRHMEH   59 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--------------------~--~~~~~~~~~--~~e~~~l~~l~h   59 (336)
                      .|.+.|.-|.-+.||-|.. ..|+.+|||+++-+                    .  .++...-..  -+|+..|++++.
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            4566788899999999888 57888999987321                    0  111111111  257888888876


Q ss_pred             CceeeecceecCCCCCCcceEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCCCCeE
Q 019728           60 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLL  136 (336)
Q Consensus        60 p~iv~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~nil  136 (336)
                      ..|...--+....       -.+||+++++  --.-.| ..-.++...+..+-.|++.-+.-|- .+++||.||+--|+|
T Consensus       226 aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  226 AGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL  297 (520)
T ss_pred             cCCCCCCceeeec-------ceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence            6655544444433       5899999974  222222 2246778888888888888777665 569999999999999


Q ss_pred             EccCCCEEEEeccCCcccC
Q 019728          137 LNASCDLKIGDFGLARTTS  155 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~  155 (336)
                      +-+ |.+.++|.+.|...+
T Consensus       298 yhd-G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  298 YHD-GKLYIIDVSQSVEHD  315 (520)
T ss_pred             EEC-CEEEEEEccccccCC
Confidence            865 469999999876544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.74  E-value=0.00064  Score=59.82  Aligned_cols=83  Identities=13%  Similarity=-0.067  Sum_probs=55.6

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecC-----cccChhHHHHHHHHHHHHhhCC--CC-ceeeecceecCCCCCCcc
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGN-----AFDNIIDARRTLREIKLLRHME--HE-NVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~~~e~~~l~~l~--hp-~iv~~~~~~~~~~~~~~~   78 (336)
                      +.||.|....||.+.+...++.|+||.-..     ...-+....+..-|...|+...  .| .+.++|.+-..       
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e-------   73 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE-------   73 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccc-------
Confidence            368999999999999864447899997631     1122445566677888887774  45 45556655433       


Q ss_pred             eEEEEEecCCc--cHHHHHH
Q 019728           79 DVYIVYELMDT--DLHQIIR   96 (336)
Q Consensus        79 ~~~iv~e~~~g--~L~~~l~   96 (336)
                      ...++||+++.  .|...+.
T Consensus        74 ~~~~vMEdL~~~~ilR~~Li   93 (370)
T TIGR01767        74 MAVTVMEDLSHHKIARKGLI   93 (370)
T ss_pred             cceehHhhCccchHHHHHHH
Confidence            35799999863  5655553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.73  E-value=3.8e-05  Score=77.51  Aligned_cols=213  Identities=16%  Similarity=0.077  Sum_probs=138.2

Q ss_pred             HHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHH
Q 019728           43 DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGL  117 (336)
Q Consensus        43 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l  117 (336)
                      ..+....|..-.+...|+++...+.-......   ...|..++++. |.+.+.|.++    .++....+-....+.+.+.
T Consensus      1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred             HHHhhhhhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence            33444556666667789999887776554433   45789999997 6999988653    2233333333333335555


Q ss_pred             HHHHhC-C----eeccCCCCCCeEEccCCCEEEEeccCCcccC-CCCcccceeeeecccCchhcccCCCCCccchHHHHH
Q 019728          118 KYVHSA-S----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  191 (336)
Q Consensus       118 ~~LH~~-~----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (336)
                      .-.|+. |    -+|+++++.|.++..+.+++++++|+.+... .........+++.|+.|+.... -.++.++|+|..|
T Consensus      1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRS 1427 (2724)
T ss_pred             chhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHH
Confidence            555543 2    6899999999999999999999999998433 3344556678888999997765 6677779999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcC
Q 019728          192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  271 (336)
Q Consensus       192 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  271 (336)
                      +.+|..-.|..+|..     .++.+   +....+.                      ....+...-.|.+.......+|-
T Consensus      1428 ~~ly~rs~~n~~fi~-----flq~~---Lkgiidn----------------------~tf~sIe~l~pgdaNve~~~~Ll 1477 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIF-----FLQPA---LKGIIDN----------------------HTFFSIEKLKPGDANVEALHRLL 1477 (2724)
T ss_pred             HHHHHHhcccHHHHH-----HHHHH---HcCcccc----------------------cccccccccCCCcccHHHHHHHH
Confidence            999999888866622     12111   1111111                      11111122234445555555565


Q ss_pred             CCCCCCCCHHHHHcCccc
Q 019728          272 FDPNKRITVEEALRHPYL  289 (336)
Q Consensus       272 ~dp~~Rpt~~ell~h~~f  289 (336)
                      +.-..||.-...++.+.|
T Consensus      1478 ~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1478 WKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             HHhhhcchhhhhcccccc
Confidence            666778888888776665

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.72  E-value=0.00093  Score=57.96  Aligned_cols=148  Identities=12%  Similarity=0.124  Sum_probs=88.5

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC--CceeeecceecCCCCCCcceEEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      +++.+..|....+|...+.  ++.+++. ...............+|+.+++.+.-  --+...++++....   .+..|.
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~  102 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFY  102 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceE
Confidence            4455555555566766664  7888888 33223445667777888888888853  33444555555443   245799


Q ss_pred             EEecCCc-cHH------------------HHHHc------------C--CCCCHHHHHHHHHHH--------------HH
Q 019728           83 VYELMDT-DLH------------------QIIRS------------D--QQLTDDHCQYFLYQL--------------LR  115 (336)
Q Consensus        83 v~e~~~g-~L~------------------~~l~~------------~--~~~~~~~~~~i~~qi--------------~~  115 (336)
                      ||+++.| .+.                  +.|..            .  ......++..+..+.              ..
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            9999877 221                  11110            0  000111111111111              12


Q ss_pred             HHHHHHhC--------CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728          116 GLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus       116 ~l~~LH~~--------~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ...+|+.+        .++|||+++.|++++..+.+-|.||+.+...++..
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~  233 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLE  233 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHH
Confidence            23344432        48999999999999999889999999998776554

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.70  E-value=0.00017  Score=58.00  Aligned_cols=97  Identities=21%  Similarity=0.146  Sum_probs=76.5

Q ss_pred             HHHHHHhhCCC-CceeeecceecCCCCCCcceEEEEEecCC-ccHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 019728           49 REIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQI---IRSDQQLTDDHCQYFLYQLLRGLKYVHS-  122 (336)
Q Consensus        49 ~e~~~l~~l~h-p~iv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~---l~~~~~~~~~~~~~i~~qi~~~l~~LH~-  122 (336)
                      .|.-+++.+++ +++.+++|++-         -+++.||.+ +++...   +..-...++.....|+.++++.+.+|+. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            58888888975 69999999873         367888987 444321   1112346789999999999999999998 


Q ss_pred             --CCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728          123 --ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus       123 --~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ..+.-.|++++|+-++++|++|++|.......
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence              35888899999999999999999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.67  E-value=0.00035  Score=61.02  Aligned_cols=72  Identities=10%  Similarity=0.053  Sum_probs=44.5

Q ss_pred             eeeecccceEEEEEEEeCC------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc-eeeecceecCCCCCCcc
Q 019728            6 RGEYDDIIFFIFSAAVNSE------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~~~   78 (336)
                      ++.|..|-...+|++....      +++.|++|......   ........|..++..+.... ..++++.+..       
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~-------   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN-------   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC-------
Confidence            3567778888999988643      36889999875432   12234567777777774322 2344444421       


Q ss_pred             eEEEEEecCCc
Q 019728           79 DVYIVYELMDT   89 (336)
Q Consensus        79 ~~~iv~e~~~g   89 (336)
                        .+|+++++|
T Consensus        73 --~~v~e~i~G   81 (302)
T cd05156          73 --GRIEEFIPS   81 (302)
T ss_pred             --CchhheeCC
Confidence              347788765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.58  E-value=0.0011  Score=57.77  Aligned_cols=141  Identities=14%  Similarity=-0.004  Sum_probs=79.0

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCC--ceeeecceecCCCC-CCcceEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPPKK-DTFNDVYI   82 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp--~iv~~~~~~~~~~~-~~~~~~~i   82 (336)
                      .+.|..|....+|++..  .+..+++|+...     .....+..|+.++..+.+.  .+.+++........ ...+..++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            56777888889998865  345789998753     1234566677777777432  24444432111000 01134689


Q ss_pred             EEecCCc-cHH-----------HHH---Hc---C--CC-----C-CHHH--HH--------HHHHHHHHHHHHHHh----
Q 019728           83 VYELMDT-DLH-----------QII---RS---D--QQ-----L-TDDH--CQ--------YFLYQLLRGLKYVHS----  122 (336)
Q Consensus        83 v~e~~~g-~L~-----------~~l---~~---~--~~-----~-~~~~--~~--------~i~~qi~~~l~~LH~----  122 (336)
                      |+++++| .+.           ..+   +.   .  ..     . ....  ..        .....+..++.++.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999986 221           011   00   0  00     0 0000  00        011112333444443    


Q ss_pred             ---CCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728          123 ---ASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus       123 ---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                         .+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence               4799999999999999887778999997643

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.55  E-value=0.001  Score=59.31  Aligned_cols=84  Identities=15%  Similarity=0.022  Sum_probs=57.9

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecC----cccChhHHHHHHHHHHHHhhCC--CC-ceeeecceecCCCCCCcc
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGN----AFDNIIDARRTLREIKLLRHME--HE-NVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~e~~~l~~l~--hp-~iv~~~~~~~~~~~~~~~   78 (336)
                      .+.||.|....||.+.+...++.|+||.-..    ...-+....+..-|...|+...  .| ++.++|.+-..       
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e-------  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV-------  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH-------
Confidence            5789999999999999854467899996531    1223556677788888888874  45 45556655433       


Q ss_pred             eEEEEEecCCc--cHHHHHH
Q 019728           79 DVYIVYELMDT--DLHQIIR   96 (336)
Q Consensus        79 ~~~iv~e~~~g--~L~~~l~   96 (336)
                      ...+|||+++.  .|...+.
T Consensus       107 ~~~~vMEdL~~~~ilR~~Li  126 (409)
T PRK12396        107 MNCCVMEDLSDHTILRTALI  126 (409)
T ss_pred             HhhHHHHhCcccHHHHHHHH
Confidence            36789999863  5555543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.41  E-value=0.0044  Score=54.27  Aligned_cols=142  Identities=13%  Similarity=0.079  Sum_probs=77.3

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc--eeeecceecCCC-CCCcceEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPK-KDTFNDVYI   82 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~-~~~~~~~~i   82 (336)
                      .+.++.|....+|.+..  ++..+++|......    ....+..|..++..|....  +.+++....... ....+..++
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            56677888889998865  24468889774421    1233445666666664222  334433211100 001145789


Q ss_pred             EEecCCc-cH----HH-------HH---Hc-CCCCC-------HHHHHH----------------HHHHHHHHHHHHHh-
Q 019728           83 VYELMDT-DL----HQ-------II---RS-DQQLT-------DDHCQY----------------FLYQLLRGLKYVHS-  122 (336)
Q Consensus        83 v~e~~~g-~L----~~-------~l---~~-~~~~~-------~~~~~~----------------i~~qi~~~l~~LH~-  122 (336)
                      +++|++| .+    .+       .+   +. ...++       ....+.                ....+...++++.. 
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            9999876 21    11       11   10 00000       000000                01112334444432 


Q ss_pred             ------CCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728          123 ------ASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus       123 ------~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                            .+++|+|+.+.|++++.++...|+||+.+..
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                  5899999999999999888778999997643

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.27  E-value=0.0047  Score=53.05  Aligned_cols=32  Identities=22%  Similarity=0.453  Sum_probs=26.5

Q ss_pred             CeeccCCCCCCeEEccCCC-EEEEeccCCcccC
Q 019728          124 SVLHRDLKPSNLLLNASCD-LKIGDFGLARTTS  155 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~  155 (336)
                      .++|+|+++.||++++++. .-|+||+.+...+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            4899999999999997565 5699999876554

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.11  E-value=0.012  Score=52.96  Aligned_cols=76  Identities=17%  Similarity=0.076  Sum_probs=52.0

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCccc-----ChhHHHHHHHHHHHHhhCC--C-CceeeecceecCCCCCC
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-----NIIDARRTLREIKLLRHME--H-ENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~--h-p~iv~~~~~~~~~~~~~   76 (336)
                      -.+.||.|....||++.+.  ++.|+||+-.....     -+....+...|...|+.+.  . .++.+++.+..+.    
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence            3568899999999999883  45699997642111     1124555566677777664  2 4777788877644    


Q ss_pred             cceEEEEEecCCc
Q 019728           77 FNDVYIVYELMDT   89 (336)
Q Consensus        77 ~~~~~iv~e~~~g   89 (336)
                         .+++||++++
T Consensus       110 ---~vlvME~L~~  119 (418)
T PLN02756        110 ---ALIGMRYLEP  119 (418)
T ss_pred             ---CEEEEeecCC
Confidence               5788999965

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.92  E-value=0.0097  Score=52.12  Aligned_cols=30  Identities=20%  Similarity=0.193  Sum_probs=27.3

Q ss_pred             CeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728          124 SVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      ++||+|+.+.|+++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999997654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.87  E-value=0.012  Score=52.09  Aligned_cols=30  Identities=33%  Similarity=0.433  Sum_probs=25.8

Q ss_pred             eeccCCCCCCeEEcc-CCCEEEEeccCCccc
Q 019728          125 VLHRDLKPSNLLLNA-SCDLKIGDFGLARTT  154 (336)
Q Consensus       125 i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~  154 (336)
                      +||+|+.+.||++++ ++.++++||..|...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            899999999999975 468999999987543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.69  E-value=0.015  Score=50.99  Aligned_cols=110  Identities=15%  Similarity=0.293  Sum_probs=75.6

Q ss_pred             ceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           78 NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        78 ~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ...|++|++-++++...    +-....++..++++.+..++-+... .+-|||+...||+++ +|++.|+||.+++....
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            45788999888765322    2345678888899988888888776 689999999999999 99999999999985443


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  201 (336)
                      ...    ......--|-.+.|  .-+..-+||-+   |-.|+.|.
T Consensus       374 q~~----isy~rldhp~lF~G--~dd~QFeIYrl---Mr~l~~g~  409 (488)
T COG5072         374 QGI----ISYNRLDHPDLFNG--VDDYQFEIYRL---MRRLLKGR  409 (488)
T ss_pred             Cce----eeccccCchhhhcC--ccceeeeHHHH---HHHHhcCc
Confidence            322    11222334555554  33667777764   33444444

>PLN02236 choline kinase

Probab=96.53  E-value=0.023  Score=50.60  Aligned_cols=30  Identities=23%  Similarity=0.422  Sum_probs=26.0

Q ss_pred             CeeccCCCCCCeEEcc-CCCEEEEeccCCcc
Q 019728          124 SVLHRDLKPSNLLLNA-SCDLKIGDFGLART  153 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~  153 (336)
                      .++|+|+++.||++++ ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986 46799999987753

>PRK10593 hypothetical protein; Provisional

Probab=96.43  E-value=0.052  Score=47.25  Aligned_cols=106  Identities=9%  Similarity=0.022  Sum_probs=70.9

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC---CceeeecceecCCCCCCcceEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH---ENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      -.+.||.|..+.||.....  +..+++|..+.    ......+..|...++.+..   -.+.++++++.....  .+..+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~~~   89 (297)
T PRK10593         18 RVECISEQPYAALWALYDS--QGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGPDV   89 (297)
T ss_pred             eeeecCCccceeEEEEEcC--CCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCCeE
Confidence            3568999999999998763  23577777532    1123567788888888853   356777776654321  13479


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA  123 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~  123 (336)
                      +|||+++| ++.+ .    ..+......+..+++.+++-||+.
T Consensus        90 LVmE~i~G~~~~~-~----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         90 LLLERLRGVSVEA-P----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEEeccCCEecCC-C----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99999987 5543 1    123444556677888999999985

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.38  E-value=0.032  Score=48.15  Aligned_cols=74  Identities=8%  Similarity=-0.054  Sum_probs=43.7

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +.-.+.++.|....+|...  .+++.+.+|+-..     .....+..|..-|+.|   .--.+.+++++....     ..
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~   86 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DD   86 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SC
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CC
Confidence            3456788999999999888  5788999998742     2234455666666666   344566777776654     33


Q ss_pred             EEEEEecCC
Q 019728           80 VYIVYELMD   88 (336)
Q Consensus        80 ~~iv~e~~~   88 (336)
                      .++|||+++
T Consensus        87 ~fLlle~l~   95 (288)
T PF03881_consen   87 AFLLLEFLE   95 (288)
T ss_dssp             CEEEEE---
T ss_pred             ceEEEEeec
Confidence            599999985

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=96.36  E-value=0.064  Score=48.34  Aligned_cols=29  Identities=28%  Similarity=0.253  Sum_probs=24.4

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      ..+||.|+.+.||+.+++ .+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence            468999999999997654 59999998764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.15  E-value=0.2  Score=44.16  Aligned_cols=28  Identities=32%  Similarity=0.385  Sum_probs=23.6

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      .+++|+|+.+.||+++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 3 57899999664

>PTZ00296 choline kinase; Provisional

Probab=95.61  E-value=0.27  Score=45.28  Aligned_cols=28  Identities=29%  Similarity=0.580  Sum_probs=23.8

Q ss_pred             CeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          124 SVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      .+||.|+.+.||+.+.++ ++|+||..+.
T Consensus       285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNKC-LRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCCC-EEEEeecccc
Confidence            589999999999886554 9999998764

>PRK06148 hypothetical protein; Provisional

Probab=95.28  E-value=0.56  Score=48.09  Aligned_cols=31  Identities=35%  Similarity=0.500  Sum_probs=25.9

Q ss_pred             CCeeccCCCCCCeEEccCC--CEE-EEeccCCcc
Q 019728          123 ASVLHRDLKPSNLLLNASC--DLK-IGDFGLART  153 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~--~~k-l~dfg~~~~  153 (336)
                      .+++|+|+.+.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  454 999997754

>PHA03111 Ser/Thr kinase; Provisional

Probab=95.20  E-value=0.056  Score=46.86  Aligned_cols=61  Identities=20%  Similarity=0.239  Sum_probs=38.3

Q ss_pred             EEEEEecCCc-----cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCCCCeEEccC
Q 019728           80 VYIVYELMDT-----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH----SASVLHRDLKPSNLLLNAS  140 (336)
Q Consensus        80 ~~iv~e~~~g-----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~nil~~~~  140 (336)
                      ..||++.+-+     ++....+.+-.-..+-++.++.||+.-.-..-    -.+++|.||||+|||+-+.
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            4678887643     23233322212234567788888877553342    2469999999999998543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.11  E-value=0.21  Score=41.23  Aligned_cols=73  Identities=14%  Similarity=0.002  Sum_probs=46.7

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC---CceeeecceecCCCCCCcceE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH---ENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +-.+++..|.--..|.+.+.  ...+.+|+-     .......+..|+.-|+.+.-   -.+.+++..-...     .+.
T Consensus        19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~-----~~s   86 (286)
T COG3001          19 KEREEVSGGDINEAWRLRDG--TDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASR-----DHS   86 (286)
T ss_pred             hcccccCCccccceeEeecC--CcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCC-----Cee
Confidence            34455666666666766663  356888864     23345566677777777754   4455555555544     679


Q ss_pred             EEEEecCC
Q 019728           81 YIVYELMD   88 (336)
Q Consensus        81 ~iv~e~~~   88 (336)
                      |+||||++
T Consensus        87 ylVle~L~   94 (286)
T COG3001          87 YLVLEYLP   94 (286)
T ss_pred             EEEEeecc
Confidence            99999986

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.03  E-value=0.023  Score=45.39  Aligned_cols=32  Identities=31%  Similarity=0.389  Sum_probs=27.4

Q ss_pred             CeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728          124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      -.+|+|+.|.|+++++++ ++|+||+.+...++
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp  109 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI  109 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence            379999999999998887 99999998865543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.03  E-value=0.063  Score=46.99  Aligned_cols=29  Identities=24%  Similarity=0.384  Sum_probs=25.3

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999987 678999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.75  E-value=0.062  Score=45.93  Aligned_cols=44  Identities=34%  Similarity=0.415  Sum_probs=33.1

Q ss_pred             HHHHHHHHHHhC--CeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728          112 QLLRGLKYVHSA--SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus       112 qi~~~l~~LH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      .+-.++.-.+..  -+||+|+.|+|++.++.+.++|+||..|...+
T Consensus       140 ~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D  185 (269)
T COG0510         140 ELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLND  185 (269)
T ss_pred             HHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCcc
Confidence            333333333333  48999999999999999999999999876544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	336
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-96
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-96
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-92
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-91
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-91
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-91
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-91
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-91
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-91
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-91
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-91
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-91
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-91
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-91
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-91
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-91
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-91
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-90
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-90
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-90
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-90
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-90
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-90
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-90
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-89
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-89
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-88
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-87
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-87
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-86
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-86
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-86
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-86
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-86
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-86
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-86
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-86
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-86
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-86
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-86
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-86
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-86
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-86
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-86
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-86
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-86
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-86
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-86
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-86
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-86
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-86
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-86
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-86
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-86
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-86
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-86
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-86
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-86
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-86
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-86
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-86
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-86
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-86
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-86
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-85
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-85
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-85
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-85
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-85
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-85
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-85
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-85
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-85
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-85
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-85
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-85
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-85
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-85
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-85
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-85
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-85
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-85
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-85
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-85
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-85
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-85
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-84
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-83
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-80
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-78
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-78
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-76
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-76
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-75
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-64
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-64
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-64
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-64
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-64
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-64
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-64
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-64
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-64
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-64
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-64
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-63
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-63
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-63
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-63
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-63
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-63
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-63
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-63
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-63
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-63
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-62
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-62
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-62
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-62
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-62
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-62
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-62
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-62
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-62
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-62
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-61
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-61
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-61
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-57
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-56
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-56
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-55
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-53
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-49
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-49
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-49
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-49
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-49
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-49
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-49
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-49
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-48
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-48
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-48
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-48
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-48
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-48
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-48
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-48
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-48
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-48
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-48
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-48
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-48
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-48
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-48
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-48
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-48
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-48
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-48
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-48
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-48
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-48
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-48
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-48
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-48
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-48
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-47
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-47
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-46
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-46
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-43
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-42
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-42
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-42
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-42
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-42
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-41
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-41
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-40
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-40
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-40
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-40
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-39
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-39
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-38
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-38
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-38
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-38
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-37
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-37
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-37
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-37
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-37
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-37
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-37
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-37
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-37
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-37
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-37
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-37
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-37
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-37
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-37
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-37
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-36
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-36
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-36
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-36
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-36
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-36
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-36
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-36
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-36
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-36
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-33
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-30
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-28
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-28
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-28
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-28
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-28
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-28
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-28
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-27
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-27
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-27
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-27
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-27
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-27
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-27
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-27
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-27
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-27
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-27
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-27
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-27
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-27
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-27
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-27
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-27
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-26
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-26
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-26
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-26
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-26
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-25
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-23
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-22
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-21
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-20
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-19
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-19
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-19
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-19
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-19
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-19
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-19
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-19
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-18
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-18
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-17
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-17
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-17
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-17
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-17
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-17
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-17
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-17
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-17
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
3soa_A	444	Full-Length Human Camkii Length = 444		3e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-17
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-15
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-15
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-13
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-13
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-13
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-07

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  349 bits (896), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 171/324 (52%), Positives = 230/324 (70%), Gaps = 6/324 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           + + S+A    T ++VAIKKI NAFD + +A+RTLRE+K+L+H +H+N+IAIKDI+RP  
Sbjct: 67  YGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126
Query: 73  KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
               F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRGLKY+HSA V+HRDLKP
Sbjct: 127 PYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKP 186
Query: 133 SNLLLNASCDLKIGDFGLART--TSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           SNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWYRAPEL+L+  EYT AID+
Sbjct: 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WSVGCI GE++ R  LFPGK+YVHQL+LI  ++G+P  A +  + ++  R Y++ LP  +
Sbjct: 247 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ 306
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF 307
              + T +P     A+ LL +ML F+P+ RI+   ALRHP+L   HD +DEP C  PF F
Sbjct: 307 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDF 366
Query: 308 DFEHSSCTEDHIRELIWRESVKFN 331
            F+  + T + I+E I  E   F+
Sbjct: 367 AFDREALTRERIKEAIVAEIEDFH 390

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  349 bits (895), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 171/324 (52%), Positives = 230/324 (70%), Gaps = 6/324 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           + + S+A    T ++VAIKKI NAFD + +A+RTLRE+K+L+H +H+N+IAIKDI+RP  
Sbjct: 68  YGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 127
Query: 73  KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
               F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRGLKY+HSA V+HRDLKP
Sbjct: 128 PYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKP 187
Query: 133 SNLLLNASCDLKIGDFGLART--TSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           SNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWYRAPEL+L+  EYT AID+
Sbjct: 188 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 247
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WSVGCI GE++ R  LFPGK+YVHQL+LI  ++G+P  A +  + ++  R Y++ LP  +
Sbjct: 248 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ 307
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF 307
              + T +P     A+ LL +ML F+P+ RI+   ALRHP+L   HD +DEP C  PF F
Sbjct: 308 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDF 367
Query: 308 DFEHSSCTEDHIRELIWRESVKFN 331
            F+  + T + I+E I  E   F+
Sbjct: 368 AFDREALTRERIKEAIVAEIEDFH 391

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  333 bits (855), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 167/323 (51%), Positives = 225/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + + S+A +   +  VAIKKI + F++    +RTLREI++L    HENVI I+DI+R   
Sbjct: 56  YGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAST 114
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL+++++S QQL++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 115 LEAMRDVYIVQDLMETDLYKLLKS-QQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 173
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLL+N +CDLKI DFGLAR        T F+TE V TRWYRAPE++LN   YT +IDIWS
Sbjct: 174 NLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWS 233
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y++ LP   K 
Sbjct: 234 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKV 293
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +A  FP   S A+DLL++ML F+PNKRITVEEAL HPYL+  +D  DEPV   PF F  
Sbjct: 294 AWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAM 353
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI++E+ +F P
Sbjct: 354 ELDDLPKERLKELIFQETARFQP 376

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  333 bits (853), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 225/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 34  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 92
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 93  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 151
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 152 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 211
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP+   L  + +  AR Y+  LP   K 
Sbjct: 212 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKV 271
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 272 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 331
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 332 ELDDLPKEKLKELIFEETARFQP 354

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  332 bits (852), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 38  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 96
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 97  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 155
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 156 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 215
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 216 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 275
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 335
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 336 ELDDLPKEKLKELIFEETARFQP 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  332 bits (852), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 56  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 114
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 115 IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 173
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 174 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 233
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 234 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 293
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 294 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 353
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 354 ELDDLPKEKLKELIFEETARFQP 376

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  332 bits (852), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 36  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 94
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 95  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 153
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 154 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 213
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 214 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 273
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 333
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 334 ELDDLPKEKLKELIFEETARFQP 356

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  332 bits (852), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 44  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 102
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 103 IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 161
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 162 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 221
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 222 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 281
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 282 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 341
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 342 ELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  332 bits (852), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 36  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 94
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 95  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 153
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 154 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 213
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 214 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 273
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 333
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 334 ELDDLPKEKLKELIFEETARFQP 356

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  332 bits (851), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 34  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 92
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 93  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 151
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 152 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 211
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 212 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 271
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 272 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 331
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 332 ELDDLPKEKLKELIFEETARFQP 354

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  332 bits (851), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 41  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 99
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 100 IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 158
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 159 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 218
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 219 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 278
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 279 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 338
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 339 ELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  332 bits (851), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 42  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 100
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 101 IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 159
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 160 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 219
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 220 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 279
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 280 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 339
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 340 ELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  332 bits (851), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 33  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 91
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 92  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 150
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 151 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 210
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 211 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 270
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 271 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 330
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 331 ELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  332 bits (851), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 40  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 99  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 337
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 338 ELDDLPKEKLKELIFEETARFQP 360

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  331 bits (849), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 38  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPT 96
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 97  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 155
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 156 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 215
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 216 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 275
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL   +D +DEP+   PF FD 
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFDM 335
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 336 ELDDLPKEKLKELIFEETARFQP 358

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  331 bits (849), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 166/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 40  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL+++++  Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 99  IEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 337
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 338 ELDDLPKEKLKELIFEETARFQP 360

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  331 bits (848), Expect = 4e-91,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 224/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAI+KI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 40  YGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 99  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 337
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 338 ELDDLPKEKLKELIFEETARFQP 360

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  330 bits (845), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 36  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 94
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 95  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 153
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 154 NLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 213
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 214 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKV 273
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 333
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 334 ELDDLPKEKLKELIFEETARFQP 356

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  329 bits (843), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 36  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 94
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 95  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 153
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 154 NLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 213
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 214 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKV 273
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 333
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 334 ELDDLPKEKLKELIFEETARFQP 356

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  328 bits (841), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 40  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPT 98
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 99  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 158 NLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 337
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 338 ELDDLPKEKLKELIFEETARFQP 360

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  328 bits (841), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 36  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 94
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 95  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 153
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 154 NLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 213
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 214 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 273
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 274 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 333
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 334 ELDDLPKEKLKELIFEETARFQP 356

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  328 bits (841), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 223/323 (69%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 40  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 99  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 158 NLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 337
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 338 ELDDLPKEKLKELIFEETARFQP 360

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  327 bits (838), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 164/323 (50%), Positives = 222/323 (68%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 40  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 99  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+ E V TRWYRAPE++LN   YT +IDIWS
Sbjct: 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWS 217
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 218 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 337
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 338 ELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  327 bits (838), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 164/323 (50%), Positives = 222/323 (68%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 41  YGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 99
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 100 IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 158
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN +CDLKI DFGLAR        T F+ E V TRWYRAPE++LN   YT +IDIWS
Sbjct: 159 NLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWS 218
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 219 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 278
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 279 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 338
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 339 ELDDLPKEKLKELIFEETARFQP 361

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  326 bits (836), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 165/323 (51%), Positives = 221/323 (68%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 38  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPT 96
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 97  IEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 155
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 156 NLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 215
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L    +  AR Y+  LP   K 
Sbjct: 216 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKV 275
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL   +D +DEP+   PF FD 
Sbjct: 276 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFDM 335
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 336 ELDDLPKEKLKELIFEETARFQP 358

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  324 bits (831), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 163/323 (50%), Positives = 220/323 (68%), Gaps = 6/323 (1%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P 
Sbjct: 56  YGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 114
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            +   DVY+V  LM  DL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPS
Sbjct: 115 IEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 173
Query: 134 NLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           NLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWS
Sbjct: 174 NLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 233
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           VGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K 
Sbjct: 234 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 293
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF 309
            +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD 
Sbjct: 294 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 353
Query: 310 EHSSCTEDHIRELIWRESVKFNP 332
           E     ++ ++ELI+ E+ +F P
Sbjct: 354 ELDDLPKEKLKELIFEETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  322 bits (826), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 166/339 (48%), Positives = 221/339 (65%), Gaps = 18/339 (5%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           +L+    +  + +  +A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENII 72
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
            I +I RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H +
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAP 172
           +V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   MTEYV TRWYRAP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFL 231
           E++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  +
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 292 LHDLND----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 326
            HD ND    EP+ P  F FD    + T   +++LIW E
Sbjct: 312 YHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 165/339 (48%), Positives = 220/339 (64%), Gaps = 18/339 (5%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           +L+    +  + +  +A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENII 72
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
            I +I RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H +
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAP 172
           +V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   MTE V TRWYRAP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFL 231
           E++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  +
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 292 LHDLND----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 326
            HD ND    EP+ P  F FD    + T   +++LIW E
Sbjct: 312 YHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 164/339 (48%), Positives = 220/339 (64%), Gaps = 18/339 (5%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           +L+    +  + +  +A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENII 72
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
            I +I RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR +K +H +
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAP 172
           +V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V TRWYRAP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFL 231
           E++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  +
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 292 LHDLND----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 326
            HD ND    EP+ P  F FD    + T   +++LIW E
Sbjct: 312 YHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 159/317 (50%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   PF   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPFDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 59  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 118
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 119 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 178 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 295
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 296 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 354
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 355 EWKSLTYDEVISFVPPP 371

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 212/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 107 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 166 NEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 342
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 343 EWKSLTYDEVISFVPPP 359

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 46  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 106 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 165 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 282
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 341
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 342 EWKSLTYDEVISFVPPP 358

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 60  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 120 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 179 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 296
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 297 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 355
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 356 EWKSLTYDEVISFVPPP 372

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 50  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 109
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 110 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 168
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 169 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 226
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 227 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 286
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 287 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 345
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 346 EWKSLTYDEVISFVPPP 362

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 36  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 96  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 155 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 272
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 331
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 332 EWKSLTYDEVISFVPPP 348

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 52  AAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 112 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 171 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 288
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 289 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 347
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 348 EWKSLTYDEVISFVPPP 364

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 51  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 110
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 111 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 170 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 228 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 287
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 288 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 346
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 347 EWKSLTYDEVISFVPPP 363

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 52  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 112 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 171 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 288
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 289 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 347
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 348 EWKSLTYDEVISFVPPP 364

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 106 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 165 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 282
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 341
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 342 EWKSLTYDEVISFVPPP 358

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 52  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 112 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 171 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 229 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 288
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 289 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 347
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 348 EWKSLTYDEVISFVPPP 364

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 107 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 166 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 342
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 343 EWKSLTYDEVISFVPPP 359

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 102 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 161 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 337
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 338 EWKSLTYDEVISFVPPP 354

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 105 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 164 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 340
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 341 EWKSLTYDEVISFVPPP 357

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 60  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 120 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 179 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 296
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 297 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 355
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 356 EWKSLTYDEVISFVPPP 372

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 105 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 164 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 340
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 341 EWKSLTYDEVISFVPPP 357

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 39  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 98
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 99  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 157
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 158 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 215
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 216 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 275
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 276 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 334
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 335 EWKSLTYDEVISFVPPP 351

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  314 bits (805), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 59  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 118
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 119 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 178 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 236 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 295
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 296 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 354
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 355 EWKSLTYDEVISFVPPP 371

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 102 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 161 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 337
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 338 EWKSLTYDEVISFVPPP 354

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 122
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 123 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 182 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 240 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 299
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 300 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 358
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 359 EWKSLTYDEVISFVPPP 375

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 102 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 161 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 337
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 338 EWKSLTYDEVISFVPPP 354

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 106 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 165 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 282
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 341
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 342 EWKSLTYDEVISFVPPP 358

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 36  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 96  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 155 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 331
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 332 EWKSLTYDEVISFVPPP 348

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 38  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 97
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 98  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 156
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 157 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 214
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 215 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 274
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 275 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 333
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 334 EWKSLTYDEVISFVPPP 350

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 37  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 96
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 97  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 156 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 214 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 273
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 274 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 332
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 333 EWKSLTYDEVISFVPPP 349

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  314 bits (804), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 37  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 96
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 97  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 156 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 214 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 273
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 274 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 332
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 333 EWKSLTYDEVISFVPPP 349

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  314 bits (804), Expect = 6e-86,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 107 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 166 NEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+    E      D
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSLESRDLLID 342
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 343 EWKSLTYDEVISFVPPP 359

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  313 bits (803), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI D+GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDYGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  313 bits (801), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 36  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++   +LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 96  NDVYLVTHLMGADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 155 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 272
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 331
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 332 EWKSLTYDEVISFVPPP 348

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  313 bits (801), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P    FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPTDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  313 bits (801), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 122
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 123 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D M  YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 182 NEDCELKILDFGLARHTD--DEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 240 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 299
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 300 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 358
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 359 EWKSLTYDEVISFVPPP 375

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  313 bits (801), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 211/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 107 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 166 NEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+    E      D
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSSESRDLLID 342
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 343 EWKSLTYDEVISFVPPP 359

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  312 bits (800), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI  FGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILGFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  312 bits (800), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 156/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D M  +V TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  312 bits (799), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P    FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPQDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  312 bits (799), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 156/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 36  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 96  NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D M  +V TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 155 NEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 272
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 331
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 332 EWKSLTYDEVISFVPPP 348

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  312 bits (799), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 156/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D M  +V TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  312 bits (799), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 158/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P    FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPRDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  311 bits (798), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  311 bits (798), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DF LAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFYLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  311 bits (798), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI D GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDAGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  311 bits (797), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI D GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDGGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  311 bits (797), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 102 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 161 NEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 219 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 278
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 279 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 337
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 338 EWKSLTYDEVISFVPPP 354

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  311 bits (797), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 106 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 165 NEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 223 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 282
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 283 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 341
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 342 EWKSLTYDEVISFVPPP 358

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  311 bits (797), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D MT  V TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDFGLARHTD--DEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  311 bits (796), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI D GLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDCELKILDRGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  311 bits (796), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 51  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 110
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 111 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 170 NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 228 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 287
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 288 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 346
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 347 EWKSLTYDEVISFVPPP 363

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  311 bits (796), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 105 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 164 NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 340
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 341 EWKSLTYDEVISFVPPP 357

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  310 bits (795), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 157/317 (49%), Positives = 210/317 (66%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 105 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 164 NEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 222 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 281
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 282 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 340
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 341 EWKSLTYDEVISFVPPP 357

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  310 bits (794), Expect = 7e-85,   Method: Compositional matrix adjust.
 Identities = 156/317 (49%), Positives = 209/317 (65%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 60  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 120 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR T   D M   V TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 179 NEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 237 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG 296
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D
Sbjct: 297 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLID 355
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 356 EWKSLTYDEVISFVPPP 372

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  309 bits (792), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 156/317 (49%), Positives = 209/317 (65%), Gaps = 5/317 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           NDVY+V  LM  DL+ I++S Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +
Sbjct: 100 NDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +LKI DFGL R T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 159 NEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F  
Sbjct: 217 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 276
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+    E      D
Sbjct: 277 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSLESRDLLID 335
Query: 318 HIRELIWRESVKFNPDP 334
             + L + E + F P P
Sbjct: 336 EWKSLTYDEVISFVPPP 352

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  305 bits (781), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 152/308 (49%), Positives = 202/308 (65%), Gaps = 5/308 (1%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYEL 86
           ++A+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P    + FNDVY+V  L
Sbjct: 78  KIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHL 137
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           M  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +N  C+LKI 
Sbjct: 138 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 196
Query: 147 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 206
           DFGLAR T   D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++T   LFPG
Sbjct: 197 DFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG 254
Query: 207 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 266
            D+++QL+ I  L G+P  + +  + S  AR Y+  LP+  K+ FA  F   +  AVDLL
Sbjct: 255 TDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLL 314
Query: 267 EKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 326
           EKMLV D +KRIT  EAL HPY    HD +DEP    P+   FE      +  + L + E
Sbjct: 315 EKMLVLDTDKRITASEALAHPYFSQYHDPDDEPES-EPYDQSFESRQLEIEEWKRLTYEE 373
Query: 327 SVKFNPDP 334
              F   P
Sbjct: 374 VCSFETPP 381

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  293 bits (750), Expect = 9e-80,   Method: Compositional matrix adjust.
 Identities = 140/315 (44%), Positives = 208/315 (66%), Gaps = 5/315 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           +A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI + D+  P    + F
Sbjct: 38  SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 97
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           ++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKY+HSA ++HRDLKPSN+ +
Sbjct: 98  SEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV 156
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 157 NEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 214
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +  + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP   ++  ++ F  
Sbjct: 215 LQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRG 274
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  A+DLL +MLV D ++R++  EAL H Y    HD  DEP    P+    E    T +
Sbjct: 275 ANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLE 333
Query: 318 HIRELIWRESVKFNP 332
             +EL ++E + F P
Sbjct: 334 EWKELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  290 bits (741), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 139/313 (44%), Positives = 207/313 (66%), Gaps = 5/313 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           +A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI + D+  P    + F
Sbjct: 46  SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 105
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           ++VY+V  LM  DL+ I++S Q L+D+H Q+ +YQLLRGLKY+HSA ++HRDLKPSN+ +
Sbjct: 106 SEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV 164
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 165 NEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +  + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP   ++  ++ F  
Sbjct: 223 LQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRG 282
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  A+DLL +MLV D ++R++  EAL H Y    HD  DEP    P+    E    T +
Sbjct: 283 ANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLE 341
Query: 318 HIRELIWRESVKF 330
             +EL ++E + F
Sbjct: 342 EWKELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  287 bits (735), Expect = 5e-78,   Method: Compositional matrix adjust.
 Identities = 138/313 (44%), Positives = 206/313 (65%), Gaps = 5/313 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           +A ++  R++VA+KK+   F ++I ARRT RE++LL+H++HENVI + D+  P    + F
Sbjct: 46  SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 105
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           ++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLRGLKY+HSA ++HRDLKPSN+ +
Sbjct: 106 SEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV 164
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N   +L+I DFGLAR   E   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E+
Sbjct: 165 NEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +  + LFPG DY+ QL+ I E++G+P    L  + S++AR Y++ LP   ++  ++ F  
Sbjct: 223 LQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRG 282
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            +  A+DLL +MLV D ++R++  EAL H Y    HD  DEP    P+    E    T +
Sbjct: 283 ANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLE 341
Query: 318 HIRELIWRESVKF 330
             +EL ++E + F
Sbjct: 342 EWKELTYQEVLSF 354

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  281 bits (718), Expect = 4e-76,   Method: Compositional matrix adjust.
 Identities = 140/315 (44%), Positives = 204/315 (64%), Gaps = 5/315 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           +AV+  T  +VAIKK+   F + + A+R  RE++LL+HM HENVI + D+  P +  D F
Sbjct: 43  SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +
Sbjct: 103 TDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR       M   VVTRWYRAPE++LN   YT  +DIWSVGCI+ E+
Sbjct: 162 NEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T + LF G D++ QL+ I ++ G+P    +  L+SD A+ Y++ LP   K+ FA+   N
Sbjct: 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            S  AV+LLEKMLV D  +R+T  EAL HPY +SLHD  DEP   + +   F+    T D
Sbjct: 280 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK-YDDSFDDVDRTLD 338
Query: 318 HIRELIWRESVKFNP 332
             + + ++E + F P
Sbjct: 339 EWKRVTYKEVLSFKP 353

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  280 bits (716), Expect = 9e-76,   Method: Compositional matrix adjust.
 Identities = 139/315 (44%), Positives = 196/315 (62%), Gaps = 5/315 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           +A++  + E+VAIKK+   F + I A+R  RE+ LL+HM+HENVI + D+  P      F
Sbjct: 60  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            D Y+V   M TDL +I+    + +++  QY +YQ+L+GLKY+HSA V+HRDLKP NL +
Sbjct: 120 YDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 177
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR       MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E+
Sbjct: 178 NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 235
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LP+  ++ F   FP 
Sbjct: 236 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 295
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            S  A DLLEKML  D +KR+T  +AL HP+ +   D  +E    +PF    EH   T D
Sbjct: 296 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVD 355
Query: 318 HIRELIWRESVKFNP 332
             ++ I++E V F+P
Sbjct: 356 EWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  279 bits (714), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 139/315 (44%), Positives = 196/315 (62%), Gaps = 5/315 (1%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTF 77
           +A++  + E+VAIKK+   F + I A+R  RE+ LL+HM+HENVI + D+  P      F
Sbjct: 42  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            D Y+V   M TDL +I+    + +++  QY +YQ+L+GLKY+HSA V+HRDLKP NL +
Sbjct: 102 YDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 159
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N  C+LKI DFGLAR       MT YVVTRWYRAPE++L+   Y   +DIWSVGCI+ E+
Sbjct: 160 NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LP+  ++ F   FP 
Sbjct: 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 317
            S  A DLLEKML  D +KR+T  +AL HP+ +   D  +E    +PF    EH   T D
Sbjct: 278 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVD 337
Query: 318 HIRELIWRESVKFNP 332
             ++ I++E V F+P
Sbjct: 338 EWKQHIYKEIVNFSP 352

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  242 bits (617), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 137/356 (38%), Positives = 210/356 (58%), Gaps = 50/356 (14%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPP 72
           + I   +++  T E VA+KKI +AF N  DA+RT REI +L  +  HEN++ + +++R  
Sbjct: 22  YGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA- 80
Query: 73  KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
             D   DVY+V++ M+TDLH +IR++  L   H QY +YQL++ +KY+HS  +LHRD+KP
Sbjct: 81  --DNDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP 137
Query: 133 SNLLLNASCDLKIGDFGLART------------------TSETD----FMTEYVVTRWYR 170
           SN+LLNA C +K+ DFGL+R+                  T   D     +T+YV TRWYR
Sbjct: 138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR 197
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 230
           APE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I  +I  P +  +  
Sbjct: 198 APEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVES 257
Query: 231 LRSDNARRYVRQLP------RCRKQQFATRFPNK----------SSGAVDLLEKMLVFDP 274
           ++S  A+  +  L       +  K+   T++ N           +  A+DLL+K+L F+P
Sbjct: 258 IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317
Query: 275 NKRITVEEALRHPYLQSLHDLNDEPVCPR----PFHFDFEHSSCTEDHIRELIWRE 326
           NKRI+  +AL+HP++   H+ N+EP C      P + + +HS    D  R L++ E
Sbjct: 318 NKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSI---DDYRNLVYSE 370

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  241 bits (614), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 195 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 253
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 254 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 312
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 372
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 373 PQIYDKQLDEREHTIEEWKELIYKE 397

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  241 bits (614), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 40  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 99
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 158 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 216
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 217 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 275
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 276 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 335
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 336 PQIYDKQLDEREHTIEEWKELIYKE 360

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  240 bits (613), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 335 PQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  240 bits (613), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 40  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 99
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 158 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 216
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 217 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 275
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 276 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 335
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 336 PQIYDKQLDEREHTIEEWKELIYKE 360

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  240 bits (613), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 335 PQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  240 bits (613), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 195 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 253
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 254 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 312
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 372
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 373 PQIYDKQLDEREHTIEEWKELIYKE 397

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  240 bits (613), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 38  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 97
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 98  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 155
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 156 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 214
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 215 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 273
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 274 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 333
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 334 PQIYDKQLDEREHTIEEWKELIYKE 358

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  240 bits (613), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 208
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 267
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 327
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 328 PQIYDKQLDEREHTIEEWKELIYKE 352

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  240 bits (612), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 33  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 92
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 150
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 151 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 209
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 210 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 268
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 269 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 328
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 329 PQIYDKQLDEREHTIEEWKELIYKE 353

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  240 bits (612), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 197/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 33  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 92
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 150
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 151 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 209
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 210 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 268
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 269 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 328
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 329 PQIYDKQLDEREHTIEEWKELIYKE 353

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/325 (40%), Positives = 196/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 335 PQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 196/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 33  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 92
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 93  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 150
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI+
Sbjct: 151 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIM 209
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 210 GEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 268
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 269 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 328
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 329 PKIPDKQLDEREHTIEEWKELIYKE 353

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 196/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 44  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 103
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 104 EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 161
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI+
Sbjct: 162 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIM 220
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 221 GEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 279
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 280 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 339
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 340 PKIPDKQLDEREHTIEEWKELIYKE 364

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 194/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  238 bits (608), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 132/325 (40%), Positives = 196/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 335 PQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  238 bits (608), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 132/325 (40%), Positives = 196/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 92  EEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSN 149
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 150 IVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 208
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 267
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  + E   
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 327
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    +    T +  +ELI++E
Sbjct: 328 PQIYDKQLDEREHTIEEWKELIYKE 352

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  238 bits (607), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 194/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VA+KK+   F N   A+R  RE+ LL+ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I    +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART      MT YVVTR+YRAPE++L    Y A +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YAANVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    +F G D++ Q   + E +G+P    +  L+    R YV   P+    +F   
Sbjct: 216 GELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP-TVRNYVENRPKYPGIKFEEL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP+KRI+V+EALRHPY+   +D  + E   
Sbjct: 275 FPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    E      +  +ELI++E
Sbjct: 335 PQIYDAQLEEREHAIEEWKELIYKE 359

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  238 bits (607), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 194/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 192/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VA+KK+   F N   A+R  RE+ LL+ + H+N+I++ ++  P K  
Sbjct: 37  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL 96
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I    +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 97  EEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 154
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART S    MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 155 IVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 213
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    +F G D++ Q   + E +G+P    +  L+    R YV   P      F   
Sbjct: 214 GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP-TVRNYVENRPAYPGIAFEEL 272
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV DP+KRI+V+EALRHPY+   +D  + E   
Sbjct: 273 FPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP 332
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+ +    E      +  +ELI++E
Sbjct: 333 PQIYDAQLEEREHAIEEWKELIYKE 357

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  237 bits (604), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 132/325 (40%), Positives = 193/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  236 bits (603), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 195/325 (60%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  M   VVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P  A +  L+    R YV   P+     F   
Sbjct: 216 GEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQP-TVRNYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 194/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 40  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 158 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 216
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 217 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 275
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 335
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 336 PKIPDKQLDEREHTIEEWKELIYKE 360

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 194/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 132/325 (40%), Positives = 193/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 132/325 (40%), Positives = 193/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  234 bits (598), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 134/334 (40%), Positives = 196/334 (58%), Gaps = 18/334 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT  VVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 335
           P+      +    T +  +ELI++E +     PT
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKEVMDLPKRPT 368

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  234 bits (597), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 131/325 (40%), Positives = 192/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVG I+
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  234 bits (596), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 125/292 (42%), Positives = 181/292 (61%), Gaps = 17/292 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  234 bits (596), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 125/323 (38%), Positives = 182/323 (56%), Gaps = 59/323 (18%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIKKI   F+++ID +R LREI +L  + H++V+ + DI+ P   + F+++Y+V E+ D
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD 140
Query: 89  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
           +D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHRDLKP+N L+N  C +K+ DF
Sbjct: 141 SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 149 GLARTTS--------------ETDF--------------MTEYVVTRWYRAPELLLNCTE 180
           GLART                E D               +T +VVTRWYRAPEL+L    
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 181 YTAAIDIWSVGCILGEIMT-----------REPLFPG--------------------KDY 209
           YT AID+WS+GCI  E++            R PLFPG                    +  
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGN 320
Query: 210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM 269
             QL +I  ++G+P +  +  L  ++A+RY+R  P+      A RFP  S+ A+ LL++M
Sbjct: 321 RDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRM 380
Query: 270 LVFDPNKRITVEEALRHPYLQSL 292
           LVF+PNKRIT+ E L HP+ + +
Sbjct: 381 LVFNPNKRITINECLAHPFFKEV 403

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  234 bits (596), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 131/325 (40%), Positives = 192/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVG I+
Sbjct: 157 IVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  233 bits (594), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 131/325 (40%), Positives = 193/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 41  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 100
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 101 EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 158
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  M  +VVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 159 IVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 217
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 218 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 276
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 277 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 336
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 337 PKIPDKQLDEREHTIEEWKELIYKE 361

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  233 bits (594), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 131/325 (40%), Positives = 194/325 (59%), Gaps = 18/325 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  M   VVTR+YRAPE++L    Y   +D+WSVGCI+
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVC 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++ E   
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 302 PRPFHFDFEHSSCTEDHIRELIWRE 326
           P+      +    T +  +ELI++E
Sbjct: 335 PKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  231 bits (589), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 124/287 (43%), Positives = 179/287 (62%), Gaps = 17/287 (5%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ +   LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 157 IVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   
Sbjct: 216 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKL 274
Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+
Sbjct: 275 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 130/380 (34%), Positives = 199/380 (52%), Gaps = 57/380 (15%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y  +       A +  T + VAIKK+   F+++ID +R LREI +L  ++ + +I +
Sbjct: 36  RGSYGYVYL-----AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            D+I P     F+++YIV E+ D+DL ++ ++   LT++H +  LY LL G  ++H + +
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGI 150
Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLART-TSETDF----------------------MTE 162
           +HRDLKP+N LLN  C +K+ DFGLART  SE D                       +T 
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREPLFPGKD--- 208
           +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            R PLFPG     
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270
Query: 209 --------YVH------QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
                    VH      QL +I  +IG+P +  L  +      +Y++  P  +      +
Sbjct: 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330
Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SS 313
           +P+ S   ++LLE ML F+PNKRIT+++AL HPYL+ +     E    +     F+    
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMV 390
Query: 314 CTEDHIRELIWRESVKFNPD 333
            +E  +R +  +E   F+P+
Sbjct: 391 LSETQLRYIFLKEVQSFHPE 410

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 123/304 (40%), Positives = 177/304 (58%), Gaps = 17/304 (5%)
Query: 19  AAVNSETREEVAIKKIGNAFD-----NIID----ARRTLREIKLLRHMEHENVIAIKDII 69
           A V+SE    VAIK++ N        NI+      +R LREI+LL H  H N++ ++DI 
Sbjct: 40  AGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98
Query: 70  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLH 127
              ++   + +Y+V ELM TDL Q+I  DQ++  +  H QYF+Y +L GL  +H A V+H
Sbjct: 99  VHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVH 157
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           RDL P N+LL  + D+ I DF LAR  +     T YV  RWYRAPEL++    +T  +D+
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ-LPRC 246
           WS GC++ E+  R+ LF G  + +QL  I E++G+P    +    S +AR Y+R  L   
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND--EPVCPRP 304
             + +    P     A+DL+ KML F+P +RI+ E+ALRHPY +SL D  D  E +  R 
Sbjct: 278 PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSER- 336
Query: 305 FHFD 308
           FHFD
Sbjct: 337 FHFD 340

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 123/304 (40%), Positives = 177/304 (58%), Gaps = 17/304 (5%)
Query: 19  AAVNSETREEVAIKKIGNAFD-----NIID----ARRTLREIKLLRHMEHENVIAIKDII 69
           A V+SE    VAIK++ N        NI+      +R LREI+LL H  H N++ ++DI 
Sbjct: 40  AGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98
Query: 70  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLH 127
              ++   + +Y+V ELM TDL Q+I  DQ++  +  H QYF+Y +L GL  +H A V+H
Sbjct: 99  VHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVH 157
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           RDL P N+LL  + D+ I DF LAR  +     T YV  RWYRAPEL++    +T  +D+
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ-LPRC 246
           WS GC++ E+  R+ LF G  + +QL  I E++G+P    +    S +AR Y+R  L   
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND--EPVCPRP 304
             + +    P     A+DL+ KML F+P +RI+ E+ALRHPY +SL D  D  E +  R 
Sbjct: 278 PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSER- 336
Query: 305 FHFD 308
           FHFD
Sbjct: 337 FHFD 340

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  211 bits (536), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 129/383 (33%), Positives = 194/383 (50%), Gaps = 60/383 (15%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG Y  +       A +    + VAIKK+   F+++ID +R LREI +L  ++ + +I +
Sbjct: 38  RGSYGYVYL-----AYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 92
Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            D+I P     F+++YIV E+ D+DL ++ ++   LT+ H +  LY LL G K++H + +
Sbjct: 93  HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGI 152
Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLART-TSETDF------------------------- 159
           +HRDLKP+N LLN  C +KI DFGLART  S+ D                          
Sbjct: 153 IHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQ 212
Query: 160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREPLFPGKD 208
           +T +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            R PLFPG  
Sbjct: 213 LTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSS 272
Query: 209 -----------YVH------QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
                       VH      QL +I  +IG+P +  L  +      +Y++  P       
Sbjct: 273 CFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDL 332
Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH 311
           + ++ + S   +DLLE ML F+  KRIT+++AL HPYL+ +   N E          F+ 
Sbjct: 333 SKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDD 392
Query: 312 -SSCTEDHIRELIWRESVKFNPD 333
               +E  +R +  +E   F+ D
Sbjct: 393 WMVLSETQLRYIFLKEIQSFHAD 415

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 122/300 (40%), Positives = 172/300 (57%), Gaps = 19/300 (6%)
Query: 15  FIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK 74
            +FSA V+++  + VAIKKI     +    +  LREIK++R ++H+N++ + +I+ P   
Sbjct: 26  LVFSA-VDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82
Query: 75  DT---------FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
                       N VYIV E M+TDL  ++     L ++H + F+YQLLRGLKY+HSA+V
Sbjct: 83  QLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFMYQLLRGLKYIHSANV 141
Query: 126 LHRDLKPSNLLLNAS-CDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCTE 180
           LHRDLKP+NL +N     LKIGDFGLAR      S    ++E +VT+WYR+P LLL+   
Sbjct: 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN 201
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
           YT AID+W+ GCI  E++T + LF G   + Q++LI E I    +     L S     Y+
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS-VIPVYI 260
Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
           R       +      P  S  AVD LE++L F P  R+T EEAL HPY+       DEP+
Sbjct: 261 RNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 29  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 83
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 84  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 143
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 144 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 203
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 204 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 261
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 262 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/282 (38%), Positives = 155/282 (54%), Gaps = 10/282 (3%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +   A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I    
Sbjct: 20  YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--- 76
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
             T N +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLK
Sbjct: 77  --TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 134
Query: 132 PSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           P NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+
Sbjct: 135 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 194
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q 
Sbjct: 195 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQD 252
Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 253 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 77
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 78  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 137
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 138 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 197
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 198 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 255
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 256 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 75
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  190 bits (483), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 152/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 75
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 108/282 (38%), Positives = 155/282 (54%), Gaps = 10/282 (3%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +   A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I    
Sbjct: 19  YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--- 75
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
             T N +Y+V+E +D DL + + +     +     + +L+QLL+GL + HS  VLHRDLK
Sbjct: 76  --TENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 133
Query: 132 PSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           P NLL+N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSL 193
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q 
Sbjct: 194 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQD 251
Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  189 bits (479), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 79
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 80  LYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLI 139
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 140 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 199
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 200 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 257
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 258 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  189 bits (479), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 77
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 78  LYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLI 137
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 138 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 197
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 198 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 255
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 256 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 26  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 80
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 81  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 140
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 141 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 200
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 201 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 258
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 259 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 78
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 79  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 138
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 139 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 198
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 199 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 256
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 257 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 75
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 78
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 79  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLI 138
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 139 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 198
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 199 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 256
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 257 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 75
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 79
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 80  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 139
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 140 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 199
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 200 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 257
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 258 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  188 bits (478), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 79
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 80  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 139
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 140 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 199
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 200 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 257
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 258 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 78
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 79  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 138
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 139 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 198
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 199 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 256
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 257 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 77
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 78  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 137
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 138 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 197
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 198 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 255
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 256 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+ KI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+ KI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 21  ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 75
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 77
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 78  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLI 137
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 138 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 197
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 198 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 255
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 256 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 23  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 77
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 78  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 137
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 138 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 197
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 198 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 255
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 256 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 150/274 (54%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 24  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 78
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 79  LYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 138
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 139 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 198
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 199 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 256
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 257 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 150/274 (54%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 79
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 80  LYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 139
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 140 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 199
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 200 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 257
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 258 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  187 bits (476), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 101/251 (40%), Positives = 145/251 (57%), Gaps = 10/251 (3%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH- 105
            +RE+ LL+ ++H N++ + DII   K  T     +V+E +D DL Q +     + + H 
Sbjct: 47  AIREVSLLKDLKHANIVTLHDIIHTEKSLT-----LVFEYLDKDLKQYLDDCGNIINMHN 101
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYV 164
            + FL+QLLRGL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T      V
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
           VT WYR P++LL  T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I  ++G+P 
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 225 DASL-GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           + +  G L ++  + Y    P+ R +   +  P   S   DLL K+L F+   RI+ E+A
Sbjct: 222 EETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 284 LRHPYLQSLHD 294
           ++HP+  SL +
Sbjct: 280 MKHPFFLSLGE 290

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 150/274 (54%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 25  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 79
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 80  LYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 139
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 140 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 199
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 200 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 257
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 258 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  187 bits (475), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 108/280 (38%), Positives = 153/280 (54%), Gaps = 10/280 (3%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           + +   A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I    
Sbjct: 15  YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--- 71
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
             T N +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLK
Sbjct: 72  --TENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 132 PSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           P NLL+N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           GCI  E++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q 
Sbjct: 190 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQD 247
Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  187 bits (475), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 150/274 (54%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL   + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR            VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 29  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 83
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 84  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 143
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+DIWS+GCI  E
Sbjct: 144 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAE 203
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 204 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 261
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 262 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 151/274 (55%), Gaps = 10/274 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 22  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENK 76
Query: 80  VYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 77  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 136
Query: 138 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL    Y+ A+DIWS+GCI  E
Sbjct: 137 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAE 196
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+     + S     Y    P+  +Q F+   P
Sbjct: 197 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVP 254
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 255 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/292 (36%), Positives = 168/292 (57%), Gaps = 31/292 (10%)
Query: 14  FFIFSAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP 72
           + +   A +S+ R  VA+K+I  +A D  I +   +REI LL+ + H N++++ D+I   
Sbjct: 34  YGVVYKAKDSQGRI-VALKRIRLDAEDEGIPST-AIREISLLKELHHPNIVSLIDVIHSE 91
Query: 73  KKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           +  T     +V+E M+ DL +++  ++  L D   + +LYQLLRG+ + H   +LHRDLK
Sbjct: 92  RCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 132 PSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           P NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+ ++DIWS+
Sbjct: 147 PQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY--VRQLPRCRK 248
           GCI  E++T +PLFPG     QL  I  ++G+P           N R +  V++LP  ++
Sbjct: 207 GCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-----------NPREWPQVQELPLWKQ 255
Query: 249 QQF--------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           + F        ++  P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 108/292 (36%), Positives = 168/292 (57%), Gaps = 31/292 (10%)
Query: 14  FFIFSAAVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP 72
           + +   A +S+ R  VA+K+I  +A D  I +   +REI LL+ + H N++++ D+I   
Sbjct: 34  YGVVYKAKDSQGRI-VALKRIRLDAEDEGIPST-AIREISLLKELHHPNIVSLIDVIHSE 91
Query: 73  KKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           +  T     +V+E M+ DL +++  ++  L D   + +LYQLLRG+ + H   +LHRDLK
Sbjct: 92  RCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 132 PSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           P NLL+N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+ ++DIWS+
Sbjct: 147 PQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY--VRQLPRCRK 248
           GCI  E++T +PLFPG     QL  I  ++G+P           N R +  V++LP  ++
Sbjct: 207 GCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-----------NPREWPQVQELPLWKQ 255
Query: 249 QQF--------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           + F        ++  P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/283 (37%), Positives = 164/283 (57%), Gaps = 22/283 (7%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
            +N  T   VA+K++    D+      T +REI L++ ++HEN++ + D+I      T N
Sbjct: 24  GLNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TEN 76
Query: 79  DVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
            + +V+E MD DL + + S       + L  +  +YF +QLL+GL + H   +LHRDLKP
Sbjct: 77  KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136
Query: 133 SNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
            NLL+N    LK+GDFGLAR      +  +  VVT WYRAP++L+    Y+ +IDIWS G
Sbjct: 137 QNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG 196
Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA---SLGFLRSDNARRYVRQLPRCRK 248
           CIL E++T +PLFPG +   QL+LI +++G+P+++   S+  L   N     R  PR  +
Sbjct: 197 CILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP-PRDLR 255
Query: 249 Q--QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           Q  Q  T+ P      +D L  +L  +P+ R++ ++AL HP+ 
Sbjct: 256 QVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 9/266 (3%)
Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           E  A+KKI    ++      T+REI +L+ ++H N++ + D+I   K+     + +V+E 
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLVFEH 81
Query: 87  MDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           +D DL +++   +  L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 146 GDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            DFGLAR         T  VVT WYRAP++L+   +Y+  IDIWSVGCI  E++   PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201
Query: 205 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 264
           PG     QL  I  ++G+P+  S  +       +Y           + +         +D
Sbjct: 202 PGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 265 LLEKMLVFDPNKRITVEEALRHPYLQ 290
           LL KML  DPN+RIT ++AL H Y +
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 9/266 (3%)
Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           E  A+KKI    ++      T+REI +L+ ++H N++ + D+I   K+     + +V+E 
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLVFEH 81
Query: 87  MDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           +D DL +++   +  L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 146 GDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            DFGLAR         T  VVT WYRAP++L+   +Y+  IDIWSVGCI  E++   PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 205 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 264
           PG     QL  I  ++G+P+  S  +       +Y           + +         +D
Sbjct: 202 PGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 265 LLEKMLVFDPNKRITVEEALRHPYLQ 290
           LL KML  DPN+RIT ++AL H Y +
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 144/266 (54%), Gaps = 9/266 (3%)
Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           E  A+KKI    ++      T+REI +L+ ++H N++ + D+I   K+     + +V+E 
Sbjct: 27  ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLVFEH 81
Query: 87  MDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
           +D DL +++   +  L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 146 GDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            DFGLAR         T  +VT WYRAP++L+   +Y+  IDIWSVGCI  E++   PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 205 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 264
           PG     QL  I  ++G+P+  S  +       +Y           + +         +D
Sbjct: 202 PGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 265 LLEKMLVFDPNKRITVEEALRHPYLQ 290
           LL KML  DPN+RIT ++AL H Y +
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 150/273 (54%), Gaps = 10/273 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N ET E VA+K++    D+       LREI LL+ ++H+N++ + D++   KK T   
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT--- 77
Query: 80  VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
             +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +VLHRDLKP NLL+N
Sbjct: 78  --LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135
Query: 139 ASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            + +LK+ DFGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI  E+
Sbjct: 136 RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 198 M-TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
                PLFPG D   QL+ I  L+G+P +     +      +     P           P
Sbjct: 196 ANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP--ATTSLVNVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             ++   DLL+ +L  +P +RI+ EEAL+HPY 
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 150/273 (54%), Gaps = 10/273 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N ET E VA+K++    D+       LREI LL+ ++H+N++ + D++   KK T   
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT--- 77
Query: 80  VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
             +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +VLHRDLKP NLL+N
Sbjct: 78  --LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135
Query: 139 ASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            + +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI  E+
Sbjct: 136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 198 MTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
                PLFPG D   QL+ I  L+G+P +     +      +     P           P
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP--ATTSLVNVVP 253
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             ++   DLL+ +L  +P +RI+ EEAL+HPY 
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/298 (35%), Positives = 153/298 (51%), Gaps = 17/298 (5%)
Query: 14  FFIFSAAVNSETREEVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 68
           F     A +  T + VAIKKI       A D I   R  LREIKLL+ + H N+I + D 
Sbjct: 23  FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNIIGLLDA 80
Query: 69  IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLH 127
                    +++ +V++ M+TDL  II+ +   LT  H + ++   L+GL+Y+H   +LH
Sbjct: 81  F-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 128 RDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
           RDLKP+NLLL+ +  LK+ DFGLA++  S        VVTRWYRAPELL     Y   +D
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVD 195
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +W+VGCIL E++ R P  PG   + QL  I E +G+P +     + S       +  P  
Sbjct: 196 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 255
Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 304
                   F       +DL++ + +F+P  RIT  +AL+  Y  +          PRP
Sbjct: 256 PLHHI---FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 164/293 (55%), Gaps = 7/293 (2%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G+  +  + +     N +T + VAIKK   + D+ +  +  LREI++L+ ++H N++ + 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 67  DIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           ++ R  ++     +++V+E  D T LH++ R  + + +   +   +Q L+ + + H  + 
Sbjct: 69  EVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PELL+  T+Y   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           +D+W++GC+  E+++  PL+PGK  V QL LI + +G           ++     V+   
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243
Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 297
               +    +FPN S  A+ LL+  L  DP +R+T E+ L HPY +++ ++ D
Sbjct: 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/254 (38%), Positives = 141/254 (55%), Gaps = 16/254 (6%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQL 101
           T+RE+ +LRH+E   H NV+ + D+    + D    + +V+E +D DL   +    +  +
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG
Sbjct: 178 SVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 222 SPDDASLGFLRSDNARRYV--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRI 278
            P +        D  R     RQ    +  Q   +F  +      DLL K L F+P KRI
Sbjct: 237 LPGE-------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289
Query: 279 TVEEALRHPYLQSL 292
           +   AL HPY Q L
Sbjct: 290 SAYSALSHPYFQDL 303

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/254 (38%), Positives = 141/254 (55%), Gaps = 16/254 (6%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQL 101
           T+RE+ +LRH+E   H NV+ + D+    + D    + +V+E +D DL   +    +  +
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG
Sbjct: 178 SVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 222 SPDDASLGFLRSDNARRYV--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRI 278
            P +        D  R     RQ    +  Q   +F  +      DLL K L F+P KRI
Sbjct: 237 LPGE-------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289
Query: 279 TVEEALRHPYLQSL 292
           +   AL HPY Q L
Sbjct: 290 SAYSALSHPYFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 98/252 (38%), Positives = 140/252 (55%), Gaps = 16/252 (6%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQL 101
           T+RE+ +LRH+E   H NV+ + D+    + D    + +V+E +D DL   +    +  +
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG
Sbjct: 178 SVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 222 SPDDASLGFLRSDNARRYV--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRI 278
            P +        D  R     RQ    +  Q   +F  +      DLL K L F+P KRI
Sbjct: 237 LPGE-------EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289
Query: 279 TVEEALRHPYLQ 290
           +   AL HPY Q
Sbjct: 290 SAYSALSHPYFQ 301

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  160 bits (405), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 97/278 (34%), Positives = 150/278 (53%), Gaps = 14/278 (5%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A+++ T E VAIK+I    +        +RE+ LL+ ++H N+I +K +I    +     
Sbjct: 53  AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR----- 107
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++++E  + DL + +  +  ++    + FLYQL+ G+ + HS   LHRDLKP NLLL+ 
Sbjct: 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 140 SCD-----LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           S       LKIGDFGLAR         T  ++T WYR PE+LL    Y+ ++DIWS+ CI
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
             E++ + PLFPG   + QL  I E++G PDD +   + +     + +  P+ R +    
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA--LPDWKQSFPKFRGKTLKR 285
Query: 254 RF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                     +DLL  ML  DP KRI+ + AL HPY  
Sbjct: 286 VLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 152/274 (55%), Gaps = 18/274 (6%)
Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI--VY 84
           +EVAIKK+      + D R   RE++++R ++H NV+ +K        D  ++V++  V 
Sbjct: 65  DEVAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYS-NGDKKDEVFLNLVL 117
Query: 85  ELMDTDLHQIIRSDQQLTDDH----CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA- 139
           E +   +++  R   +L         + ++YQLLR L Y+HS  + HRD+KP NLLL+  
Sbjct: 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177
Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           S  LK+ DFG A+     +     + +R+YRAPEL+   T YT  IDIWS GC++ E+M 
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNK 258
            +PLFPG+  + QL  I +++G+P       +++ N      + P+ R   F+  F P  
Sbjct: 238 GQPLFPGESGIDQLVEIIKVLGTPSREQ---IKTMNPNYMEHKFPQIRPHPFSKVFRPRT 294
Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
              A+DL+ ++L + P+ R+T  EAL HP+   L
Sbjct: 295 PPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 152/272 (55%), Gaps = 9/272 (3%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N +T   VAIKK   + D+ +  +  +REIKLL+ + HEN++ + ++ +  K+      Y
Sbjct: 46  NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-----WY 100
Query: 82  IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +V+E +D T L  +      L     Q +L+Q++ G+ + HS +++HRD+KP N+L++ S
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160
Query: 141 CDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ DFG ART  +  +   + V TRWYRAPELL+   +Y  A+D+W++GC++ E+  
Sbjct: 161 GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ-FATRFPNK 258
            EPLFPG   + QL  I   +G+           +     VR LP  ++++    R+P  
Sbjct: 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR-LPEIKEREPLERRYPKL 279
Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           S   +DL +K L  DP+KR    E L H + Q
Sbjct: 280 SEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/254 (38%), Positives = 135/254 (53%), Gaps = 20/254 (7%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQL 101
           T+RE+ LLR +E   H NV+ + D+    + D    V +V+E +D DL   +       L
Sbjct: 58  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 117
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 178 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNK 276
            P +        D+  R V  LPR        R      P        LL +ML F+P+K
Sbjct: 237 LPPE--------DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 277 RITVEEALRHPYLQ 290
           RI+   AL+H YL 
Sbjct: 288 RISAFRALQHSYLH 301

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 158/295 (53%), Gaps = 26/295 (8%)
Query: 14  FFIFSAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP 71
           F +   A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++     
Sbjct: 33  FGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFFYS 84
Query: 72  P--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSA 123
              KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS 
Sbjct: 85  SGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 124 SVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 201
Query: 183 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 242
           ++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      +
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFK 258
Query: 243 LPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
            P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 157/295 (53%), Gaps = 26/295 (8%)
Query: 14  FFIFSAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP 71
           F +   A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++     
Sbjct: 33  FGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFFYS 84
Query: 72  P--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSA 123
              KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS 
Sbjct: 85  SGEKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 124 SVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 201
Query: 183 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 242
           ++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N       
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFA 258
Query: 243 LPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
            P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 96/254 (37%), Positives = 134/254 (52%), Gaps = 20/254 (7%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQL 101
           T+RE+ LLR +E   H NV+ + D+    + D    V +V+E +D DL   +       L
Sbjct: 50  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    + 
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALA 169
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 170 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 228
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNK 276
            P +        D+  R V  LPR        R      P        LL +ML F+P+K
Sbjct: 229 LPPE--------DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 279
Query: 277 RITVEEALRHPYLQ 290
           RI+   AL+H YL 
Sbjct: 280 RISAFRALQHSYLH 293

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/254 (37%), Positives = 134/254 (52%), Gaps = 20/254 (7%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQL 101
           T+RE+ LLR +E   H NV+ + D+    + D    V +V+E +D DL   +       L
Sbjct: 50  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    + 
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALD 169
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 170 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 228
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNK 276
            P +        D+  R V  LPR        R      P        LL +ML F+P+K
Sbjct: 229 LPPE--------DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 279
Query: 277 RITVEEALRHPYLQ 290
           RI+   AL+H YL 
Sbjct: 280 RISAFRALQHSYLH 293

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/254 (37%), Positives = 134/254 (52%), Gaps = 20/254 (7%)
Query: 47  TLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQL 101
           T+RE+ LLR +E   H NV+ + D+    + D    V +V+E +D DL   +       L
Sbjct: 50  TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 109
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
             +  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    + 
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF 169
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
             VVT WYRAPE+LL  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG
Sbjct: 170 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 228
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNK 276
            P +        D+  R V  LPR        R      P        LL +ML F+P+K
Sbjct: 229 LPPE--------DDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 279
Query: 277 RITVEEALRHPYLQ 290
           RI+   AL+H YL 
Sbjct: 280 RISAFRALQHSYLH 293

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 61  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 114
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 115 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 171
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 172 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 231
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 232 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 288
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 289 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 341

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 67  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 121 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 237
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 238 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 294
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 33  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 87  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 260
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 46  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 99
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 100 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 156
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 157 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 216
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 217 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 273
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 274 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 326

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 38  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 91
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 92  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 148
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 149 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 208
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 209 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 265
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 266 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 318

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RP 71
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 112 FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 165
Query: 72  PKKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 166 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 222
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 223 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 282
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 283 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 339
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 340 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 392

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 69  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 122
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 123 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 179
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 180 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 239
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 240 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 296
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 297 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 349

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RP 71
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 71  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 124
Query: 72  PKKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 125 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 181
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++
Sbjct: 182 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 241
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 242 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 298
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 299 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 156/295 (52%), Gaps = 26/295 (8%)
Query: 14  FFIFSAAVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP 71
           F +   A   ++ E VAIKK+  G AF N        RE++++R ++H N++ ++     
Sbjct: 33  FGVVYQAKLCDSGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFFYS 84
Query: 72  P--KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSA 123
              KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS 
Sbjct: 85  SGEKKD---EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 124 SVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYT 201
Query: 183 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 242
           ++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N       
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFA 258
Query: 243 LPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
            P+ +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 154/284 (54%), Gaps = 14/284 (4%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR---PPKKDT 76
           A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I R    P    
Sbjct: 36  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95
Query: 77  FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   +LHRD+K +N+
Sbjct: 96  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 155
Query: 136 LLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  
Sbjct: 156 LITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGA 215
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR-QLPRCRKQ 249
           GCI+ E+ TR P+  G    HQL LI++L GS       +   DN   Y + +L + +K+
Sbjct: 216 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--WPNVDNYELYEKLELVKGQKR 273
Query: 250 QFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           +   R     +   A+DL++K+LV DP +RI  ++AL H +  S
Sbjct: 274 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 154/284 (54%), Gaps = 14/284 (4%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR---PPKKDT 76
           A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I R    P    
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 96
Query: 77  FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   +LHRD+K +N+
Sbjct: 97  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 156
Query: 136 LLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  
Sbjct: 157 LITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGA 216
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR-QLPRCRKQ 249
           GCI+ E+ TR P+  G    HQL LI++L GS       +   DN   Y + +L + +K+
Sbjct: 217 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--WPNVDNYELYEKLELVKGQKR 274
Query: 250 QFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           +   R     +   A+DL++K+LV DP +RI  ++AL H +  S
Sbjct: 275 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 97/284 (34%), Positives = 154/284 (54%), Gaps = 14/284 (4%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR---PPKKDT 76
           A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I R    P    
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 96
Query: 77  FNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   +LHRD+K +N+
Sbjct: 97  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 156
Query: 136 LLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W  
Sbjct: 157 LITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGA 216
Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR-QLPRCRKQ 249
           GCI+ E+ TR P+  G    HQL LI++L GS       +   DN   Y + +L + +K+
Sbjct: 217 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--WPNVDNYELYEKLELVKGQKR 274
Query: 250 QFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           +   R     +   A+DL++K+LV DP +RI  ++AL H +  S
Sbjct: 275 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 94/320 (29%), Positives = 167/320 (52%), Gaps = 48/320 (15%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---- 69
           F I     + E+ +  A+KK+      + D R   RE+ +++ ++H N+I + D      
Sbjct: 20  FGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73
Query: 70  ----RPP-----------KKDTFND--------------VYIVYELMDTDLHQI----IR 96
               +PP           K +  N+              + ++ E +   LH++    IR
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR 133
Query: 97  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTS 155
           S + +  +    ++YQL R + ++HS  + HRD+KP NLL+N+  + LK+ DFG A+   
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193
Query: 156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 215
            ++     + +R+YRAPEL+L  TEYT +ID+WS+GC+ GE++  +PLF G+  + QL  
Sbjct: 194 PSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVR 253
Query: 216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDP 274
           I +++G+P    +  +R +     VR  P  + + +    P  + S A+DLLE++L ++P
Sbjct: 254 IIQIMGTPTKEQM--IRMNPHYTEVR-FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310
Query: 275 NKRITVEEALRHPYLQSLHD 294
           + RI   EA+ HP+   L +
Sbjct: 311 DLRINPYEAMAHPFFDHLRN 330

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 156/285 (54%), Gaps = 16/285 (5%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN- 78
           A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I R  K   +N 
Sbjct: 37  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT-KASPYNR 95
Query: 79  ---DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
               +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   +LHRD+K +N
Sbjct: 96  CKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 155
Query: 135 LLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           +L+     LK+ DFGLAR       S+ +     VVT WYR PELLL   +Y   ID+W 
Sbjct: 156 VLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWG 215
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR-QLPRCRK 248
            GCI+ E+ TR P+  G    HQL LI++L GS       +   DN   Y + +L + +K
Sbjct: 216 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV--WPNVDNYELYEKLELVKGQK 273
Query: 249 QQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           ++   R     +   A+DL++K+LV DP +RI  ++AL H +  S
Sbjct: 274 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 37  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 90
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 91  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 147
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 148 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 207
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 208 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 264
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 265 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 317

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 33  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 87  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 203
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 260
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 45  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 98
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 99  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 155
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 156 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 215
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 216 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 272
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 273 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 52  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 105
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 106 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 162
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 163 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 222
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 223 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 279
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 280 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 332

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RP 71
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 67  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120
Query: 72  PKKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 121 EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 237
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 238 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 294
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 41  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 94
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 95  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 151
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 152 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 211
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 212 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 268
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 269 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 321

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 34  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 87
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 88  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 144
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 145 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 204
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 205 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 261
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 262 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 314

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 45  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 98
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 99  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 155
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 156 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 215
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 216 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 272
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 273 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 156/293 (53%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 33  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD   +VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 87  EKKD---EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 203
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 260
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 155/293 (52%), Gaps = 22/293 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP- 72
           F +   A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       
Sbjct: 33  FGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 86
Query: 73  -KKDTFNDVYI--VYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            KKD    VY+  V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  +
Sbjct: 87  EKKDV---VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 126 LHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
            HRD+KP NLLL+  +  LK+ DFG A+     +     + +R+YRAPEL+   T+YT++
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSS 203
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       +R  N      + P
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ---IREMNPNYTEFKFP 260
Query: 245 RCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           + +   +   F P     A+ L  ++L + P  R+T  EA  H +   L D N
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 98/286 (34%), Positives = 148/286 (51%), Gaps = 25/286 (8%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFNDVY 81
           T   VAIKK+      I D R   RE+++++ +    H N++ ++       +    D+Y
Sbjct: 47  TGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 82  --IVYELMDTDLHQIIRS--DQQLTDDHC--QYFLYQLLRGLKYVH--SASVLHRDLKPS 133
             +V E +   LH+  R+   +Q+       + FL+QL+R +  +H  S +V HRD+KP 
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160
Query: 134 NLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+L+N A   LK+ DFG A+  S ++    Y+ +R+YRAPEL+     YT A+DIWSVGC
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220
Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I  E+M  EP+F G +   QL  I  ++G P   S   LR  N       L   +   ++
Sbjct: 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP---SREVLRKLNPSHTDVDLYNSKGIPWS 277
Query: 253 TRFPNKS----SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
             F + S      A DLL  +L + P +R+   EAL HPY   LHD
Sbjct: 278 NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 95/274 (34%), Positives = 139/274 (50%), Gaps = 36/274 (13%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--------- 99
           REI LLR ++H NVI+++ +           V+++++  + DL  II+  +         
Sbjct: 67  REIALLRELKHPNVISLQKVFL---SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 100 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTS 155
           QL     +  LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 156 ET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF------- 204
                   +   VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F       
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 205 -PGKDYVH-QLRLITELIGSPDDASLGFLR-----SDNARRYVRQ-LPRCRKQQFATRFP 256
                Y H QL  I  ++G P D     ++     S   + + R     C   ++  +  
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 257 NK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            K  S A  LL+K+L  DP KRIT E+A++ PY 
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 154/303 (50%), Gaps = 38/303 (12%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG+Y ++       A+N    E+V +K +     N I      REIK+L ++    N+I 
Sbjct: 47  RGKYSEVF-----EAINITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPNIIT 96
Query: 65  IKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
           + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y HS 
Sbjct: 97  LADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 124 SVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++   Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 183 AAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DASLG 229
            ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D    
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 270
Query: 230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ HPY 
Sbjct: 271 DILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 290 QSL 292
            ++
Sbjct: 325 YTV 327

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAIK I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 87  ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 203 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 243
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 244 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAIK I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 28  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 85
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 86  ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 141
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 142 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 201
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 202 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 242
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 243 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAIK I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 35  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 92
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 93  ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 148
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 149 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 208
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 209 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 249
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 250 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAIK I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 87  ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 203 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 243
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 244 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAIK I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 87  ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 203 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 243
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 244 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAI+ I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 168 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 225
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 226 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 281
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 282 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 341
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 342 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 382
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 383 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 44/283 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT------LREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAI+ I      I  AR          EI++L+ + H  +I IK+      
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211
Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 267
Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL   ++  P  P  ++  Q+ L  ++             +     ++ ++    
Sbjct: 328 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI-------------TSGKYNFIPEV---- 368
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 369 -------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N+L++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 134/241 (55%), Gaps = 21/241 (8%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y
Sbjct: 94  NIIKLIDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDY 147
Query: 120 VHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 207
Query: 179 TEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS---- 233
             Y  ++D+WS+GC+L   I  REP F G+D   QL  I +++G+  +   G+L+     
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHID 265
Query: 234 --DNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
              +    + Q  R R + F     N+   S  A+DLL+K+L +D  +R+T +EA+ HPY
Sbjct: 266 LDPHFNDILGQHSRKRWENF-IHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324
Query: 289 L 289
Sbjct: 325 F 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 134/241 (55%), Gaps = 21/241 (8%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y
Sbjct: 99  NIIKLIDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDY 152
Query: 120 VHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 212
Query: 179 TEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS---- 233
             Y  ++D+WS+GC+L   I  REP F G+D   QL  I +++G+  +   G+L+     
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHID 270
Query: 234 --DNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 288
              +    + Q  R R + F     N+   S  A+DLL+K+L +D  +R+T +EA+ HPY
Sbjct: 271 LDPHFNDILGQHSRKRWENF-IHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329
Query: 289 L 289
Sbjct: 330 F 330

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 38/270 (14%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T++E A+K I  A     D    LRE++LL+ ++H N++ + +I+        +  YIV 
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVG 100
Query: 85  EL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--- 140
           EL    +L   I   ++ ++      + Q+  G+ Y+H  +++HRDLKP N+LL +    
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++ 
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSG 218
Query: 201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS 260
            P F GK+    L+ +                     +Y   LP+ R           S 
Sbjct: 219 TPPFYGKNEYDILKRV------------------ETGKYAFDLPQWR---------TISD 251
Query: 261 GAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 91  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 144
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 319 HPYFYTV 325

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 38/270 (14%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T++E A+K I  A     D    LRE++LL+ ++H N++ + +I+        +  YIV 
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVG 100
Query: 85  EL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--- 140
           EL    +L   I   ++ ++      + Q+  G+ Y+H  +++HRDLKP N+LL +    
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++ 
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSG 218
Query: 201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS 260
            P F GK+                      L+     +Y   LP+ R           S 
Sbjct: 219 TPPFYGKN------------------EYDILKRVETGKYAFDLPQWR---------TISD 251
Query: 261 GAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 38/270 (14%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T++E A+K I  A     D    LRE++LL+ ++H N++ + +I+        +  YIV 
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVG 100
Query: 85  EL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--- 140
           EL    +L   I   ++ ++      + Q+  G+ Y+H  +++HRDLKP N+LL +    
Sbjct: 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL  +++ 
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSG 218
Query: 201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS 260
            P F GK+                      L+     +Y   LP+ R           S 
Sbjct: 219 TPPFYGKN------------------EYDILKRVETGKYAFDLPQWR---------TISD 251
Query: 261 GAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 92  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 145
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 320 HPYFYTV 326

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 92  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 145
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 320 HPYFYTV 326

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 98  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 151
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 152 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 271
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 272 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 325
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 326 HPYFYTV 332

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYLQSL 292
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 127/244 (52%), Gaps = 27/244 (11%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 119
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 120 VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 179 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 225
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 286 HPYL 289
           HPY 
Sbjct: 321 HPYF 324

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 129/250 (51%), Gaps = 25/250 (10%)
Query: 57  MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 116
           M   N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ 
Sbjct: 83  MGGPNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKA 137
Query: 117 LKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 175
           L Y HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 176 LNCTEYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD---------- 224
           ++  +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+            
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 225 --DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 282
             D  L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  E
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALE 311
Query: 283 ALRHPYLQSL 292
           A+ HPY Q +
Sbjct: 312 AMTHPYFQQV 321

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 142
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 317 PYFQQV 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 89  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 143
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 263
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 264 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 317
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 318 PYFQQV 323

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 142
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 317 PYFQQV 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 61  NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 120
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 108 NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 162
Query: 121 HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 179
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 180 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 226
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDP 282
Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 283 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 336
Query: 287 PYLQSL 292
           PY Q +
Sbjct: 337 PYFQQV 342

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 91/323 (28%), Positives = 158/323 (48%), Gaps = 44/323 (13%)
Query: 1   MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 60
           + V  +G +  ++      A + +  + VA+K + N        R+   EI++L H+  +
Sbjct: 102 LKVIGKGSFGQVV-----KAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQ 153
Query: 61  NVIAIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGL 117
           +     ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 118 KYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 175
             +H   ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---L 228
           L    Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P     DAS    
Sbjct: 272 LG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330
Query: 229 GFLRSDNARRY-----------VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLE 267
            F+      RY           V    R R+ +      +  + N   G      +D L+
Sbjct: 331 NFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 268 KMLVFDPNKRITVEEALRHPYLQ 290
           + L +DP  R+T  +ALRHP+L+
Sbjct: 391 QCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 91/323 (28%), Positives = 158/323 (48%), Gaps = 44/323 (13%)
Query: 1   MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 60
           + V  +G +  ++      A + +  + VA+K + N        R+   EI++L H+  +
Sbjct: 102 LKVIGKGSFGQVV-----KAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQ 153
Query: 61  NVIAIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGL 117
           +     ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 118 KYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 175
             +H   ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---L 228
           L    Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P     DAS    
Sbjct: 272 LG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330
Query: 229 GFLRSDNARRY-----------VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLE 267
            F+      RY           V    R R+ +      +  + N   G      +D L+
Sbjct: 331 NFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 268 KMLVFDPNKRITVEEALRHPYLQ 290
           + L +DP  R+T  +ALRHP+L+
Sbjct: 391 QCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 91/323 (28%), Positives = 158/323 (48%), Gaps = 44/323 (13%)
Query: 1   MSVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE 60
           + V  +G +  ++      A + +  + VA+K + N        R+   EI++L H+  +
Sbjct: 102 LKVIGKGXFGQVV-----KAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRKQ 153
Query: 61  NVIAIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGL 117
           +     ++I   +  TF N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 118 KYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 175
             +H   ++H DLKP N+LL       +K+ DFG   +  E   +   + +R+YRAPE++
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVI 271
Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---L 228
           L    Y   ID+WS+GCIL E++T  PL PG+D   QL  + EL+G P     DAS    
Sbjct: 272 LG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAK 330
Query: 229 GFLRSDNARRY-----------VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLE 267
            F+      RY           V    R R+ +      +  + N   G      +D L+
Sbjct: 331 NFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 268 KMLVFDPNKRITVEEALRHPYLQ 290
           + L +DP  R+T  +ALRHP+L+
Sbjct: 391 QCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A + +T+++VA+K I        D   R  REI  L+ + H ++I + D+I  P      
Sbjct: 28  ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82
Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           D+ +V E    +L   I   +++T+D  + F  Q++  ++Y H   ++HRDLKP NLLL+
Sbjct: 83  DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
            + ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G +L  ++
Sbjct: 143 DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN- 257
                      V +L    E I +         +  N+  YV               P+ 
Sbjct: 203 -----------VGRLPFDDEFIPN-------LFKKVNSCVYV--------------MPDF 230
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            S GA  L+ +M+V DP +RIT++E  R P+ 
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI +LR ++HEN++A++DI   P     N +Y+V +L+   +L   I      T+     
Sbjct: 70  EIAVLRKIKHENIVALEDIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDAST 124
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVV 165
            + Q+L  + Y+H   ++HRDLKP NLL    +    + I DFGL++   + D M+    
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE+L     Y+ A+D WS+G I   ++   P F                     
Sbjct: 185 TPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF--------------------- 222
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                   +N  +   Q+ +   +  +  + + S  A D +  ++  DPNKR T E+A R
Sbjct: 223 ------YDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAAR 276
Query: 286 HPYLQSLHDLN 296
           HP++     LN
Sbjct: 277 HPWIAGDTALN 287

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 38/272 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-NDVYIV 83
           T  E AIK I     +     + L E+ +L+ ++H N++ + D     +      + Y  
Sbjct: 61  THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 84  YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--- 140
            EL D  +H++     +  +      + Q+L G+ Y+H  +++HRDLKP NLLL +    
Sbjct: 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD 175
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
             +KI DFGL+        M E + T +Y APE+L    +Y    D+WS+G IL  ++  
Sbjct: 176 ALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAG 233
Query: 201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS 260
            P F G+     LR + +                   +Y    P          + N S 
Sbjct: 234 YPPFGGQTDQEILRKVEK------------------GKYTFDSPE---------WKNVSE 266
Query: 261 GAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           GA DL+++ML FD  +RI+ ++AL HP+++ +
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 25  TREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDV 80
           T +E A+K I         D    LRE++LL+ ++H N++ + +      K  F    +V
Sbjct: 74  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEV 131
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL + 
Sbjct: 132 YTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 186
Query: 141 ---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +
Sbjct: 187 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYIL 244
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++  P F G +    L+ + +                   +Y  +LP+ +K         
Sbjct: 245 LSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV-------- 278
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 279 -SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 311

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 25  TREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDV 80
           T +E A+K I         D    LRE++LL+ ++H N++ + +      K  F    +V
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEV 107
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL + 
Sbjct: 108 YTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162
Query: 141 ---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYIL 220
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++  P F G +    L+ + +                   +Y  +LP+ +K         
Sbjct: 221 LSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV-------- 254
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 255 -SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 25  TREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDV 80
           T +E A+K I         D    LRE++LL+ ++H N++ + +      K  F    +V
Sbjct: 73  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEV 130
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL + 
Sbjct: 131 YTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 185
Query: 141 ---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +
Sbjct: 186 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYIL 243
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++  P F G +    L+ + +                   +Y  +LP+ +K         
Sbjct: 244 LSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV-------- 277
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 278 -SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 310

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 25  TREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDV 80
           T +E A+K I         D    LRE++LL+ ++H N++ + +      K  F    +V
Sbjct: 56  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEV 113
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL + 
Sbjct: 114 YTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 168
Query: 141 ---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL  +
Sbjct: 169 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYIL 226
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++  P F G +                      L+     +Y  +LP+ +K         
Sbjct: 227 LSGCPPFNGAN------------------EYDILKKVEKGKYTFELPQWKKV-------- 260
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 261 -SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 127/267 (47%), Gaps = 37/267 (13%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A ++ T ++VA+K I        D + R  REI  LR + H ++I + D+I+     + +
Sbjct: 23  AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 77
Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++ +V E    +L   I    ++++   + F  Q++  ++Y H   ++HRDLKP NLLL+
Sbjct: 78  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 137
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++
Sbjct: 138 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 197
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
            R   F                   DD S+  L   N    V  LP+             
Sbjct: 198 CRRLPF-------------------DDESIPVLFK-NISNGVYTLPKFL----------- 226
Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALR 285
           S GA  L+++ML+ +P  RI++ E ++
Sbjct: 227 SPGAAGLIKRMLIVNPLNRISIHEIMQ 253

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A ++ T ++VA+K I        D + R  REI  LR + H ++I + D+I+     + +
Sbjct: 27  AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 81
Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++ +V E    +L   I    ++++   + F  Q++  ++Y H   ++HRDLKP NLLL+
Sbjct: 82  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 141
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++
Sbjct: 142 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 201
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
            R   F                   DD S+  L   N    V  LP+             
Sbjct: 202 CRRLPF-------------------DDESIPVLFK-NISNGVYTLPKFL----------- 230
Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 231 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A ++ T ++VA+K I        D + R  REI  LR + H ++I + D+I+     + +
Sbjct: 33  AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 87
Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++ +V E    +L   I    ++++   + F  Q++  ++Y H   ++HRDLKP NLLL+
Sbjct: 88  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 147
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++
Sbjct: 148 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 207
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
            R   F                   DD S+  L   N    V  LP+             
Sbjct: 208 CRRLPF-------------------DDESIPVLFK-NISNGVYTLPKFL----------- 236
Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 237 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR-RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A ++ T ++VA+K I        D + R  REI  LR + H ++I + D+I+     + +
Sbjct: 32  AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 86
Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++ +V E    +L   I    ++++   + F  Q++  ++Y H   ++HRDLKP NLLL+
Sbjct: 87  EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 146
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              ++KI DFGL+   ++ +F+     +  Y APE++         +D+WS G IL  ++
Sbjct: 147 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 206
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
            R   F                   DD S+  L   N    V  LP+             
Sbjct: 207 CRRLPF-------------------DDESIPVLFK-NISNGVYTLPKFL----------- 235
Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 236 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 56/288 (19%)
Query: 40  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ 99
           N  D   T R +++L   EH   I I                 V+EL+    +  I+ + 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICI-----------------VFELLGLSTYDFIKENG 111
Query: 100 QLTD--DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----------------- 140
            L    DH +   YQ+ + + ++HS  + H DLKP N+L   S                 
Sbjct: 112 FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 141 --CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              D+K+ DFG A  T + +  +  V TR YRAPE++L    ++   D+WS+GCIL E  
Sbjct: 172 INPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYY 228
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--------------DNARRYVRQLP 244
               +FP  D    L ++  ++G      +   R                +A RYV +  
Sbjct: 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288
Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           +  K+ F      +     DL++KML +DP KRIT+ EAL+HP+   L
Sbjct: 289 KPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 56/288 (19%)
Query: 40  NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ 99
           N  D   T R +++L   EH   I I                 V+EL+    +  I+ + 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICI-----------------VFELLGLSTYDFIKENG 111
Query: 100 QLTD--DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----------------- 140
            L    DH +   YQ+ + + ++HS  + H DLKP N+L   S                 
Sbjct: 112 FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 141 --CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              D+K+ DFG A  T + +  +  V  R YRAPE++L    ++   D+WS+GCIL E  
Sbjct: 172 INPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYY 228
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--------------DNARRYVRQLP 244
               +FP  D    L ++  ++G      +   R                +A RYV +  
Sbjct: 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288
Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           +  K+ F      +     DL++KML +DP KRIT+ EAL+HP+   L
Sbjct: 289 KPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 43/274 (15%)
Query: 25  TREEVAIKKIGN-AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDV 80
           T +E A+K I         D    LRE++LL+ ++H N+  + +      K  F    +V
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFED--KGYFYLVGEV 107
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y   EL D      I S ++ ++      + Q+L G+ Y H   ++HRDLKP NLLL + 
Sbjct: 108 YTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESK 162
Query: 141 ---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +++I DFGL+     +    + + T +Y APE+L     Y    D+WS G IL  +
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYIL 220
Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++  P F G +    L+ + +                   +Y  +LP+ +K         
Sbjct: 221 LSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV-------- 254
Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            S  A DL+ K L + P+ RI+  +AL H ++Q+
Sbjct: 255 -SESAKDLIRKXLTYVPSXRISARDALDHEWIQT 287

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 138/280 (49%), Gaps = 37/280 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D I   +
Sbjct: 18  FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---Q 74
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           +++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP
Sbjct: 75  EESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 132
Query: 133 SNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
            NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+
Sbjct: 133 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWA 191
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
            G IL  ++   P F  +D   Q RL  ++                A  Y    P     
Sbjct: 192 CGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP----- 228
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 229 EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 138/280 (49%), Gaps = 37/280 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D I   +
Sbjct: 19  FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---Q 75
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           +++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP
Sbjct: 76  EESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133
Query: 133 SNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
            NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWA 192
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
            G IL  ++   P F  +D   Q RL  ++                A  Y    P     
Sbjct: 193 CGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP----- 229
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 230 EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 138/280 (49%), Gaps = 37/280 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D I+   
Sbjct: 19  FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--- 75
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           +++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP
Sbjct: 76  EESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133
Query: 133 SNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
            NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     Y+  +DIW+
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWA 192
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
            G IL  ++   P F  +D   Q RL  ++                A  Y    P     
Sbjct: 193 CGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYDYPSP----- 229
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 230 EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 141/289 (48%), Gaps = 37/289 (12%)
Query: 5   LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA 64
           ++ E     F +    V+  T  E A K I     +  D ++  RE ++ R ++H N++ 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 65  IKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
           + D I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS 
Sbjct: 93  LHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 124 SVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 180
            ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +PE+L     
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DP 206
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
           Y+  +DIW+ G IL  ++   P F  +D   Q RL  ++                A  Y 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI---------------KAGAYD 248
Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              P     ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 249 YPSP-----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 158/333 (47%), Gaps = 59/333 (17%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVI 63
           +G +  ++      A +   +E VAIK I N  AF N     +   E++LL  M   +  
Sbjct: 64  KGSFGQVV-----KAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTE 113
Query: 64  AIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYV 120
               I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 121 HSA--SVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 176
            +   S++H DLKP N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLL 231
Query: 177 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 236
               Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++  A
Sbjct: 232 G-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKA 288
Query: 237 RRYVRQLP---------RCRKQQF-------------------ATRFPNKSSGAV----- 263
           R++  +LP         +  K+++                     R   +S   V     
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 264 --DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
             DL+ +ML +DP  RI    AL+H + +   D
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 92/336 (27%), Positives = 160/336 (47%), Gaps = 65/336 (19%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVI 63
           +G +  ++      A +   +E VAIK I N  AF N     +   E++LL  M   +  
Sbjct: 64  KGSFGQVV-----KAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTE 113
Query: 64  AIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYV 120
               I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 121 HSA--SVLHRDLKPSNLLLNASCD-----LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 173
            +   S++H DLKP N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE
Sbjct: 174 ATPELSIIHCDLKPENILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPE 228
Query: 174 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 233
           +LL    Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++
Sbjct: 229 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QA 285
Query: 234 DNARRYVRQLP---------RCRKQQF-------------------ATRFPNKSSGAV-- 263
             AR++  +LP         +  K+++                     R   +S   V  
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345
Query: 264 -----DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
                DL+ +ML +DP  RI    AL+H + +   D
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 113/255 (44%), Gaps = 38/255 (14%)
Query: 42  IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ 100
           +D +    EI +L  + H N+I +K+I   P      ++ +V EL+   +L   I     
Sbjct: 90  VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGY 144
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSET 157
            ++      + Q+L  + Y+H   ++HRDLKP NLL         LKI DFGL++     
Sbjct: 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLI 216
             M     T  Y APE+L  C  Y   +D+WSVG I   ++   EP +            
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFY------------ 251
Query: 217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 276
                  D+    F+         R++  C     +  +   S  A DL+ K++V DP K
Sbjct: 252 -------DERGDQFM--------FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKK 296
Query: 277 RITVEEALRHPYLQS 291
           R+T  +AL+HP++  
Sbjct: 297 RLTTFQALQHPWVTG 311

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 158/333 (47%), Gaps = 59/333 (17%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGN--AFDNIIDARRTLREIKLLRHMEHENVI 63
           +G +  ++      A +   +E VAIK I N  AF N     +   E++LL  M   +  
Sbjct: 45  KGSFGQVV-----KAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTE 94
Query: 64  AIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYV 120
               I+   +   F N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 121 HSA--SVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 176
            +   S++H DLKP N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLL 212
Query: 177 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 236
               Y  AID+WS+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++  A
Sbjct: 213 G-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKA 269
Query: 237 RRYVRQLP---------RCRKQQF-------------------ATRFPNKSSGAV----- 263
           R++  +LP         +  K+++                     R   +S   V     
Sbjct: 270 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 329
Query: 264 --DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
             DL+ +ML +DP  RI    AL+H + +   D
Sbjct: 330 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 362

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 38/281 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    V     +E A K I     +  D ++  RE ++ R ++H N++ + D I    
Sbjct: 44  FSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---S 100
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           ++ F+  Y+V++L+   +L + I + +  ++    + ++Q+L  + ++H   ++HRDLKP
Sbjct: 101 EEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKP 158
Query: 133 SNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
            NLLL + C    +K+ DFGLA     E      +  T  Y +PE+L     Y   +DIW
Sbjct: 159 ENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDIW 217
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           + G IL  ++   P F  +D   Q +L  ++     D                  P    
Sbjct: 218 ACGVILYILLVGYPPFWDED---QHKLYQQIKAGAYD-----------------FP---S 254
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            ++ T  P     A +L+ +ML  +P KRIT ++AL+HP++
Sbjct: 255 PEWDTVTPE----AKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 52/287 (18%)
Query: 21  VNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHME-HENVIAIKDIIRPP 72
           ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +  H N+I +KD     
Sbjct: 37  IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 93
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           + +TF   ++V++LM   +L   +     L++   +  +  LL  +  +H  +++HRDLK
Sbjct: 94  ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 151
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAID 186
           P N+LL+   ++K+ DFG +      + + E   T  Y APE++      N   Y   +D
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDASLGFLRSDNARRYVRQL 243
           +WS G I+  ++   P F  +  +  LR+I       GSP+                   
Sbjct: 212 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE------------------- 252
Query: 244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                      + + S    DL+ + LV  P KR T EEAL HP+ Q
Sbjct: 253 -----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 41/289 (14%)
Query: 9   YDDI---IFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           Y+DI    F +    V   T  E A K I     +  D ++  RE ++ R ++H N++ +
Sbjct: 9   YEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL 68
Query: 66  KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            D I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   
Sbjct: 69  HDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 125 VLHRDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTE 180
           V+HRDLKP NLLL + C    +K+ DFGLA     +      +  T  Y +PE+L     
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-EA 182
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
           Y   +DIW+ G IL  ++   P F  +D   Q +L  ++     D               
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPFWDED---QHKLYQQIKAGAYD--------------- 224
Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              P     ++ T  P     A +L+ +ML  +P KRIT  EAL+HP++
Sbjct: 225 --FP---SPEWDTVTPE----AKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 52/287 (18%)
Query: 21  VNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHME-HENVIAIKDIIRPP 72
           ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +  H N+I +KD     
Sbjct: 24  IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 80
Query: 73  KKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           + +TF   ++V++LM   +L   +     L++   +  +  LL  +  +H  +++HRDLK
Sbjct: 81  ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 138
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAID 186
           P N+LL+   ++K+ DFG +      + + E   T  Y APE++      N   Y   +D
Sbjct: 139 PENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 198
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDASLGFLRSDNARRYVRQL 243
           +WS G I+  ++   P F  +  +  LR+I       GSP+                   
Sbjct: 199 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE------------------- 239
Query: 244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                      + + S    DL+ + LV  P KR T EEAL HP+ Q
Sbjct: 240 -----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 123/253 (48%), Gaps = 43/253 (16%)
Query: 47  TLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDD 104
           T RE  +LR +  H ++I + D       ++ + +++V++LM   +L   +     L++ 
Sbjct: 146 TRRETHILRQVAGHPHIITLID-----SYESSSFMFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
             +  +  LL  + ++H+ +++HRDLKP N+LL+ +  +++ DFG +      + + E  
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 165 VTRWYRAPELLLNCT------EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 218
            T  Y APE+L  C+       Y   +D+W+ G IL  ++   P F  +  +  LR+I E
Sbjct: 261 GTPGYLAPEIL-KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
Query: 219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKR 277
                                        + QF++  + ++SS   DL+ ++L  DP  R
Sbjct: 320 ----------------------------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEAR 351
Query: 278 ITVEEALRHPYLQ 290
           +T E+AL+HP+ +
Sbjct: 352 LTAEQALQHPFFE 364

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 45/277 (16%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFND 79
           ++  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD+      D    
Sbjct: 42  IHKATNMEFAVKIIDKS------KRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90
Query: 80  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL- 136
           VY+V ELM     L +I+R  +  ++      L+ + + ++Y+H+  V+HRDLKPSN+L 
Sbjct: 91  VYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 137 LNASCD---LKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           ++ S +   ++I DFG A+   +E   +     T  + APE +L    Y AA DIWS+G 
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGV 208
Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L  ++T                 T     PDD     L    + ++             
Sbjct: 209 LLYTMLTG---------------YTPFANGPDDTPEEILARIGSGKFSLS---------G 244
Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             + + S  A DL+ KML  DP++R+T    LRHP++
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 140/310 (45%), Gaps = 49/310 (15%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN--- 78
           ++  + +VA+K I N       AR  +  +K ++  + EN      +      D FN   
Sbjct: 41  HARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLM-----SDWFNFHG 95
Query: 79  DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
            + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H   + H DLKP N+L
Sbjct: 96  HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 137 L-----------NASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 177
                       + SC+        +++ DFG A  T + +  T  V TR YR PE++L 
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE 213
Query: 178 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL--------- 228
              +    D+WS+GCIL E      LF   +    L ++ +++G      +         
Sbjct: 214 LG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 272
Query: 229 ---GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 282
              G +  +N+   RYV++   C+  + +  +   +     DL+ +ML FDP +RIT+ E
Sbjct: 273 YKGGLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
Query: 283 ALRHPYLQSL 292
           AL HP+   L
Sbjct: 331 ALLHPFFAGL 340

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 140/310 (45%), Gaps = 49/310 (15%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN--- 78
           ++  + +VA+K I N       AR  +  +K ++  + EN       +     D FN   
Sbjct: 50  HARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN-----KFLCVLMSDWFNFHG 104
Query: 79  DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
            + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H   + H DLKP N+L
Sbjct: 105 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 164
Query: 137 L-----------NASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 177
                       + SC+        +++ DFG A  T + +  T  V TR YR PE++L 
Sbjct: 165 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE 222
Query: 178 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL--------- 228
              +    D+WS+GCIL E      LF   +    L ++ +++G      +         
Sbjct: 223 LG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 281
Query: 229 ---GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 282
              G +  +N+   RYV++   C+  + +  +   +     DL+ +ML FDP +RIT+ E
Sbjct: 282 YKGGLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 339
Query: 283 ALRHPYLQSL 292
           AL HP+   L
Sbjct: 340 ALLHPFFAGL 349

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 45/273 (16%)
Query: 25  TREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
           T  E AIK I  ++     ++   L E+ +L+ ++H N++ + +     +     + Y+V
Sbjct: 45  TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR-----NYYLV 99
Query: 84  YELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            E+    +L   I   Q+ ++      + Q+L G  Y+H  +++HRDLKP NLLL +   
Sbjct: 100 MEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSR 159
Query: 143 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              +KI DFGL+        M E + T +Y APE+L    +Y    D+WS G IL  ++ 
Sbjct: 160 DALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--KYDEKCDVWSCGVILYILLC 217
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-- 257
             P F G+                 D  +              L R  K +F+   P+  
Sbjct: 218 GYPPFGGQ----------------TDQEI--------------LKRVEKGKFSFDPPDWT 247
Query: 258 -KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             S  A  L++ ML ++P+KRI+ EEAL HP++
Sbjct: 248 QVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFND 79
           V+  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD+      D    
Sbjct: 47  VHKATNMEYAVKVIDKS------KRDPSEEIEILLRYGQHPNIITLKDVY-----DDGKH 95
Query: 80  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           VY+V ELM     L +I+R  +  ++    + L+ + + ++Y+HS  V+HRDLKPSN+L 
Sbjct: 96  VYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY 154
Query: 138 -----NASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
                N  C L+I DFG A+   +E   +     T  + APE+L     Y    DIWS+G
Sbjct: 155 VDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR-QGYDEGCDIWSLG 212
Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
            +L  ++                  T     P D     L    + ++            
Sbjct: 213 ILLYTMLAG---------------YTPFANGPSDTPEEILTRIGSGKFTLS--------- 248
Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              +   S  A DL+ KML  DP++R+T ++ L+HP++
Sbjct: 249 GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFND 79
           V+  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD+      D    
Sbjct: 47  VHKATNMEYAVKVIDKS------KRDPSEEIEILLRYGQHPNIITLKDVY-----DDGKH 95
Query: 80  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           VY+V ELM     L +I+R  +  ++    + L+ + + ++Y+HS  V+HRDLKPSN+L 
Sbjct: 96  VYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILY 154
Query: 138 -----NASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
                N  C L+I DFG A+   +E   +     T  + APE+L     Y    DIWS+G
Sbjct: 155 VDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR-QGYDEGCDIWSLG 212
Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
            +L  ++                  T     P D     L    + ++            
Sbjct: 213 ILLYTMLAG---------------YTPFANGPSDTPEEILTRIGSGKFTLS--------- 248
Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
              +   S  A DL+ KML  DP++R+T ++ L+HP++
Sbjct: 249 GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 140/310 (45%), Gaps = 49/310 (15%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN--- 78
           ++  + +VA+K I N       AR  +  +K ++  + EN       +     D FN   
Sbjct: 73  HARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN-----KFLCVLMSDWFNFHG 127
Query: 79  DVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
            + I +EL+  +  + ++ +  Q     H ++  YQL   L+++H   + H DLKP N+L
Sbjct: 128 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 187
Query: 137 L-----------NASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 177
                       + SC+        +++ DFG A  T + +  T  V TR YR PE++L 
Sbjct: 188 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE 245
Query: 178 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL--------- 228
              +    D+WS+GCIL E      LF   +    L ++ +++G      +         
Sbjct: 246 LG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 304
Query: 229 ---GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 282
              G +  +N+   RYV++   C+  + +  +   +     DL+ +ML FDP +RIT+ E
Sbjct: 305 YKGGLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 362
Query: 283 ALRHPYLQSL 292
           AL HP+   L
Sbjct: 363 ALLHPFFAGL 372

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 45/273 (16%)
Query: 25  TREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
           T  E AIK I  ++     ++   L E+ +L+ ++H N++ + +     +     + Y+V
Sbjct: 28  TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR-----NYYLV 82
Query: 84  YELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            E+    +L   I   Q+ ++      + Q+L G  Y+H  +++HRDLKP NLLL +   
Sbjct: 83  MEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSR 142
Query: 143 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              +KI DFGL+        M E + T +Y APE+L    +Y    D+WS G IL  ++ 
Sbjct: 143 DALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK--KYDEKCDVWSCGVILYILLC 200
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-- 257
             P F G+                 D  +              L R  K +F+   P+  
Sbjct: 201 GYPPFGGQ----------------TDQEI--------------LKRVEKGKFSFDPPDWT 230
Query: 258 -KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             S  A  L++ ML ++P+KRI+ EEAL HP++
Sbjct: 231 QVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 65
           G + ++I      A +  T++ VAIK I  A + +     ++  EI +L  ++H N++A+
Sbjct: 29  GAFSEVIL-----AEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 66  KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   
Sbjct: 82  DDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 125 VLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 181
           ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPY 195
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
           + A+D WS+G I   ++   P F                             +N  +   
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFE 228
Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 229 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 130/291 (44%), Gaps = 47/291 (16%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIA 64
           G + ++I      A +  T++ VAIK I       ++ +      EI +L  ++H N++A
Sbjct: 29  GAFSEVIL-----AEDKRTQKLVAIKCIAK---KALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 65  IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
           + DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H  
Sbjct: 81  LDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 124 SVLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 180
            ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KP 194
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
           Y+ A+D WS+G I   ++   P F                             +N  +  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLF 227
Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 228 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 52/287 (18%)
Query: 21  VNSETREEVAIKKI----GNAF--DNIIDARR-TLREIKLLRHME-HENVIAIKDIIRPP 72
           ++  T +E A+K I    G +F  + + + R  TL+E+ +LR +  H N+I +KD     
Sbjct: 37  IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 93
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           + +TF   ++V++LM   +L   +     L++   +  +  LL  +  +H  +++HRDLK
Sbjct: 94  ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 151
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAID 186
           P N+LL+   ++K+ DFG +      + +     T  Y APE++      N   Y   +D
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDASLGFLRSDNARRYVRQL 243
           +WS G I+  ++   P F  +  +  LR+I       GSP+                   
Sbjct: 212 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE------------------- 252
Query: 244 PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                      + + S    DL+ + LV  P KR T EEAL HP+ Q
Sbjct: 253 -----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 65
           G + ++I      A +  T++ VAIK I  A + +     ++  EI +L  ++H N++A+
Sbjct: 29  GAFSEVIL-----AEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 66  KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   
Sbjct: 82  DDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 125 VLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 181
           ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPY 195
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
           + A+D WS+G I   ++   P F                             +N  +   
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFE 228
Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 229 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 65
           G + ++I      A +  T++ VAIK I  A + +     ++  EI +L  ++H N++A+
Sbjct: 29  GAFSEVIL-----AEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 66  KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            DI      ++   +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   
Sbjct: 82  DDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 125 VLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 181
           ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y APE+L     Y
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPY 195
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
           + A+D WS+G I   ++   P F                             +N  +   
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPF---------------------------YDENDAKLFE 228
Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 229 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE ++N        D+WS+G I   +++    F G      L  ++ + 
Sbjct: 175 KNIFGTPAFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
              +D                             F N S+ A D + ++LV DP KR+T+
Sbjct: 234 YEFEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 62  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 173
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 174 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 218
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 219 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 266 QDSLQHPWIK 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 62  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 173
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 174 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 218
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 219 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 266 QDSLQHPWIK 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G      L  ++ + 
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
              +D                             F N S+ A D + ++LV DP KR+T+
Sbjct: 234 YEFEDEY---------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 49/299 (16%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPP 72
           F I    V+ ++ +  A+K I    +       T +EI  L+  E H N++ + ++    
Sbjct: 24  FSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKLHEV---- 74
Query: 73  KKDTFND---VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
               F+D    ++V EL++  +L + I+  +  ++    Y + +L+  + ++H   V+HR
Sbjct: 75  ----FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 129 DLKPSNLLL---NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           DLKP NLL    N + ++KI DFG AR    +   +     T  Y APE LLN   Y  +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDES 189
Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
            D+WS+G IL  +++ +  F   D                       RS      V  + 
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHD-----------------------RSLTCTSAVEIMK 226
Query: 245 RCRKQQFA---TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
           + +K  F+     + N S  A DL++ +L  DPNKR+ +     + +LQ    L+  P+
Sbjct: 227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 38/245 (15%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI LL+ ++H N+I + D+    K       Y+V E  +  +L + I +  +  +     
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVV 165
            + Q+L G+ Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + 
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T +Y APE+L    +Y    D+WS G I+  ++   P F G+                  
Sbjct: 211 TAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ------------------ 250
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                    N +  ++++ + +       + N S  A +L++ ML +D NKR T EEAL 
Sbjct: 251 ---------NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
Query: 286 HPYLQ 290
             +++
Sbjct: 302 SRWIK 306

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G              
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG-------------- 219
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
                        D  +  +  +     +     F N S+ A D + ++LV DP KR+T+
Sbjct: 220 -------------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 119/250 (47%), Gaps = 44/250 (17%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQ 107
           RE+ +L+ ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++   
Sbjct: 63  REVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174
Query: 164 ---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  + APE++ N        D+WS+G I   +++    F G      L  ++ + 
Sbjct: 175 KNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
              +D                             F N S+ A D + ++LV DP KR+T+
Sbjct: 234 YEFEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 281 EEALRHPYLQ 290
           +++L+HP+++
Sbjct: 267 QDSLQHPWIK 276

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/166 (37%), Positives = 89/166 (53%), Gaps = 15/166 (9%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDD 104
           E+ LLR ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 105 HCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETD 158
                + QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + + D
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           F  E+V T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 172 FAKEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 38/253 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D   
Sbjct: 57  REVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +     
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G+     L  I+ +    
Sbjct: 172 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D+                             F N S  A D + ++LV DP +R+T+ ++
Sbjct: 231 DEEY---------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 284 LRHPYLQSLHDLN 296
           L H +++++   N
Sbjct: 264 LEHSWIKAIRRRN 276

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 91/153 (59%), Gaps = 6/153 (3%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD 104
            +  +EI +L+ ++H NV+ + +++  P +D    +Y+V+EL++      + + + L++D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEY 163
             +++   L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++     +D  ++  
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 164 VVTRWYRAPELLLNCTEYTA--AIDIWSVGCIL 194
           V T  + APE L    +  +  A+D+W++G  L
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 38/281 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    V     +E A K I     +  D ++  RE ++ R ++H N++ + D I    
Sbjct: 35  FSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 94
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                  Y++++L+   +L + I + +  ++    + + Q+L  + + H   V+HRDLKP
Sbjct: 95  HH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKP 149
Query: 133 SNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
            NLLL +      +K+ DFGLA     E      +  T  Y +PE+L     Y   +D+W
Sbjct: 150 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLW 208
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           + G IL  ++   P F  +D   Q RL  ++     D                  P    
Sbjct: 209 ACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------FP---S 245
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            ++ T  P     A DL+ KML  +P+KRIT  EAL+HP++
Sbjct: 246 PEWDTVTPE----AKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 38/281 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    +   T +E A K I     +  D ++  RE ++ R ++H N++ + D I    
Sbjct: 17  FSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---S 73
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++HRDLKP
Sbjct: 74  EEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKP 131
Query: 133 SNLLL---NASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
            NLLL   +    +K+ DFGLA     +      +  T  Y +PE+L     Y   +D+W
Sbjct: 132 ENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDMW 190
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           + G IL  ++   P F  +D   Q RL  ++     D                  P    
Sbjct: 191 ACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------FP---S 227
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            ++ T  P     A DL+ KML  +P KRIT  EAL+HP++
Sbjct: 228 PEWDTVTPE----AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 38/281 (13%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           F +    +   T +E A K I     +  D ++  RE ++ R ++H N++ + D I    
Sbjct: 17  FSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---S 73
Query: 74  KDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L  + + H   ++HRDLKP
Sbjct: 74  EEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKP 131
Query: 133 SNLLL---NASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
            NLLL   +    +K+ DFGLA     +      +  T  Y +PE+L     Y   +D+W
Sbjct: 132 ENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDMW 190
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           + G IL  ++   P F  +D   Q RL  ++     D                  P    
Sbjct: 191 ACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD-----------------FP---S 227
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            ++ T  P     A DL+ KML  +P KRIT  EAL+HP++
Sbjct: 228 PEWDTVTPE----AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 44/271 (16%)
Query: 25  TREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           T  +VA+K +      + D +   RR ++ +KL RH    ++I +  +I  P     +D+
Sbjct: 40  TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH---PHIIKLYQVISTP-----SDI 91
Query: 81  YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++V E +   +L   I  + +L +   +    Q+L G+ Y H   V+HRDLKP N+LL+A
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA 151
Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             + KI DFGL+   S+ +F+     +  Y APE++         +DIWS G IL  ++ 
Sbjct: 152 HMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
                                      +L F   D+     +++  C    +  ++ N S
Sbjct: 212 --------------------------GTLPF-DDDHVPTLFKKI--CDGIFYTPQYLNPS 242
Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
              + LL+ ML  DP KR T+++   H + +
Sbjct: 243 --VISLLKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDW---KEK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDW---KEK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNA-FDNI--IDARRTLREIKLLRHMEHENVIAIKDIIR 70
           F +    +N ET ++ A+K +  A F +   +      RE  +   ++H +++   +++ 
Sbjct: 37  FSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV---ELLE 93
Query: 71  PPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASV 125
               D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y H  ++
Sbjct: 94  TYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 126 LHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEY-VVTRWYRAPELLLNCTEY 181
           +HRD+KP N+LL +   S  +K+GDFG+A    E+  +    V T  + APE++     Y
Sbjct: 152 IHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPY 210
Query: 182 TAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
              +D+W  G IL  +++   P +  K+     RL   +I                +   
Sbjct: 211 GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGII----------------KGKY 249
Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           +  PR        ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 250 KMNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPK 73
           I   A    T ++VA+KK+    D     RR L   E+ ++R   H+NV+ +        
Sbjct: 60  IVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDYHHDNVVDMYS-----S 110
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
               +++++V E ++      I +  ++ ++        +LR L Y+H+  V+HRD+K  
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 170
Query: 134 NLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           ++LL +   +K+ DFG  A+ + E       V T ++ APE +++   Y   +DIWS+G 
Sbjct: 171 SILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGI 229
Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           ++ E++  EP +  +  +  +R I                 D+    V+ L +       
Sbjct: 230 MVIEMIDGEPPYFNEPPLQAMRRI----------------RDSLPPRVKDLHKV------ 267
Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH 311
                 SS     L+ MLV +P++R T +E L HP+L+    L   P C  P    + H
Sbjct: 268 ------SSVLRGFLDLMLVREPSQRATAQELLGHPFLK----LAGPPSCIVPLMRQYRH 316

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 88/166 (53%), Gaps = 15/166 (9%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDD 104
           E+ LLR ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 105 HCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETD 158
                + QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           F   +V T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 172 FAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 130/271 (47%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA++ I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + + E+  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 213 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 241
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 38/253 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D   
Sbjct: 78  REVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +     
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 192
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G+     L  I+ +    
Sbjct: 193 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 251
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D+                             F N S  A D + ++LV DP +R+ + ++
Sbjct: 252 DEEY---------------------------FSNTSELAKDFIRRLLVKDPKRRMXIAQS 284
Query: 284 LRHPYLQSLHDLN 296
           L H +++++   N
Sbjct: 285 LEHSWIKAIRRRN 297

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 88/166 (53%), Gaps = 15/166 (9%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDD 104
           E+ LLR ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 105 HCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETD 158
                + QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
           F   +V T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 172 FAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 118/246 (47%), Gaps = 43/246 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           EI + R + H++V+              ND V++V EL     L ++ +  + LT+   +
Sbjct: 89  EISIHRSLAHQHVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEAR 142
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-- 165
           Y+L Q++ G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  
Sbjct: 143 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCG 201
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE +L+   ++  +D+WS+GCI                     + T L+G P  
Sbjct: 202 TPNYIAPE-VLSKKGHSFEVDVWSIGCI---------------------MYTLLVGKPP- 238
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
               F  S     Y+    R +K +++    + +  A  L++KML  DP  R T+ E L 
Sbjct: 239 ----FETSCLKETYL----RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 289
Query: 286 HPYLQS 291
             +  S
Sbjct: 290 DEFFTS 295

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 24  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 73
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 74  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 130
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 191 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 222
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITI 254

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 118/246 (47%), Gaps = 43/246 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           EI + R + H++V+              ND V++V EL     L ++ +  + LT+   +
Sbjct: 91  EISIHRSLAHQHVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEAR 144
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-- 165
           Y+L Q++ G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCG 203
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE +L+   ++  +D+WS+GCI                     + T L+G P  
Sbjct: 204 TPNYIAPE-VLSKKGHSFEVDVWSIGCI---------------------MYTLLVGKPP- 240
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
               F  S     Y+    R +K +++    + +  A  L++KML  DP  R T+ E L 
Sbjct: 241 ----FETSCLKETYL----RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 291
Query: 286 HPYLQS 291
             +  S
Sbjct: 292 DEFFTS 297

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 145/309 (46%), Gaps = 44/309 (14%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA+K I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 213 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 241
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP---VCPRPFHFDFEHSSCTEDHIR 320
           +LL+K L+ +P+KR T+E+ ++  ++   H+ +DE    V P P   D++    TE  + 
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHE-DDELKPYVAPLP---DYKDPRRTELMVS 297
Query: 321 ELIWRESVK 329
               RE ++
Sbjct: 298 MGYTREEIQ 306

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSXQEYSDW---KEK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 118/246 (47%), Gaps = 43/246 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           EI + R + H++V+              ND V++V EL     L ++ +  + LT+   +
Sbjct: 65  EISIHRSLAHQHVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEAR 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-- 165
           Y+L Q++ G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCG 177
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE +L+   ++  +D+WS+GCI                     + T L+G P  
Sbjct: 178 TPNYIAPE-VLSKKGHSFEVDVWSIGCI---------------------MYTLLVGKPP- 214
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
               F  S     Y+    R +K +++    + +  A  L++KML  DP  R T+ E L 
Sbjct: 215 ----FETSCLKETYL----RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 265
Query: 286 HPYLQS 291
             +  S
Sbjct: 266 DEFFTS 271

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI + + + HENV+      R  
Sbjct: 25  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-- 74
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 75  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 131
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVW 191
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 192 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 223
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 224 KTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 38/248 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D   
Sbjct: 64  REVNILREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY 163
            FL Q+L G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +     
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G+     L          
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---------- 227
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
              ++  +  D    Y               F N S  A D + ++LV DP +R+ + ++
Sbjct: 228 --TNISAVNYDFDEEY---------------FSNTSELAKDFIRRLLVKDPKRRMXIAQS 270
Query: 284 LRHPYLQS 291
           L H ++++
Sbjct: 271 LEHSWIKA 278

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H NVI + D+      +   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASC-DLKIGDFGLARTTSETDFMTEY 163
            F+ Q+L G+ Y+H+  + H DLKP N++L   N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D                        ++F   F + S  A D + K+LV +  KR+T++EA
Sbjct: 238 D------------------------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 284 LRHPYL 289
           LRHP++
Sbjct: 271 LRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H NVI + D+      +   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASC-DLKIGDFGLARTTSETDFMTEY 163
            F+ Q+L G+ Y+H+  + H DLKP N++L   N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D                        ++F   F + S  A D + K+LV +  KR+T++EA
Sbjct: 238 D------------------------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 284 LRHPYL 289
           LRHP++
Sbjct: 271 LRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H NVI + D+      +   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASC-DLKIGDFGLARTTSETDFMTEY 163
            F+ Q+L G+ Y+H+  + H DLKP N++L   N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D                        ++F   F   S  A D + K+LV +  KR+T++EA
Sbjct: 238 D------------------------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 284 LRHPYL 289
           LRHP++
Sbjct: 271 LRHPWI 276

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 129/278 (46%), Gaps = 47/278 (16%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFND 79
           ++  T  E A+K I  +       R    EI+ LLR+ +H N+I +KD+      D    
Sbjct: 42  IHKATNXEFAVKIIDKS------KRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90
Query: 80  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL- 136
           VY+V EL      L +I+R  +  ++      L+ + + ++Y+H+  V+HRDLKPSN+L 
Sbjct: 91  VYVVTELXKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 137 LNASCD---LKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           ++ S +   ++I DFG A+   +E   +     T  + APE +L    Y AA DIWS+G 
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VLERQGYDAACDIWSLGV 208
Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L   +T                 T     PDD     L    + ++            +
Sbjct: 209 LLYTXLTG---------------YTPFANGPDDTPEEILARIGSGKF----------SLS 243
Query: 253 TRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
             + N  S  A DL+ K L  DP++R+T    LRHP++
Sbjct: 244 GGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H NVI + D+      +   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASC-DLKIGDFGLARTTSETDFMTEY 163
            F+ Q+L G+ Y+H+  + H DLKP N++L   N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D                        ++F   F + S  A D + K+LV +  KR+T++EA
Sbjct: 238 D------------------------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 284 LRHPYL 289
           LRHP++
Sbjct: 271 LRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H NVI + D+      +   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASC-DLKIGDFGLARTTSETDFMTEY 163
            F+ Q+L G+ Y+H+  + H DLKP N++L   N     +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D                        ++F   F   S  A D + K+LV +  KR+T++EA
Sbjct: 238 D------------------------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 284 LRHPYL 289
           LRHP++
Sbjct: 271 LRHPWI 276

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA+K I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 213 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 241
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 128/271 (47%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA+K I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +     Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 213 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 241
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 38/252 (15%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQL 101
           D ++  RE ++ R ++H N++ + D I           Y++++L+   +L + I + +  
Sbjct: 53  DHQKLEREARICRLLKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYY 107
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLA-RTTSET 157
           ++    + + Q+L  + + H   V+HR+LKP NLLL +      +K+ DFGLA     E 
Sbjct: 108 SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 217
                +  T  Y +PE+L     Y   +D+W+ G IL  ++   P F  +D   Q RL  
Sbjct: 168 QAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQ 223
Query: 218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 277
           ++     D                  P     ++ T  P     A DL+ KML  +P+KR
Sbjct: 224 QIKAGAYD-----------------FP---SPEWDTVTPE----AKDLINKMLTINPSKR 259
Query: 278 ITVEEALRHPYL 289
           IT  EAL+HP++
Sbjct: 260 ITAAEALKHPWI 271

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 117/272 (43%), Gaps = 52/272 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-------REIKLLRHMEHENVIAIKDIIRPP 72
           AVN  T E VA+K        I+D +R +       +EI +   + HENV+      R  
Sbjct: 26  AVNRVTEEAVAVK--------IVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRR-- 75
Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                N  Y+  E     +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+K
Sbjct: 76  ---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 132 PSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL     +   +D+W
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S G +L  ++  E                     P D       SD+ + Y        K
Sbjct: 193 SCGIVLTAMLAGE--------------------LPWDQP-----SDSCQEYSDWK---EK 224
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 280
           + +   +    S  + LL K+LV +P+ RIT+
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 107/193 (55%), Gaps = 29/193 (15%)
Query: 29  VAIKKIGNAFDNIIDARR---TLREIKLLRHMEHENVIA-----IKDIIRPPKKDTFNDV 80
           VA+KK+   FD ++DA+     ++EI LL+ + H NVI      I+D          N++
Sbjct: 60  VALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----------NEL 107
Query: 81  YIVYELMDT-DLHQIIR---SDQQLTDDHC--QYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            IV EL D  DL ++I+     ++L  +    +YF+ QL   L+++HS  V+HRD+KP+N
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV-QLCSALEHMHSRRVMHRDIKPAN 166
Query: 135 LLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           + + A+  +K+GD GL R  +S+T      V T +Y +PE +     Y    DIWS+GC+
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCL 225
Query: 194 LGEIMTREPLFPG 206
           L E+   +  F G
Sbjct: 226 LYEMAALQSPFYG 238

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 117/246 (47%), Gaps = 43/246 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           EI + R + H++V+              ND V++V EL     L ++ +  + LT+   +
Sbjct: 71  EISIHRSLAHQHVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEAR 124
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-- 165
           Y+L Q++ G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  
Sbjct: 125 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCG 183
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE +L+   ++  +D+WS+GCI                     + T L+G P  
Sbjct: 184 TPNYIAPE-VLSKKGHSFEVDVWSIGCI---------------------MYTLLVGKPP- 220
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
               F  S     Y+    R +K +++    + +  A  L++KML  DP  R T+ E L 
Sbjct: 221 ----FETSCLKETYL----RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 271
Query: 286 HPYLQS 291
             +  S
Sbjct: 272 DEFFTS 277

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 117/246 (47%), Gaps = 43/246 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           EI + R + H++V+              ND V++V EL     L ++ +  + LT+   +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEAR 120
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-- 165
           Y+L Q++ G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCG 179
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE +L+   ++  +D+WS+GCI                     + T L+G P  
Sbjct: 180 TPNYIAPE-VLSKKGHSFEVDVWSIGCI---------------------MYTLLVGKPP- 216
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
               F  S     Y+    R +K +++    + +  A  L++KML  DP  R T+ E L 
Sbjct: 217 ----FETSCLKETYL----RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 267
Query: 286 HPYLQS 291
             +  S
Sbjct: 268 DEFFTS 273

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 117/246 (47%), Gaps = 43/246 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           EI + R + H++V+              ND V++V EL     L ++ +  + LT+   +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEAR 120
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-- 165
           Y+L Q++ G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   +  +  
Sbjct: 121 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLCG 179
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE +L+   ++  +D+WS+GCI                     + T L+G P  
Sbjct: 180 TPNYIAPE-VLSKKGHSFEVDVWSIGCI---------------------MYTLLVGKPP- 216
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
               F  S     Y+    R +K +++    + +  A  L++KML  DP  R T+ E L 
Sbjct: 217 ----FETSCLKETYL----RIKKNEYSIP-KHINPVAASLIQKMLQTDPTARPTINELLN 267
Query: 286 HPYLQS 291
             +  S
Sbjct: 268 DEFFTS 273

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 128/271 (47%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA+K I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 85
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +   + +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 86  EYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 145
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 146 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 206 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 234
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 235 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 265

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 38/246 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQ 107
           RE+ +LR + H N+I + D+      +   DV ++ EL+   +L   +   + L+++   
Sbjct: 64  REVSILRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEY 163
            F+ Q+L G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             T  + APE ++N        D+WS+G I   +++    F G      L  IT +    
Sbjct: 179 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D                        ++F   F   S  A D + K+LV +  KR+T++EA
Sbjct: 238 D------------------------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 284 LRHPYL 289
           LRHP++
Sbjct: 271 LRHPWI 276

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI + + +++ +V+         + D F  VY+V E+     L ++ +  + +T+   +Y
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTR 167
           F+ Q ++G++Y+H+  V+HRDLK  NL LN   D+KIGDFGLA +   + +   +   T 
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 207 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA++ I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI-----ETEKTLYLVM 92
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 93  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNI 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 213 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 241
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 242 NLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 39/220 (17%)
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLL-LNA------------------SCDLKIGD 147
           ++  +QL + +K++H   + H DLKP N+L +N+                  S  +++ D
Sbjct: 140 RHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVD 199
Query: 148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 207
           FG A  T + +  +  V TR YRAPE++L    ++   D+WS+GCI+ E      LF   
Sbjct: 200 FGSA--TFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTH 256
Query: 208 DYVHQLRLITELIGSPDD--------------ASLGFLRSDNARRYVRQLPRCRK-QQFA 252
           D    L ++  ++G                    L +  + +A RYVR+   C+  +++ 
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRE--NCKPLRRYL 314
Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           T    +     DL+E ML ++P KR+T+ EAL+HP+   L
Sbjct: 315 TSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI + + +++ +V+         + D F  VY+V E+     L ++ +  + +T+   +Y
Sbjct: 76  EIAIHKSLDNPHVVGFHGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTR 167
           F+ Q ++G++Y+H+  V+HRDLK  NL LN   D+KIGDFGLA +   + +   +   T 
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 191 NYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI + + +++ +V+         + D F  VY+V E+     L ++ +  + +T+   +Y
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--T 166
           F+ Q ++G++Y+H+  V+HRDLK  NL LN   D+KIGDFGLA T  E D   +  +  T
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKTLCGT 205
Query: 167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
             Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 206 PNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 127/271 (46%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T  EVAIK I     N    ++  RE+++++ + H N++ + ++I     +T   +Y++ 
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLIM 90
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 91  EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNI 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +    +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 151 KIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 211 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 239
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL++ LV +P KR T+E+ ++  ++ + H+
Sbjct: 240 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 270

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 25  TREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 82
           T+E VA+K I  G A D  +      REI   R + H N++  K++I  P       + I
Sbjct: 44  TKELVAVKYIERGAAIDENVQ-----REIINHRSLRHPNIVRFKEVILTP-----THLAI 93
Query: 83  VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           + E     +L++ I +  + ++D  ++F  QLL G+ Y HS  + HRDLK  N LL+ S 
Sbjct: 94  IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP 153
Query: 142 D--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI-DIWSVGCIL---- 194
              LKI DFG ++++         V T  Y APE+LL   EY   I D+WS G  L    
Sbjct: 154 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVML 212
Query: 195 -GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
            G     +P  P +DY   + R+++     PDD              +R  P C      
Sbjct: 213 VGAYPFEDPEEP-RDYRKTIQRILSVKYSIPDD--------------IRISPEC------ 251
Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                       L+ ++ V DP  RI++ E   H + 
Sbjct: 252 ----------CHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI + + +++ +V+         + D F  VY+V E+     L ++ +  + +T+   +Y
Sbjct: 92  EIAIHKSLDNPHVVGFHGFF---EDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--T 166
           F+ Q ++G++Y+H+  V+HRDLK  NL LN   D+KIGDFGLA T  E D   +  +  T
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKXLCGT 205
Query: 167 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
             Y APE+L     ++  +DIWS+GCIL  ++  +P F
Sbjct: 206 PNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 126/271 (46%), Gaps = 37/271 (13%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T  EVAIK I     N    ++  RE+++++ + H N++ + ++I     +T   +Y++ 
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLIM 93
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 94  EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNI 153
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +    +  +     Y APEL          +D+WS+G IL  +++    
Sbjct: 154 KIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 263
           F G++ + +LR                              R  + ++   F   S+   
Sbjct: 214 FDGQN-LKELR-----------------------------ERVLRGKYRIPF-YMSTDCE 242
Query: 264 DLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +LL++ LV +P KR T+E+ ++  ++ + H+
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   TE  
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 221
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 222 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQY 108
           +EI+LLR + H+NVI + D++   +K     +Y+V E     + +++ S  +     CQ 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA 111
Query: 109 FLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEY 163
             Y  QL+ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D     
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 164 VVTRWYRAPELLLNCTEYTA-AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 222
             +  ++ PE+      ++   +DIWS G  L  I T   L+P                 
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG--LYP----------------- 212
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 282
                      DN  +    + +          P  S    DLL+ ML ++P KR ++ +
Sbjct: 213 --------FEGDNIYKLFENIGKGSYAIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQ 260
Query: 283 ALRHPYLQSLHDLNDEPV 300
             +H + +  H   + PV
Sbjct: 261 IRQHSWFRKKHPPAEAPV 278

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 95/175 (54%), Gaps = 21/175 (12%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY-IVYELMDT-DLHQIIRSDQQLT 102
           +R  RE+     + H+N++++ D+      D  +D Y +V E ++   L + I S   L+
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDV------DEEDDCYYLVMEYIEGPTLSEYIESHGPLS 109
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MT 161
            D    F  Q+L G+K+ H   ++HRD+KP N+L++++  LKI DFG+A+  SET    T
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 162 EYVV-TRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 210
            +V+ T  Y +PE         CT      DI+S+G +L E++  EP F G+  V
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECT------DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 113/249 (45%), Gaps = 43/249 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSD---QQLTDD 104
           EI++L+ ++H N+I I ++      + ++++YIV E  +    L +I+ +    + L++ 
Sbjct: 70  EIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMT 161
           +    + Q++  L Y HS  V+H+DLKP N+L   +     +KI DFGLA      +  T
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 162 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
               T  Y APE+     + T   DIWS G ++  ++T    F G               
Sbjct: 185 NAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG--------------- 227
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 281
                         +   V+Q    ++  +A      +  AVDLL++ML  DP +R +  
Sbjct: 228 -------------TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAA 274
Query: 282 EALRHPYLQ 290
           + L H + +
Sbjct: 275 QVLHHEWFK 283

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 40/245 (16%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 108
           EI +L+ ++HEN++ ++DI      ++    Y+V +L+   +L   I      T+     
Sbjct: 56  EIAVLKKIKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL 110
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVV 165
            + Q+L  +KY+H   ++HRDLKP NLL      +  + I DFGL++   +   M+    
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACG 169
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE+L     Y+ A+D WS+G I   ++   P F  +        I E       
Sbjct: 170 TPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE------- 221
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEAL 284
              G+                   +F + F +  S  A D +  +L  DPN+R T E+AL
Sbjct: 222 ---GYY------------------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260
Query: 285 RHPYL 289
            HP++
Sbjct: 261 SHPWI 265

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 114/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+  
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 172
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 173 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 226
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 227 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 260 LEHPWITA 267

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 114/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 58  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+  
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 168
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 169 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 222
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 223 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 255
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 256 LEHPWITA 263

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 135/289 (46%), Gaps = 46/289 (15%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVIAIKDIIR 70
           F +    +N ET ++ A+K +  A       +      RE  +   ++H +++   +++ 
Sbjct: 39  FSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV---ELLE 95
Query: 71  PPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASV 125
               D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y H  ++
Sbjct: 96  TYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 153
Query: 126 LHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEY-VVTRWYRAPELLLNCTEY 181
           +HRD+KP  +LL +   S  +K+G FG+A    E+  +    V T  + APE++     Y
Sbjct: 154 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPY 212
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
              +D+W  G IL  +++    F    Y  + RL   +I                +   +
Sbjct: 213 GKPVDVWGCGVILFILLSGCLPF----YGTKERLFEGII----------------KGKYK 252
Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             PR        ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 253 MNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 114/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+  
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 221
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 222 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 135/289 (46%), Gaps = 46/289 (15%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVIAIKDIIR 70
           F +    +N ET ++ A+K +  A       +      RE  +   ++H +++   +++ 
Sbjct: 37  FSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV---ELLE 93
Query: 71  PPKKDTFNDVYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASV 125
               D    +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y H  ++
Sbjct: 94  TYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 126 LHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEY-VVTRWYRAPELLLNCTEY 181
           +HRD+KP  +LL +   S  +K+G FG+A    E+  +    V T  + APE++     Y
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPY 210
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
              +D+W  G IL  +++    F    Y  + RL   +I                +   +
Sbjct: 211 GKPVDVWGCGVILFILLSGCLPF----YGTKERLFEGII----------------KGKYK 250
Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             PR        ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 251 MNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 83  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 134
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 135 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 193
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 194 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 247
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 248 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 280
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 281 LEHPWITA 288

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 114/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T+  
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 221
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 222 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 61  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLC 171
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +   P F    Y    R I+ +     
Sbjct: 172 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV----- 225
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  + ++R+T+ E 
Sbjct: 226 -------------------------EFT--FPDFVTEGARDLISRLLKHNASQRLTLAEV 258
Query: 284 LRHPYLQS 291
           L HP++++
Sbjct: 259 LEHPWIKA 266

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 74  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 125
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 126 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 184
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 185 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 238
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 239 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 271
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 272 LEHPWITA 279

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 221
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 222 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 170
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 224
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 225 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 258 LEHPWITA 265

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 172
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 173 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 226
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 227 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 260 LEHPWITA 267

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 45/282 (15%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++ ET + VAIK++    D     +  ++EI +++  +  +V+          K+T  D
Sbjct: 48  AIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYF---KNT--D 98
Query: 80  VYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           ++IV E      +  IIR  ++ LT+D     L   L+GL+Y+H    +HRD+K  N+LL
Sbjct: 99  LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158
Query: 138 NASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           N     K+ DFG+A     TD M +    + T ++ APE++     Y    DIWS+G   
Sbjct: 159 NTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG-YNCVADIWSLGITA 215
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E+   +P  P  D +H +R I  +  +P                    P  RK +    
Sbjct: 216 IEMAEGKP--PYAD-IHPMRAIFMIPTNPP-------------------PTFRKPELW-- 251
Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
               S    D +++ LV  P +R T  + L+HP+++S   ++
Sbjct: 252 ----SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 206
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 207 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 61  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 112
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 171
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 172 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 210
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 211 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 258
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 259 LEHPWITA 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 56  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 107
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 108 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 166
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 167 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 205
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 206 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 253
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 254 LEHPWITA 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 52/288 (18%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T +EVA+K I     N    ++  RE+++ + + H N++ + ++I     +T   +Y+V 
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVI-----ETEKTLYLVX 92
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  +  +   +    Q++  ++Y H   ++HRDLK  NLLL+A  ++
Sbjct: 93  EYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNI 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +     Y APEL          +D+WS+G IL  +++    
Sbjct: 153 KIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGA 262
           F G++       + EL                         R R  +   R P   S+  
Sbjct: 213 FDGQN-------LKEL-------------------------RERVLRGKYRIPFYXSTDC 240
Query: 263 VDLLEKMLVFDPNKRITVEEALR-------------HPYLQSLHDLND 297
            +LL+K L+ +P+KR T+E+  +              PY++ L D  D
Sbjct: 241 ENLLKKFLILNPSKRGTLEQIXKDRWXNVGHEDDELKPYVEPLPDYKD 288

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 172
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE +     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 173 GTLDYLPPEXI-EGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 226
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 227 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPXLREV 259
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 260 LEHPWITA 267

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 122/264 (46%), Gaps = 41/264 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 179 VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEF 229
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 289
Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APEL+     Y   +DIWS+G ++ E++  EP + 
Sbjct: 290 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 348
Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 349 NEPPLKAMKMI----------------RDNLPPRLKNLHKV------------SPSLKGF 380
Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 381 LDRLLVRDPAQRATAAELLKHPFL 404

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 170
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 209
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 210 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 258 LEHPWITA 265

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 54/280 (19%)
Query: 22  NSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           + +  E VA+K I  G   D  +      REI   R + H N++  K++I  P       
Sbjct: 40  DKQANELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTP-----TH 89
Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 90  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLD 149
Query: 139 ASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI-DIWSVGCIL- 194
            S    LKI DFG ++ +         V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 150 GSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 208
Query: 195 ----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
               G     +P  P K++   + R++      PD              YV   P CR  
Sbjct: 209 VMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD--------------YVHISPECRH- 252
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                          L+ ++ V DP KRI++ E   H + 
Sbjct: 253 ---------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL---TEKSACKSSDLWA 217
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 260
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 104 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 163
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 164 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSACKSSDLWA 220
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 263
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 264 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 54  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 105
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 106 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLC 164
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 165 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 203
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 204 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 251
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 252 LEHPWITA 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 58  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   T   
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLS 168
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 169 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 222
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 223 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 255
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 256 LEHPWITA 263

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 89/161 (55%), Gaps = 10/161 (6%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ-- 107
           EI L +H++H+N++     +    ++ F  +++  ++    L  ++RS      D+ Q  
Sbjct: 55  EIALHKHLKHKNIV---QYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTI 110
Query: 108 -YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YV 164
            ++  Q+L GLKY+H   ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE + 
Sbjct: 111 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 170
Query: 165 VTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            T  Y APE++      Y  A DIWS+GC + E+ T +P F
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 163 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 219
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 262
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 37/251 (14%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQ 100
           D      EI ++  ++H N+I + D       ++ ND+ +V E +D      +II     
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYN 183
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETD 158
           LT+     F+ Q+  G++++H   +LH DLKP N+L     +  +KI DFGLAR     +
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 218
            +     T  + APE ++N    +   D+WSVG I   +++    F G            
Sbjct: 244 KLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG------------ 290
Query: 219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 278
                          DN    +  +  CR       F + S  A + + K+L+ + + RI
Sbjct: 291 ---------------DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI 335
Query: 279 TVEEALRHPYL 289
           +  EAL+HP+L
Sbjct: 336 SASEALKHPWL 346

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 89/161 (55%), Gaps = 10/161 (6%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ-- 107
           EI L +H++H+N++     +    ++ F  +++  ++    L  ++RS      D+ Q  
Sbjct: 69  EIALHKHLKHKNIV---QYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 108 -YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YV 164
            ++  Q+L GLKY+H   ++HRD+K  N+L+N  S  LKI DFG ++  +  +  TE + 
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184
Query: 165 VTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            T  Y APE++      Y  A DIWS+GC + E+ T +P F
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 44  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 103
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 104 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 163
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 164 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 220
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 221 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 263
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 264 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 78  NDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 132
            DV+I  ELMDT L     Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 123 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWS 189
           SN+L+NA   +K+ DFG++    ++   T     + Y APE +   LN   Y+   DIWS
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G  + E+      FP   +    + + +++  P                    P+    
Sbjct: 243 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 281
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +F+  F       VD   + L  +  +R T  E ++HP+  +LH+
Sbjct: 282 KFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 318

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/329 (25%), Positives = 149/329 (45%), Gaps = 50/329 (15%)
Query: 3   VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 62
           +K+ G+      F+      S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 63  IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 180
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 202
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRY 239
           +T + D WS G ++ E++T    F GKD    + +I +  +G P      FL S  A+  
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSL 256
Query: 240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-- 297
           +R L +        R P    GA           P+    VEE  RH +  ++ D N   
Sbjct: 257 LRMLFK--------RNPANRLGA----------GPD---GVEEIKRHSFFSTI-DWNKLY 294
Query: 298 --------EPVCPRP---FHFDFEHSSCT 315
                   +P   RP   F+FD E ++ T
Sbjct: 295 RREIHPPFKPATGRPEDTFYFDPEFTAKT 323

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 163 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 219
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 262
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 66/289 (22%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 46  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 105
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 106 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 165
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 166 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 222
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +GCI+ +++   P F                           R+ N     +++ +    
Sbjct: 223 LGCIIYQLVAGLPPF---------------------------RAGNEYLIFQKIIKLEYD 255
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
             A  FP     A DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 256 FPAAFFPK----ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 163 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 219
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 262
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 102 VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 152
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 212
Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APE L++   Y   +DIWS+G ++ E++  EP + 
Sbjct: 213 DFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271
Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 272 NEPPLKAMKMI----------------RDNLPPRLKNLHKV------------SPSLKGF 303
Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 304 LDRLLVRDPAQRATAAELLKHPFL 327

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 217
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 260
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 83  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 134
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +    +  
Sbjct: 135 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLC 193
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 194 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 247
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 248 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 280
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 281 LEHPWITA 288

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 100 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 159
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 160 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSACKSSDLWA 216
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 217 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 259
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 260 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 20  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 79
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 80  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 139
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 140 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 196
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 197 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 239
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 240 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 57  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 107
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 108 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 167
Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APE L++   Y   +DIWS+G ++ E++  EP + 
Sbjct: 168 DFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 226
Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 227 NEPPLKAMKMI----------------RDNLPPRLKNLHKV------------SPSLKGF 258
Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 259 LDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 41  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 217
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 218 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 260
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 48  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQ 107
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 108 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 167
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 168 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 224
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 225 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 267
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 268 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 114/252 (45%), Gaps = 55/252 (21%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQ 100
           RE+++  H+ H N++ +           F+D   VY +++         +L ++ + D+Q
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQ 113
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
            T      ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   
Sbjct: 114 RTAT----YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR 168
Query: 161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
           T    T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ + 
Sbjct: 169 TTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV- 226
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRIT 279
                                        +F   FP+  + GA DL+ ++L  +P++R  
Sbjct: 227 -----------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPM 255
Query: 280 VEEALRHPYLQS 291
           + E L HP++ +
Sbjct: 256 LREVLEHPWITA 267

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 59  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 109
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 110 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 169
Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APE L++   Y   +DIWS+G ++ E++  EP + 
Sbjct: 170 DFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 228
Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 229 NEPPLKAMKMI----------------RDNLPPRLKNLHKV------------SPSLKGF 260
Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 261 LDRLLVRDPAQRATAAELLKHPFL 284

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 19  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 79  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 195
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 238
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 239 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 25  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 84
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 85  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 144
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 145 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 201
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 202 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 244
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 245 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 94/185 (50%), Gaps = 6/185 (3%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T  EVA+K I     N    ++  RE+++++ + H N++ + ++I     +T   +Y+V 
Sbjct: 39  TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKTLYLVM 93
Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+   ++
Sbjct: 94  EYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNI 153
Query: 144 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           KI DFG +   +  + +  +  +  Y APEL          +D+WS+G IL  +++    
Sbjct: 154 KIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 204 FPGKD 208
           F G++
Sbjct: 214 FDGQN 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 25  TREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           T  +VA+K +      + D +   +R ++ +KL RH    ++I +  +I  P      D 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH---PHIIKLYQVISTP-----TDF 86
Query: 81  YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++V E +   +L   I    ++ +   +    Q+L  + Y H   V+HRDLKP N+LL+A
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA 146
Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             + KI DFGL+   S+ +F+ +   +  Y APE++         +DIWS G IL  ++ 
Sbjct: 147 HMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
               F   D  H   L  ++ G                  V  +P    +  AT      
Sbjct: 207 GTLPF---DDEHVPTLFKKIRGG-----------------VFYIPEYLNRSVAT------ 240
Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
                LL  ML  DP KR T+++   H + + 
Sbjct: 241 -----LLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 21  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 80
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 81  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 140
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 141 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 197
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 198 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 240
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 241 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 40  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 99
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 100 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 159
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 160 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 216
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 217 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 259
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 260 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 18  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 77
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 78  DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 137
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 138 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 194
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 195 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 237
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 238 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 59  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 110
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI +FG +   + +   T   
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLC 169
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 170 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 223
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 224 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 256
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 257 LEHPWITA 264

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 48  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 98
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 99  LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158
Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APE L++   Y   +DIWS+G ++ E++  EP + 
Sbjct: 159 DFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217
Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 218 NEPPLKAMKMI----------------RDNLPPRLKNLHKV------------SPSLKGF 249
Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFL 273

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 122/280 (43%), Gaps = 54/280 (19%)
Query: 22  NSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           + ++ E VA+K I  G   D  +      REI   R + H N++  K++I  P       
Sbjct: 39  DKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 88
Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 89  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 148
Query: 139 ASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI-DIWSVGCIL- 194
            S    LKI DFG ++++         V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 149 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 207
Query: 195 ----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
               G     +P  P K++   + R++      PD              YV   P CR  
Sbjct: 208 VMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD--------------YVHISPECRH- 251
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                          L+ ++ V DP KRI++ E   H + 
Sbjct: 252 ---------------LISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           VA+KK+    D     RR L   E+ ++R  +HENV+ + +          +++++V E 
Sbjct: 52  VAVKKM----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVMEF 102
Query: 87  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           ++      I +  ++ ++        +L+ L  +H+  V+HRD+K  ++LL     +K+ 
Sbjct: 103 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 162
Query: 147 DFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFG  A+ + E       V T ++ APE L++   Y   +DIWS+G ++ E++  EP + 
Sbjct: 163 DFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 221
Query: 206 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
            +  +  +++I                 DN    ++ L +             S      
Sbjct: 222 NEPPLKAMKMI----------------RDNLPPRLKNLHKV------------SPSLKGF 253
Query: 266 LEKMLVFDPNKRITVEEALRHPYL 289
           L+++LV DP +R T  E L+HP+L
Sbjct: 254 LDRLLVRDPAQRATAAELLKHPFL 277

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALC 170
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 224
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 225 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 258 LEHPWITA 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 115/250 (46%), Gaps = 51/250 (20%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 61  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA--RTTSETDFMTE 162
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +    +S  D +  
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCG 172
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 222
              T  Y  PE++     +   +D+WS+G +  E +   P F    Y    R I+ +   
Sbjct: 173 ---TLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV--- 225
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVE 281
                                      +F   FP+  + GA DL+ ++L  + ++R+T+ 
Sbjct: 226 ---------------------------EFT--FPDFVTEGARDLISRLLKHNASQRLTLA 256
Query: 282 EALRHPYLQS 291
           E L HP++++
Sbjct: 257 EVLEHPWIKA 266

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 37  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 82
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 83  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 142
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +TE   T +Y APE +L   +Y  + D+W
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMW 201
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 202 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 235
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 236 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +    +  
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLC 170
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 209
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 210 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 258 LEHPWITA 265

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI +FG +   + +   T   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLC 170
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 209
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 210 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 258 LEHPWITA 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 59  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 110
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +       
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLC 169
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +     
Sbjct: 170 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----- 223
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                                    +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 224 -------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 256
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 257 LEHPWITA 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +       
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 206
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 207 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 51/250 (20%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 58  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA--RTTSETDFMTE 162
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +    +S  D +  
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCG 169
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 222
              T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ +   
Sbjct: 170 ---TLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--- 222
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVE 281
                                      +F   FP+  + GA DL+ ++L  +P++R  + 
Sbjct: 223 ---------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLR 253
Query: 282 EALRHPYLQS 291
           E L HP++ +
Sbjct: 254 EVLEHPWITA 263

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 50/278 (17%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + ++ E VA+K I    + I  A    REI   R + H N++  K++I  P       + 
Sbjct: 40  DKQSNELVAVKYIERG-EKI--AANVKREIINHRSLRHPNIVRFKEVILTPTH-----LA 91
Query: 82  IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  V HRDLK  N LL+ S
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 151
Query: 141 CD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI-DIWSVGCIL--- 194
               LKI DFG ++++         V T  Y APE+LL   EY   + D+WS G  L   
Sbjct: 152 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLYVM 210
Query: 195 --GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
             G     +P  P K++   + R++      PD              YV   P CR    
Sbjct: 211 LVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD--------------YVHISPECRH--- 252
Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                        L+ ++ V DP KRI++ E   H + 
Sbjct: 253 -------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +       
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 206
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 207 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 44/272 (16%)
Query: 25  TREEVAIKKIGN----AFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           T  +VA+K +      + D +   +R ++ +KL RH    ++I +  +I  P      D 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH---PHIIKLYQVISTP-----TDF 86
Query: 81  YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++V E +   +L   I    ++ +   +    Q+L  + Y H   V+HRDLKP N+LL+A
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA 146
Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             + KI DFGL+   S+ +F+     +  Y APE++         +DIWS G IL  ++ 
Sbjct: 147 HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
               F   D  H   L  ++ G                  V  +P    +  AT      
Sbjct: 207 GTLPF---DDEHVPTLFKKIRGG-----------------VFYIPEYLNRSVAT------ 240
Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
                LL  ML  DP KR T+++   H + + 
Sbjct: 241 -----LLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           N  +++  L   DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+LL
Sbjct: 93  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 152
Query: 138 NASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +    +KI DFG+ +     D  T E+  T  Y APE+LL   +Y  ++D WS G +L E
Sbjct: 153 DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 211
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++  +  F G+D         EL  S        +R DN               F  R+ 
Sbjct: 212 MLIGQSPFHGQDE-------EELFHS--------IRMDNP--------------FYPRWL 242
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSLH 293
            K   A DLL K+ V +P KR+ V   +R HP  + ++
Sbjct: 243 EKE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 278

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 88  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 147
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 148 FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 202
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 230
Query: 203 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 261
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 231 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 260
Query: 262 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 60  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +       
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLC 170
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F                    
Sbjct: 171 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------------------- 209
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                      A  Y     R  + +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 210 ----------EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 258 LEHPWITA 265

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 127/267 (47%), Gaps = 34/267 (12%)
Query: 25  TREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 82
           T E+VA+K +   +  ++I D ++   EI++LR++ HEN++  K I     +D  N + +
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICT---EDGGNGIKL 102
Query: 83  VYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           + E + +  L + +  ++   +   Q  +  Q+ +G+ Y+ S   +HRDL   N+L+ + 
Sbjct: 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162
Query: 141 CDLKIGDFGLARTTSETDFMTEYVV------TRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +KIGDFGL +   ETD     V         WY APE L+    Y A+ D+WS G  L
Sbjct: 163 HQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIAS-DVWSFGVTL 219
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++T    +   D    + L  ++IG P    +   R  N  +  ++LP C        
Sbjct: 220 HELLT----YCDSD-SSPMALFLKMIG-PTHGQMTVTRLVNTLKEGKRLP-CP------- 265
Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVE 281
            PN       L+ K   F P+ R + +
Sbjct: 266 -PNCPDEVYQLMRKCWEFQPSNRTSFQ 291

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        +  L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 103 DDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 163 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSASKSSDLWA 219
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G +Y+   ++I              L  D   ++    P+ R 
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR- 262
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 112/224 (50%), Gaps = 9/224 (4%)
Query: 3   VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 62
           +K+ G+      F+      S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 30  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 63  IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 90  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 180
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 203
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSP 223
           +T + D WS G ++ E++T    F GKD    + +I +  +G P
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 112/224 (50%), Gaps = 9/224 (4%)
Query: 3   VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV 62
           +K+ G+      F+      S+ R+  A+K +  A   + D  RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 63  IAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           + +    +     T   +Y++ + +   DL   +  +   T++  +++L +L   L ++H
Sbjct: 89  VKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTE 180
           S  +++RDLKP N+LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 202
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSP 223
           +T + D WS G ++ E++T    F GKD    + +I +  +G P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLT---DD 104
           RE+++  H+ H N++ +           F+D   VY +++   L  + R  Q+L+   + 
Sbjct: 57  REVEIQSHLRHPNILRLYGY--------FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQ 108
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
               ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +       
Sbjct: 109 RTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALC 167
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            T  Y  PE++     +   +D+WS+G +  E +  +P F    Y               
Sbjct: 168 GTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 211
Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEA 283
                    D  +R  R        +F   FP+  + GA DL+ ++L  +P++R  + E 
Sbjct: 212 --------QDTYKRISRV-------EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 254
Query: 284 LRHPYLQS 291
           L HP++ +
Sbjct: 255 LEHPWITA 262

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 127/267 (47%), Gaps = 34/267 (12%)
Query: 25  TREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI 82
           T E+VA+K +   +  ++I D ++   EI++LR++ HEN++  K I     +D  N + +
Sbjct: 37  TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGIC---TEDGGNGIKL 90
Query: 83  VYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           + E + +  L + +  ++   +   Q  +  Q+ +G+ Y+ S   +HRDL   N+L+ + 
Sbjct: 91  IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 150
Query: 141 CDLKIGDFGLARTTSETDFMTEYVV------TRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +KIGDFGL +   ETD     V         WY APE L+    Y A+ D+WS G  L
Sbjct: 151 HQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIAS-DVWSFGVTL 207
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++T    +   D    + L  ++IG P    +   R  N  +  ++LP C        
Sbjct: 208 HELLT----YCDSD-SSPMALFLKMIG-PTHGQMTVTRLVNTLKEGKRLP-CP------- 253
Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVE 281
            PN       L+ K   F P+ R + +
Sbjct: 254 -PNCPDEVYQLMRKCWEFQPSNRTSFQ 279

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 98/190 (51%), Gaps = 16/190 (8%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           ++E   +  IK+I  +  +  +   + RE+ +L +M+H N++  ++        +F +  
Sbjct: 45  STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE--------SFEENG 96
Query: 82  IVYELMD----TDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            +Y +MD     DL + I + + +   +D    +  Q+   LK+VH   +LHRD+K  N+
Sbjct: 97  SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156
Query: 136 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
            L     +++GDFG+AR  + T +     + T +Y +PE+  N   Y    DIW++GC+L
Sbjct: 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVL 215
Query: 195 GEIMTREPLF 204
            E+ T +  F
Sbjct: 216 YELCTLKHAF 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 49/286 (17%)
Query: 30  AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI-------KDIIRP----PKKDTFN 78
           AIKKI +  + +      L E+ LL  + H+ V+         ++ ++P     KK T  
Sbjct: 35  AIKKIRHTEEKL---STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST-- 89
Query: 79  DVYIVYELMDTD-LHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            ++I  E  +   L+ +I S+   Q  D++ + F  Q+L  L Y+HS  ++HRDLKP N+
Sbjct: 90  -LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHRDLKPMNI 147
Query: 136 LLNASCDLKIGDFGLARTT---------------SETDFMTEYVVTRWYRAPELLLNCTE 180
            ++ S ++KIGDFGLA+                   +D +T  + T  Y A E+L     
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRY 239
           Y   ID++S+G I  E++   P   G + V+ L+ +  + I  P D        DN  + 
Sbjct: 208 YNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDF------DDNKMKV 259
Query: 240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
            +++ R          PNK  GA  LL    +   ++   ++EAL+
Sbjct: 260 EKKIIRL----LIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 113/252 (44%), Gaps = 55/252 (21%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD--------TDLHQIIRSDQQ 100
           RE+++  H+ H N++ +           F+D   VY +++         +L ++ + D+Q
Sbjct: 62  REVEIQSHLRHPNILRLYGY--------FHDATRVYLILEYAPRGEVYKELQKLSKFDEQ 113
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
            T      ++ +L   L Y HS  V+HRD+KP NLLL ++ +LKI DFG +   + +   
Sbjct: 114 RTAT----YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR 168
Query: 161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
                T  Y  PE++     +   +D+WS+G +  E +  +P F    Y    + I+ + 
Sbjct: 169 XXLXGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV- 226
Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRIT 279
                                        +F   FP+  + GA DL+ ++L  +P++R  
Sbjct: 227 -----------------------------EFT--FPDFVTEGARDLISRLLKHNPSQRPM 255
Query: 280 VEEALRHPYLQS 291
           + E L HP++ +
Sbjct: 256 LREVLEHPWITA 267

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 31/185 (16%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVV 165
            + Q+L G+ Y+H  +++H DLKP N+LL++     D+KI DFG++R       + E + 
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 225
           T  Y APE+L N    T A D+W++G I   ++T    F G+D                 
Sbjct: 196 TPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGED----------------- 237
Query: 226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                    N   Y+  + +         F + S  A D ++ +LV +P KR T E  L 
Sbjct: 238 ---------NQETYLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
Query: 286 HPYLQ 290
           H +LQ
Sbjct: 288 HSWLQ 292

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 49/286 (17%)
Query: 30  AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI-------KDIIRP----PKKDTFN 78
           AIKKI +  + +      L E+ LL  + H+ V+         ++ ++P     KK T  
Sbjct: 35  AIKKIRHTEEKL---STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST-- 89
Query: 79  DVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            ++I  E  +   L+ +I S+   Q  D++ + F  Q+L  L Y+HS  ++HRDLKP N+
Sbjct: 90  -LFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHRDLKPMNI 147
Query: 136 LLNASCDLKIGDFGLARTT---------------SETDFMTEYVVTRWYRAPELLLNCTE 180
            ++ S ++KIGDFGLA+                   +D +T  + T  Y A E+L     
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRY 239
           Y   ID++S+G I  E++   P   G + V+ L+ +  + I  P D        DN  + 
Sbjct: 208 YNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPDF------DDNKMKV 259
Query: 240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
            +++ R          PNK  GA  LL    +   ++   ++EAL+
Sbjct: 260 EKKIIRL----LIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 43  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 88
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 89  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 148
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 149 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 207
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 208 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 241
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 242 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 64/288 (22%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   +   ++ D+W++G
Sbjct: 163 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALG 221
Query: 192 CILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           CI+ +++   P F  G + +   ++I              L  D   ++    P+ R   
Sbjct: 222 CIIYQLVAGLPPFRAGNEGLIFAKIIK-------------LEYDFPEKF---FPKAR--- 262
Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                        DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 -------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 45  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 90
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 91  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 150
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 151 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 209
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 210 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 243
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 244 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 38  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 83
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 84  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 143
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 144 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 202
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 203 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 236
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 237 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 68/290 (23%)
Query: 36  NAFDNIIDARR--TLRE--IKLL--RHMEHENVIAI----KDIIRPPKKDTFNDVYIVYE 85
            +F  ++ AR   T RE  IK+L  RH+  EN +      +D++       F  +Y  ++
Sbjct: 43  GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102
Query: 86  -----------LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                        + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N
Sbjct: 103 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162
Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWS 189
           +LLN    ++I DFG A+     S+      +V T  Y +PELL   TE +A  + D+W+
Sbjct: 163 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWA 219
Query: 190 VGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           +GCI+ +++   P F  G + +   ++I              L  D   ++    P+ R 
Sbjct: 220 LGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------------LEYDFPEKF---FPKAR- 262
Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                          DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 ---------------DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 53  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 98
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 99  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 158
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 159 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 217
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 218 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 251
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 252 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 44  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 89
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 90  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 149
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 150 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 208
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 209 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 242
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 243 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 122/280 (43%), Gaps = 54/280 (19%)
Query: 22  NSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           + ++ E VA+K I  G   D  +      REI   R + H N++  K++I  P       
Sbjct: 40  DKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 89
Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 90  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 149
Query: 139 ASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI-DIWSVGCIL- 194
            S    LKI  FG ++++       + V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 150 GSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 208
Query: 195 ----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
               G     +P  P K++   + R++      PD              YV   P CR  
Sbjct: 209 VMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD--------------YVHISPECRH- 252
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                          L+ ++ V DP KRI++ E   H + 
Sbjct: 253 ---------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V   GEY D           ++ R + AIK +      +      LRE  L+R + H N
Sbjct: 35  GVVYHGEYID----------QAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPN 83
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYV 120
           V+A+  I+ PP  +    V + Y +   DL Q IRS Q+  T      F  Q+ RG++Y+
Sbjct: 84  VLALIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT- 179
                +HRDL   N +L+ S  +K+ DFGLAR   +     EY   + +R   L +  T 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REYYSVQQHRHARLPVKWTA 196
Query: 180 -------EYTAAIDIWSVGCILGEIMTR 200
                   +T   D+WS G +L E++TR
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 37  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 82
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 83  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 142
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 201
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 202 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 235
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 236 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 39  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 84
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 85  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 203
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 204 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 237
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 238 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 121/280 (43%), Gaps = 54/280 (19%)
Query: 22  NSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           + ++ E VA+K I  G   D  +      REI   R + H N++  K++I  P       
Sbjct: 40  DKQSNELVAVKYIERGEKIDENVK-----REIINHRSLRHPNIVRFKEVILTPTH----- 89
Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           + IV E     +L + I +  + ++D  ++F  QL+ G+ Y H+  V HRDLK  N LL+
Sbjct: 90  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 149
Query: 139 ASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI-DIWSVGCIL- 194
            S    LKI  FG ++++         V T  Y APE+LL   EY   + D+WS G  L 
Sbjct: 150 GSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKVADVWSCGVTLY 208
Query: 195 ----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
               G     +P  P K++   + R++      PD              YV   P CR  
Sbjct: 209 VMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD--------------YVHISPECRH- 252
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                          L+ ++ V DP KRI++ E   H + 
Sbjct: 253 ---------------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 39  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 84
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 85  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 203
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 204 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 237
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 238 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 41/253 (16%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQ 100
           D     +EI+ +  + H  ++ + D       +  N++ ++YE M       ++     +
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETD 158
           +++D    ++ Q+ +GL ++H  + +H DLKP N++     S +LK+ DFGL        
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 159 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 216
            +     T  + APE+        YT   D+WSVG +L  I+              L  +
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVG-VLSYIL--------------LSGL 353
Query: 217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 276
           +   G  DD +L            R +  C      + F   S    D + K+L+ DPN 
Sbjct: 354 SPFGGENDDETL------------RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401
Query: 277 RITVEEALRHPYL 289
           R+T+ +AL HP+L
Sbjct: 402 RMTIHQALEHPWL 414

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           N  +++  L   DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+LL
Sbjct: 92  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 138 NASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G +L E
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 210
Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++  +  F G+D         EL  S        +R DN               F  R+ 
Sbjct: 211 MLIGQSPFHGQDE-------EELFHS--------IRMDNP--------------FYPRWL 241
Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSLH 293
            K   A DLL K+ V +P KR+ V   +R HP  + ++
Sbjct: 242 EKE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 83  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 128
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 188
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 247
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 248 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 281
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 282 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 55/294 (18%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG + ++       AV   TR   A KKI   F  + D  R  +EI++++ ++H N+I +
Sbjct: 36  RGSWGEV-----KIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRL 88
Query: 66  KDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            +       +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +
Sbjct: 89  YETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 143
Query: 125 VLHRDLKPSN-LLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 181
           V HRDLKP N L L  S D  LK+ DFGLA        M   V T +Y +P++L     Y
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--Y 201
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
               D WS G ++  ++   P F                 +P D  +             
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV------------- 232
Query: 242 QLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            + + R+  F   FP K     S  A  L+ ++L   P +RIT  +AL H + +
Sbjct: 233 -MLKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 41/253 (16%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQ 100
           D     +EI+ +  + H  ++ + D       +  N++ ++YE M       ++     +
Sbjct: 91  DKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNK 145
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETD 158
           +++D    ++ Q+ +GL ++H  + +H DLKP N++     S +LK+ DFGL        
Sbjct: 146 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205
Query: 159 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 216
            +     T  + APE+        YT   D+WSVG +L  I+              L  +
Sbjct: 206 SVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVG-VLSYIL--------------LSGL 247
Query: 217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 276
           +   G  DD +L            R +  C      + F   S    D + K+L+ DPN 
Sbjct: 248 SPFGGENDDETL------------RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 295
Query: 277 RITVEEALRHPYL 289
           R+T+ +AL HP+L
Sbjct: 296 RMTIHQALEHPWL 308

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 55/294 (18%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG + ++       AV   TR   A KKI   F  + D  R  +EI++++ ++H N+I +
Sbjct: 19  RGSWGEV-----KIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 66  KDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
            +       +   D+Y+V EL    +L + +   +   +      +  +L  + Y H  +
Sbjct: 72  YETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 125 VLHRDLKPSN-LLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY 181
           V HRDLKP N L L  S D  LK+ DFGLA        M   V T +Y +P++L     Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--Y 184
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
               D WS G ++  ++   P F                 +P D  +             
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV------------- 215
Query: 242 QLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            + + R+  F   FP K     S  A  L+ ++L   P +RIT  +AL H + +
Sbjct: 216 -MLKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 89  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 134
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 135 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 194
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+W
Sbjct: 195 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 253
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 254 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 287
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 288 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 15  FIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK 74
           F+       ++    A+K +  A   + D  RT  E  +L  + H  V+ +    +    
Sbjct: 45  FLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQ---- 100
Query: 75  DTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            T   +Y++ + +   DL   +  +   T++  +++L +L  GL ++HS  +++RDLKP 
Sbjct: 101 -TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPE 159
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+LL+    +K+ DFGL++   + +     +  T  Y APE ++N   ++ + D WS G 
Sbjct: 160 NILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGV 218
Query: 193 ILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           ++ E++T    F GKD    + LI +  +G P      FL S  A+  +R L    K+  
Sbjct: 219 LMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ-----FL-STEAQSLLRAL---FKRNP 269
Query: 252 ATRFPNKSSGAVDL 265
           A R  +   GA ++
Sbjct: 270 ANRLGSGPDGAEEI 283

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 114/255 (44%), Gaps = 35/255 (13%)
Query: 42  IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLH-QIIRSDQQ 100
           +D      EI ++  + H  +I + D      +D +  V I+  L   +L  +I   D +
Sbjct: 90  LDKYTVKNEISIMNQLHHPKLINLHDAF----EDKYEMVLILEFLSGGELFDRIAAEDYK 145
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL--LNASCDLKIGDFGLARTTSETD 158
           +++     ++ Q   GLK++H  S++H D+KP N++     +  +KI DFGLA   +  +
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 218
            +     T  + APE++ +        D+W++G +   +++    F G+D +  L+    
Sbjct: 206 IVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---- 260
Query: 219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 278
                                   + RC  +     F + S  A D ++ +L  +P KR+
Sbjct: 261 -----------------------NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297
Query: 279 TVEEALRHPYLQSLH 293
           TV +AL HP+L+  H
Sbjct: 298 TVHDALEHPWLKGDH 312

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 78  NDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 132
            DV+I  ELMDT L     Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWS 189
           SN+L+NA   +K+ DFG++    +          + Y APE +   LN   Y+   DIWS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G  + E+      FP   +    + + +++  P                    P+    
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 237
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +F+  F       VD   + L  +  +R T  E ++HP+  +LH+
Sbjct: 238 KFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 274

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 49/286 (17%)
Query: 30  AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI-------KDIIRP----PKKDTFN 78
           AIKKI +  + +      L E+ LL  + H+ V+         ++ ++P     KK T  
Sbjct: 35  AIKKIRHTEEKL---STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKST-- 89
Query: 79  DVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            ++I  E  +   L+ +I S+   Q  D++ + F  Q+L  L Y+HS  ++HR+LKP N+
Sbjct: 90  -LFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHRNLKPXNI 147
Query: 136 LLNASCDLKIGDFGLARTT---------------SETDFMTEYVVTRWYRAPELLLNCTE 180
            ++ S ++KIGDFGLA+                   +D +T  + T  Y A E+L     
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGH 207
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRY 239
           Y   ID +S+G I  E +   P   G + V+ L+ +  + I  P D        DN  + 
Sbjct: 208 YNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSVSIEFPPDF------DDNKXKV 259
Query: 240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
            +++ R          PNK  GA  LL    +   ++   ++EAL+
Sbjct: 260 EKKIIRL----LIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 53/283 (18%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR------EIKLLRHMEHENVIAI-KDI 68
           I   A    +  +VA+K        ++D R+  R      E+ ++R  +H NV+ + K  
Sbjct: 60  IVCLAREKHSGRQVAVK--------MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 69  IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
           +         +++++ E +       I S  +L ++        +L+ L Y+H+  V+HR
Sbjct: 112 L------VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 129 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           D+K  ++LL     +K+ DFG  A+ + +       V T ++ APE +++ + Y   +DI
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDI 224
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G ++ E++  EP +     V  ++ + +   SP                    P+ +
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-------------------PKLK 262
Query: 248 KQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 289
                    +K S  + D LE+MLV DP +R T +E L HP+L
Sbjct: 263 NS-------HKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 110/262 (41%), Gaps = 57/262 (21%)
Query: 77  FNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           ++ + +++E +   L++II  +       +  + +  ++L+ L Y+   S+ H DLKP N
Sbjct: 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167
Query: 135 LLLN-------------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWY 169
           +LL+                          S  +K+ DFG A  T ++D+    + TR Y
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQY 225
Query: 170 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 229
           RAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++  +I       L 
Sbjct: 226 RAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA---------------------VDLLEK 268
                N  +YV       K +    +P  +S                        D L  
Sbjct: 285 EATKTNGSKYV------NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338
Query: 269 MLVFDPNKRITVEEALRHPYLQ 290
           +L  DP  R +  E L+H +L+
Sbjct: 339 ILQIDPTLRPSPAELLKHKFLE 360

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++I+ E +       +     L + +    L ++L+GL Y+HS   +HRD+K +N+LL+ 
Sbjct: 92  LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 151
Query: 140 SCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
             D+K+ DFG+A   ++T      +V T ++ APE ++  + Y    DIWS+G    E+ 
Sbjct: 152 QGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELA 210
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL----PRCR------- 247
             EP  P  D +H +R++  LI      +L    S   + +V       PR R       
Sbjct: 211 KGEP--PNSD-LHPMRVLF-LIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266
Query: 248 KQQFATRFPNKSSGAVDLLEK 268
           K +F TR+  K+S   +L+++
Sbjct: 267 KHKFITRYTKKTSFLTELIDR 287

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 11/194 (5%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           ++ +T E+VAIK+           R  L EI++++ + H NV++ +++    +K   ND+
Sbjct: 35  IHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 93
Query: 81  -YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +  E  +  DL + +   +    L +   +  L  +   L+Y+H   ++HRDLKP N+
Sbjct: 94  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 153
Query: 136 LLNASCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           +L         KI D G A+   + +  TE+V T  Y APELL    +YT  +D WS G 
Sbjct: 154 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGT 212
Query: 193 ILGEIMTR-EPLFP 205
           +  E +T   P  P
Sbjct: 213 LAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 11/194 (5%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           ++ +T E+VAIK+           R  L EI++++ + H NV++ +++    +K   ND+
Sbjct: 34  IHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92
Query: 81  -YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +  E  +  DL + +   +    L +   +  L  +   L+Y+H   ++HRDLKP N+
Sbjct: 93  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152
Query: 136 LLNASCDL---KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           +L         KI D G A+   + +  TE+V T  Y APELL    +YT  +D WS G 
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGT 211
Query: 193 ILGEIMTR-EPLFP 205
           +  E +T   P  P
Sbjct: 212 LAFECITGFRPFLP 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVI 63
           +G Y  +  F       + T +  A+K +  A    N  D   T  E  +L  ++H  ++
Sbjct: 27  KGGYGKV--FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 64  AIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 122
              D+I   +  T   +Y++ E L   +L   +  +    +D   ++L ++   L ++H 
Sbjct: 85  ---DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEY 181
             +++RDLKP N++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  + +
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMR-SGH 198
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKD 208
             A+D WS+G ++ +++T  P F G++
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 17  FSAAVNSETRE--EVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDIIRPPK 73
           F  A+    RE  EV + K    FD   + +RT L+E+K++R +EH NV+    ++   K
Sbjct: 23  FGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80
Query: 74  KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           +  F   YI        L  II+S D Q        F   +  G+ Y+HS +++HRDL  
Sbjct: 81  RLNFITEYI----KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNS 136
Query: 133 SNLLLNASCDLKIGDFGLA-------------RTTSETDFMTEYVVTR--WYRAPELLLN 177
            N L+  + ++ + DFGLA             R+  + D    Y V    ++ APE ++N
Sbjct: 137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE-MIN 195
Query: 178 CTEYTAAIDIWSVGCILGEIMTR 200
              Y   +D++S G +L EI+ R
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 25  TREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
           T  EVAIK I   A       +R   E+K+   ++H +++ + +       +  N VY+V
Sbjct: 35  TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSNYVYLV 89
Query: 84  YELM-DTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
            E+  + ++++ +++  +  +++  ++F++Q++ G+ Y+HS  +LHRDL  SNLLL  + 
Sbjct: 90  LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM 149
Query: 142 DLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++KI DFGLA T  +      Y +  T  Y +PE+    + +    D+WS+GC+   ++ 
Sbjct: 150 NIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLI 207
Query: 200 REPLF 204
             P F
Sbjct: 208 GRPPF 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVI 63
           +G Y  +  F       + T +  A+K +  A    N  D   T  E  +L  ++H  ++
Sbjct: 27  KGGYGKV--FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 64  AIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 122
              D+I   +  T   +Y++ E L   +L   +  +    +D   ++L ++   L ++H 
Sbjct: 85  ---DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEY 181
             +++RDLKP N++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  + +
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGH 198
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKD 208
             A+D WS+G ++ +++T  P F G++
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           GE  D  F     A N ET    A K I    +   +    + EI +L   +H N++ + 
Sbjct: 43  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLL 100
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDL--HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
           D          N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H   
Sbjct: 101 DAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE--- 180
           ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 181 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 239
            Y    D+WS+G  L E+   EP        H+L                     N  R 
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPH------HEL---------------------NPMRV 248
Query: 240 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 249 LLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 7/167 (4%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T     
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYV 164
             +    + L + H   ++HRD+KP+N+L++A+  +K+ DFG+AR  +++      T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 165 V-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 210
           + T  Y +PE         A  D++S+GC+L E++T EP F G   V
Sbjct: 180 IGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           GE  D  F     A N ET    A K I    +   +    + EI +L   +H N++ + 
Sbjct: 43  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLL 100
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDL--HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
           D          N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H   
Sbjct: 101 DAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE--- 180
           ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 181 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 239
            Y    D+WS+G  L E+   EP        H+L                     N  R 
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPH------HEL---------------------NPMRV 248
Query: 240 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 249 LLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           GE  D  F     A N ET    A K I    +   +    + EI +L   +H N++ + 
Sbjct: 43  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLL 100
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDL--HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
           D          N+++I+ E          ++  ++ LT+   Q    Q L  L Y+H   
Sbjct: 101 DAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE--- 180
           ++HRDLK  N+L     D+K+ DFG+ A+ T        ++ T ++ APE+++  T    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 181 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 239
            Y    D+WS+G  L E+   EP        H+L                     N  R 
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPH------HEL---------------------NPMRV 248
Query: 240 VRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           + ++ +      A   P++ SS   D L+K L  + + R T  + L+HP++
Sbjct: 249 LLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 7/167 (4%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T     
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYV 164
             +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 165 V-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 210
           + T  Y +PE         A  D++S+GC+L E++T EP F G   V
Sbjct: 180 IGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 7/167 (4%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T     
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYV 164
             +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 165 V-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 210
           + T  Y +PE         A  D++S+GC+L E++T EP F G   V
Sbjct: 180 IGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++ A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +  ++      
Sbjct: 31  VWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------ 79
Query: 76  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHSASVLHRDLKP 132
           T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++   + +HRDL+ 
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 139
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWS 189
           +N+L++AS   KI DFGLAR   + ++          +W  APE  +N   +T   D+WS
Sbjct: 140 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWS 197
Query: 190 VGCILGEIMT--REPLFPG 206
            G +L EI+T  R P +PG
Sbjct: 198 FGILLMEIVTYGRIP-YPG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 81  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 140 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 196 EIMTREPLFPGKDYV 210
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 7/163 (4%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           RE +    + H  ++A+ D     +       YIV E +D   L  I+ ++  +T     
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYV 164
             +    + L + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T  V
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 165 V-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 206
           + T  Y +PE         A  D++S+GC+L E++T EP F G
Sbjct: 180 IGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++ A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +  ++      
Sbjct: 204 VWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------ 252
Query: 76  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHSASVLHRDLKP 132
           T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++   + +HRDL+ 
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWS 189
           +N+L++AS   KI DFGLAR   + ++          +W  APE  +N   +T   D+WS
Sbjct: 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWS 370
Query: 190 VGCILGEIMT--REPLFPG 206
            G +L EI+T  R P +PG
Sbjct: 371 FGILLMEIVTYGRIP-YPG 388

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 81  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 140 SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 227
Query: 196 EIMTREPLFPGKDYV 210
           E++T EP F G   V
Sbjct: 228 EVLTGEPPFTGDSPV 242

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 61/297 (20%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 83  NKRTQEKFALKXLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 128
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+         +   ++Y+HS ++ HRD+K
Sbjct: 129 AGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVK 188
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D W
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXW 247
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I   ++   P F      H L +      SP   +                 R R 
Sbjct: 248 SLGVIXYILLCGYPPFYSN---HGLAI------SPGXKT-----------------RIRX 281
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R T+ E   HP++     +   P+
Sbjct: 282 GQY--EFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPL 336

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E M   D+   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E M   D+   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 20/172 (11%)
Query: 49  REIKLLRHMEHENVIAIKDI-IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 107
           +E KL   ++H N+IA++ + ++ P      ++ +V E         + S +++  D   
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEP------NLCLVMEFARGGPLNRVLSGKRIPPDILV 108
Query: 108 YFLYQLLRGLKYVHSASV---LHRDLKPSNLLLNASCD--------LKIGDFGLARTTSE 156
            +  Q+ RG+ Y+H  ++   +HRDLK SN+L+    +        LKI DFGLAR    
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           T  M+      W  APE ++  + ++   D+WS G +L E++T E  F G D
Sbjct: 169 TTKMSAAGAYAWM-APE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 75/131 (57%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 146
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y APE  L  T Y+   DIWS+G  L 
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLV 204
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 205 ELAVGRYPIPP 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 66/109 (60%), Gaps = 5/109 (4%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTR 167
            L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T 
Sbjct: 125 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 184
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 216
           ++ APE ++  + Y +  DIWS+G    E+   EP  P  D +H +R++
Sbjct: 185 FWMAPE-VIQQSAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 105/244 (43%), Gaps = 39/244 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           REI++  H+ H N++ + +     K+     +Y++ E     +L++ ++   +  +    
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSA 118
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
            F+ +L   L Y H   V+HRD+KP NLL+    +LKI DFG +   + +        T 
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTL 177
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 227
            Y  PE++   T +   +D+W  G +  E +   P F    +    R I        +  
Sbjct: 178 DYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-------NVD 229
Query: 228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
           L F                         P  S G+ DL+ K+L + P +R+ ++  + HP
Sbjct: 230 LKFP------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 265
Query: 288 YLQS 291
           ++++
Sbjct: 266 WVKA 269

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 105/244 (43%), Gaps = 39/244 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           REI++  H+ H N++ + +     K+     +Y++ E     +L++ ++   +  +    
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
            F+ +L   L Y H   V+HRD+KP NLL+    +LKI DFG +   + +        T 
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTL 176
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 227
            Y  PE++   T +   +D+W  G +  E +   P F    +    R I        +  
Sbjct: 177 DYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-------NVD 228
Query: 228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
           L F                         P  S G+ DL+ K+L + P +R+ ++  + HP
Sbjct: 229 LKFP------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 288 YLQS 291
           ++++
Sbjct: 265 WVKA 268

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 65/288 (22%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K++   F +I      L EIKLL   + H NVI           D F  +YI  EL 
Sbjct: 60  VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELC 109
Query: 88  DTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ 
Sbjct: 110 NLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 168
Query: 140 SCDLK-------------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE- 180
           S                 I DFGL +   + +  F   +     T  +RAPELL   T+ 
Sbjct: 169 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 181 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 239
             T +IDI+S+GC+   I+++     G  Y  +  +I  +       SL  ++  + R  
Sbjct: 229 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSL 282
Query: 240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
           + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 283 IAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 39/273 (14%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 39  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDE 91
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL  
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +E V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 152 DGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 210
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P K
Sbjct: 211 EGEPPYLNENPLRALYLIA-TNGTPE----------------------------LQNPEK 241
Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D  KR + +E L+H +L+
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 51/304 (16%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           +++ A   E +    ++++ +A +   D+      +KLL H  H+    +          
Sbjct: 57  VYTEAAEDEIK---LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH--------- 104
Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKP 132
               V +V+E++  +L  +I+  +   +   + +    QLL GL Y+H    ++H D+KP
Sbjct: 105 ----VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 133 SNLLLNAS------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
            N+L+           +KI D G A    E    T  + TR YR+PE+LL    +    D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGAD 217
Query: 187 IWSVGCILGEIMTREPLFP---GKDYVHQLRLITELIGSPDDASLGFLRSD-------NA 236
           IWS  C++ E++T + LF    G  Y      I ++I    +     LR+        N+
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 237 RRYVRQLPRCR----------KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
           R  +R + + +          K +F+    +++    D L  ML  DP KR      + H
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSK---DEAKEISDFLSPMLQLDPRKRADAGGLVNH 334
Query: 287 PYLQ 290
           P+L+
Sbjct: 335 PWLK 338

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 51/304 (16%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           +++ A   E +    ++++ +A +   D+      +KLL H  H+    +          
Sbjct: 57  VYTEAAEDEIK---LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH--------- 104
Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKP 132
               V +V+E++  +L  +I+  +   +   + +    QLL GL Y+H    ++H D+KP
Sbjct: 105 ----VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 133 SNLLLNAS------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
            N+L+           +KI D G A    E    T  + TR YR+PE+LL    +    D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGAD 217
Query: 187 IWSVGCILGEIMTREPLFP---GKDYVHQLRLITELIGSPDDASLGFLRSD-------NA 236
           IWS  C++ E++T + LF    G  Y      I ++I    +     LR+        N+
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 237 RRYVRQLPRCR----------KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
           R  +R + + +          K +F+    +++    D L  ML  DP KR      + H
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSK---DEAKEISDFLSPMLQLDPRKRADAGGLVNH 334
Query: 287 PYLQ 290
           P+L+
Sbjct: 335 PWLK 338

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 65/288 (22%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K++   F +I      L EIKLL   + H NVI           D F  +YI  EL 
Sbjct: 60  VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELC 109
Query: 88  DTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ 
Sbjct: 110 NLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 168
Query: 140 SCDLK-------------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE- 180
           S                 I DFGL +   + +  F   +     T  +RAPELL   T+ 
Sbjct: 169 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 181 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY 239
             T +IDI+S+GC+   I+++     G  Y  +  +I  +       SL  ++  + R  
Sbjct: 229 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEMKCLHDRSL 282
Query: 240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
           + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 283 IAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 54/296 (18%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA------IKDII 69
           +  AA  +  +E+VAIK+I N           L+EI+ +    H N+++      +KD  
Sbjct: 30  VVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-- 86
Query: 70  RPPKKDTFNDVYIVYELM------DTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYV 120
                    ++++V +L+      D   H + + + +   L +      L ++L GL+Y+
Sbjct: 87  ---------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTRWYRAPEL 174
           H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T  + APE+
Sbjct: 138 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 234
           +     Y    DIWS G    E+ T     P   Y     L+  L   P     G    +
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255
Query: 235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             ++Y +   +                   ++   L  DP KR T  E LRH + Q
Sbjct: 256 MLKKYGKSFRK-------------------MISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   +      R  L E  ++   EH N+I ++ ++          V I+ E M+
Sbjct: 47  VAIKTLKGGYTER-QRREFLSEASIMGQFEHPNIIRLEGVV-----TNSMPVMILTEFME 100
Query: 89  TD-LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D Q T       L  +  G++Y+   S +HRDL   N+L+N++   K+ 
Sbjct: 101 NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVS 160
Query: 147 DFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFGL+R         +ET  +   +  RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 161 DFGLSRFLEENSSDPTETSSLGGKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 132/310 (42%), Gaps = 60/310 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN 78
            +N  T +E A+K I     +I    R  RE+++L   + H NV+ + +     ++D F 
Sbjct: 32  CINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIEFFE--EEDRF- 86
Query: 79  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
             Y+V+E M    +   I   +   +      +  +   L ++H+  + HRDLKP N+L 
Sbjct: 87  --YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 138 ---NASCDLKIGDFGLARTT---------SETDFMTEYVVTRWYRAPELLLNCTE----Y 181
              N    +KI DFGL             S  + +T    +  Y APE++   +E    Y
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIY 203
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
               D+WS+G IL  +++  P F G+             GS      G+ R +       
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGR------------CGS----DCGWDRGEAC----- 242
Query: 242 QLPRCRKQQFAT------RFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             P C+   F +       FP+K     S  A DL+ K+LV D  +R++  + L+HP++Q
Sbjct: 243 --PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
Query: 291 SLHDLNDEPV 300
                N  P 
Sbjct: 301 GCAPENTLPT 310

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 54  LRHMEHEN-------VIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLT 102
           L+ +EH N       ++    IIR     TF D   ++ +MD     +L  ++R  Q+  
Sbjct: 47  LKQVEHTNDERLMLSIVTHPFIIR--MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP 104
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
           +   +++  ++   L+Y+HS  +++RDLKP N+LL+ +  +KI DFG A+   +  +   
Sbjct: 105 NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL- 163
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              T  Y APE +++   Y  +ID WS G ++ E++ 
Sbjct: 164 -CGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 54/296 (18%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA------IKDII 69
           +  AA  +  +E+VAIK+I N           L+EI+ +    H N+++      +KD  
Sbjct: 25  VVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-- 81
Query: 70  RPPKKDTFNDVYIVYELM------DTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYV 120
                    ++++V +L+      D   H + + + +   L +      L ++L GL+Y+
Sbjct: 82  ---------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 132
Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTRWYRAPEL 174
           H    +HRD+K  N+LL     ++I DFG++   +    +T       +V T  + APE+
Sbjct: 133 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 234
           +     Y    DIWS G    E+ T     P   Y     L+  L   P     G    +
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLETGVQDKE 250
Query: 235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             ++Y +   +                   ++   L  DP KR T  E LRH + Q
Sbjct: 251 MLKKYGKSFRK-------------------MISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 45/220 (20%)
Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 152
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 212
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F        
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------- 210
Query: 213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLE 267
                        ++ G   S   +R      R R  Q+   FPN      S  A  L+ 
Sbjct: 211 ------------YSNTGQAISPGMKR------RIRLGQYG--FPNPEWSEVSEDAKQLIR 250
Query: 268 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR-PFH 306
            +L  DP +R+T+ + + HP+      +N   V P+ P H
Sbjct: 251 LLLKTDPTERLTITQFMNHPW------INQSMVVPQTPLH 284

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 45/220 (20%)
Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 152
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 212
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F        
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------- 229
Query: 213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLE 267
                        ++ G   S   +R      R R  Q+   FPN      S  A  L+ 
Sbjct: 230 ------------YSNTGQAISPGMKR------RIRLGQYG--FPNPEWSEVSEDAKQLIR 269
Query: 268 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR-PFH 306
            +L  DP +R+T+ + + HP+      +N   V P+ P H
Sbjct: 270 LLLKTDPTERLTITQFMNHPW------INQSMVVPQTPLH 303

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++ A  N  T+  V   K G+     +     L E  +++ ++H+ ++ +  ++      
Sbjct: 198 VWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVV------ 246
Query: 76  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHSASVLHRDLKP 132
           T   +YI+ E M    L   ++SD+       +   F  Q+  G+ ++   + +HRDL+ 
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 306
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           +N+L++AS   KI DFGLAR  ++          +W  APE  +N   +T   D+WS G 
Sbjct: 307 ANILVSASLVCKIADFGLARVGAK-------FPIKW-TAPE-AINFGSFTIKSDVWSFGI 357
Query: 193 ILGEIMT--REPLFPG 206
           +L EI+T  R P +PG
Sbjct: 358 LLMEIVTYGRIP-YPG 372

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 155
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 213
Query: 196 EI-MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           E+ + R P+  G   +    L+  ++  P                    P+     F+  
Sbjct: 214 EMAVGRYPIGSGSGSMAIFELLDYIVNEPP-------------------PKLPSGVFSLE 254
Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           F        D + K L+ +P +R  +++ + H +++
Sbjct: 255 FQ-------DFVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 78  NDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 132
            DV+I  EL DT L     Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 106 GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 165
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWS 189
           SN+L+NA   +K  DFG++    +          + Y APE +   LN   Y+   DIWS
Sbjct: 166 SNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G    E+      FP   +    + + +++  P                    P+    
Sbjct: 226 LGITXIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 264
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           +F+  F       VD   + L  +  +R T  E  +HP+  +LH+
Sbjct: 265 KFSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFF-TLHE 301

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   +      R  L E  ++   EH N+I ++ ++          V I+ E M+
Sbjct: 45  VAIKTLKGGYTER-QRREFLSEASIMGQFEHPNIIRLEGVV-----TNSMPVMILTEFME 98
Query: 89  TD-LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D Q T       L  +  G++Y+   S +HRDL   N+L+N++   K+ 
Sbjct: 99  NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVS 158
Query: 147 DFGLARTTSE-------TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFGL+R   E       T  +   +  RW  APE +    ++T+A D WS G ++ E+M+
Sbjct: 159 DFGLSRFLEENSSDPTYTSSLGGKIPIRW-TAPEAIA-FRKFTSASDAWSYGIVMWEVMS 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 69/292 (23%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K++   F +I      L EIKLL   + H NVI           D F  +YI  EL 
Sbjct: 42  VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELC 91
Query: 88  DTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ 
Sbjct: 92  NLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 140 SCDLK-------------IGDFGLART--TSETDFMTEY---VVTRWYRAPELLLNCTE- 180
           S                 I DFGL +   + ++ F T       T  +RAPELL      
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 181 -----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 235
                 T +IDI+S+GC+   I+++     G  Y  +  +I  +       SL  ++  +
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEMKCLH 264
Query: 236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
            R  + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 265 DRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 17/180 (9%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK + + +      R  L E  ++   +H NVI ++ ++    K T   V I+ E M+
Sbjct: 64  VAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVV---TKST--PVMIITEFME 117
Query: 89  T-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D Q T       L  +  G+KY+   + +HRDL   N+L+N++   K+ 
Sbjct: 118 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS 177
Query: 147 DFGLAR----TTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFGL+R     TS+   T  +   +  RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 121/278 (43%), Gaps = 50/278 (17%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           +VA+K+I     +  D     RE++LLR   EH NVI         K   F   YI  EL
Sbjct: 50  DVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRY---FCTEKDRQFQ--YIAIEL 99
Query: 87  MDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCD 142
               L + + + D           L Q   GL ++HS +++HRDLKP N+L+   NA   
Sbjct: 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGK 159
Query: 143 LK--IGDFGLAR--TTSETDFMTEYVV--TRWYRAPELLL-NCTEY-TAAIDIWSVGCIL 194
           +K  I DFGL +        F     V  T  + APE+L  +C E  T  +DI+S GC+ 
Sbjct: 160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
             +++      GK    Q  +   L+G+    SL  L  +     +              
Sbjct: 220 YYVISEGSHPFGKSLQRQANI---LLGA---CSLDCLHPEKHEDVI-------------- 259
Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
                  A +L+EKM+  DP KR + +  L+HP+  SL
Sbjct: 260 -------ARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G +  +  + +    N  T E VA+K +       + +    REI++LR + HE+++  K
Sbjct: 20  GHFGKVSLYCYDP-TNDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILRTLYHEHIVKYK 77
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC----QYFLY--QLLRGLKYV 120
                  + +   V +V E +       + S +     HC    Q  L+  Q+  G+ Y+
Sbjct: 78  GCCEDQGEKS---VQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICEGMAYL 128
Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAP 172
           H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R        WY AP
Sbjct: 129 HAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-AP 184
Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E L  C  Y A+ D+WS G  L E++T
Sbjct: 185 ECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 39  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDE 91
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL  
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 152 DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 210
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P K
Sbjct: 211 EGEPPYLNENPLRALYLIA-TNGTPE----------------------------LQNPEK 241
Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D  KR + +E L+H +L+
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G +  +  + +    N  T E VA+K +       + +    REI++LR + HE+++  K
Sbjct: 19  GHFGKVSLYCYDP-TNDGTGEMVAVKALKEGCGPQLRSGWQ-REIEILRTLYHEHIVKYK 76
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHC----QYFLY--QLLRGLKYV 120
                  + +   V +V E +       + S +     HC    Q  L+  Q+  G+ Y+
Sbjct: 77  GCCEDQGEKS---VQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICEGMAYL 127
Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAP 172
           H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R        WY AP
Sbjct: 128 HAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-AP 183
Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E L  C  Y A+ D+WS G  L E++T
Sbjct: 184 ECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KD    V  +    D   H          +    ++  ++  GL+ +H   +++RDLKP 
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE 315
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + D W++GC+
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCL 374
Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           L E++  +                    SP       ++ +   R V+++P    ++++ 
Sbjct: 375 LYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP----EEYSE 410
Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 293
           RF   S  A  L  ++L  DP +R+     +  E   HP  + L+
Sbjct: 411 RF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGLAR      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KD    V  +    D   H          +    ++  ++  GL+ +H   +++RDLKP 
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE 315
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + D W++GC+
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCL 374
Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           L E++  +                    SP       ++ +   R V+++P    ++++ 
Sbjct: 375 LYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP----EEYSE 410
Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 293
           RF   S  A  L  ++L  DP +R+     +  E   HP  + L+
Sbjct: 411 RF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 39  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDE 91
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL  
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 152 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 210
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P K
Sbjct: 211 EGEPPYLNENPLRALYLIAT-NGTPE----------------------------LQNPEK 241
Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D  KR + +E L+H +L+
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 27  EEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEHENVIAIKD-IIRPPKKDTFNDVYIVY 84
           E VAIKK+  +     +  +  ++E++ L+ + H N I  +   +R       +  ++V 
Sbjct: 80  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE------HTAWLVM 133
Query: 85  EL---MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           E      +DL ++ +  + L +       +  L+GL Y+HS +++HRD+K  N+LL+   
Sbjct: 134 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 191
Query: 142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMT 199
            +K+GDFG A   +  +    +V T ++ APE++L   E  Y   +D+WS+G    E+  
Sbjct: 192 LVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 200 REP 202
           R+P
Sbjct: 249 RKP 251

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 27  EEVAIKKIGNAFDNIIDARR-TLREIKLLRHMEHENVIAIKD-IIRPPKKDTFNDVYIVY 84
           E VAIKK+  +     +  +  ++E++ L+ + H N I  +   +R       +  ++V 
Sbjct: 41  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE------HTAWLVM 94
Query: 85  EL---MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           E      +DL ++ +  + L +       +  L+GL Y+HS +++HRD+K  N+LL+   
Sbjct: 95  EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152
Query: 142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMT 199
            +K+GDFG A   +  +    +V T ++ APE++L   E  Y   +D+WS+G    E+  
Sbjct: 153 LVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 200 REP 202
           R+P
Sbjct: 210 RKP 212

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 106
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 166
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 31/197 (15%)
Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K + +A DN   AR+   RE +LL +++HE+++    +         + + +V+E M
Sbjct: 46  VAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYM 97
Query: 88  D-TDLHQIIRSD-------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
              DL++ +R+               +LT     +   Q+  G+ Y+ S   +HRDL   
Sbjct: 98  KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 157
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           N L+  +  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D+WS
Sbjct: 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWS 215
Query: 190 VGCILGEIMT--REPLF 204
           +G +L EI T  ++P +
Sbjct: 216 LGVVLWEIFTYGKQPWY 232

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 106
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 166
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 106
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 166
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 29  VAIKKIGNAFD-NIIDARRTLREIKLLRHMEHE-NVIAIKDIIRPPK--------KDTFN 78
           V  K+ GN +   I+D ++ ++    L+ +EH  N   I+  +  P         KD  N
Sbjct: 61  VKHKETGNHYAMKILDKQKVVK----LKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSN 116
Query: 79  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            +Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL+
Sbjct: 117 -LYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 175
Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E+
Sbjct: 176 DQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEM 232
Query: 198 MTREPLF 204
               P F
Sbjct: 233 AAGYPPF 239

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 40  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDE 92
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL  
Sbjct: 93  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 152
Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 153 DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 211
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P K
Sbjct: 212 EGEPPYLNENPLRALYLIA-TNGTPE----------------------------LQNPEK 242
Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D  KR + +E ++H +L+
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 106
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 57  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 111
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 112 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 171
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 172 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 230
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 231 RTLSPEAKSLLAGLLKKDPKQR 252

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 55  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 109
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 110 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 169
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 170 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 228
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 229 RTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           T+ E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  T++ 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLSRERVFTEER 106
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYV 164
            +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   M  + 
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL--- 219
            T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+   
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 220 -IGSPDDASL--GFLRSDNARR 238
              SP+  SL  G L+ D  +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 60/310 (19%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFN 78
            +N  T +E A+K I     +I    R  RE+++L   + H NV+ + +     ++D F 
Sbjct: 32  CINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIEFFE--EEDRF- 86
Query: 79  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
             Y+V+E M    +   I   +   +      +  +   L ++H+  + HRDLKP N+L 
Sbjct: 87  --YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 138 ---NASCDLKIGDFGLARTT---------SETDFMTEYVVTRWYRAPELLLNCTE----Y 181
              N    +KI DF L             S  + +T    +  Y APE++   +E    Y
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIY 203
Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
               D+WS+G IL  +++  P F G+             GS      G+ R +       
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGR------------CGS----DCGWDRGEAC----- 242
Query: 242 QLPRCRKQQFAT------RFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             P C+   F +       FP+K     S  A DL+ K+LV D  +R++  + L+HP++Q
Sbjct: 243 --PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
Query: 291 SLHDLNDEPV 300
                N  P 
Sbjct: 301 GCAPENTLPT 310

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN F   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 60  VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMV 119
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 203 LF 204
            F
Sbjct: 237 PF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN F   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 60  VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMV 119
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 203 LF 204
            F
Sbjct: 237 PF 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 116
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 177 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 91  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 148
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 207
Query: 193 ILGEIMTREP 202
              E+   EP
Sbjct: 208 TAIELARGEP 217

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN F   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 60  VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMV 119
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 120 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E+    P
Sbjct: 180 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 203 LF 204
            F
Sbjct: 237 PF 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFT 116
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 177 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 193
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 194 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 233

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 89  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 144 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 203
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 204 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLT 102
           R  L E  ++   +H N+I ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDF 159
                  L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  +
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 160 MTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T    +  RW  +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 TTRGGKIPIRW-TSPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 76  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 133
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 134 NVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 192
Query: 193 ILGEIMTREP 202
              E+   EP
Sbjct: 193 TAIELARGEP 202

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFGLA+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 69/292 (23%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K++   F +I      L EIKLL   + H NVI           D F  +YI  EL 
Sbjct: 42  VAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRY---YCSETTDRF--LYIALELC 91
Query: 88  DTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLKP N+L++ 
Sbjct: 92  NLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 140 SCDLK-------------IGDFGLART--TSETDF---MTEYVVTRWYRAPELLLNCTE- 180
           S                 I DFGL +   + +  F   +     T  +RAPELL      
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNL 210
Query: 181 -----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 235
                 T +IDI+S+GC+   I+++     G  Y  +  +I  +       SL  ++  +
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEMKCLH 264
Query: 236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
            R  + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 265 DRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 76  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 133
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 134 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 192
Query: 193 ILGEIMTREP 202
              E+   EP
Sbjct: 193 TAIELARGEP 202

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 94/185 (50%), Gaps = 20/185 (10%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 38  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 93
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 94  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +KIGDFGL +   +     E+   +        WY APE L   ++++ A D+WS G +L
Sbjct: 153 VKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVL 207
Query: 195 GEIMT 199
            E+ T
Sbjct: 208 YELFT 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 96  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 153
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 154 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 212
Query: 193 ILGEIMTREP 202
              E+   EP
Sbjct: 213 TAIELARGEP 222

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 16/160 (10%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDH 105
           L E  ++    H N+I ++ +I       +  + I+ E M+   L + +R  D + +   
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 165
               L  +  G+KY+ + + +HRDL   N+L+N++   K+ DFGL+R   E D    Y  
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTT 207
Query: 166 T------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           +      RW  APE  ++  ++T+A D+WS G ++ E+MT
Sbjct: 208 SGGKIPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 94  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 152
           ++  D+ LT+   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+
Sbjct: 107 MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166
Query: 153 TTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWSVGCILGEIMTREP 202
                     ++ T ++ APE++    +  T Y    DIWS+G  L E+   EP
Sbjct: 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 48/296 (16%)
Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF 77
            AV+ +  +E A+K I     +     R  RE++ L   + ++N++   ++I   + DT 
Sbjct: 31  GAVSLQNGKEYAVKIIEKQAGH--SRSRVFREVETLYQCQGNKNIL---ELIEFFEDDT- 84
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
              Y+V+E L    +   I+  +   +      +  +   L ++H+  + HRDLKP N+L
Sbjct: 85  -RFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENIL 143
Query: 137 LNAS--------CDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLL----NCTE 180
             +         CD  +G  G+    S T   T  + T      Y APE++       T 
Sbjct: 144 CESPEKVSPVKICDFDLGS-GMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATF 202
Query: 181 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
           Y    D+WS+G +L  +++  P F G                   A  G+ R +  R   
Sbjct: 203 YDKRCDLWSLGVVLYIMLSGYPPFVGH----------------CGADCGWDRGEVCRVCQ 246
Query: 241 RQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            +L     Q+    FP+K     SS A DL+ K+LV D  +R++  + L+HP++Q 
Sbjct: 247 NKLFE-SIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 94  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 152
           ++  D+ LT+   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+
Sbjct: 99  MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 158
Query: 153 TTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWSVGCILGEIMTREP 202
                     ++ T ++ APE++    +  T Y    DIWS+G  L E+   EP
Sbjct: 159 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 96/183 (52%), Gaps = 16/183 (8%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +    ++ ++ 
Sbjct: 41  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIM 95
Query: 85  ELMD-TDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           E +    L + ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+    
Sbjct: 96  EFLPYGSLREYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 154
Query: 142 DLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGE 196
            +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E
Sbjct: 155 RVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYE 212
Query: 197 IMT 199
           + T
Sbjct: 213 LFT 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 53/87 (60%), Gaps = 1/87 (1%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 171
           Q+ +G+ Y+HS  ++HRDLKPSN+ L  +  +KIGDFGL  +       T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 172 PELLLNCTEYTAAIDIWSVGCILGEIM 198
           PE  ++  +Y   +D++++G IL E++
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 94/185 (50%), Gaps = 20/185 (10%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 39  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 94
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HR+L   N+L+     
Sbjct: 95  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENR 153
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +KIGDFGL +   +     EY   +        WY APE L   ++++ A D+WS G +L
Sbjct: 154 VKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVL 208
Query: 195 GEIMT 199
            E+ T
Sbjct: 209 YELFT 213

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+++    
Sbjct: 121 MEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY 180
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E+    P
Sbjct: 181 IKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 237
Query: 203 LF 204
            F
Sbjct: 238 PF 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 16/163 (9%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRS-DQQLT 102
           R  L E  ++   +H NV+ ++ ++   K      V IV E M+   L   +R  D Q T
Sbjct: 89  RDFLCEASIMGQFDHPNVVHLEGVVTRGKP-----VMIVIEFMENGALDAFLRKHDGQFT 143
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
                  L  +  G++Y+     +HRDL   N+L+N++   K+ DFGL+R   E D    
Sbjct: 144 VIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAV 202
Query: 163 YVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           Y  T      RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 203 YTTTGGKIPVRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 99/238 (41%), Gaps = 54/238 (22%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDF-------- 159
           ++  L + LK +H   ++HRD+KPSN L N       + DFGLA+ T +T          
Sbjct: 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 160 ---------------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
                                +     T  +RAPE+L  C   T AID+WS G I   ++
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 199 T-REPLFPGKDYVHQLRLITELIGSPD--DASLGFLRSDNARRYV-----RQL-PRCRKQ 249
           + R P +   D +  L  I  + GS +   A+  F +S    + V     R+L  R R  
Sbjct: 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301
Query: 250 QFAT-RFPNKSSGAVDLLE--------------KMLVFDPNKRITVEEALRHPYLQSL 292
             +T +  +   G    LE              K+L  +P  RIT EEAL HP+ + +
Sbjct: 302 DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 139 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 198
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 199 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 256
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 257 EMAVGRYPIPP 267

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 15/178 (8%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   + +    R  L E  ++   +H N+I ++ ++   K      V I+ E M+
Sbjct: 60  VAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP-----VMIITEYME 113
Query: 89  T-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D + T       L  +  G+KY+   S +HRDL   N+L+N++   K+ 
Sbjct: 114 NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVS 173
Query: 147 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFG++R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 174 DFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 229

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGATWTL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 251
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 252 MAAGYPPF 259

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 46/260 (17%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQ 107
           E++++  +++E  +  + II       +++VYI+YE M+ D   I++ D+   + D +  
Sbjct: 93  ELQIITDIKNEYCLTCEGIIT-----NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYT 145
Query: 108 YFL---------YQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
            F+           +L    Y+H+  ++ HRD+KPSN+L++ +  +K+ DFG      E+
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG------ES 199
Query: 158 DFMTEYVV-----TRWYRAPELLLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVH 211
           ++M +  +     T  +  PE   N + Y  A +DIWS+G  L  +      F  K  + 
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 212 QL--RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM 269
           +L   + T+ I  P D           R +       +K   +  F   S+  +D L+  
Sbjct: 260 ELFNNIRTKNIEYPLD-----------RNHFLYPLTNKKSTCSNNFL--SNEDIDFLKLF 306
Query: 270 LVFDPNKRITVEEALRHPYL 289
           L  +P +RIT E+AL+H +L
Sbjct: 307 LRKNPAERITSEDALKHEWL 326

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--AGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQ 107
           E+ +LR   H N++        P+      + IV +  +     H +  S+ +       
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEY 163
               Q  RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F    
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 164 VVTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
               W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G
Sbjct: 184 GSILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG 239
Query: 222 ----SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 256
               SPD   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 240 RGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQ 107
           E+ +LR   H N++        P+      + IV +  +     H +  S+ +       
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEY 163
               Q  RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F    
Sbjct: 124 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 164 VVTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 221
               W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G
Sbjct: 184 GSILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG 239
Query: 222 ----SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 256
               SPD   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 240 RGSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQ 107
           E+ +LR   H N++        P+      + IV +  +     H +  S+ +       
Sbjct: 58  EVGVLRKTRHVNILLFMGYSTKPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLI 111
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---V 164
               Q  RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++    
Sbjct: 112 DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 165 VTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG- 221
            +  + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G 
Sbjct: 172 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGR 228
Query: 222 ---SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 256
              SPD   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 229 GSLSPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 265

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 51/258 (19%)
Query: 49  REIKLLRHMEHENVIA------IKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSD 98
           +EI +L+   H   IA      IK    PP  D  + +++V E       TDL +  + +
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGN 124
Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET- 157
             L ++   Y   ++LRGL ++H   V+HRD+K  N+LL  + ++K+ DFG++     T 
Sbjct: 125 T-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 158 DFMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 212
                ++ T ++ APE++  C E     Y    D+WS+G    E+    P  P  D +H 
Sbjct: 184 GRRNTFIGTPYWMAPEVIA-CDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHP 239
Query: 213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF 272
           +R +             FL   N        PR + ++++ +F +        +E  LV 
Sbjct: 240 MRAL-------------FLIPRNP------APRLKSKKWSKKFQS-------FIESCLVK 273
Query: 273 DPNKRITVEEALRHPYLQ 290
           + ++R   E+ ++HP+++
Sbjct: 274 NHSQRPATEQLMKHPFIR 291

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 40  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDE 92
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HR++K  N+LL  
Sbjct: 93  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGM 152
Query: 140 SCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 153 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 211
Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI    G+P+                             + P K
Sbjct: 212 EGEPPYLNENPLRALYLIAT-NGTPE----------------------------LQNPEK 242
Query: 259 SSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
            S    D L + L  D  KR + +E ++H +L+
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 81  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 140
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 141 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 200
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 201 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 257
Query: 203 LF 204
            F
Sbjct: 258 PF 259

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 29/204 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N+ T+  V   K G      +  +  L E  L++ ++H+ ++ +  ++   +  
Sbjct: 29  VWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTREEP- 82
Query: 76  TFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
               +YI+ E M    L   ++SD+       +L D     F  Q+  G+ Y+   + +H
Sbjct: 83  ----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIH 133
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L++ S   KI DFGLAR   + ++          +W  APE  +N   +T  
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGCFTIK 191
Query: 185 IDIWSVGCILGEIMTREPL-FPGK 207
            D+WS G +L EI+T   + +PG+
Sbjct: 192 SDVWSFGILLYEIVTYGKIPYPGR 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 21  GQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 77
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 78  GVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 189
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 222 EMAVGRYPIPP 232

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237
Query: 203 LF 204
            F
Sbjct: 238 PF 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--XGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 53  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 112
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 113 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 172
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 173 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 229
Query: 203 LF 204
            F
Sbjct: 230 PF 231

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 42  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 97
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 98  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 156
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 214
Query: 198 MT 199
            T
Sbjct: 215 FT 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237
Query: 203 LF 204
            F
Sbjct: 238 PF 239

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK + + +      R  L E  ++   +H NVI ++ ++    K T   V I+ E M+
Sbjct: 38  VAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVV---TKST--PVMIITEFME 91
Query: 89  T-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D Q T       L  +  G+KY+   + +HR L   N+L+N++   K+ 
Sbjct: 92  NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVS 151
Query: 147 DFGLAR----TTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFGL+R     TS+   T  +   +  RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 61  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 120
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 121 MEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 180
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 181 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237
Query: 203 LF 204
            F
Sbjct: 238 PF 239

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 44  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 99
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 100 YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 158
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 216
Query: 198 MT 199
            T
Sbjct: 217 FT 218

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 43  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 98
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 99  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 157
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 215
Query: 198 MT 199
            T
Sbjct: 216 FT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 41  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 96
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 97  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 155
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 213
Query: 198 MT 199
            T
Sbjct: 214 FT 215

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 45  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 100
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 101 YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 159
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 217
Query: 198 MT 199
            T
Sbjct: 218 FT 219

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 4/122 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 139
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    + +   E+V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 140 LVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 197
Query: 196 EI 197
           E+
Sbjct: 198 EM 199

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFGLA+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 69  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 124
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 125 YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 241
Query: 198 MT 199
            T
Sbjct: 242 FT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 38  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 93
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 94  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 210
Query: 198 MT 199
            T
Sbjct: 211 FT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 18/184 (9%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV--YI 82
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +     +  Y+
Sbjct: 37  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 94
Query: 83  VYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
            Y  +   L +      +   DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+   
Sbjct: 95  PYGSLRDYLQK-----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 149
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L 
Sbjct: 150 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLY 207
Query: 196 EIMT 199
           E+ T
Sbjct: 208 ELFT 211

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 401 GQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLI 457
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 458 GVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 569
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 18/184 (9%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV--YI 82
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +     +  Y+
Sbjct: 36  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 83  VYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
            Y  +   L +      +   DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+   
Sbjct: 94  PYGSLRDYLQK-----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 148
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L 
Sbjct: 149 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLY 206
Query: 196 EIMT 199
           E+ T
Sbjct: 207 ELFT 210

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 29/204 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N+ T+  V   K G      +  +  L E  L++ ++H+ ++ +  ++   +  
Sbjct: 28  VWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP- 81
Query: 76  TFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
               +YI+ E M    L   ++SD+       +L D     F  Q+  G+ Y+   + +H
Sbjct: 82  ----IYIITEFMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIH 132
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L++ S   KI DFGLAR   + ++          +W  APE  +N   +T  
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGCFTIK 190
Query: 185 IDIWSVGCILGEIMTREPL-FPGK 207
            ++WS G +L EI+T   + +PG+
Sbjct: 191 SNVWSFGILLYEIVTYGKIPYPGR 214

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 18/184 (9%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV--YI 82
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +     +  Y+
Sbjct: 56  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 83  VYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
            Y  +   L +      +   DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+   
Sbjct: 114 PYGSLRDYLQK-----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 168
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L 
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLY 226
Query: 196 EIMT 199
           E+ T
Sbjct: 227 ELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 38  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 93
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   ++  ++  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 94  YLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 210
Query: 198 MT 199
            T
Sbjct: 211 FT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 18/184 (9%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV--YI 82
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +     +  Y+
Sbjct: 56  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 83  VYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
            Y  +   L +      +   DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+   
Sbjct: 114 PYGSLRDYLQK-----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 168
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L 
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLY 226
Query: 196 EIMT 199
           E+ T
Sbjct: 227 ELFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           T E VA+KK+ ++ +  +  R   REI++L+ ++H+N++  K +     +       I+ 
Sbjct: 41  TGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIME 96
Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L    L   +++  +  D H +   Y  Q+ +G++Y+ +   +HRDL   N+L+     
Sbjct: 97  YLPYGSLRDYLQAHAERID-HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 155
Query: 143 LKIGDFGLARTTSETDFMTEYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +KIGDFGL +   +     +          WY APE L   ++++ A D+WS G +L E+
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYEL 213
Query: 198 MT 199
            T
Sbjct: 214 FT 215

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 45  RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD 104
           R  L E  ++   +H N+I ++ ++   K       Y+    +DT L    ++D Q T  
Sbjct: 68  RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVI 124
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMT 161
                L  +  G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T
Sbjct: 125 QLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
Query: 162 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
               +  RW  APE +    ++T+A D+WS G ++ E+++
Sbjct: 185 RGGKIPIRW-TAPEAIA-FRKFTSASDVWSYGIVMWEVVS 222

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 176 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 100 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 159
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 160 IDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 216
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 217 MAAGYPPF 224

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 101 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 160
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 161 IDEQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 217
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 218 MAAGYPPF 225

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 83/159 (52%), Gaps = 8/159 (5%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQL 101
           + R   +E+++++ +EH  ++ +    +  +     D+++V +L+   DL   ++ +   
Sbjct: 58  EVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-----DMFMVVDLLLGGDLRYHLQQNVHF 112
Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 161
            ++  + F+ +L+  L Y+ +  ++HRD+KP N+LL+    + I DF +A        +T
Sbjct: 113 KEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 162 EYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIM 198
               T+ Y APE+  +     Y+ A+D WS+G    E++
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 61  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 175 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 51  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 104
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 105 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 164
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 165 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 15/178 (8%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   + +    R  L E  ++   +H N+I ++ ++   K      V I+ E M+
Sbjct: 39  VAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP-----VMIITEYME 92
Query: 89  T-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D + T       L  +  G+KY+   S +HRDL   N+L+N++   K+ 
Sbjct: 93  NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVS 152
Query: 147 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFG++R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 153 DFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 78  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 135
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 196 EI-MTREPLFP 205
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 15/178 (8%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   + +    R  L E  ++   +H N+I ++ ++   K      V I+ E M+
Sbjct: 45  VAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP-----VMIITEYME 98
Query: 89  T-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
              L   +R +D + T       L  +  G+KY+   S +HRDL   N+L+N++   K+ 
Sbjct: 99  NGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVS 158
Query: 147 DFGLARTTS---ETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           DFG++R      E  + T    +  RW  APE +    ++T+A D+WS G ++ E+M+
Sbjct: 159 DFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAY-RKFTSASDVWSYGIVMWEVMS 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 66  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 180 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 46  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 101
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 102 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 161
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 162 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 219
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 220 WELMTRGAPPYP 231

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 258
Query: 214 RLITE 218
           +L+ E
Sbjct: 259 KLLKE 263

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 52  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 107
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 167
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 168 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 225
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 226 WELMTRGAPPYP 237

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI--AIKDIIRPPKKDTFNDVYIVYEL 86
           V  K+ GN +   I  ++ + ++K + H  +E  I  A+        + +F D   +Y +
Sbjct: 53  VKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 112
Query: 87  MD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           M+     ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL++    
Sbjct: 113 MEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 172
Query: 143 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E+    P
Sbjct: 173 IQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 229
Query: 203 LF 204
            F
Sbjct: 230 PF 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 72  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 127
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 128 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 187
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 188 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 245
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 246 WELMTRGAPPYP 257

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 143 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 261
Query: 214 RLITE 218
           +L+ E
Sbjct: 262 KLLKE 266

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 256
Query: 214 RLITE 218
           +L+ E
Sbjct: 257 KLLKE 261

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 51  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 106
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 166
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 167 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 224
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 225 WELMTRGAPPYP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 169
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 170 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 227
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 228 WELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 53  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 108
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 168
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 169 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 226
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 227 WELMTRGAPPYP 238

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 49  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 104
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 164
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 222
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 223 WELMTRGAPPYP 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 69/128 (53%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 73  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 128
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 129 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 188
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 189 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 246
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 247 WELMTRGAPPYP 258

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 69/128 (53%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 251
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 252 MAAGYPPF 259

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 169
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ + +  T      +W       L   ++T   D+WS G +L
Sbjct: 170 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 227
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 228 WELMTRGAPPYP 239

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 63/125 (50%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+       R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 109 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 168
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 169 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 225
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 226 MAAGYPPF 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 34/200 (17%)
Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K +    D  + AR+   RE +LL +++HE+++    +         + + +V+E M
Sbjct: 48  VAVKALK---DPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDGDPLIMVFEYM 99
Query: 88  D-TDLHQIIRS---------DQQLTDDHCQYFLYQLLR-------GLKYVHSASVLHRDL 130
              DL++ +R+         D Q      +  L Q+L        G+ Y+ S   +HRDL
Sbjct: 100 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 159
Query: 131 KPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAID 186
              N L+ A+  +KIGDFG++R    TD+        +  RW   PE ++   ++T   D
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESD 217
Query: 187 IWSVGCILGEIMT--REPLF 204
           +WS G IL EI T  ++P F
Sbjct: 218 VWSFGVILWEIFTYGKQPWF 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ +
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYQ 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 131/319 (41%), Gaps = 77/319 (24%)
Query: 47  TLREIKLLRHMEHE-----NVIAIKDIIRPPKKDTFNDVYI--VYELMDTDL-HQIIRSD 98
            L EIKLL+ +        N   +  +I   K    N +++  V+E++   L   II+S+
Sbjct: 74  ALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSN 133
Query: 99  QQLTDDHC-QYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLL------------------- 137
            Q     C +  + Q+L+GL Y+HS   ++H D+KP N+L+                   
Sbjct: 134 YQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQK 193
Query: 138 -------------NASCDL---------------KIGDFGLARTTSETDFMTEYVVTRWY 169
                          + DL               KI D G A    +    TE + TR Y
Sbjct: 194 AGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHK--HFTEDIQTRQY 251
Query: 170 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF---PGKDYVH---QLRLITELIGS- 222
           R+ E+L+    Y+   DIWS  C+  E+ T + LF    G+DY      +  I EL+GS 
Sbjct: 252 RSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSI 310
Query: 223 PDDASLGFLRSD---NARRYVRQLPRCRKQQF------ATRFPNKSSGA-VDLLEKMLVF 272
           P   +L    S    N R  +R + + +             +P++ +    D L  ML  
Sbjct: 311 PRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEM 370
Query: 273 DPNKRITVEEALRHPYLQS 291
            P KR +  E LRHP+L S
Sbjct: 371 VPEKRASAGECLRHPWLNS 389

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255
Query: 214 RLITE 218
           +L+ E
Sbjct: 256 KLLKE 260

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254
Query: 214 RLITE 218
           +L+ E
Sbjct: 255 KLLKE 259

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251
Query: 214 RLITE 218
           +L+ E
Sbjct: 252 KLLKE 256

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 214 RLITE 218
           +L+ E
Sbjct: 248 KLLKE 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  ++I DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 401 GQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLI 457
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 458 GVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 569
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 214 RLITE 218
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 113 NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 168
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 286
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 287 WELMTRGAPPYP 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 214 RLITE 218
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 169
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 227
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 228 WELMTRGAPPYP 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLI 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y APE+++    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIII-SKGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 59  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 114
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 115 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 174
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 175 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 232
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 233 WELMTRGAPPYP 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 214 RLITE 218
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 63/125 (50%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D   +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 214 RLITE 218
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           D   +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 72/281 (25%)
Query: 80  VYIVYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRGLKYVHSAS-VLHRDLKPSNLL 136
           + +V+E++   L + II+S+ Q     C +  + Q+L+GL Y+H+   ++H D+KP N+L
Sbjct: 104 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 163
Query: 137 LNAS-------------------------------------------------CDLKIGD 147
           L+ +                                                   +KI D
Sbjct: 164 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 223
Query: 148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF--- 204
            G A    +    TE + TR YR+ E+L+  + Y    DIWS  C+  E+ T + LF   
Sbjct: 224 LGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPH 280
Query: 205 PGKDYVH---QLRLITELIGS-------PDDASLGFLRSDNARRYVRQL-PRCRKQQFAT 253
            G++Y      + LI EL+G            S  F       +++ +L P    +    
Sbjct: 281 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 340
Query: 254 RF---PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           ++     +++G  D L  ML   P KR T  E LRHP+L S
Sbjct: 341 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 381

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 64  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 85/166 (51%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 52  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 105
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HR+L+ +N+L++ +   KI DFGLAR   + ++     
Sbjct: 106 KLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 165
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 166 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 55  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 110
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 170
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 171 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 228
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 229 WELMTRGAPPYP 240

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 72/135 (53%), Gaps = 3/135 (2%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +Y V E ++  DL   I+   +  +    ++  ++  GL ++H   +++RDLK  N
Sbjct: 91  TVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDN 150
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           ++L++   +KI DFG+ +        T E+  T  Y APE++     Y  ++D W+ G +
Sbjct: 151 VMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVL 209
Query: 194 LGEIMTREPLFPGKD 208
           L E++  +P F G+D
Sbjct: 210 LYEMLAGQPPFDGED 224

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 176 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 21  GQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 77
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 78  GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 189
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 214 RLITE 218
           +L+ E
Sbjct: 304 KLLKE 308

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 72/281 (25%)
Query: 80  VYIVYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRGLKYVHSAS-VLHRDLKPSNLL 136
           + +V+E++   L + II+S+ Q     C +  + Q+L+GL Y+H+   ++H D+KP N+L
Sbjct: 120 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 137 LNAS-------------------------------------------------CDLKIGD 147
           L+ +                                                   +KI D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF--- 204
            G A    +    TE + TR YR+ E+L+  + Y    DIWS  C+  E+ T + LF   
Sbjct: 240 LGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 205 PGKDYVH---QLRLITELIGS-------PDDASLGFLRSDNARRYVRQL-PRCRKQQFAT 253
            G++Y      + LI EL+G            S  F       +++ +L P    +    
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 254 RFP---NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           ++     +++G  D L  ML   P KR T  E LRHP+L S
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 109
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 169
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 227
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 228 WELMTRGAPPYP 239

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 53  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 108
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+  
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 168
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +  + +  T      +W       L   ++T   D+WS G +L
Sbjct: 169 FTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 226
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 227 WELMTRGAPPYP 238

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 52  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 107
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 167
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 168 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 225
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 226 WELMTRGAPPYP 237

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 195 GEIM 198
            +++
Sbjct: 382 FKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 195 GEIM 198
            +++
Sbjct: 382 FKLL 385

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 65  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 179 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 262 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 321
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 322 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 380
Query: 195 GEIM 198
            +++
Sbjct: 381 FKLL 384

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 195 GEIM 198
            +++
Sbjct: 382 FKLL 385

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 21  GQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 77
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 78  GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 189
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 58  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 172 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 23  GQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 79
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 80  GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 133
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 191
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 57  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 110
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 171 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 26  GQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 82
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 83  GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 194
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T  Y AP ++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPAIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDD 104
           L E  L++ ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYV 164
                  Q+  G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +      
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 165 VT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 206
                +W  APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 170 AKFPIKW-TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 18  GQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 74
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 75  GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 186
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 49  GQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 105
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 106 GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 159
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 217
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 24  GQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 80
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 81  GVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 134
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  APE  +N   +
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE-SINFRRF 192
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I     +   + + 
Sbjct: 55  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLV 110
Query: 82  IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           ++  +   DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+  
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 170
Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + +F + +  T      +W       L   ++T   D+WS G +L
Sbjct: 171 FTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLL 228
Query: 195 GEIMTR-EPLFP 205
            E+MTR  P +P
Sbjct: 229 WELMTRGAPPYP 240

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 132/305 (43%), Gaps = 55/305 (18%)
Query: 17  FSAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           F     ++ R ++VAIK+I    ++  + +  + E++ L  + H N++ +          
Sbjct: 21  FGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA------- 69
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS---ASVLHR 128
             N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS    +++HR
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 129 DLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           DLKP NLLL A    LKI DFG A        MT    +  + APE+    + Y+   D+
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SNYSEKCDV 186
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           +S G IL E++TR   F             + IG P    +  + +      ++ LP+  
Sbjct: 187 FSWGIILWEVITRRKPF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-- 231
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF 307
                   P +S     L+ +    DP++R ++EE ++       H +   P    P  +
Sbjct: 232 --------PIES-----LMTRCWSKDPSQRPSMEEIVK----IMTHLMRYFPGADEPLQY 274
Query: 308 DFEHS 312
             +HS
Sbjct: 275 PCQHS 279

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 132/305 (43%), Gaps = 55/305 (18%)
Query: 17  FSAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           F     ++ R ++VAIK+I    ++  + +  + E++ L  + H N++ +          
Sbjct: 22  FGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA------- 70
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS---ASVLHR 128
             N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS    +++HR
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 129 DLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           DLKP NLLL A    LKI DFG A        MT    +  + APE+    + Y+   D+
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG-SNYSEKCDV 187
Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           +S G IL E++TR   F             + IG P    +  + +      ++ LP+  
Sbjct: 188 FSWGIILWEVITRRKPF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-- 232
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF 307
                   P +S     L+ +    DP++R ++EE ++       H +   P    P  +
Sbjct: 233 --------PIES-----LMTRCWSKDPSQRPSMEEIVK----IMTHLMRYFPGADEPLQY 275
Query: 308 DFEHS 312
             +HS
Sbjct: 276 PCQHS 280

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIK 66
           G++ D+   I+ +  N      VAIK   N   + +   + L+E   +R  +H +++ + 
Sbjct: 21  GQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLI 77
Query: 67  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSAS 124
            +I      T N V+I+ EL      +     ++ + D     LY  QL   L Y+ S  
Sbjct: 78  GVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEY 181
            +HRD+   N+L++++  +K+GDFGL+R   ++         +  +W  APE  +N   +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-APE-SINFRRF 189
Query: 182 TAAIDIWSVGCILGEIM 198
           T+A D+W  G  + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 82
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 83  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 199 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 31  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 79
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M+   L   ++ +        QL D   Q     +  G+ YV   + +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ-----IASGMAYVERMNYVH 134
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 192
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPG 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 72
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 189 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  +   K GN     +     L+E ++++ + HE ++ +  ++      
Sbjct: 201 VWMGTWNGTTRVAIKTLKPGN-----MSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 249
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 304
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGL R   + ++          +W  APE  L    +T  
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 362
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 363 SDVWSFGILLTELTTKGRVPYPG 385

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 72
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 189 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 82
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 83  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 199 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 283 VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 331
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 386
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFTIK 444
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPG 467

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 26  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 76
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 77  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 193 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 61/125 (48%), Gaps = 5/125 (4%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 158 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 213
           D   +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 214 RLITE 218
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 26  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 76
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 77  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 193 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/221 (21%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 39  DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-----------NDVYIVYELM 87
           + +  A + L++  +L+  E +++++ ++++    K  F           + +Y V + +
Sbjct: 62  EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121
Query: 88  DT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
           +  +L   ++ ++   +   +++  ++   L Y+HS ++++RDLKP N+LL++   + + 
Sbjct: 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 181
Query: 147 DFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 205
           DFGL +   E +  T  +  T  Y APE +L+   Y   +D W +G +L E++   P F 
Sbjct: 182 DFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
Query: 206 GKDYVHQ--------LRLITELIGSPDDASLGFLRSDNARR 238
            ++            L+L   +  S      G L+ D  +R
Sbjct: 241 SRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D 
Sbjct: 57  TLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDR 111
Query: 106 CQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEY 163
            +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +
Sbjct: 112 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 171
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL-- 219
             T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+  
Sbjct: 172 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 230
Query: 220 --IGSPDDASL--GFLRSDNARR 238
                P+  SL  G L+ D  +R
Sbjct: 231 PRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 65
           G +  +  + +    N  T E VA+K +    D     R   + EI +LR + HE++I  
Sbjct: 25  GHFGKVSLYCYDP-TNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 66  KDIIRPPKKDTFNDV--YI-VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 122
           K       + +   V  Y+ +  L D      I   Q L       F  Q+  G+ Y+HS
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FAQQICEGMAYLHS 135
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPEL 174
              +HR+L   N+LL+    +KIGDFGLA+   E     EY   R        WY APE 
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-APEC 191
Query: 175 LLNCTEYTAAIDIWSVGCILGEIMT 199
           L     Y A+ D+WS G  L E++T
Sbjct: 192 LKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 2   SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN 61
            V  RGE+D       S AV     + ++  +   A D+ I      RE+  +  ++H N
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFI------REVNAMHSLDHRN 72
Query: 62  VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH 121
           +I +  ++  P      ++  +  L+D    ++ +            +  Q+  G+ Y+ 
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 122 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAPELLLN 177
           S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + APE L  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 178 CTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 225
            T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 189 RT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 31  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 79
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M+   L   ++ +        QL D   Q     +  G+ YV   + +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ-----IASGMAYVERMNYVH 134
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW-TAPEAALY-GRFTIK 192
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 193 SDVWSFGILLTELTTKGRVPYPG 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 25  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 73
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 128
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 186
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 187 SDVWSFGILLTELTTKGRVPYPG 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D 
Sbjct: 56  TLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDR 110
Query: 106 CQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEY 163
            +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +
Sbjct: 111 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 170
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL-- 219
             T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+  
Sbjct: 171 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 229
Query: 220 --IGSPDDASL--GFLRSDNARR 238
                P+  SL  G L+ D  +R
Sbjct: 230 PRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 23  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 71
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 126
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 184
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 185 SDVWSFGILLTELTTKGRVPYPG 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D 
Sbjct: 55  TLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDR 109
Query: 106 CQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEY 163
            +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +
Sbjct: 110 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 169
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL-- 219
             T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+  
Sbjct: 170 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 228
Query: 220 --IGSPDDASL--GFLRSDNARR 238
                P+  SL  G L+ D  +R
Sbjct: 229 PRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 19/196 (9%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPK 73
           ++   VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +        
Sbjct: 47  VYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF----- 98
Query: 74  KDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
               +D+ +VY  M      D    +     L+             G+ ++H    +HRD
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158
Query: 130 LKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
           +K +N+LL+ +   KI DFGLAR +   ++T   +  V T  Y APE L    E T   D
Sbjct: 159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG--EITPKSD 216
Query: 187 IWSVGCILGEIMTREP 202
           I+S G +L EI+T  P
Sbjct: 217 IYSFGVVLLEIITGLP 232

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 3/145 (2%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++ S  +++RDLK  N
Sbjct: 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           ++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G +
Sbjct: 473 VMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVL 531
Query: 194 LGEIMTREPLFPGKDYVHQLRLITE 218
           L E++  +  F G+D     + I E
Sbjct: 532 LYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 27  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 75
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 130
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 188
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 189 SDVWSFGILLTELTTKGRVPYPG 211

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D 
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDR 249
Query: 106 CQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEY 163
            +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL-- 219
             T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+  
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 368
Query: 220 --IGSPDDASL--GFLRSDNARR 238
                P+  SL  G L+ D  +R
Sbjct: 369 PRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 47  TLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDH 105
           TL E ++L++  H  + A+K   +     T + +  V E  +  +L   +  ++  ++D 
Sbjct: 198 TLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRERVFSEDR 252
Query: 106 CQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEY 163
            +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +   M  +
Sbjct: 253 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITEL-- 219
             T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ E+  
Sbjct: 313 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 371
Query: 220 --IGSPDDASL--GFLRSDNARR 238
                P+  SL  G L+ D  +R
Sbjct: 372 PRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 200 VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 248
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 303
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 361
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPG 384

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 78  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++    +++ DFG A+      +      T    APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEALAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 197 IMTREPLF 204
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 49  REIKLLRHMEHENVIAIKDIIRP----PKKDTFND-------VYIVYELMDTD-LHQII- 95
           RE+K L  ++H N++            P+  + N        ++I  E  D   L Q I 
Sbjct: 53  REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 96  -RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 154
            R  ++L          Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  + 
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 155 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
                      T  Y +PE  ++  +Y   +D++++G IL E++
Sbjct: 173 KNDGKRXRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 72/135 (53%), Gaps = 3/135 (2%)
Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++ S  +++RDLK  N
Sbjct: 92  TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151
Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           ++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G +
Sbjct: 152 VMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVL 210
Query: 194 LGEIMTREPLFPGKD 208
           L E++  +  F G+D
Sbjct: 211 LYEMLAGQAPFEGED 225

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 200 VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 248
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 303
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 361
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPG 384

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 200 VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 248
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 303
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 361
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPG 384

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 65
           G +  +  + +    N  T E VA+K +    D     R   + EI +LR + HE++I  
Sbjct: 25  GHFGKVSLYCYDP-TNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 66  KDIIRPPKKDTFNDV--YI-VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS 122
           K       + +   V  Y+ +  L D      I   Q L       F  Q+  G+ Y+H+
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL------FAQQICEGMAYLHA 135
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPEL 174
              +HR+L   N+LL+    +KIGDFGLA+   E     EY   R        WY APE 
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWY-APEC 191
Query: 175 LLNCTEYTAAIDIWSVGCILGEIMT 199
           L     Y A+ D+WS G  L E++T
Sbjct: 192 LKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 109/218 (50%), Gaps = 40/218 (18%)
Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSE 156
           ++ T+   Q ++ +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 157 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 215
           T+   ++  T  Y AP+++    + +  A+D WS+G ++ E++T    F           
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT---------- 263
Query: 216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVFDP 274
              + G  +       +++ +RR ++  P          +P + S  A DL++++L+ DP
Sbjct: 264 ---VDGEKNS------QAEISRRILKSEP---------PYPQEMSALAKDLIQRLLMKDP 305
Query: 275 NKRIT-----VEEALRHPYLQSLH--DLNDEPVCPRPF 305
            KR+       +E   H + Q ++  DL  + V P PF
Sbjct: 306 KKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV-PAPF 342

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL  +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T  
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 41/194 (21%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLAR-----TTSETDFMTEYV 164
           Q+   L Y+H+  + HRD+KP N L   N S ++K+ DFGL++        E   MT   
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 165 VTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
            T ++ APE+L    E Y    D WS G +L  ++     FPG   V+    I++++   
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG---VNDADTISQVL--- 289
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITV 280
                                    ++     PN    S  A DLL  +L  + ++R   
Sbjct: 290 ------------------------NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 281 EEALRHPYLQSLHD 294
             AL+HP++    D
Sbjct: 326 MRALQHPWISQFSD 339

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 75  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 188
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKEL-KQRV 405
Query: 249 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 283
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPK 73
           ++   VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +        
Sbjct: 47  VYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF----- 98
Query: 74  KDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
               +D+ +VY  M      D    +     L+             G+ ++H    +HRD
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158
Query: 130 LKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
           +K +N+LL+ +   KI DFGLAR +   ++T      V T  Y APE L    E T   D
Sbjct: 159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG--EITPKSD 216
Query: 187 IWSVGCILGEIMTREP 202
           I+S G +L EI+T  P
Sbjct: 217 IYSFGVVLLEIITGLP 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 16/111 (14%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++QL+     +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----- 214
Query: 158 DFM--TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 215 DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 75  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 188
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKEL-KQRV 405
Query: 249 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 283
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 75  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 188
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKELKQ-RV 405
Query: 249 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 283
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 75  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 188
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKEL-KQRV 405
Query: 249 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 283
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 29/173 (16%)
Query: 48  LREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY-----------ELMDTDLHQII 95
           + E+K++ H+ +HEN++ +               Y  Y            +++TD    I
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 155
            +    T D   +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR   
Sbjct: 157 ANSTASTRD-LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--- 212
Query: 156 ETDFM--TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 213 --DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 34  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 82
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 137
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + +           +W  APE  L    +T  
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALY-GRFTIK 195
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPG 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 7   GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR-EIKLLRHMEHENVIAI 65
           G +  +  + +    N  T E VA+K +    D     R   + EI +LR + HE++I  
Sbjct: 42  GHFGKVSLYCYDP-TNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 66  KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
           K         +     +V E +     +       +       F  Q+  G+ Y+H+   
Sbjct: 99  KGCCEDAGAASLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-------WYRAPELLLNC 178
           +HRDL   N+LL+    +KIGDFGLA+   E      Y V         WY APE L   
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVREDGDSPVFWY-APECLKEY 212
Query: 179 TEYTAAIDIWSVGCILGEIMT 199
             Y A+ D+WS G  L E++T
Sbjct: 213 KFYYAS-DVWSFGVTLYELLT 232

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 97/201 (48%), Gaps = 28/201 (13%)
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 141 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 143 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 201
Query: 200 -REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
            R P               +++GS D+         N   Y+ Q+   ++     R P  
Sbjct: 202 GRSPF--------------DIVGSSDNP------DQNTEDYLFQVILEKQ----IRIPRS 237
Query: 259 -SSGAVDLLEKMLVFDPNKRI 278
            S  A  +L+  L  DP +R+
Sbjct: 238 LSVKAASVLKSFLNKDPKERL 258

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 141 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 158 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 216
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NK 258
               F             +++GS D+         N   Y+ Q+    KQ    R P + 
Sbjct: 217 GRSPF-------------DIVGSSDNP------DQNTEDYLFQVI-LEKQ---IRIPRSM 253
Query: 259 SSGAVDLLEKMLVFDPNKRI 278
           S  A  +L+  L  DP +R+
Sbjct: 254 SVKAASVLKSFLNKDPKERL 273

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 29/173 (16%)
Query: 48  LREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVY-----------ELMDTDLHQII 95
           + E+K++ H+ +HEN++ +               Y  Y            +++TD    I
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 155
            ++  L+     +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR   
Sbjct: 157 -ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--- 212
Query: 156 ETDFM--TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 213 --DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 141 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 147 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK- 258
               F             +++GS D+         N   Y+ Q+    KQ    R P   
Sbjct: 206 GRSPF-------------DIVGSSDNP------DQNTEDYLFQV-ILEKQ---IRIPRSL 242
Query: 259 SSGAVDLLEKMLVFDPNKRI 278
           S  A  +L+  L  DP +R+
Sbjct: 243 SVKAASVLKSFLNKDPKERL 262

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIA 64
           F     AV+ E  +EV +K I    + +++          + TL EI +L  +EH N+I 
Sbjct: 37  FGFVWTAVDKEKNKEVVVKFIKK--EKVLEDCWIEDPKLGKVTL-EIAILSRVEHANIIK 93
Query: 65  IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
           + DI    +   F  + +       DL   I    +L +    Y   QL+  + Y+    
Sbjct: 94  VLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           ++HRD+K  N+++     +K+ DFG A           +  T  Y APE+L+        
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPE 210
Query: 185 IDIWSVGCILGEIMTREPLF 204
           +++WS+G  L  ++  E  F
Sbjct: 211 LEMWSLGVTLYTLVFEENPF 230

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 141 CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 190 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK- 258
               F             +++GS D+         N   Y+ Q+   ++     R P   
Sbjct: 249 GRSPF-------------DIVGSSDNP------DQNTEDYLFQVILEKQ----IRIPRSL 285
Query: 259 SSGAVDLLEKMLVFDPNKRI 278
           S  A  +L+  L  DP +R+
Sbjct: 286 SVKAASVLKSFLNKDPKERL 305

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 19/127 (14%)
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------- 158
           C +   Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 159 ------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 212
                   T  V T+ Y +PE  ++   Y+  +DI+S+G IL E+     L+P    + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 213 LRLITEL 219
           +R +T++
Sbjct: 234 VRTLTDV 240

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +GE+ D++   +          +VA+K I     N   A+  L E  ++  + H N++ +
Sbjct: 22  KGEFGDVMLGDYRG-------NKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 66  KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 122
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+  
Sbjct: 71  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE L     ++
Sbjct: 127 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPEALREAA-FS 183
Query: 183 AAIDIWSVGCILGEIMTRE----PLFPGKDYV 210
              D+WS G +L EI +      P  P KD V
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 215

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 80/155 (51%), Gaps = 5/155 (3%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 107
           LRE+ +++ + H N++     +  P   +    Y+    +   LH+   + +QL +    
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRL 140
Query: 108 YFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 165
              Y + +G+ Y+H+ +  ++HR+LK  NLL++    +K+ DFGL+R  + T   ++   
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 166 -TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T  + APE+L +      + D++S G IL E+ T
Sbjct: 201 GTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +GE+ D++   +          +VA+K I     N   A+  L E  ++  + H N++ +
Sbjct: 31  KGEFGDVMLGDYRG-------NKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 66  KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 122
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+  
Sbjct: 80  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE L    +++
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPEALRE-KKFS 192
Query: 183 AAIDIWSVGCILGEIMTRE----PLFPGKDYV 210
              D+WS G +L EI +      P  P KD V
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 13/177 (7%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   +      R  L E  ++   +H N+I ++ ++   +       Y+    +D
Sbjct: 80  VAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 89  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
           T L      D Q T       L  +  G++Y+     +HRDL   N+L++++   K+ DF
Sbjct: 139 TFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 149 GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           GL+R   E D    Y  T      RW  APE +   T +++A D+WS G ++ E++ 
Sbjct: 196 GLSRVL-EDDPDAAYTTTGGKIPIRW-TAPEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 5/155 (3%)
Query: 48  LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 107
           LRE+ +++ + H N++     +  P   +    Y+    +   LH+   + +QL +    
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRL 140
Query: 108 YFLYQLLRGLKYVHS--ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 165
              Y + +G+ Y+H+    ++HRDLK  NLL++    +K+ DFGL+R  +     ++   
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA 200
Query: 166 -TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            T  + APE+L +      + D++S G IL E+ T
Sbjct: 201 GTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +GE+ D++   +          +VA+K I     N   A+  L E  ++  + H N++ +
Sbjct: 203 KGEFGDVMLGDYRG-------NKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 66  KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 122
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+  
Sbjct: 252 LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE L    +++
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPEALRE-KKFS 364
Query: 183 AAIDIWSVGCILGEIMTRE----PLFPGKDYV 210
              D+WS G +L EI +      P  P KD V
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 48  LREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH- 105
           + E+K++ H+ +HEN++ +               Y  Y  +   L +   +D    D   
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 106 -----CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
                  +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIM 203
Query: 161 --TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 204 NDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +GE+ D++   +          +VA+K I     N   A+  L E  ++  + H N++ +
Sbjct: 16  KGEFGDVMLGDYRG-------NKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 66  KDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS 122
             +I   K      +YIV E M    L   +RS  +  L  D    F   +   ++Y+  
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
            + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE L    +++
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPEALRE-KKFS 177
Query: 183 AAIDIWSVGCILGEIMTRE----PLFPGKDYV 210
              D+WS G +L EI +      P  P KD V
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTL--REIKLLRHMEHENVIAIKDIIRPPK 73
           ++   VN+ T   VA+KK+    D   +  +    +EIK++   +HEN++ +        
Sbjct: 41  VYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF----- 92
Query: 74  KDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
               +D+ +VY  M      D    +     L+             G+ ++H    +HRD
Sbjct: 93  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 152
Query: 130 LKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
           +K +N+LL+ +   KI DFGLAR +   ++       V T  Y APE L    E T   D
Sbjct: 153 IKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG--EITPKSD 210
Query: 187 IWSVGCILGEIMTREP 202
           I+S G +L EI+T  P
Sbjct: 211 IYSFGVVLLEIITGLP 226

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 37  RGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 95
Query: 65  IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------LTDDHCQYFLY 111
           +      P       + ++ E     +L   +RS +             LT +H   + +
Sbjct: 96  LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---YVVTR 167
           Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    +  +
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE + +   YT   D+WS G +L EI +
Sbjct: 212 WM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 36/234 (15%)
Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHC-QYFLYQL----LRGLKYV-HSASVLHRDLK 131
            D +I  ELM T   +  +    + DD   +  L ++    ++ L ++  +  ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIW 188
           PSN+LL+ S ++K+ DFG++    ++   T     R Y APE +    +   Y    D+W
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELI-GSPDDASLGFLRSDNARRYVRQLPRCR 247
           S+G  L E+ T    FP   +      +T+++ G P                  QL    
Sbjct: 214 SLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPP-----------------QLSNSE 254
Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 301
           +++F+  F       ++ +   L  D +KR   +E L+HP++    +   E  C
Sbjct: 255 EREFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 48  LREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH- 105
           + E+K++ H+ +HEN++ +               Y  Y  +   L +   +D    D   
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 106 -----CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
                  +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIM 211
Query: 161 --TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 212 NDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           +   T   VA+K++ ++  +    R   REI++L+ +  + ++  + +   P + +    
Sbjct: 34  LGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR-- 89
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLN 138
            +V E + +   +      +   D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ 
Sbjct: 90  -LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 148
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSV 190
           +   +KI DFGLA+         +Y V R        WY APE L +   ++   D+WS 
Sbjct: 149 SEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSF 203
Query: 191 GCILGEIMT 199
           G +L E+ T
Sbjct: 204 GVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           +   T   VA+K++ ++  +    R   REI++L+ +  + ++  + +   P + +    
Sbjct: 35  LGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR-- 90
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLN 138
            +V E + +   +      +   D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ 
Sbjct: 91  -LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 149
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSV 190
           +   +KI DFGLA+         +Y V R        WY APE L +   ++   D+WS 
Sbjct: 150 SEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSF 204
Query: 191 GCILGEIMT 199
           G +L E+ T
Sbjct: 205 GVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           +   T   VA+K++ ++  +    R   REI++L+ +  + ++  + +   P + +    
Sbjct: 47  LGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR-- 102
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLN 138
            +V E + +   +      +   D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ 
Sbjct: 103 -LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 161
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSV 190
           +   +KI DFGLA+         +Y V R        WY APE L +   ++   D+WS 
Sbjct: 162 SEAHVKIADFGLAKLLP---LDKDYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSF 216
Query: 191 GCILGEIMT 199
           G +L E+ T
Sbjct: 217 GVVLYELFT 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 19/127 (14%)
Query: 106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF------ 159
           C +   Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 160 -MTEY------VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 212
            M  Y      V T+ Y +PE  ++   Y+  +DI+S+G IL E+     L+     + +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFEL-----LYSFSTQMER 279
Query: 213 LRLITEL 219
           +R+IT++
Sbjct: 280 VRIITDV 286

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 37  RGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 95
Query: 65  IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------LTDDHCQYFLY 111
           +      P       + ++ E     +L   +RS +             LT +H   + +
Sbjct: 96  LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---YVVTR 167
           Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    +  +
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE + +   YT   D+WS G +L EI +
Sbjct: 212 WM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 165
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 166 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++ LT      F +Q+ +G++Y+   S++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 158 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 165
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 166 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 223 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 233
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 234 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 279

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 230
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 231 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 276

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 165
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 166 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 167
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 168 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 221
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL 247
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 248 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 294

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 16/101 (15%)
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV 165
           +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 216
Query: 166 -------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                   +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 217 KGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 255
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 256 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 301

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 8/157 (5%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E M       + S+  + +   +++  +++  L  +HS  ++HRD+KP N+LL+ 
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 209
Query: 140 SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCIL 194
              LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGS---PDDASL 228
            E++  +  F     V     I +   S   P+DA +
Sbjct: 270 FEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI 306

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 233
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 234 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 279

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 165
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 166 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 256
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 257 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 302

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 228
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 229 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 165
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 166 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 168
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 222
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 228
Query: 223 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 229 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 116 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 172
           G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           E L    E T   DI+S G +L EI+T  P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 35  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 94  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 207
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 208 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 264

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 26  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 84
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 85  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 140 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 198
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 199 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 255

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 22  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 80
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 81  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 136 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 194
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 195 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 251

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 167
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 168 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 221
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL 227
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 228 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 167
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 168 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 221
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL 255
Query: 222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 270
           SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 256 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 302

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 28  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 86
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 87  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 200
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 201 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 257

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 29  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 87
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 88  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 201
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 202 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 258

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 28  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 86
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 87  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 200
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 201 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 257

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 57  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 115
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 116 LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 171 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 229
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 230 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 286

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 35  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +    ++                ++ 
Sbjct: 94  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 207
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 208 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 264

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  T+  VAIK +       +     L E ++++ ++H+ ++ +  ++      
Sbjct: 25  VWMGTWNGNTK--VAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV------ 73
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           +   +YIV E M+   L   ++  +   L   +      Q+  G+ Y+   + +HRDL+ 
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRS 133
Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWS 189
           +N+L+      KI DFGLAR   + +           +W  APE  L    +T   D+WS
Sbjct: 134 ANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YGRFTIKSDVWS 191
Query: 190 VGCILGEIMTREPL-FPGKD 208
            G +L E++T+  + +PG +
Sbjct: 192 FGILLTELVTKGRVPYPGMN 211

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 118/297 (39%), Gaps = 82/297 (27%)
Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N  T+E+ A+K +        D  +  RE++L  H        I  I+     D + ++Y
Sbjct: 39  NKRTQEKFALKMLQ-------DCPKARREVEL--HWRASQCPHIVRIV-----DVYENLY 84
Query: 82  -------IVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
                  IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+K
Sbjct: 85  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 144
Query: 132 PSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           P NLL  +   +  LK+ DFG A+ T+                        +Y  + D+W
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMW 182
Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G I+  ++   P F      H L +      SP   +                 R R 
Sbjct: 183 SLGVIMYILLCGYPPFYSN---HGLAI------SPGMKT-----------------RIRM 216
Query: 249 QQFATRFPNKSSGAVD-----LLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            Q+   FPN     V      L+  +L  +P +R+T+ E + HP++     +   P+
Sbjct: 217 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 80  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 139 ------ASCDLK----IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
                 A CD      +   GL ++    D++     T  + APE++L      A +D+W
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG---TETHMAPEVVLG-RSCDAKVDVW 275
Query: 189 SVGCIL 194
           S  C++
Sbjct: 276 SSCCMM 281

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 95
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 150
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE--- 162
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +   
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 211 RLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 25  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 83
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +    ++                ++ 
Sbjct: 84  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 139 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 197
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 198 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 254

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           ++    N  TR  VAIK +       +     L+E ++++ + HE ++ +  ++      
Sbjct: 24  VWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------ 72
Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLH 127
           +   + IV E M    L   ++ +        QL D        Q+  G+ YV   + +H
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVH 127
Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAA 184
           RDL+ +N+L+  +   K+ DFGLAR   + +           +W  APE  L    +T  
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALY-GRFTIK 185
Query: 185 IDIWSVGCILGEIMTREPL-FPG 206
            D+WS G +L E+ T+  + +PG
Sbjct: 186 SDVWSFGILLTELTTKGRVPYPG 208

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 39  RGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 97
Query: 65  IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--------------LTDDHCQYF 109
           +      P       + ++ E     +L   +RS +               LT +H   +
Sbjct: 98  LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW- 168
            +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +          R  
Sbjct: 154 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 169 --YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
             + APE + +   YT   D+WS G +L EI +
Sbjct: 214 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 86
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 141
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE--- 162
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +   
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 202 RLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 86
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 141
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE--- 162
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +   
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 202 RLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 74  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 132
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 187
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE--- 162
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +   
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 248 RLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 282

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 29  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 87
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 88  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  RW  
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM- 201
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 202 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 258

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG + ++    FS  + ++    VA+K         + A+  L+E ++L+   H N++ +
Sbjct: 124 RGNFGEV----FSGRLRADN-TLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRL 177
Query: 66  KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSA 123
             +    +      +YIV EL+   D    +R++  +L        +     G++Y+ S 
Sbjct: 178 IGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCT 179
             +HRDL   N L+     LKI DFG++R  ++  +        V  +W  APE  LN  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYG 290
Query: 180 EYTAAIDIWSVGCILGEIMT 199
            Y++  D+WS G +L E  +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 47/206 (22%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           +VA+K +    D+  +    + E+K++  +  HEN++ +              +Y+++E 
Sbjct: 77  QVAVKMLKEKADSS-EREALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEY 130
Query: 87  M-DTDLHQIIRSD-QQLTDDHCQY----------------------FLYQLLRGLKYVHS 122
               DL   +RS  ++ ++D  +Y                      F YQ+ +G++++  
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190
Query: 123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV-------TRWYRAPE 173
            S +HRDL   N+L+     +KI DFGLAR     D M++  YVV        +W  APE
Sbjct: 191 KSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIMSDSNYVVRGNARLPVKW-MAPE 244
Query: 174 LLLNCTEYTAAIDIWSVGCILGEIMT 199
            L     YT   D+WS G +L EI +
Sbjct: 245 SLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK + N   ++ +    L E  +++     +V+ +
Sbjct: 20  QGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRL 78
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 79  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  RW  
Sbjct: 134 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM- 192
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 193 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 249

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLT 102
           +  + + E  ++++++H +++ +  II         ++Y   EL     H + R+   L 
Sbjct: 68  NKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLK 123
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
                 +  Q+ + + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D+   
Sbjct: 124 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 163 YVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 204
            V     +W  +PE  +N   +T A D+W     + EI++  ++P F
Sbjct: 184 SVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 9/123 (7%)
Query: 80  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 139 A-SCDLKIGDFGLARTTSE----TDFMT-EYV-VTRWYRAPELLLNCTEYTAAIDIWSVG 191
           +      + DFG A          D +T +Y+  T  + APE++L      A +D+WS  
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDAKVDVWSSC 259
Query: 192 CIL 194
           C++
Sbjct: 260 CMM 262

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLT 102
           +  + + E  ++++++H +++ +  II         ++Y   EL     H + R+   L 
Sbjct: 56  NKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLK 111
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
                 +  Q+ + + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D+   
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 163 YVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 204
            V     +W  +PE  +N   +T A D+W     + EI++  ++P F
Sbjct: 172 SVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 11/176 (6%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD 88
           VAIK +   +      R  L E  ++   +H N+I ++ ++   +       Y+    +D
Sbjct: 80  VAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 89  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
           T L      D Q T       L  +  G++Y+     +HRDL   N+L++++   K+ DF
Sbjct: 139 TFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 149 GLARTT-----SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           GL+R       +        +  RW  APE +   T +++A D+WS G ++ E++ 
Sbjct: 196 GLSRVLEDDPDAAXTTTGGKIPIRW-TAPEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 104/244 (42%), Gaps = 39/244 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQ 107
           REI++  H+ H N++ + +     ++     +Y++ E     +L++ ++      +    
Sbjct: 72  REIEIQAHLHHPNILRLYNYFYDRRR-----IYLILEYAPRGELYKELQKSCTFDEQRTA 126
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 167
             + +L   L Y H   V+HRD+KP NLLL    +LKI DFG +         T    T 
Sbjct: 127 TIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTL 185
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 227
            Y  PE++     +   +D+W +G +  E++   P F    +    R I ++        
Sbjct: 186 DYLPPEMI-EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-------- 236
Query: 228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
                                 +F    P   +GA DL+ K+L  +P++R+ + +   HP
Sbjct: 237 --------------------DLKFPASVP---TGAQDLISKLLRHNPSERLPLAQVSAHP 273
Query: 288 YLQS 291
           ++++
Sbjct: 274 WVRA 277

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 29  VAIKKIG----NAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDVYI 82
           VAIK +     + +  + +  R   E+ LL+ +      VI + D    P  D+F    +
Sbjct: 36  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP--DSF---VL 90
Query: 83  VYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           + E M+   DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +
Sbjct: 91  ILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 150
Query: 141 -CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +LK+ DFG      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 151 RGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 204

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLT 102
           +  + + E  ++++++H +++ +  II         ++Y   EL     H + R+   L 
Sbjct: 52  NKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLK 107
Query: 103 DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 162
                 +  Q+ + + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D+   
Sbjct: 108 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 167
Query: 163 YVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 204
            V     +W  +PE  +N   +T A D+W     + EI++  ++P F
Sbjct: 168 SVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRW 168
           Q  +G+ Y+H+ +++HRD+K +N+ L+    +KIGDFGLA   S    +  + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 169 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTRE 201
           + APE+  + +   ++   D++S G +L E+MT E
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 158 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 98  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 157
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 158 DFMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMT 199
           D    YV     R P   +         YT   D+WS G +L EI+T
Sbjct: 204 D---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 35/235 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKK 74
           +F  A   +T + VAIK + +  +  +  R   R   +LR  ++H NV+ +  ++    K
Sbjct: 47  LFGPAPGEQT-QAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLGVV---TK 100
Query: 75  DTFNDVYIVYELMDTDLHQII-----RSDQQLTDDH-----------CQYFLYQLLRGLK 118
           D    +   Y     DLH+ +      SD   TDD              + + Q+  G++
Sbjct: 101 DQPLSMIFSY-CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 159
Query: 119 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPEL 174
           Y+ S  V+H+DL   N+L+    ++KI D GL R     D+        +  RW  APE 
Sbjct: 160 YLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEA 218
Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITELIGSPDD 225
           ++   +++   DIWS G +L E+ +   +P   +  +D V  +R   +++  PDD
Sbjct: 219 IMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCPDD 271

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 26/238 (10%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           +G +  +   +    V  E    VAIK +  A  ++ +    L E  +++     +V+ +
Sbjct: 22  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 80
Query: 66  KDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDH----------CQYFLYQLL 114
             ++   +        ++ ELM   DL   +RS +   +++                ++ 
Sbjct: 81  LGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYR 170
            G+ Y+++   +HRDL   N  +     +KIGDFG+ R   ETD+  +     +  RW  
Sbjct: 136 DGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 194
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPDD 225
           +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD+
Sbjct: 195 SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 251

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 39  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 97
Query: 65  IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------LTDDHCQ 107
           +      P       + ++ E     +L   +RS +                 LT +H  
Sbjct: 98  LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 108 YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTE---Y 163
            + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D++ +    
Sbjct: 154 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 214 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 95
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 150
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 166
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +          
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 167 RW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           R    + APE + +   YT   D+WS G +L EI +
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 77/187 (41%), Gaps = 9/187 (4%)
Query: 30  AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDVYIVYELMD 88
           A+K+  + F    D  R L E+       HE V      +R  +  +    +Y+  EL  
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVG-----SHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 89  TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 147
             L Q   +    L +     +L   L  L ++HS  ++H D+KP+N+ L      K+GD
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD 200
Query: 148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 207
           FGL                  Y APELL     Y  A D++S+G  + E+     L  G 
Sbjct: 201 FGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG 258
Query: 208 DYVHQLR 214
           +   QLR
Sbjct: 259 EGWQQLR 265

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI--IRPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +  + PP        YIV E 
Sbjct: 60  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPP-------FYIVTEY 109
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + +++T     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 110 MPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVV 169
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L   T ++   D+W+ G +L EI T 
Sbjct: 170 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATY 227
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 228 GMSP-YPGID 236

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 35/235 (14%)
Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKK 74
           +F  A   +T + VAIK + +  +  +  R   R   +LR  ++H NV+ +  ++    K
Sbjct: 30  LFGPAPGEQT-QAVAIKTLKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLGVV---TK 83
Query: 75  DTFNDVYIVYELMDTDLHQII-----RSDQQLTDDH-----------CQYFLYQLLRGLK 118
           D    +   Y     DLH+ +      SD   TDD              + + Q+  G++
Sbjct: 84  DQPLSMIFSY-CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142
Query: 119 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPEL 174
           Y+ S  V+H+DL   N+L+    ++KI D GL R     D+        +  RW  APE 
Sbjct: 143 YLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEA 201
Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITELIGSPDD 225
           ++   +++   DIWS G +L E+ +   +P   +  +D V  +R   +++  PDD
Sbjct: 202 IMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCPDD 254

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 86
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 141
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 166
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +          
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 167 RW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           R    + APE + +   YT   D+WS G +L EI +
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 28  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 86
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 87  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 141
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 166
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +          
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 167 RW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           R    + APE + +   YT   D+WS G +L EI +
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 268
                    E+IG               + + RQ                SS    L+  
Sbjct: 215 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 237
Query: 269 MLVFDPNKRITVEEALRHPYLQSL 292
            L   P+ R T EE   HP++Q +
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 95
Query: 65  IKDIIRPPKKD--------TFNDV----------YIVYELMDTDLHQIIRSDQQLTDDHC 106
           +      P            F ++          ++ Y++   DL++       LT +H 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-----LTLEHL 150
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 166
             + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +          
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 167 RW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           R    + APE + +   YT   D+WS G +L EI +
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE-NVIA 64
           RG +  +I         + T   VA+K +     +  + R  + E+K+L H+ H  NV+ 
Sbjct: 38  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 96
Query: 65  IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---------------LTDDHCQY 108
           +      P       + ++ E     +L   +RS +                LT +H   
Sbjct: 97  LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 168
           + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +          R 
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 169 ---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
              + APE + +   YT   D+WS G +L EI +
Sbjct: 213 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 268
                    E+IG               + + RQ                SS    L+  
Sbjct: 247 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 269
Query: 269 MLVFDPNKRITVEEALRHPYLQSL 292
            L   P+ R T EE   HP++Q +
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 268
                    E+IG               + + RQ                SS    L+  
Sbjct: 248 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 270
Query: 269 MLVFDPNKRITVEEALRHPYLQSL 292
            L   P+ R T EE   HP++Q +
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 268
                    E+IG               + + RQ                SS    L+  
Sbjct: 248 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 270
Query: 269 MLVFDPNKRITVEEALRHPYLQSL 292
            L   P+ R T EE   HP++Q +
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 268
                    E+IG               + + RQ                SS    L+  
Sbjct: 247 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 269
Query: 269 MLVFDPNKRITVEEALRHPYLQSL 292
            L   P+ R T EE   HP++Q +
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           +VAIK +    +   D    +RE +++  +++  ++ +  + +         + +V E+ 
Sbjct: 39  DVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMA 91
Query: 88  DTD-LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
               LH+ ++   +++   +    L+Q+  G+KY+   + +HRDL   N+LL      KI
Sbjct: 92  GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 151
Query: 146 GDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            DFGL++     D + T     +W   + APE  +N  ++++  D+WS G  + E ++
Sbjct: 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 6   RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAI 65
           RG + ++    FS  + ++    VA+K         + A+  L+E ++L+   H N++ +
Sbjct: 124 RGNFGEV----FSGRLRADN-TLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRL 177
Query: 66  KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSA 123
             +    +      +YIV EL+   D    +R++  +L        +     G++Y+ S 
Sbjct: 178 IGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCT 179
             +HRDL   N L+     LKI DFG++R  ++           V  +W  APE  LN  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPE-ALNYG 290
Query: 180 EYTAAIDIWSVGCILGEIMT 199
            Y++  D+WS G +L E  +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 88
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L EI T 
Sbjct: 149 KVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 206
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 207 GMSP-YPGID 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 80  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 139 ------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
                 A CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 201 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 256
Query: 189 SVGCIL 194
           S  C++
Sbjct: 257 SSCCMM 262

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 80  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 139 ------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
                 A CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 240
Query: 189 SVGCIL 194
           S  C++
Sbjct: 241 SSCCMM 246

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/247 (21%), Positives = 113/247 (45%), Gaps = 39/247 (15%)
Query: 49  REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-QLTDDHC 106
           +EI +L    H N++ + +       ++  ++ +++E +   D+ + I +   +L +   
Sbjct: 50  KEISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREI 104
Query: 107 QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYV 164
             +++Q+   L+++HS ++ H D++P N++     S  +KI +FG AR     D      
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSP 223
               Y APE+  +    TA  D+WS+G ++  +++   P     +         ++I + 
Sbjct: 165 TAPEYYAPEVHQHDVVSTAT-DMWSLGTLVYVLLSGINPFLAETN--------QQIIENI 215
Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
            +A   F   + A                  F   S  A+D ++++LV +   R+T  EA
Sbjct: 216 MNAEYTF--DEEA------------------FKEISIEAMDFVDRLLVKERKSRMTASEA 255
Query: 284 LRHPYLQ 290
           L+HP+L+
Sbjct: 256 LQHPWLK 262

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 80  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 139 ------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
                 A CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 199 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 254
Query: 189 SVGCIL 194
           S  C++
Sbjct: 255 SSCCMM 260

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 88
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L EI T 
Sbjct: 149 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 206
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 207 GMSP-YPGID 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 88
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 149 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 206
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 207 GMSP-YPGID 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           +   T   VA+K++ ++  +    R   REI++L+ +  + ++  + +   P +    ++
Sbjct: 31  LGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRP---EL 85
Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLN 138
            +V E + +   +      +   D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ 
Sbjct: 86  RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 145
Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSV 190
           +   +KI DFGLA+         +  V R        WY APE L +   ++   D+WS 
Sbjct: 146 SEAHVKIADFGLAKLLP---LDKDXXVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSF 200
Query: 191 GCILGEIMT 199
           G +L E+ T
Sbjct: 201 GVVLYELFT 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E M       + S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+ 
Sbjct: 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 203
Query: 140 SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCIL 194
           S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 195 GEIMTREPLF 204
            E++  +  F
Sbjct: 264 YEMLVGDTPF 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E M       + S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+ 
Sbjct: 149 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 208
Query: 140 SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCIL 194
           S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 209 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 268
Query: 195 GEIMTREPLF 204
            E++  +  F
Sbjct: 269 YEMLVGDTPF 278

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 96  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 201 E-PLFPGKDYVHQLRLI 216
               +PG D      L+
Sbjct: 214 GMSPYPGIDLSQVYELL 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 159
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 160 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 90
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 209 GMSP-YPGID 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 90
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 209 GMSP-YPGID 217

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 159
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 160 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 209 GMSP-YPGID 217

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 159
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 160 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 209 GMSP-YPGID 217

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 159
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 160 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E M       + S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+ 
Sbjct: 149 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK 208
Query: 140 SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCIL 194
           S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 209 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 268
Query: 195 GEIMTREPLF 204
            E++  +  F
Sbjct: 269 YEMLVGDTPF 278

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/178 (22%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           +VAIK +    +   D    +RE +++  +++  ++ +  + +         + +V E+ 
Sbjct: 365 DVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMA 417
Query: 88  DTD-LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
               LH+ ++   +++   +    L+Q+  G+KY+   + +HR+L   N+LL      KI
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI 477
Query: 146 GDFGLARTTSETD-FMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            DFGL++     D + T     +W   + APE  +N  ++++  D+WS G  + E ++
Sbjct: 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 95/198 (47%), Gaps = 23/198 (11%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 200 -REPLFPGKDYVHQLRLI 216
              P +PG D      L+
Sbjct: 214 GMSP-YPGIDLSQVYELL 230

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 227

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 204

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 33/199 (16%)
Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K +  A ++   AR+   RE +LL  ++H++++    +    +      + +V+E M
Sbjct: 74  VAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP-----LLMVFEYM 125
Query: 88  -DTDLHQIIRS---DQQLTDDH-----CQYFLYQLLR-------GLKYVHSASVLHRDLK 131
              DL++ +RS   D +L             L QLL        G+ Y+     +HRDL 
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDI 187
             N L+     +KIGDFG++R    TD+        +  RW   PE +L   ++T   D+
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTESDV 243
Query: 188 WSVGCILGEIMT--REPLF 204
           WS G +L EI T  ++P +
Sbjct: 244 WSFGVVLWEIFTYGKQPWY 262

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 91
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 151
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L EI T 
Sbjct: 152 KVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 209
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 210 GMSP-YPGID 218

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 214 GMSP-YPGID 222

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 33/199 (16%)
Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K +  A ++   AR+   RE +LL  ++H++++    +    +      + +V+E M
Sbjct: 45  VAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP-----LLMVFEYM 96
Query: 88  -DTDLHQIIRS---DQQLTDDH-----CQYFLYQLLR-------GLKYVHSASVLHRDLK 131
              DL++ +RS   D +L             L QLL        G+ Y+     +HRDL 
Sbjct: 97  RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 156
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDI 187
             N L+     +KIGDFG++R    TD+        +  RW   PE +L   ++T   D+
Sbjct: 157 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTESDV 214
Query: 188 WSVGCILGEIMT--REPLF 204
           WS G +L EI T  ++P +
Sbjct: 215 WSFGVVLWEIFTYGKQPWY 233

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 45  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 94
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 95  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 155 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 212
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 213 GMSP-YPGID 221

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 33/199 (16%)
Query: 29  VAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           VA+K +  A ++   AR+   RE +LL  ++H++++    +    +      + +V+E M
Sbjct: 51  VAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP-----LLMVFEYM 102
Query: 88  -DTDLHQIIRS---DQQLTDDH-----CQYFLYQLLR-------GLKYVHSASVLHRDLK 131
              DL++ +RS   D +L             L QLL        G+ Y+     +HRDL 
Sbjct: 103 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 162
Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDI 187
             N L+     +KIGDFG++R    TD+        +  RW   PE +L   ++T   D+
Sbjct: 163 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-PPESILY-RKFTTESDV 220
Query: 188 WSVGCILGEIMT--REPLF 204
           WS G +L EI T  ++P +
Sbjct: 221 WSFGVVLWEIFTYGKQPWY 239

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 95
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 213
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 214 GMSP-YPGID 222

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 156 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATY 213
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 214 GMSP-YPGID 222

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 48/206 (23%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-------ART 153
           LT+D   + L  + RGL+ +H+    HRDLKP+N+LL       + D G           
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 154 TSETDFMTEYVVTRW---YRAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 207
           + +   + ++   R    YRAPEL     +C       D+WS+GC+L  +M  E      
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGE------ 243
Query: 208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE 267
                          P D  + F + D+    V      + Q    + P  SS    LL 
Sbjct: 244 --------------GPYD--MVFQKGDSVALAV------QNQLSIPQSPRHSSALWQLLN 281
Query: 268 KMLVFDPNKR------ITVEEALRHP 287
            M+  DP++R      ++  EAL+ P
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEALQPP 307

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 54  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 103
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 104 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 163
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L EI T 
Sbjct: 164 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 221
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 222 GMSP-YPGID 230

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 252

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 209 GMSP-YPGID 217

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 148
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 149 GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 153 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 210
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 211 GMSP-YPGID 219

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L EI T 
Sbjct: 153 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 210
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 211 GMSP-YPGID 219

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI-IRPPKKDTFNDVYIVYEL 86
           +VA+K +        D    LRE   ++  +H +V  +  + +R   K       ++   
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 87  MD-TDLHQIIRSDQ------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           M   DLH  + + +       L       F+  +  G++Y+ S + +HRDL   N +L  
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172
Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCTEYTAAIDIWSVGCILG 195
              + + DFGL+R     D+  +   +    +W     L  N   YT   D+W+ G  + 
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL--YTVHSDVWAFGVTMW 230
Query: 196 EIMTR 200
           EIMTR
Sbjct: 231 EIMTR 235

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 151 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATY 208
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 209 GMSP-YPGID 217

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 195 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 224

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 248 VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 297
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HR+L   N L+  +  +
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 358 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATY 415
Query: 201 E-PLFPGKD 208
               +PG D
Sbjct: 416 GMSPYPGID 424

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 67/131 (51%), Gaps = 3/131 (2%)
Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++ V E ++  DL   I+  ++  +   +++  +++  L ++H   +++RDLK  N+LL+
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 139 ASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
                K+ DFG+ +        T  +  T  Y APE+L     Y  A+D W++G +L E+
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEM 217
Query: 198 MTREPLFPGKD 208
           +     F  ++
Sbjct: 218 LCGHAPFEAEN 228

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 61/114 (53%), Gaps = 9/114 (7%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 168
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +         TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 169 ---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG----KDYVHQLR 214
              + APE + +   Y+   D+WS G +L EI +     +PG    +D+  +LR
Sbjct: 264 PLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLR 316

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 151 ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 49/298 (16%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDV 80
           EVA+ K+ NA  + + A + L + ++L+  E       +D++              F D 
Sbjct: 89  EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146
Query: 81  YIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +Y +MD     DL  ++ + + +L ++  +++L +++  +  VH    +HRD+KP N+
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLL----NCTEYTAAIDIWS 189
           L++ +  +++ DFG      E   +   V   T  Y +PE+L         Y    D WS
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G  + E++  E  F  +  V                            Y + +    + 
Sbjct: 267 LGVCMYEMLYGETPFYAESLVET--------------------------YGKIMNHKERF 300
Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLHDLNDEPVCPRPF 305
           QF T+  + S  A DL+ +++    ++  +  +E+  +HP+   + D ++   C  P+
Sbjct: 301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI-DWDNIRNCEAPY 357

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 287 VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 336
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HR+L   N L+  +  +
Sbjct: 337 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 396
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           K+ DFGL+R  +  D  T +   ++   + APE L    +++   D+W+ G +L EI T 
Sbjct: 397 KVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATY 454
Query: 201 E-PLFPGKD 208
               +PG D
Sbjct: 455 GMSPYPGID 463

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 44  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 83  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 131
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET  +      RW  
Sbjct: 132 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW-S 188
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 189 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 216

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 199 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPS 133
           T  DV+I  ELM T   ++ +  Q  + +         +++ L Y+     V+HRD+KPS
Sbjct: 95  TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154
Query: 134 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWS 189
           N+LL+    +K+ DFG++    +            Y APE +        +Y    D+WS
Sbjct: 155 NILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELI 220
           +G  L E+ T +  FP K+      ++T+++
Sbjct: 215 LGISLVELATGQ--FPYKNCKTDFEVLTKVL 243

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 91
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 151
Query: 144 KIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +   +          +W  APE L    +++   D+W+ G +L EI T 
Sbjct: 152 KVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLAY-NKFSIKSDVWAFGVLLWEIATY 209
Query: 200 -REPLFPGKDYVHQLRLI 216
              P +PG D      L+
Sbjct: 210 GMSP-YPGIDLSQVYELL 226

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 90/190 (47%), Gaps = 23/190 (12%)
Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 87  MD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M   +L   +R  + Q++      Y   Q+   ++Y+   + +HRDL   N L+  +  +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 144 KIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           K+ DFGL+R  +   +          +W  APE  L   +++   D+W+ G +L EI T 
Sbjct: 153 KVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 210
Query: 200 -REPLFPGKD 208
              P +PG D
Sbjct: 211 GMSP-YPGID 219

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 151 ART--TSETDFMTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           ++     E  +  +       +WY APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 167
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ET +  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 28  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 66
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 67  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 115
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  
Sbjct: 116 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-S 172
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 173 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 24  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 63  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 111
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  
Sbjct: 112 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-S 168
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 169 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 196

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 44  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 83  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 131
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  
Sbjct: 132 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-S 188
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 189 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 29  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 68  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 116
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  
Sbjct: 117 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-S 173
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 174 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 140 SCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A   +  + +      V T  Y  PE + + +            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +  F  +  ++Q+  +  +I  P+                      
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---------------------- 284
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 285 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 35  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 73
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 74  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 122
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  
Sbjct: 123 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-S 179
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 180 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 207

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 167
           Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+      + +  R
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           W     +  N   YT   D+W+ G +L EI +
Sbjct: 242 WMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 140 SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 205
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 206 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 240
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 241 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 140 SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 237
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 238 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 4   KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI 63
           K RG+YD                  VAIK I    +  +     + E K++ ++ HE ++
Sbjct: 29  KWRGQYD------------------VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 64  AIKDIIRPPKKDTFNDVYIVYELMDT--------DLHQIIRSDQ--QLTDDHCQYFLYQL 113
            +  +    +      ++I+ E M          ++    ++ Q  ++  D C+      
Sbjct: 68  QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE------ 116
Query: 114 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---EYVVTRWYR 170
              ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  
Sbjct: 117 --AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW-S 173
Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT 199
            PE+L+  +++++  DIW+ G ++ EI +
Sbjct: 174 PPEVLMY-SKFSSKSDIWAFGVLMWEIYS 201

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 140 SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 201
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 202 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 236
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 237 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 140 SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +  F  +  ++Q+  +  +I  P+                      
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---------------------- 284
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 285 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 140 SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 256
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 257 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 7/202 (3%)
Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            +++ET  EVA  ++ +      + +R   E + L+ ++H N++   D      K     
Sbjct: 45  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCI 104
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLL 137
           V +        L   ++  +       + +  Q+L+GL+++H+ +  ++HRDLK  N+ +
Sbjct: 105 VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 138 NA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG-CILG 195
              +  +KIGD GLA T     F    + T  + APE      +Y  ++D+++ G C L 
Sbjct: 165 TGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEE--KYDESVDVYAFGXCXLE 221
Query: 196 EIMTREPLFPGKDYVHQLRLIT 217
              +  P    ++     R +T
Sbjct: 222 XATSEYPYSECQNAAQIYRRVT 243

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 9/164 (5%)
Query: 46  RTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDD 104
           R  RE +    ++  +V+ I D       +    +Y+   L++  DL   +R    L   
Sbjct: 80  RXQREARTAGRLQEPHVVPIHDF-----GEIDGQLYVDXRLINGVDLAAXLRRQGPLAPP 134
Query: 105 HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTE 162
                + Q+   L   H+A   HRD+KP N+L++A     + DFG+A  T++     +  
Sbjct: 135 RAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194
Query: 163 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 206
            V T +Y APE   + +  T   DI+++ C+L E +T  P + G
Sbjct: 195 TVGTLYYXAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 140 SCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCTE----------YTAAID 186
              LK+ DFG+A               V T  Y  PE + + +            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 256
Query: 247 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 257 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 15  FIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVI---AIKDIIR 70
           F++ A      RE    + + N  +     R  ++E+  ++ +  H N++   +   I +
Sbjct: 43  FVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99
Query: 71  PPKKDTFNDVYIVYELMDTDLHQIIR---SDQQLTDDHCQYFLYQLLRGLKYVHSAS--V 125
                   +  ++ EL    L + ++   S   L+ D      YQ  R ++++H     +
Sbjct: 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI 159
Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTS---------ETDFMTEYVVTR----WYRAP 172
           +HRDLK  NLLL+    +K+ DFG A T S         +   + E  +TR     YR P
Sbjct: 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 173 ELLLNCTEYTAA--IDIWSVGCIL 194
           E++   + +      DIW++GCIL
Sbjct: 220 EIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 140 SCDLKIGDFGLAR-----TTS--------ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 186
              LK+ DFG+A      TTS          ++M    +     + E   + ++ +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+GCIL  +   +  F  +  ++Q+  +  +I  P+                      
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---------------------- 284
Query: 247 RKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   FP+       D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 285 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 6/160 (3%)
Query: 50  EIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYF 109
           E++++    H N++ ++     P +      Y+    + + L +   S   L     Q  
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 110 LYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV- 165
                RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D      V 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 166 -TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 204
            T  + APE  L+  + +   D++  G +L E++T +  F
Sbjct: 205 GTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 26  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 85
           +++VAIK I    +  +     + E +++  + H  ++ +  +           + +V+E
Sbjct: 31  KDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-----ICLVFE 82
Query: 86  LMDTD-LHQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
            M+   L   +R+ + L   +        +  G+ Y+  ASV+HRDL   N L+  +  +
Sbjct: 83  FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVI 142
Query: 144 KIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           K+ DFG+ R   +  + T    T++   + +PE + + + Y++  D+WS G ++ E+ +
Sbjct: 143 KVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
           L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 161 T-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 199 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART----TSETDFMTEYVVTR 167
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR       E +     +  +
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 168 WYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 209
           W     + L C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 185 W-----MALECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDV 80
           EVA+ K+ N     I A + L + ++L+  E       +D++              F D 
Sbjct: 105 EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDE 162
Query: 81  YIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +Y +MD     DL  ++ + + +L +D  ++++ +++  +  +H    +HRD+KP N+
Sbjct: 163 NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 222
Query: 136 LLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWS 189
           LL+ +  +++ DFG  L      T   +  V T  Y +PE+L        +Y    D WS
Sbjct: 223 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 282
Query: 190 VGCILGEIMTREPLFPGKDYV 210
           +G  + E++  E  F  +  V
Sbjct: 283 LGVCMYEMLYGETPFYAESLV 303

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 101 LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 160
           L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 161 T-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 189 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------TFNDV 80
           EVA+ K+ N     I A + L + ++L+  E       +D++              F D 
Sbjct: 89  EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDE 146
Query: 81  YIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             +Y +MD     DL  ++ + + +L +D  ++++ +++  +  +H    +HRD+KP N+
Sbjct: 147 NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 206
Query: 136 LLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWS 189
           LL+ +  +++ DFG  L      T   +  V T  Y +PE+L        +Y    D WS
Sbjct: 207 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 266
Query: 190 VGCILGEIMTREPLFPGKDYV 210
           +G  + E++  E  F  +  V
Sbjct: 267 LGVCMYEMLYGETPFYAESLV 287

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 107 QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 161
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 162 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 211 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 248

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 107 QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 161
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 162 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 187 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 107 QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 161
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 162 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 178 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 109 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTE--YV 164
           +  Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     ET++  +   V
Sbjct: 124 WCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 209
             +W     +L     +T   D+WS G  + E+MT    F  K Y
Sbjct: 184 PIKWMALESILRR--RFTHQSDVWSYGVTVWELMT----FGAKPY 222

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 107 QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 161
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 162 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 107 QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 161
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 162 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	336
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	0.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	0.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	0.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	0.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	0.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	0.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	0.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	0.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-166
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-159
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-156
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-154
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-146
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-126
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-112
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-103
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-101
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-101
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-101
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-101
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-101
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-100
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-100
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-99
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-99
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-98
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-61
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-55
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-55
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-55
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-54
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-54
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-53
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-53
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-53
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-52
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-52
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-51
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-51
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-50
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-50
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-49
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-48
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-47
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-47
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-47
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-47
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-47
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-47
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-47
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-47
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-46
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-46
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-46
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-46
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-46
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-46
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-45
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-45
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-45
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-45
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-45
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-45
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-44
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-44
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-44
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-44
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-44
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-43
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-43
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-42
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-42
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-42
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-42
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-42
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-42
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-42
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-42
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-41
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-41
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-41
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-41
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-41
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-41
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-40
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-40
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-39
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-39
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-38
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-38
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-35
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-31
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-31
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-31
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-27
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-27
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-05

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  566 bits (1461), Expect = 0.0
 Identities = 166/322 (51%), Positives = 223/322 (69%), Gaps = 6/322 (1%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           +  +A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P  +
Sbjct: 42  MVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100

Query: 76  TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPSNL
Sbjct: 101 QMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159

Query: 136 LLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           LLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVG
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           CIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K  +
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH 311
              FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD E 
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMEL 339

Query: 312 SSCTEDHIRELIWRESVKFNPD 333
               ++ ++ELI+ E+ +F P 
Sbjct: 340 DDLPKEKLKELIFEETARFQPG 361

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  551 bits (1423), Expect = 0.0
 Identities = 139/320 (43%), Positives = 197/320 (61%), Gaps = 5/320 (1%)

Query: 14  FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           +    +A++  + E+VAIKK+   F + I A+R  RE+ LL+HM+HENVI + D+  P  
Sbjct: 37  YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96

Query: 74  K-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
               F D Y+V   M TDL +I+    + +++  QY +YQ+L+GLKY+HSA V+HRDLKP
Sbjct: 97  SLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP 154

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
            NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++L+   Y   +DIWSVGC
Sbjct: 155 GNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I+ E++T + LF GKDY+ QL  I ++ G P    +  L    A+ Y++ LP+  ++ F 
Sbjct: 213 IMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT 272

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS 312
             FP  S  A DLLEKML  D +KR+T  +AL HP+ +   D  +E    +PF    EH 
Sbjct: 273 QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHE 332

Query: 313 SCTEDHIRELIWRESVKFNP 332
             T D  ++ I++E V F+P
Sbjct: 333 KLTVDEWKQHIYKEIVNFSP 352

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  550 bits (1420), Expect = 0.0
 Identities = 162/324 (50%), Positives = 213/324 (65%), Gaps = 18/324 (5%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           +A +  T E VAIKKI   FD  + A RTLREIK+L+H +HEN+I I +I RP   + FN
Sbjct: 29  SATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +VYI+ ELM TDLH++I + Q L+DDH QYF+YQ LR +K +H ++V+HRDLKPSNLL+N
Sbjct: 88  EVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

Query: 139 ASCDLKIGDFGLART-----------TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           ++CDLK+ DFGLAR            T +   M E+V TRWYRAPE++L   +Y+ A+D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRSDNARRYVRQLPRC 246
           WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  D  L  + S  AR Y++ LP  
Sbjct: 207 WSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY 266

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC----P 302
                   FP  +   +DLL++MLVFDP KRIT +EAL HPYLQ+ HD NDEP      P
Sbjct: 267 PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPP 326

Query: 303 RPFHFDFEHSSCTEDHIRELIWRE 326
             F FD    + T   +++LIW E
Sbjct: 327 SFFEFDHYKEALTTKDLKKLIWNE 350

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  550 bits (1420), Expect = 0.0
 Identities = 142/318 (44%), Positives = 205/318 (64%), Gaps = 5/318 (1%)

Query: 18  SAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DT 76
            +AV+  T  +VAIKK+   F + + A+R  RE++LL+HM HENVI + D+  P +  D 
Sbjct: 42  CSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101

Query: 77  FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           F D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL 
Sbjct: 102 FTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +N  C+LKI DFGLAR       MT YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E
Sbjct: 161 VNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++T + LF G D++ QL+ I ++ G+P    +  L+SD A+ Y++ LP   K+ FA+   
Sbjct: 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE 316
           N S  AV+LLEKMLV D  +R+T  EAL HPY +SLHD  DEP     +   F+    T 
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTL 337

Query: 317 DHIRELIWRESVKFNPDP 334
           D  + + ++E + F P  
Sbjct: 338 DEWKRVTYKEVLSFKPPR 355

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  550 bits (1418), Expect = 0.0
 Identities = 157/320 (49%), Positives = 211/320 (65%), Gaps = 5/320 (1%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
              AA +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  
Sbjct: 44  SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSN
Sbjct: 104 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 162

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           L +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++LN   Y   +DIWSVGCI+
Sbjct: 163 LAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSC 314
           F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+    E    
Sbjct: 281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDL 339

Query: 315 TEDHIRELIWRESVKFNPDP 334
             D  + L + E + F P P
Sbjct: 340 LIDEWKSLTYDEVISFVPPP 359

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  544 bits (1403), Expect = 0.0
 Identities = 119/324 (36%), Positives = 177/324 (54%), Gaps = 13/324 (4%)

Query: 19  AAVNSETREEVAIKKIGNA---------FDNIIDARRTLREIKLLRHMEHENVIAIKDII 69
           A V+SE    VAIK++ N            +    +R LREI+LL H  H N++ ++DI 
Sbjct: 40  AGVDSEG-IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98

Query: 70  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHR 128
              ++   + +Y+V ELM TDL Q+I   +  ++  H QYF+Y +L GL  +H A V+HR
Sbjct: 99  VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHR 158

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           DL P N+LL  + D+ I DF LAR  +     T YV  RWYRAPEL++    +T  +D+W
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMW 218

Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ-LPRCR 247
           S GC++ E+  R+ LF G  + +QL  I E++G+P    +    S +AR Y+R  L    
Sbjct: 219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF 307
            + +    P     A+DL+ KML F+P +RI+ E+ALRHPY +SL D  D         F
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERF 337

Query: 308 DFEHSSCTEDHIRELIWRESVKFN 331
            F+ S      + ++   E  +FN
Sbjct: 338 HFDESVTDVYDMHKIFTAEVERFN 361

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  542 bits (1399), Expect = 0.0
 Identities = 123/367 (33%), Positives = 192/367 (52%), Gaps = 52/367 (14%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
            A +  T + VAIKK+   F+++ID +R LREI +L  ++ + +I + D+I P     F+
Sbjct: 44  LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++YIV E+ D+DL ++ ++   LT++H +  LY LL G  ++H + ++HRDLKP+N LLN
Sbjct: 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163

Query: 139 ASCDLKIGDFGLARTTS-----------------------ETDFMTEYVVTRWYRAPELL 175
             C +K+ DFGLART +                           +T +VVTRWYRAPEL+
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223

Query: 176 LNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPG-----------------K 207
           L    YT +IDIWS GCI  E++            R PLFPG                 K
Sbjct: 224 LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEK 283

Query: 208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE 267
               QL +I  +IG+P +  L  +      +Y++  P  +      ++P+ S   ++LLE
Sbjct: 284 SNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343

Query: 268 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS-SCTEDHIRELIWRE 326
            ML F+PNKRIT+++AL HPYL+ +     E    +     F+     +E  +R +  +E
Sbjct: 344 SMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKE 403

Query: 327 SVKFNPD 333
              F+P+
Sbjct: 404 VQSFHPE 410

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  535 bits (1380), Expect = 0.0
 Identities = 130/375 (34%), Positives = 196/375 (52%), Gaps = 60/375 (16%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
            A +   +  VAIKKI   F+++ID +R LREI +L  + H++V+ + DI+ P   + F+
Sbjct: 71  EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           ++Y+V E+ D+D  ++ R+   LT+ H +  LY LL G+KYVHSA +LHRDLKP+N L+N
Sbjct: 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190

Query: 139 ASCDLKIGDFGLARTTSETD----------------------------FMTEYVVTRWYR 170
             C +K+ DFGLART    +                             +T +VVTRWYR
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250

Query: 171 APELLLNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPGKDYV--------- 210
           APEL+L    YT AID+WS+GCI  E++            R PLFPG             
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAG 310

Query: 211 -----------HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
                       QL +I  ++G+P +  +  L  ++A+RY+R  P+      A RFP  S
Sbjct: 311 NDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370

Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE-HSSCTEDH 318
           + A+ LL++MLVF+PNKRIT+ E L HP+ + +     E          F    +  E  
Sbjct: 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQ 430

Query: 319 IRELIWRESVKFNPD 333
           +R    +E  +++P+
Sbjct: 431 LRYAFVKEIQRYHPE 445

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  527 bits (1359), Expect = 0.0
 Identities = 127/355 (35%), Positives = 202/355 (56%), Gaps = 44/355 (12%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF 77
            +++  T E VA+KKI +AF N  DA+RT REI +L  +  HEN++ + +++R       
Sbjct: 27  KSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND 83

Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            DVY+V++ M+TDLH +IR+   L   H QY +YQL++ +KY+HS  +LHRD+KPSN+LL
Sbjct: 84  RDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142

Query: 138 NASCDLKIGDFGLART----------------------TSETDFMTEYVVTRWYRAPELL 175
           NA C +K+ DFGL+R+                        +   +T+YV TRWYRAPE+L
Sbjct: 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202

Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 235
           L  T+YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I  +I  P +  +  ++S  
Sbjct: 203 LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPF 262

Query: 236 ARRYVRQLPRCRKQQFATRF----------------PNKSSGAVDLLEKMLVFDPNKRIT 279
           A+  +  L    + + + +                  + +  A+DLL+K+L F+PNKRI+
Sbjct: 263 AKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322

Query: 280 VEEALRHPYLQSLHDLNDEPVCPRPFHFDF-EHSSCTEDHIRELIWRESVKFNPD 333
             +AL+HP++   H+ N+EP C         ++   + D  R L++ E  +   +
Sbjct: 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRE 377

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  516 bits (1332), Expect = 0.0
 Identities = 132/333 (39%), Positives = 193/333 (57%), Gaps = 18/333 (5%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I + ++  P K  
Sbjct: 40  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 158 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIM 216

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++    LFPG D++ Q   + E +G+P    +  L     R YV   P+     F   
Sbjct: 217 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKL 275

Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC- 301
           FP+            K+S A DLL KMLV D +KRI+V+EAL+HPY+   +D ++     
Sbjct: 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 335

Query: 302 PRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 334
           P+      +    T +  +ELI++E +      
Sbjct: 336 PKIPDKQLDEREHTIEEWKELIYKEVMDLEHHH 368

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  515 bits (1329), Expect = 0.0
 Identities = 132/331 (39%), Positives = 196/331 (59%), Gaps = 18/331 (5%)

Query: 16  IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK- 74
           I  AA ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +++ + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+
Sbjct: 195 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIM 253

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           GE++  + LFPG+DY+ Q   + E +G+P    +  L     R YV   P+     F   
Sbjct: 254 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKL 312

Query: 255 FPN------------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE-PVC 301
           FP+            K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  +     
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 372

Query: 302 PRPFHFDFEHSSCTEDHIRELIWRESVKFNP 332
           P+ +    +    T +  +ELI++E +    
Sbjct: 373 PQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  505 bits (1302), Expect = 0.0
 Identities = 119/296 (40%), Positives = 169/296 (57%), Gaps = 18/296 (6%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK---- 74
           +AV+++  + VAIKKI     +    +  LREIK++R ++H+N++ + +I+ P       
Sbjct: 29  SAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86

Query: 75  -----DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
                   N VYIV E M+TDL  ++     L ++H + F+YQLLRGLKY+HSA+VLHRD
Sbjct: 87  DVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRD 145

Query: 130 LKPSNLLLNAS-CDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           LKP+NL +N     LKIGDFGLAR           ++E +VT+WYR+P LLL+   YT A
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA 205

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           ID+W+ GCI  E++T + LF G   + Q++LI E I    +     L S     Y+R   
Sbjct: 206 IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS-VIPVYIRNDM 264

Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
               +      P  S  AVD LE++L F P  R+T EEAL HPY+       DEP+
Sbjct: 265 TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  467 bits (1203), Expect = e-166
 Identities = 94/323 (29%), Positives = 147/323 (45%), Gaps = 18/323 (5%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
                 T   VAIKK+     +     R L+ ++ L  + H N++ ++       +    
Sbjct: 41  LGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97

Query: 79  DVY--IVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDL 130
           D+Y  +V E +   LH+  R+             + FL+QL+R +  +H  S +V HRD+
Sbjct: 98  DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDI 157

Query: 131 KPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           KP N+L+N A   LK+ DFG A+  S ++    Y+ +R+YRAPEL+     YT A+DIWS
Sbjct: 158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC-RK 248
           VGCI  E+M  EP+F G +   QL  I  ++G P    L  L   +    +         
Sbjct: 218 VGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWS 277

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE-----PVCPR 303
             F+      +  A DLL  +L + P +R+   EAL HPY   LHD   +      +   
Sbjct: 278 NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPED 337

Query: 304 PFHFDFEHSSCTEDHIRELIWRE 326
            F F         +  +  + R+
Sbjct: 338 LFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  449 bits (1157), Expect = e-159
 Identities = 91/366 (24%), Positives = 168/366 (45%), Gaps = 61/366 (16%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR-------- 70
              + E+ +  A+KK+      + D R   RE+ +++ ++H N+I + D           
Sbjct: 25  EVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78

Query: 71  -------------------------PPKKDTFNDVYIVYELMDTDLHQIIR----SDQQL 101
                                             + ++ E +   LH++++    S + +
Sbjct: 79  PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSI 138

Query: 102 TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFM 160
             +    ++YQL R + ++HS  + HRD+KP NLL+N+    LK+ DFG A+    ++  
Sbjct: 139 PMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS 198

Query: 161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 220
             Y+ +R+YRAPEL+L  TEYT +ID+WS+GC+ GE++  +PLF G+  + QL  I +++
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIM 258

Query: 221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNKRIT 279
           G+P    +  +            P  + + +    P  + S A+DLLE++L ++P+ RI 
Sbjct: 259 GTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315

Query: 280 VEEALRHPYLQSLHDLNDEPVC-------------PRPFHFDFEHSSCTEDHIRELIWRE 326
             EA+ HP+   L +  +  V              P+ F+F     S    ++   I  +
Sbjct: 316 PYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPK 375

Query: 327 SVKFNP 332
           +   N 
Sbjct: 376 NFSPNY 381

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  443 bits (1141), Expect = e-156
 Identities = 94/316 (29%), Positives = 160/316 (50%), Gaps = 20/316 (6%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTF 77
            A   ++ E VAIKK+      + D R   RE++++R ++H N++ ++       +K   
Sbjct: 72  QAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125

Query: 78  NDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
             + +V + +   ++++ R    + Q L   + + ++YQL R L Y+HS  + HRD+KP 
Sbjct: 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185

Query: 134 NLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           NLLL+     LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++ID+WS GC
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L E++  +P+FPG   V QL  I +++G+P       +R  N      + P+ +   + 
Sbjct: 246 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKAHPWT 302

Query: 253 TRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP----FHF 307
             F P     A+ L  ++L + P  R+T  EA  H +   L D N +    R     F+F
Sbjct: 303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 362

Query: 308 DFEHSSCTEDHIRELI 323
             +  S        LI
Sbjct: 363 TTQELSSNPPLATILI 378

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  436 bits (1123), Expect = e-154
 Identities = 102/315 (32%), Positives = 162/315 (51%), Gaps = 21/315 (6%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTFN 78
           A   E+ E VAIKK+      + D R   RE++++R ++H NV+ +K        K    
Sbjct: 59  AKLVESDE-VAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111

Query: 79  DVYIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            + +V E +   +++  R      Q +     + ++YQLLR L Y+HS  + HRD+KP N
Sbjct: 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171

Query: 135 LLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           LLL+     LK+ DFG A+     +    Y+ +R+YRAPEL+   T YT  IDIWS GC+
Sbjct: 172 LLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCV 231

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           + E+M  +PLFPG+  + QL  I +++G+P       +++ N      + P+ R   F+ 
Sbjct: 232 MAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE---QIKTMNPNYMEHKFPQIRPHPFSK 288

Query: 254 RF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN----DEPVCPRPFHFD 308
            F P     A+DL+ ++L + P+ R+T  EAL HP+   L        +    P  F++ 
Sbjct: 289 VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWT 348

Query: 309 FEHSSCTEDHIRELI 323
            E  S   D I  L+
Sbjct: 349 KEELSVRPDLISRLV 363

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  414 bits (1067), Expect = e-146
 Identities = 80/285 (28%), Positives = 149/285 (52%), Gaps = 19/285 (6%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF 77
            A+N    E+V +K +       +  ++  REIK+L ++    N+I + DI++ P     
Sbjct: 54  EAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVS--R 106

Query: 78  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
               +   + +TD  Q+    Q LTD   ++++Y++L+ L Y HS  ++HRD+KP N+++
Sbjct: 107 TPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163

Query: 138 NAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +     L++ D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+L  
Sbjct: 164 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223

Query: 197 IMTR-EPLFPGKDYVHQLRLITELIGSPD-DASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           ++ R EP F G D   QL  I +++G+ D    +     +   R+   L R  ++++   
Sbjct: 224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 283

Query: 255 FPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
             ++     S  A+D L+K+L +D   R+T  EA+ HPY  ++  
Sbjct: 284 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  362 bits (931), Expect = e-126
 Identities = 86/287 (29%), Positives = 158/287 (55%), Gaps = 7/287 (2%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             N +T + VAIKK   + D+ +  +  LREI++L+ ++H N++ + ++ R  ++     
Sbjct: 22  CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR----- 76

Query: 80  VYIVYELMDTDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +++V+E  D  + H++ R  + + +   +   +Q L+ + + H  + +HRD+KP N+L+ 
Sbjct: 77  LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136

Query: 139 ASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
               +K+ DFG AR  T  +D+  + V TRWYR+PELL+  T+Y   +D+W++GC+  E+
Sbjct: 137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++  PL+PGK  V QL LI + +G           ++     V+       +    +FPN
Sbjct: 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPN 256

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 304
            S  A+ LL+  L  DP +R+T E+ L HPY +++ ++ D       
Sbjct: 257 ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDK 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  328 bits (842), Expect = e-112
 Identities = 91/277 (32%), Positives = 152/277 (54%), Gaps = 11/277 (3%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             N +T   VAIKK   + D+ +  +  +REIKLL+ + HEN++ + ++ +  K+     
Sbjct: 44  CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR----- 98

Query: 80  VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            Y+V+E +D  +   +      L     Q +L+Q++ G+ + HS +++HRD+KP N+L++
Sbjct: 99  WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158

Query: 139 ASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            S  +K+ DFG ART  +  +   + V TRWYRAPELL+   +Y  A+D+W++GC++ E+
Sbjct: 159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQ-FATRF 255
              EPLFPG   + QL  I   +G+        F  + N      +LP  ++++    R+
Sbjct: 219 FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF--NKNPVFAGVRLPEIKEREPLERRY 276

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           P  S   +DL +K L  DP+KR    E L H + Q  
Sbjct: 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  300 bits (771), Expect = e-101
 Identities = 96/284 (33%), Positives = 140/284 (49%), Gaps = 19/284 (6%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHM---EHENVIAIKDIIRP 71
           A +  +   VA+K +     N           T+RE+ LLR +   EH NV+ + D+   
Sbjct: 28  ARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85

Query: 72  PKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
            + D    V +V+E +D DL   +       L  +  +  + Q LRGL ++H+  ++HRD
Sbjct: 86  SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRD 145

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           LKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+LL  T Y   +D+WS
Sbjct: 146 LKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWS 204

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRK 248
           VGCI  E+  R+PLF G     QL  I +LIG P +      +            P    
Sbjct: 205 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-----AFPPRGP 259

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           +   +  P        LL +ML F+P+KRI+   AL+H YL   
Sbjct: 260 RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  301 bits (774), Expect = e-101
 Identities = 97/281 (34%), Positives = 146/281 (51%), Gaps = 19/281 (6%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVIAIKDIIRPPKK 74
           A +  T + VAIKKI     +  +A+       LREIKLL+ + H N+I + D       
Sbjct: 29  ARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG---- 82

Query: 75  DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
              +++ +V++ M+TDL  II+     LT  H + ++   L+GL+Y+H   +LHRDLKP+
Sbjct: 83  -HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 141

Query: 134 NLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPELL     Y   +D+W+VGC
Sbjct: 142 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQF 251
           IL E++ R P  PG   + QL  I E +G+P +          +                
Sbjct: 202 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY----VTFKSFPGIPL 257

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
              F       +DL++ + +F+P  RIT  +AL+  Y  + 
Sbjct: 258 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  299 bits (769), Expect = e-101
 Identities = 98/277 (35%), Positives = 151/277 (54%), Gaps = 22/277 (7%)

Query: 25  TREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
               VA+K+I       +DA         +REI LL+ + H N++++ D+I   +     
Sbjct: 44  QGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC---- 93

Query: 79  DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            + +V+E M+ DL +++      L D   + +LYQLLRG+ + H   +LHRDLKP NLL+
Sbjct: 94  -LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152

Query: 138 NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N+   LK+ DFGLAR         T  VVT WYRAP++L+   +Y+ ++DIWS+GCI  E
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQFATRF 255
           ++T +PLFPG     QL  I  ++G+P+             ++         K+ +++  
Sbjct: 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR--TFQVFEKKPWSSII 270

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  299 bits (769), Expect = e-101
 Identities = 105/293 (35%), Positives = 156/293 (53%), Gaps = 25/293 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDA-----RRTLREIKLLRHMEHENVIAIKDIIRPPKK 74
             +  T   VA+K+I       ++         +RE+ LL+ ++H N++ + DII   K 
Sbjct: 21  GKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74

Query: 75  DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
                + +V+E +D DL Q +      +   + + FL+QLLRGL Y H   VLHRDLKP 
Sbjct: 75  -----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQ 129

Query: 134 NLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++LL  T+Y+  ID+W VGC
Sbjct: 130 NLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC 189

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQF 251
           I  E+ T  PLFPG     QL  I  ++G+P + +  G L ++  + Y    P+ R +  
Sbjct: 190 IFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPKYRAEAL 247

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 304
            +  P   S   DLL K+L F+   RI+ E+A++HP+  SL     E +   P
Sbjct: 248 LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL----GERIHKLP 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  297 bits (764), Expect = e-101
 Identities = 97/279 (34%), Positives = 144/279 (51%), Gaps = 23/279 (8%)

Query: 23  SETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           +   E  A+KKI       ++         T+REI +L+ ++H N++ + D+I   K+  
Sbjct: 23  NNYGETFALKKI------RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-- 74

Query: 77  FNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              + +V+E +D DL +++   +  L     + FL QLL G+ Y H   VLHRDLKP NL
Sbjct: 75  ---LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131

Query: 136 LLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           L+N   +LKI DFGLAR         T  +VT WYRAP++L+   +Y+  IDIWSVGCI 
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQFAT 253
            E++   PLFPG     QL  I  ++G+P+  +           +Y           + +
Sbjct: 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV---TELPKYDPNFTVYEPLPWES 248

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
                    +DLL KML  DPN+RIT ++AL H Y +  
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  298 bits (765), Expect = e-100
 Identities = 99/305 (32%), Positives = 147/305 (48%), Gaps = 29/305 (9%)

Query: 24  ETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHM---EHENVIAIKDIIRPPKK 74
                VA+K++       +          T+RE+ +LRH+   EH NV+ + D+    + 
Sbjct: 35  NGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88

Query: 75  DTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           D    + +V+E +D DL   +    +  +  +  +  ++QLLRGL ++HS  V+HRDLKP
Sbjct: 89  DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
            N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  + Y   +D+WSVGC
Sbjct: 149 QNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGC 207

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQF 251
           I  E+  R+PLF G   V QL  I ++IG P +      +                 Q  
Sbjct: 208 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ-----AFHSKSAQPI 262

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH 311
                +      DLL K L F+P KRI+   AL HPY Q L    +        H     
Sbjct: 263 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL----ERCKENLDSHL-PPS 317

Query: 312 SSCTE 316
            + +E
Sbjct: 318 QNTSE 322

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  298 bits (764), Expect = e-100
 Identities = 98/287 (34%), Positives = 151/287 (52%), Gaps = 28/287 (9%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEHENVIAIKDIIRPPK 73
           A+++ T E VAIK+I       ++          +RE+ LL+ ++H N+I +K +I    
Sbjct: 53  AIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106

Query: 74  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           +     +++++E  + DL + +  +  ++    + FLYQL+ G+ + HS   LHRDLKP 
Sbjct: 107 R-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ 161

Query: 134 NLLLNASCD-----LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           NLLL+ S       LKIGDFGLAR         T  ++T WYR PE+LL    Y+ ++DI
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDI 221

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRC 246
           WS+ CI  E++ + PLFPG   + QL  I E++G PDD +  G     +   + +  P+ 
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD---WKQSFPKF 278

Query: 247 RKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           R +              +DLL  ML  DP KRI+ + AL HPY    
Sbjct: 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  294 bits (756), Expect = 7e-99
 Identities = 100/312 (32%), Positives = 158/312 (50%), Gaps = 25/312 (8%)

Query: 20  AVNSETREEVAIKKI--GNAFDNI-IDARRTLREIKLLRHMEHENVIAIKDII---RPPK 73
           A + +T ++VA+KK+   N  +   I A   LREIK+L+ ++HENV+ + +I      P 
Sbjct: 36  ARHRKTGQKVALKKVLMENEKEGFPITA---LREIKILQLLKHENVVNLIEICRTKASPY 92

Query: 74  KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
                 +Y+V++  + DL  ++ +   + T    +  +  LL GL Y+H   +LHRD+K 
Sbjct: 93  NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 152

Query: 133 SNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           +N+L+     LK+ DFGLAR       S+ +  T  VVT WYR PELLL   +Y   ID+
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 212

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRC 246
           W  GCI+ E+ TR P+  G    HQL LI++L GS            +   +   +L + 
Sbjct: 213 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL--ELVKG 270

Query: 247 RKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 304
           +K++   R     +   A+DL++K+LV DP +RI  ++AL H +  S     D       
Sbjct: 271 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS-----DPMPSDLK 325

Query: 305 FHFDFEHSSCTE 316
                  +S  E
Sbjct: 326 GMLSTHLTSMFE 337

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  292 bits (750), Expect = 8e-99
 Identities = 100/283 (35%), Positives = 151/283 (53%), Gaps = 24/283 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR------TLREIKLLRHMEHENVIAIKDIIRPPK 73
           A N ET E VA+K++       +D          LREI LL+ ++H+N++ + D++   K
Sbjct: 21  AKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74

Query: 74  KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           K     + +V+E  D DL +   S +  L  +  + FL+QLL+GL + HS +VLHRDLKP
Sbjct: 75  K-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129

Query: 133 SNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
            NLL+N + +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID+WS G
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189

Query: 192 CILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQ 249
           CI  E+     PLFPG D   QL+ I  L+G+P +       +  + + Y          
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM---YPATT 246

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
                 P  ++   DLL+ +L  +P +RI+ EEAL+HPY    
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  291 bits (748), Expect = 4e-98
 Identities = 95/305 (31%), Positives = 157/305 (51%), Gaps = 32/305 (10%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR-----TLREIKLLRHMEHENVIAIKDIIRPPKK 74
            +N  T   VA+K++       +D+        +REI L++ ++HEN++ + D+I    K
Sbjct: 24  GLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK 77

Query: 75  DTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
                + +V+E MD DL + + S       + L  +  +YF +QLL+GL + H   +LHR
Sbjct: 78  -----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHR 132

Query: 129 DLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           DLKP NLL+N    LK+GDFGLAR      +  +  VVT WYRAP++L+    Y+ +IDI
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDI 192

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRC 246
           WS GCIL E++T +PLFPG +   QL+LI +++G+P+++      +      Y   + + 
Sbjct: 193 WSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK---YNPNIQQR 249

Query: 247 RKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 301
             +                  +D L  +L  +P+ R++ ++AL HP+    +        
Sbjct: 250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGS 309

Query: 302 PRPFH 306
               H
Sbjct: 310 RSHHH 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  271 bits (694), Expect = 6e-89
 Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 42/305 (13%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + +  ++ A+K+I      I  +    REI LLR ++H NVI+++ +           V+
Sbjct: 44  DGKDDKDYALKQIE--GTGISMS--ACREIALLRELKHPNVISLQKVFLSHAD---RKVW 96

Query: 82  IVYELMDTDLHQIIRS---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           ++++  + DL  II+            QL     +  LYQ+L G+ Y+H+  VLHRDLKP
Sbjct: 97  LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156

Query: 133 SNLLLNASCD----LKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELLLNCTEYTA 183
           +N+L+         +KI D G AR  +       D     VVT WYRAPELLL    YT 
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VVTFWYRAPELLLGARHYTK 215

Query: 184 AIDIWSVGCILGEIMTREPLFPGKD---------YVHQLRLITELIGSPDDA------SL 228
           AIDIW++GCI  E++T EP+F  +          +  QL  I  ++G P D        +
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM 275

Query: 229 GFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
               +            C   ++         S A  LL+K+L  DP KRIT E+A++ P
Sbjct: 276 PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335

Query: 288 YLQSL 292
           Y    
Sbjct: 336 YFLED 340

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  199 bits (509), Expect = 6e-61
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 43/306 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-- 77
           A + +  + VA+K + N        R+   EI++L H+  ++     ++I     + F  
Sbjct: 116 AYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIH--MLENFTF 170

Query: 78  -NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +H   ++H DLKP N
Sbjct: 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPEN 230

Query: 135 LLLN--ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           +LL       +K+ DFG +    E   +  Y+ +R+YRAPE++L    Y   ID+WS+GC
Sbjct: 231 ILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGC 287

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDD--------ASLGFLRSDNAR------- 237
           IL E++T  PL PG+D   QL  + EL+G P          A          R       
Sbjct: 288 ILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTL 347

Query: 238 ---RYVRQLPRCRKQQFATRFPNKSSGA----------VDLLEKMLVFDPNKRITVEEAL 284
                V    R R+ +      ++  G           +D L++ L +DP  R+T  +AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407

Query: 285 RHPYLQ 290
           RHP+L+
Sbjct: 408 RHPWLR 413

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  187 bits (476), Expect = 2e-56
 Identities = 82/313 (26%), Positives = 139/313 (44%), Gaps = 50/313 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-- 77
           A +   +E VAIK I N         +   E++LL  M   +      I+    K  F  
Sbjct: 73  AYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL--KRHFMF 127

Query: 78  -NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS--ASVLHRDLKP 132
            N + +V+E++  +L+ ++R+     ++ +  + F  Q+   L ++ +   S++H DLKP
Sbjct: 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187

Query: 133 SNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
            N+LL       +KI DFG +        + +Y+ +R+YR+PE+LL    Y  AID+WS+
Sbjct: 188 ENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSL 244

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPD------------------DASLGFLR 232
           GCIL E+ T EPLF G + V Q+  I E++G P                   D +    +
Sbjct: 245 GCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKK 304

Query: 233 SDNARRYVRQLPRCRKQQFATRFPNKSSGA---------------VDLLEKMLVFDPNKR 277
           + + +R  +     +             G                 DL+ +ML +DP  R
Sbjct: 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364

Query: 278 ITVEEALRHPYLQ 290
           I    AL+H + +
Sbjct: 365 IQPYYALQHSFFK 377

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  184 bits (467), Expect = 2e-55
 Identities = 45/305 (14%), Positives = 80/305 (26%), Gaps = 54/305 (17%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIK---------DII 69
             + E  E+ A+K     A ++  +  R          +  E+    +         D +
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 70  RPPKKDTFND------------VYIVYELMDTDLHQIIR-------SDQQLTDDHCQYFL 110
               +  F                ++      DL  +                       
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 111 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 170
            QL+R    + S  ++H    P NL +     L +GD                 V   Y 
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYA 258

Query: 171 APELL-LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 229
             E L  +   +T A++ W +G  +  +      F       +       +  P   SL 
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318

Query: 230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
           F               C                  L+ + L FD  +R+   EA+  P  
Sbjct: 319 F-------------GSC---------TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

Query: 290 QSLHD 294
             L +
Sbjct: 357 LQLQN 361

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  182 bits (463), Expect = 2e-55
 Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 51/284 (17%)

Query: 23  SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDV 80
           +E ++  AIK +     +         EI  L  ++   + +I + D        T   +
Sbjct: 49  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQYI 103

Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+   
Sbjct: 104 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG 163

Query: 141 CDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNC----------TEYTAAIDI 187
             LK+ DFG+A        +      V T  Y  PE + +           ++ +   D+
Sbjct: 164 M-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222

Query: 188 WSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           WS+GCIL  +   +  F    + + +L  I +                    +  + P  
Sbjct: 223 WSLGCILYYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP-- 262

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                            D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 263 ---------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  183 bits (467), Expect = 3e-55
 Identities = 79/324 (24%), Positives = 127/324 (39%), Gaps = 46/324 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHENVIAIKDIIRPPKK 74
           A +      VA+K +               EIKLL+ +       E+ +    I++    
Sbjct: 38  AKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILK--LL 92

Query: 75  DTFND-------VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS-AS 124
           D FN        V +V+E++  +L  +I+    + +   + +    QLL GL Y+H    
Sbjct: 93  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 152

Query: 125 VLHRDLKPSNLLLNASCD------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
           ++H D+KP N+L+           +KI D G A    E    T  + TR YR+PE+LL  
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA 210

Query: 179 TEYTAAIDIWSVGCILGEIMTREPLFPGKDY------VHQLRLITELIGSPDDA------ 226
             +    DIWS  C++ E++T + LF   +          +  I EL+G           
Sbjct: 211 -PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269

Query: 227 -SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA----VDLLEKMLVFDPNKRITVE 281
            +  F  S    R + +L     +   T     S        D L  ML  DP KR    
Sbjct: 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329

Query: 282 EALRHPYLQSLHDLNDEPVCPRPF 305
             + HP+L+    + +  V  R  
Sbjct: 330 GLVNHPWLKDTLGMEEIRVPDREL 353

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  181 bits (461), Expect = 8e-55
 Identities = 80/308 (25%), Positives = 135/308 (43%), Gaps = 51/308 (16%)

Query: 25  TREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIKDIIRPPKKDTF---ND 79
               VA+K + N     +D        EI++L H+   +  +    ++    + F     
Sbjct: 39  GGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ--MLEWFEHHGH 91

Query: 80  VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + IV+EL+    +  I+ +       DH +   YQ+ + + ++HS  + H DLKP N+L 
Sbjct: 92  ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151

Query: 138 N-------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 178
                                + D+K+ DFG A  T + +  +  V TR YRAPE++L  
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILAL 209

Query: 179 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP--------------D 224
             ++   D+WS+GCIL E      +FP  D    L ++  ++G                 
Sbjct: 210 -GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268

Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 284
              L +    +A RYV +  +  K+   ++         DL++KML +DP KRIT+ EAL
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER-LFDLIQKMLEYDPAKRITLREAL 327

Query: 285 RHPYLQSL 292
           +HP+   L
Sbjct: 328 KHPFFDLL 335

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  179 bits (455), Expect = 3e-54
 Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 59/300 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD--------IIRP 71
           A N+      AIKKI +  +        L E+ LL  + H+ V+            +   
Sbjct: 25  ARNALDSRYYAIKKIRHTEE---KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81

Query: 72  PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD-DHCQYFLYQLLRGLKYVHSASVLHRD 129
                 + ++I  E  +   L+ +I S+      D       Q+L  L Y+HS  ++HRD
Sbjct: 82  TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRD 141

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSET---------------DFMTEYVVTRWYRAPEL 174
           LKP N+ ++ S ++KIGDFGLA+    +               D +T  + T  Y A E+
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201

Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 234
           L     Y   ID++S+G I  E++   P   G + V+ L+ +                  
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL------------------ 241

Query: 235 NARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 293
                     R    +F   F  NK      ++  ++  DPNKR      L   +L   H
Sbjct: 242 ----------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  180 bits (458), Expect = 4e-54
 Identities = 75/313 (23%), Positives = 131/313 (41%), Gaps = 51/313 (16%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIKDIIRPPKKDTF-- 77
           ++  + +VA+K I N     +   R     EI +L+ ++ ++       +     D F  
Sbjct: 41  HARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVL--MSDWFNF 93

Query: 78  -NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              + I +EL+  +  + ++  + Q     H ++  YQL   L+++H   + H DLKP N
Sbjct: 94  HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPEN 153

Query: 135 LLLN-------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 175
           +L                      +  +++ DFG A  T + +  T  V TR YR PE++
Sbjct: 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVI 211

Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD----------- 224
           L    +    D+WS+GCIL E      LF   +    L ++ +++G              
Sbjct: 212 LEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQK 270

Query: 225 ---DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 281
                 L +  + +  RYV++  +  K               DL+ +ML FDP +RIT+ 
Sbjct: 271 YFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ-LFDLMRRMLEFDPAQRITLA 329

Query: 282 EALRHPYLQSLHD 294
           EAL HP+   L  
Sbjct: 330 EALLHPFFAGLTP 342

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  177 bits (451), Expect = 3e-53
 Identities = 60/294 (20%), Positives = 111/294 (37%), Gaps = 53/294 (18%)

Query: 23  SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDV 80
           +E ++  AIK +     +         EI  L  ++   + +I + D        T   +
Sbjct: 30  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQYI 84

Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+   
Sbjct: 85  YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG 144

Query: 141 CDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN----------CTEYTAAIDI 187
             LK+ DFG+A        +      V T  Y  PE + +           ++ +   D+
Sbjct: 145 M-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203

Query: 188 WSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           WS+GCIL  +   +  F    + + +L  I                              
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQISKLHAII----------------------------- 234

Query: 247 RKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
                   FP+       D+L+  L  DP +RI++ E L HPY+Q      ++ 
Sbjct: 235 -DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  179 bits (455), Expect = 5e-53
 Identities = 71/283 (25%), Positives = 111/283 (39%), Gaps = 50/283 (17%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIV 83
              +VA+K+I     +  D     RE++LLR   EH NVI      +          YI 
Sbjct: 47  DNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTEK-----DRQFQYIA 96

Query: 84  YELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----- 137
            EL    L + + + D           L Q   GL ++HS +++HRDLKP N+L+     
Sbjct: 97  IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA 156

Query: 138 NASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVG 191
           +      I DFGL +            +    T  + APE+L    +   T  +DI+S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           C+   +++      GK    Q      L+G+     L                       
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQAN---ILLGACSLDCL----------------------- 250

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
                ++   A +L+EKM+  DP KR + +  L+HP+  SL  
Sbjct: 251 -HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  175 bits (447), Expect = 5e-53
 Identities = 64/274 (23%), Positives = 95/274 (34%), Gaps = 43/274 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
             + E     A+K+  + F    D  R L E+     + +H   + ++            
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG 130

Query: 79  DVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            +Y+  EL    L Q        L +     +L   L  L ++HS  ++H D+KP+N+ L
Sbjct: 131 ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
                 K+GDFGL                  Y APELL     Y  A D++S+G  + E+
Sbjct: 191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEV 248

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
                L  G +   QLR   +    P                               F  
Sbjct: 249 ACNMELPHGGEGWQQLR---QGYLPP------------------------------EFTA 275

Query: 258 K-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             SS    +L  ML  DP  R T E  L  P L+
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  173 bits (441), Expect = 2e-52
 Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 56/285 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD-----------I 68
           A +    +   IK++        +  +  RE+K L  ++H N++                
Sbjct: 30  AKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83

Query: 69  IRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASV 125
            +   +     ++I  E  D   L Q I  R  ++L          Q+ +G+ Y+HS  +
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL 143

Query: 126 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
           ++RDLKPSN+ L  +  +KIGDFGL  +       T    T  Y +PE + +  +Y   +
Sbjct: 144 INRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEV 202

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D++++G IL E++         +       +                             
Sbjct: 203 DLYALGLILAELLH--VCDTAFETSKFFTDL----------------------------- 231

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            R    +  F         LL+K+L   P  R    E LR   + 
Sbjct: 232 -RDGIISDIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  176 bits (447), Expect = 4e-52
 Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 53/294 (18%)

Query: 23  SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFNDV 80
           +E ++  AIK +     +         EI  L  ++   + +I + D        T   +
Sbjct: 77  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQYI 131

Query: 81  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+   
Sbjct: 132 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG 191

Query: 141 CDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN----------CTEYTAAIDI 187
             LK+ DFG+A        +      V    Y  PE + +           ++ +   D+
Sbjct: 192 M-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 188 WSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           WS+GCIL  +   +  F    + + +L  I                              
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAII----------------------------- 281

Query: 247 RKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
                   FP+       D+L+  L  DP +RI++ E L HPY+Q      ++ 
Sbjct: 282 -DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  173 bits (441), Expect = 1e-51
 Identities = 66/325 (20%), Positives = 133/325 (40%), Gaps = 72/325 (22%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIKD---IIRPPKK 74
             + + ++  A+K + N     I         E  +L+ +++++     +   I++    
Sbjct: 54  CQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDD----INNNNIVK--YH 102

Query: 75  DTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
             F   + + +++E +   L++II  +       +  + +  ++L+ L Y+   S+ H D
Sbjct: 103 GKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTD 162

Query: 130 LKPSNLLLN-------------------------ASCDLKIGDFGLARTTSETDFMTEYV 164
           LKP N+LL+                          S  +K+ DFG A  T ++D+    +
Sbjct: 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSII 220

Query: 165 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 224
            TR YRAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++  +I    
Sbjct: 221 NTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIP 279

Query: 225 D-------------------ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 265
                                 L +  + ++   ++ + +C           K     D 
Sbjct: 280 KNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL----YKIIKHELFCDF 335

Query: 266 LEKMLVFDPNKRITVEEALRHPYLQ 290
           L  +L  DP  R +  E L+H +L+
Sbjct: 336 LYSILQIDPTLRPSPAELLKHKFLE 360

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  170 bits (434), Expect = 3e-51
 Identities = 61/308 (19%), Positives = 110/308 (35%), Gaps = 58/308 (18%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD-------IIRPP 72
           A N       AIK+I    +  +   + +RE+K L  +EH  ++   +         +  
Sbjct: 24  AKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82

Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHR 128
                  +YI  +L    +L   +     +       C +   Q+   ++++HS  ++HR
Sbjct: 83  PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTTSETDFM-------------TEYVVTRWYRAPELL 175
           DLKPSN+       +K+GDFGL     + +               T  V T+ Y +PE +
Sbjct: 143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202

Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 235
                Y+  +DI+S+G IL E++   P     + V  L  +                   
Sbjct: 203 HG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV------------------- 240

Query: 236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 295
                      R  +F   F  K      +++ ML   P +R      + +   + L   
Sbjct: 241 -----------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289

Query: 296 NDEPVCPR 303
               +  R
Sbjct: 290 GKTVLRQR 297

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  172 bits (439), Expect = 1e-50
 Identities = 87/284 (30%), Positives = 134/284 (47%), Gaps = 44/284 (15%)

Query: 20  AVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAI+ I        +      A     EI++L+ + H  +I IK+      
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 209

Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
            D   D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 210 -DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 267

Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 327

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G IL              ++        L G P      F           Q+   +
Sbjct: 328 WSLGVIL--------------FI--C-----LSGYPP-----FSEHRTQVSLKDQITSGK 361

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ 
Sbjct: 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  168 bits (428), Expect = 3e-50
 Identities = 52/299 (17%), Positives = 111/299 (37%), Gaps = 31/299 (10%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             + +T +  AIK   N    +      +RE ++L+ + H+N++ +  I    ++ T   
Sbjct: 28  GRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE---EETTTRH 83

Query: 80  VYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             ++ E      L+ ++        L +      L  ++ G+ ++    ++HR++KP N+
Sbjct: 84  KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143

Query: 136 LLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL-------LNCTEYTAA 184
           +     D     K+ DFG AR   + +       T  Y  P++         +  +Y A 
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI--GSPDDASLGFLRSDNAR-RYVR 241
           +D+WS+G       T    F   +   + + +   I  G P  A  G  +++N    +  
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263

Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP----YLQSLHDLN 296
            +P        +           +L  +L  D  K    ++         +  + H  +
Sbjct: 264 DMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHHH 317

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  169 bits (429), Expect = 6e-50
 Identities = 58/276 (21%), Positives = 113/276 (40%), Gaps = 40/276 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             ++E   +  IK+I  +  +  +   + RE+ +L +M+H N++  ++            
Sbjct: 43  VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS 97

Query: 80  VYIVYELMDT-DLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +YIV +  +  DL + I + +     +D    +  Q+   LK+VH   +LHRD+K  N+ 
Sbjct: 98  LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L     +++GDFG+AR  + T  +    + T +Y +PE+  N   Y    DIW++GC+L 
Sbjct: 158 LTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLY 216

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E+ T +  F      + +  I                          +            
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKII-------------------SGSFPPVS----------- 246

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            + S     L+ ++   +P  R +V   L   ++  
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  166 bits (422), Expect = 1e-49
 Identities = 73/279 (26%), Positives = 114/279 (40%), Gaps = 47/279 (16%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
              + +  K++        + +  + E+ LLR ++H N++   D I      T    YIV
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL---YIV 85

Query: 84  YELMDT-DLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHS-----ASVLHRDLKPS 133
            E  +  DL  +I    +    L ++     + QL   LK  H       +VLHRDLKP+
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145

Query: 134 NLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE +     Y    DIWS+GC
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGC 204

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L E+    P F           I E  G                               
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIRE--GKFR---------------------------- 234

Query: 253 TRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            R P + S    +++ +ML      R +VEE L +P + 
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  163 bits (416), Expect = 1e-48
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 42/289 (14%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
                T +E A K I     ++    +      RE+ +LR + H N+I + DI      +
Sbjct: 24  CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----E 78

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              DV ++ EL+   +L   +   + LT+D    FL Q+L G+ Y+HS  + H DLKP N
Sbjct: 79  NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138

Query: 135 LLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           ++L      +  +K+ DFG+A      +       T  + APE ++N        D+WS+
Sbjct: 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSI 197

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G I   +++    F G+     L  I+         +  F                    
Sbjct: 198 GVITYILLSGASPFLGETKQETLTNISA-------VNYDFDEEY---------------- 234

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
               F N S  A D + ++LV DP +R+T+ ++L H +++++   N   
Sbjct: 235 ----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  172 bits (436), Expect = 1e-48
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 17/289 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            ++ +T E+VAIK+      +  +  R   EI++++ + H NV++ +++    +K   ND
Sbjct: 33  WIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91

Query: 80  -VYIVYELMDT-DLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              +  E  +  DL + +        L +   +  L  +   L+Y+H   ++HRDLKP N
Sbjct: 92  LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151

Query: 135 LLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           ++L         KI D G A+   + +  TE+V T  Y APELL    +YT  +D WS G
Sbjct: 152 IVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFG 210

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
            +  E +T    F       Q           ++  + +     A ++   LP       
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVR--EKSNEHIVVYDDLTGAVKFSSVLPTPNH--- 265

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
                  +      L+ ML++   +R T  +       Q+L  +    +
Sbjct: 266 --LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  162 bits (413), Expect = 5e-48
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 54/298 (18%)

Query: 20  AVNSETREEVAIKKI-------GNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRP 71
            ++  T +E A+K I        +A +       TL+E+ +LR +  H N+I +KD    
Sbjct: 36  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 93

Query: 72  PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
              +T    ++V++LM   +L   +     L++   +  +  LL  +  +H  +++HRDL
Sbjct: 94  ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDL 150

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL-----LNCTEYTAAI 185
           KP N+LL+   ++K+ DFG +      + + E   T  Y APE++      N   Y   +
Sbjct: 151 KPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 210

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP---DDASLGFLRSDNARRYVRQ 242
           D+WS G I+              Y   L     L GSP       +  LR   +  Y   
Sbjct: 211 DMWSTGVIM--------------YT--L-----LAGSPPFWHRKQMLMLRMIMSGNY--- 246

Query: 243 LPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
                  QF +    + S    DL+ + LV  P KR T EEAL HP+ Q         
Sbjct: 247 -------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  162 bits (411), Expect = 1e-47
 Identities = 88/284 (30%), Positives = 134/284 (47%), Gaps = 44/284 (15%)

Query: 20  AVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           A   +T ++VAIK I        +      A     EI++L+ + H  +I IK+      
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 84

Query: 74  KDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
            D   D YIV ELM+  +L   +  +++L +  C+ + YQ+L  ++Y+H   ++HRDLKP
Sbjct: 85  -DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142

Query: 133 SNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDI 187
            N+LL++    C +KI DFG ++   ET  M     T  Y APE+L++     Y  A+D 
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS    LG I+          ++        L G P      F           Q+   +
Sbjct: 203 WS----LGVIL----------FI----C---LSGYPP-----FSEHRTQVSLKDQITSGK 236

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
                  +   S  A+DL++K+LV DP  R T EEALRHP+LQ 
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  166 bits (421), Expect = 2e-47
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 38/285 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             +  T  E AIK I     +     + L E+ +L+ ++H N++ + D       +   +
Sbjct: 56  CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110

Query: 80  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
            Y+V E     +L   I    +  +      + Q+L G+ Y+H  +++HRDLKP NLLL 
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                  +KI DFGL+        M E + T +Y APE+L     Y    D+WS+G IL 
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILF 228

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            ++   P F G+     LR +    G        F   +                    +
Sbjct: 229 ILLAGYPPFGGQTDQEILRKV--EKGKYT-----FDSPE--------------------W 261

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            N S GA DL+++ML FD  +RI+ ++AL HP+++ +    +  +
Sbjct: 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGI 306

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  165 bits (419), Expect = 3e-47
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 39/288 (13%)

Query: 20  AVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             +  T +E A+K I         D    LRE++LL+ ++H N++ + +       +   
Sbjct: 45  CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
             Y+V E+    +L   I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159

Query: 138 ---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
              +   +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
             +++  P F G +    L+ +    G        F                        
Sbjct: 218 YILLSGCPPFNGANEYDILKKV--EKGKYT-----FELPQ-------------------- 250

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP 302
           +   S  A DL+ KML + P+ RI+  +AL H ++Q+          P
Sbjct: 251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  160 bits (406), Expect = 3e-47
 Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 39/277 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D I        + 
Sbjct: 25  CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL 
Sbjct: 80  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139

Query: 139 ASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +      +K+ DFGLA   ++++    +  T  Y +PE +L    Y+  +DIW+ G IL 
Sbjct: 140 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVIL- 197

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR- 254
                        Y+  L     L+G P      F   ++  R   Q+       + +  
Sbjct: 198 -------------YI--L-----LVGYPP-----F-WDEDQHRLYAQIKAG-AYDYPSPE 230

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           +   +  A  L++ ML  +P KRIT ++AL+ P++ +
Sbjct: 231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  161 bits (409), Expect = 4e-47
 Identities = 79/318 (24%), Positives = 131/318 (41%), Gaps = 62/318 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIAIKDIIR 70
             +++T+E  A K        I+            +   EI + R + H++V+       
Sbjct: 60  ISDADTKEVFAGK--------IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF- 110

Query: 71  PPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
               +  + V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRD
Sbjct: 111 ----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDI 187
           LK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE+L     ++  +D+
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDV 224

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+GCI+  ++  +P F           I                              +
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRI------------------------------K 254

Query: 248 KQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS--LHDLNDEPVCPRP 304
           K ++    P   +  A  L++KML  DP  R T+ E L   +  S  +           P
Sbjct: 255 KNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIP 312

Query: 305 FHFDFEHSSCTEDHIREL 322
             F    SS    + + L
Sbjct: 313 PRFSIAPSSLDPSNRKPL 330

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  160 bits (408), Expect = 4e-47
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 42/284 (14%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
                T  E A K I      A    +      RE+ +LR + H NVI + D+      +
Sbjct: 31  CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+  + H DLKP N
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145

Query: 135 LLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           ++L         +K+ DFGLA    +         T  + APE ++N        D+WS+
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSI 204

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G I   +++    F G      L  IT         S  F                    
Sbjct: 205 GVITYILLSGASPFLGDTKQETLANITS-------VSYDFDEEF---------------- 241

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
               F + S  A D + K+LV +  KR+T++EALRHP++  + +
Sbjct: 242 ----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  159 bits (404), Expect = 7e-47
 Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 38/275 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I+     +  + 
Sbjct: 41  CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
            YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++HRDLKP N+LL 
Sbjct: 96  FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL 
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILY 213

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++  P F GK+    L+ +    G        F                        +
Sbjct: 214 ILLSGTPPFYGKNEYDILKRV--ETGKYA-----FDLPQ--------------------W 246

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
              S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  161 bits (409), Expect = 8e-47
 Identities = 68/289 (23%), Positives = 127/289 (43%), Gaps = 55/289 (19%)

Query: 20  AVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPP 72
            V+  T  E A+K +       +          T RE  +LR +  H ++I + D     
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--- 169

Query: 73  KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
             ++ + +++V++LM   +L   +     L++   +  +  LL  + ++H+ +++HRDLK
Sbjct: 170 --ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLK 227

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-----YTAAID 186
           P N+LL+ +  +++ DFG +      + + E   T  Y APE+L    +     Y   +D
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287

Query: 187 IWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
           +W+ G IL     G      P F  +  +  LR+I  + G           S        
Sbjct: 288 LWACGVILFTLLAG-----SPPFWHRRQILMLRMI--MEGQYQ------FSSPE------ 328

Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                        + ++SS   DL+ ++L  DP  R+T E+AL+HP+ +
Sbjct: 329 -------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  159 bits (404), Expect = 8e-47
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 60/285 (21%)

Query: 20  AVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIAIKDIIR 70
             +++T+E  A K        I+            +   EI + R + H++V+       
Sbjct: 34  ISDADTKEVFAGK--------IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF- 84

Query: 71  PPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
               +  + V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRD
Sbjct: 85  ----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDI 187
           LK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE+L     ++  +D+
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDV 198

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+GCI+  ++  +P F           I                              +
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRI------------------------------K 228

Query: 248 KQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           K ++    P   +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 229 KNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  160 bits (407), Expect = 1e-46
 Identities = 71/285 (24%), Positives = 132/285 (46%), Gaps = 39/285 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V+  T  E A K I     +  D ++  RE ++ R ++H N++ + D I        + 
Sbjct: 48  CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            Y+V++L+   +L + I + +  ++    + + Q+L  + Y HS  ++HR+LKP NLLL 
Sbjct: 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162

Query: 139 ASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +      +K+ DFGLA   ++++    +  T  Y +PE +L    Y+  +DIW+ G IL 
Sbjct: 163 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVIL- 220

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR- 254
                        Y+  L     L+G P      F   ++  R   Q+       + +  
Sbjct: 221 -------------YI--L-----LVGYPP-----F-WDEDQHRLYAQIKAG-AYDYPSPE 253

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
           +   +  A  L++ ML  +P KRIT ++AL+ P++ +   +    
Sbjct: 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  160 bits (407), Expect = 1e-46
 Identities = 75/291 (25%), Positives = 121/291 (41%), Gaps = 46/291 (15%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
                T  E A K I      A    +      RE+ +LR + H N+I + D+      +
Sbjct: 31  CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              DV ++ EL+   +L   +   + L+++    F+ Q+L G+ Y+H+  + H DLKP N
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145

Query: 135 LLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           ++L         +K+ DFGLA    +         T  + APE ++N        D+WS+
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSI 204

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIG-SPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           G I               Y+  L     L G SP      FL  D  +  +  +      
Sbjct: 205 GVIT--------------YI--L-----LSGASP------FL-GDTKQETLANITAV-SY 235

Query: 250 QFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
            F    F   S  A D + K+LV +  KR+T++EALRHP++  +       
Sbjct: 236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMV 286

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  161 bits (408), Expect = 2e-46
 Identities = 57/326 (17%), Positives = 122/326 (37%), Gaps = 28/326 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             + +T +  AIK   N    +      +RE ++L+ + H+N++ +  I    ++ T   
Sbjct: 28  GRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE---EETTTRH 83

Query: 80  VYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
             ++ E      L+ ++        L +      L  ++ G+ ++    ++HR++KP N+
Sbjct: 84  KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143

Query: 136 LLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL-------LNCTEYTAA 184
           +     D     K+ DFG AR   + +       T  Y  P++         +  +Y A 
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI--GSPDDASLGFLRSDNAR-RYVR 241
           +D+WS+G       T    F   +   + + +   I  G P  A  G  +++N    +  
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263

Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY-LQSLHDLNDEPV 300
            +P        +           +L  +L  D  K    ++       +     ++   +
Sbjct: 264 DMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSL 318

Query: 301 CPRPFHFDFEHSSCTEDHIRELIWRE 326
                H  + HS  T     EL++++
Sbjct: 319 QQMTAHKIYIHSYNTATIFHELVYKQ 344

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  158 bits (401), Expect = 5e-46
 Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 45/297 (15%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
                T  + A K I      +    +      RE+ +L+ ++H NVI + ++      +
Sbjct: 30  CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84

Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              DV ++ EL+   +L   +   + LT++    FL Q+L G+ Y+HS  + H DLKP N
Sbjct: 85  NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144

Query: 135 LLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           ++L         +KI DFGLA      +       T  + APE ++N        D+WS+
Sbjct: 145 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSI 203

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G I   +++    F G      L  ++         +  F                    
Sbjct: 204 GVITYILLSGASPFLGDTKQETLANVSA-------VNYEFEDEY---------------- 240

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHF 307
               F N S+ A D + ++LV DP KR+T++++L+HP+++     + +    R    
Sbjct: 241 ----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---PKDTQQALSRKASA 290

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  161 bits (410), Expect = 6e-46
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 38/276 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             +  T++E A+K I  A     D    LRE++LL+ ++H N++ + +I+     +  + 
Sbjct: 41  CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95

Query: 80  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
            YIV EL    +L   I   ++ ++      + Q+  G+ Y+H  +++HRDLKP N+LL 
Sbjct: 96  FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                CD+KI DFGL+    +   M + + T +Y APE+L     Y    D+WS G IL 
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILY 213

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++  P F GK+    L+ +    G                                ++
Sbjct: 214 ILLSGTPPFYGKNEYDILKRV--ETGKYA------FDLP-------------------QW 246

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
              S  A DL+ KML F P+ RIT  + L HP++Q 
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  157 bits (399), Expect = 8e-46
 Identities = 63/299 (21%), Positives = 127/299 (42%), Gaps = 44/299 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V + +++    K +     + +  ++   EI +L    H N++ + +       ++  +
Sbjct: 24  CVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLHESF-----ESMEE 75

Query: 80  VYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + +++E +   D+  +I  S  +L +     +++Q+   L+++HS ++ H D++P N++ 
Sbjct: 76  LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135

Query: 138 NASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                  +KI +FG AR     D          Y APE +      + A D+WS+G ++ 
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLV- 193

Query: 196 EIMTREPLFPGKDYVHQLRLITELIG-SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
                        YV  L     L G +P      FL   N +     +    +  F   
Sbjct: 194 -------------YV--L-----LSGINP------FLAETNQQII-ENIMNA-EYTFDEE 225

Query: 255 -FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS 312
            F   S  A+D ++++LV +   R+T  EAL+HP+L+   +     V     H  + H+
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  159 bits (405), Expect = 1e-45
 Identities = 73/302 (24%), Positives = 118/302 (39%), Gaps = 67/302 (22%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV 80
            S     VA+K++   F +I        EIKLL    +H NVI            T   +
Sbjct: 35  GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTESDDHPNVIRYYCSE-----TTDRFL 84

Query: 81  YIVYELMDTDLHQII-------RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           YI  EL + +L  ++        + +   + +    L Q+  G+ ++HS  ++HRDLKP 
Sbjct: 85  YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144

Query: 134 NLLLNAS-------------CDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELL 175
           N+L++ S               + I DFGL +      +S    +     T  +RAPELL
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204

Query: 176 LNCTE------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 229
                       T +IDI+S+GC+   I+++     G  Y  +  +I  +    +   L 
Sbjct: 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLH 264

Query: 230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
                                      +  + A DL+ +M+  DP KR T  + LRHP  
Sbjct: 265 -------------------------DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

Query: 290 QS 291
             
Sbjct: 300 WP 301

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  155 bits (393), Expect = 2e-45
 Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 40/284 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           AV   TR   A KKI      + D  R  +EI++++ ++H N+I + +       +   D
Sbjct: 28  AVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTD 80

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
           +Y+V EL    +L + +   +   +      +  +L  + Y H  +V HRDLKP N L  
Sbjct: 81  IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +    LK+ DFGLA        M   V T +Y +P++L     Y    D WS G ++ 
Sbjct: 141 TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMY 198

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            ++   P F        +  I    G+       F   D                    +
Sbjct: 199 VLLCGYPPFSAPTDSEVMLKI--REGTFT-----FPEKD--------------------W 231

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
            N S  A  L+ ++L   P +RIT  +AL H + +     +   
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  155 bits (395), Expect = 2e-45
 Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 44/280 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A        VA+KK+     +++DA+     ++EI LL+ + H NVI             
Sbjct: 51  AACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----E 103

Query: 77  FNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
            N++ IV EL D  DL ++I+  ++    + +     +  QL   L+++HS  V+HRD+K
Sbjct: 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK 163

Query: 132 PSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           P+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE +     Y    DIWS+
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSL 222

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           GC+L E+   +  F G                 D  +L  L     +     LP      
Sbjct: 223 GCLLYEMAALQSPFYG-----------------DKMNLYSLCKKIEQCDYPPLPS----- 260

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                 + S     L+   +  DP KR  V          
Sbjct: 261 -----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  157 bits (399), Expect = 4e-45
 Identities = 60/285 (21%), Positives = 117/285 (41%), Gaps = 39/285 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V   T      K I       +D      EI ++  + H  +I + D       +   +
Sbjct: 70  CVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYE 122

Query: 80  VYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + ++ E +   +L  +I   D ++++     ++ Q   GLK++H  S++H D+KP N++ 
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               +  +KI DFGLA   +  + +     T  + APE +++        D+W++G +  
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGY 241

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++    F G+D +  L+ +             F                        F
Sbjct: 242 VLLSGLSPFAGEDDLETLQNVKR-------CDWEFDEDA--------------------F 274

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
            + S  A D ++ +L  +P KR+TV +AL HP+L+  H      +
Sbjct: 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  154 bits (392), Expect = 4e-45
 Identities = 66/279 (23%), Positives = 115/279 (41%), Gaps = 44/279 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                +  E  IK I N   + +   +   EI++L+ ++H N+I I ++      + +++
Sbjct: 41  VEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN 94

Query: 80  VYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           +YIV E  +       +       + L++ +    + Q++  L Y HS  V+H+DLKP N
Sbjct: 95  MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154

Query: 135 LLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
           +L    +    +KI DFGLA      +  T    T  Y APE+     + T   DIWS G
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAG 212

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
            ++  ++T    F G       +        P+                          +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPN--------------------------Y 244

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           A      +  AVDLL++ML  DP +R +  + L H + +
Sbjct: 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  159 bits (403), Expect = 8e-45
 Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 49/295 (16%)

Query: 20  AVNSETREEVAIKKI-----------GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 68
                   E AIK I            +  +          EI LL+ ++H N+I + D+
Sbjct: 55  CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114

Query: 69  IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH 127
                 +     Y+V E  +  +L + I +  +  +      + Q+L G+ Y+H  +++H
Sbjct: 115 F-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVH 169

Query: 128 RDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 184
           RD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y APE+L     Y   
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK--YNEK 227

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
            D+WS G I+  ++   P F G++    ++ +    G        F  +D          
Sbjct: 228 CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKGKYY-----FDFND---------- 270

Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
                     + N S  A +L++ ML +D NKR T EEAL   +++   +  ++ 
Sbjct: 271 ----------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  153 bits (388), Expect = 1e-44
 Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 67/288 (23%)

Query: 20  AVNSETREEVAIKKIGNAFDNIID---------ARRTLREIKLLRHMEHENVIAIKDIIR 70
           A +  T  EVAIK        +ID          +R   E+K+   ++H +++ + +   
Sbjct: 30  AESIHTGLEVAIK--------MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF- 80

Query: 71  PPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS 124
               +  N VY+V       E+       +    +  +++  ++F++Q++ G+ Y+HS  
Sbjct: 81  ----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132

Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 183
           +LHRDL  SNLLL  + ++KI DFGLA +     +       T  Y +PE+    + +  
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGL 191

Query: 184 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 243
             D+WS+GC+   ++   P F      + L  +                           
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------------------- 224

Query: 244 PRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  +    P+  S  A DL+ ++L  +P  R+++   L HP++ 
Sbjct: 225 ---VLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  154 bits (391), Expect = 2e-44
 Identities = 67/327 (20%), Positives = 114/327 (34%), Gaps = 84/327 (25%)

Query: 20  AVNSETREEVAIKKI---GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A+ ++TR   AIK +        N  D  R   E++L++ + H N+  + ++      + 
Sbjct: 45  AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99

Query: 77  FNDVYIVYELM-----------------------------------------DTDLHQII 95
              + +V EL                                           +      
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159

Query: 96  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLAR- 152
             D    +      + Q+   L Y+H+  + HRD+KP N L   N S ++K+ DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 153 ----TTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGK 207
                  E   MT    T ++ APE+L    E Y    D WS G +L  ++     FPG 
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279

Query: 208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE 267
           +    +  +           L F   +                    +   S  A DLL 
Sbjct: 280 NDADTISQVLN-------KKLCFENPN--------------------YNVLSPLARDLLS 312

Query: 268 KMLVFDPNKRITVEEALRHPYLQSLHD 294
            +L  + ++R     AL+HP++    D
Sbjct: 313 NLLNRNVDERFDAMRALQHPWISQFSD 339

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  153 bits (388), Expect = 4e-44
 Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 40/279 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFN 78
            ++  T +E A K +             L EI +L   +    VI + ++      +  +
Sbjct: 48  CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS 102

Query: 79  DVYIVYELMDT-DL-HQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           ++ ++ E     ++    +    + ++++     + Q+L G+ Y+H  +++H DLKP N+
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162

Query: 136 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           LL       D+KI DFG++R       + E + T  Y APE +LN    T A D+W++G 
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGI 221

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I   ++T    F G+D       I++        ++ +                      
Sbjct: 222 IAYMLLTHTSPFVGEDNQETYLNISQ-------VNVDYSEET------------------ 256

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
             F + S  A D ++ +LV +P KR T E  L H +LQ 
Sbjct: 257 --FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  152 bits (385), Expect = 5e-44
 Identities = 59/297 (19%), Positives = 103/297 (34%), Gaps = 66/297 (22%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
            V        AIK+        +D +  LRE+     + +H +V+          +D  +
Sbjct: 30  CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW---AED--D 84

Query: 79  DVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            + I  E  +   L   I    R      +   +  L Q+ RGL+Y+HS S++H D+KPS
Sbjct: 85  HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144

Query: 134 NLLLN-------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 174
           N+ ++                        KIGD G     S             + A E+
Sbjct: 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE---EGDSRFLANEV 201

Query: 175 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 234
           L     +    DI+++   +      EPL    D  H++R                    
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR-------------------- 241

Query: 235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
             +  + ++P+             S    +LL+ M+  DP +R +    ++H  L S
Sbjct: 242 --QGRLPRIPQVL-----------SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  151 bits (384), Expect = 8e-44
 Identities = 68/307 (22%), Positives = 127/307 (41%), Gaps = 77/307 (25%)

Query: 20  AVNSETREEVAIKKI------------------------GNAFDNIIDARRTLREIKLLR 55
           A N       A+K +                        G          +  +EI +L+
Sbjct: 32  AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91

Query: 56  HMEHENVIAIKDIIRPPKKDTFNDVYIVYE------LMDTDLHQIIRSDQQLTDDHCQYF 109
            ++H NV+ + +++  P +D    +Y+V+E      +M+      + + + L++D  +++
Sbjct: 92  KLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVME------VPTLKPLSEDQARFY 142

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRW 168
              L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++     +D +    V T  
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA 202

Query: 169 YRAPELLLNCT-EYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-D 224
           + APE L      ++  A+D+W++G  L              Y      +    G  P  
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTL--------------YC----FVF---GQCPFM 241

Query: 225 DASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
           D  +  L S           + + Q       P+ +    DL+ +ML  +P  RI V E 
Sbjct: 242 DERIMCLHS-----------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

Query: 284 LRHPYLQ 290
             HP++ 
Sbjct: 291 KLHPWVT 297

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  157 bits (398), Expect = 9e-44
 Identities = 60/275 (21%), Positives = 112/275 (40%), Gaps = 39/275 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                T    A K +     +  D     +EI+ +  + H  ++ + D       +  N+
Sbjct: 176 VTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNE 228

Query: 80  VYIVYELMD-TDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + ++YE M   +L  ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N++ 
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               S +LK+ DFGL         +     T  + APE +          D+WSVG +  
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSY 347

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++    F G++    LR +       +        S                     F
Sbjct: 348 ILLSGLSPFGGENDDETLRNVKS--CDWN-----MDDSA--------------------F 380

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
              S    D + K+L+ DPN R+T+ +AL HP+L 
Sbjct: 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  152 bits (387), Expect = 1e-43
 Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 52/295 (17%)

Query: 20  AVNSETREEVAIKKIGNA---FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
            +N ET ++ A+K +  A       +      RE  +   ++H +++ + +        +
Sbjct: 43  CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97

Query: 77  FNDVYIVYELMD-TDL-HQIIR---SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
              +Y+V+E MD  DL  +I++   +    ++    +++ Q+L  L+Y H  +++HRD+K
Sbjct: 98  DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK 157

Query: 132 PSNLLL---NASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           P  +LL     S  +K+G FG+A    E+       V T  + APE ++    Y   +D+
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDV 216

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP--DDASLGFLRSDNARRYVRQLPR 245
           W  G IL              ++  L     L G                  +Y      
Sbjct: 217 WGCGVIL--------------FI--L-----LSGCLPFYGTKERLFEGIIKGKY------ 249

Query: 246 CRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
               +   R + + S  A DL+ +ML+ DP +RITV EAL HP+L+       + 
Sbjct: 250 ----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  152 bits (387), Expect = 1e-43
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 39/275 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
              + T  ++A K I      + D      EI ++  ++H N+I + D       ++ ND
Sbjct: 108 CEETATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKND 160

Query: 80  VYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + +V E +D  +L  +II     LT+     F+ Q+  G++++H   +LH DLKP N+L 
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               +  +KI DFGLAR     + +     T  + APE ++N    +   D+WSVG I  
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAY 279

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++    F G +    L  I                 +                    F
Sbjct: 280 MLLSGLSPFLGDNDAETLNNILA-------CRWDLEDEE--------------------F 312

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            + S  A + + K+L+ + + RI+  EAL+HP+L 
Sbjct: 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  150 bits (380), Expect = 2e-43
 Identities = 59/281 (20%), Positives = 119/281 (42%), Gaps = 56/281 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A   +++  +A+K +      +  A    +  RE+++  H+ H N++ +        +  
Sbjct: 28  AREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-- 83

Query: 77  FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              VY++ E      +++ ++   +  +     ++ +L   L Y HS  V+HRD+KP NL
Sbjct: 84  ---VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140

Query: 136 LLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           LL ++ +LKI DFG +     +         +Y+       PE++     +   +D+WS+
Sbjct: 141 LLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEMIEG-RMHDEKVDLWSL 193

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G +  E +  +P F    Y    + I                               + +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRI------------------------------SRVE 223

Query: 251 FATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
           F   FP+  + GA DL+ ++L  +P++R  + E L HP++ 
Sbjct: 224 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  149 bits (379), Expect = 1e-42
 Identities = 82/305 (26%), Positives = 124/305 (40%), Gaps = 71/305 (23%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR--TLREIKLLRHM-EHENVIAIKDIIRPPKKDT 76
            ++  T  E A+K        IID  +     EI++L    +H N+I +KD+      D 
Sbjct: 41  CIHKATNMEFAVK--------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DD 87

Query: 77  FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              VY+V ELM   +L   I   +  ++      L+ + + ++Y+H+  V+HRDLKPSN+
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147

Query: 136 LL-----NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           L      N    ++I DFG A+   +E   +     T  + APE +L    Y AA DIWS
Sbjct: 148 LYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWS 205

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSP------DDASLGFLRSDNARRYVRQL 243
           +G +L   M                    L G        DD     L            
Sbjct: 206 LGVLL-YTM--------------------LTGYTPFANGPDDTPEEILA----------- 233

Query: 244 PRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE 298
            R    +F            S  A DL+ KML  DP++R+T    LRHP++     L   
Sbjct: 234 -RIGSGKF--SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290

Query: 299 PVCPR 303
            +  +
Sbjct: 291 QLNRQ 295

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  148 bits (375), Expect = 2e-42
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 40/276 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                T +  A+K I  +            EI +L+ ++HEN++ ++DI      ++   
Sbjct: 28  VKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH 80

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
            Y+V +L+   +L   I      T+      + Q+L  +KY+H   ++HRDLKP NLL  
Sbjct: 81  YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               +  + I DFGL++   +   M+    T  Y APE +L    Y+ A+D WS+G I  
Sbjct: 141 TPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVITY 198

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            ++   P F  +        I E           F                        +
Sbjct: 199 ILLCGYPPFYEETESKLFEKIKE-------GYYEFESPF--------------------W 231

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            + S  A D +  +L  DPN+R T E+AL HP++  
Sbjct: 232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  148 bits (375), Expect = 3e-42
 Identities = 60/342 (17%), Positives = 111/342 (32%), Gaps = 103/342 (30%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD------------ 67
           A N       AIK+I    +  +   + +RE+K L  +EH  ++   +            
Sbjct: 25  AKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83

Query: 68  ----------------------------------------IIRPPKKDTFNDVYIVYELM 87
                                                   + +         +YI  +L 
Sbjct: 84  EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143

Query: 88  D-TDLHQIIRSDQQLTD---DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
              +L   +     L D     C +   Q+   ++++HS  ++HRDLKPSN+       +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203

Query: 144 KIGDFGLARTTSETDF-------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           K+GDFGL     + +               T  V T+ Y +PE +     Y+  +DI+S+
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSL 262

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G IL E++         + V  +  +                              R  +
Sbjct: 263 GLILFELLY--SFSTQMERVRIITDV------------------------------RNLK 290

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           F   F  K      +++ ML   P +R    + + +   ++L
Sbjct: 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  149 bits (377), Expect = 3e-42
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 44/296 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                T++  A+K +       +D +    EI +L  + H N+I +K+I      +T  +
Sbjct: 72  CKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTE 122

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
           + +V EL+   +L   I      ++      + Q+L  + Y+H   ++HRDLKP NLL  
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                  LKI DFGL++       M     T  Y APE +L    Y   +D+WSVG I  
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE-ILRGCAYGPEVDMWSVGIIT- 240

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR- 254
                        Y+  L     L G        F      +   R++  C +  F +  
Sbjct: 241 -------------YI--L-----LCGFEP-----FYDERGDQFMFRRILNC-EYYFISPW 274

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS--LHDLNDEPVCPRPFHFD 308
           +   S  A DL+ K++V DP KR+T  +AL+HP++     + ++ +    +   F+
Sbjct: 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFN 330

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  147 bits (374), Expect = 3e-42
 Identities = 60/285 (21%), Positives = 93/285 (32%), Gaps = 48/285 (16%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                     A+K+I        D     RE  + R   H N++ +       +      
Sbjct: 48  VEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE- 104

Query: 80  VYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            +++        L   I   +     LT+D   + L  + RGL+ +H+    HRDLKP+N
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN 164

Query: 135 LLLNASCDLKIGDFGLART------TSETDFMTEYVVTR----WYRAPELLLN--CTEYT 182
           +LL       + D G           S      +    +     YRAPEL          
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224

Query: 183 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 242
              D+WS+GC+L  +M  E  +   D V Q      L                       
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPY---DMVFQKGDSVALA---------------------- 259

Query: 243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
               + Q    + P  SS    LL  M+  DP++R  +   L   
Sbjct: 260 ---VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  148 bits (375), Expect = 4e-42
 Identities = 61/287 (21%), Positives = 114/287 (39%), Gaps = 40/287 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPPKKDTFN 78
             +  T ++ A+K +        D+ +  +E+          +++ I D+          
Sbjct: 48  CFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-R 99

Query: 79  DVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            + I+ E M+      +I  R DQ  T+      +  +   ++++HS ++ HRD+KP NL
Sbjct: 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159

Query: 136 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           L         LK+ DFG A+ T++    T    T +Y APE +L   +Y  + D+WS+G 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGV 217

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I+  ++   P F           +   I        GF   +                  
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRL---GQYGFPNPE------------------ 256

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
             +   S  A  L+  +L  DP +R+T+ + + HP++     +   P
Sbjct: 257 --WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  146 bits (371), Expect = 4e-42
 Identities = 79/290 (27%), Positives = 121/290 (41%), Gaps = 68/290 (23%)

Query: 20  AVNSETREEVAIK-----KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK 74
           AVN  T E VA+K     +  +  +NI       +EI + + + HENV+           
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINKMLNHENVVKFYGHR----- 74

Query: 75  DTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
              N  Y+   Y    EL D      I  D  + +   Q F +QL+ G+ Y+H   + HR
Sbjct: 75  REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129

Query: 129 DLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA- 184
           D+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL    E+ A  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEP 188

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL----RSDNARRYV 240
           +D+WS G +L                    ++            G L     SD+ + Y 
Sbjct: 189 VDVWSCGIVL--------------TA----MLA-----------GELPWDQPSDSCQEYS 219

Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                  K+ +   +    S  + LL K+LV +P+ RIT+ +  +  +  
Sbjct: 220 D---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  146 bits (371), Expect = 5e-42
 Identities = 59/293 (20%), Positives = 115/293 (39%), Gaps = 56/293 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR---RTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A   + +  +A+K +      +       +  REI++  H+ H N++ + +     K+  
Sbjct: 33  AREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR-- 88

Query: 77  FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              +Y++ E     +L++ ++   +  +     F+ +L   L Y H   V+HRD+KP NL
Sbjct: 89  ---IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145

Query: 136 LLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           L+    +LKI DFG +         T     +Y+       PE++     +   +D+W  
Sbjct: 146 LMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMIEGK-THDEKVDLWCA 198

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G +  E +   P F    +    R I                                  
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRI------------------------------VNVD 228

Query: 251 FATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP 302
              +FP   S G+ DL+ K+L + P +R+ ++  + HP++++       PV  
Sbjct: 229 L--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  147 bits (373), Expect = 7e-42
 Identities = 71/315 (22%), Positives = 142/315 (45%), Gaps = 49/315 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A +  T  EVAIK I     N    ++  RE+++++ + H N++ + ++I     +T   
Sbjct: 34  ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKT 88

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           +Y++ E     ++   + +  ++ +   +    Q++  ++Y H   ++HRDLK  NLLL+
Sbjct: 89  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGEI 197
           A  ++KI DFG +   +    +  +     Y APEL     +Y    +D+WS+G IL  +
Sbjct: 149 ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTL 207

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           ++    F                   D  +L  LR            R  + ++  R P 
Sbjct: 208 VSGSLPF-------------------DGQNLKELRE-----------RVLRGKY--RIPF 235

Query: 258 K-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP--VCPRPFHFDFEHSS- 313
             S+   +LL++ LV +P KR T+E+ ++  ++ + H+ ++    V P     D +    
Sbjct: 236 YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDI 295

Query: 314 -----CTEDHIRELI 323
                 +++ I+E +
Sbjct: 296 MVGMGYSQEEIQESL 310

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  149 bits (379), Expect = 9e-42
 Identities = 72/289 (24%), Positives = 123/289 (42%), Gaps = 46/289 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V     +E A   I     +  D ++  RE ++ R ++H N++ + D I          
Sbjct: 30  CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84

Query: 80  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            Y++++L+   +L + I + +  ++    + + Q+L  + + H   V+HR+LKP NLLL 
Sbjct: 85  HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144

Query: 139 ASCD---LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +      +K+ DFGLA     E      +  T  Y +PE +L    Y   +D+W+ G IL
Sbjct: 145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVIL 203

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSP---DDASLGFLRSDNARRYVRQLPRCRKQQF 251
                         Y+  L     L+G P   D+      +   A  Y           F
Sbjct: 204 --------------YI--L-----LVGYPPFWDEDQHRLYQQIKAGAY----------DF 232

Query: 252 ATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
            +      +  A DL+ KML  +P+KRIT  EAL+HP++     +    
Sbjct: 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  148 bits (376), Expect = 1e-41
 Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 39/287 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
             N  T+E+ A+K +        D  +  RE++L     +  +++ I D+          
Sbjct: 81  IFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-K 132

Query: 79  DVYIVYELMD--TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            + IV E +D      +I  R DQ  T+      +  +   ++Y+HS ++ HRD+KP NL
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 192

Query: 136 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           L      +  LK+ DFG A+ T+  + +T    T +Y APE +L   +Y  + D+WS+G 
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGV 251

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I+  ++   P F     +     +   I         F   +                  
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPNPE------------------ 290

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
             +   S     L+  +L  +P +R+T+ E + HP++     +   P
Sbjct: 291 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  146 bits (370), Expect = 2e-41
 Identities = 83/317 (26%), Positives = 125/317 (39%), Gaps = 70/317 (22%)

Query: 20  AVNSETREEVAIK-----KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK 74
           AVN  T E VA+K     +  +  +NI       +EI + + + HENV+           
Sbjct: 26  AVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINKMLNHENVVKFYGHR----- 74

Query: 75  DTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
              N  Y+   Y    EL D      I  D  + +   Q F +QL+ G+ Y+H   + HR
Sbjct: 75  REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129

Query: 129 DLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA- 184
           D+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y APELL    E+ A  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEP 188

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL----RSDNARRYV 240
           +D+WS G +L                    ++            G L     SD+ + Y 
Sbjct: 189 VDVWSCGIVL--------------TA----MLA-----------GELPWDQPSDSCQEYS 219

Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 300
                  K+ +   +    S  + LL K+LV +P+ RIT+ +  +  +      L     
Sbjct: 220 D---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN--KPLKKGAK 274

Query: 301 CPRPFHFDFEHSSCTED 317
            PR        S     
Sbjct: 275 RPRVTSGGVSESPSGFS 291

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  145 bits (369), Expect = 2e-41
 Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 43/289 (14%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARR---TLREIKLLRHM-EHENVIAIKDIIRPPKKD 75
            V+ ++ +  A+K        II  R    T +EI  L+    H N++ + ++       
Sbjct: 30  CVHKKSNQAFAVK--------IISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----H 76

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
                ++V EL++  +L + I+  +  ++    Y + +L+  + ++H   V+HRDLKP N
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136

Query: 135 LLL---NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           LL    N + ++KI DFG AR    +   +     T  Y APE LLN   Y  + D+WS+
Sbjct: 137 LLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSL 195

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G IL  +++ +  F   D         E++         F                    
Sbjct: 196 GVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA---------------- 239

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
               + N S  A DL++ +L  DPNKR+ +     + +LQ    L+  P
Sbjct: 240 ----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  146 bits (370), Expect = 3e-41
 Identities = 81/317 (25%), Positives = 132/317 (41%), Gaps = 55/317 (17%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-----REIKLLRHMEHENVIAIKDIIRPPKK 74
             +  T+E VA+K         I+    +     REI   R + H N++  K++I     
Sbjct: 39  MRDKLTKELVAVK--------YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI----- 85

Query: 75  DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
            T   + I+ E     +L++ I +  + ++D  ++F  QLL G+ Y HS  + HRDLK  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145

Query: 134 NLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAIDIWSV 190
           N LL  + +  LKI DFG ++++         V T  Y APE+LL   EY     D+WS 
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSC 204

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G  L              YV        L+G     +  F   +  R Y + + R    +
Sbjct: 205 GVTL--------------YVM-------LVG-----AYPFEDPEEPRDYRKTIQRILSVK 238

Query: 251 FATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHP-YLQSLHDLNDEPVCPRPFH 306
           +    P+    S     L+ ++ V DP  RI++ E   H  +L++L              
Sbjct: 239 Y--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296

Query: 307 FDFEHSSCTEDHIRELI 323
            + E    + D I ++I
Sbjct: 297 QEPEQPMQSLDTIMQII 313

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  147 bits (371), Expect = 3e-41
 Identities = 47/315 (14%), Positives = 96/315 (30%), Gaps = 78/315 (24%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVI-------AIKDI 68
           A + ET E   +           + I   +  +  ++LLR ++++             D+
Sbjct: 92  ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151

Query: 69  IRPPKKDTFNDV------------YIVYELMDTD-------LHQIIRSDQQLTDDHCQYF 109
           ++ P+K     V            + +Y  M ++       L     + + L        
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 169
             Q++R L  +H   ++H  L+P +++L+    + +  F                V+R +
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGF 268

Query: 170 RAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 219
             PEL              T  T + D W++G ++  I   +        +     I   
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--- 325

Query: 220 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT 279
                             R  + +P                    LLE  L +    R+ 
Sbjct: 326 -----------------FRSCKNIP---------------QPVRALLEGFLRYPKEDRLL 353

Query: 280 VEEALRHPYLQSLHD 294
             +A+  P  + L  
Sbjct: 354 PLQAMETPEYEQLRT 368

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  145 bits (367), Expect = 6e-41
 Identities = 85/317 (26%), Positives = 144/317 (45%), Gaps = 53/317 (16%)

Query: 20  AVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A + +T+++VA+K I            R  REI  L+ + H ++I + D+I      T  
Sbjct: 28  ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT 82

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           D+ +V E    +L   I   +++T+D  + F  Q++  ++Y H   ++HRDLKP NLLL+
Sbjct: 83  DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGEI 197
            + ++KI DFGL+   ++ +F+     +  Y APE++     Y    +D+WS G +L   
Sbjct: 143 DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDVWSCGIVL--- 198

Query: 198 MTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
                      YV        L+G  P DD  +  L             +     +    
Sbjct: 199 -----------YV-------MLVGRLPFDDEFIPNLFK-----------KVNSCVY--VM 227

Query: 256 PN-KSSGAVDLLEKMLVFDPNKRITVEEALRHP--------YLQSLHDLNDEPVCPRPFH 306
           P+  S GA  L+ +M+V DP +RIT++E  R P        YL+ + ++       R   
Sbjct: 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVS 287

Query: 307 FDFEHSSCTEDHIRELI 323
              E    +ED+I E +
Sbjct: 288 KLGEAMGFSEDYIVEAL 304

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  144 bits (365), Expect = 6e-41
 Identities = 74/323 (22%), Positives = 130/323 (40%), Gaps = 64/323 (19%)

Query: 20  AVNSETREEVAIK--------KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP 71
            ++SET    A+K        +I N   N+       +EI+LLR + H+NVI + D++  
Sbjct: 24  VLDSETLCRRAVKILKKKKLRRIPNGEANV------KKEIQLLRRLRHKNVIQLVDVLYN 77

Query: 72  PKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
            +K     +Y+V E       ++   +  +++        +  QL+ GL+Y+HS  ++H+
Sbjct: 78  EEK---QKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK 133

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTEYT-AA 184
           D+KP NLLL     LKI   G+A      +  D       +  ++ PE+      ++   
Sbjct: 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFK 193

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVRQ 242
           +DIWS G  L              Y     + T   G  P +  ++  L           
Sbjct: 194 VDIWSAGVTL--------------YN----ITT---GLYPFEGDNIYKLFE--------- 223

Query: 243 LPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH--DLNDEP 299
                K  +    P        DLL+ ML ++P KR ++ +  +H + +  H       P
Sbjct: 224 --NIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP 279

Query: 300 VCPRPFHFDFEHSSCTEDHIREL 322
           + P P   D   S     ++ +L
Sbjct: 280 IPPSPDTKDRWRSMTVVPYLEDL 302

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  142 bits (361), Expect = 1e-40
 Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 46/277 (16%)

Query: 20  AVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             +  T  +VA+K +      ++    +  REI+ L+   H ++I +  +I      T  
Sbjct: 30  GEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84

Query: 79  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           D ++V E +   +L   I    ++ +   +    Q+L  + Y H   V+HRDLKP N+LL
Sbjct: 85  DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGE 196
           +A  + KI DFGL+   S+ +F+     +  Y APE++     Y    +DIWS G IL  
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSCGVIL-- 201

Query: 197 IMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
                       Y         L G+ P DD  +  L             + R   F   
Sbjct: 202 ------------YAL-------LCGTLPFDDEHVPTLFK-----------KIRGGVF--Y 229

Query: 255 FPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            P   +     LL  ML  DP KR T+++   H + +
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  144 bits (364), Expect = 1e-40
 Identities = 63/298 (21%), Positives = 107/298 (35%), Gaps = 57/298 (19%)

Query: 20  AVNSETREEVAIKKI------GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPK 73
           AV+ E  +EV +K I       + +       +   EI +L  +EH N+I + DI     
Sbjct: 43  AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98

Query: 74  KDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
            +      +V E   +  DL   I    +L +    Y   QL+  + Y+    ++HRD+K
Sbjct: 99  -ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIK 157

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAIDIWSV 190
             N+++     +K+ DFG A           +  T  Y APE+L+    Y    +++WS+
Sbjct: 158 DENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEMWSL 216

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G  L              Y     L+                       V          
Sbjct: 217 GVTL--------------YT----LVF-----------EENPFCELEETVEAAIHP---- 243

Query: 251 FATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ---SLHDLNDEPVCPRP 304
                P   S   + L+  +L   P +R T+E+ +  P++    +L D   E V    
Sbjct: 244 -----PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVN 296

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  144 bits (364), Expect = 2e-40
 Identities = 60/300 (20%), Positives = 119/300 (39%), Gaps = 57/300 (19%)

Query: 24  ETREEVAIKKI---------------GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI 68
           +  +  A+KK                 +             E++++  +++E  +  + I
Sbjct: 52  KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111

Query: 69  IRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKY 119
           I       +++VYI+  Y     ++  D +  +        +     +  +  +L    Y
Sbjct: 112 I-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166

Query: 120 VHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPE 173
           +H+  ++ HRD+KPSN+L++ +  +K+ DFG +    +          E++       PE
Sbjct: 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM------PPE 220

Query: 174 LLLNCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL--RLITELIGSPDDASLGF 230
              N + Y  A +DIWS+G  L  +      F  K  + +L   + T+ I  P D +   
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN--- 277

Query: 231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                       L     ++        S+  +D L+  L  +P +RIT E+AL+H +L 
Sbjct: 278 ----------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (356), Expect = 7e-40
 Identities = 55/275 (20%), Positives = 118/275 (42%), Gaps = 36/275 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            +++ET  EVA  ++ +      + +R   E ++L+ ++H N++   D      K     
Sbjct: 45  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KC 103

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--ASVLHRDLKPSNLL 136
           + +V ELM +  L   ++  + +     + +  Q+L+GL+++H+    ++HRDLK  N+ 
Sbjct: 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163

Query: 137 LNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +      +KIGD GLA     + F    + T  + APE+     +Y  ++D+++ G  + 
Sbjct: 164 ITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCML 220

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E+ T E  +       Q+         P  AS   +     +                  
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK------------------ 260

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   +++E  +  + ++R ++++ L H + Q
Sbjct: 261 --------EIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  141 bits (357), Expect = 1e-39
 Identities = 62/302 (20%), Positives = 114/302 (37%), Gaps = 60/302 (19%)

Query: 19  AAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLRHMEHE--NVIAIKDIIRPP 72
           + +       VAIK +     + +  + +  R   E+ LL+ +      VI + D     
Sbjct: 61  SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 117

Query: 73  KKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
             +  +   ++ E  +   DL   I     L ++  + F +Q+L  +++ H+  VLHRD+
Sbjct: 118 --ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDI 175

Query: 131 KPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA-IDIW 188
           K  N+L++    +LK+ DFG      +T +   +  TR Y  PE +     Y      +W
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRY-HRYHGRSAAVW 233

Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G +L              Y     ++            G +  ++    +R     R 
Sbjct: 234 SLGILL--------------YD----MVC-----------GDIPFEHDEEIIRGQVFFR- 263

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS------LHDLNDEPVCP 302
                     SS    L+   L   P+ R T EE   HP++Q         +++   + P
Sbjct: 264 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316

Query: 303 RP 304
            P
Sbjct: 317 GP 318

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  141 bits (357), Expect = 1e-39
 Identities = 63/307 (20%), Positives = 109/307 (35%), Gaps = 57/307 (18%)

Query: 19  AAVNSETREEVAIKKIG----NAFDNIIDARRTLREIKLLR----HMEHENVIAIKDIIR 70
           A      R +VAIK I       +  + D+     E+ LL        H  VI + D   
Sbjct: 49  AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF- 107

Query: 71  PPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
               +T     +V E      DL   I     L +   + F  Q++  +++ HS  V+HR
Sbjct: 108 ----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHR 163

Query: 129 DLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA-ID 186
           D+K  N+L++      K+ DFG      +  +   +  TR Y  PE +    +Y A    
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISR-HQYHALPAT 221

Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 246
           +WS+G +L              Y     ++            G +  +  +  +      
Sbjct: 222 VWSLGILL--------------YD----MVC-----------GDIPFERDQEILEAELHF 252

Query: 247 RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS-LHDLNDEPVCPRPF 305
                     + S     L+ + L   P+ R ++EE L  P++Q+   D+   P    P 
Sbjct: 253 P--------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPA 304

Query: 306 HFDFEHS 312
              +   
Sbjct: 305 PLAWSLL 311

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (350), Expect = 6e-39
 Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 42/283 (14%)

Query: 19  AAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A  +   +  +AIK+I               EI L +H++H+N++               
Sbjct: 40  AGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGSFS-----ENG 92

Query: 79  DVYIVYELMDTD-LHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            + I  E +    L  ++RS     +  +    ++  Q+L GLKY+H   ++HRD+K  N
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152

Query: 135 LLLNA-SCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPE-LLLNCTEYTAAIDIWSVG 191
           +L+N  S  LKI DFG ++  +  +  TE    T  Y APE +      Y  A DIWS+G
Sbjct: 153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           C + E+ T +P  P  +       +   +G                    ++P       
Sbjct: 213 CTIIEMATGKP--PFYELGEPQAAMF-KVGMFKVH--------------PEIP------- 248

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
                + S+ A   + K    DP+KR    + L   +L+    
Sbjct: 249 ----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  138 bits (350), Expect = 1e-38
 Identities = 66/299 (22%), Positives = 113/299 (37%), Gaps = 58/299 (19%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPPKKDTFN 78
            +N  T +E A+K I           R  RE+++L     H NV+ + +       +  +
Sbjct: 32  CINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEED 84

Query: 79  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
             Y+V+E M    +   I   +   +      +  +   L ++H+  + HRDLKP N+L 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144

Query: 138 ---NASCDLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELLLNCTE----YT 182
              N    +KI DF L          +   T  +     +  Y APE++   +E    Y 
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204

Query: 183 AAIDIWSVGCIL-----------GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 231
              D+WS+G IL           G   +      G+       ++ E I         F 
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE---GKYEFP 261

Query: 232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
             D                    + + S  A DL+ K+LV D  +R++  + L+HP++Q
Sbjct: 262 DKD--------------------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (350), Expect = 1e-38
 Identities = 58/279 (20%), Positives = 108/279 (38%), Gaps = 49/279 (17%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             + +T  + A+KK+      +   R    E+     +    ++ +   +R         
Sbjct: 77  MKDKQTGFQCAVKKV-----RLEVFRV--EELVACAGLSSPRIVPLYGAVR-----EGPW 124

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184

Query: 139 AS-CDLKIGDFGLAR-----TTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVG 191
           +      + DFG A         ++    +Y+  T  + APE+++      A +DIWS  
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSC 243

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
           C++  ++      P   Y  +  L    I S                   ++P       
Sbjct: 244 CMMLHMLNGCH--PWTQY-FRGPLCL-KIASEPPPIR-------------EIP------- 279

Query: 252 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
               P+ +      +++ L  +P  R +  E  R     
Sbjct: 280 ----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  139 bits (352), Expect = 3e-38
 Identities = 47/309 (15%), Positives = 88/309 (28%), Gaps = 71/309 (22%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRH-------MEHENVIAIKDI 68
           A + ET E   +           + I   +  +  ++LLR          H   I   D+
Sbjct: 97  ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156

Query: 69  IRPPKKDTFNDV------------YIVYELMDTDLHQIIRS-------DQQLTDDHCQYF 109
           ++ P+K     V            + +Y  M ++L              + L        
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 110 LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTR 167
             Q++R L  +H   ++H  L+P +++L+    + +  F        +            
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP 276

Query: 168 WYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
              A  +L     + T  T A D W++G  +  I   +        +     I       
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------- 329

Query: 224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 283
                                 C          N       LLE  L +    R+   +A
Sbjct: 330 -------------------FRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQA 361

Query: 284 LRHPYLQSL 292
           +  P  + L
Sbjct: 362 METPEYEQL 370

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  137 bits (348), Expect = 3e-38
 Identities = 59/292 (20%), Positives = 114/292 (39%), Gaps = 59/292 (20%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
           A +  +  E A+K++    +     R  ++E+  ++ +  H N++         K+++  
Sbjct: 47  AQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104

Query: 79  DVYIVYELMD----TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDL 130
                  L +      +  + + + +  L+ D      YQ  R ++++H     ++HRDL
Sbjct: 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDL 164

Query: 131 KPSNLLLNASCDLKIGDFGLART---------TSETDFMTEYVVTR----WYRAPEL--L 175
           K  NLLL+    +K+ DFG A T         +++   + E  +TR     YR PE+  L
Sbjct: 165 KVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224

Query: 176 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 235
            +        DIW++GCIL  +  R+  F                          LR  N
Sbjct: 225 YSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---------------------AKLRIVN 263

Query: 236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
             +Y   +P             + +    L+  ML  +P +R+++ E +   
Sbjct: 264 G-KY--SIP---------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  139 bits (353), Expect = 6e-38
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 51/309 (16%)

Query: 20  AVNSETREEVAIKKIG-NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             +  T  +VA+K +      ++    +  REI+ L+   H ++I +  +I      T +
Sbjct: 35  GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89

Query: 79  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           D+++V E +   +L   I  + +L +   +    Q+L G+ Y H   V+HRDLKP N+LL
Sbjct: 90  DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL 149

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGE 196
           +A  + KI DFGL+   S+ +F+     +  Y APE++     Y    +DIWS G IL  
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVIL-- 206

Query: 197 IMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
                       Y   L     L G+ P DD  +  L             +     F   
Sbjct: 207 ------------YA--L-----LCGTLPFDDDHVPTLFK-----------KICDGIF--Y 234

Query: 255 FPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSS 313
            P   +   + LL+ ML  DP KR T+++   H + +      D P    P    +  + 
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-----DLPKYLFPEDPSYSSTM 289

Query: 314 CTEDHIREL 322
             ++ ++E+
Sbjct: 290 IDDEALKEV 298

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  130 bits (329), Expect = 1e-35
 Identities = 58/287 (20%), Positives = 105/287 (36%), Gaps = 60/287 (20%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
             N  T+E+ A+K +        D  +  RE++L     +  +++ I D+          
Sbjct: 37  IFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89

Query: 79  DVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            + IV E +D      +I  R DQ  T+      +  +   ++Y+HS ++ HRD+KP NL
Sbjct: 90  -LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148

Query: 136 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           L      +  LK+ DFG                     A E      +Y  + D+WS+G 
Sbjct: 149 LYTSKRPNAILKLTDFGF--------------------AKETTG--EKYDKSCDMWSLGV 186

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I+  ++   P F     +     +   I         F   +                  
Sbjct: 187 IMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPNPE------------------ 225

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP 299
             +   S     L+  +L  +P +R+T+ E + HP++     +   P
Sbjct: 226 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  125 bits (316), Expect = 3e-33
 Identities = 77/353 (21%), Positives = 131/353 (37%), Gaps = 92/353 (26%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-----EHENVIAIKDIIRPPKK 74
           + + + ++ VA+K +  + ++  +      EI+LL+ +        N    ++++     
Sbjct: 56  SWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRNSDPNDPN----REMVVQLL- 107

Query: 75  DTFND-------VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS-AS 124
           D F         + +V+E++   L + I     Q L     +  + Q+L+GL Y+H+   
Sbjct: 108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR 167

Query: 125 VLHRDLKPSNLLLNAS-------------------------------------------- 140
           ++H D+KP N+LL+ +                                            
Sbjct: 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227

Query: 141 -----CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                  +KI D G A    +    TE + TR YR+ E+L+    Y    DIWS  C+  
Sbjct: 228 KNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAF 284

Query: 196 EIMTREPLFPGKD------YVHQLRLITELIGSPD-------DASLGFLRSDNARRYVRQ 242
           E+ T + LF              + LI EL+G            S  F       +++ +
Sbjct: 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344

Query: 243 LPRCRKQQFATRFPNKS----SGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           L      +        S    +G  D L  ML   P KR T  E LRHP+L S
Sbjct: 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  120 bits (302), Expect = 4e-32
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 24/199 (12%)

Query: 27  EEVAIKKIGNAFDNIIDARRT--LREIKLLRHMEHENVIAIKDI-IRPPKKDTFNDVYIV 83
           +EVA+K   +  D  I        +E KL   ++H N+IA++ + ++ P       + +V
Sbjct: 31  DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN------LCLV 84

Query: 84  YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS---ASVLHRDLKPSNLLLNA 139
            E      L++++   +++  D    +  Q+ RG+ Y+H      ++HRDLK SN+L+  
Sbjct: 85  MEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143

Query: 140 SCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
             +        LKI DFGLAR    T  M+      W  APE++   + ++   D+WS G
Sbjct: 144 KVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPEVI-RASMFSKGSDVWSYG 201

Query: 192 CILGEIMTREPLFPGKDYV 210
            +L E++T E  F G D +
Sbjct: 202 VLLWELLTGEVPFRGIDGL 220

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (306), Expect = 8e-32
 Identities = 56/316 (17%), Positives = 100/316 (31%), Gaps = 44/316 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-- 77
           A    T E V +++I     +         E+ + +   H N++  +         TF  
Sbjct: 46  ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA--------TFIA 97

Query: 78  -NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
            N++++V   M      DL      D  + +    Y L  +L+ L Y+H    +HR +K 
Sbjct: 98  DNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLKALDYIHHMGYVHRSVKA 156

Query: 133 SNLLLNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELLL-NCTEYTA 183
           S++L++    + +              R     DF    V    + +PE+L  N   Y A
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216

Query: 184 AIDIWSVGCILGEIMTREP----------LF-------PGKDYVHQLRLITELIGSPDDA 226
             DI+SVG    E+               L        P       +      +      
Sbjct: 217 KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276

Query: 227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
           +   L         R            R    S      +E+ L  +P+ R +    L H
Sbjct: 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHR--TFSPHFHHFVEQCLQRNPDARPSASTLLNH 334

Query: 287 PYLQSLHDLNDEPVCP 302
            + + +     E +  
Sbjct: 335 SFFKQIKRRASEALPE 350

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (296), Expect = 4e-31
 Identities = 45/194 (23%), Positives = 86/194 (44%), Gaps = 13/194 (6%)

Query: 26  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 85
             +VA+K +          +    E+ +LR   H N++        P+      + IV +
Sbjct: 46  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ------LAIVTQ 99

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
             +   L+  + + + +           Q  RG+ Y+H+ S++HRDLK +N+ L+    +
Sbjct: 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159

Query: 144 KIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIM 198
           KIGDFGLA      S +    +   +  + APE++       Y+   D+++ G +L E+M
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219

Query: 199 TREPLFPGKDYVHQ 212
           T +  +   +   Q
Sbjct: 220 TGQLPYSNINNRDQ 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (296), Expect = 4e-31
 Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 53/285 (18%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIA-----IKDIIRPPK 73
             +  + + +A+K+I  A  N  + +R L ++   +R ++    +       ++      
Sbjct: 26  MRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE------ 78

Query: 74  KDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHR 128
                DV+I  ELMDT       Q+I   Q + +D        +++ L+++HS  SV+HR
Sbjct: 79  ----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE---LLLNCTEYTAAI 185
           D+KPSN+L+NA   +K+ DFG++    +          + Y APE     LN   Y+   
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKS 194

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DIWS+G  + E+      FP   +    + + +++  P                    P+
Sbjct: 195 DIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQ 233

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
               +F       S+  VD   + L  +  +R T  E ++HP+  
Sbjct: 234 LPADKF-------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  117 bits (296), Expect = 7e-31
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 15/192 (7%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIVYE 85
            +VA+K +     +       LRE+ +++ + H N++  +  + +PP       + IV E
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN------LSIVTE 114

Query: 86  LMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS--ASVLHRDLKPSNLLLNA 139
            +    L++++      +QL +       Y + +G+ Y+H+    ++HR+LK  NLL++ 
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174

Query: 140 SCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFGL+R  + T         T  + APE +L         D++S G IL E+ 
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELA 233

Query: 199 TREPLFPGKDYV 210
           T +  +   +  
Sbjct: 234 TLQQPWGNLNPA 245

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  117 bits (295), Expect = 8e-31
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 22/194 (11%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
           ++VAIK+I    ++  + +  + E++ L  + H N++ +            N V +V E 
Sbjct: 32  KDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGA-------CLNPVCLVMEY 80

Query: 87  MDT-DLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHS---ASVLHRDLKPSNLLLNA 139
            +   L+ ++   +     T  H   +  Q  +G+ Y+HS    +++HRDLKP NLLL A
Sbjct: 81  AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140

Query: 140 SCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
               LKI DFG A        MT    +  + APE +   + Y+   D++S G IL E++
Sbjct: 141 GGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVI 197

Query: 199 TREPLFPGKDYVHQ 212
           TR   F        
Sbjct: 198 TRRKPFDEIGGPAF 211

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (293), Expect = 3e-30
 Identities = 58/292 (19%), Positives = 119/292 (40%), Gaps = 33/292 (11%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-----IKDIIRPPKK 74
             +  +   +A K I +         + +RE+++L       ++        D       
Sbjct: 52  VSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD------- 103

Query: 75  DTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 132
               ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KP
Sbjct: 104 ---GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           SN+L+N+  ++K+ DFG++    ++   + +V TR Y +PE L   T Y+   DIWS+G 
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQG-THYSVQSDIWSMGL 218

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELI-----------GSPDDASLGFLRSDNARRYVR 241
            L E+       P  D      +    +            +P      F         + 
Sbjct: 219 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF 278

Query: 242 QLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           +L      +   + P+   S    D + K L+ +P +R  +++ + H +++ 
Sbjct: 279 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (290), Expect = 4e-30
 Identities = 46/200 (23%), Positives = 85/200 (42%), Gaps = 24/200 (12%)

Query: 26  REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIVY 84
             EVAI+ I    DN    +   RE+   R   HENV+  +   + PP       + I+ 
Sbjct: 55  HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH------LAIIT 108

Query: 85  ELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            L     L+ ++R     L  +  +    ++++G+ Y+H+  +LH+DLK  N+  + +  
Sbjct: 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK 167

Query: 143 LKIGDFGLARTTSETDFMTEY----VVTRWYR--APELLLNCTE--------YTAAIDIW 188
           + I DFGL   +             +   W    APE++   +         ++   D++
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227

Query: 189 SVGCILGEIMTREPLFPGKD 208
           ++G I  E+  RE  F  + 
Sbjct: 228 ALGTIWYELHAREWPFKTQP 247

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  114 bits (287), Expect = 6e-30
 Identities = 34/187 (18%), Positives = 67/187 (35%), Gaps = 14/187 (7%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
            ++ +K +     +   +R    E   LR   H NV+ +    + P         ++   
Sbjct: 34  NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP---TLITHW 90

Query: 87  MDT-DLHQIIRSDQQLTDDHCQY--FLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASC 141
           M    L+ ++        D  Q   F   + RG+ ++H+    +    L   +++++   
Sbjct: 91  MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150

Query: 142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMT 199
             +I    +  +      M       W  APE L          + D+WS   +L E++T
Sbjct: 151 TARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTNRRSADMWSFAVLLWELVT 206

Query: 200 REPLFPG 206
           RE  F  
Sbjct: 207 REVPFAD 213

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  114 bits (287), Expect = 8e-30
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 26/201 (12%)

Query: 27  EEVAIKKI-GNAFDNIIDARRTL----REIKLLRHMEHENVIAIKDI-IRPPKKDTFNDV 80
             VAIK +     +   +         RE+ ++ ++ H N++ +  +   PP        
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-------- 96

Query: 81  YIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS--ASVLHRDLKPSNLL 136
            +V E +   DL+  +      +        +  +  G++Y+ +    ++HRDL+  N+ 
Sbjct: 97  RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156

Query: 137 L-----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSV 190
           L     NA    K+ DFGL++ +  +  ++  +    + APE +    E YT   D +S 
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214

Query: 191 GCILGEIMTREPLFPGKDYVH 211
             IL  I+T E  F    Y  
Sbjct: 215 AMILYTILTGEGPFDEYSYGK 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (286), Expect = 1e-29
 Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 58/294 (19%)

Query: 20  AVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIA-----IKDIIRPP 72
           A  +  +E+VAIK+I       ++ +  +   EI+ +    H N+++     +       
Sbjct: 34  AYCAPKKEKVAIKRINLEKCQTSMDELLK---EIQAMSQCHHPNIVSYYTSFVVK----- 85

Query: 73  KKDTFNDVYIVYELMD----TDLHQIIRSDQQ-----LTDDHCQYFLYQLLRGLKYVHSA 123
                +++++V +L+      D+ + I +  +     L +      L ++L GL+Y+H  
Sbjct: 86  -----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLN 177
             +HRD+K  N+LL     ++I DFG++   +    +T       +V T  + APE++  
Sbjct: 141 GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200

Query: 178 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 237
              Y    DIWS G    E+ T     P   Y   ++++              L   N  
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAA--PYHKY-PPMKVL-------------MLTLQNDP 244

Query: 238 RYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                 P             K       ++   L  DP KR T  E LRH + Q
Sbjct: 245 ------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  113 bits (285), Expect = 5e-29
 Identities = 60/279 (21%), Positives = 119/279 (42%), Gaps = 47/279 (16%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTF- 77
           A +    E VAIKK+  +     +  + + +E++ L+ + H N I  +          + 
Sbjct: 73  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG--------CYL 124

Query: 78  --NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
             +  ++V E        ++    + L +       +  L+GL Y+HS +++HRD+K  N
Sbjct: 125 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 184

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGC 192
           +LL+    +K+GDFG A   +  +     V T ++ APE++L   E  Y   +D+WS+G 
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
              E+  R+P  P  + ++ +  +             +  + N      + P  +   ++
Sbjct: 242 TCIELAERKP--PLFN-MNAMSAL-------------YHIAQN------ESPALQSGHWS 279

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
             F        + ++  L   P  R T E  L+H ++  
Sbjct: 280 EYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 5e-29
 Identities = 64/283 (22%), Positives = 124/283 (43%), Gaps = 44/283 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI-IRPPKKDTF 77
             + +T +  AIK +    D   + ++   EI +L+    H N+       I+       
Sbjct: 43  GRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYGAFIKKNPPGMD 99

Query: 78  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 133
           + +++V E       TDL +  +    L ++   Y   ++LRGL ++H   V+HRD+K  
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158

Query: 134 NLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTE----YTAAIDIW 188
           N+LL  + ++K+ DFG++     T      ++ T ++ APE++         Y    D+W
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218

Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+G    E+    P  P  D +H +R +             FL   N        PR + 
Sbjct: 219 SLGITAIEMAEGAP--PLCD-MHPMRAL-------------FLIPRN------PAPRLKS 256

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           ++++ +F          +E  LV + ++R   E+ ++HP+++ 
Sbjct: 257 KKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 7e-29
 Identities = 37/286 (12%), Positives = 78/286 (27%), Gaps = 63/286 (22%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           +++ +++  +K    A  N  +     + ++ L+       +              N   
Sbjct: 91  DAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAH-----LFQNGSV 143

Query: 82  IVYELMD-TDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           +V EL     L   I       ++ +       F  ++L  ++ VH   ++H D+KP N 
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203

Query: 136 LLNASCD-----------LKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCTEY 181
           +L                L + D G +       +    T    T  ++  E+L N   +
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-W 262

Query: 182 TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
              ID + V   +  ++    +    +                            RR   
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNEGGE------------------CKPEGLFRRL-- 302

Query: 242 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 287
                                 +    ML       +   + LR  
Sbjct: 303 ---------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  111 bits (279), Expect = 1e-28
 Identities = 67/281 (23%), Positives = 126/281 (44%), Gaps = 53/281 (18%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-- 77
           A++  T +EVAI+++             + EI ++R  ++ N++   D        ++  
Sbjct: 39  AMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD--------SYLV 88

Query: 78  -NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
            +++++V E +     TD    + ++  + +        + L+ L+++HS  V+HRD+K 
Sbjct: 89  GDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144

Query: 133 SNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 191
            N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLG 203

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 251
            +  E++  EP  P  +  + LR +             +L + N        P  +    
Sbjct: 204 IMAIEMIEGEP--PYLN-ENPLRAL-------------YLIATNGT------PELQN--- 238

Query: 252 ATRFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHPYLQS 291
               P K S    D L + L  D  KR + +E L+H +L+ 
Sbjct: 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (281), Expect = 1e-28
 Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 73/291 (25%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           A    +  +VA+K +        + +        E+ ++R  +H NV+ +          
Sbjct: 64  AREKHSGRQVAVKMMDLRKQQRRELLF------NEVVIMRDYQHFNVVEMYK-------- 109

Query: 76  TF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
           ++    +++++ E +     TD+   +R    L ++        +L+ L Y+H+  V+HR
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQGVIHR 165

Query: 129 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
           D+K  ++LL     +K+ DFG  A+ + +       V T ++ APE++   + Y   +DI
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDI 224

Query: 188 WSVGCILGEIMTRE------PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR 241
           WS+G     IM  E      P F        ++ +                 D+      
Sbjct: 225 WSLG-----IMVIEMVDGEPPYF----SDSPVQAM-------------KRLRDSPP---- 258

Query: 242 QLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
             P+ +   + +           D LE+MLV DP +R T +E L HP+L  
Sbjct: 259 --PKLKNSHKVSPVL-------RDFLERMLVRDPQERATAQELLDHPFLLQ 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  111 bits (279), Expect = 1e-28
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 29/202 (14%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVY 81
           ET E + +K++    +   + +RT L+E+K++R +EH NV+  I  + +  +      + 
Sbjct: 33  ETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR------LN 83

Query: 82  IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
            + E +    L  II+S D Q        F   +  G+ Y+HS +++HRDL   N L+  
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 143

Query: 140 SCDLKIGDFGLARTTSETDF---------------MTEYVVTRWYRAPELLLNCTEYTAA 184
           + ++ + DFGLAR   +                      V   ++ APE++     Y   
Sbjct: 144 NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEK 202

Query: 185 IDIWSVGCILGEIMTREPLFPG 206
           +D++S G +L EI+ R    P 
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPD 224

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (276), Expect = 7e-28
 Identities = 57/286 (19%), Positives = 120/286 (41%), Gaps = 51/286 (17%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIA-----IKDIIRPPK 73
            V+  + + +A+K+I  +  +  + ++ L ++  ++R  +   ++       ++      
Sbjct: 41  MVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE------ 93

Query: 74  KDTFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLH 127
                D +I  ELM T   +  +      D  + ++         ++ L ++     ++H
Sbjct: 94  ----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149

Query: 128 RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAA 184
           RD+KPSN+LL+ S ++K+ DFG++    ++   T     R Y APE +    +   Y   
Sbjct: 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR 209

Query: 185 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
            D+WS+G  L E+ T    FP   +      +T+++                     QL 
Sbjct: 210 SDVWSLGITLYELATGR--FPYPKWNSVFDQLTQVVKGD----------------PPQLS 251

Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
              +++F       S   ++ +   L  D +KR   +E L+HP++ 
Sbjct: 252 NSEEREF-------SPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (273), Expect = 1e-27
 Identities = 72/282 (25%), Positives = 126/282 (44%), Gaps = 55/282 (19%)

Query: 20  AVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A++ ET + VAIK++   +    II      +EI +++  +  +V+            ++
Sbjct: 48  AIHKETGQIVAIKQVPVESDLQEII------KEISIMQQCDSPHVVKYYG--------SY 93

Query: 78  ---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
               D++IV E       +D+ ++   ++ LT+D     L   L+GL+Y+H    +HRD+
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151

Query: 131 KPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           K  N+LLN     K+ DFG+  + T         + T ++ APE++     Y    DIWS
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWS 210

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G    E+   +P  P  D +H +R I             F+   N        P  RK 
Sbjct: 211 LGITAIEMAEGKP--PYAD-IHPMRAI-------------FMIPTNPP------PTFRKP 248

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
           +        S    D +++ LV  P +R T  + L+HP+++S
Sbjct: 249 E------LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  108 bits (271), Expect = 3e-27
 Identities = 49/195 (25%), Positives = 78/195 (40%), Gaps = 26/195 (13%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIVYE 85
           E+VA+K     F     +     EI     M HEN++  I   I+     T   +Y++ +
Sbjct: 61  EKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT--QLYLITD 115

Query: 86  LMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLL 136
             +   L+  ++S   L         Y  + GL ++H+         ++ HRDLK  N+L
Sbjct: 116 YHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174

Query: 137 LNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELL-----LNCTEYTAAID 186
           +  +    I D GLA      T          V T+ Y  PE+L      N  +     D
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234

Query: 187 IWSVGCILGEIMTRE 201
           ++S G IL E+  R 
Sbjct: 235 MYSFGLILWEVARRC 249

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (270), Expect = 3e-27
 Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 50/284 (17%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIA-----IKDIIRPPK 73
               +T   +A+K++     N  + +R L ++  +L+  +   ++      I +      
Sbjct: 44  MRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN------ 96

Query: 74  KDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLK 131
                DV+I  ELM T   ++  R    + +         +++ L Y+     V+HRD+K
Sbjct: 97  ----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK 152

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE----LLLNCTEYTAAIDI 187
           PSN+LL+    +K+ DFG++    +            Y APE          +Y    D+
Sbjct: 153 PSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS+G  L E+ T +  FP K+      ++T+++                      LP   
Sbjct: 213 WSLGISLVELATGQ--FPYKNCKTDFEVLTKVLQEE----------------PPLLP--G 252

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
              F       S      ++  L  D  KR    + L H +++ 
Sbjct: 253 HMGF-------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (277), Expect = 5e-27
 Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 20/239 (8%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
            V +K + ++ D        + E + L  + H +++ I + +    +      YIV E +
Sbjct: 108 PVVLKGLVHSGDAE-AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166

Query: 88  D-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 146
               L +     Q+L       +L ++L  L Y+HS  +++ DLKP N++L     LK+ 
Sbjct: 167 GGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI 223

Query: 147 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 206
           D G     +   ++     T  ++APE++   T  T A DI++VG  L  +    P   G
Sbjct: 224 DLGAVSRINSFGYL---YGTPGFQAPEIVR--TGPTVATDIYTVGRTLAALTLDLPTRNG 278

Query: 207 KDYVHQLRLITELIGSP---DDASLGFLRSDNARRY------VRQLPRCRKQQFATRFP 256
             YV  L     ++ +           +  D  +R+        QL    ++  A    
Sbjct: 279 -RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  107 bits (268), Expect = 5e-27
 Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 30/197 (15%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLRE--IKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIV 83
           E VA+K       +  D +   RE  +     + HEN++  I   +      T   ++++
Sbjct: 32  ENVAVKIF-----SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST--QLWLI 84

Query: 84  YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSN 134
               +   L+  ++    L    C   +  +  GL ++H          ++ HRDLK  N
Sbjct: 85  THYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL-----LNCTEYTAA 184
           +L+  +    I D GLA   S++    +        T+ Y APE+L     ++C +    
Sbjct: 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203

Query: 185 IDIWSVGCILGEIMTRE 201
           +DIW+ G +L E+  R 
Sbjct: 204 VDIWAFGLVLWEVARRM 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (267), Expect = 6e-27
 Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 62/294 (21%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
           A N ET    A K I        ++ I       EI++L   +H  ++ +          
Sbjct: 38  AKNKETGALAAAKVIETKSEEELEDYI------VEIEILATCDHPYIVKLLG-------- 83

Query: 76  TF---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
            +     ++I+ E         +  ++  D+ LT+   Q    Q+L  L ++HS  ++HR
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141

Query: 129 DLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT----EYTA 183
           DLK  N+L+    D+++ DFG+ A+          ++ T ++ APE+++  T     Y  
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201

Query: 184 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 243
             DIWS+G  L E+   EP  P  + ++ +R++                + +        
Sbjct: 202 KADIWSLGITLIEMAQIEP--PHHE-LNPMRVL-------------LKIAKSDP------ 239

Query: 244 PRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           P           P+K S    D L+  L  +P  R +  + L HP++ S+    
Sbjct: 240 PTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (264), Expect = 2e-26
 Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 56/282 (19%)

Query: 20  AVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
            +++ T++ VAIK I    A D I D ++   EI +L   +   V             ++
Sbjct: 41  GIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYYG--------SY 89

Query: 78  ---NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
                ++I+ E +      DL +       L +      L ++L+GL Y+HS   +HRD+
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDI 145

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           K +N+LL+   ++K+ DFG+A   ++T      +V T ++ APE++   + Y +  DIWS
Sbjct: 146 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWS 204

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G    E+   EP  P  +  H ++++             FL           +P+    
Sbjct: 205 LGITAIELARGEP--PHSEL-HPMKVL-------------FL-----------IPKNNPP 237

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
                +   S    + +E  L  +P+ R T +E L+H ++  
Sbjct: 238 TLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  102 bits (256), Expect = 4e-25
 Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 42/293 (14%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIVYE 85
           E VA+K           + +   E+  L  M+HEN++  I    R    D   D++++  
Sbjct: 48  EYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV--DLWLITA 102

Query: 86  LMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA----------SVLHRDLKPSN 134
             +   L   +++   ++ +   +    + RGL Y+H            ++ HRD+K  N
Sbjct: 103 FHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161

Query: 135 LLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDI 187
           +LL  +    I DFGLA               V TR Y APE+L        +    ID+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR-QLP-R 245
           +++G +L E+ +R     G    + L    E+       SL  ++     +  R  L   
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEI---GQHPSLEDMQEVVVHKKKRPVLRDY 278

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLHDL 295
            +K               + +E+    D   R++   V E +    +Q L ++
Sbjct: 279 WQKHAGMAML-------CETIEECWDHDAEARLSAGCVGERITQ--MQRLTNI 322

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  101 bits (252), Expect = 1e-24
 Identities = 45/204 (22%), Positives = 77/204 (37%), Gaps = 30/204 (14%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLRE--IKLLRHMEHENVIA-IKDIIRPPKKDTFNDVYIV 83
           EEVA+K       +  + R   RE  I     + HEN++  I    +     T   +++V
Sbjct: 66  EEVAVKIF-----SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT--QLWLV 118

Query: 84  YELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSN 134
            +  +   L   +     +T +           GL ++H          ++ HRDLK  N
Sbjct: 119 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL-----LNCTEYTAA 184
           +L+  +    I D GLA          +        T+ Y APE+L     +   E    
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237

Query: 185 IDIWSVGCILGEIMTREPLFPGKD 208
            DI+++G +  EI  R  +    +
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHE 261

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 96.6 bits (241), Expect = 5e-23
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 22/215 (10%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRT-LREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
              T   VA+K++     +  D +R   REI++L+ +  + ++  + +   P + +   +
Sbjct: 48  GDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS---L 101

Query: 81  YIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            +V E + +  L   ++    +L       +  Q+ +G++Y+ S   +HRDL   N+L+ 
Sbjct: 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 161

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVG 191
           +   +KI DFGLA+          YVV         WY APE L +   ++   D+WS G
Sbjct: 162 SEAHVKIADFGLAKLLPLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSFG 217

Query: 192 CILGEIMT--REPLFPGKDYVHQLRLITELIGSPD 224
            +L E+ T   +   P  +++  +    ++     
Sbjct: 218 VVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.8 bits (239), Expect = 6e-23
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 22  NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
              T E+VA+K  K  +  ++I D     +EI++LR++ HEN++  K I     +D  N 
Sbjct: 46  GDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGIC---TEDGGNG 99

Query: 80  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + ++ E + +  L + +     ++       +  Q+ +G+ Y+ S   +HRDL   N+L+
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 190
            +   +KIGDFGL +          Y V         WY APE L+    +  A D+WS 
Sbjct: 160 ESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY-APECLMQSK-FYIASDVWSF 215

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
           G  L E++T             + L  ++IG  
Sbjct: 216 GVTLHELLTY-----CDSDSSPMALFLKMIGPT 243

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 95.8 bits (239), Expect = 7e-23
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 16/186 (8%)

Query: 28  EVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV-YIV 83
            VA+K +     +  D     R  RE +    ++  +V+ I D          +   Y+ 
Sbjct: 61  IVALKLMSETLSS--DPVFRTRMQREARTAGRLQEPHVVPIHDF------GEIDGQLYVD 112

Query: 84  YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
             L++  DL  ++R    L        + Q+   L   H+A   HRD+KP N+L++A   
Sbjct: 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF 172

Query: 143 LKIGDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
             + DFG+A  T++         V T +Y APE     +  T   DI+++ C+L E +T 
Sbjct: 173 AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTG 231

Query: 201 EPLFPG 206
            P + G
Sbjct: 232 SPPYQG 237

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 18/187 (9%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
              T E VA+KK+ ++ +     R   REI++L+ ++H+N++  K +     +     + 
Sbjct: 66  QDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LK 120

Query: 82  IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++ E +    L   ++   +++       +  Q+ +G++Y+ +   +HRDL   N+L+  
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGC 192
              +KIGDFGL +   +      Y V         WY APE L     ++ A D+WS G 
Sbjct: 181 ENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGV 236

Query: 193 ILGEIMT 199
           +L E+ T
Sbjct: 237 VLYELFT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 18/187 (9%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
              T E VA+KK+ ++ +     R   REI++L+ ++H+N++  K +     +     + 
Sbjct: 35  QDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LK 89

Query: 82  IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++ E +    L   ++   +++       +  Q+ +G++Y+ +   +HRDL   N+L+  
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 149

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGC 192
              +KIGDFGL +   +      + V         WY APE L     ++ A D+WS G 
Sbjct: 150 ENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGV 205

Query: 193 ILGEIMT 199
           +L E+ T
Sbjct: 206 VLYELFT 212

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 52/258 (20%), Positives = 112/258 (43%), Gaps = 45/258 (17%)

Query: 43  DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQIIRSD 98
           + R   +E+++++ +EH  ++ +          +F    D+++V +L+   DL   ++ +
Sbjct: 58  EVRNVFKELQIMQGLEHPFLVNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQN 109

Query: 99  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 158
               ++  + F+ +L+  L Y+ +  ++HRD+KP N+LL+    + I DF +A       
Sbjct: 110 VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

Query: 159 FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 216
            +T    T+ Y APE+  +     Y+ A+D WS+G    E++     +  +         
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-------- 221

Query: 217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPN 275
                           S +++  V              +P+  S   V LL+K+L  +P+
Sbjct: 222 ----------------STSSKEIVHTFETTVV-----TYPSAWSQEMVSLLKKLLEPNPD 260

Query: 276 KRI-TVEEALRHPYLQSL 292
           +R   + +    PY+  +
Sbjct: 261 QRFSQLSDVQNFPYMNDI 278

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 60/186 (32%), Positives = 97/186 (52%), Gaps = 16/186 (8%)

Query: 28  EVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV-YIV 83
           +VAIK I             +R  RE+     + H+N++++ D+      D  +D  Y+V
Sbjct: 38  KVAIKAIFIPPRE--KEETLKRFEREVHNSSQLSHQNIVSMIDV------DEEDDCYYLV 89

Query: 84  YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            E ++   L + I S   L+ D    F  Q+L G+K+ H   ++HRD+KP N+L++++  
Sbjct: 90  MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149

Query: 143 LKIGDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           LKI DFG+A+  SET    T +V+ T  Y +PE            DI+S+G +L E++  
Sbjct: 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVG 208

Query: 201 EPLFPG 206
           EP F G
Sbjct: 209 EPPFNG 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 26/212 (12%)

Query: 22  NSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           N  T E VA+K  K      +        +EI +LR + HE++I  K         +   
Sbjct: 56  NDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYHEHIIKYKGCCEDAGAAS--- 109

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           + +V E +    L   +     +       F  Q+  G+ Y+H+   +HRDL   N+LL+
Sbjct: 110 LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVG 191
               +KIGDFGLA+   E      Y V         WY APE L     +  A D+WS G
Sbjct: 169 NDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-APECLKEYK-FYYASDVWSFG 224

Query: 192 CILGEIMTREPLFPGKDYVHQLRLITELIGSP 223
             L E++T                  ELIG  
Sbjct: 225 VTLYELLTH-----CDSSQSPPTKFLELIGIA 251

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 60/282 (21%)

Query: 24  ETREEVAIKKIGNAFDNII---DARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
            T  E AIK +     +II         RE  ++  ++H   + +          TF D 
Sbjct: 53  ATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKLYF--------TFQDD 102

Query: 81  YIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
             +Y  +      +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+L
Sbjct: 103 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 162

Query: 137 LNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           LN    ++I DFG A+     S+      +V T  Y +PELL        + D+W++GCI
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCI 221

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           + +++   P F   +      LI + I          ++ +                   
Sbjct: 222 IYQLVAGLPPFRAGNE----YLIFQKI----------IKLE------------------Y 249

Query: 254 RFPNK-SSGAVDLLEKMLVFDPNKRIT------VEEALRHPY 288
            FP K    A DL+EK+LV D  KR+             HP+
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 42/196 (21%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDV 80
             +  + VA+K + N  ++       L E  +++ +++  ++ +  I             
Sbjct: 40  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-------W 92

Query: 81  YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
            +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL  
Sbjct: 93  MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 152

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGC 192
               KI DFGL++     +    Y          +WY APE  +N  ++++  D+WS G 
Sbjct: 153 QHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGV 208

Query: 193 ILGEIMT--REPLFPG 206
           ++ E  +  ++P + G
Sbjct: 209 LMWEAFSYGQKP-YRG 223

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 65/320 (20%), Positives = 109/320 (34%), Gaps = 55/320 (17%)

Query: 27  EEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDVY 81
             VA+K         F N        + I  +  MEH+N+   I    R           
Sbjct: 37  RPVAVKVFSFANRQNFIN-------EKNIYRVPLMEHDNIARFIVGDERVTADGRME-YL 88

Query: 82  IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVLHRDLK 131
           +V E      L + +               + + RGL Y+H+          ++ HRDL 
Sbjct: 89  LVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDF---------MTEYVVTRWYRAPELL------L 176
             N+L+       I DFGL+   +                 V T  Y APE+L       
Sbjct: 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207

Query: 177 NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSD 234
           +       +D++++G I  EI  R   LFPG+    +Q+   TE+    +  +   ++  
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV---GNHPTFEDMQVL 264

Query: 235 NARRYVR-QLP-RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
            +R   R + P   ++   A R         + +E     D   R+T + A     +  L
Sbjct: 265 VSREKQRPKFPEAWKENSLAVR------SLKETIEDCWDQDAEARLTAQXAEE--RMAEL 316

Query: 293 HDLNDEPVCPRPF-HFDFEH 311
             + +      P  H    H
Sbjct: 317 MMIWERNKSVSPTAHHHHHH 336

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 25/191 (13%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIV 83
            VA+K  +     D        L+E ++L+   H N++ +  +   + P       +YIV
Sbjct: 141 LVAVKSCRETLPPDLKAKF---LQEARILKQYSHPNIVRLIGVCTQKQP-------IYIV 190

Query: 84  YELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
            EL+   D    +R+   +L        +     G++Y+ S   +HRDL   N L+    
Sbjct: 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250

Query: 142 DLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            LKI DFG++R  ++  +     +     +W  APE L     Y++  D+WS G +L E 
Sbjct: 251 VLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSESDVWSFGILLWET 308

Query: 198 MT--REPLFPG 206
            +    P +P 
Sbjct: 309 FSLGASP-YPN 318

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 25/192 (13%)

Query: 28  EVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYE 85
            VA+K +  +           +RE+  +  ++H N+I +  ++  PP       + +V E
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTE 100

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           L     L   +R             +  Q+  G+ Y+ S   +HRDL   NLLL     +
Sbjct: 101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 160

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           KIGDFGL R   + D    YV+         W  APE  L    ++ A D W  G  L E
Sbjct: 161 KIGDFGLMRALPQND--DHYVMQEHRKVPFAWC-APE-SLKTRTFSHASDTWMFGVTLWE 216

Query: 197 IMT--REPLFPG 206
           + T  +EP + G
Sbjct: 217 MFTYGQEP-WIG 227

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 37/224 (16%)

Query: 76  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            +++     F      H+ +   E+                  R    +           
Sbjct: 382 FKLLRGHSPF----RQHKTKDKHEID-----------------RMTLTMA--------VE 412

Query: 255 FPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
            P+  S     LLE +L  D N+R+       +E    P+ +SL
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 54/254 (21%), Positives = 104/254 (40%), Gaps = 44/254 (17%)

Query: 76  TFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
           T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWS 189
           KP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D ++
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFA 374

Query: 190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 249
           +G  L E++     F  +    + + + + +                             
Sbjct: 375 LGVTLYEMIAARGPFRARGEKVENKELKQRV-----------LEQAV------------- 410

Query: 250 QFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVC 301
                +P+K S  + D  E +L  DP KR+     + +    HP  + +    L    + 
Sbjct: 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466

Query: 302 PRPFHFDFEHSSCT 315
           P PF  D       
Sbjct: 467 P-PFVPDSRTVYAK 479

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 88.4 bits (220), Expect = 2e-20
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 31/193 (16%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVY 84
            VAIK  K   +          L+E   +R  +H +++ +  +I   P       V+I+ 
Sbjct: 45  AVAIKTCKNCTSDSVREKF---LQEALTMRQFDHPHIVKLIGVITENP-------VWIIM 94

Query: 85  ELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           EL    +L   ++     L       + YQL   L Y+ S   +HRD+   N+L++++  
Sbjct: 95  ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 154

Query: 143 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +K+GDFGL+R   ++     Y          +W  APE  +N   +T+A D+W  G  + 
Sbjct: 155 VKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMW 208

Query: 196 EIMT--REPLFPG 206
           EI+    +P F G
Sbjct: 209 EILMHGVKP-FQG 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 28/191 (14%)

Query: 29  VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYE 85
           VAIK  +   +     +    L E  ++  +++ +V  +  I            V ++ +
Sbjct: 47  VAIKELREATSPKANKE---ILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           LM    L   +R     +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156

Query: 144 KIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           KI DFGLA+     +   EY         +W  A E  +    YT   D+WS G  + E+
Sbjct: 157 KITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWEL 212

Query: 198 MT--REPLFPG 206
           MT   +P + G
Sbjct: 213 MTFGSKP-YDG 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 43/184 (23%), Positives = 86/184 (46%), Gaps = 24/184 (13%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 85
           +VAIK  K G    +  +    +RE +++  +++  ++ +  +           + +V E
Sbjct: 39  DVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRLIGVC------QAEALMLVME 89

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           +     LH+ +    +++   +    L+Q+  G+KY+   + +HRDL   N+LL      
Sbjct: 90  MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           KI DFGL++     D  + Y          +WY APE  +N  ++++  D+WS G  + E
Sbjct: 150 KISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWE 205

Query: 197 IMTR 200
            ++ 
Sbjct: 206 ALSY 209

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.1 bits (219), Expect = 4e-20
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 12/187 (6%)

Query: 28  EVAIKKIGNAFDNIIDA---RRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
           +VA+K +        D     R  RE +    + H  ++A+ D             YIV 
Sbjct: 39  DVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVM 95

Query: 85  ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A+  +
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155

Query: 144 KIGDFGLARTTSETDF---MTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L E++T
Sbjct: 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLT 214

Query: 200 REPLFPG 206
            EP F G
Sbjct: 215 GEPPFTG 221

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)

Query: 76  TFNDVYIVYELMDT-DL-HQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 132
           T + + +V  LM+  DL   I    Q    +    ++  ++  GL+ +H   +++RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314

Query: 133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
            N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + D W++GC
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGC 373

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           +L E++  +  F  +    +   +  L+                            ++  
Sbjct: 374 LLYEMIAGQSPFQQRKKKIKREEVERLV----------------------------KEVP 405

Query: 253 TRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
             +  + S  A  L  ++L  DP +R+     +  E   HP  + L
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 42/184 (22%), Positives = 86/184 (46%), Gaps = 24/184 (13%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYE 85
           +VAIK  K G    +  +    +RE +++  +++  ++ +  +           + +V E
Sbjct: 365 DVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRLIGVC------QAEALMLVME 415

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           +     LH+ +    +++   +    L+Q+  G+KY+   + +HR+L   N+LL      
Sbjct: 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA 475

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           KI DFGL++     D  + Y          +WY APE  +N  ++++  D+WS G  + E
Sbjct: 476 KISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWE 531

Query: 197 IMTR 200
            ++ 
Sbjct: 532 ALSY 535

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 86.5 bits (215), Expect = 9e-20
 Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 33/192 (17%)

Query: 28  EVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFND 79
           +VA+K I       AF         L E  ++  + H N++ +  +I   +         
Sbjct: 46  KVAVKCIKNDATAQAF---------LAEASVMTQLRHSNLVQLLGVIVEEKGG------- 89

Query: 80  VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +YIV E M    L   +RS     L  D    F   +   ++Y+   + +HRDL   N+L
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++     K+ DFGL +  S T    +  V +W  APE  L   +++   D+WS G +L E
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGILLWE 206

Query: 197 IMT--REPLFPG 206
           I +  R P +P 
Sbjct: 207 IYSFGRVP-YPR 217

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 28/191 (14%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           +VA+K +       +     L E  +++ ++H+ ++ +  ++      T   +YI+ E M
Sbjct: 214 KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV------TKEPIYIITEFM 264

Query: 88  DT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
               L   ++SD   +        F  Q+  G+ ++   + +HRDL+ +N+L++AS   K
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK 324

Query: 145 IGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           I DFGLAR   +     EY          +W  APE  +N   +T   D+WS G +L EI
Sbjct: 325 IADFGLARVIED----NEYTAREGAKFPIKWT-APE-AINFGSFTIKSDVWSFGILLMEI 378

Query: 198 MT--REPLFPG 206
           +T  R P +PG
Sbjct: 379 VTYGRIP-YPG 388

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 41/192 (21%), Positives = 83/192 (43%), Gaps = 30/192 (15%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYE 85
           +VA+K I    +  +      +E + +  + H  ++    +     P       +YIV E
Sbjct: 34  DVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-------IYIVTE 83

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
            +    L   +RS  + L         Y +  G+ ++ S   +HRDL   N L++    +
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           K+ DFG+ R   +     +YV +       +W  APE + +  +Y++  D+W+ G ++ E
Sbjct: 144 KVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APE-VFHYFKYSSKSDVWAFGILMWE 197

Query: 197 IMT--REPLFPG 206
           + +  + P +  
Sbjct: 198 VFSLGKMP-YDL 208

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 15/181 (8%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
             A+K + N   +I +  + L E  +++   H NV+++  I    +        +V   M
Sbjct: 55  HCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYM 109

Query: 88  DT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 145
              DL   IR+     T      F  Q+ +G+KY+ S   +HRDL   N +L+    +K+
Sbjct: 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 169

Query: 146 GDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            DFGLAR   + ++ + +  T      +W  A E  L   ++T   D+WS G +L E+MT
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMT 227

Query: 200 R 200
           R
Sbjct: 228 R 228

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 23/193 (11%)

Query: 24  ETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
            T  +VA+K  K+ N+     +    L E   ++   H NVI +  +             
Sbjct: 60  GTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117

Query: 82  IVYELMDT-DLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
           ++   M   DLH  +         + +       F+  +  G++Y+ + + LHRDL   N
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDI 187
            +L     + + DFGL++     D    Y          +W  A E L +   YT+  D+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAKMPVKWI-AIESLAD-RVYTSKSDV 232

Query: 188 WSVGCILGEIMTR 200
           W+ G  + EI TR
Sbjct: 233 WAFGVTMWEIATR 245

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 39/192 (20%), Positives = 84/192 (43%), Gaps = 30/192 (15%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYE 85
           +VAIK I    +  +     + E +++  + H  ++ +  +   + P       + +V E
Sbjct: 34  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-------ICLVTE 83

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
            M+   L   +R+       +        +  G+ Y+  A V+HRDL   N L+  +  +
Sbjct: 84  FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 143

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           K+ DFG+ R   +     +Y  +       +W  +PE + + + Y++  D+WS G ++ E
Sbjct: 144 KVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPE-VFSFSRYSSKSDVWSFGVLMWE 197

Query: 197 IMT--REPLFPG 206
           + +  + P +  
Sbjct: 198 VFSEGKIP-YEN 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 21/188 (11%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFND 79
           + +    VAIK +  A          L E  ++    H N+I ++ +I    P       
Sbjct: 69  SGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP------- 120

Query: 80  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + I+ E M+   L + +R  D + +       L  +  G+KY+ + + +HRDL   N+L+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVG 191
           N++   K+ DFGL+R   E D    Y  +      RW  APE  ++  ++T+A D+WS G
Sbjct: 181 NSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT-APE-AISYRKFTSASDVWSFG 237

Query: 192 CILGEIMT 199
            ++ E+MT
Sbjct: 238 IVMWEVMT 245

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
            VAIK +       +     L+E ++++ + HE ++ +  ++      +   +YIV E M
Sbjct: 210 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYM 260

Query: 88  D-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
               L   ++ +  + L          Q+  G+ YV   + +HRDL+ +N+L+  +   K
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 320

Query: 145 IGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-- 199
           + DFGLAR   + ++          +W  APE       +T   D+WS G +L E+ T  
Sbjct: 321 VADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKG 378

Query: 200 REPLFPG 206
           R P +PG
Sbjct: 379 RVP-YPG 384

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 84.9 bits (211), Expect = 3e-19
 Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 31/193 (16%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVY 84
            VA+K  K     DN       + E  ++++++H +++ +  II   P        +I+ 
Sbjct: 42  NVAVKTCKKDCTLDNKEK---FMSEAVIMKNLDHPHIVKLIGIIEEEP-------TWIIM 91

Query: 85  ELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           EL    +L   +      L       +  Q+ + + Y+ S + +HRD+   N+L+ +   
Sbjct: 92  ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC 151

Query: 143 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +K+GDFGL+R   + D    Y          +W  +PE  +N   +T A D+W     + 
Sbjct: 152 VKLGDFGLSRYIEDED----YYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMW 205

Query: 196 EIMT--REPLFPG 206
           EI++  ++P F  
Sbjct: 206 EILSFGKQP-FFW 217

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
            VAIK +       +     L+E ++++ + HE ++ +  ++      +   +YIV E M
Sbjct: 293 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYM 343

Query: 88  D-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
               L   ++ +  + L          Q+  G+ YV   + +HRDL+ +N+L+  +   K
Sbjct: 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 403

Query: 145 IGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-- 199
           + DFGLAR   + ++          +W  APE       +T   D+WS G +L E+ T  
Sbjct: 404 VADFGLARLIEDNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKG 461

Query: 200 REPLFPG 206
           R P +PG
Sbjct: 462 RVP-YPG 467

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 25/183 (13%)

Query: 29  VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYE 85
           VAIK  +   +     +    L E  ++  +++ +V  +  I            V ++ +
Sbjct: 47  VAIKELREATSPKANKE---ILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           LM    L   +R     +   +   +  Q+ +G+ Y+    ++HRDL   N+L+     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156

Query: 144 KIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           KI DFGLA+     +   EY         +W  A E  +    YT   D+WS G  + E+
Sbjct: 157 KITDFGLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWEL 212

Query: 198 MTR 200
           MT 
Sbjct: 213 MTF 215

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 33/192 (17%)

Query: 28  EVAIKKI-----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFND 79
           +VA+K I       AF         L E  ++  + H N++ +  +I   +         
Sbjct: 218 KVAVKCIKNDATAQAF---------LAEASVMTQLRHSNLVQLLGVIVEEKGG------- 261

Query: 80  VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
           +YIV E M    L   +RS     L  D    F   +   ++Y+   + +HRDL   N+L
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 321

Query: 137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           ++     K+ DFGL +  S T    +  V +W  APE  L   +++   D+WS G +L E
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGILLWE 378

Query: 197 IMT--REPLFPG 206
           I +  R P +P 
Sbjct: 379 IYSFGRVP-YPR 389

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 84.6 bits (210), Expect = 5e-19
 Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 30/192 (15%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYE 85
           +VAIK I    +  +     + E K++ ++ HE ++ +  +   + P       ++I+ E
Sbjct: 50  DVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-------IFIITE 99

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
            M    L   +R    +            +   ++Y+ S   LHRDL   N L+N    +
Sbjct: 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           K+ DFGL+R   +     EY  +       RW   PE+L+    +++  DIW+ G ++ E
Sbjct: 160 KVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWE 213

Query: 197 IMT--REPLFPG 206
           I +  + P +  
Sbjct: 214 IYSLGKMP-YER 224

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 58/270 (21%), Positives = 112/270 (41%), Gaps = 60/270 (22%)

Query: 44  ARRTLREIKLLRHMEHENVIAIKDI---IRPP----KKDTFNDVYIVYELMDT----DLH 92
           A + L + K+++  + E+ +  K I   +  P     + +F D   +Y +M+     ++ 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 93  QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 152
             +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++    +++ DFG A+
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 153 TTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 208
                 +      E +      APE++L+   Y  A+D W++G ++ E+    P F    
Sbjct: 190 RVKGRTWTLCGTPEAL------APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

Query: 209 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLE 267
            +     I  + G                                RFP+  SS   DLL 
Sbjct: 243 PIQIYEKI--VSGKV------------------------------RFPSHFSSDLKDLLR 270

Query: 268 KMLVFDPNKRI-----TVEEALRHPYLQSL 292
            +L  D  KR       V +   H +  + 
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 23/183 (12%)

Query: 28  EVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVY 84
            VAIK +     +     R  L E  ++   +H N+I ++ ++              IV 
Sbjct: 79  PVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL-------AMIVT 129

Query: 85  ELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           E M+   L   +R+ D Q T       L  +  G++Y+     +HRDL   N+L++++  
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189

Query: 143 LKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
            K+ DFGL+R   E D    Y  T      RW  APE  +    +++A D+WS G ++ E
Sbjct: 190 CKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWE 246

Query: 197 IMT 199
           ++ 
Sbjct: 247 VLA 249

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.1 bits (211), Expect = 6e-19
 Identities = 37/193 (19%), Positives = 79/193 (40%), Gaps = 30/193 (15%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVY 84
            V IK  +  +   +          +  +  ++H +++ +  +            + +V 
Sbjct: 44  PVCIKVIEDKSGRQSFQA---VTDHMLAIGSLDHAHIVRLLGLCPGSS-------LQLVT 93

Query: 85  ELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           + +    L   +R     L       +  Q+ +G+ Y+    ++HR+L   N+LL +   
Sbjct: 94  QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ 153

Query: 143 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +++ DFG+A      D   + ++        +W  A E  ++  +YT   D+WS G  + 
Sbjct: 154 VQVADFGVADLLPPDD---KQLLYSEAKTPIKWM-ALE-SIHFGKYTHQSDVWSYGVTVW 208

Query: 196 EIMT--REPLFPG 206
           E+MT   EP + G
Sbjct: 209 ELMTFGAEP-YAG 220

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 21/184 (11%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKDTFNDVYIVY 84
             A+K + N   +I +  + L E  +++   H NV+++  I                +V 
Sbjct: 119 HCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS-------PLVVL 170

Query: 85  ELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
             M   DL   IR+     T      F  Q+ +G+K++ S   +HRDL   N +L+    
Sbjct: 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 230

Query: 143 LKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +K+ DFGLAR   + +F + +  T      +W  A E  L   ++T   D+WS G +L E
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALE-SLQTQKFTTKSDVWSFGVLLWE 288

Query: 197 IMTR 200
           +MTR
Sbjct: 289 LMTR 292

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 28/183 (15%)

Query: 29  VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII-RPPKKDTFNDVYIVYE 85
           VAIK  K   +          L+E   +R  +H +++ +  +I   P       V+I+ E
Sbjct: 421 VAIKTCKNCTSDSVREK---FLQEALTMRQFDHPHIVKLIGVITENP-------VWIIME 470

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           L    +L   ++     L       + YQL   L Y+ S   +HRD+   N+L++++  +
Sbjct: 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           K+GDFGL+R   ++     Y          +W  APE  +N   +T+A D+W  G  + E
Sbjct: 531 KLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWE 584

Query: 197 IMT 199
           I+ 
Sbjct: 585 ILM 587

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 27/197 (13%)

Query: 17  FSAAVNSETREE--VAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--R 70
            S  +   +++E  VAIK  K+G         R  L E  ++   +H N+I ++ ++   
Sbjct: 62  CSGRLKLPSKKEISVAIKTLKVGYTEK---QRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 71  PPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
            P       V IV E M+   L   +R  D Q T       L  +  G+KY+     +HR
Sbjct: 119 KP-------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYT 182
           DL   N+L+N++   K+ DFGL R   E D    Y         RW  +PE  +   ++T
Sbjct: 172 DLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWT-SPE-AIAYRKFT 228

Query: 183 AAIDIWSVGCILGEIMT 199
           +A D+WS G +L E+M+
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.3 bits (209), Expect = 7e-19
 Identities = 36/195 (18%), Positives = 69/195 (35%), Gaps = 27/195 (13%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYE 85
           EV +K +  A  N   +        ++  + H++++    +               +V E
Sbjct: 42  EVLLKVLDKAHRN--YSESFFEAASMMSKLSHKHLVLNYGVCVCGDE-------NILVQE 92

Query: 86  LMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
            +    L   ++     +          QL   + ++   +++H ++   N+LL    D 
Sbjct: 93  FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152

Query: 144 --------KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                   K+ D G++ T    D + E +   W   PE + N      A D WS G  L 
Sbjct: 153 KTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPECIENPKNLNLATDKWSFGTTLW 209

Query: 196 EIMT--REPLFPGKD 208
           EI +   +P     D
Sbjct: 210 EICSGGDKP-LSALD 223

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 31/195 (15%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYE 85
            VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E
Sbjct: 247 TVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITE 296

Query: 86  LMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            M   +L   +R    Q+++     Y   Q+   ++Y+   + +HR+L   N L+  +  
Sbjct: 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356

Query: 143 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +K+ DFGL+R  +       Y          +W  APE  L   +++   D+W+ G +L 
Sbjct: 357 VKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWAFGVLLW 410

Query: 196 EIMT--REPLFPGKD 208
           EI T    P +PG D
Sbjct: 411 EIATYGMSP-YPGID 424

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 84.2 bits (209), Expect = 8e-19
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 31/193 (16%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYE 85
            VA+K +    ++ ++    L+E  +++ ++H N++ +  +    PP        YI+ E
Sbjct: 40  TVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITE 89

Query: 86  LMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
            M   +L   +R    Q+++     Y   Q+   ++Y+   + +HRDL   N L+  +  
Sbjct: 90  FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149

Query: 143 LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +K+ DFGL+R     D    Y          +W  APE  L   +++   D+W+ G +L 
Sbjct: 150 VKVADFGLSRLM-TGD---TYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWAFGVLLW 203

Query: 196 EIMT--REPLFPG 206
           EI T    P +PG
Sbjct: 204 EIATYGMSP-YPG 215

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 83.8 bits (208), Expect = 8e-19
 Identities = 50/188 (26%), Positives = 94/188 (50%), Gaps = 22/188 (11%)

Query: 28  EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYELM 87
           +VA+K +       +     L E  L++ ++H+ ++ +  ++      T   +YI+ E M
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV------TQEPIYIITEYM 89

Query: 88  DT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           +   L   +++    +LT +       Q+  G+ ++   + +HRDL+ +N+L++ +   K
Sbjct: 90  ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149

Query: 145 IGDFGLARTTSETDFMTEYVVT----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT- 199
           I DFGLAR   + ++ T         +W  APE +   T +T   D+WS G +L EI+T 
Sbjct: 150 IADFGLARLIEDNEY-TAREGAKFPIKWT-APEAINYGT-FTIKSDVWSFGILLTEIVTH 206

Query: 200 -REPLFPG 206
            R P +PG
Sbjct: 207 GRIP-YPG 213

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 84.7 bits (210), Expect = 9e-19
 Identities = 47/192 (24%), Positives = 78/192 (40%), Gaps = 20/192 (10%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI-IRPPKKDTFNDVYI 82
            +  +VA+K +        D    LRE   ++  +H +V  +  + +R   K       +
Sbjct: 49  GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108

Query: 83  VYELMDT-DLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
           +   M   DLH  + +         L       F+  +  G++Y+ S + +HRDL   N 
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC 168

Query: 136 LLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIW 188
           +L     + + DFGL+R     D    Y          +W  A E L +   YT   D+W
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPVKWL-ALESLAD-NLYTVHSDVW 223

Query: 189 SVGCILGEIMTR 200
           + G  + EIMTR
Sbjct: 224 AFGVTMWEIMTR 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 36/213 (16%), Positives = 74/213 (34%), Gaps = 38/213 (17%)

Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L  + +  +++  +  +++L +++  +  VH    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 151 A-RTTSETDFMTEYVV-TRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMTREP 202
             +  ++    +   V T  Y +PE+L           Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 203 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA 262
            F           I                          +                  A
Sbjct: 269 PFYADSTAETYGKI--------------------------VHYKEHLSLPLVDEGVPEEA 302

Query: 263 VDLLEKMLVFDPNKRIT---VEEALRHPYLQSL 292
            D ++++L   P  R+      +   HP+   L
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 62/237 (26%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           EL     H  +  ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +K
Sbjct: 91  ELF---FH--LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145

Query: 145 IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           I DFGL +     + +++    +       Y APE+L +  +Y  A+D W +G ++ E+M
Sbjct: 146 ITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

Query: 199 TREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
                F  +D   + +L L+ E+                                  RFP
Sbjct: 200 CGRLPFYNQDHERLFELILMEEI----------------------------------RFP 225

Query: 257 NK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 305
              S  A  LL  +L  DP +R+       +E + H +  S+   D+  + + P PF
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP-PF 281

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 25/186 (13%)

Query: 28  EVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVI---AIKDIIRPPKKDTFNDVYI 82
           + AIK          +      LRE  L+R + H NV+    I               ++
Sbjct: 51  QCAIKSLSRITEMQQVEA---FLREGLLMRGLNHPNVLALIGIMLPPEGL-------PHV 100

Query: 83  VYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +   M   DL Q IRS  +  T      F  Q+ RG++Y+     +HRDL   N +L+ S
Sbjct: 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES 160

Query: 141 CDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCIL 194
             +K+ DFGLAR   + ++ +           +W  A E L     +T   D+WS G +L
Sbjct: 161 FTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQT-YRFTTKSDVWSFGVLL 218

Query: 195 GEIMTR 200
            E++TR
Sbjct: 219 WELLTR 224

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 42/211 (19%), Positives = 88/211 (41%), Gaps = 36/211 (17%)

Query: 91  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 150
           L  + + + +L ++  +++L +++  +  VH    +HRD+KP N+L++ +  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 151 A-RTTSETDFMTEYVV-TRWYRAPELLLNCTE----YTAAIDIWSVGCILGEIMTREPLF 204
             +   +    +   V T  Y +PE+L         Y    D WS+G  + E++  E  F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 205 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 264
             +  V     I                          +    + QF T+  + S  A D
Sbjct: 282 YAESLVETYGKI--------------------------MNHKERFQFPTQVTDVSENAKD 315

Query: 265 LLEKMLVFDPNKRIT---VEEALRHPYLQSL 292
           L+ +++      R+    +E+  +HP+   +
Sbjct: 316 LIRRLIC-SREHRLGQNGIEDFKKHPFFSGI 345

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 49/226 (21%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+LL+    +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 150 LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           + +     + M     T        Y APE+LL   +Y  ++D WS G +L E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGA 262
           F G+D       I       D+                             +P      A
Sbjct: 218 FHGQDEEELFHSIRM-----DNP---------------------------FYPRWLEKEA 245

Query: 263 VDLLEKMLVFDPNKRITVEEALR-HPYLQSL--HDLNDEPVCPRPF 305
            DLL K+ V +P KR+ V   +R HP  + +   +L  + + P PF
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDP-PF 290

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 48/236 (20%), Positives = 91/236 (38%), Gaps = 59/236 (25%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           +LM    H  I+  ++  +   +++  +++  L ++H   +++RDLK  N+LL+     K
Sbjct: 110 DLM---FH--IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

Query: 145 IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           + DFG+ +     + +   V T        Y APE+L     Y  A+D W++G +L E++
Sbjct: 165 LADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
                F  ++       I       D+                             +P  
Sbjct: 219 CGHAPFEAENEDDLFEAILN-----DEV---------------------------VYPTW 246

Query: 259 -SSGAVDLLEKMLVFDPNKRI------TVEEALRHPYLQSL--HDLNDEPVCPRPF 305
               A  +L+  +  +P  R+           LRHP+ + +    LN   + P PF
Sbjct: 247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP-PF 301

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 39/203 (19%)

Query: 21  VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII---RPPKKD 75
           V  E    VAIK      +    I+    L E  +++     +V+ +  ++   +P    
Sbjct: 50  VKDEPETRVAIKTVNEAASMRERIE---FLNEASVMKEFNCHHVVRLLGVVSQGQPT--- 103

Query: 76  TFNDVYIVYELMDT-DLHQIIRS----------DQQLTDDHCQYFLYQLLRGLKYVHSAS 124
                 ++ ELM   DL   +RS              +         ++  G+ Y+++  
Sbjct: 104 -----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158

Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLN 177
            +HRDL   N ++     +KIGDFG+ R   ETD+   Y          RW  +PE L +
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKD 214

Query: 178 CTEYTAAIDIWSVGCILGEIMTR 200
              +T   D+WS G +L EI T 
Sbjct: 215 GV-FTTYSDVWSFGVVLWEIATL 236

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.5 bits (197), Expect = 5e-17
 Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 57/221 (25%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           EL    +   +  +    +D   ++L ++   L ++H   +++RDLKP N++LN    +K
Sbjct: 107 ELF---MQ--LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

Query: 145 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           + DFGL + +     +T       EY+      APE+L+  + +  A+D WS+G ++ ++
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYM------APEILMR-SGHNRAVDWWSLGALMYDM 214

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +T  P F G++    +  I              L+                       P 
Sbjct: 215 LTGAPPFTGENRKKTIDKI--------------LKCK------------------LNLPP 242

Query: 258 K-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
             +  A DLL+K+L  +   R+        E   HP+ + +
Sbjct: 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 50/247 (20%), Positives = 101/247 (40%), Gaps = 56/247 (22%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 150 LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           + +     + +     T        Y APE+L    +Y  ++D W++G ++ E+M     
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGA 262
           F                              N   Y+ Q+   ++     R P   S  A
Sbjct: 210 FDIVGSSDNPD-------------------QNTEDYLFQVILEKQ----IRIPRSLSVKA 246

Query: 263 VDLLEKMLVFDPNKRI------TVEEALRHPYLQSL--HDLNDEPVCPRPF--------- 305
             +L+  L  DP +R+         +   HP+ +++    +  + V P PF         
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP-PFKPNISGEFG 305

Query: 306 --HFDFE 310
             +FD +
Sbjct: 306 LDNFDSQ 312

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 46/222 (20%), Positives = 100/222 (45%), Gaps = 52/222 (23%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           EL     H  +   ++ T+   Q ++ +++  L+++H   +++RD+K  N+LL+++  + 
Sbjct: 145 ELF---TH--LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199

Query: 145 IGDFGLARTTSETDFMTEYVVTRW-------YRAPELLLNCTE-YTAAIDIWSVGCILGE 196
           + DFGL++     +F+ +     +       Y AP+++      +  A+D WS+G ++ E
Sbjct: 200 LTDFGLSK-----EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++T    F      +    I+  I          L+S+                    +P
Sbjct: 255 LLTGASPFTVDGEKNSQAEISRRI----------LKSE------------------PPYP 286

Query: 257 NK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
            + S+ A DL++++L+ DP KR+       +E   H + Q +
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 17/180 (9%)

Query: 76  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
            F D   +Y +M+     DL  ++ +   + +   +++  +++  L  +HS   +HRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 132 PSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLLNC---TEYTAAID 186
           P N+LL+ S  LK+ DFG   +   E     +  V T  Y +PE+L +      Y    D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 187 IWSVGCILGEIMTREPLFPGKDYVHQLRLI---TELIGSPDDASLGFLRSDNARRYVRQL 243
            WSVG  L E++  +  F     V     I      +  PDD  +    S  A+  +   
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI----SKEAKNLICAF 311

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.3 bits (194), Expect = 1e-16
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 53/227 (23%)

Query: 76  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
           TF D   ++ +MD     +L  ++R  Q+  +   +++  ++   L+Y+HS  +++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133

Query: 132 PSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDI 187
           P N+LL+ +  +KI DFG A+   +  +      +Y+      APE++     Y  +ID 
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDW 186

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
           WS G ++ E++     F   + +     I  L                            
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAEL------------------------ 220

Query: 248 KQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 288
                 RFP   +    DLL +++  D ++R+       E+   HP+
Sbjct: 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 50/218 (22%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDL 143
           EL     H  +  ++  ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +
Sbjct: 234 ELF---FH--LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288

Query: 144 KIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 202
           KI DFGL +    +   M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M    
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 203 LFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-S 259
            F  +D   + +L L+ E+                                  RFP    
Sbjct: 348 PFYNQDHEKLFELILMEEI----------------------------------RFPRTLG 373

Query: 260 SGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
             A  LL  +L  DP +R+       +E ++H +   +
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 61/223 (27%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           +L        +  +   T++  +++L +L   L ++HS  +++RDLKP N+LL+    +K
Sbjct: 112 DLF---TR--LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166

Query: 145 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           + DFGL++ + + +          EY+      APE++     +T + D WS G ++ E+
Sbjct: 167 LTDFGLSKESIDHEKKAYSFCGTVEYM------APEVVNR-RGHTQSADWWSFGVLMFEM 219

Query: 198 MTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           +T    F GKD      + L  +L                                    
Sbjct: 220 LTGTLPFQGKDRKETMTMILKAKL----------------------------------GM 245

Query: 256 PNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
           P   S  A  LL  +   +P  R+      VEE  RH +  ++
Sbjct: 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 48/231 (20%), Positives = 97/231 (41%), Gaps = 45/231 (19%)

Query: 90  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
           DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 150 LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 203
           + +     + +     T        Y APE+L    +Y  ++D W++G ++ E+M     
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGA 262
           F                              N   Y+ Q+   ++     R P   S  A
Sbjct: 253 FDIVGSSDNPD-------------------QNTEDYLFQVILEKQ----IRIPRSLSVKA 289

Query: 263 VDLLEKMLVFDPNKRI------TVEEALRHPYLQSL--HDLNDEPVCPRPF 305
             +L+  L  DP +R+         +   HP+ +++    +  + V P PF
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP-PF 339

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 44/238 (18%), Positives = 93/238 (39%), Gaps = 64/238 (26%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           +LM    + I +  +   + H  ++  ++  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 107 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

Query: 145 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           I DFG+ +        T       +Y+      APE++     Y  ++D W+ G +L E+
Sbjct: 162 IADFGMCKENIWDGVTTKTFCGTPDYI------APEIIAY-QPYGKSVDWWAFGVLLYEM 214

Query: 198 MTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           +  +  F G+D   + Q  +   +                                   +
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNV----------------------------------AY 240

Query: 256 PNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 305
           P   S  AV + + ++   P KR+        +   H + + +    L  + + P P+
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP-PY 297

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 60/222 (27%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           EL     H  ++ ++   +   +++  ++   L Y+HS ++++RDLKP N+LL++   + 
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179

Query: 145 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           + DFGL +   E +  T       EY+      APE+L     Y   +D W +G +L E+
Sbjct: 180 LTDFGLCKENIEHNSTTSTFCGTPEYL------APEVLHK-QPYDRTVDWWCLGAVLYEM 232

Query: 198 MTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           +   P F  ++   ++   L   L                                  + 
Sbjct: 233 LYGLPPFYSRNTAEMYDNILNKPL----------------------------------QL 258

Query: 256 P-NKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQSL 292
             N ++ A  LLE +L  D  KR+       E   H +   +
Sbjct: 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 45/238 (18%), Positives = 93/238 (39%), Gaps = 64/238 (26%)

Query: 85  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 144
           +LM    H  I+   +  + H  ++  ++  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 428 DLM---YH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482

Query: 145 IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           I DFG+ +        T       +Y+      APE++     Y  ++D W+ G +L E+
Sbjct: 483 IADFGMCKENIWDGVTTKTFCGTPDYI------APEIIAY-QPYGKSVDWWAFGVLLYEM 535

Query: 198 MTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           +  +  F G+D   + Q  +   +                                   +
Sbjct: 536 LAGQAPFEGEDEDELFQSIMEHNV----------------------------------AY 561

Query: 256 PNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 305
           P   S  AV + + ++   P KR+        +   H + + +    L  + + P P+
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP-PY 618

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 30/243 (12%), Positives = 61/243 (25%), Gaps = 51/243 (20%)

Query: 20  AVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A+++    +VA+  +           + TL     L  ++   V  + D++      T  
Sbjct: 50  ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRA 104

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
              +V E +    L ++  +    +       +  L       H A V      PS + +
Sbjct: 105 GGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV 162

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +   D+ +                                        DI  +G  L  +
Sbjct: 163 SIDGDVVLAYPATMPDA---------------------------NPQDDIRGIGASLYAL 195

Query: 198 MTREPLFPGKDYVHQLR-LITELIGSP--------------DDASLGFLRSDNARRYVRQ 242
           +      P       L     +  G P                 +   ++ D   R    
Sbjct: 196 LVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSAST 255

Query: 243 LPR 245
           L  
Sbjct: 256 LLN 258

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 39/196 (19%)

Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYEL 86
           VA+K +  A ++    +   RE +LL  ++H++++    +     P       + +V+E 
Sbjct: 74  VAVKALKEASES--ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP-------LLMVFEY 124

Query: 87  MDT-DLHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
           M   DL++ +RS                  L          Q+  G+ Y+     +HRDL
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTA 183
              N L+     +KIGDFG++R    TD+   Y V        RW   PE +L   ++T 
Sbjct: 185 ATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPESILY-RKFTT 239

Query: 184 AIDIWSVGCILGEIMT 199
             D+WS G +L EI T
Sbjct: 240 ESDVWSFGVVLWEIFT 255

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 84  YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
              ++ +          LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 144 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           KI DFGLAR   +     +YV         +W  APE + +   YT   D+WS G +L E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 197 IMT 199
           I +
Sbjct: 288 IFS 290

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 42/198 (21%)

Query: 29  VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVI---AIKDIIRPPKKDTFNDVYIVYE 85
           VA+K + +        +   RE +LL +++HE+++    +     P        + +V+E
Sbjct: 48  VAVKALKDPTLA--ARKDFQREAELLTNLQHEHIVKFYGVCGDGDP--------LIMVFE 97

Query: 86  LMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
            M   DL++ +R+                  +L      +   Q+  G+ Y+ S   +HR
Sbjct: 98  YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 157

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEY 181
           DL   N L+ A+  +KIGDFG++R    TD+   Y V        RW   PE ++   ++
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWM-PPESIMY-RKF 212

Query: 182 TAAIDIWSVGCILGEIMT 199
           T   D+WS G IL EI T
Sbjct: 213 TTESDVWSFGVILWEIFT 230

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 38/178 (21%)

Query: 48  LREIKLLRHMEHENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS------- 97
             E  L   ++H NV+ +  ++    P       + +++      DLH+ +         
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHSDV 112

Query: 98  ---------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 148
                       L      + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI D 
Sbjct: 113 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL 172

Query: 149 GLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           GL R     D    Y +        RW  APE ++    ++   DIWS G +L E+ +
Sbjct: 173 GLFREVYAAD---YYKLLGNSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEVFS 225

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 37/177 (20%)

Query: 48  LREIKLLRHM-EHENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS------ 97
           + E+K++ H+ +HEN++ +        P       V ++ E     DL   +R       
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLE 149

Query: 98  --------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 149
                   +   +     +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFG
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209

Query: 150 LARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           LAR          Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 210 LARDIMNDS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 50/226 (22%)

Query: 21  VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHM-EHENVI----AIKDIIRPPK 73
             + T   VA+K  K G            + E+K+L H+  H NV+    A      P  
Sbjct: 52  DKTATCRTVAVKMLKEGATHSEHRA---LMSELKILIHIGHHLNVVNLLGACTKPGGP-- 106

Query: 74  KDTFNDVYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRG 116
                 + ++ E     +L   +RS                   LT +H   + +Q+ +G
Sbjct: 107 ------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160

Query: 117 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWY 169
           ++++ S   +HRDL   N+LL+    +KI DFGLAR   +     +YV         +W 
Sbjct: 161 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWM 217

Query: 170 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQL 213
            APE + +   YT   D+WS G +L EI +    P +PG     + 
Sbjct: 218 -APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 260

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 42/208 (20%)

Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI--IRPPKKDTF 77
           + S+    VA+K +     ++ +    + E+K+L ++  H N++ +     I  P     
Sbjct: 48  IKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP----- 101

Query: 78  NDVYIVYELM-DTDLHQIIRS------------------DQQLTDDHCQYFLYQLLRGLK 118
               ++ E     DL   +R                   +  L  +    F YQ+ +G+ 
Sbjct: 102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159

Query: 119 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRA 171
           ++ S + +HRDL   N+LL      KI DFGLAR          YVV        +W  A
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---NYVVKGNARLPVKWM-A 215

Query: 172 PELLLNCTEYTAAIDIWSVGCILGEIMT 199
           PE + NC  YT   D+WS G  L E+ +
Sbjct: 216 PESIFNCV-YTFESDVWSYGIFLWELFS 242

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 37/201 (18%)

Query: 21  VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI--IRPPKKDT 76
            N  +  +VA+K      +  + +D    L E  ++    H+N++    +     P    
Sbjct: 55  PNDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFNHQNIVRCIGVSLQSLP---- 107

Query: 77  FNDVYIVYELMDT-DLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
               +I+ ELM   DL   +R           L      +    +  G +Y+     +HR
Sbjct: 108 ---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 164

Query: 129 DLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNC 178
           D+   N LL         KIGDFG+AR      +   Y          +W   PE  +  
Sbjct: 165 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFME- 219

Query: 179 TEYTAAIDIWSVGCILGEIMT 199
             +T+  D WS G +L EI +
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFS 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 37/201 (18%)

Query: 21  VNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDI--IRPPKKDT 76
            N  +  +VA+K      +  + +D    L E  ++    H+N++    +     P    
Sbjct: 96  PNDPSPLQVAVKTLPEVCSEQDELD---FLMEALIISKFNHQNIVRCIGVSLQSLP---- 148

Query: 77  FNDVYIVYELMDT-DLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
               +I+ ELM   DL   +R           L      +    +  G +Y+     +HR
Sbjct: 149 ---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205

Query: 129 DLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNC 178
           D+   N LL         KIGDFG+AR      +   Y          +W   PE  +  
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWM-PPEAFMEG 261

Query: 179 TEYTAAIDIWSVGCILGEIMT 199
             +T+  D WS G +L EI +
Sbjct: 262 I-FTSKTDTWSFGVLLWEIFS 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 44/200 (22%)

Query: 29  VAIK--KIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI--IRPPKKDTFNDVYIV 83
           VA+K  K      ++ D    + E+++++ + +H+N+I +        P       +Y++
Sbjct: 70  VAVKMLKDDATEKDLSD---LVSEMEMMKMIGKHKNIINLLGACTQDGP-------LYVI 119

Query: 84  YELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHSASVL 126
            E     +L + +R+                ++Q+T        YQL RG++Y+ S   +
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179

Query: 127 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCT 179
           HRDL   N+L+  +  +KI DFGLAR  +  D    Y  T       +W  APE L +  
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEALFDRV 235

Query: 180 EYTAAIDIWSVGCILGEIMT 199
            YT   D+WS G ++ EI T
Sbjct: 236 -YTHQSDVWSFGVLMWEIFT 254

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 4e-14
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 169
            G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 170 RAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
            APE L    E T   DI+S G +L EI+T
Sbjct: 202 MAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 48/189 (25%), Positives = 76/189 (40%), Gaps = 52/189 (27%)

Query: 48  LREIKLLRHMEHENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS---- 97
           L E  +L+ + H +VI +     +D   P          ++ E      L   +R     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQD--GPL--------LLIVEYAKYGSLRGFLRESRKV 123

Query: 98  --------------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
                               ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV 183

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 190
                +KI DFGL+R   E D    YV         +W  A E L +   YT   D+WS 
Sbjct: 184 AEGRKMKISDFGLSRDVYEED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSF 238

Query: 191 GCILGEIMT 199
           G +L EI+T
Sbjct: 239 GVLLWEIVT 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 39/179 (21%)

Query: 48  LREIKLLRHM-EHENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS------ 97
           + E+++++ + +H+N+I +        P       +Y++ E     +L + +R+      
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 186

Query: 98  ----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 147
                     ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI D
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 246

Query: 148 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           FGLAR  +  D    Y  T       +W  APE L +   YT   D+WS G ++ EI T
Sbjct: 247 FGLARDINNID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 39/179 (21%)

Query: 48  LREIKLLRHM-EHENVIAIKDI--IRPPKKDTFNDVYIVYELMDT-DLHQIIRS------ 97
           + E+++++ + +H+N+I +        P       +Y++ E     +L + +++      
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174

Query: 98  ----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 147
                     ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234

Query: 148 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           FGLAR     D    Y  T       +W  APE L +   YT   D+WS G +L EI T
Sbjct: 235 FGLARDIHHID---YYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFT 288

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 45/208 (21%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDI--IRPPKKD 75
                 R + AIK++   A  +  D R    E+++L  +  H N+I +      R     
Sbjct: 46  IKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--- 100

Query: 76  TFNDVYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLK 118
               +Y+  E     +L   +R                    L+     +F   + RG+ 
Sbjct: 101 ----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156

Query: 119 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRA 171
           Y+     +HRDL   N+L+  +   KI DFGL+R          YV         RW  A
Sbjct: 157 YLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGRLPVRWM-A 209

Query: 172 PELLLNCTEYTAAIDIWSVGCILGEIMT 199
            E  LN + YT   D+WS G +L EI++
Sbjct: 210 IE-SLNYSVYTTNSDVWSYGVLLWEIVS 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 39/137 (28%), Positives = 60/137 (43%), Gaps = 18/137 (13%)

Query: 70  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
           R    +   +      L + +   ++  +  L       F YQ+ +G++++   S +HRD
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLL------CFAYQVAKGMEFLEFKSCVHRD 197

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYT 182
           L   N+L+     +KI DFGLAR          YVV        +W  APE L     YT
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWM-APESLFEGI-YT 252

Query: 183 AAIDIWSVGCILGEIMT 199
              D+WS G +L EI +
Sbjct: 253 IKSDVWSYGILLWEIFS 269

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 42/189 (22%), Positives = 69/189 (36%), Gaps = 52/189 (27%)

Query: 48  LREIKLLRHMEHENVIAI-----KDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS---- 97
            RE  L+   ++ N++ +         +P          +++E M   DL++ +RS    
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVG--KPM--------CLLFEYMAYGDLNEFLRSMSPH 147

Query: 98  --------------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
                                  L+         Q+  G+ Y+     +HRDL   N L+
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 207

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 190
             +  +KI DFGL+R     D    Y          RW   PE +     YT   D+W+ 
Sbjct: 208 GENMVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWM-PPESIFYNR-YTTESDVWAY 262

Query: 191 GCILGEIMT 199
           G +L EI +
Sbjct: 263 GVVLWEIFS 271

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 115 RGLKYVHSAS---VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW--- 168
           RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 169 --YRAPELLLN--CTEYTAAIDIWSVGCILGEIMT 199
             + APE L     +E T   D++  G +L E++T
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELIT 230

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.1 bits (157), Expect = 7e-12
 Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 21/101 (20%)

Query: 115 RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 169
           RGL Y+H+ +++HRD+K  N+LL+ +   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 170 RAPELLLNCTEY------TAAIDIWSVGCILGEIMT-REPL 203
             P       EY      T   D++S G +L E++  R  +
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.6 bits (138), Expect = 1e-09
 Identities = 33/223 (14%), Positives = 66/223 (29%), Gaps = 54/223 (24%)

Query: 25  TREEVAIKKIGNAFDNIID------ARRTLREIKLLRHME---------HENVIAIKDII 69
               VAIK I     ++++          L EI + + +           E  I +  + 
Sbjct: 42  DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101

Query: 70  -------------------------RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDD 104
                                      P     + ++IV E     +       +  +  
Sbjct: 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLA 161

Query: 105 HCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY 163
             +  L+QL   L    ++    HRDL   N+LL  +   K+      ++++        
Sbjct: 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC---- 217

Query: 164 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 206
                     L ++  +YT +        +  ++   E LF G
Sbjct: 218 ---------GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.1 bits (133), Expect = 9e-09
 Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 16/140 (11%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             N  T E VAIK      + +      L  E +  + +   +   I  +        +N
Sbjct: 28  GKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG--SGDGIPQVYYFGPCGKYN 80

Query: 79  DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
              +V EL+   L  +    D+  +         QL+  ++YVHS ++++RD+KP N L+
Sbjct: 81  --AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138

Query: 138 -----NASCDLKIGDFGLAR 152
                     + I DF LA+
Sbjct: 139 GRPGNKTQQVIHIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 27/151 (17%), Positives = 52/151 (34%), Gaps = 23/151 (15%)

Query: 20  AVNSETREEVAIK--KIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
           A  +   E+ A    K+        +      E+K  + +  ++ I      +       
Sbjct: 56  AFPTNKPEKDARHVVKVEYQ-----ENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110

Query: 78  NDVY--------------IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 123
              Y              +V E +  DL +I   +             ++L  L+Y+H  
Sbjct: 111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN 170

Query: 124 SVLHRDLKPSNLLLNASCDLKI--GDFGLAR 152
             +H D+K +NLLL      ++   D+GL+ 
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 8e-08
 Identities = 34/138 (24%), Positives = 60/138 (43%), Gaps = 14/138 (10%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             +    EEVAIK      + +      L  E K+ + M+    + I  I     +  +N
Sbjct: 28  GTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYN 80

Query: 79  DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
              +V EL+   L  +     ++ +         Q++  ++Y+HS + +HRD+KP N L+
Sbjct: 81  --VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138

Query: 138 NASCD---LKIGDFGLAR 152
                   + I DFGLA+
Sbjct: 139 GLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 14/138 (10%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             N +T EEVAIK      +N+      L  E K+ R ++      I ++     +  +N
Sbjct: 26  GTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ--GGTGIPNVRWFGVEGDYN 78

Query: 79  DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
              +V +L+   L  +     ++L+         Q++  +++VHS S LHRD+KP N L+
Sbjct: 79  --VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136

Query: 138 NASCD---LKIGDFGLAR 152
                   + I DFGLA+
Sbjct: 137 GLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 26/140 (18%), Positives = 56/140 (40%), Gaps = 16/140 (11%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTL-REIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             N    ++VAIK     F+        L  E +  + +       I ++    ++   N
Sbjct: 29  GTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA--GCTGIPNVYYFGQEGLHN 81

Query: 79  DVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
              +V +L+   L  ++    ++ +         Q+L  ++ +H  S+++RD+KP N L+
Sbjct: 82  --VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139

Query: 138 NASCDLK-----IGDFGLAR 152
                       + DFG+ +
Sbjct: 140 GRPNSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 17/43 (39%), Positives = 26/43 (60%), Gaps = 2/43 (4%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 152
           ++L  L+Y+H    +H D+K SNLLLN     ++   D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 8/43 (18%), Positives = 21/43 (48%), Gaps = 2/43 (4%)

Query: 112 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 152
           +LL  L+++H    +H ++   N+ ++     ++    +G A 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 26/120 (21%), Positives = 47/120 (39%), Gaps = 18/120 (15%)

Query: 39  DNIIDARRTLREIKLLRHMEHENVIA--IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR 96
           D  I   RT RE + L  ++   + A  I D+      D  N   ++  +       +I 
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDV------DLDNKRIMMSYINGKLAKDVIE 431

Query: 97  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 156
            +            Y++   +  +H   V+H DL  SN + +    + I DFGL + ++ 
Sbjct: 432 DNLD--------IAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI-I-DFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	336
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.18
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.43
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.23
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.23
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.45
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.37
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.34
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.25
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.25
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.93
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.69
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.17
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.53
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.01
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.59

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-69  Score=483.86  Aligned_cols=331  Identities=51%  Similarity=0.905  Sum_probs=293.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++|||||++++++..... .....+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            5999999999999999999999999999999998776677777889999999999999999999999875432 123579


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC---
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  157 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (336)
                      |+|||||+|+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....   
T Consensus       135 ~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~  214 (398)
T 4b99_A          135 YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE  214 (398)
T ss_dssp             EEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999865432   


Q ss_pred             --CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          158 --DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                        ......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..|....+.++...........
T Consensus       215 ~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~  294 (398)
T 4b99_A          215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER  294 (398)
T ss_dssp             -CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----C
T ss_pred             cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence              234467899999999998876678999999999999999999999999999999999999999999888777766677


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT  315 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (336)
                      ...+...............++..++++.+||++||..||++|||++|+|+||||+..+.+...+.+..++++.++....+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~~~~~~  374 (398)
T 4b99_A          295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALT  374 (398)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHHHSCCC
T ss_pred             hhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCCCCccchhhcC
Confidence            77777777776666667778899999999999999999999999999999999999999888888888888888888899


Q ss_pred             HHHHHHHHHHHHhhcCC
Q 019728          316 EDHIRELIWRESVKFNP  332 (336)
Q Consensus       316 ~~~~~~~~~~~~~~~~~  332 (336)
                      .+++++.+.+|..+|+.
T Consensus       375 ~~~~k~~i~~ei~~~~~  391 (398)
T 4b99_A          375 RERIKEAIVAEIEDFHA  391 (398)
T ss_dssp             HHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHH
Confidence            99999999999888753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4e-66  Score=439.40  Aligned_cols=254  Identities=26%  Similarity=0.444  Sum_probs=210.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.++++++||||+++++++.+.     ..+
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~   88 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEI   88 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            58999999999999999999999999999999976532 334456788999999999999999999999887     679


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+|||||+|+|.+.+...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus        89 ~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           89 IMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999887766666


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ...+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.....                   
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-------------------  229 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-------------------  229 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------------------
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            6779999999999998845567899999999999999999999998887766666544211                   


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                  .....+|+++++||++||+.||++|||++|+++||||+.
T Consensus       230 ------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 ------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                        112356899999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.6e-65  Score=440.10  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=225.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||+||+|++..+|+.||||++.+.. .+......+.+|+.++++++||||+++++++.+.     ..+
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~  107 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKL  107 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEE
Confidence            3899999999999999999999999999999996543 2334567788999999999999999999999987     779


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      |+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999997 599999998899999999999999999999999999999999999999999999999999999876432  


Q ss_pred             -CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+..-               
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------  251 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---------------  251 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------------
T ss_pred             cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence             23456789999999999987 7889999999999999999999999999888777777655211               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE------ALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e------ll~h~~f~~~~  293 (336)
                                      .....+|+++++||++||+.||++|||++|      +++||||+++.
T Consensus       252 ----------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          252 ----------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ----------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence                            112356899999999999999999999988      58999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.9e-65  Score=446.06  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=220.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++++.||+|+||+||+|++..+|+.||||++.....+......+.+|+.++++++|||||++++++.+.     ..+|
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~y   99 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSLY   99 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence            69999999999999999999999999999999987666667788899999999999999999999999887     6799


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|||||+ |+|.++|...  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999998 5999999654  457999999999999999999999999999999999999999999999999998765432


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....                 
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----------------  241 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-----------------  241 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------------
T ss_pred             ccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----------------
Confidence             2345689999999999987 789999999999999999999999999988877776665521                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                   .++....+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus       242 -------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 -------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                         11223467999999999999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-64  Score=441.49  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=223.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|+++++||+|+||+||+|.+..+|+.||||++.....  ...+.+.+|+.++++++|||||++++++.+.     ..+|
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~  147 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELW  147 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            38899999999999999999999999999999965432  2345578999999999999999999999987     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +|||||+ |+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            9999998 599998876 57999999999999999999999999999999999999999999999999999876543 34


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......                
T Consensus       227 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------------  289 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------------  289 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC----------------
T ss_pred             ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------
Confidence            556799999999999987 789999999999999999999999999988877777665522111                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                  ...+..+|+++.+||.+||+.||++|||++|+|+||||+...
T Consensus       290 ------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          290 ------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                        111245799999999999999999999999999999998743

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-63  Score=425.69  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=215.5

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      ++.++||+|+||+||+|.+..++..||+|++............+.+|+.++++++|||||++++++..... +...+|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCcEEEEE
Confidence            67889999999999999999999999999997766666777889999999999999999999999865321 11458999


Q ss_pred             EecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEcc-CCCEEEEeccCCcccCCCCc
Q 019728           84 YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ||||+ |+|.+++...+++++.+++.|+.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|+..... .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-~  186 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-F  186 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-S
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-c
Confidence            99998 599999998889999999999999999999999999  999999999999974 789999999999764433 3


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ....+||+.|||||++.+  .++.++|||||||++|+|++|..||.+......+.....  ....+              
T Consensus       187 ~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~--~~~~~--------------  248 (290)
T 3fpq_A          187 AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKP--------------  248 (290)
T ss_dssp             BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCCC--------------
T ss_pred             cCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH--cCCCC--------------
Confidence            455689999999999864  689999999999999999999999987655443322211  11100              


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                  .......++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       249 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                        1112356889999999999999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-64  Score=434.25  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=217.1

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++++.||+|+||+||+|++.   .+++.||||++.+..........+.+|+.++++++|||||++++++.+.     .
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~   99 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----G   99 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----T
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----C
Confidence            4899999999999999999984   4688999999976544444445678899999999999999999999987     7


Q ss_pred             eEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .+|+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            7999999998 599999998899999999999999999999999999999999999999999999999999999865433


Q ss_pred             -CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+...               
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------  243 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL---------------  243 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------
T ss_pred             CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC---------------
Confidence             34456789999999999987 7899999999999999999999999999888877777654211               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                      .....+|+++.+||++||+.||++|||     ++|+++||||+++.
T Consensus       244 ----------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          244 ----------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                            112357999999999999999999998     58999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-63  Score=442.80  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=223.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|+++++||+|+||+||+|.+..+|+.||||++....  ....+.+.+|+.+|+.++|||||++++++...     ..+|
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~  224 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELW  224 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEE
Confidence            4899999999999999999999999999999996543  22345678999999999999999999999987     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +|||||+ |+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            9999998 599998876 57999999999999999999999999999999999999999999999999999876543 34


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ....+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......                
T Consensus       304 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------------  366 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------------  366 (423)
T ss_dssp             BCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred             ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------
Confidence            566799999999999987 789999999999999999999999999988877777665422111                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                  ...+..+|+++.+||.+||+.||++|||++|+|+||||+..
T Consensus       367 ------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          367 ------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                        12234679999999999999999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-62  Score=427.75  Aligned_cols=253  Identities=21%  Similarity=0.266  Sum_probs=215.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++.++||+|+||+||+|++..+|+.||||+++.....       .+|+.++++++|||||++++++.+.     ..+|+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~i  127 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREG-----PWVNI  127 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            67889999999999999999999999999999654322       3699999999999999999999887     67999


Q ss_pred             EEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccCCCCc-
Q 019728           83 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~-  159 (336)
                      |||||+ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+....... 
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999998 59999999888999999999999999999999999999999999999999988 599999999987654321 


Q ss_pred             -----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          160 -----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       160 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                           ....+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...               
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---------------  271 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---------------  271 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---------------
T ss_pred             cceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---------------
Confidence                 223579999999999988 78999999999999999999999999887655544444331               


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH-------------HcCcccccCcCCC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA-------------LRHPYLQSLHDLN  296 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el-------------l~h~~f~~~~~~~  296 (336)
                                   ........+.+|+.+.+||.+||+.||.+|||+.|+             |.|||+...+++.
T Consensus       272 -------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          272 -------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                         011123346789999999999999999999999998             5799998876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-59  Score=427.61  Aligned_cols=333  Identities=37%  Similarity=0.700  Sum_probs=289.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+++.||||++.....+......+.+|+.+++.++||||+++++++..........+|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            68999999999999999999999999999999987767777888999999999999999999999999876544456799


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (336)
                      +||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus       107 lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  186 (432)
T 3n9x_A          107 IVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN  186 (432)
T ss_dssp             EEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------
T ss_pred             EEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999998654332   


Q ss_pred             --------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-----------CCCCCCCC
Q 019728          159 --------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----------REPLFPGK  207 (336)
Q Consensus       159 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~~pf~~~  207 (336)
                                          ......+|+.|+|||++.....++.++|||||||++|+|++           |..+|.+.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~  266 (432)
T 3n9x_A          187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS  266 (432)
T ss_dssp             ------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCS
T ss_pred             ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCc
Confidence                                12556789999999997655789999999999999999998           44455554


Q ss_pred             C-----------------hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhc
Q 019728          208 D-----------------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML  270 (336)
Q Consensus       208 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  270 (336)
                      +                 ..+++..+...++.++..............+...............++..++++.+||++||
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL  346 (432)
T 3n9x_A          267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESML  346 (432)
T ss_dssp             CSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHS
T ss_pred             cccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHh
Confidence            3                 36788899999999999888877888888888888877777777788899999999999999


Q ss_pred             CCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCC-CcCCHHHHHHHHHHHHhhcCCCC
Q 019728          271 VFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SSCTEDHIRELIWRESVKFNPDP  334 (336)
Q Consensus       271 ~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  334 (336)
                      +.||++|||++|+|+||||++++....++.+.......+.. ...+++++++.+.+|...|.|+.
T Consensus       347 ~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  411 (432)
T 3n9x_A          347 KFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPEL  411 (432)
T ss_dssp             CSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred             cCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCccc
Confidence            99999999999999999999999888888887777776664 57899999999999999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-59  Score=430.74  Aligned_cols=332  Identities=39%  Similarity=0.739  Sum_probs=280.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++++.||.|+||+||+|.+..+++.||||++.....+......+.+|+.+++.++||||+++++++..........+|
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            58999999999999999999999999999999987766777788899999999999999999999999766544456799


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (336)
                      +||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus       134 lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  213 (458)
T 3rp9_A          134 VVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN  213 (458)
T ss_dssp             EEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCC
T ss_pred             EEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999998654221   


Q ss_pred             -------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-----------CCC
Q 019728          159 -------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----------REP  202 (336)
Q Consensus       159 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~~  202 (336)
                                               .....++|+.|+|||++.....++.++|||||||++|+|++           |..
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p  293 (458)
T 3rp9_A          214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP  293 (458)
T ss_dssp             CCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCC
T ss_pred             cccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccc
Confidence                                     22345779999999987654789999999999999999998           677


Q ss_pred             CCCCCC--------------------hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhH
Q 019728          203 LFPGKD--------------------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA  262 (336)
Q Consensus       203 pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
                      +|.+.+                    ..+.+..+...++.++..............+...............++..+.++
T Consensus       294 ~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  373 (458)
T 3rp9_A          294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADA  373 (458)
T ss_dssp             SCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHH
T ss_pred             cCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHH
Confidence            776654                    357888899999999988888888888888888888887888888889999999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcC-CCcCCHHHHHHHHHHHHhhcCCC
Q 019728          263 VDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE-HSSCTEDHIRELIWRESVKFNPD  333 (336)
Q Consensus       263 ~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  333 (336)
                      .+||++||..||++|||++|+|+||||+++.....++.+..+....+. ...++.+++++.+.+|...|.|+
T Consensus       374 ~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~  445 (458)
T 3rp9_A          374 IHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE  445 (458)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCTT
T ss_pred             HHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCcc
Confidence            999999999999999999999999999999887777777666665554 35789999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-59  Score=414.88  Aligned_cols=328  Identities=43%  Similarity=0.772  Sum_probs=280.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.....+......+.+|+.+++.++||||+++++++..... .....+
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            5899999999999999999999999999999997766677777889999999999999999999999987532 123457


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....  .
T Consensus       106 ~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~  182 (367)
T 1cm8_A          106 YLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--M  182 (367)
T ss_dssp             EEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--C
T ss_pred             EEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--c
Confidence            99999998899999987 57999999999999999999999999999999999999999999999999999876543  3


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++......+.......+.
T Consensus       183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~  262 (367)
T 1cm8_A          183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM  262 (367)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred             CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Confidence            44578999999999887678999999999999999999999999999999999999999999998887777778888888


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..+...........++..++.+.+||++||+.||.+|||++|+|+||||++++....++.+. +++.+++....+.+.++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  341 (367)
T 1cm8_A          263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWK  341 (367)
T ss_dssp             HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC-----CCHHHHH
T ss_pred             HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CCCCChhhhcCCHHHHH
Confidence            88888877788888889999999999999999999999999999999999998888777765 67777777788999999


Q ss_pred             HHHHHHHhhcCCC
Q 019728          321 ELIWRESVKFNPD  333 (336)
Q Consensus       321 ~~~~~~~~~~~~~  333 (336)
                      .++..+.+.|.|.
T Consensus       342 ~~~~~~~~~~~~~  354 (367)
T 1cm8_A          342 RVTYKEVLSFKPP  354 (367)
T ss_dssp             HHHHHHHHTCCC-
T ss_pred             HHHHHHHHHhccc
Confidence            9999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.2e-59  Score=414.96  Aligned_cols=329  Identities=47%  Similarity=0.830  Sum_probs=276.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.....+......+.+|+.+++.++||||+++++++..... ......
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            6899999999999999999999999999999997766677778889999999999999999999999876421 122458


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |++||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....  .
T Consensus       110 ~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~  186 (367)
T 2fst_X          110 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--M  186 (367)
T ss_dssp             EEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------
T ss_pred             EEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--C
Confidence            99999999999998876 67999999999999999999999999999999999999999999999999999765433  3


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++..............+.
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~  266 (367)
T 2fst_X          187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI  266 (367)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHH
T ss_pred             CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHH
Confidence            44578999999999887567899999999999999999999999999999999999999999998888877777788888


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..+...........++..++.+.+||++||+.||.+|||+.|+|+||||+........+.+. ++.+++.......+.++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  345 (367)
T 2fst_X          267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWK  345 (367)
T ss_dssp             HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CCCGGGSSCCCCHHHHH
T ss_pred             hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CCCcchhhccCCHHHHH
Confidence            88877777777777888999999999999999999999999999999999998887777665 67777777788999999


Q ss_pred             HHHHHHHhhcCCCC
Q 019728          321 ELIWRESVKFNPDP  334 (336)
Q Consensus       321 ~~~~~~~~~~~~~~  334 (336)
                      +++++|...|.|.+
T Consensus       346 ~~~~~e~~~~~~~~  359 (367)
T 2fst_X          346 SLTYDEVISFVPPP  359 (367)
T ss_dssp             HHHHHHHHHCCCCC
T ss_pred             HHHHHHHHHhccCc
Confidence            99999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3e-59  Score=414.38  Aligned_cols=280  Identities=27%  Similarity=0.432  Sum_probs=218.7

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.++||+|+||+||+|.++   .+++.||+|++....    ...++.+|+++++.+ +||||+++++++...     
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-----   92 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-----   92 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-----
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-----
Confidence            5999999999999999999874   467889999985532    235677899999998 699999999999887     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~  155 (336)
                      .++|+|||||+ |+|.+++   +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            77999999997 5999998   469999999999999999999999999999999999999877 799999999997543


Q ss_pred             CCC-----------------------------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCC-
Q 019728          156 ETD-----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP-  205 (336)
Q Consensus       156 ~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-  205 (336)
                      ...                             .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||. 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            221                             12335799999999999875678999999999999999999999984 


Q ss_pred             CCChHHHHHHHHHHhCCCCcccc-----------cccccchHHHHHHhCCcc------------ccccccccCCCCChhH
Q 019728          206 GKDYVHQLRLITELIGSPDDASL-----------GFLRSDNARRYVRQLPRC------------RKQQFATRFPNKSSGA  262 (336)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~  262 (336)
                      +.+..+++..|....+.+.....           ...+..............            ........+..+|+++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            55667888888877764322110           111111122111111100            0011123456789999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          263 VDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       263 ~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .+||++||+.||++|+|++|+|+||||++++
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.1e-60  Score=408.69  Aligned_cols=257  Identities=23%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-------
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-------   75 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-------   75 (336)
                      |++++.||+|+||+||+|.++.+|+.||||++.... .....+.+.+|+.++++++|||||++++++......       
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            789999999999999999999999999999996542 344567788999999999999999999998654321       


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCC---CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ....+|+|||||+ |+|.+++.....+   ....++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence            1135799999997 5999999876554   45668899999999999999999999999999999999999999999999


Q ss_pred             cccCCCCc-------------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 019728          152 RTTSETDF-------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  218 (336)
Q Consensus       152 ~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  218 (336)
                      +.......             ....+||+.|||||++.+ ..++.++|||||||++|+|++   ||...  .+....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~  239 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTD  239 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHH
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHH
Confidence            87554321             133579999999999987 789999999999999999996   77542  233333333


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ......                           ++.+...++.+.+||++||+.||++|||+.|+++||||+++.
T Consensus       240 ~~~~~~---------------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          240 VRNLKF---------------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHTTCC---------------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HhcCCC---------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            222111                           111223466788999999999999999999999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-58  Score=416.63  Aligned_cols=327  Identities=39%  Similarity=0.721  Sum_probs=264.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++..............+|+.+++.+. ||||+++++++.....   ..+
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~   86 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---RDV   86 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---SCE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---CEE
Confidence            689999999999999999999999999999999877677788888999999999997 9999999999976533   468


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC----
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE----  156 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~----  156 (336)
                      |+||||++|+|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....    
T Consensus        87 ~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           87 YLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred             EEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence            99999999999999987 5799999999999999999999999999999999999999999999999999975432    


Q ss_pred             ------------------CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 019728          157 ------------------TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE  218 (336)
Q Consensus       157 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  218 (336)
                                        ........+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                              11223457899999999998767889999999999999999999999999999999999999


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCccc---cccccc-------------cCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCR---KQQFAT-------------RFPNKSSGAVDLLEKMLVFDPNKRITVEE  282 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  282 (336)
                      .++.|...............+........   ......             .....++++.+||++||+.||++|||++|
T Consensus       246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence            99988877655544444333333222111   111111             12367899999999999999999999999


Q ss_pred             HHcCcccccCcCCCCCCCCCCCCCCCcC-CCcCCHHHHHHHHHHHHhhcCC
Q 019728          283 ALRHPYLQSLHDLNDEPVCPRPFHFDFE-HSSCTEDHIRELIWRESVKFNP  332 (336)
Q Consensus       283 ll~h~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  332 (336)
                      +|+||||+.++....++.+...+...+. ....+.++.++.+..+..+|.+
T Consensus       326 ~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (388)
T 3oz6_A          326 ALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKR  376 (388)
T ss_dssp             HTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHH
T ss_pred             HhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhh
Confidence            9999999999999889988888777776 4567889999999999988765

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.6e-57  Score=402.65  Aligned_cols=331  Identities=49%  Similarity=0.855  Sum_probs=285.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.++++++||||+++++++...........|
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            699999999999999999999999999999999642 3445567788999999999999999999999876544445689


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc--
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (336)
                      +|||+++|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+........  
T Consensus       107 iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  185 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  185 (364)
T ss_dssp             EEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             EEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcc
Confidence            9999999999999976 5699999999999999999999999999999999999999999999999999976553321  


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.............
T Consensus       186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  265 (364)
T 3qyz_A          186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR  265 (364)
T ss_dssp             CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHH
Confidence              234578999999999876567899999999999999999999999999999999999999999888776666666666


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHH
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED  317 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (336)
                      .+................+..+.++.+||++||+.||++|||+.|+|+||||+........+....++.++........+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (364)
T 3qyz_A          266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKE  345 (364)
T ss_dssp             HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCHH
T ss_pred             HHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcccccccCCHH
Confidence            66666666555555666778999999999999999999999999999999999998888888888888888888889999


Q ss_pred             HHHHHHHHHHhhcCCCC
Q 019728          318 HIRELIWRESVKFNPDP  334 (336)
Q Consensus       318 ~~~~~~~~~~~~~~~~~  334 (336)
                      .+++++.++..+|.|+.
T Consensus       346 ~~~~~~~~e~~~~~~~~  362 (364)
T 3qyz_A          346 KLKELIFEETARFQPGY  362 (364)
T ss_dssp             HHHHHHHHHTGGGCC--
T ss_pred             HHHHHHHHHHHHhhhhc
Confidence            99999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-57  Score=416.77  Aligned_cols=327  Identities=40%  Similarity=0.707  Sum_probs=257.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... .....+
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            5899999999999999999999999999999998776677778889999999999999999999999976542 233568


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|.+.+..  .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       143 ~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  220 (464)
T 3ttj_A          143 YLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  220 (464)
T ss_dssp             EEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC
T ss_pred             EEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCccc
Confidence            99999999999998854  5999999999999999999999999999999999999999999999999999887766556


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+.+.++.+.+..+.... .....+.
T Consensus       221 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~-~~~~~~~  298 (464)
T 3ttj_A          221 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYV  298 (464)
T ss_dssp             ----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-HHHHHHH
T ss_pred             CCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-hhhhhHh
Confidence            67789999999999988 689999999999999999999999999999999999999999988876654432 2333344


Q ss_pred             HhCCccccccccccCCCC------------ChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCC-CCCCCCCCC
Q 019728          241 RQLPRCRKQQFATRFPNK------------SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE-PVCPRPFHF  307 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~-~~~~~~~~~  307 (336)
                      ..............++..            ++++.+||++||+.||++|||++|+|+||||+........ +..+..+..
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~  378 (464)
T 3ttj_A          299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDK  378 (464)
T ss_dssp             TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC------
T ss_pred             hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCc
Confidence            333332222222222221            5679999999999999999999999999999986654332 233344566


Q ss_pred             CcCCCcCCHHHHHHHHHHHHhhcCC
Q 019728          308 DFEHSSCTEDHIRELIWRESVKFNP  332 (336)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~  332 (336)
                      +++......+.+++.+.++..++..
T Consensus       379 ~~~~~~~~~~~~~~~~~~e~~~~~~  403 (464)
T 3ttj_A          379 QLDEREHTIEEWKELIYKEVMNSEE  403 (464)
T ss_dssp             -----CCCHHHHHHHHHHHHHC---
T ss_pred             chhhccCCHHHHHHHHHHHHHHhhh
Confidence            6677778899999999999887764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-58  Score=398.02  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=213.3

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .|.+.++||+|+||+||+|.+.     .++..||||+++..  +....+.+.+|+.++++++|||||++++++.+.    
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----   87 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----   87 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC----
Confidence            3778999999999999999874     35788999999653  455667889999999999999999999999887    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD  142 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~  142 (336)
                       ..+|+|||||+ |+|.+++...             ..+++.++..|+.||+.||+|||+++|+||||||+|||++.++.
T Consensus        88 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           88 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence             56999999997 6999999753             36999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 019728          143 LKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE  218 (336)
Q Consensus       143 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~  218 (336)
                      +||+|||+|+.......   .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+..
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999986544322   234578999999999987 789999999999999999998 8999999887777666654


Q ss_pred             HhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          219 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ...                              .+....+|+++.+|+.+||+.||++|||+.++  ++|++++.
T Consensus       246 ~~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          246 GRV------------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             TCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             CCC------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            211                              12234678999999999999999999999999  56777654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.3e-58  Score=428.52  Aligned_cols=259  Identities=24%  Similarity=0.392  Sum_probs=229.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+++.||+|+||.||+|.++.+|+.||+|++...  .......+.+|+.+|+.++||||+++++++.+.     ..+|
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~  230 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV  230 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence            589999999999999999999999999999999654  344567788999999999999999999999987     7799


Q ss_pred             EEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC--CCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~--~~~kl~dfg~~~~~~~~  157 (336)
                      +|||||+ |+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.....
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999997 599999965 4679999999999999999999999999999999999999854  88999999999988777


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......++             
T Consensus       311 ~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------  376 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------------  376 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred             CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC-------------
Confidence            66677789999999999988 7889999999999999999999999999988887777655322221             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                    ...+..+|+++.+||++||+.||.+|||+.|+|+||||+.....
T Consensus       377 --------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          377 --------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             --------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             --------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence                          12335779999999999999999999999999999999976543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-57  Score=392.40  Aligned_cols=251  Identities=20%  Similarity=0.254  Sum_probs=206.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ++++.++||+|+||+||+|.+..   .||||+++....+....+.+.+|+.++++++|||||++++++..      ..+|
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~~  107 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNLA  107 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeEE
Confidence            46789999999999999998743   59999997766677778889999999999999999999998754      3479


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      +|||||+ |+|.+++... .++++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999998 6999999754 67999999999999999999999999999999999999999999999999999865432  


Q ss_pred             -CcccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          158 -DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                       .......||+.|||||++.+.  .+++.++|||||||++|||++|+.||.+.+....+..+......            
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~------------  255 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA------------  255 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC------------
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC------------
Confidence             223456899999999998642  46899999999999999999999999887665554444331111            


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                   ..........+++.+.+|+.+||+.||++|||+.|++++
T Consensus       256 -------------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          256 -------------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             -------------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             -------------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         111123345678999999999999999999999988653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-56  Score=399.91  Aligned_cols=327  Identities=43%  Similarity=0.768  Sum_probs=285.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...... .....
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            58899999999999999999999999999999987766777778889999999999999999999999876432 12235


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+......  .
T Consensus       123 ~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~  198 (371)
T 4exu_A          123 YLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--M  198 (371)
T ss_dssp             EEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred             EEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--c
Confidence            9999999999998874  45999999999999999999999999999999999999999999999999999765543  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++......+.......+.
T Consensus       199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  278 (371)
T 4exu_A          199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI  278 (371)
T ss_dssp             -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred             CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence            34567999999999887578899999999999999999999999999999999999999999988877777777777777


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..............++..++.+.+||++||+.||.+|||+.|+|+||||+.+...........++...........+.++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (371)
T 4exu_A          279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK  358 (371)
T ss_dssp             HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHH
T ss_pred             hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcchhhcccchHHHH
Confidence            77777766667777788999999999999999999999999999999999988777777777777777777788899999


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      +.++.+.++|.|
T Consensus       359 ~~~~~~~~~~~~  370 (371)
T 4exu_A          359 QHIYKEIVNFSP  370 (371)
T ss_dssp             HHHHHHHHHCCC
T ss_pred             HHHHHHHHhccc
Confidence            999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.7e-58  Score=426.97  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=215.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc----cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF----DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|.+++.||+|+||.||+|+++.+|+.||||++.+..    ...........++.+++.++|||||+++++|.+.     
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-----  264 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----  264 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-----
Confidence            4899999999999999999999999999999996532    1222233334556778888999999999999988     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+|+|||||+ |+|.++|...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            77999999998 59999999889999999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .. ....+||+.|+|||++.....++.++|+|||||++|+|++|..||.+.+..+............             
T Consensus       345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-------------  410 (689)
T 3v5w_A          345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-------------  410 (689)
T ss_dssp             CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-------------
T ss_pred             CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-------------
Confidence            43 3456899999999999754679999999999999999999999997643221111111111100             


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                     ...+..+|+++++||++||+.||++|++     ++|+++||||+++.
T Consensus       411 ---------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          411 ---------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             ---------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence                           1223467999999999999999999997     89999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.3e-57  Score=393.91  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=204.2

Q ss_pred             cceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            3 VKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      |.+.++||+|+||+||+|.+.     .+++.||||+++..  +....+.+.+|+.++++++|||||++++++.+.     
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----  115 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG-----  115 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            678899999999999999864     46888999999653  455677899999999999999999999999887     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD---------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ..+|+|||||+ |+|.++++..               +++++.++..|+.||+.||+|||+++|+||||||+|||++.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            56999999998 6999999753               3589999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 019728          142 DLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  217 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~  217 (336)
                      .+||+|||+++......   ......||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+..+.
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999998654432   2234578999999999987 789999999999999999999 899999988777766664


Q ss_pred             HHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ....                              .+....+++++.+|+.+||+.||++|||+.|++.+
T Consensus       275 ~g~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          275 QGRE------------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HTCC------------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cCCC------------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4211                              12224678999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-57  Score=390.80  Aligned_cols=248  Identities=20%  Similarity=0.290  Sum_probs=209.0

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      .+++.++||+|+||+||+|...     .+++.||||+++... .....+.+.+|+.++++++|||||++++++...    
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence            3678999999999999999853     467889999996542 334457788999999999999999999999877    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA  139 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~  139 (336)
                       ..+++|||||+ |+|.++|...                ..+++.++..|+.||+.||+|||+++|+||||||+|||+++
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence             56899999997 6999999643                35899999999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 019728          140 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRL  215 (336)
Q Consensus       140 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  215 (336)
                      ++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999998654332   2345578999999999987 789999999999999999998 8999999887766655


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +....                              ..+.....|.++.+|+.+||+.||++|||+.||+++
T Consensus       260 i~~~~------------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQ------------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCC------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            53311                              112234678999999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-55  Score=391.77  Aligned_cols=327  Identities=43%  Similarity=0.767  Sum_probs=282.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      +|.+.+.||.|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...... .....
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            58999999999999999999999999999999977666667778889999999999999999999999876321 12346


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |++|||++++|.+++.  ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+......  .
T Consensus       105 ~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~  180 (353)
T 3coi_A          105 YLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--M  180 (353)
T ss_dssp             EEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred             EEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--c
Confidence            9999999999988774  35999999999999999999999999999999999999999999999999999765433  2


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++......+.......+.
T Consensus       181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  260 (353)
T 3coi_A          181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI  260 (353)
T ss_dssp             ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHH
T ss_pred             cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHH
Confidence            34577899999999877567899999999999999999999999999999999999998888887776666666666777


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ...............+..++.+.+||.+||+.||.+|||+.++++||||+........+....++.........+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
T 3coi_A          261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK  340 (353)
T ss_dssp             HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCHHHHH
T ss_pred             HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCccchhhccCCHHHHH
Confidence            77766666666667778899999999999999999999999999999999988777777777777777777788999999


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      ..+..+.++|.|
T Consensus       341 ~~~~~~~~~~~~  352 (353)
T 3coi_A          341 QHIYKEIVNFSP  352 (353)
T ss_dssp             HHHHHHHHTCCC
T ss_pred             HHHHHHHHhhcc
Confidence            999999999976

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.5e-55  Score=385.34  Aligned_cols=258  Identities=23%  Similarity=0.386  Sum_probs=229.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.....+......+.+|+.+++.++||||+++++++...     ...|
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~   90 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLY   90 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence            58999999999999999999999999999999977666777788899999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      +||||++ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            9999997 599999988889999999999999999999999999999999999999999999999999999877666556


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ...+|++.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....                   
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------  231 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-------------------  231 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence            6678999999999998744456899999999999999999999999887766665544211                   


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                  ......++++.+||++||+.||.+|||++|+++||||+.....
T Consensus       232 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          232 ------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             ------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                        1123468899999999999999999999999999999986543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.8e-55  Score=381.36  Aligned_cols=285  Identities=35%  Similarity=0.633  Sum_probs=233.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||+++++++...     ...+
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   95 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RCLT   95 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SCEE
T ss_pred             hhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CEEE
Confidence            6899999999999999999995 599999999976555555667888999999999999999999999877     6699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||++|+|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...... ..
T Consensus        96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            99999999999988765 45999999999999999999999999999999999999999999999999999876533 23


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....+.+.+..+.......... 
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-  254 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK-  254 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH-
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh-
Confidence            3445779999999998775678999999999999999999999999998888999999988887765543322211100 


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ................+..++++.+||++||+.||++|||++|+++||||+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            001111112223344567899999999999999999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-54  Score=389.30  Aligned_cols=327  Identities=40%  Similarity=0.684  Sum_probs=250.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||||++.....+......+.+|+.+++.++||||+++++++..... ......
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            6899999999999999999999999999999997766666777888999999999999999999999876532 122478


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++|+|.+.+..  .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus       106 ~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  183 (371)
T 2xrw_A          106 YIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  183 (371)
T ss_dssp             EEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred             EEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccccc
Confidence            99999999999999864  6899999999999999999999999999999999999999999999999999877655445


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.+....... .....+.
T Consensus       184 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~  261 (371)
T 2xrw_A          184 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYV  261 (371)
T ss_dssp             ------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC-HHHHHHH
T ss_pred             CCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh-hHHHHHH
Confidence            56688999999999987 778999999999999999999999999999888888888777766554433221 1122222


Q ss_pred             HhCCccccccccccC-----C-------CCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCC-CCCCCCCC
Q 019728          241 RQLPRCRKQQFATRF-----P-------NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEP-VCPRPFHF  307 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~-----~-------~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~-~~~~~~~~  307 (336)
                      ...............     +       ..+..+.+||++||+.||++|||++|+|+||||+......... ..+.....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  341 (371)
T 2xrw_A          262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK  341 (371)
T ss_dssp             HSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTT
T ss_pred             hhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCCh
Confidence            222111111111111     1       1256799999999999999999999999999998765433222 22233344


Q ss_pred             CcCCCcCCHHHHHHHHHHHHhhcCC
Q 019728          308 DFEHSSCTEDHIRELIWRESVKFNP  332 (336)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~  332 (336)
                      +........+.+++++..+..+|+-
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~  366 (371)
T 2xrw_A          342 QLDEREHTIEEWKELIYKEVMDLEH  366 (371)
T ss_dssp             TTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred             hhccccCcHHHHHHHHHHHHHHHhh
Confidence            5556678889999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-54  Score=374.86  Aligned_cols=284  Identities=33%  Similarity=0.569  Sum_probs=235.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...     ...+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   77 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEEE
Confidence            69999999999999999999999999999999977666666778888999999999999999999999877     6799


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||++|++.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...... ..
T Consensus        78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999999988887765 578999999999999999999999999999999999999999999999999999765533 23


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....+......... 
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  236 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY-  236 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC-
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc-
Confidence            34557799999999998755689999999999999999987766 6777778888888888887766544322110000 


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                       ................+.++..+.+||++||+.||++|||++|+++||||+++
T Consensus       237 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          237 -KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             -CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             -cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence             00000001112223445689999999999999999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.9e-55  Score=386.40  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=206.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-----CceEEEEEecCcccChhHHHHHHHHHHHHhhCCC-CceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-----REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||+||+|.+..+     ++.||||++.... .......+.+|+.++.+++| ||||++++++....  
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~--  141 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--  141 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC--
Confidence            578999999999999999997543     4679999986542 34456778899999999965 99999999986542  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                        ..+|+|||||+ |+|.++|+..                ..+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus       142 --~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          142 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             --SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             --CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence              35899999998 6999999753                3489999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019728          139 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  214 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  214 (336)
                      .++.+||+|||+|+......   ......||+.|||||++.+ ..++.++|||||||++|||+| |..||.+.+..+.+.
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998764432   2335678999999999987 789999999999999999998 999998866443333


Q ss_pred             HHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .....-.                             ........++++.++|.+||+.||++|||+.|+++|
T Consensus       299 ~~i~~g~-----------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCC-----------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2222110                             112224568899999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-53  Score=378.17  Aligned_cols=325  Identities=50%  Similarity=0.865  Sum_probs=268.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.++++++||||+++++++...........|
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            589999999999999999999999999999999542 3455567788999999999999999999988765444446799


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc--
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (336)
                      ++|||++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+........  
T Consensus        91 lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  169 (353)
T 2b9h_A           91 IIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN  169 (353)
T ss_dssp             EEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccc
Confidence            9999999999999877 5799999999999999999999999999999999999999999999999999976543211  


Q ss_pred             ---------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc-cc
Q 019728          160 ---------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS-LG  229 (336)
Q Consensus       160 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~  229 (336)
                               .....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+.... ..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T 2b9h_A          170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR  249 (353)
T ss_dssp             ----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTT
T ss_pred             cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccc
Confidence                     12346789999999987657889999999999999999999999999999888888888888766432 33


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCC----CCCCC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV----CPRPF  305 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~----~~~~~  305 (336)
                      .........+...............++.+++.+.+||++||+.||++|||+.|+++||||+........+.    .+..+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~  329 (353)
T 2b9h_A          250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFF  329 (353)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGG
T ss_pred             ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCccee
Confidence            33344455555655554444555566789999999999999999999999999999999999876554332    22334


Q ss_pred             CCCcCCCcCCHHHHHHHHHHHHh
Q 019728          306 HFDFEHSSCTEDHIRELIWRESV  328 (336)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~  328 (336)
                      .++......+...+++++.+|+.
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 2b9h_A          330 EFDHYKEALTTKDLKKLIWNEIF  352 (353)
T ss_dssp             GGGCCSSCCCHHHHHHHHHHHHT
T ss_pred             eecchhhcCCHHHHHHHHHHHhh
Confidence            55666778999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.3e-53  Score=379.55  Aligned_cols=328  Identities=36%  Similarity=0.634  Sum_probs=259.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc---------ChhHHHHHHHHHHHHhhCCCCceeeecceecCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD---------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPP   72 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   72 (336)
                      +|++.+.||+|+||.||+|.+.. |+.||||++.....         +......+.+|+.++++++||||+++++++...
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            68999999999999999999965 99999999854321         233457888999999999999999999998654


Q ss_pred             CCCCcceEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           73 KKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        73 ~~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ........|+||||++|+|.+.+... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       102 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  181 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA  181 (362)
T ss_dssp             CTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-
T ss_pred             cCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcc
Confidence            43333678999999999999998765 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          152 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .............++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+.+........
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (362)
T 3pg1_A          182 REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF  261 (362)
T ss_dssp             --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHT
T ss_pred             cccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhc
Confidence            86665555556688999999999887577899999999999999999999999999999999999998888776654444


Q ss_pred             ccchHHHHHHhCC-ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcC
Q 019728          232 RSDNARRYVRQLP-RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE  310 (336)
Q Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~  310 (336)
                      .......+..... ...........+..++.+.+||.+||+.||.+|||+.|+++||||+++........ ...-.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~-~~~~~~~~~  340 (362)
T 3pg1_A          262 SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTE-GLSERFHFD  340 (362)
T ss_dssp             SCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTT-TCCCCCCCC
T ss_pred             cchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccc-ccccccChh
Confidence            3333333332222 22222334455678999999999999999999999999999999999865443332 223445667


Q ss_pred             CCcCCHHHHHHHHHHHHhhcC
Q 019728          311 HSSCTEDHIRELIWRESVKFN  331 (336)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~  331 (336)
                      ....+...++..+..|..+|+
T Consensus       341 ~~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          341 ESVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHC
T ss_pred             hhhhhHHHHHHHHHHHHHHhc
Confidence            777888999999999998886

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-54  Score=379.69  Aligned_cols=294  Identities=34%  Similarity=0.604  Sum_probs=235.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++++...     ...+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT   76 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence            68999999999999999999999999999999864321 11122345799999999999999999999877     6699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||++|+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+...... ..
T Consensus        77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             EEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            99999999999998765 45899999999999999999999999999999999999999999999999998765433 22


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....+.+....+.......... 
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-  235 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH-
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc-
Confidence            3445779999999998875778999999999999999999999999999999999999999988776554332221111 


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP  302 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~  302 (336)
                      ................+.+++++.+||++||+.||.+|||++|+|+||||+++.........+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  298 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDT  298 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCC
Confidence            111222222333445567899999999999999999999999999999999987654444433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-54  Score=375.56  Aligned_cols=290  Identities=30%  Similarity=0.564  Sum_probs=229.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|+||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++...     ...+
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRLH   78 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeEE
Confidence            68999999999999999999999999999999977665666677888999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||+++ +|.+++...+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...... ..
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999996 77777777788999999999999999999999999999999999999999999999999999765533 23


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+...++.++||||||+++|+|++|..||.+....+....+....+...+..............
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            34557899999999998767789999999999999999999999999999888888888776654432111100000000


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                      ................+.++..+.+||++||+.||.+|||++|+++||||+++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            000000001111223457899999999999999999999999999999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.5e-54  Score=372.93  Aligned_cols=283  Identities=35%  Similarity=0.587  Sum_probs=229.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+ .+++.||+|++............+.+|+.++++++||||+++++++...     ...+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV   76 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence            689999999999999999999 6799999999976544444456788999999999999999999999876     6699


Q ss_pred             EEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...... ..
T Consensus        77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            99999999999999764 67999999999999999999999999999999999999999999999999998765432 22


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.......  .+
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  234 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP--KY  234 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TC
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc--cc
Confidence            3345779999999999775678999999999999999999999999999888888888887776554332211000  00


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ..................++.++.+||++||+.||++|||++|+++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            00001111111223345689999999999999999999999999999999863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.9e-54  Score=381.03  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=224.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC----hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|.+.+.||.|+||+||+|.+..+|+.||+|++......    ......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----   87 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-----   87 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-----
Confidence            489999999999999999999999999999999654322    12356788999999999999999999999877     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC----CEEEEeccCCc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  152 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~  152 (336)
                      ..+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++    .++|+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            67999999996 69999998888999999999999999999999999999999999999998877    79999999998


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ............|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.......+        
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--------  238 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------  238 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             EcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence            7766555566789999999999977 7889999999999999999999999999887776666544221111        


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                         ...+..++..+.+||++||..||.+|||+.|+++||||+.+
T Consensus       239 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          239 -------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             -------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                               11235678999999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-54  Score=374.15  Aligned_cols=287  Identities=33%  Similarity=0.527  Sum_probs=232.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc---ChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD---NIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.....   .........+|+.+++.+   +||||+++++++......
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            69999999999999999999999999999999864321   111223445666666655   599999999998876443


Q ss_pred             CcceEEEEEecCCccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      .....+++||+++|+|.+++.....  +++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+..
T Consensus        90 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  169 (308)
T 3g33_A           90 REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI  169 (308)
T ss_dssp             SEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred             CceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence            3346899999999999999987654  99999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+.....
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (308)
T 3g33_A          170 YSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  248 (308)
T ss_dssp             STTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCS
T ss_pred             cCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhh
Confidence            766655666788999999999987 7789999999999999999999999999999999999999888777654432111


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ...    ..+............+.++..+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       249 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          249 LPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            000    11111222233344567899999999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-53  Score=371.52  Aligned_cols=286  Identities=33%  Similarity=0.604  Sum_probs=220.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.++++++||||+++++++...     ...|
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   79 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NKLT   79 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----CeEE
Confidence            5899999999999999999999999999999986543 223346677999999999999999999999877     6799


Q ss_pred             EEEecCCccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           82 IVYELMDTDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      +||||++|+|.+++...      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+....
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            99999999999998653      458999999999999999999999999999999999999999999999999997654


Q ss_pred             CC-CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          156 ET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .. .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....+.++...+......
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            33 23345578999999999977567899999999999999999999999999999999999888887665443221110


Q ss_pred             hHHHHHHhCCccccc-----cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          235 NARRYVRQLPRCRKQ-----QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      ..  +..........     ........++.++.+||++||+.||.+|||+.|+++||||++....
T Consensus       240 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          240 PK--YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TT--CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hh--cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            00  00000000000     0112234678899999999999999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.5e-53  Score=372.37  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=222.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++++.||+|+||+||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...     ..+
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~   80 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRL   80 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----CEE
Confidence            5899999999999999999999999999999996532 1233456788999999999999999999999887     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~  158 (336)
                      |+||||++| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++.... ..
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999975 9999998888999999999999999999999999999999999999999999999999999976432 33


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+....                  
T Consensus       161 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------------  221 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------------  221 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------
T ss_pred             cccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            4456789999999999987 788999999999999999999999999887666655554311                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                   ......+++++.+||++||+.||++||     +++|+++||||+++.
T Consensus       222 -------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          222 -------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence                         011235689999999999999999999     999999999998763

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-53  Score=374.39  Aligned_cols=285  Identities=34%  Similarity=0.598  Sum_probs=224.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...     ...|
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  109 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----HRLH  109 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----CEEE
Confidence            68999999999999999999999999999999976655555567778999999999999999999999877     6799


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc-----cCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-----ASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~-----~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++     .++.++|+|||.+.....
T Consensus       110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            999999999999999988999999999999999999999999999999999999994     445599999999876543


Q ss_pred             C-CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          157 T-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      . .......++..|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....+.++...+.......
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            3 223445779999999999875668999999999999999999999999999999999998888877665433211100


Q ss_pred             HHHHHHhCCcccccccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          236 ARRYVRQLPRCRKQQFA-TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .  +............. .....++.++.+||++||+.||++|||++|+|+||||++..
T Consensus       270 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          270 D--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             T--CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             h--hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            0  00000000000000 11123688999999999999999999999999999999853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.9e-53  Score=376.23  Aligned_cols=258  Identities=27%  Similarity=0.444  Sum_probs=226.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...     ...|
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~  104 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHY  104 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEE
Confidence            48999999999999999999999999999999977665666778889999999999999999999999887     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~~~~  157 (336)
                      +||||+.| +|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            99999985 9999998888899999999999999999999999999999999999997654   5999999999877665


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+             
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  250 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-------------  250 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred             cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            55556688999999999987 6789999999999999999999999998877666665544221111             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                    ...+..+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       251 --------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          251 --------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             --------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             --------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                          11224568999999999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.4e-53  Score=383.45  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=224.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...     ...|
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~   86 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----GHHY   86 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----SEEE
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----CEEE
Confidence            58999999999999999999999999999999977665666677888999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc---cCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||+. |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999997 49999999989999999999999999999999999999999999999998   4578999999999766543


Q ss_pred             C-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 D-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      . ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+            
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------  233 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP------------  233 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------------
T ss_pred             CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC------------
Confidence            2 2345678999999999987 6789999999999999999999999998887777766655322211            


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                     .+.+..+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       234 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          234 ---------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ---------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ---------------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                           12235679999999999999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.6e-54  Score=377.51  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=217.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~   84 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TDI   84 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEE
Confidence            68999999999999999999999999999999864321 122235678999999999999999999999887     679


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++||||++|+|.+++...+++++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus        85 ~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           85 VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred             EEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999877766666


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ...+|++.|+|||++.+....+.++|||||||++|+|++|..||.........                           
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------------------  217 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------------------  217 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------------------
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------------------
Confidence            66789999999999987444578999999999999999999999764321100                           


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                          .............+++.+.+||++||+.||.+|||++|+++||||+.-
T Consensus       218 ----~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          218 ----KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ----CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ----HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                000111112234578999999999999999999999999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-53  Score=369.99  Aligned_cols=256  Identities=22%  Similarity=0.368  Sum_probs=223.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+...   ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~   77 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence            689999999999999999999999999999998643   34456678999999999999999999999877     6799


Q ss_pred             EEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc--CCCEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||++| +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||+++.  ++.++|+|||++......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999985 999999765 47999999999999999999999999999999999999987  789999999999887666


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+.            
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------  224 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------------  224 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------------
T ss_pred             CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh------------
Confidence            55566788999999999987 67899999999999999999999999998877776666553222211            


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                     ..++.++.++.+||++||..||.+|||+.|+|+||||+...
T Consensus       225 ---------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          225 ---------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ---------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ---------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                           12356799999999999999999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=369.32  Aligned_cols=258  Identities=27%  Similarity=0.426  Sum_probs=223.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC----hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++......    ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   86 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----   86 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence            488999999999999999999999999999998654322    12457788999999999999999999999876     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC----CEEEEeccCCc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  152 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~  152 (336)
                      ...++||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+|+||||+||+++.++    .++|+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            67999999997 59999998888899999999999999999999999999999999999998887    79999999998


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......+        
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------  237 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--------  237 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC--------
Confidence            7765544556678999999999976 7789999999999999999999999998877766665544221111        


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                         ...+...+..+.+||++||+.||.+|||+.|+++||||+..
T Consensus       238 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          238 -------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                               11224678899999999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-53  Score=376.24  Aligned_cols=255  Identities=21%  Similarity=0.332  Sum_probs=218.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+.. ...........|..+++.+ +||||+++++++...     ..
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~   98 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-----DR   98 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----CE
Confidence            5899999999999999999999999999999996542 2334556778899999998 699999999999887     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  157 (336)
                      +|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999998 599999988889999999999999999999999999999999999999999999999999999864332 


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.....                
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------  241 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------  241 (353)
T ss_dssp             -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred             ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            33445689999999999987 6789999999999999999999999999888777776655211                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~ell~h~~f~~~~  293 (336)
                                     .....++..+.+||++||+.||.+||++      +|+++||||+++.
T Consensus       242 ---------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          242 ---------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence                           1113468899999999999999999998      8999999999863

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-52  Score=363.24  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=219.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++...     ...|
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            6899999999999999999999999999999986543  22346678999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++ |+|.+++... .+++.+++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus        94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            9999996 5999998764 69999999999999999999999999999999999999999999999999987655432 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+........               
T Consensus       173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  236 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------------  236 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------
T ss_pred             cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence            345578999999999987 7889999999999999999999999998877666555544221110               


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   .....++..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       237 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 -------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             -------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                         11235688899999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.2e-52  Score=358.51  Aligned_cols=262  Identities=26%  Similarity=0.441  Sum_probs=229.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++.....+......+.+|+.++++++||||+++++++...     ...+
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHY   81 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CEEE
Confidence            68999999999999999999999999999999977666667778888999999999999999999999877     6789


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~  157 (336)
                      ++|||+.| +|.+.+...+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999975 99999988888999999999999999999999999999999999999987655   999999999877666


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......+             
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  227 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP-------------  227 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred             ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-------------
Confidence            55556688999999999987 7789999999999999999999999988877766665544222111             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                                    .+.+..+++.+.+||.+||+.||++|||+.|+++||||++.....
T Consensus       228 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          228 --------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             --------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             --------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence                          122346789999999999999999999999999999999865443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3e-52  Score=370.80  Aligned_cols=291  Identities=33%  Similarity=0.513  Sum_probs=232.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC---Ccc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---~~~   78 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++......   ...
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            68999999999999999999999999999999976655555556778999999999999999999998764310   125


Q ss_pred             eEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..|+||||++|+|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+......
T Consensus        98 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  177 (351)
T 3mi9_A           98 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA  177 (351)
T ss_dssp             EEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCC
T ss_pred             eEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccc
Confidence            68999999999998888764 57999999999999999999999999999999999999999999999999998765422


Q ss_pred             -----CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 -----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                           .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+.++...+....
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  257 (351)
T 3mi9_A          178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD  257 (351)
T ss_dssp             SSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence                 222345679999999999775678999999999999999999999999999999999999888877665443221


Q ss_pred             cchHHHHHHhCCccc--cccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          233 SDNARRYVRQLPRCR--KQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      .....   .......  ........  ...++.+.+||.+||+.||++|||++|+|+||||++....
T Consensus       258 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          258 NYELY---EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             GCGGG---TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             cchhh---cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            11100   0000000  00000000  0136789999999999999999999999999999986543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-52  Score=365.23  Aligned_cols=253  Identities=21%  Similarity=0.359  Sum_probs=221.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++.+... .......+.+|..+++.++||||+++++++.+.     ..+
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~   81 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQI   81 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----CEE
Confidence            58999999999999999999999999999999965321 223456677899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++......  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999997 599999998889999999999999999999999999999999999999999999999999999876543  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.....                  
T Consensus       160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  220 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------  220 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            334578999999999987 7789999999999999999999999998887666665544210                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                   .....++.++.++|++||+.||++||     +++++++||||+++.
T Consensus       221 -------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          221 -------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             -------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence                         11235688999999999999999999     999999999998763

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-52  Score=377.12  Aligned_cols=286  Identities=32%  Similarity=0.544  Sum_probs=229.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+++ ||+|++......      ..+|+.+++.++||||+++++++..... .....+
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            69999999999999999999977665 888887543211      1269999999999999999999865432 122447


Q ss_pred             EEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc-cCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~  155 (336)
                      ++||||+++++...+.    ....+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++...
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            8999999987776654    357899999999999999999999999999999999999999 78999999999998776


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .........+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+............
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            66556667889999999999775679999999999999999999999999999999999999998887765432211100


Q ss_pred             HHHHHHhCCcccccccccc-CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCC
Q 019728          236 ARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND  297 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~  297 (336)
                      .   ...+........... .+..++++.+||.+||+.||.+|||+.|+++||||+.+.....
T Consensus       274 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          274 M---EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             S---SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred             h---hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence            0   000111111111122 2357899999999999999999999999999999999865443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-52  Score=367.87  Aligned_cols=287  Identities=34%  Similarity=0.560  Sum_probs=229.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh---hHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI---IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.......   .....+.+|+.+++.++||||+++++++...     .
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~   85 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----S   85 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----T
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-----C
Confidence            6899999999999999999999999999999996533221   2234677999999999999999999999876     5


Q ss_pred             eEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++||||++++|.+.+... ..+++.+++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            68999999999999998765 46899999999999999999999999999999999999999999999999999876433


Q ss_pred             -CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          158 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+........
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             2334557899999999997656789999999999999999999999999999999988888877766554332211000


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                      .   ..............+...+.++.+||++||+.||.+|||+.|+++||||++.....
T Consensus       246 ~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          246 Y---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             C---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             c---ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            0   00000001111223456789999999999999999999999999999999875443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-52  Score=373.38  Aligned_cols=259  Identities=20%  Similarity=0.390  Sum_probs=219.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...     ...
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~   90 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----EDM   90 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEE
Confidence            5899999999999999999999999999999986532 2334457788999999999999999999999987     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++........
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999996 59999999988999999999999999999999999999999999999999999999999999987766656


Q ss_pred             ccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .....||+.|+|||++.+.  ..++.++|+|||||++|+|++|..||...........+......               
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------  235 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---------------  235 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------------
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------------
Confidence            6677899999999998642  45889999999999999999999999754332221111111100               


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~ell~h~~f~~~~  293 (336)
                                   .......++..+.+||++||+.||.+||+ ++++++||||+++.
T Consensus       236 -------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          236 -------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             -------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence                         01122456899999999999999999998 99999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.5e-52  Score=371.21  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...     ...|
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~   92 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA   92 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEE
Confidence            69999999999999999999999999999999965432   235577999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC--EEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999996 599999988888999999999999999999999999999999999999987765  9999999998655444


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI-TELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......|++.|+|||++.+....+.++|||||||++|+|++|..||.+.........+ ........             
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------  239 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-------------  239 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-------------
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-------------
Confidence            4556689999999999987344455599999999999999999999875432222211 11111100             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   ..+....+++.+.+||++||+.||.+|||+.|+++||||...
T Consensus       240 -------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          240 -------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                         011123568999999999999999999999999999999653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-52  Score=370.57  Aligned_cols=286  Identities=31%  Similarity=0.539  Sum_probs=228.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++...     ...|
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  100 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KRWY  100 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CEEE
Confidence            68999999999999999999999999999999976655666677788999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +||||+++ +|.+++...+.+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+...... ..
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999996 66666666788999999999999999999999999999999999999999999999999999765433 23


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+...+.....+........
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            34457899999999998755789999999999999999999999999998888888887776654432211100000000


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ...-............+.++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            00000001111223345789999999999999999999999999999999863

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.7e-52  Score=372.95  Aligned_cols=255  Identities=20%  Similarity=0.354  Sum_probs=213.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++++.||+|+||+||+|++..+++.||+|++.+... .......+..|..+++++ +||||+++++++...     ..
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~  127 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SR  127 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----CE
Confidence            48899999999999999999999999999999976432 333445677899999887 899999999999887     67


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc-CCC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SET  157 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~-~~~  157 (336)
                      +|+||||++| +|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. ...
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999975 99999988889999999999999999999999999999999999999999999999999999863 333


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHHHhCCCCcccc
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---------QLRLITELIGSPDDASL  228 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~  228 (336)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||......+         ....+..          
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------  276 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------  276 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH----------
T ss_pred             CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc----------
Confidence            44556789999999999987 788999999999999999999999996532111         1111111          


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHHcCcccccCc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  293 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~ell~h~~f~~~~  293 (336)
                                           ........++.++.+||++||+.||++||++      +|+++||||+++.
T Consensus       277 ---------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          277 ---------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             ---------------------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             ---------------------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence                                 0012224679999999999999999999984      8999999999873

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7e-52  Score=367.35  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=221.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++++.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...     ..+
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~  116 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNL  116 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEE
Confidence            5899999999999999999999999999999986532 2234456788999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++......  
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            99999997 599999988888999999999999999999999999999999999999999999999999999876543  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.....                  
T Consensus       195 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------  255 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------------  255 (350)
T ss_dssp             BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            335689999999999987 7789999999999999999999999998887766666554210                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~  292 (336)
                                   .....++..+.++|++||+.||.+||+     ++++++||||+++
T Consensus       256 -------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          256 -------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence                         112356899999999999999999998     9999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-51  Score=364.61  Aligned_cols=255  Identities=20%  Similarity=0.355  Sum_probs=216.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|..+++++ +||||+++++++...     ..
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~   84 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SR   84 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----CE
Confidence            5899999999999999999999999999999997654 3445667788999999988 899999999999887     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ET  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~  157 (336)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++... ..
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999997 5999999888889999999999999999999999999999999999999999999999999997643 23


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCCcccc
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---------HQLRLITELIGSPDDASL  228 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~  228 (336)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||......         .....+..          
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~----------  233 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------  233 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH----------
T ss_pred             CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc----------
Confidence            33455688999999999987 77899999999999999999999999653211         11111111          


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHHcCcccccCc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYLQSLH  293 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~ell~h~~f~~~~  293 (336)
                                           ........++..+.+||++||+.||.+||++      +|+++||||+++.
T Consensus       234 ---------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          234 ---------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             ---------------------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                                 0011224678999999999999999999985      8999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-52  Score=373.11  Aligned_cols=284  Identities=30%  Similarity=0.576  Sum_probs=228.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-------   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-------   74 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++......      ..+|+.+++.++||||+++++++.....       
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            699999999999999999999999999999998643221      2279999999999999999998854321       


Q ss_pred             --------------------------CCcceEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019728           75 --------------------------DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSAS  124 (336)
Q Consensus        75 --------------------------~~~~~~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~  124 (336)
                                                ......++||||++|+|.+.+.    ..+.+++..++.++.||+.||+|||++|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                      1124589999999998777764    4578999999999999999999999999


Q ss_pred             eeccCCCCCCeEEc-cCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCC
Q 019728          125 VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  203 (336)
Q Consensus       125 i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  203 (336)
                      |+||||||+||+++ .++.+||+|||.+.............++..|+|||++.+...++.++|||||||++|+|++|..|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            99999999999997 68899999999998776666666678899999999988756789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 019728          204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEE  282 (336)
Q Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  282 (336)
                      |.+.+..+.+..+.+..+.+....+.........   ..+.......... .....+.++.+||++||+.||.+|||+.|
T Consensus       242 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            9999999999999998888776543211110000   0000001111111 22357889999999999999999999999


Q ss_pred             HHcCcccccCcC
Q 019728          283 ALRHPYLQSLHD  294 (336)
Q Consensus       283 ll~h~~f~~~~~  294 (336)
                      +++||||+.+..
T Consensus       319 ~l~hp~f~~~~~  330 (383)
T 3eb0_A          319 AMAHPFFDHLRN  330 (383)
T ss_dssp             HHTSGGGHHHHH
T ss_pred             HhcCHHHHHHHh
Confidence            999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-52  Score=369.28  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=220.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+.+.||+|+||.||+|.+..+|+.||||++.+.. ...........|..++..+ +||||+++++++...     ..
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-----~~   92 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----EN   92 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-----CE
Confidence            5889999999999999999999999999999996532 1223456677889998877 899999999999887     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-C
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-T  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~  157 (336)
                      +|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++.... .
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999997 59999998888899999999999999999999999999999999999999999999999999976432 2


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.....                
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------  235 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP----------------  235 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred             CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            23455688999999999987 7789999999999999999999999998887766665543110                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-ell~h~~f~~~~  293 (336)
                                     .....++.++.+||++||+.||++||++. ++++||||+++.
T Consensus       236 ---------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          236 ---------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             ---------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence                           11134689999999999999999999998 999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-51  Score=369.00  Aligned_cols=257  Identities=23%  Similarity=0.394  Sum_probs=222.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~  124 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV  124 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEE
Confidence            588999999999999999999999999999998654  234456788999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc--CCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||+. |+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+||+++.  .+.+||+|||++......
T Consensus       125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999997 59999997653 7999999999999999999999999999999999999974  567999999999887666


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......              
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------------  269 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF--------------  269 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC--------------
T ss_pred             cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence            55556678999999999987 778999999999999999999999999988776666554421111              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ....+..+++++.+||++||+.||.+|||+.|+++||||++..
T Consensus       270 -------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          270 -------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                         1122356799999999999999999999999999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-51  Score=361.56  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=223.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh----hHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.++++++||||+++++++...     
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   87 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-----   87 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence            4899999999999999999999999999999986543221    2457788999999999999999999999877     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC----CEEEEeccCCc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  152 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~  152 (336)
                      ...++||||++ ++|.+++...+.+++..++.++.||+.||+|||+.|++|+||||+||+++.++    .++|+|||.+.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            67999999996 59999999888899999999999999999999999999999999999999888    79999999998


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......+        
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------  238 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------  238 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC--------
Confidence            7766554556678999999999977 7789999999999999999999999998877666655543221111        


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                         ...+...+..+.+||++||+.||++|||+.|+++||||+.+
T Consensus       239 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          239 -------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             -------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             -------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence                               11224678899999999999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.9e-52  Score=366.73  Aligned_cols=255  Identities=21%  Similarity=0.306  Sum_probs=220.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+..|..++..+ +||||+++++++...     ..
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~   95 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR   95 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----SE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----CE
Confidence            5889999999999999999999999999999996542 1233456778899999988 799999999999887     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-C
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-T  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~  157 (336)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..... .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            999999997 59999998878899999999999999999999999999999999999999999999999999986432 2


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.....                
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------  238 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------------  238 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred             cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            33455688999999999987 7789999999999999999999999998887776666654110                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                     .....++.++.+||++||+.||.+||     +++++++||||+.+.
T Consensus       239 ---------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          239 ---------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence                           11235689999999999999999999     479999999998763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-51  Score=382.58  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=220.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+++.++||||+++++++...     ...|
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~  112 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNYY  112 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEE
Confidence            58999999999999999999999999999999976554444567788999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC---CCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~  157 (336)
                      +|||||. |+|.+.+....++++..++.++.||+.||+|||++||+||||||+||+++..   +.+||+|||++......
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999997 5999999888899999999999999999999999999999999999999764   45999999999877666


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......|++.|+|||++.  ..++.++|||||||++|+|++|..||.+....+....+.......+             
T Consensus       193 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  257 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-------------  257 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred             ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            5556678999999999986  4689999999999999999999999999888777776655322221             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                    .+.+..+++.+.+||++||+.||.+|||+.++|+||||+..
T Consensus       258 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          258 --------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             --------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             --------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                          12235679999999999999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.8e-52  Score=383.00  Aligned_cols=258  Identities=31%  Similarity=0.511  Sum_probs=222.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...     ..+|
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~   97 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFY   97 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----CEEE
Confidence            58999999999999999999999999999999965444444567788999999999999999999999887     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc---cCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||+. |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999997 59999998888999999999999999999999999999999999999995   4567999999999877665


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......|++.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.            
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------  243 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------------  243 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------------
T ss_pred             CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------------
Confidence            55556678999999999875  5899999999999999999999999998887777766553221111            


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                     +.+..+|+.+.+||++||+.||.+|||+.++|+||||+...
T Consensus       244 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          244 ---------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ---------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ---------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                           22345789999999999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.1e-52  Score=363.28  Aligned_cols=258  Identities=27%  Similarity=0.364  Sum_probs=212.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~   81 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY   81 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEE
Confidence            6899999999999999999999999999999985432 122345677999999999999999999999887     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC---
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (336)
                      +||||++ |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......   
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999997 499999988888999999999999999999999999999999999999999999999999999754322   


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......|++.|+|||++.+....+.++|||||||++|+|++|..||................                 
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----------------  224 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----------------  224 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-----------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-----------------
Confidence            223456789999999999874445789999999999999999999997765432211111100                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                 ......+..++..+.+||++||+.||.+|||++|+++||||+...
T Consensus       225 -----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          225 -----------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             -----------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -----------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                       001111245688999999999999999999999999999998753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-51  Score=359.45  Aligned_cols=289  Identities=34%  Similarity=0.537  Sum_probs=231.4

Q ss_pred             ccceeeeecccceEEEEEEEeC-CCCceEEEEEecCcccChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+   +||||+++++++........
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            5899999999999999999995 6788999999865433222223444566665555   89999999999873222222


Q ss_pred             ceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...++||||++|+|.+++...  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        92 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  171 (326)
T 1blx_A           92 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  171 (326)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             ceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence            678999999999999999764  349999999999999999999999999999999999999999999999999998766


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+....+.+....+.......
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (326)
T 1blx_A          172 FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP  250 (326)
T ss_dssp             GGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred             CCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccc
Confidence            5544555678999999999987 678999999999999999999999999999988888888888776655432211100


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      .    ...............+.++..+.+||.+||+.||.+|||+.|+++||||+++...
T Consensus       251 ~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          251 R----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             G----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             h----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            0    0111111222334456789999999999999999999999999999999987643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-51  Score=377.91  Aligned_cols=255  Identities=27%  Similarity=0.408  Sum_probs=222.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~   91 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDI   91 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            58999999999999999999999999999999965321 223456788999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999996 69999998888999999999999999999999999999999999999999999999999999988766655


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      ....+|++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+.....                  
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------  233 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------------------  233 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC------------------
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc------------------
Confidence            56678999999999998744457899999999999999999999998776665555433110                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   .....+++++.+||++||+.||.+|||+.|+++||||+..
T Consensus       234 -------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 -------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                         1123468899999999999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9e-51  Score=369.14  Aligned_cols=287  Identities=29%  Similarity=0.527  Sum_probs=228.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.....      ...+|+.+++.++||||+++++++..... .....+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            68999999999999999999999999999999854321      12369999999999999999998854321 112447


Q ss_pred             EEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCcccC
Q 019728           81 YIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~  155 (336)
                      ++||||++++|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            8999999998877764    35779999999999999999999999999999999999999965 568999999998766


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .........+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+.......
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            55555567889999999999775689999999999999999999999999999999999999888877654332110000


Q ss_pred             HHHHHHhCCccccccccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCC
Q 019728          236 ARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND  297 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~  297 (336)
                      . .  ..+.......... ..+..+.++.+||++||+.||.+|||+.|++.||||+.+.....
T Consensus       289 ~-~--~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          289 T-E--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             C-C--CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             h-h--hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence            0 0  0000000000011 12457899999999999999999999999999999998865543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-51  Score=359.14  Aligned_cols=251  Identities=24%  Similarity=0.257  Sum_probs=208.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.++||+|+||+||+|.+..+++.||||++...............|+..+.++ +||||+++++++...     ...
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~~  132 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GIL  132 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CEE
Confidence            48899999999999999999999999999999877666666666677777666666 899999999999876     679


Q ss_pred             EEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus       133 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999999999988654 5699999999999999999999999999999999999999999999999999987766555


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....|++.|+|||++.+  .++.++|||||||++|+|++|..|+.......   .+..   ..                
T Consensus       213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~---~~----------------  268 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ---GY----------------  268 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT---TC----------------
T ss_pred             CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc---cC----------------
Confidence            556678999999999875  68999999999999999999976665432211   1110   00                


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                ........++.++.+||.+||+.||++|||++|+++||||++
T Consensus       269 ----------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ----------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                      001122467899999999999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.4e-51  Score=369.99  Aligned_cols=290  Identities=17%  Similarity=0.210  Sum_probs=217.1

Q ss_pred             ccceeeeeccc--ceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDI--IFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|  +||+||+|.+..+|+.||||++............+.+|+.++++++||||+++++++...     ..
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  100 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NE  100 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-----CE
Confidence            68999999999  999999999999999999999987666667778888999999999999999999999877     67


Q ss_pred             EEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           80 VYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999997 5999999765  6799999999999999999999999999999999999999999999999998754321


Q ss_pred             C--------CcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-Cc-
Q 019728          157 T--------DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DD-  225 (336)
Q Consensus       157 ~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~-  225 (336)
                      .        .......++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+....... .. 
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            1        112234678889999998764 468999999999999999999999998766554443322111000 00 


Q ss_pred             -----ccccc-----cccchHHHH-HH--hCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          226 -----ASLGF-----LRSDNARRY-VR--QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       226 -----~~~~~-----~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                           .....     ......... ..  ...........+....+++.+.+||++||+.||++|||+.|+|+||||+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                 00000     000000000 00  000000111122345679999999999999999999999999999999988


Q ss_pred             cCCC
Q 019728          293 HDLN  296 (336)
Q Consensus       293 ~~~~  296 (336)
                      ....
T Consensus       341 ~~~~  344 (389)
T 3gni_B          341 KRRA  344 (389)
T ss_dssp             ---C
T ss_pred             hhcc
Confidence            6543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.5e-52  Score=373.93  Aligned_cols=259  Identities=23%  Similarity=0.280  Sum_probs=218.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|..+++.++||||+++++++.+.     ..+
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~  144 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----RYL  144 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEE
Confidence            5889999999999999999999999999999985421 1122234467899999999999999999999987     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            99999996 599999876 5799999999999999999999999999999999999999999999999999977654432


Q ss_pred             --ccceeeeecccCchhcccCC---CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          160 --MTEYVVTRWYRAPELLLNCT---EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                        ....+||+.|+|||++.+..   .++.++|+|||||++|+|++|..||.+.+.......+.......           
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----------  292 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-----------  292 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-----------
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc-----------
Confidence              33568999999999987632   17789999999999999999999999988777776665421100           


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~~  293 (336)
                                      ..+....++.++.+||++||+.+|.+  |++++|+++||||+++.
T Consensus       293 ----------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          293 ----------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             ----------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             ----------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence                            01112467999999999999999988  99999999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-51  Score=351.96  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=223.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..++..||+|++.....  .....+.+|+.++++++||||+++++++...     ...+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   82 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIY   82 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEE
Confidence            58999999999999999999999999999999865432  3356788999999999999999999999877     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||++| +|.+++...+.+++.+++.++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            99999975 999999888889999999999999999999999999999999999999   78889999999999877666


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......+++.|+|||++.+  .++.++||||||+++|+|++|..||......+....+.......+..           
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  229 (277)
T 3f3z_A          163 KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK-----------  229 (277)
T ss_dssp             SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----------
T ss_pred             cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----------
Confidence            55566688999999999875  48999999999999999999999999988777666665532222211           


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                      .+..+++.+.++|++||+.||.+|||+.++++||||++..
T Consensus       230 ----------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          230 ----------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ----------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                            1235689999999999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.6e-51  Score=359.50  Aligned_cols=254  Identities=23%  Similarity=0.384  Sum_probs=209.8

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCccc--ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||+|+||.||+|.+.   .+++.||+|++.....  +......+.+|+.+++.++||||+++++++...    
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   93 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG----   93 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC----
Confidence            5899999999999999999985   6899999999976432  334456677899999999999999999999887    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           94 -GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             -SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence             66999999997 5999999888889999999999999999999999999999999999999999999999999987543


Q ss_pred             CC-CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          156 ET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .. .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.....             
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------  238 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------------  238 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------------
T ss_pred             cCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence            32 23345578999999999987 6789999999999999999999999998887766665544211             


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                                        ...+.++..+.+||++||+.||.+||     ++.|+++||||+.+
T Consensus       239 ------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          239 ------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             ------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence                              11245688999999999999999999     89999999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-51  Score=365.20  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=213.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc---cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++....   ........+.+|+.+++.++||||+++++++...     .
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~   99 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-----G   99 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            4899999999999999999999999999999985422   1122456788999999999999999999999876     6


Q ss_pred             eEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccC
Q 019728           79 DVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGL  150 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~  150 (336)
                      .+|+||||++ |+|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            7999999998 599887754    235899999999999999999999999999999999999987655   99999999


Q ss_pred             CcccCCCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          151 ARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       151 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      +........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ......+.......      
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~------  251 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM------  251 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC------
Confidence            987655432 345678999999999987 678999999999999999999999998753 23333332211101      


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                           ....+..++..+.+||++||+.||++|||+.|+++||||+..
T Consensus       252 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          252 ---------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             ---------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             ---------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                 111224678999999999999999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-51  Score=375.46  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=211.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...     ..+
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~  223 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRL  223 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----TEE
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----CEE
Confidence            4889999999999999999999999999999996532 2334456677899999999999999999999877     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-C
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-T  157 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~  157 (336)
                      |+||||++| +|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++..... .
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            999999975 999999888899999999999999999999998 9999999999999999999999999999976433 2


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....                
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------  366 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------  366 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred             cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            33445688999999999987 7889999999999999999999999998887666655543111                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                     .....+++++.+||.+||+.||.+||     +++|+++||||+++.
T Consensus       367 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          367 ---------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ---------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence                           11235689999999999999999999     999999999999873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=356.86  Aligned_cols=256  Identities=25%  Similarity=0.447  Sum_probs=208.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC------------------------hhHHHHHHHHHHHHhhC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN------------------------IIDARRTLREIKLLRHM   57 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l   57 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++......                        ......+.+|+.+++++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            589999999999999999999999999999998654211                        12235678999999999


Q ss_pred             CCCceeeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           58 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        58 ~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                      +||||+++++++.....   ...|+||||+++ +|.+++ ..+++++.+++.++.||+.||+|||++|++|+||||+||+
T Consensus        94 ~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            99999999999986432   578999999985 776654 3467999999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCC-cccceeeeecccCchhcccCCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  213 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  213 (336)
                      ++.++.+||+|||++....... ......+++.|+|||++.+...  .+.++|||||||++|+|++|..||.........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  249 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH  249 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence            9999999999999997655432 2345578999999999876332  477899999999999999999999887765544


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                      ..+......                             .+..+.++..+.+||.+||+.||.+|||+.|+++||||+
T Consensus       250 ~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          250 SKIKSQALE-----------------------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHCCCC-----------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHhcccCC-----------------------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            444331100                             111246789999999999999999999999999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.8e-51  Score=364.93  Aligned_cols=278  Identities=25%  Similarity=0.385  Sum_probs=223.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-----CCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----HENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.++||+|+||+||+|.+..+++.||+|++..   ..........|+.+++.++     ||||+++++++...    
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~----  108 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY----  108 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET----
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC----
Confidence            68999999999999999999999999999999964   2345566778999999996     99999999999877    


Q ss_pred             cceEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---------------
Q 019728           77 FNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---------------  139 (336)
Q Consensus        77 ~~~~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---------------  139 (336)
                       ...++||||++++|.+++....  .+++.+++.++.||+.||+|||++||+||||||+|||++.               
T Consensus       109 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          109 -DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             -TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             -CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence             6799999999889999997654  5999999999999999999999999999999999999975               


Q ss_pred             ----------CCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 019728          140 ----------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  209 (336)
Q Consensus       140 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  209 (336)
                                ++.+||+|||++......  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                      788999999999765443  345578999999999987 7899999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCcc---------------ccccccccCCCCChhHHHHHHHhcCCCC
Q 019728          210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC---------------RKQQFATRFPNKSSGAVDLLEKMLVFDP  274 (336)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~dp  274 (336)
                      .+....+....+..+..............+.......               .....+......++.+.+||++||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            9999988888776665432111100000000000000               0000000111235778899999999999


Q ss_pred             CCCCCHHHHHcCcccc
Q 019728          275 NKRITVEEALRHPYLQ  290 (336)
Q Consensus       275 ~~Rpt~~ell~h~~f~  290 (336)
                      .+|||+.|+|+||||+
T Consensus       345 ~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          345 TLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGSCCHHHHTTSGGGC
T ss_pred             hhCCCHHHHhcCcccC
Confidence            9999999999999996

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.6e-51  Score=351.46  Aligned_cols=254  Identities=27%  Similarity=0.403  Sum_probs=210.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...     ...+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   96 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNMY   96 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeEE
Confidence            4889999999999999999999999999999986543 233457788999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcc
Q 019728           82 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLART  153 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~  153 (336)
                      +||||++| +|.+.+..    ...+++..++.++.||+.||+|||+.|++|+||||+||++   +.++.++|+|||.+..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999985 99998853    3679999999999999999999999999999999999999   4567899999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........++..|+|||++.  ..++.++||||||+++|+|++|..||.+....+....+......           
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----------  243 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN-----------  243 (285)
T ss_dssp             ----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             cCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc-----------
Confidence            66555555667899999999986  46889999999999999999999999988766555444331111           


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                       .......+++.+.+||++||+.||++|||+.|+++||||+.
T Consensus       244 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 -----------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -----------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -----------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                             11112346889999999999999999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.4e-52  Score=358.62  Aligned_cols=265  Identities=19%  Similarity=0.203  Sum_probs=189.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.++||+|+||+||+|.+  +|+.||||++....   ........|+..+.+++|||||++++++..... ....+|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~   77 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLW   77 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEE
Confidence            478899999999999999998  68999999985431   111222345666678899999999999876532 113689


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      +|||||+ |+|.++++. .++++..+..++.|++.||+|||+.        +|+||||||+|||++.++.+||+|||+|+
T Consensus        78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999998 699999976 4689999999999999999999987        99999999999999999999999999997


Q ss_pred             ccCCCCc-----ccceeeeecccCchhcccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 019728          153 TTSETDF-----MTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS  222 (336)
Q Consensus       153 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  222 (336)
                      .......     .....||+.|+|||++.+..     .++.++|||||||++|||++|..||.......          .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~----------~  226 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----------L  226 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC----------C
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc----------c
Confidence            6544321     22457999999999987521     35678999999999999999987764332100          0


Q ss_pred             CCccccccccc-chHHHHHHhCCc-cccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          223 PDDASLGFLRS-DNARRYVRQLPR-CRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       223 ~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +   ....... .........+.. ......+...  ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       227 p---~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          227 P---YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             T---TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             c---chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0   0000000 001111111100 0001111111  1223568899999999999999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.1e-51  Score=378.86  Aligned_cols=258  Identities=27%  Similarity=0.405  Sum_probs=221.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh-----------hHHHHHHHHHHHHhhCCCCceeeecceec
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI-----------IDARRTLREIKLLRHMEHENVIAIKDIIR   70 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   70 (336)
                      +|++++.||+|+||+||+|.+..+++.||+|++.......           .....+.+|+.++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            5899999999999999999999999999999996543221           33567889999999999999999999998


Q ss_pred             CCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEEE
Q 019728           71 PPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIG  146 (336)
Q Consensus        71 ~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl~  146 (336)
                      ..     ...|+|||||+| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||+++.++   .+||+
T Consensus       117 ~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          117 DK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             CS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             cC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            77     679999999974 9999998888999999999999999999999999999999999999998776   69999


Q ss_pred             eccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          147 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                      |||++.............|++.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......+  
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--  267 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD--  267 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            9999987766655566789999999999864  689999999999999999999999999888777776655322111  


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                               ...+..+|+++.+||++||+.||.+|||++|+|+||||+...
T Consensus       268 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          268 -------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             -------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             -------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence                                     112356799999999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.6e-51  Score=381.27  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=226.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.++++++||||+++++++...     ...
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  101 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-----GYF  101 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEE
Confidence            5899999999999999999999999999999996543 2344567888999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcccCC
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  156 (336)
                      |+||||+. |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999997 5999999998999999999999999999999999999999999999999   5678899999999987766


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      ........+++.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......+            
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------  247 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE------------  247 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred             ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence            555556678999999999875  689999999999999999999999999888777776655322111            


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                     .+.+..+|+.+.+||++||+.||.+|||+.|+|+||||+....
T Consensus       248 ---------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          248 ---------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             ---------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             ---------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                           1223457899999999999999999999999999999987643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.2e-51  Score=362.75  Aligned_cols=254  Identities=28%  Similarity=0.433  Sum_probs=200.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.++++++||||+++++++...     ...+
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  124 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEIS  124 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEE
Confidence            4889999999999999999999999999999986532    335577899999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||++ |+|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+||+++.   ++.+||+|||++......
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999997 599999988888999999999999999999999999999999999999975   889999999999876655


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccccchH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+....                
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~----------------  267 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE----------------  267 (349)
T ss_dssp             --------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC----------------
T ss_pred             cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC----------------
Confidence            44556678999999999987 678999999999999999999999997765443 222222210                


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                 .....+.+..++..+.+||++||+.||++|||+.|+++||||++.
T Consensus       268 -----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          268 -----------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             -----------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             -----------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                       011112235678999999999999999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-51  Score=373.98  Aligned_cols=261  Identities=20%  Similarity=0.328  Sum_probs=220.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|..++..++||||+++++++.+.     ..+
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~  149 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-----NNL  149 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEE
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CEE
Confidence            5889999999999999999999999999999996421 1122233477899999999999999999999987     679


Q ss_pred             EEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||+. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            99999996 699999987 5789999999999999999999999999999999999999999999999999997654433


Q ss_pred             c--ccceeeeecccCchhcc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          159 F--MTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .  ....+||+.|+|||++.    +...++.++|+|||||++|+|++|..||.+.+..+....+.....           
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------  298 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----------  298 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----------
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-----------
Confidence            2  23457899999999986    235689999999999999999999999999887777766654211           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHHcCcccccCc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLH  293 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~ell~h~~f~~~~  293 (336)
                                     ...++.....+++++.+||++||..+|++  |++++|+++||||+++.
T Consensus       299 ---------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          299 ---------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             ---------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ---------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence                           01112223467999999999999998888  99999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.6e-51  Score=365.27  Aligned_cols=255  Identities=21%  Similarity=0.354  Sum_probs=212.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHH-HhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKL-LRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+... .......+..|..+ ++.++||||+++++++...     ..
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-----~~  113 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DK  113 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-----SE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----CE
Confidence            58899999999999999999999999999999976432 33344556677776 5678999999999999887     67


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ET  157 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~  157 (336)
                      +|+||||++| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++... ..
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            9999999975 999999888889999999999999999999999999999999999999999999999999998633 23


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....                 
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----------------  255 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-----------------  255 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-----------------
T ss_pred             CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------
Confidence            34456689999999999987 788999999999999999999999999888777666654411                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~ell~h~~f~~~~  293 (336)
                                    ....+.++..+.+||++||+.||.+||++    .++++||||+.+.
T Consensus       256 --------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          256 --------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             --------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             --------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence                          01124678999999999999999999986    6999999998863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-51  Score=367.24  Aligned_cols=298  Identities=30%  Similarity=0.452  Sum_probs=223.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC--CCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK--DTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--~~~~~   79 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++....   .......+++..+..++||||+++++++.....  .....
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            5899999999999999999999999999999885432   223456678888888999999999999865322  11234


Q ss_pred             EEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCCCCeEEcc-CCCEEEEeccCCc
Q 019728           80 VYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLNA-SCDLKIGDFGLAR  152 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~  152 (336)
                      .++||||++++|...+.    ....+++..++.++.||+.||+|||  +.||+||||||+||+++. ++.+||+|||++.
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            78999999988776554    4577899999999999999999999  999999999999999997 8999999999998


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ............+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.++........
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence            87766555566789999999998775668999999999999999999999999999999999998888877654432211


Q ss_pred             cchHH-HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCC
Q 019728          233 SDNAR-RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP  302 (336)
Q Consensus       233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~  302 (336)
                      ..... .............+.......+.++.+||.+||+.||.+|||+.|+|+||||+++..........
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~  331 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNN  331 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTS
T ss_pred             cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCC
Confidence            10000 00000000000011122234678899999999999999999999999999999987665544433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.4e-51  Score=352.68  Aligned_cols=257  Identities=23%  Similarity=0.299  Sum_probs=200.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++..............++...++.++||||+++++++...     ...+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~~~   82 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GDVW   82 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SSEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CCEE
Confidence            58999999999999999999999999999999976544444445555666678888999999999999877     5699


Q ss_pred             EEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++|+|.+++.    ....+++..++.++.||+.||+|||++ |++|+||||+||+++.++.++|+|||.+.....
T Consensus        83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            999999999887765    357899999999999999999999998 999999999999999999999999999987666


Q ss_pred             CCcccceeeeecccCchhcc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccc
Q 019728          157 TDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ........+++.|+|||++.   ....++.++|||||||++|+|++|..||.... .............           
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  231 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-----------  231 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-----------
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-----------
Confidence            55555557899999999972   33678899999999999999999999998643 2333322222100           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                        .......++..+.++|.+||+.||++|||+.|+++||||+..
T Consensus       232 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          232 ------------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ------------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ------------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                              011123568899999999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5e-51  Score=358.85  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=190.9

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEEEEEe
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      +.||+|+||+||+|.+..+++.||+|++...     ......+|+.+++.+. ||||+++++++...     ...|+|||
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~e   86 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVME   86 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEC
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEEE
Confidence            7899999999999999999999999998542     3456778999999997 99999999999877     67999999


Q ss_pred             cCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEEEeccCCcccCCC-Ccc
Q 019728           86 LMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLARTTSET-DFM  160 (336)
Q Consensus        86 ~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~~~~~~~-~~~  160 (336)
                      |++| +|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++   .++|+|||++...... ...
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            9975 9999999988999999999999999999999999999999999999998766   7999999999765433 233


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+......                    ......
T Consensus       167 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------------~~~~~~  225 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT--------------------SAVEIM  225 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC--------------------CHHHHH
T ss_pred             cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc--------------------cHHHHH
Confidence            45577999999999977 788999999999999999999999997754311000                    000001


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      ..+...........+..+++++.+||++||+.||.+|||+.|+++||||++....
T Consensus       226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence            1111111111112224679999999999999999999999999999999986443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.4e-51  Score=350.86  Aligned_cols=254  Identities=23%  Similarity=0.396  Sum_probs=216.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|++|+||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   84 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRV   84 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----CEE
Confidence            5899999999999999999999999999999985432 1223346678899999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++||||++ |+|.+.+...+++++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence            99999998 5999999888889999999999999999999999999999999999999999999999999886554432 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+......                 
T Consensus       164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  225 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------------  225 (279)
T ss_dssp             ----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-----------------
T ss_pred             ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-----------------
Confidence            234578999999999987 77899999999999999999999999988776666655442111                 


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                    .....+..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       226 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          226 --------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             --------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             --------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                          1234688899999999999999999999999999998854

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-50  Score=367.56  Aligned_cols=278  Identities=29%  Similarity=0.500  Sum_probs=225.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC------CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM------EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||+||+|.+..+++.||||++...   ......+.+|+.+++.+      +|+||+++++++...   
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  171 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---  171 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence            689999999999999999999999999999999653   33445666777777776      577999999999877   


Q ss_pred             CcceEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC--EEEEeccCC
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLA  151 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~  151 (336)
                        ..+++||||++++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+|||++.++.  +||+|||++
T Consensus       172 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          172 --NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             --TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             --CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence              6799999999999999997653  4999999999999999999999999999999999999999987  999999999


Q ss_pred             cccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          152 RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ......  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.......
T Consensus       250 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~  326 (429)
T 3kvw_A          250 CYEHQR--VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS  326 (429)
T ss_dssp             EETTCC--CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred             eecCCc--ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            765433  334578999999999987 77899999999999999999999999999999999999999888776543221


Q ss_pred             ccchHHHHHHhCCcccc-----------------------------ccc-cccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 019728          232 RSDNARRYVRQLPRCRK-----------------------------QQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVE  281 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~-----------------------------~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  281 (336)
                      ..  ...+.......+.                             ... .......++.+.+||++||+.||++|||++
T Consensus       327 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          327 KR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            11  1111110000000                             000 001123478899999999999999999999


Q ss_pred             HHHcCcccccC
Q 019728          282 EALRHPYLQSL  292 (336)
Q Consensus       282 ell~h~~f~~~  292 (336)
                      |+|+||||+..
T Consensus       405 e~L~Hpw~~~~  415 (429)
T 3kvw_A          405 QALRHPWLRRR  415 (429)
T ss_dssp             HHHTSTTTC--
T ss_pred             HHhCChhhccC
Confidence            99999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.8e-51  Score=368.03  Aligned_cols=286  Identities=33%  Similarity=0.542  Sum_probs=214.1

Q ss_pred             cce-eeeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            3 VKL-RGEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i-~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      |.+ .++||+|+||+||+|.+.  .+++.||||++......    ..+.+|+.++++++||||+++++++.....   ..
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~   94 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHAD---RK   94 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTT---TE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCC---Ce
Confidence            455 458999999999999965  57899999999654322    357789999999999999999999954322   67


Q ss_pred             EEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE----ccCCCEEEE
Q 019728           80 VYIVYELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIG  146 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~----~~~~~~kl~  146 (336)
                      +|+||||++|+|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+
T Consensus        95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            9999999999999988531         259999999999999999999999999999999999999    677899999


Q ss_pred             eccCCcccCCC----CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---------HHHH
Q 019728          147 DFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY---------VHQL  213 (336)
Q Consensus       147 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~  213 (336)
                      |||++......    .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+...         .+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999865533    2234457899999999998756689999999999999999999999976654         4788


Q ss_pred             HHHHHHhCCCCccccccccc-chHHHHHHhCCcccccc------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          214 RLITELIGSPDDASLGFLRS-DNARRYVRQLPRCRKQQ------FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ..+...++.++...+..... .................      ........+..+.+||++||+.||.+|||++|+|+|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            88888888887765544322 12222222222111000      011122447889999999999999999999999999


Q ss_pred             cccccCcCC
Q 019728          287 PYLQSLHDL  295 (336)
Q Consensus       287 ~~f~~~~~~  295 (336)
                      |||+.....
T Consensus       335 p~f~~~~~~  343 (405)
T 3rgf_A          335 PYFLEDPLP  343 (405)
T ss_dssp             GGGTSSSCC
T ss_pred             hhhccCCCC
Confidence            999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-50  Score=357.17  Aligned_cols=259  Identities=26%  Similarity=0.393  Sum_probs=219.0

Q ss_pred             cccee-eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcce
Q 019728            2 SVKLR-GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+. +.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++...     ..
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-----~~  103 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-----SE  103 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-----Ce
Confidence            36666 8999999999999999999999999999776555556678889999999995 79999999999877     67


Q ss_pred             EEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCcc
Q 019728           80 VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLART  153 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~  153 (336)
                      .|+||||+.| +|.+++...  +.+++.+++.++.||+.||+|||++|++||||||+||+++.   ++.++|+|||.+..
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            9999999975 999988543  67999999999999999999999999999999999999987   78999999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.......+         
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------  253 (327)
T 3lm5_A          184 IGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS---------  253 (327)
T ss_dssp             C---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---------
T ss_pred             cCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC---------
Confidence            766555556678999999999987 7889999999999999999999999999887776666555322221         


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                        ...+..++..+.+||++||+.||.+|||++++|+||||+++.
T Consensus       254 ------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          254 ------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             ------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence                              122356789999999999999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=356.17  Aligned_cols=291  Identities=40%  Similarity=0.640  Sum_probs=223.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-------   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-------   74 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++...  +......+.+|+.++++++||||+++++++.....       
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            689999999999999999999999999999998643  45667788899999999999999999998754321       


Q ss_pred             --CCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc-cCCCEEEEeccCC
Q 019728           75 --DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLA  151 (336)
Q Consensus        75 --~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~  151 (336)
                        ......|+||||++|+|.+++.. +++++..++.++.||+.||+|||++|++|+||||+||+++ .++.+||+|||.+
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~  168 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA  168 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence              12256899999999999999865 6799999999999999999999999999999999999997 5678999999999


Q ss_pred             cccCCC----CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          152 RTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       152 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ......    .......++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+...........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (320)
T 2i6l_A          169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED  248 (320)
T ss_dssp             BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred             cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence            865432    1223345688899999987657889999999999999999999999999988888877777655443332


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                      ......... .+................+.++.++.+||++||+.||.+|||++|+++||||+....+.
T Consensus       249 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          249 RQELLSVIP-VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             HHHHHTTSC-HHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             hhhhhhcCc-ccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            111100000 00111111111222334467899999999999999999999999999999999875443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9e-51  Score=363.40  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=214.1

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ..+.||.|+||.||+|.+..+|+.||+|++...  .......+.+|+.++++++||||+++++++...     ...++||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~  165 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVM  165 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEE
Confidence            367899999999999999999999999999654  334567788999999999999999999999887     6799999


Q ss_pred             ecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE--ccCCCEEEEeccCCcccCCCCcc
Q 019728           85 ELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        85 e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ||++ ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||++  +.++.+||+|||++.........
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            9997 5998888654 469999999999999999999999999999999999999  56678999999999877666555


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+                
T Consensus       246 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----------------  308 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE----------------  308 (373)
T ss_dssp             CCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC----------------
T ss_pred             ccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----------------
Confidence            56678999999999876 7789999999999999999999999999887777766655321111                


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                 ...+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       309 -----------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          309 -----------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             -----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             -----------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                       12235679999999999999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-50  Score=350.14  Aligned_cols=260  Identities=28%  Similarity=0.448  Sum_probs=218.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC----hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++......    ......+.+|+.++++++||||+++++++...     
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   80 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-----   80 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-----
Confidence            589999999999999999999999999999998654322    22467788999999999999999999999876     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC----CEEEEeccCCc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  152 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~  152 (336)
                      ...++||||++ ++|.+++.....+++.+++.++.||+.||+|||++|++|+||+|+||+++.++    .++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            67999999996 69999998878899999999999999999999999999999999999998877    79999999998


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ............+++.|+|||++.+ ..++.++|+||||+++|+|++|..||......+....+.......+        
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  231 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD--------  231 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             eccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--------
Confidence            7665544455678999999999977 7789999999999999999999999998876665555433211111        


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                         .......+..+.++|++||+.||.+|||+.++++||||+.+..
T Consensus       232 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          232 -------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             -------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             -------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence                               1122467889999999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.3e-50  Score=356.62  Aligned_cols=254  Identities=24%  Similarity=0.333  Sum_probs=217.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++++++||||+++++++...     ...
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CeE
Confidence            3788999999999999999999999999999996543 3344557788999999999999999999999876     679


Q ss_pred             EEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||+.|+|.+.+. ...++++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......  
T Consensus       130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9999999999999885 4567999999999999999999999999999999999999999999999999998766533  


Q ss_pred             ccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ....+++.|+|||++.+  ...++.++|||||||++|+|++|..||...+....+..+......               
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---------------  271 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------------  271 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------------
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------------
Confidence             34578999999999852  367889999999999999999999999888766655544331110               


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                    .......+..+.+||.+||+.||++|||++++++||||...
T Consensus       272 --------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          272 --------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                          01123568899999999999999999999999999999763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.1e-51  Score=360.80  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=214.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC------hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++......      ......+.+|+.++++++||||+++++++...   
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~---  101 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ---  101 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC---
Confidence            589999999999999999999999999999999654321      12344566899999999999999999999877   


Q ss_pred             CcceEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           76 TFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                        ...++||||+. | +|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||.+..
T Consensus       102 --~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          102 --GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             --SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             --CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence              67999999985 5 9999999988999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........+++.|+|||++.+....+.++|||||||++|+|++|..||......                       
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------------  236 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------------  236 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------------
T ss_pred             CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------------
Confidence            776665666788999999999987444588999999999999999999999653210                       


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                    ..........++.++.+||++||+.||.+|||+.++++||||+..
T Consensus       237 --------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 --------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             --------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             --------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                          000011123478999999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.8e-51  Score=379.67  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=216.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...     ..+
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l  259 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL  259 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----CEE
Confidence            4889999999999999999999999999999996532 1223456678999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           81 YIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      |+||||++ |+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999997 59999997754  4999999999999999999999999999999999999999999999999999877655


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCccccccccc
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY----VHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....    ......+...              
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--------------  404 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------------  404 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--------------
T ss_pred             ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--------------
Confidence            55555689999999999987 6789999999999999999999999987542    1122222110              


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                       .......+++++.+||++||+.||.+||     +++|+++||||+++.
T Consensus       405 -----------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          405 -----------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             -----------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence                             0111245789999999999999999999     899999999999863

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-51  Score=367.74  Aligned_cols=260  Identities=18%  Similarity=0.254  Sum_probs=217.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|..++..++||||+++++++.+.     ..+
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~  136 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-----NYL  136 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEE
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEE
Confidence            4889999999999999999999999999999996432 1223344577899999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999996 6999999764 479999999999999999999999999999999999999999999999999997765443


Q ss_pred             c--ccceeeeecccCchhccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          159 F--MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      .  ....+||+.|+|||++..      ...++.++|+|||||++|+|++|..||.+.+..+....+......        
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------  288 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--------  288 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Confidence            2  234588999999999873      256899999999999999999999999998877776666542110        


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHHcCcccccCc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~ell~h~~f~~~~  293 (336)
                                        ...+.....+|.++++||++||. +|.+|   |+++|+++||||+++.
T Consensus       289 ------------------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          289 ------------------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ------------------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             ------------------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence                              00111124679999999999999 99998   5999999999998863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.5e-50  Score=346.90  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=215.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||+|+||+||+|.+..++..||+|.+.....+......+.+|+.++++++||||+++++++..... ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC-CCceEE
Confidence            4788999999999999999999999999999997766667778889999999999999999999998765322 115689


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEc-cCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||++ |+|.+++...+.+++..++.++.||+.||+|||+.|  ++|+||||+||+++ .++.++|+|||++......
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            9999997 599999988888999999999999999999999999  99999999999997 7889999999998755443


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......+++.|+|||++.+  .++.++|||||||++|+|++|..||..............  ....             
T Consensus       186 -~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~-------------  247 (290)
T 1t4h_A          186 -FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVK-------------  247 (290)
T ss_dssp             -SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCC-------------
T ss_pred             -ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh--ccCC-------------
Confidence             2334568999999998864  589999999999999999999999987654433322211  1000             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                   ........++.+.++|.+||+.||.+|||+.|+++||||++
T Consensus       248 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                         01112345788999999999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.9e-50  Score=357.49  Aligned_cols=257  Identities=26%  Similarity=0.467  Sum_probs=219.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc--C----hhHHHHHHHHHHHHhhC-CCCceeeecceecCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD--N----IIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKK   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~   74 (336)
                      +|.+.+.||.|++|.||+|.+..+|+.||||++.....  .    ......+.+|+.+++++ +||||+++++++...  
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  172 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS--  172 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS--
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC--
Confidence            48899999999999999999999999999999865431  1    12245677899999999 799999999999876  


Q ss_pred             CCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           75 DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        75 ~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                         ...|+||||++| +|.+++.....+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       173 ---~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          173 ---SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             ---SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ---CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence               679999999985 9999998878899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      ...........|++.|+|||++.+.     ..++.++|||||||++|+|++|..||...........+.......+    
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  325 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS----  325 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence            7665555667889999999998642     3578899999999999999999999988876666655544221111    


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                             .+.+...+..+.+||++||+.||++|||+.++++||||+
T Consensus       326 -----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          326 -----------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             -----------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             -----------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence                                   112245688999999999999999999999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-50  Score=357.18  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=210.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++......      ..+|+.++.++ +||||+++++++.+.     ...
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~   91 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG-----KYV   91 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS-----SEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC-----CEE
Confidence            488999999999999999999999999999999654322      34678888887 799999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC----CCEEEEeccCCcccC
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~----~~~kl~dfg~~~~~~  155 (336)
                      |+||||++ |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+||++..+    +.+||+|||++....
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999997 5999999988899999999999999999999999999999999999998543    349999999998654


Q ss_pred             CC-CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCccccccc
Q 019728          156 ET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---YVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .. .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+..   ..+....+.....          
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~----------  240 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF----------  240 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC----------
T ss_pred             CCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc----------
Confidence            33 23445678999999999976 568889999999999999999999997632   2333333322110          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                       ......+..++.++.+||++||+.||++|||+.++++||||.....
T Consensus       241 -----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          241 -----------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             -----------------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             -----------------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence                             0111223567999999999999999999999999999999977543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.6e-50  Score=347.34  Aligned_cols=260  Identities=27%  Similarity=0.427  Sum_probs=222.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-------ChhHHHHHHHHHHHHhhCC-CCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-------NIIDARRTLREIKLLRHME-HENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   73 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++.....       .......+.+|+.+++++. ||||+++++++... 
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-   96 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-   96 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC-
Confidence            58999999999999999999999999999999865421       1233466779999999995 99999999999876 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                          ...++||||++ ++|.+++.....+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        97 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           97 ----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence                67999999998 5999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccCchhccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ............++..|+|||++.+     ...++.++||||||+++|+|++|..||...+.......+.......+   
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  249 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG---  249 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC---
Confidence            7766555556678999999999852     25678899999999999999999999988877666555544221111   


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                              .+....++..+.++|.+||+.||.+|||+.|+++||||++..
T Consensus       250 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          250 ------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             ------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             ------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence                                    111235688999999999999999999999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8e-50  Score=348.25  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=217.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|++....  ......+.+|+.+++.++||||+++++++...     ...|
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   82 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYY   82 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEE
Confidence            5899999999999999999999999999999996532  22345677999999999999999999999877     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||++ ++|.+++...+.+++..++.++.||+.||+|||+.|++|+||||+||++   +.++.++|+|||.+......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999997 5999999888889999999999999999999999999999999999999   77889999999998765433


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......              
T Consensus       163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------------  226 (304)
T 2jam_A          163 -IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF--------------  226 (304)
T ss_dssp             -TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC--------------
T ss_pred             -ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence             2334568999999999977 778999999999999999999999999887766665554421111              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   .......++..+.+||.+||+.||.+|||++++++||||++..
T Consensus       227 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          227 -------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             -------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             -------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                         1122356789999999999999999999999999999998753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.1e-50  Score=347.00  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=210.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|++|.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...     ...
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   86 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----TDF   86 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CeE
Confidence            5899999999999999999999999999999985432 1223456788999999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999997 59999998888899999999999999999999999999999999999999999999999999987766554


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+++.|+|||++.+....+.++|+||||+++|+|++|..||...........+.....                  
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------  228 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------------------  228 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------------
Confidence            55567899999999998744447899999999999999999999988776555544433110                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   .....++..+.++|.+||+.||.+|||+.++++||||++.
T Consensus       229 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 -------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                         1123468899999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.7e-50  Score=350.45  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=215.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |...+.||+|+||.||+|.+..+|+.||||++....  ......+.+|+.++++++||||+++++++...     ...++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  119 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV  119 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            667789999999999999999999999999986542  33456788999999999999999999999877     67999


Q ss_pred             EEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-cc
Q 019728           83 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FM  160 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~  160 (336)
                      ||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++....... ..
T Consensus       120 v~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  198 (321)
T 2c30_A          120 LMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  198 (321)
T ss_dssp             EECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence            999997 489888765 579999999999999999999999999999999999999999999999999987655432 23


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......                 
T Consensus       199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  260 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-----------------  260 (321)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------------
T ss_pred             ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------------
Confidence            45578999999999977 778999999999999999999999998887766655544321100                 


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                 ......+++.+.++|.+||+.||++|||+.|+++||||+..
T Consensus       261 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          261 -----------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             -----------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             -----------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence                       01112468889999999999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-49  Score=345.97  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=221.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...     ...
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   90 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFV   90 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----CEE
Confidence            5899999999999999999999999999999986543 3455667788999999999999999999999876     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      ++||||++ ++|.+++...+.+++.+++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999998 599999988788999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+....+....                  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  231 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------------  231 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------------
T ss_pred             ccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc------------------
Confidence            2344568899999999977 678999999999999999999999998877655444332210                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                                   ......++..+.++|++||+.||++|||++++++||||++.....
T Consensus       232 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          232 -------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             -------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence                         111235688999999999999999999999999999999865433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.9e-50  Score=346.23  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=219.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   89 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----KRI   89 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----CEE
Confidence            58999999999999999999999999999999854321 222346778999999999999999999999876     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++ |+|.+++...+.+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence            99999997 5999999888889999999999999999999999999999999999999999999999999986654432 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+....+....                   
T Consensus       169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------  228 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-------------------  228 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------------
T ss_pred             cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-------------------
Confidence            334578999999999987 678999999999999999999999998877665554443210                   


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                                  ......++..+.++|.+||+.||.+|||++++++||||+....
T Consensus       229 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          229 ------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             ------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                        0112456889999999999999999999999999999997544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-50  Score=354.27  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=209.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC--CceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||++.+. +++.||+|++............+.+|+.+++.++|  |||+++++++...     ..
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~   83 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QY   83 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             EEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----CE
Confidence            5899999999999999999994 68999999997766667777888999999999976  9999999999877     67


Q ss_pred             EEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           80 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      .|+|||+.+++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+|||++ ++.+||+|||++........
T Consensus        84 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           84 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            99999988889999999989999999999999999999999999999999999999997 57899999999987654322


Q ss_pred             ---ccceeeeecccCchhccc----------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          160 ---MTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                         .....|++.|+|||++.+          ...++.++|||||||++|+|++|..||......  ...+......... 
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~-  239 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHE-  239 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCTTSC-
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHhcCCcc-
Confidence               234578999999999853          256788999999999999999999999764322  1112221111100 


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                               .......+..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       240 -------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          240 -------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             -------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             -------------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence                                     111234467899999999999999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-50  Score=357.70  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=214.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc---cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF---DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   .+......+.+|+.++++++||||+++++++...     .
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~  101 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-----Q  101 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-----C
Confidence            5899999999999999999999999999999986432   2345667888999999999999999999999877     6


Q ss_pred             eEEEEEecCC-ccHHHHHHc----------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 019728           79 DVYIVYELMD-TDLHQIIRS----------------------------------------DQQLTDDHCQYFLYQLLRGL  117 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~l  117 (336)
                      ..++||||++ |+|.+++..                                        ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            7999999997 599998842                                        11246788999999999999


Q ss_pred             HHHHhCCeeccCCCCCCeEEccCC--CEEEEeccCCcccCCCC-----cccceeeeecccCchhcccC-CCCCccchHHH
Q 019728          118 KYVHSASVLHRDLKPSNLLLNASC--DLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWS  189 (336)
Q Consensus       118 ~~LH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Diws  189 (336)
                      +|||+.|++|+||||+||+++.++  .++|+|||.+.......     ......+++.|+|||++.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998776  89999999997543211     13345789999999998643 57889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHh
Q 019728          190 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM  269 (336)
Q Consensus       190 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  269 (336)
                      |||++|+|++|..||.+....+....+.......+.                           +....+++.+.+||.+|
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~  314 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------PNYNVLSPLARDLLSNL  314 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------GGGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------cccccCCHHHHHHHHHH
Confidence            999999999999999998877776666552221111                           12234688999999999


Q ss_pred             cCCCCCCCCCHHHHHcCcccccCcC
Q 019728          270 LVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       270 L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                      |+.||.+|||+.++++||||+++..
T Consensus       315 l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          315 LNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             SCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             cCCChhHCCCHHHHhcChhhccChH
Confidence            9999999999999999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.8e-50  Score=353.10  Aligned_cols=281  Identities=27%  Similarity=0.513  Sum_probs=218.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++...     ....+.+|+.++++++ ||||+++++++.....   ...
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~~~  108 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTP  108 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CCE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---Cce
Confidence            589999999999999999999999999999998542     2466789999999997 9999999999987433   568


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccCCCC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~  158 (336)
                      ++||||+++ +|.+++.   .+++.+++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            999999984 8888874   489999999999999999999999999999999999999777 79999999998766555


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCcccc----ccccc
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASL----GFLRS  233 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~  233 (336)
                      ......++..|+|||++.+...++.++|||||||++|+|++|..||.. ....+.+..+....+.+.....    .....
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            555668899999999987767789999999999999999999999844 4455566555554442211100    00000


Q ss_pred             chHHHHHHhCCcccccc--ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          234 DNARRYVRQLPRCRKQQ--FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .................  .......++.++.+||++||+.||.+|||++|+|+||||+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            00111111110000000  0111223789999999999999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.9e-50  Score=346.72  Aligned_cols=258  Identities=31%  Similarity=0.516  Sum_probs=222.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...     ...|
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   97 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFY   97 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----CeEE
Confidence            58999999999999999999999999999999976555555677888999999999999999999999876     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC---CCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~  157 (336)
                      +|||++. ++|.+.+...+.+++.+++.++.||+.||+|||++|++|+||+|+||+++.+   +.++|+|||.+......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            9999997 5999999887889999999999999999999999999999999999999764   46999999998876655


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......++..|+|||++.+  .++.++|+||||+++|+|++|..||.+.+..+....+.......+             
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  242 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------------  242 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            44455568899999999875  488999999999999999999999998877666555544211111             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                    .+.+..++..+.++|++||+.||.+|||+.++++||||+...
T Consensus       243 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          243 --------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             --------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             --------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence                          122346789999999999999999999999999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-49  Score=351.17  Aligned_cols=257  Identities=26%  Similarity=0.373  Sum_probs=222.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...     ...
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  116 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFV  116 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeE
Confidence            5899999999999999999999999999999986543 3455667888999999999999999999999877     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      |+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+...... .
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            99999998 599999988788999999999999999999999999999999999999999999999999999765432 2


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....                  
T Consensus       197 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------  257 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------------  257 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------------
T ss_pred             cccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC------------------
Confidence            2344578899999999987 678999999999999999999999998877665554443311                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                   ......++..+.+||++||+.||++|||+.|+++||||++....
T Consensus       258 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          258 -------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             -------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                         01123568899999999999999999999999999999986543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-49  Score=358.25  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=210.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC--CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||.|+||+||++.+.. ++.||||++............+.+|+.++++++  ||||+++++++...     ..
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~~  130 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QY  130 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----CE
Confidence            38999999999999999999965 899999999776556677788999999999996  59999999999877     66


Q ss_pred             EEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           80 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +|+|||+.+++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+|||++ ++.+||+|||++....... 
T Consensus       131 ~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99999977789999999888999999999999999999999999999999999999995 5789999999998765432 


Q ss_pred             --cccceeeeecccCchhccc----------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCc
Q 019728          159 --FMTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDD  225 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~  225 (336)
                        ......|++.|+|||++.+          ...++.++|||||||++|+|++|..||...... ..+.   ........
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---~~~~~~~~  286 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHE  286 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH---HHHCTTSC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH---HHhCcccc
Confidence              2234578999999999864          136888999999999999999999999765322 2222   22111100


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                                .......+..+.+||++||+.||.+|||+.|+++||||+...
T Consensus       287 --------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          287 --------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             --------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             --------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                                      011123477899999999999999999999999999998654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-49  Score=344.49  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=209.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|++|+||+|.+..+++.||+|++............+.+|+..+..+ +||||+++++++...     ...
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~~   86 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----DHM   86 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeE
Confidence            58899999999999999999999999999999987665666778888999999999 899999999999876     679


Q ss_pred             EEEEecCCc-cHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC---------------
Q 019728           81 YIVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---------------  140 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~---------------  140 (336)
                      ++||||++| +|.+++...    ..+++.+++.++.||+.||+|||++||+|+||||+||+++.+               
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999975 999999764    679999999999999999999999999999999999999844               


Q ss_pred             ----CCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 019728          141 ----CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  216 (336)
Q Consensus       141 ----~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  216 (336)
                          ..++|+|||.+.......   ...++..|+|||++.+...++.++|||||||++|+|++|..|+......   ..+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHH
Confidence                479999999988765442   3358999999999987456778999999999999999999776544221   111


Q ss_pred             HHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ..                              .........++..+.++|.+||+.||.+|||+.++++||||++.
T Consensus       241 ~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          241 RQ------------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HT------------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             Hc------------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            11                              11122234678999999999999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-50  Score=366.68  Aligned_cols=259  Identities=32%  Similarity=0.495  Sum_probs=203.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc------ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+.+.||+|+||+||+|.+..+++.||+|++.....      .......+.+|+.++++++||||+++++++..    
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----  211 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----  211 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES----
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence            58899999999999999999999999999999865421      12222356789999999999999999999854    


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEEEeccCC
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGLA  151 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl~dfg~~  151 (336)
                        ...|+||||++ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              34799999997 59999998888999999999999999999999999999999999999997554   4999999999


Q ss_pred             cccCCCCcccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          152 RTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      +............|++.|+|||++.+  ...++.++|||||||++|+|++|..||........+.......         
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~---------  360 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG---------  360 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT---------
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC---------
Confidence            88776655566789999999999853  3567889999999999999999999997654321111111100         


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                       .....+..+..++..+.+||++||+.||.+|||++|+|+||||+..
T Consensus       361 -----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          361 -----------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             -----------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             -----------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence                             0011122335679999999999999999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.8e-50  Score=351.00  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=204.9

Q ss_pred             cccee-eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLR-GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+. +.||+|+||+||+|.+..+++.||||++....  ......+.+|+.++.++ +||||+++++++...     ..
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~   85 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR   85 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence            47775 78999999999999999999999999996542  33456788999999985 799999999999876     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccCCcccC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTS  155 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~  155 (336)
                      .|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||++....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999997 699999988888999999999999999999999999999999999999988776   9999999987543


Q ss_pred             CCC--------cccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-------------
Q 019728          156 ETD--------FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-------------  210 (336)
Q Consensus       156 ~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------  210 (336)
                      ...        ......++..|+|||++.+    ...++.++|||||||++|+|++|..||.+....             
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            221        1123458999999999864    135788999999999999999999999775421             


Q ss_pred             --HHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          211 --HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       211 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                        .....+...                           ........+..++..+.+||++||+.||.+|||+.|+++|||
T Consensus       246 ~~~~~~~i~~~---------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          246 QNMLFESIQEG---------------------------KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             HHHHHHHHHHC---------------------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             HHHHHHHHhcc---------------------------CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence              111111110                           000011122467899999999999999999999999999999


Q ss_pred             cccCc
Q 019728          289 LQSLH  293 (336)
Q Consensus       289 f~~~~  293 (336)
                      |++..
T Consensus       299 ~~~~~  303 (316)
T 2ac3_A          299 VQGCA  303 (316)
T ss_dssp             CC---
T ss_pred             hcCCC
Confidence            99753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-49  Score=351.21  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-------   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-------   74 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++.....       
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            5899999999999999999999999999999996543 34566788899999999999999999998755421       


Q ss_pred             ---------------------------------------------CCcceEEEEEecCCc-cHHHHHHcCCC---CCHHH
Q 019728           75 ---------------------------------------------DTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDH  105 (336)
Q Consensus        75 ---------------------------------------------~~~~~~~iv~e~~~g-~L~~~l~~~~~---~~~~~  105 (336)
                                                                   ......+++|||++| +|.+++.....   .++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                         011248999999985 99999987543   45667


Q ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-------------cccceeeeecccCc
Q 019728          106 CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRAP  172 (336)
Q Consensus       106 ~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~y~aP  172 (336)
                      ++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......             ......+++.|+||
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            89999999999999999999999999999999999999999999998765442             22335689999999


Q ss_pred             hhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCcccccccc
Q 019728          173 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA  252 (336)
Q Consensus       173 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (336)
                      |++.+ ..++.++|||||||++|+|++|..|+.     .....+........                           +
T Consensus       246 E~~~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~---------------------------~  292 (332)
T 3qd2_B          246 EQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF---------------------------P  292 (332)
T ss_dssp             HHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC---------------------------C
T ss_pred             HHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC---------------------------C
Confidence            99987 788999999999999999999876542     22222222111111                           1


Q ss_pred             ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       253 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ......++.+.+||++||+.||++|||+.|+++||||+++
T Consensus       293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            1112346788999999999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.5e-50  Score=381.86  Aligned_cols=255  Identities=21%  Similarity=0.317  Sum_probs=222.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++++.||+|+||.||+|.+..+++.||||++.+.. ...........|..++..+ +||+|+++++++...     ..
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-----~~  416 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR  416 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-----SE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-----CE
Confidence            5889999999999999999999999999999996532 2233456778899999988 699999999999887     67


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC-CC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ET  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~-~~  157 (336)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            999999997 5999999988899999999999999999999999999999999999999999999999999998633 23


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.....                
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------------  559 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------------  559 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------------
T ss_pred             cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            33456689999999999987 7889999999999999999999999999887777666644111                


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~ell~h~~f~~~~  293 (336)
                                     .....++.++.+||++||+.||++||++     +|+++||||+++.
T Consensus       560 ---------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          560 ---------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             ---------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence                           1124579999999999999999999987     9999999999863

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-50  Score=343.38  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=191.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...     ...
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   86 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----NYV   86 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----SEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----CeE
Confidence            58999999999999999999999999999999854321 222346788999999999999999999999876     679


Q ss_pred             EEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      |+||||++ ++|.+++... .++++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            99999997 5999999875 679999999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...........+.                    
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------------  225 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--------------------  225 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--------------------
T ss_pred             CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--------------------
Confidence             2234568899999999877 678999999999999999999999997754322211100                    


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                 .........++.++.++|.+||+.||++|||++++++||||+..
T Consensus       226 -----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          226 -----------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             -----------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             -----------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                       00011224578899999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.3e-49  Score=350.25  Aligned_cols=281  Identities=28%  Similarity=0.481  Sum_probs=225.1

Q ss_pred             ccceeeeecccceEEEEEEEe-CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCC------ceeeecceecCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE------NVIAIKDIIRPPKK   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp------~iv~~~~~~~~~~~   74 (336)
                      +|++.+.||+|+||+||+|.+ ..+++.||+|++...   ......+.+|+.+++.++|+      +++++++++...  
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--   89 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--   89 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence            699999999999999999999 567899999998643   34556777899999888655      499999998876  


Q ss_pred             CCcceEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-------------
Q 019728           75 DTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------------  139 (336)
Q Consensus        75 ~~~~~~~iv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-------------  139 (336)
                         ...++||||++++|.+++...+  ++++.+++.++.||+.||+|||++|++||||||+||+++.             
T Consensus        90 ---~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           90 ---GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ---TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             ---CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence               6799999999889999998765  6899999999999999999999999999999999999987             


Q ss_pred             ------CCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019728          140 ------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  213 (336)
Q Consensus       140 ------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  213 (336)
                            ++.++|+|||.+......  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+..
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                  668999999998765433  334578999999999987 78899999999999999999999999999988888


Q ss_pred             HHHHHHhCCCCccccccc--------------ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 019728          214 RLITELIGSPDDASLGFL--------------RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  279 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  279 (336)
                      ..+....+..+.......              ............... ...........++.+.+||++||+.||.+|||
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            888888876665422111              111111111111100 00111112234677999999999999999999


Q ss_pred             HHHHHcCcccccCcC
Q 019728          280 VEEALRHPYLQSLHD  294 (336)
Q Consensus       280 ~~ell~h~~f~~~~~  294 (336)
                      +.|+++||||+.+..
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999998653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-49  Score=358.92  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=199.5

Q ss_pred             ccee-eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHh-hCCCCceeeecceecCCCCCCcceE
Q 019728            3 VKLR-GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         3 ~~i~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      |.+. +.||.|+||+||++.+..+++.||||++...       ....+|+.++. ..+||||+++++++..... +...+
T Consensus        63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-~~~~~  134 (400)
T 1nxk_A           63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL  134 (400)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred             ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc-CCcEE
Confidence            5555 6899999999999999999999999998532       34567888764 4589999999998864111 11568


Q ss_pred             EEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCccc
Q 019728           81 YIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~  154 (336)
                      |+||||++ |+|.+++...+  .+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            99999997 59999998753  5999999999999999999999999999999999999987   788999999999876


Q ss_pred             CCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCcccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH----QLRLITELIGSPDDASLGF  230 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~  230 (336)
                      .........++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......    ....+....          
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~----------  283 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----------  283 (400)
T ss_dssp             C-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC----------
T ss_pred             CCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc----------
Confidence            65555566788999999999976 788999999999999999999999997654211    111111100          


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                       .......+..++.++.+||++||+.||.+|||+.|+++||||....
T Consensus       284 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          284 -----------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             -----------------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             -----------------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                             0011122356799999999999999999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.5e-49  Score=343.04  Aligned_cols=261  Identities=25%  Similarity=0.366  Sum_probs=216.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||++.+..+++.||+|++....  ........+.+|+.++++++||||+++++++.....   ..
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~   82 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---QK   82 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------C
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---Ce
Confidence            6999999999999999999999999999999996542  123456778899999999999999999999854432   56


Q ss_pred             EEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           80 VYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .|+||||++++|.+++..  ...+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            899999999888888865  467999999999999999999999999999999999999999999999999998765432


Q ss_pred             ---CcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 ---DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                         .......++..|+|||++.+. ...+.++||||||+++|+|++|..||...+.......+....             
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------------  229 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------------  229 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------------
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------------
Confidence               222345678999999998752 234779999999999999999999999877665555443311             


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                                        .......+..+.+||++||+.||.+|||+.|+++||||+......
T Consensus       230 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 ------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                              011235688999999999999999999999999999999865443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4e-50  Score=351.21  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=215.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.... .+......+.+|+.++++++||||+++++++......+ ...
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~-~~~   91 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLP   91 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE-EEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC-ccc
Confidence            6899999999999999999999999999999997653 34455677889999999999999999999987653211 245


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++ ++|.+++...+++++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+....... 
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence            99999997 5999999888899999999999999999999999999999999999999999999999999997654432 


Q ss_pred             ---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 ---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                         ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+................+            
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------  238 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------------  238 (311)
T ss_dssp             ----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC------------
T ss_pred             ccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC------------
Confidence               1233468999999999987 788999999999999999999999999887665554443321111            


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                     .......++.++.++|.+||+.||.+||++.+++.|+|++...
T Consensus       239 ---------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          239 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ---------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ---------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                           1112346799999999999999999999999999999998654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.5e-51  Score=367.24  Aligned_cols=254  Identities=17%  Similarity=0.222  Sum_probs=201.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHH---HHHhhCCCCceeeec-------ceec
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREI---KLLRHMEHENVIAIK-------DIIR   70 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~---~~l~~l~hp~iv~~~-------~~~~   70 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+   .++++++||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            4788999999999999999999999999999996542 3445667788999   455555799999998       4444


Q ss_pred             CCCC---------CCc---ceEEEEEecCCccHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           71 PPKK---------DTF---NDVYIVYELMDTDLHQIIRSDQQLTD-------DHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        71 ~~~~---------~~~---~~~~iv~e~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                      ....         ...   ...|++|||++|+|.+++...+.+++       ..++.|+.||+.||+|||++||+|||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik  233 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR  233 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            3311         000   13789999999999999987555555       7888899999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccC----------CCCCccchHHHHHHHHHHHHhCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~  201 (336)
                      |+|||++.++.+||+|||++.....  ......| +.|+|||++.+.          ..++.++|||||||++|+|++|.
T Consensus       234 p~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~  310 (377)
T 3byv_A          234 PVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD  310 (377)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence            9999999999999999999986443  2334466 899999999873          27899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH
Q 019728          202 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  281 (336)
Q Consensus       202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  281 (336)
                      .||.........                                   .........+++.+.+||.+||+.||.+|||+.
T Consensus       311 ~Pf~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  355 (377)
T 3byv_A          311 LPITKDAALGGS-----------------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL  355 (377)
T ss_dssp             CCC------CCS-----------------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred             CCCcccccccch-----------------------------------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence            999664321100                                   011122357799999999999999999999999


Q ss_pred             HHHcCcccccCc
Q 019728          282 EALRHPYLQSLH  293 (336)
Q Consensus       282 ell~h~~f~~~~  293 (336)
                      ++++||||+++.
T Consensus       356 e~l~hp~f~~~~  367 (377)
T 3byv_A          356 QAMETPEYEQLR  367 (377)
T ss_dssp             HHHTSHHHHHHH
T ss_pred             HHhhChHHHHHH
Confidence            999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-49  Score=368.07  Aligned_cols=255  Identities=23%  Similarity=0.301  Sum_probs=215.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|.+.+.||.|+||.||+|.+..+|+.||+|++.+... .......+..|+.++++++||||+++++++...     ..+
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l  260 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----TDL  260 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----CEE
Confidence            47889999999999999999999999999999965421 223456778999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      |+||||++ |+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++....
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999998 5999998763    469999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCcccccc
Q 019728          156 ETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY----VHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      .... ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....    ......+...           
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----------  408 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----------  408 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----------
T ss_pred             CCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----------
Confidence            4432 334589999999999987 7889999999999999999999999977532    2222222210           


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~~  293 (336)
                                          .......++..+.+||++||+.||.+||+     ++++++||||+++.
T Consensus       409 --------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          409 --------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             --------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence                                01112467899999999999999999995     58999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-49  Score=341.21  Aligned_cols=257  Identities=27%  Similarity=0.382  Sum_probs=214.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY   81 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEE
Confidence            5899999999999999999999999999999986432 234457788999999999999999999999876     6789


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC---
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (336)
                      +||||++| +|.+++.....+++.+++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999975 99999988788999999999999999999999999999999999999999999999999998754322   


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccccchH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .......++..|+|||++.+....+.++|+||||+++|+|++|..||....... ....+...                 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  224 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----------------  224 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-----------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-----------------
Confidence            123445788999999999874445789999999999999999999998765321 11111110                 


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                  .........++..+.++|++||+.||.+|||++|+++||||+...
T Consensus       225 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          225 ------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             ------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ------------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                        000111235688999999999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-49  Score=348.44  Aligned_cols=258  Identities=33%  Similarity=0.504  Sum_probs=209.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc------ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||.||+|.+..+++.||||++.....      .......+.+|+.++++++||||+++++++...   
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   87 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---   87 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC---
Confidence            58999999999999999999999999999999865421      122334577899999999999999999998654   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccCC
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLA  151 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~  151 (336)
                         ..|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus        88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence               3899999997 599999988889999999999999999999999999999999999999987665   999999999


Q ss_pred             cccCCCCcccceeeeecccCchhcc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCcccc
Q 019728          152 RTTSETDFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ-LRLITELIGSPDDASL  228 (336)
Q Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  228 (336)
                      .............++..|+|||++.  +...++.++|||||||++|+|++|..||........ ...+....        
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  236 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--------  236 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC--------
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc--------
Confidence            8776554444557899999999974  236788999999999999999999999976543211 11111100        


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                         ....+.....++..+.+||++||+.||.+|||+.++++||||+..
T Consensus       237 -------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          237 -------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             -------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             -------------------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                               001112235678999999999999999999999999999999763

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.4e-49  Score=352.37  Aligned_cols=279  Identities=30%  Similarity=0.487  Sum_probs=222.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CC-----ceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HE-----NVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp-----~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||+||+|.+..+++.||||++...   .........|+.+++.++ |+     +++++++++...   
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  128 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR---  128 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET---
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC---
Confidence            589999999999999999999999999999999643   344566677888888885 55     489999998876   


Q ss_pred             CcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCCCCeEEc--cCCCEEEEecc
Q 019728           76 TFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSNLLLN--ASCDLKIGDFG  149 (336)
Q Consensus        76 ~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~nil~~--~~~~~kl~dfg  149 (336)
                        ...|+||||++|+|.+++...  +.+++..++.++.||+.||+|||  +.||+||||||+|||++  .++.+||+|||
T Consensus       129 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 --NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             --CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence              679999999999999999765  46999999999999999999999  57999999999999994  47789999999


Q ss_pred             CCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          150 LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      ++......  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.....
T Consensus       207 ~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  283 (382)
T 2vx3_A          207 SSCQLGQR--IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD  283 (382)
T ss_dssp             TCEETTCC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             Cceecccc--cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99876543  334578999999999987 678999999999999999999999999999999999999988877665433


Q ss_pred             ccccchHHHHHHhCCccccc---------c-ccc------------------cCCC-------CChhHHHHHHHhcCCCC
Q 019728          230 FLRSDNARRYVRQLPRCRKQ---------Q-FAT------------------RFPN-------KSSGAVDLLEKMLVFDP  274 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~---------~-~~~------------------~~~~-------~~~~~~~li~~~L~~dp  274 (336)
                      ..+  ....+...+......         . ..+                  ...+       .+..+.+||++||+.||
T Consensus       284 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          284 QAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             TCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             hhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            221  111121111110000         0 000                  0000       01378999999999999


Q ss_pred             CCCCCHHHHHcCcccccCc
Q 019728          275 NKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       275 ~~Rpt~~ell~h~~f~~~~  293 (336)
                      ++|||++|+|+||||+...
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.2e-49  Score=356.86  Aligned_cols=281  Identities=27%  Similarity=0.397  Sum_probs=218.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC--------CCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--------HENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--------hp~iv~~~~~~~~~~   73 (336)
                      +|++.+.||+|+||+||+|.+..+++.||||++...   ......+.+|+.+++.++        ||||+++++++....
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            689999999999999999999999999999999643   445677788999999985        788999999987321


Q ss_pred             CCCcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCC---------
Q 019728           74 KDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASC---------  141 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~---------  141 (336)
                      .. ....|+||||++++|.+.+...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++         
T Consensus       115 ~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          115 VN-GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             TT-EEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CC-CceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence            11 1578999999999888888654  5699999999999999999999998 999999999999998775         


Q ss_pred             ----------------------------------------CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCC
Q 019728          142 ----------------------------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY  181 (336)
Q Consensus       142 ----------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  181 (336)
                                                              .++|+|||.+......  .....+|..|+|||++.+ ..+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~  270 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG-SGY  270 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT-SCC
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC-CCC
Confidence                                                    7999999999766543  344578999999999987 678


Q ss_pred             CccchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccc------
Q 019728          182 TAAIDIWSVGCILGEIMTREPLFPGKD------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ------  249 (336)
Q Consensus       182 ~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  249 (336)
                      +.++|||||||++|+|++|..||...+      ....+..+....+.++.........  ...+..........      
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY--SKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT--GGGTBCTTSSBSSCCCCCCC
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc--cccccCCccccccccccCCc
Confidence            999999999999999999999997655      4566777777777665432100000  00000000000000      


Q ss_pred             -------cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          250 -------QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       250 -------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                             .........+..+.+||.+||+.||++|||+.|+|+||||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                   000011123567889999999999999999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.6e-49  Score=340.34  Aligned_cols=260  Identities=25%  Similarity=0.319  Sum_probs=212.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.++++++||||+++++++...     ...
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~   86 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----DCY   86 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----SEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----CeE
Confidence            6999999999999999999999999999999986543 3455667888999999999999999999999877     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++| +|.+++...+++++.+++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+........
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            999999975 9999999888999999999999999999999999999999999999999999999999999987654322


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+............  ...+             
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~-------------  230 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSVP-------------  230 (294)
T ss_dssp             --------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCCC-------------
T ss_pred             cccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccCC-------------
Confidence              234568999999999987 7789999999999999999999999988776544322221  1111             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                 .......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus       231 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          231 -----------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -----------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -----------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                       011123356799999999999999999999555556667765544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-49  Score=353.50  Aligned_cols=282  Identities=19%  Similarity=0.266  Sum_probs=218.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...     ...|
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  107 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS  107 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEEE
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEEE
Confidence            5899999999999999999999999999999986542 455667888999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++| +|.+++...+.+++..++.++.||+.||+|||+. ||+|+||||+||+++.++.++|+|||.+...... .
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  186 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  186 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-c
Confidence            99999975 9999998888899999999999999999999996 9999999999999999999999999998654322 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc-----------
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-----------  228 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------  228 (336)
                      .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+............           
T Consensus       187 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             ----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            234578999999999987 78899999999999999999999999887765543332211111000000           


Q ss_pred             ----cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          229 ----GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                          ...+...............  ........++.++.+||++||+.||.+|||++|+|+||||+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             --------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                0000000111111110000  00111234688999999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-48  Score=340.68  Aligned_cols=253  Identities=21%  Similarity=0.314  Sum_probs=207.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+  +|+.||+|++............+.+|+.++++++||||+++++++...     ...+
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~  110 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PNLS  110 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TCCE
T ss_pred             HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CceE
Confidence            588999999999999999988  688999999987666677778899999999999999999999999877     5689


Q ss_pred             EEEecCCc-cHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           82 IVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      +||||++| +|.+++...+.   +++..++.++.||+.||+|||+.|  ++||||||+||+++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999975 99999987654   999999999999999999999999  9999999999999999999999999987654


Q ss_pred             CCC-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          156 ETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      ... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....             
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------------  256 (309)
T 3p86_A          191 STFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------------  256 (309)
T ss_dssp             -----------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------------
T ss_pred             ccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------
Confidence            432 2334578999999999987 7789999999999999999999999998876665544432111             


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc--Cccccc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  291 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~--h~~f~~  291 (336)
                                      .......+++.+.+||++||+.||.+|||+.++++  .+++++
T Consensus       257 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 ----------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                            11223467899999999999999999999999987  566655

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-48  Score=346.97  Aligned_cols=280  Identities=26%  Similarity=0.472  Sum_probs=222.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc------eeeecceecCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN------VIAIKDIIRPPKK   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~------iv~~~~~~~~~~~   74 (336)
                      +|++.+.||+|+||+||+|.+..++ +.||+|++...   ......+.+|+.+++.++|++      ++.+++++...  
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--   94 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--   94 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--
Confidence            6899999999999999999998777 68999999643   345567778999999987655      88888888776  


Q ss_pred             CCcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---------------
Q 019728           75 DTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---------------  137 (336)
Q Consensus        75 ~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---------------  137 (336)
                         ...++||||++++|.+.+...  .++++.+++.++.||+.||+|||++||+||||||+||++               
T Consensus        95 ---~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           95 ---GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             ---TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             ---CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence               679999999999998888765  369999999999999999999999999999999999999               


Q ss_pred             ----ccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019728          138 ----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  213 (336)
Q Consensus       138 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  213 (336)
                          +.++.++|+|||.+......  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+..
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                66789999999999765433  234578999999999987 78899999999999999999999999999988888


Q ss_pred             HHHHHHhCCCCcccccccc--------------cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 019728          214 RLITELIGSPDDASLGFLR--------------SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  279 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  279 (336)
                      ..+....+..+........              ......+...... ............+..+.+||++||+.||++|||
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            8888888776654221110              0001111110000 000000111223557999999999999999999


Q ss_pred             HHHHHcCcccccCc
Q 019728          280 VEEALRHPYLQSLH  293 (336)
Q Consensus       280 ~~ell~h~~f~~~~  293 (336)
                      +.|+++||||+++.
T Consensus       328 ~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          328 LAEALLHPFFAGLT  341 (355)
T ss_dssp             HHHHTTSGGGGGCC
T ss_pred             HHHHhcChhhcCCC
Confidence            99999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-48  Score=338.52  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=211.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+....    ....+.+|+.+++.++||||+++++++...     ...|
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~  100 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLW  100 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            5889999999999999999999999999999986532    245678999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +||||++| +|.+++. ....+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999985 9999986 45689999999999999999999999999999999999999999999999999987654432 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......               
T Consensus       181 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  244 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT---------------  244 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred             ccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc---------------
Confidence            2334578899999999987 678999999999999999999999998877655443332211000               


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ......++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus       245 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          245 -------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             -------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             -------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                         011124588999999999999999999999999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-48  Score=340.88  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=210.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...  +......+.+|+.+++.++||||+++++++...     ...+
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   92 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW   92 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence            589999999999999999999999999999998643  334467788999999999999999999999876     5699


Q ss_pred             EEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           82 IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      +||||++| +|.+++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999975 89888765 567999999999999999999999999999999999999999999999999987532211 1


Q ss_pred             cccceeeeecccCchhcc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 FMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      ......++..|+|||++.    ....++.++||||||+++|+|++|..||...+.......+.......           
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  241 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-----------  241 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----------
Confidence            123446789999999984    23678899999999999999999999999887666554443321100           


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                       ......++..+.++|.+||+.||.+|||+.++++||||+++.
T Consensus       242 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          242 -----------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             -----------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             -----------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                             011134588899999999999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.4e-49  Score=338.76  Aligned_cols=257  Identities=27%  Similarity=0.371  Sum_probs=216.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|++|.||++.+..+++.||+|.+.....+......+.+|+.++++++||||+++++++.....   ...|
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~   83 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLY   83 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ceEE
Confidence            5899999999999999999999999999999997665566677888999999999999999999998754322   5689


Q ss_pred             EEEecCCc-cHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           82 IVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      +||||++| +|.+++...    ..+++..++.++.||+.||+|||+.|     ++|+||+|+||+++.++.++|+|||.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            99999974 999998653    34999999999999999999999999     999999999999999999999999998


Q ss_pred             cccCCCCc-ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          152 RTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       152 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+.....         
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---------  233 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---------  233 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred             eeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---------
Confidence            76554321 234467899999999987 6789999999999999999999999998876655544433110         


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                           ......++..+.++|.+||+.||.+|||+.|+++|+|+..-
T Consensus       234 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 ---------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ---------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                                 11223568899999999999999999999999999999863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-49  Score=344.70  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=193.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++++...     ...+
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   89 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DELW   89 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----SCEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CCcE
Confidence            5899999999999999999999999999999986432 223456778999999999999999999999877     5699


Q ss_pred             EEEecCC-ccHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           82 IVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      +||||++ ++|.+++..        .+.+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999997 599999863        4569999999999999999999999999999999999999999999999999886


Q ss_pred             ccCCCC------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          153 TTSETD------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       153 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                      ......      ......+++.|+|||++.+...++.++||||||+++|+|++|..||..............  ..++..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~  247 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPSL  247 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCCT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCcc
Confidence            543321      123456789999999987545689999999999999999999999988765443322211  111100


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ..                   ..........++..+.++|.+||+.||.+|||+.++++||||++..
T Consensus       248 ~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          248 ET-------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             TC------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cc-------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            00                   0011223456789999999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.4e-48  Score=337.08  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=217.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||+|++|.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...     ...|
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   96 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW   96 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            48899999999999999999999999999999865432 33467788999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||++| +|.+++.. +++++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence            99999985 99998865 679999999999999999999999999999999999999999999999999987655432 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+....                   
T Consensus       176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------  235 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------------------  235 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------------
T ss_pred             cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-------------------
Confidence            334578899999999987 678899999999999999999999998877655544433210                   


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                 .......++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       236 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 -----------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                       111224678899999999999999999999999999999763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8e-49  Score=344.21  Aligned_cols=275  Identities=16%  Similarity=0.208  Sum_probs=211.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.....   ...+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~   85 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKV   85 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---ceEE
Confidence            5899999999999999999999999999999996532 22335667899999999999999999999877633   4689


Q ss_pred             EEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE----ccCCCEEEEeccCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLART  153 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~~~~  153 (336)
                      +||||++ ++|.+++....   .+++.+++.++.||+.||+|||+.||+|+||||+||++    +.++.+||+|||.+..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999997 59999997643   39999999999999999999999999999999999999    7778899999999987


Q ss_pred             cCCCCcccceeeeecccCchhccc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCC
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLN-------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY----VHQLRLITELIGS  222 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~~~~  222 (336)
                      ...........++..|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+..+...   
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---  242 (319)
T 4euu_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---  242 (319)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH---
T ss_pred             cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC---
Confidence            766655556678999999999862       26788999999999999999999999965332    2333333222   


Q ss_pred             CCcccccccccchHHHHHHhCCcc--ccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          223 PDDASLGFLRSDNARRYVRQLPRC--RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                      .+.............     ....  ...........++..+.++|++||+.||++|||++|+|+||-
T Consensus       243 ~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENG-----PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTC-----CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCC-----ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            221111100000000     0000  000001111234667899999999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=340.61  Aligned_cols=259  Identities=21%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCC-cce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDT-FND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~-~~~   79 (336)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   .....+.+|+.+++++ +||||+++++++......+ ...
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            5899999999999999999999999999999986542   2345677899999999 7999999999987643211 256


Q ss_pred             EEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           80 VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .|+||||+++ +|.+++...  ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            8999999985 999999764  5799999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-cccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      .. ......++..|+|||++..    ...++.++|||||||++|+|++|..||...........+.....          
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  251 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----------  251 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----------
T ss_pred             CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------
Confidence            32 2334578999999999862    25688999999999999999999999988776555443322100          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                         .......++..+.+||++||..||.+|||+.++++||||++.
T Consensus       252 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 -------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             -------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             -------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                               001124568899999999999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-48  Score=343.29  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=190.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHH-HHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++..... .........|+. +++.++||||+++++++...     ...
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~~   96 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GDC   96 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cce
Confidence            58899999999999999999999999999999965432 334445555655 77778999999999999877     679


Q ss_pred             EEEEecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      ++||||++|+|.+++..     ...+++..++.++.|++.||+|||+. |++|+||||+||+++.++.+||+|||.+...
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99999999999888863     57899999999999999999999999 9999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccCchhcc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ..........++..|+|||++.   ....++.++|||||||++|+|++|..||........  .+.....          
T Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~----------  244 (327)
T 3aln_A          177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQVVK----------  244 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC----------
T ss_pred             ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHHhc----------
Confidence            6554444557899999999984   225688999999999999999999999976432110  0000000          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   .............++..+.+||++||+.||.+|||+.++++||||....
T Consensus       245 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          245 -------------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                         0000011122346789999999999999999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=338.20  Aligned_cols=259  Identities=19%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++............+.++..+++.++||||+++++++...     ...+
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~  100 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TDVF  100 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEE
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CcEE
Confidence            57889999999999999999999999999999976543444444445556678888999999999999887     6799


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||+++.+..+... ...+++..++.++.||+.||+|||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus       101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            9999997777666643 56799999999999999999999995 999999999999999999999999999977655544


Q ss_pred             ccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccccc
Q 019728          160 MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .....++..|+|||++..    ...++.++|||||||++|+|++|..||.... ..+....+.....             
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  247 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-------------  247 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-------------
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-------------
Confidence            555678999999999852    2567889999999999999999999998743 3333333322110             


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                     ...+....++..+.++|.+||+.||.+|||+.++++||||+...
T Consensus       248 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          248 ---------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             ---------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ---------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                           00111235789999999999999999999999999999998754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.1e-48  Score=346.30  Aligned_cols=288  Identities=25%  Similarity=0.364  Sum_probs=219.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-----------CCceeeecceec
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----------HENVIAIKDIIR   70 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------hp~iv~~~~~~~   70 (336)
                      +|++.+.||+|+||+||+|.+..+++.||||++...   ......+.+|+.++++++           ||||+++++++.
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            689999999999999999999999999999999643   344566778999888886           899999999987


Q ss_pred             CCCCCCcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCCCCeEEcc------CC
Q 019728           71 PPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNA------SC  141 (336)
Q Consensus        71 ~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~nil~~~------~~  141 (336)
                      .....+ ...+++||+++++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+||+++.      .+
T Consensus        97 ~~~~~~-~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNG-VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTE-EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCC-ceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            653211 368999999988999999763  5599999999999999999999998 9999999999999954      34


Q ss_pred             CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHH
Q 019728          142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD------YVHQLRL  215 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~  215 (336)
                      .++|+|||++......  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||....      ....+..
T Consensus       176 ~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eEEEcccccccccCCC--CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            7999999999766543  334478999999999987 678999999999999999999999998654      4556667


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCcccc---c----------cccccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRK---Q----------QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  282 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  282 (336)
                      +....+.++........  ....+.........   .          .........+..+.+||++||+.||.+|||+.|
T Consensus       253 ~~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGK--YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHCSCCHHHHHHCT--THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHhcCCCCHHHHhccc--hhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            77777766543221100  00000000000000   0          000111234678999999999999999999999


Q ss_pred             HHcCcccccCcCCCCC
Q 019728          283 ALRHPYLQSLHDLNDE  298 (336)
Q Consensus       283 ll~h~~f~~~~~~~~~  298 (336)
                      +|+||||++.......
T Consensus       331 ll~hp~f~~~~~~~~~  346 (373)
T 1q8y_A          331 LVNHPWLKDTLGMEEI  346 (373)
T ss_dssp             HHTCGGGTTCTTCTTC
T ss_pred             HhhChhhhcccCcccc
Confidence            9999999987554433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.5e-49  Score=351.82  Aligned_cols=268  Identities=15%  Similarity=0.109  Sum_probs=193.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhC--CCCceeeecc-------eecC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHM--EHENVIAIKD-------IIRP   71 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l--~hp~iv~~~~-------~~~~   71 (336)
                      .|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+  +||||++++.       ++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            38899999999999999999999999999999977543 334555666775444444  6999888553       3322


Q ss_pred             CCCC------------CcceEEEEEecCCccHHHHHHcC-CCCCHHHH------HHHHHHHHHHHHHHHhCCeeccCCCC
Q 019728           72 PKKD------------TFNDVYIVYELMDTDLHQIIRSD-QQLTDDHC------QYFLYQLLRGLKYVHSASVLHRDLKP  132 (336)
Q Consensus        72 ~~~~------------~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~LH~~~i~H~dlkp  132 (336)
                      ....            ....+|+||||++|+|.+++... ..+.....      ..++.||+.||+|||++||+||||||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp  222 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP  222 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence            2110            01448999999999999999763 33444445      57779999999999999999999999


Q ss_pred             CCeEEccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 019728          133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  211 (336)
Q Consensus       133 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  211 (336)
                      +|||++.++.+||+|||++...+....  ...+++.|+|||++.+. ..++.++|||||||++|+|++|..||.......
T Consensus       223 ~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~  300 (371)
T 3q60_A          223 DNLFIMPDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI  300 (371)
T ss_dssp             GGEEECTTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred             HHEEECCCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence            999999999999999999987654321  34556999999998642 468999999999999999999999997763210


Q ss_pred             HHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          212 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                      ..        ......              ...........+..+.+++.+.+||.+||+.||++|||+.++++||||++
T Consensus       301 ~~--------~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          301 KG--------SWKRPS--------------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             TT--------CCCBCC--------------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cc--------chhhhh--------------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            00        000000              00000011112223578999999999999999999999999999999987


Q ss_pred             Cc
Q 019728          292 LH  293 (336)
Q Consensus       292 ~~  293 (336)
                      +.
T Consensus       359 ~~  360 (371)
T 3q60_A          359 LQ  360 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-49  Score=351.57  Aligned_cols=260  Identities=19%  Similarity=0.311  Sum_probs=209.6

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCccc--ChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||.||++.+.   .+++.||||++.....  .......+.+|+.+++.+ +||||+++++++...   
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---  131 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE---  131 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET---
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC---
Confidence            5899999999999999999984   5899999999865321  223344566799999999 699999999999876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ...++||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus       132 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          132 --TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             --TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             --ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence              67999999997 599999988888999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--cccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          155 SETD--FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....  ......+++.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.....          
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----------  279 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----------  279 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----------
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh----------
Confidence            4322  22345789999999998752 4578899999999999999999999975432111111111000          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                       .........++..+.+||++||+.||.+||     +++|+++||||+.+.
T Consensus       280 -----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          280 -----------------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             -----------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -----------------ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence                             001122346788999999999999999999     999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-47  Score=334.50  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=207.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC--CCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||++.+. +++.||+|++............+.+|+.++++++  ||||+++++++...     ..
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~  102 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QY  102 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-----SE
T ss_pred             eEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-----CE
Confidence            5899999999999999999995 5899999999766666677788899999999997  59999999999877     67


Q ss_pred             EEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           80 VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        80 ~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      .|++||+.+++|.+++...+.+++.+++.++.||+.||+|||++|++|+||||+||++++ +.++|+|||.+........
T Consensus       103 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             EEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence            999999878899999998889999999999999999999999999999999999999964 8899999999986544321


Q ss_pred             ---ccceeeeecccCchhcccC----------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          160 ---MTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       160 ---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                         .....++..|+|||++.+.          ..++.++||||||+++|+|++|..||........  .+........  
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~--  257 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHAIIDPNH--  257 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHCTTS--
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--HHHHHHhccc--
Confidence               2345689999999998641          3678899999999999999999999976543211  1111111100  


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                              ........+..+.++|++||+.||.+|||+.|+++||||+...
T Consensus       258 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          258 ------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             ------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ------------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                                    0111234578899999999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.9e-48  Score=340.44  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=195.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc---eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC-c
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT-F   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~-~   77 (336)
                      +|++.+.||+|+||.||+|.+..++.   .||+|++............+.+|+.++++++||||+++++++......+ .
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            58999999999999999999987765   8999999776556667788999999999999999999999988764321 1


Q ss_pred             ceEEEEEecCCc-cHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           78 NDVYIVYELMDT-DLHQIIRSDQ------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      ...+++|||+.+ +|.+++....      .+++.+++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~  183 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL  183 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccc
Confidence            224999999985 9999986432      689999999999999999999999999999999999999999999999999


Q ss_pred             CcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 019728          151 ARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  226 (336)
Q Consensus       151 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (336)
                      +........   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....      
T Consensus       184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------  256 (323)
T 3qup_A          184 SRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN------  256 (323)
T ss_dssp             -----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------
T ss_pred             cccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC------
Confidence            976544322   223345678999999987 778999999999999999999 999998877655544443211      


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-------HHHHHcCcccccC
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-------VEEALRHPYLQSL  292 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~ell~h~~f~~~  292 (336)
                                              .....+..+..+.+||.+||+.||.+|||       +++++.|||+.+.
T Consensus       257 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          257 ------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             ------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                                    11223467889999999999999999999       7778889998874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-48  Score=346.33  Aligned_cols=271  Identities=22%  Similarity=0.312  Sum_probs=213.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh---------------hHHHHHHHHHHHHhhCCCCceeeec
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI---------------IDARRTLREIKLLRHMEHENVIAIK   66 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~hp~iv~~~   66 (336)
                      +|++.+.||.|+||.||+|.+  +++.||+|++.......               .....+.+|+.++++++||||++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            689999999999999999999  89999999986432211               1127788999999999999999999


Q ss_pred             ceecCCCCCCcceEEEEEecCCc-cHHHH------HHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeE
Q 019728           67 DIIRPPKKDTFNDVYIVYELMDT-DLHQI------IRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL  136 (336)
Q Consensus        67 ~~~~~~~~~~~~~~~iv~e~~~g-~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil  136 (336)
                      +++...     ...|+||||++| +|.++      +..  ...+++..++.++.||+.||+|||+ .|++|+||+|+||+
T Consensus       110 ~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          110 GIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             EEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             EEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            999887     679999999986 99988      655  5779999999999999999999999 99999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA-AIDIWSVGCILGEIMTREPLFPGKDY-VHQLR  214 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~  214 (336)
                      ++.++.++|+|||.+...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||..... .+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999999775444 3344578999999999987435555 99999999999999999999988765 44444


Q ss_pred             HHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      .+.......+.......            ..............++..+.+||.+||+.||.+|||+.|+++||||++.
T Consensus       264 ~i~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFL------------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHTSCCCCCCCSSSSST------------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHhccCcCCccchhhhh------------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            33221111111000000            0000000111225679999999999999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=330.60  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=205.2

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV   83 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv   83 (336)
                      .....||.|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++.++||||+++++++...     ...++|
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv   97 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIF   97 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEE
Confidence            3445899999999999999999999999998654  334557788999999999999999999999876     679999


Q ss_pred             EecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-CCCEEEEeccCCcccCCCC
Q 019728           84 YELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        84 ~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~  158 (336)
                      |||++ ++|.+++...   ..+++..++.++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||.+.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99997 5999999764   24678999999999999999999999999999999999987 8999999999987654432


Q ss_pred             -cccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 -FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       ......++..|+|||++.+. ..++.++||||||+++|+|++|..||.................               
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------  242 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK---------------  242 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC---------------
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc---------------
Confidence             23345788999999998752 2478999999999999999999999976543322111111111               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                   ........++..+.++|.+||+.||++|||+.++++||||+...
T Consensus       243 -------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          243 -------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             -------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             -------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                         01122346789999999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=336.81  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=207.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCce---EEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREE---VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~---vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||.||+|.+..+++.   ||||++.... .......+.+|+.++++++||||+++++++...     .
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  123 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----R  123 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----G
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            589999999999999999999866654   9999996542 445567788999999999999999999999776     5


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|+||||++| +|.+++... +.+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            68999999974 999999754 6799999999999999999999999999999999999999999999999999986554


Q ss_pred             CCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...    .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.....          
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------  272 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----------  272 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC----------
Confidence            321    122344668999999977 678999999999999999999 9999988877766655543211          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          ......++..+.++|.+||+.||.+|||+.++++
T Consensus       273 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 --------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                1122466889999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-47  Score=341.86  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=207.1

Q ss_pred             ccceeeeecccceEEEEEEEeC-------CCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|++.+.||+|+||.||+|.+.       .++..||+|++... ........+.+|+.+++++ +||||+++++++... 
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-  159 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-  159 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS-
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC-
Confidence            5889999999999999999974       34567999999654 3455667889999999999 899999999999876 


Q ss_pred             CCCcceEEEEEecCCc-cHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMDT-DLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~g-~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ..+|+||||++| +|.+++...+                .++..+++.++.||+.||+|||++||+||||||+||+
T Consensus       160 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          160 ----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             ----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence                568999999975 9999997643                4789999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.+||+|||++........   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999986544321   223456788999999987 789999999999999999999 9999988765544


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+....                              .......++.++.++|.+||+.||.+|||+.|++++
T Consensus       315 ~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43332211                              112234678899999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-47  Score=331.90  Aligned_cols=258  Identities=26%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-------   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-------   74 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..   .......+.+|+.++++++||||+++++++.....       
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            58999999999999999999999999999999854   34556778899999999999999999998764321       


Q ss_pred             -CCcceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           75 -DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        75 -~~~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                       ......|+||||++ |+|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence             11256899999997 5999999754 45788999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC---------------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 019728          152 RTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRL  215 (336)
Q Consensus       152 ~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~  215 (336)
                      ......               .......++..|+|||++.+...++.++|||||||++|+|++   ||..... ......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK  240 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence            765422               122345678999999999875678999999999999999998   5543221 112211


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      +.....                           ..........+..+.++|++||+.||.+|||+.++++||||+..
T Consensus       241 ~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          241 LRSVSI---------------------------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHSTTC---------------------------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             cccccc---------------------------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            111000                           00011224567789999999999999999999999999999763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.7e-48  Score=335.98  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=208.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++...  +......+.+|+.++++++||||+++++++...     ...+
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            588999999999999999999999999999988543  556678889999999999999999999999876     6799


Q ss_pred             EEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++| +|.+++.. ...+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999975 99999987 56799999999999999999999999999999999999999999999999999976543322


Q ss_pred             c---------------cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 019728          160 M---------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  224 (336)
Q Consensus       160 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (336)
                      .               ....|++.|+|||++.+ ..++.++||||||+++|+|++|..||........            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~------------  230 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------------  230 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT------------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH------------
Confidence            1               14468999999999987 7889999999999999999999998865321000            


Q ss_pred             cccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                        .    ..........          ....+.+++.+.++|.+||+.||++|||+.++++  |++.+
T Consensus       231 --~----~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          231 --D----FGLNVRGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             --T----SSBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --H----Hhhhhhcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence              0    0000001111          1123567889999999999999999999999986  55544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-48  Score=343.57  Aligned_cols=253  Identities=21%  Similarity=0.262  Sum_probs=208.7

Q ss_pred             ccceeeeecccceEEEEEEE-----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||+|+||.||+|.     +..+++.||||++... ........+.+|+.++++++||||+++++++...    
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  146 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----  146 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            48899999999999999999     4567889999998643 3445566788999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC---CEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~---~~kl  145 (336)
                       ...|+||||+. |+|.+++...       ..+++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||
T Consensus       147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          147 -LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             -CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence             55799999996 5999999754       3589999999999999999999999999999999999999655   4999


Q ss_pred             EeccCCcccCCC---CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||+++.....   .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999998743221   22233466889999999987 789999999999999999998 9999998887666555443211


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                                    .......+..+.+||.+||+.||.+|||+.+++++.++..
T Consensus       305 ------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 ------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             ------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                                          1112456889999999999999999999999999877643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.3e-48  Score=340.38  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=209.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh----hHHHHHHHHHHHHhhCC--CCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHME--HENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.++++++  ||||+++++++...   
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~---  120 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP---  120 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS---
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC---
Confidence            6899999999999999999999999999999986543211    12244567999999996  59999999999887   


Q ss_pred             CcceEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc-cCCCEEEEeccCCc
Q 019728           76 TFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLAR  152 (336)
Q Consensus        76 ~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~  152 (336)
                        ...+++||++.  ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++ .++.+||+|||.+.
T Consensus       121 --~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          121 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             --CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence              67999999996  69999998888999999999999999999999999999999999999999 78899999999987


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ...... .....++..|+|||++.+....+.++|||||||++|+|++|..||.....      +..  .           
T Consensus       199 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~-----------  258 (320)
T 3a99_A          199 LLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G-----------  258 (320)
T ss_dssp             ECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C-----------
T ss_pred             cccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--c-----------
Confidence            765442 33457899999999987744457889999999999999999999965321      100  0           


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                        .......++..+.+||++||+.||.+|||++++++||||++..
T Consensus       259 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          259 ------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                              0011245789999999999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-47  Score=325.67  Aligned_cols=245  Identities=18%  Similarity=0.308  Sum_probs=207.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+. +++.||+|++......   ...+.+|+.++++++||||+++++++...     ...+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   81 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEE
T ss_pred             hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceE
Confidence            5889999999999999999996 5778999999764333   35678999999999999999999999876     5699


Q ss_pred             EEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +||||++| +|.+++... +.+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999975 999999654 568999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||......+....+.....               
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------------  225 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------------  225 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------------
T ss_pred             ccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc---------------
Confidence             1223355778999999987 778999999999999999999 9999998887666555533211               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     .......+..+.+++.+||+.||.+|||+.+++++
T Consensus       226 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ---------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                           11123458899999999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-47  Score=339.96  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=206.9

Q ss_pred             ccceeeeecccceEEEEEEE-----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||.||+|.     +..+++.||||++... ........+.+|+.++.++ +||||+++++++....  
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~--   99 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   99 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC--
Confidence            58999999999999999999     5667789999999654 2445567788999999999 7999999999987652  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCC------------------------------------------------------
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQ------------------------------------------------------  100 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~------------------------------------------------------  100 (336)
                        ...++||||++ |+|.+++.....                                                      
T Consensus       100 --~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A          100 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             --SCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             --CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence              34799999998 599999976533                                                      


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---cccceee
Q 019728          101 ------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVV  165 (336)
Q Consensus       101 ------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~  165 (336)
                                  +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......   ......+
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                        8999999999999999999999999999999999999999999999999997654332   2234567


Q ss_pred             eecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCC
Q 019728          166 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP  244 (336)
Q Consensus       166 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (336)
                      +..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...............                       
T Consensus       258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------------------  313 (359)
T 3vhe_A          258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-----------------------  313 (359)
T ss_dssp             CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-----------------------
T ss_pred             CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-----------------------
Confidence            888999999987 788999999999999999998 9999988764443333322111                       


Q ss_pred             ccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                            ........++++.++|.+||+.||.+|||+.|+++|
T Consensus       314 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          314 ------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                  111224568899999999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-48  Score=341.77  Aligned_cols=260  Identities=21%  Similarity=0.304  Sum_probs=181.7

Q ss_pred             ccceee-eecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRG-EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~-~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+ .||.|+||+||+|.+..+++.||+|++...   ..   ...+....++.++||||+++++++..... +....
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~  101 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHH-GKRCL  101 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccC-CCceE
Confidence            577855 599999999999999999999999998542   11   11223344667799999999999875321 11458


Q ss_pred             EEEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCccc
Q 019728           81 YIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~  154 (336)
                      ++||||++| +|.+++...+  .+++.+++.++.||+.||+|||++|++|+||||+||+++.   ++.++|+|||.+...
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999999975 9999998753  6999999999999999999999999999999999999976   445999999999765


Q ss_pred             CCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          155 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.................             
T Consensus       182 ~~~~-~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------  246 (336)
T 3fhr_A          182 TQNA-LQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR-------------  246 (336)
T ss_dssp             ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred             cccc-cccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh-------------
Confidence            5432 334577999999999876 6788999999999999999999999976543322111111000             


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                ..........+..++..+.+||++||+.||.+|||+.|+++||||+...
T Consensus       247 ----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          247 ----------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             ----------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                      0001111223356799999999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-47  Score=342.63  Aligned_cols=247  Identities=21%  Similarity=0.306  Sum_probs=207.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.++++++||||+++++++...     ...|
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~  188 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIY  188 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CCcE
Confidence            478999999999999999999999999999998643 2344556778999999999999999999999876     5589


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++ |+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999997 6999999764 4699999999999999999999999999999999999999999999999999876543322


Q ss_pred             c---cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 M---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....              
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------  333 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR--------------  333 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC--------------
T ss_pred             eecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            1   12245778999999986 678999999999999999998 9999998876555444332110              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .+.....+..+.++|.+||+.||.+|||+.++++
T Consensus       334 ----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ----------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                            1122356889999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.9e-47  Score=324.13  Aligned_cols=245  Identities=19%  Similarity=0.276  Sum_probs=206.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+. ++..||+|++......   ...+.+|+.++++++||||+++++++...     ...+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPIY   79 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEE
T ss_pred             heeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CceE
Confidence            6899999999999999999885 5778999999654333   35678999999999999999999999876     5699


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++ ++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999997 5899999765 4599999999999999999999999999999999999999999999999999876554432


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....               
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------  223 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------------  223 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------------
T ss_pred             hcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC---------------
Confidence              223345667999999977 678899999999999999999 9999988877665554433111               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     .......++.+.++|.+||+.||.+|||+.+++++
T Consensus       224 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 ---------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           11123458889999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=338.56  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=209.6

Q ss_pred             ccceeeeecccceEEEEEEEeCC-------CCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|.+.+.||+|+||.||+|.+..       .+..||+|++... ........+.+|+.+++++ +||||+++++++... 
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-  147 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-  147 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC-
Confidence            58899999999999999999753       3357999999654 3455667888999999999 899999999999877 


Q ss_pred             CCCcceEEEEEecCCc-cHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMDT-DLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~g-~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ...++||||++| +|.+++....                .+++.+++.++.||+.||+|||+.||+||||||+||+
T Consensus       148 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          148 ----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence                568999999975 9999997653                4899999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.+||+|||++.......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998665432   2233456788999999987 788999999999999999999 9999998876665


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+.....                              .......+.++.+||++||+.||++|||+.|++++
T Consensus       303 ~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            544433111                              11224568899999999999999999999999974

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.5e-47  Score=325.73  Aligned_cols=245  Identities=19%  Similarity=0.290  Sum_probs=204.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+. ++..||+|++......   ...+.+|+.++++++||||+++++++...     ...+
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   95 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIF   95 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEE
T ss_pred             HHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCeE
Confidence            5889999999999999999885 6778999999764333   35678999999999999999999999876     5699


Q ss_pred             EEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++ ++|.+++.. ...+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999996 599999976 46799999999999999999999999999999999999999999999999999876543321


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+......              
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------------  240 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------------  240 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------------
T ss_pred             ccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------------
Confidence              222345678999999987 678999999999999999998 99999988876666555432111              


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                      ......++.+.++|.+||+.||.+|||+.++++|
T Consensus       241 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 ----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                            1123458889999999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-46  Score=320.81  Aligned_cols=246  Identities=15%  Similarity=0.181  Sum_probs=207.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+.  ++.||+|++.....+......+.+|+.++++++||||+++++++.....   ...+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~   85 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA---PHPT   85 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS---SSCE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC---CCeE
Confidence            6899999999999999999994  8899999998766666777889999999999999999999999887633   4589


Q ss_pred             EEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++ |+|.+++....  .+++.+++.++.||+.||+|||++|  ++|+||||+||+++.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999998 59999998765  4899999999999999999999999  99999999999999999999999988755332


Q ss_pred             CCcccceeeeecccCchhcccCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                      .    ...+++.|+|||++.+..  .++.++|||||||++|+|++|..||...+.......+.....             
T Consensus       166 ~----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------  228 (271)
T 3kmu_A          166 P----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-------------  228 (271)
T ss_dssp             T----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC-------------
T ss_pred             c----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC-------------
Confidence            2    346789999999987622  233379999999999999999999988876655444433111             


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      .......++..+.++|.+||+.||++|||++++++
T Consensus       229 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 ----------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            11223467899999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4e-47  Score=329.78  Aligned_cols=264  Identities=20%  Similarity=0.322  Sum_probs=202.6

Q ss_pred             ccceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||+||+|.    +..+++.||+|++...  .......+.+|+.++++++||||+++++++.....   
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   85 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---   85 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH---
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---
Confidence            68999999999999999998    6778999999998643  45566788899999999999999999998865422   


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ..+++||||++ |+|.+++...+ ++++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            44799999996 59999997754 49999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....    .....++..|+|||++.+ ..++.++||||||+++|+|++|..||......     .....+.......   
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~---  236 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQM---  236 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHH---
T ss_pred             CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccch---
Confidence            4321    223345677999999987 77899999999999999999999988654211     1111111111000   


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                         .........   ......+.....++++.++|++||+.||++|||+.|+++
T Consensus       237 ---~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 ---IVFHLIELL---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             ---HHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---hHHHHHHHH---hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               000000000   011122334577899999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7e-47  Score=331.02  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=207.8

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||.|+||.||+|.+.     .+++.||+|++... ........+.+|+.++++++||||+++++++...    
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   98 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD----   98 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC----
Confidence            5889999999999999999983     45688999998653 3455667888999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSDQQ------------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                       ...++||||++ |+|.+++...+.                        +++.+++.++.||+.||+|||++|++|+|||
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           99 -GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             -CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence             56899999998 699999976543                        8999999999999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  207 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  207 (336)
                      |+||+++.++.++|+|||++........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999976544322   223355778999999987 678999999999999999999 99999887


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ........+....                              .......++..+.++|.+||+.||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          257 PPERLFNLLKTGH------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHhhcCC------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6554443332211                              112234678999999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-46  Score=328.13  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=201.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...     ...
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~  109 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----GQL  109 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----CeE
Confidence            58999999999999999999999999999999976433 344557788999999999999999999999876     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |++|||++| +|.+++...+++++.+++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||.+....... 
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            999999985 999999888889999999999999999999999999999999999999999999999999987655432 


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+..   ..              
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~--------------  251 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AI--------------  251 (309)
T ss_dssp             -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---CC--------------
T ss_pred             ccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---CC--------------
Confidence             2234568899999999987 7889999999999999999999999987654422222211   00              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-TVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~ell~  285 (336)
                                 .......+.++..+.++|.+||+.||++|| +++++++
T Consensus       252 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 -----------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -----------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -----------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                       011123357899999999999999999999 8888875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=334.80  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=202.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh----hHHHHHHHHHHHHhhC----CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI----IDARRTLREIKLLRHM----EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l----~hp~iv~~~~~~~~~~   73 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.++.++    +||||+++++++... 
T Consensus        32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-  110 (312)
T 2iwi_A           32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-  110 (312)
T ss_dssp             -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-
Confidence            5899999999999999999999999999999996543211    2233445789999888    899999999999876 


Q ss_pred             CCCcceEEEEEec-CC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc-cCCCEEEEeccC
Q 019728           74 KDTFNDVYIVYEL-MD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGL  150 (336)
Q Consensus        74 ~~~~~~~~iv~e~-~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~-~~~~~kl~dfg~  150 (336)
                          ...++|||+ +. ++|.+++...+.+++..++.++.||+.||+|||+.|++|+||||+||+++ .++.++|+|||.
T Consensus       111 ----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          111 ----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             ----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence                568999998 55 69999998888899999999999999999999999999999999999999 889999999999


Q ss_pred             CcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          151 ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      +....... .....++..|+|||++.+....+.++||||||+++|+|++|..||.....      +...           
T Consensus       187 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-----------  248 (312)
T 2iwi_A          187 GALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA-----------  248 (312)
T ss_dssp             CEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT-----------
T ss_pred             hhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh-----------
Confidence            88765443 33456889999999987644445689999999999999999999975321      1110           


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                          .......++..+.++|.+||+.||++|||++|+++||||+...
T Consensus       249 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 --------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             --------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                                0011245788999999999999999999999999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-46  Score=329.66  Aligned_cols=254  Identities=19%  Similarity=0.224  Sum_probs=200.1

Q ss_pred             ccceeeeecccceEEEEEEEeCC---CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||+|+||.||+|.+..   ++..||+|.+............+.+|+.++++++||||+++++++......+..
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            58899999999999999998764   556899999977666667778899999999999999999999999876543334


Q ss_pred             eEEEEEecCC-ccHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           79 DVYIVYELMD-TDLHQIIR------SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      ..++||||+. |+|.+++.      ....+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~  194 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS  194 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence            5799999998 59999984      3456999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          152 RTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      .......   ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....       
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  266 (313)
T 3brb_A          195 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-------  266 (313)
T ss_dssp             ----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------
T ss_pred             eecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-------
Confidence            7654332   1223355778999999987 788999999999999999999 899998876555444332211       


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                             .......++..+.++|.+||+.||.+|||+.+++++
T Consensus       267 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 -----------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -----------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   112234678899999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-46  Score=324.99  Aligned_cols=247  Identities=18%  Similarity=0.268  Sum_probs=204.8

Q ss_pred             ccceee-eecccceEEEEEEE--eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRG-EYDDIIFFIFSAAV--NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~-~lg~G~~g~v~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+ .||.|+||.||+|.  +..+++.||+|++............+.+|+.+++.++||||+++++++..      .
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   90 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------E   90 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------S
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC------C
Confidence            477888 99999999999994  46678899999997665555667888999999999999999999999843      4


Q ss_pred             eEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..++||||++ ++|.+++...+.+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            5899999998 599999998888999999999999999999999999999999999999999999999999998766543


Q ss_pred             Ccc----cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 DFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ...    ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+....            
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------  237 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------  237 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence            221    22234678999999976 678899999999999999999 999999887665544433211            


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        .......++..+.++|++||+.||.+||++.++++
T Consensus       238 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 ------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              11122467899999999999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-47  Score=334.27  Aligned_cols=248  Identities=20%  Similarity=0.261  Sum_probs=207.8

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||+|+||.||+|.+.     .+++.||+|++.... .......+.+|+.++++++||||+++++++...    
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----  122 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG----  122 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC----
Confidence            5889999999999999999996     455889999996542 345567788999999999999999999999876    


Q ss_pred             cceEEEEEecCCc-cHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           77 FNDVYIVYELMDT-DLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        77 ~~~~~iv~e~~~g-~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                       ...|+||||++| +|.+++...                        .++++.+++.++.||+.||+|||++||+|+|||
T Consensus       123 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          123 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             -CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence             568999999975 999999763                        568999999999999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  207 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  207 (336)
                      |+||+++.++.++|+|||++.......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            999999999999999999987644332   2233466888999999887 678999999999999999999 99999888


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+....+....                              .......++..+.++|++||+.||.+|||+.+++++
T Consensus       281 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIYYVRDGN------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHhCCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            7665554443210                              111224668899999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-46  Score=332.27  Aligned_cols=247  Identities=17%  Similarity=0.163  Sum_probs=203.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+.+++++ +||||+++++++...     ...
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~   80 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYN   80 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Ccc
Confidence            58999999999999999999999999999999864322    23577899999999 899999999999876     678


Q ss_pred             EEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC-----EEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~-----~kl~dfg~~~~~  154 (336)
                      ++||||++++|.+++.. .+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.     ++|+|||++...
T Consensus        81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99999998899999986 468999999999999999999999999999999999999998887     999999999865


Q ss_pred             CCCCc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 019728          155 SETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---HQLRLITELIGSP  223 (336)
Q Consensus       155 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~  223 (336)
                      .....        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..   +....+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            43321        235678999999999987 77899999999999999999999999875432   2333332211101


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      +.                          .......+ ++.++|..||+.||.+||+++++++
T Consensus       240 ~~--------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PI--------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CH--------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CH--------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            00                          00112334 8999999999999999999998875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.3e-46  Score=324.37  Aligned_cols=248  Identities=15%  Similarity=0.134  Sum_probs=205.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++....    ....+.+|+.+++.+ +|+|++++++++...     ...
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~   81 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN   81 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----cee
Confidence            5899999999999999999999999999999985432    223467899999999 799999999998776     679


Q ss_pred             EEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC-----EEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~-----~kl~dfg~~~~~  154 (336)
                      ++||||++++|.+++... .++++.+++.++.||+.||+|||++||+||||||+||+++.++.     ++|+|||.+...
T Consensus        82 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           82 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999999988999999865 46999999999999999999999999999999999999987776     999999999765


Q ss_pred             CCCCc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC
Q 019728          155 SETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---YVHQLRLITELIGSP  223 (336)
Q Consensus       155 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~  223 (336)
                      .....        .....++..|+|||++.+ ..++.++|||||||++|+|++|..||....   .......+...... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  239 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-  239 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-
Confidence            54321        234568999999999987 778999999999999999999999998753   22333322221110 


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                               .......+.++.++.++|.+||+.||.+||+++++++
T Consensus       240 -------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 -------------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             -------------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                                     1111223467999999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-46  Score=324.53  Aligned_cols=245  Identities=20%  Similarity=0.359  Sum_probs=209.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...   ......+.+|+.++++++||||+++++++...     ...|
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   85 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY   85 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEE
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCEE
Confidence            588999999999999999999999999999999653   34567788999999999999999999999876     5699


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ ++|.+++...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999998 5999999763  459999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+.....              
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------------  230 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------  230 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------
T ss_pred             cccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------------
Confidence            2  233456778999999987 678999999999999999999 9999988765554443332111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      ......+++.+.+||++||+.||.+|||+.++++
T Consensus       231 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ----------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                            1222467889999999999999999999999976

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=332.72  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=203.9

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+.+.||.|+||.||+|.+     ..++..||+|++.... .......+.+|+.+++++ +||||+++++++...   
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---  121 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS---  121 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC---
Confidence            578999999999999999997     3456789999996432 334457788999999999 899999999999876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ-----------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                        ...++||||++ |+|.+++....                       .+++..++.++.||+.||+|||+.||+|+|||
T Consensus       122 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          122 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             --CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence              56899999997 59999997643                       37899999999999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  207 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  207 (336)
                      |+||+++.++.++|+|||++........   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999976543322   234566788999999877 778999999999999999998 99999886


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                      ........+.....                             ........+..+.+||.+||+.||.+|||+.+++++.
T Consensus       279 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          279 PVDANFYKLIQNGF-----------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CCSHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            64433333222100                             0112245688999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-46  Score=323.66  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=196.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCC---CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||.||+|.+..+   +..||+|.+... ........+.+|+.++++++||||+++++++..      .
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~   88 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N   88 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------C
Confidence            689999999999999999998654   456999988643 345566788899999999999999999999854      3


Q ss_pred             eEEEEEecCCc-cHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|+||||+++ +|.+++...+ .+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            47999999985 9999997654 699999999999999999999999999999999999999999999999999977654


Q ss_pred             CCc--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+....             
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-------------  234 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------  234 (281)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------------
T ss_pred             ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-------------
Confidence            332  223345678999999976 788999999999999999996 999998876655544443211             


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                       .....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       235 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 -----------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             112234678999999999999999999999999863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3e-46  Score=326.89  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=207.6

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||.||+|.+     ..+++.||+|++.... .......+.+|+.+++++ +||||+++++++...   
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---   99 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG---   99 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC---
Confidence            688999999999999999985     4677899999996542 344567788999999999 899999999999876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                        ...++||||++ |+|.+++....                  .+++.+++.++.||+.||+|||++|++|+||||+||+
T Consensus       100 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          100 --GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (313)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             --CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence              56899999997 59999997653                  4899999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++|+|||.+........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+......
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            99999999999999987654432   233456788999999887 788999999999999999998 9999987664443


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ..........                             .......+..+.++|.+||+.||.+|||+.|++++
T Consensus       257 ~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          257 FYKMIKEGFR-----------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCCC-----------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3333221110                             11124568899999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-46  Score=321.24  Aligned_cols=246  Identities=20%  Similarity=0.282  Sum_probs=202.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHH-----HHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDA-----RRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||.|+||+||+|.+..+++.||+|++..........     ..+.+|+.++++++||||+++++++...    
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   95 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP----   95 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT----
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC----
Confidence            6899999999999999999999999999999986543222211     6788999999999999999999998765    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCC-----EEEEe
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCD-----LKIGD  147 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~-----~kl~d  147 (336)
                         .++||||++ |+|.+.+... .++++..++.++.||+.||+|||+.|  ++|+||||+||+++.++.     ++|+|
T Consensus        96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence               379999998 6998888654 57999999999999999999999999  999999999999988776     99999


Q ss_pred             ccCCcccCCCCcccceeeeecccCchhccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Q 019728          148 FGLARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ--LRLITELIGSPD  224 (336)
Q Consensus       148 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~  224 (336)
                      ||.+......  .....+++.|+|||++.+ ...++.++|||||||++|+|++|..||........  ...+.. .    
T Consensus       173 fg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~----  245 (287)
T 4f0f_A          173 FGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-E----  245 (287)
T ss_dssp             CTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-S----
T ss_pred             CCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-c----
Confidence            9998755433  344578999999999843 24578899999999999999999999976553322  211111 0    


Q ss_pred             cccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          225 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                              .........+++.+.++|.+||+.||.+|||+.++++
T Consensus       246 ------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 ------------------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ------------------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                    0111223467899999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.8e-46  Score=321.51  Aligned_cols=250  Identities=20%  Similarity=0.273  Sum_probs=197.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||++.+..   .||+|++............+.+|+.++++++||||++++++...      ...+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~   95 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQLA   95 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred             ceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------CccE
Confidence            68999999999999999998753   59999998776677778889999999999999999999997643      3479


Q ss_pred             EEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           82 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      +||||++ ++|.+++.. ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+......  
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999998 599999854 456999999999999999999999999999999999999999999999999998755432  


Q ss_pred             -CcccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          158 -DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                       .......++..|+|||++..  ...++.++||||||+++|+|++|..||......+............+          
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  245 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----------  245 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC----------
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc----------
Confidence             22334568999999999862  25678899999999999999999999988766555444433211111          


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     ........+++.+.+||.+||+.||.+|||+.++++
T Consensus       246 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ---------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ---------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                           111223467899999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-46  Score=320.43  Aligned_cols=246  Identities=25%  Similarity=0.316  Sum_probs=194.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc--ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD--NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||+|.+  +++.||+|++.....  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   80 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----PN   80 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-------
T ss_pred             heeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence            689999999999999999998  488999999865432  223456788999999999999999999999877     56


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCCCCeEEcc--------CCCEEEEe
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS---VLHRDLKPSNLLLNA--------SCDLKIGD  147 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~nil~~~--------~~~~kl~d  147 (336)
                      .++||||++ ++|.+++.. +++++..++.++.||+.||+|||++|   ++|+||||+||+++.        ++.++|+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            899999997 588888754 68999999999999999999999999   899999999999986        67899999


Q ss_pred             ccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       148 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ||.+........ ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+....       
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------  230 (271)
T 3dtc_A          160 FGLAREWHRTTK-MSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-------  230 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-------
T ss_pred             CCcccccccccc-cCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-------
Confidence            999976554432 34578999999999987 778999999999999999999999998877655443332210       


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                            .........+..+.++|.+||+.||.+|||+.|++++
T Consensus       231 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ----------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                  0112234668899999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.8e-47  Score=332.35  Aligned_cols=248  Identities=22%  Similarity=0.283  Sum_probs=204.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceE--EEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEV--AIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||.|+||.||+|.+..++..+  |+|.+... ........+.+|+.+++++ +||||+++++++...     .
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~   99 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   99 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----C
Confidence            5889999999999999999998888865  99988642 2334556788999999999 899999999999876     6


Q ss_pred             eEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ..|+||||++ |+|.+++...+                .+++.+++.++.||+.||+|||++|++|+||||+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            7999999997 59999997654                799999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 019728          142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELI  220 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~  220 (336)
                      .++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            999999999875443333344456788999999976 678999999999999999998 999998887655443332210


Q ss_pred             CCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                    .......++..+.+||.+||+.||.+|||+.+++++
T Consensus       259 ------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 ------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                          011224568899999999999999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-46  Score=335.33  Aligned_cols=247  Identities=22%  Similarity=0.316  Sum_probs=197.0

Q ss_pred             ccceeeeecccceEEEEEEEeC---CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS---ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||+|+||.||+|.+.   .++..||||.+.... .......+.+|+.++++++||||+++++++...     .
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  119 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-----K  119 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----C
Confidence            5889999999999999999986   467789999986543 455667888999999999999999999999876     5


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..++||||++ |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            6899999996 6999999775 4699999999999999999999999999999999999999999999999999976554


Q ss_pred             CCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...    .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.....          
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~----------  268 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR----------  268 (373)
T ss_dssp             --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE----------
T ss_pred             CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            321    112234668999999987 788999999999999999998 9999988776655544432111          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          .+.....+..+.++|.+||+.||.+||++.++++
T Consensus       269 --------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 --------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                1112356889999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-46  Score=325.32  Aligned_cols=243  Identities=16%  Similarity=0.245  Sum_probs=202.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-------ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-------EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   74 (336)
                      +|.+.+.||+|+||+||+|.+..++       ..||+|++...  .......+.+|+.++++++||||+++++++...  
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            5899999999999999999998777       46999998543  344567788999999999999999999999876  


Q ss_pred             CCcceEEEEEecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC--------EE
Q 019728           75 DTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--------LK  144 (336)
Q Consensus        75 ~~~~~~~iv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~--------~k  144 (336)
                         ...++||||++ |+|.+++...+. +++..++.++.||+.||+|||++|++||||||+||+++.++.        ++
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence               55799999998 599999987654 999999999999999999999999999999999999998887        99


Q ss_pred             EEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCC
Q 019728          145 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                      |+|||.+......   ....++..|+|||++.+...++.++|||||||++|+|++| ..||.............. .   
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~---  234 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-R---  234 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-T---
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-c---
Confidence            9999998665433   2345678899999998756789999999999999999995 455555544333222211 0   


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                  .......+..+.++|++||+.||.+|||+.+++++
T Consensus       235 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 ----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                        11123457889999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=330.73  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=190.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCC---CCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKK---DTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~---~~~   77 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++++. ||||+++++++.....   ...
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            689999999999999999999999999999988443  4556677889999999996 9999999998843221   222


Q ss_pred             ceEEEEEecCCccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           78 NDVYIVYELMDTDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        78 ~~~~iv~e~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      ..++++|||++|+|.+++..   .+++++.+++.++.||+.||+|||+.|  ++|+||||+||+++.++.++|+|||.+.
T Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            56899999999999998864   567999999999999999999999999  9999999999999999999999999998


Q ss_pred             ccCCCCcc-------------cceeeeecccCchhcc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 019728          153 TTSETDFM-------------TEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT  217 (336)
Q Consensus       153 ~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  217 (336)
                      ........             ....+++.|+|||++.  ....++.++|||||||++|+|++|..||..........   
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---  263 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN---  263 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc---
Confidence            76543221             1345789999999983  22678899999999999999999999997643221110   


Q ss_pred             HHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 019728          218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  288 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~  288 (336)
                      ..                              .........+..+.+||++||+.||.+|||+.|++++-+
T Consensus       264 ~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          264 GK------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             Cc------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            00                              001112355778999999999999999999999998744

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.8e-46  Score=317.70  Aligned_cols=245  Identities=18%  Similarity=0.298  Sum_probs=206.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||++.+. +++.||+|++......   .+.+.+|+.++++++||||+++++++...     ...+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   79 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCE
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeE
Confidence            5889999999999999999996 6788999999764333   35688999999999999999999999876     5689


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      ++|||++ ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            9999997 5999999765 568999999999999999999999999999999999999999999999999987654321 


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                       ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...........+.....               
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---------------  223 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------------  223 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------------
T ss_pred             cccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc---------------
Confidence             1223355778999999987 678999999999999999999 8999998876665554433111               


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                     .......+..+.+++.+||+.||.+|||+.+++++
T Consensus       224 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ---------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                           11123458899999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.4e-46  Score=327.41  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=207.3

Q ss_pred             ccceeeeecccceEEEEEEEeC-------CCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-------ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|++.+.||+|+||.||+|.+.       .++..||+|++... ........+.+|+.+++++ +||||+++++++... 
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  113 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-  113 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC-
Confidence            5889999999999999999985       45678999998654 2445667888999999999 899999999999876 


Q ss_pred             CCCcceEEEEEecCCc-cHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMDT-DLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~g-~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ...|+||||++| +|.+++....                .+++.+++.++.||+.||+|||+.|++|+||||+||+
T Consensus       114 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          114 ----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence                568999999975 9999997654                3899999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.+||+|||.+........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+.
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            99999999999999976554322   223355778999999877 678999999999999999999 9999998876665


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      ...+.....                              ......++..+.++|.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          269 FKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            554433211                              11224568899999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-46  Score=329.97  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=197.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceE----EEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEV----AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||+||+|.+..+++.+    |+|.+... ........+.+|+.++++++||||+++++++...     
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   89 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence            5899999999999999999998887765    77766432 2334557788999999999999999999999864     


Q ss_pred             ceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..+++++++. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             3678888887 699999976 4679999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.....          
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------
T ss_pred             CCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC----------
Confidence            4322   123345778999999987 788999999999999999999 9999988765544433322111          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                          .......+..+.+++.+||+.||.+|||+.+++.+
T Consensus       238 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 --------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             --------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             --------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                11224568899999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5e-46  Score=326.82  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=208.0

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||.|+||.||+|.+.     .+++.||+|.+... ........+.+|+.+++.++||||+++++++...    
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----  100 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG----  100 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS----
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC----
Confidence            5889999999999999999886     46788999998643 2344556788999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                       ...++||||++ |+|.+++...          .++++..++.++.||+.||+|||++||+||||||+||+++.++.++|
T Consensus       101 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          101 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             -CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence             56899999997 5999998652          45799999999999999999999999999999999999999999999


Q ss_pred             EeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||.+.......   ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+.... 
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  257 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-  257 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-
Confidence            9999987654332   1233456788999999987 778999999999999999999 899998877665554443210 


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                   .......++..+.++|.+||+.||.+|||+.|++++
T Consensus       258 -----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 -----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                         112234678899999999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.1e-46  Score=324.90  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=206.0

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||.|+||+||+|.+     ..+++.||+|++.... .......+.+|+.+++++ +||||+++++++....  
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--  104 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--  104 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC--
Confidence            588999999999999999985     4577899999996542 344566788999999999 6999999999987652  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQ----------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                        ..+++||||++ |+|.+++.....                +++..++.++.||+.||+|||+.|++|+||||+||+++
T Consensus       105 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          105 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             --SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             --CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence              34899999998 599999987544                89999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 019728          139 ASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLR  214 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  214 (336)
                      .++.++|+|||.+........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+........
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            999999999999976544322   234567888999999987 788999999999999999998 999998765433322


Q ss_pred             HHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .......                             ........++.+.++|.+||+.||.+|||+.++++|
T Consensus       262 ~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          262 RRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCc-----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222110                             011223568899999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.5e-46  Score=327.81  Aligned_cols=253  Identities=21%  Similarity=0.262  Sum_probs=204.9

Q ss_pred             ccceeeeecccceEEEEEEE-----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAV-----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++.+.||.|+||.||+|.     +..+++.||+|.+... ........+.+|+.++++++||||+++++++...    
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----  105 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----  105 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC----
Confidence            68999999999999999999     5567889999998643 3445667788999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl  145 (336)
                       ...|+||||++ |+|.+++...       ..+++.+++.++.||+.||+|||+.|++|+||||+||+++.   +..++|
T Consensus       106 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          106 -LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             -CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence             55899999996 6999999765       34899999999999999999999999999999999999984   445999


Q ss_pred             EeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||.+.......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            9999986543221   1233456888999999977 778999999999999999998 9999988776555444432110


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                                    ......++..+.++|.+||+.||.+||++.+++++.|+..
T Consensus       264 ------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          264 ------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             ------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                                          1122456889999999999999999999999999988753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=332.65  Aligned_cols=260  Identities=13%  Similarity=0.094  Sum_probs=198.2

Q ss_pred             ccceeeeecccceEEEEEEEeCC---CCceEEEEEecCcccChh---------HHHHHHHHHHHHhhCCCCceeeeccee
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE---TREEVAIKKIGNAFDNII---------DARRTLREIKLLRHMEHENVIAIKDII   69 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~~~   69 (336)
                      +|++.+.||+|+||.||+|.+..   ++..||+|++........         ....+.+|+..++.++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            58999999999999999999987   788999999865421111         113355788899999999999999998


Q ss_pred             cCCCCCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC--CEEEEe
Q 019728           70 RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC--DLKIGD  147 (336)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~--~~kl~d  147 (336)
                      ..... +....|+||||++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++  .++|+|
T Consensus       118 ~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~D  196 (345)
T 2v62_A          118 LTEFK-GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD  196 (345)
T ss_dssp             EEESS-SCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred             ccccC-CCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence            77221 116799999999779999998877899999999999999999999999999999999999998887  999999


Q ss_pred             ccCCcccCCCC--------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHH
Q 019728          148 FGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQLRLIT  217 (336)
Q Consensus       148 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~  217 (336)
                      ||+++......        ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...  +.........
T Consensus       197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  275 (345)
T 2v62_A          197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT  275 (345)
T ss_dssp             CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHH
T ss_pred             CCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHH
Confidence            99997653221        1134578999999999987 67899999999999999999999999552  2222222222


Q ss_pred             HHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          218 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ......+.....                      .......+.++.++|.+||+.||++|||++++++
T Consensus       276 ~~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          276 NLLDELPQSVLK----------------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHTTTHHHHH----------------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hhcccccHHHHh----------------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            221111111000                      0001267899999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.2e-46  Score=327.44  Aligned_cols=264  Identities=20%  Similarity=0.297  Sum_probs=207.1

Q ss_pred             ccceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.    +..+++.||+|++...  .......+.+|+.++++++||||+++++++.....   
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   98 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---   98 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS---
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC---
Confidence            68999999999999999999    5778999999999654  45556778899999999999999999998875433   


Q ss_pred             ceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...|+||||++ ++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            56899999996 599999976 4569999999999999999999999999999999999999999999999999998655


Q ss_pred             CCC----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...    ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.........     .......      
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~------  246 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERD------  246 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC----------
T ss_pred             cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hcccccc------
Confidence            432    1233456778999999977 67899999999999999999999998764322110     0000000      


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                       ...........   ...........+++.+.+||.+||+.||.+|||+.+++++
T Consensus       247 -~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          247 -VPALSRLLELL---EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             -CCHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cccHHHHHHHh---hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             00000111111   0111123345789999999999999999999999999753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-46  Score=331.06  Aligned_cols=247  Identities=19%  Similarity=0.249  Sum_probs=201.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCce----EEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREE----VAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||+||+|.+..+++.    ||+|.+.... .......+.+|+.++++++||||+++++++..      
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   86 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------   86 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence            689999999999999999999888876    6777664321 22333456789999999999999999998863      


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...++||||+. |+|.+++... +.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            45899999997 5999999775 579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.....          
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  235 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----------  235 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----------
T ss_pred             cccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----------
Confidence            432   2234456778999999987 778999999999999999999 9999988765554444432111          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                          .......+..+.++|.+||+.||.+|||+.+++++
T Consensus       236 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 --------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             --------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             --------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                11123457789999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=324.17  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC----ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|.+.+.||+|+||.||+|.+..++    ..||+|.+.... .......+.+|+.++++++||||+++++++...     
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  118 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----  118 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-----
Confidence            5788999999999999999986553    359999986543 445566788999999999999999999999876     


Q ss_pred             ceEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...++||||++| +|.+++... +.+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            569999999975 999999764 679999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ....    .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.....         
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---------  268 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---------  268 (333)
T ss_dssp             ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------
T ss_pred             cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---------
Confidence            4321    112234678999999976 788999999999999999998 9999988776655544433111         


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                           .+.....+..+.++|.+||+.||.+||++.+++++
T Consensus       269 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 ---------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 11123568899999999999999999999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-45  Score=321.96  Aligned_cols=264  Identities=23%  Similarity=0.368  Sum_probs=203.4

Q ss_pred             ccceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.    +..+++.||+|++.... .......+.+|+.+++.++||||+++++++.....   
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   97 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---   97 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---
Confidence            48999999999999999999    67789999999996543 33345778899999999999999999999987643   


Q ss_pred             ceEEEEEecCCc-cHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            458999999975 9999994 44679999999999999999999999999999999999999999999999999997765


Q ss_pred             CCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....    .....++..|+|||++.+ ..++.++||||||+++|+|++|..|+....     ..............    
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~----  247 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQM----  247 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGG----
T ss_pred             CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccccc----
Confidence            4421    233456778999999977 678899999999999999999998864321     11112111111110    


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                         ..........   ..........+++.+.+||.+||+.||.+|||+.++++
T Consensus       248 ---~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 ---TVTRLVNTLK---EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             ---HHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---CHHHHHHHHh---ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence               0111111111   11112234578999999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=318.56  Aligned_cols=248  Identities=18%  Similarity=0.279  Sum_probs=205.9

Q ss_pred             ccceee-eecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRG-EYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~-~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+ .||+|+||.||+|.+.  .++..||+|++... ........+.+|+.++++++||||+++++++..      .
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            356666 9999999999999864  46778999999654 245567788899999999999999999999843      3


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..++||||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            48999999985 999999654 5699999999999999999999999999999999999999999999999999976643


Q ss_pred             CCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          157 TDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       157 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...    .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+....           
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-----------  230 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----------  230 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-----------
T ss_pred             CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-----------
Confidence            322    122345788999999976 678999999999999999998 999998877665554443211           


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                                         .......+++.+.++|.+||+.||.+||++.+++++.
T Consensus       231 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          231 -------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             -------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                               1122346789999999999999999999999999753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=343.05  Aligned_cols=252  Identities=27%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|.+.+.||+|+||+|+. ....+++.||||++.....     ....+|+.+++.+ +||||+++++++...     ...
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~   93 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR-----QFQ   93 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC-----CEE
Confidence            588999999999999764 3445789999999865322     2245799999999 799999999998876     679


Q ss_pred             EEEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-----CCCEEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-----SCDLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-----~~~~kl~dfg~~~~~  154 (336)
                      |+|||||+|+|.+++.... .+.+.+++.++.||+.||+|||++||+||||||+||+++.     ...++|+|||++...
T Consensus        94 ~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           94 YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9999999999999997653 4566677899999999999999999999999999999953     235889999999766


Q ss_pred             CCCC----cccceeeeecccCchhccc--CCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          155 SETD----FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       155 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||..........    .........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~----~~~~~~~~~  249 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----LLGACSLDC  249 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH----HTTCCCCTT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH----HhccCCccc
Confidence            5332    2334578999999999874  2567789999999999999999 999996654322211    111110000


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                              .......+..+.+||.+||+.||.+|||+.++++||||.++
T Consensus       250 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          250 ------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             ------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                                    00011224568899999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.2e-45  Score=319.24  Aligned_cols=249  Identities=27%  Similarity=0.395  Sum_probs=194.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCc-ccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNA-FDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.++++++||||+++++++...     ...
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~  107 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NEL  107 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CcE
Confidence            589999999999999999999999999999999753 23456677888999999999999999999999876     679


Q ss_pred             EEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           81 YIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999985 99998864    4679999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCcccccccc
Q 019728          156 ETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+...  ......+.. ...+         
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~---------  256 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP---------  256 (310)
T ss_dssp             -----------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSC---------
T ss_pred             CCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCC---------
Confidence            432 2234567899999999887 7789999999999999999999999976432  111111111 0000         


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         ......++.++.++|.+||+.||.+|||+.++++
T Consensus       257 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 -------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             -------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                               0112456889999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.2e-46  Score=337.58  Aligned_cols=252  Identities=29%  Similarity=0.326  Sum_probs=191.1

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |.+.+.||+|+||+||.+. ..+|+.||||++...     ....+.+|+.+++++ +||||+++++++...     ...|
T Consensus        17 ~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~   85 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTD-----RFLY   85 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEE
T ss_pred             eeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEE
Confidence            5667899999999998754 457999999998542     234567899999876 899999999999876     6799


Q ss_pred             EEEecCCccHHHHHHcCCCC-------CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-------------C
Q 019728           82 IVYELMDTDLHQIIRSDQQL-------TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-------------C  141 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~-------~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-------------~  141 (336)
                      +|||||+|+|.+++......       ++..++.++.||+.||+|||++||+||||||+||+++.+             +
T Consensus        86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence            99999999999999875433       233457799999999999999999999999999999754             4


Q ss_pred             CEEEEeccCCcccCCCCc-----ccceeeeecccCchhccc------CCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 019728          142 DLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  209 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  209 (336)
                      .++|+|||++........     .....|++.|+|||++.+      ...++.++|||||||++|+|++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            799999999987654321     234578999999999865      2568899999999999999999 9999976543


Q ss_pred             HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          210 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                      ..  ..+.......+..  .                      ......++.++.+||++||+.||.+|||+.++++||||
T Consensus       246 ~~--~~i~~~~~~~~~~--~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          246 RE--SNIIRGIFSLDEM--K----------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             HH--HHHHHTCCCCCCC--T----------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hH--HHHhcCCCCcccc--c----------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            32  1222111100000  0                      00011235789999999999999999999999999999


Q ss_pred             cc
Q 019728          290 QS  291 (336)
Q Consensus       290 ~~  291 (336)
                      ..
T Consensus       300 ~~  301 (434)
T 2rio_A          300 WP  301 (434)
T ss_dssp             SC
T ss_pred             CC
Confidence            64

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-45  Score=325.25  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=205.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc-----eEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|.+.+.||.|+||.||+|.+..+++     .||+|.+.... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---  122 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG---  122 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC---
Confidence            58899999999999999999976664     79999986542 344567788999999999 899999999999876   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRS--------------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS  140 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~  140 (336)
                        ...|+||||++ |+|.+++..              ...+++..++.++.||+.||+|||+.|++|+||||+||+++.+
T Consensus       123 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          123 --GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             --CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence              56899999997 599999864              3468999999999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 019728          141 CDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLI  216 (336)
Q Consensus       141 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~  216 (336)
                      +.++|+|||++........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            9999999999976543321   233456788999999887 778999999999999999998 99999876544433333


Q ss_pred             HHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          217 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ......                             .......+..+.++|.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          280 VKDGYQ-----------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            221110                             1112345889999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.3e-46  Score=318.90  Aligned_cols=247  Identities=19%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             ccceeeeecccceEEEEEEEeCC---CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE---TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||+||+|.+..   ++..||+|.+.... .......+.+|+.+++.++||||+++++++...      
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   85 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE------   85 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS------
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------
Confidence            58899999999999999999653   34469999986542 345567888999999999999999999998653      


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            3589999998 5999999764 4599999999999999999999999999999999999999999999999999876654


Q ss_pred             CCc--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+.....            
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------------  232 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------------  232 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC------------
T ss_pred             ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC------------
Confidence            322  223355778999999976 778999999999999999998 9999987665554444433111            


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                        .......++.+.++|.+||+.||.+|||+.|++++
T Consensus       233 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 ------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                              11223568899999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-45  Score=319.03  Aligned_cols=248  Identities=24%  Similarity=0.309  Sum_probs=205.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-------   74 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-------   74 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....      ..+.+|+.++++++||||+++++++.....       
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            5899999999999999999999999999999986532      245689999999999999999998754110       


Q ss_pred             ----CCcceEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEe
Q 019728           75 ----DTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD  147 (336)
Q Consensus        75 ----~~~~~~~iv~e~~~g-~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~d  147 (336)
                          ......++||||+++ +|.+++...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  165 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD  165 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence                112458999999985 999999653  6799999999999999999999999999999999999999999999999


Q ss_pred             ccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          148 FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       148 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ||.+.............+++.|+|||++.+ ..++.++||||||+++|+|++|..|+...     .........      
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRD------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHT------
T ss_pred             chhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhc------
Confidence            999987766555555678999999999987 77899999999999999999999877421     111111100      


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                              ......++..+.++|.+||+.||.+|||+.|++++.+...
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                    0112356888999999999999999999999999987654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-45  Score=337.86  Aligned_cols=241  Identities=23%  Similarity=0.318  Sum_probs=201.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+.  ++.||||+++...    ....+.+|+.++++++||||+++++++....    ...|
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  263 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY  263 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred             HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence            4789999999999999999984  7799999996542    4467889999999999999999999976642    3589


Q ss_pred             EEEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ |+|.+++...+.  +++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++......
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            9999997 599999986543  7999999999999999999999999999999999999999999999999987554332


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+....                 
T Consensus       344 --~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-----------------  403 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------------  403 (450)
T ss_dssp             -----CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-----------------
T ss_pred             --cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence              22356788999999987 789999999999999999998 999998876555444433211                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                   ........++.+.++|.+||+.||.+|||+.++++
T Consensus       404 -------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 -------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                         01223467899999999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-46  Score=329.58  Aligned_cols=266  Identities=20%  Similarity=0.223  Sum_probs=197.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+.  ++.||||++...   .........|+.++++++||||+++++++...... ...++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~~~~~   98 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV-DVDLW   98 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SEEEE
T ss_pred             hchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC-CceEE
Confidence            6899999999999999999984  789999999543   33344556689999999999999999998865321 14589


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA----------SVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      +||||+++ +|.+++.. ..+++..++.++.||+.||+|||+.          ||+||||||+||+++.++.+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            99999975 99999977 4699999999999999999999999          999999999999999999999999999


Q ss_pred             CcccCCCCc---ccceeeeecccCchhcccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 019728          151 ARTTSETDF---MTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP  223 (336)
Q Consensus       151 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  223 (336)
                      +........   .....+++.|+|||++.+.    ..++.++|||||||++|+|++|..||.+................+
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            976543322   2335789999999998762    234567899999999999999999997653211111000000000


Q ss_pred             CcccccccccchHHHHHHhCC-ccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          224 DDASLGFLRSDNARRYVRQLP-RCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                 .......... ..........+  ...+..+.+||.+||+.||++|||+.|+++
T Consensus       258 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          258 -----------SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             -----------CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                       0001111000 00001111111  112345999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-45  Score=318.75  Aligned_cols=249  Identities=19%  Similarity=0.172  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+..+++.||+|++......    ..+.+|+.+++.++|++++..+..+....    ...+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~   81 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNV   81 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCC----CceE
Confidence            689999999999999999999999999999998654322    35778999999999888766665543321    5689


Q ss_pred             EEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +||||++++|.+++. ..+++++.+++.++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+......
T Consensus        82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            999999889999997 35679999999999999999999999999999999999999   48889999999999765543


Q ss_pred             Cc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCcc
Q 019728          158 DF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---HQLRLITELIGSPDDA  226 (336)
Q Consensus       158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~  226 (336)
                      ..        .....++..|+|||++.+ ..++.++|||||||++|+|++|..||......   .....+......    
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----
T ss_pred             ccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC----
Confidence            22        234578999999999987 77899999999999999999999999764321   122222111000    


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                            .........+++.+.++|.+||+.||.+|||+.++++
T Consensus       237 ----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 ----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                  0011122567899999999999999999999999976

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-45  Score=330.28  Aligned_cols=261  Identities=14%  Similarity=0.087  Sum_probs=198.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-----CceEEEEEecCcccChh---------HHHHHHHHHHHHhhCCCCceeeecc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-----REEVAIKKIGNAFDNII---------DARRTLREIKLLRHMEHENVIAIKD   67 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~---------~~~~~~~e~~~l~~l~hp~iv~~~~   67 (336)
                      +|++.+.||+|+||.||+|.+..+     ++.||+|++........         .......|+..+..++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            689999999999999999999764     58899999865421111         1122345666778889999999999


Q ss_pred             eecCCCCCCcceEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc--cCCCEE
Q 019728           68 IIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASCDLK  144 (336)
Q Consensus        68 ~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~--~~~~~k  144 (336)
                      ++..... +....|+||||++++|.+++... +++++.+++.++.||+.||+|||++||+||||||+|||++  .++.+|
T Consensus       116 ~~~~~~~-~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k  194 (364)
T 3op5_A          116 SGLHDKN-GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY  194 (364)
T ss_dssp             EEEEEET-TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred             eeeeccC-CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence            9876422 11458999999977999999775 6799999999999999999999999999999999999999  889999


Q ss_pred             EEeccCCcccCCCCc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 019728          145 IGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRL  215 (336)
Q Consensus       145 l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~  215 (336)
                      |+|||+++.......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~  273 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD  273 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence            999999976543321        123458999999999987 6789999999999999999999999986332 222211


Q ss_pred             HHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          216 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ........            ........         -.....+.++.+++..||+.||.+||++.++++
T Consensus       274 ~~~~~~~~------------~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          274 SKIRYREN------------IASLMDKC---------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHC------------HHHHHHHH---------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhhhh------------HHHHHHHh---------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11110000            00000000         011467899999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-45  Score=317.07  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=201.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc---eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|.+.+.||+|+||+||+|.+..+++   .||+|.+... ........+.+|+.++++++||||+++++++....    .
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----G   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----C
Confidence            57788999999999999999755444   7999998643 34456678889999999999999999999997653    2


Q ss_pred             eEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+++|||+. |+|.+++.. ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            3489999996 699999987 46689999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          157 TD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       157 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ..     ......++..|+|||.+.+ ..++.++||||||+++|+|++|. .||...+..+....+.....         
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---------  246 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---------  246 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---------
T ss_pred             CcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---------
Confidence            22     1233456788999999987 78899999999999999999954 55555554443333322111         


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                           .......+..+.++|++||+.||.+|||+.++++
T Consensus       247 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 ---------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                 1122456889999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.8e-47  Score=354.57  Aligned_cols=283  Identities=22%  Similarity=0.252  Sum_probs=213.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      +|++.+.||.|+||+||+|.+..+|+.||||++... ........+.+|+.++++++||||+++++++...... .....
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            589999999999999999999999999999998654 3455667888999999999999999999987662211 12568


Q ss_pred             EEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCC---EEEEeccCCcc
Q 019728           81 YIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLART  153 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~  153 (336)
                      |+||||++ |+|.+++....   .+++..++.++.||+.||+|||+.||+|+||||+||+++.++.   ++|+|||.+..
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            99999996 59999998644   6999999999999999999999999999999999999997765   89999999988


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+...........................
T Consensus       174 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          174 LDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             TTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             cccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            776665666788999999999987 7889999999999999999999999987643322110000000000000000000


Q ss_pred             chHHHHHHhCCc-cccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          234 DNARRYVRQLPR-CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                              .... ............++..+.+||.+||..||++|||+.++++||||+.+..
T Consensus       253 --------~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          253 --------AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             --------SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             --------ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence                    0000 0000011122346788999999999999999999999999999987653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-46  Score=329.88  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=202.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++...     ...+
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  111 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----NEMI  111 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----TCCE
T ss_pred             ccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEE
Confidence            5889999999999999999974 6899999988654  334567788999999999999999999999876     5689


Q ss_pred             EEEecCC-ccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||++ |+|.+++....    .+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999997 59999886543    589999999999999999999999999999999999999999999999999876443


Q ss_pred             C---CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHhCCCCcccccc
Q 019728          157 T---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT---ELIGSPDDASLGF  230 (336)
Q Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (336)
                      .   .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+......   ......       
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  263 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-------  263 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT-------
T ss_pred             ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc-------
Confidence            2   22334568999999999877 678999999999999999999999997643221110000   000000       


Q ss_pred             cccchHHHHHHhCCccccc-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 019728          231 LRSDNARRYVRQLPRCRKQ-QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  287 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~  287 (336)
                                 .+...... ......+..+..+.+++.+||+.||++|||+.|++++.
T Consensus       264 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          264 -----------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             -----------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                       00000000 00111123456789999999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-45  Score=336.76  Aligned_cols=243  Identities=24%  Similarity=0.374  Sum_probs=205.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+. ++..||||++....   ...+.+.+|+.++++++||||+++++++..      ...|
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~~  258 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY  258 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred             HeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------CccE
Confidence            4789999999999999999995 47789999997543   346778899999999999999999999863      3479


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+. |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999997 5999999754  368999999999999999999999999999999999999999999999999998754332


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+......             
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------  404 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------------  404 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-------------
T ss_pred             eeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            1  122345678999999976 778999999999999999999 99999988877766655442211             


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                       +....++..+.++|.+||+.||++|||++++++
T Consensus       405 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 -----------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                             112356889999999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.6e-46  Score=342.64  Aligned_cols=245  Identities=20%  Similarity=0.350  Sum_probs=207.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..++..||||.+....   .....+.+|+.++++++||||+++++++...     ..+|
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~  292 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY  292 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEE
Confidence            4788999999999999999999889999999996543   2356788999999999999999999999876     5689


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+. |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999998 6999999763  458999999999999999999999999999999999999999999999999998765432


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+....               
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------------  436 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------------  436 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---------------
T ss_pred             eeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            2  223345678999999977 678999999999999999999 999998876554444332211               


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     .......++..+.+||.+||+.||.+|||+.++++
T Consensus       437 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ---------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                           01223467899999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-46  Score=334.57  Aligned_cols=275  Identities=16%  Similarity=0.228  Sum_probs=207.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++.....   ...+
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~   85 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKV   85 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC---CeeE
Confidence            5899999999999999999999999999999996532 22335667799999999999999999999887643   4689


Q ss_pred             EEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE----ccCCCEEEEeccCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLART  153 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~~~~  153 (336)
                      +||||++ |+|.+++....   .+++..++.++.||+.||+|||++||+||||||+||++    +.++.+||+|||.+..
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999997 59999997543   39999999999999999999999999999999999999    7777899999999987


Q ss_pred             cCCCCcccceeeeecccCchhcccC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSPDD  225 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~  225 (336)
                      ...........++..|+|||++.+.       ..++.++|||||||++|+|++|..||..... ......+.......+.
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            7666555566789999999998641       3567799999999999999999999964322 1112222222222222


Q ss_pred             ccccccccchHHHHHHhCCcc--ccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          226 ASLGFLRSDNARRYVRQLPRC--RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ............     ....  ...........++..+.++|++||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          246 GAISGVQKAENG-----PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             TCCEEEECSTTC-----CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             ccchhheeccCC-----CcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            211110000000     0000  000001111234567889999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=324.40  Aligned_cols=246  Identities=21%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceE----EEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEV----AIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|+||.||+|.+..+++.+    |+|.+... ........+.+|+.++++++||||+++++++...     
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   89 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence            6899999999999999999998888766    56655432 2344567788999999999999999999999864     


Q ss_pred             ceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..+++++++. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus        90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence             3788888887 599999976 4679999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.....          
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------  237 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------  237 (327)
T ss_dssp             -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------
T ss_pred             CccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            4322   222345678999999987 788999999999999999999 9999988776554443332111          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          .......+.++.++|++||+.||.+|||+.|+++
T Consensus       238 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 --------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             --------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                1223456889999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.2e-46  Score=321.47  Aligned_cols=249  Identities=18%  Similarity=0.160  Sum_probs=199.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.+++.++|++++..+..+....    ...+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~   81 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNV   81 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCC----CceE
Confidence            68999999999999999999999999999998754322    234678999999999888777666553321    5689


Q ss_pred             EEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ++|||++++|.+++.. .+++++.+++.++.||+.||+|||++|++|+||||+||++   +.++.+||+|||.+......
T Consensus        82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            9999998899999974 4679999999999999999999999999999999999999   78999999999999765543


Q ss_pred             Cc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCcc
Q 019728          158 DF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH---QLRLITELIGSPDDA  226 (336)
Q Consensus       158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  226 (336)
                      ..        .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.....   ....+.....     
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  235 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-----  235 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-----
T ss_pred             ccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-----
Confidence            22        234578999999999987 678999999999999999999999997653221   1111111000     


Q ss_pred             cccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                           ..........+++++.++|.+||+.||++|||+.++++
T Consensus       236 ---------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 ---------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ---------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ---------------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                 00111222467899999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=314.91  Aligned_cols=240  Identities=26%  Similarity=0.364  Sum_probs=192.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+  .++.||+|++..    ......+.+|+.++++++||||+++++++...       .+
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-------~~   75 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VC   75 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-------TE
T ss_pred             HeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-------cE
Confidence            588999999999999999998  478899999853    23456788999999999999999999988743       69


Q ss_pred             EEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCCCCeEEccCCC-EEEEeccCCcc
Q 019728           82 IVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFGLART  153 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~  153 (336)
                      +||||++ |+|.+++....   .++...++.++.||+.||+|||+   +|++|+||||+||+++.++. +||+|||.+..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999997 59999998764   37899999999999999999999   89999999999999998887 79999999876


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ....  .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......            
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~------------  219 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-MWAVHN------------  219 (307)
T ss_dssp             -----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-HHHHHT------------
T ss_pred             cccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-HHHHhc------------
Confidence            5433  233468999999999987 788999999999999999999999997643221111 101000            


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                     .........++..+.++|.+||+.||.+|||+.++++
T Consensus       220 ---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          220 ---------------GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ---------------TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                           0112223567899999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=327.94  Aligned_cols=250  Identities=10%  Similarity=0.090  Sum_probs=198.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCC--------CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecc------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET--------REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKD------   67 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~------   67 (336)
                      +|++.+.||+|+||.||+|.+..+        ++.||+|.+...       ..+.+|+.++++++||||+++++      
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            689999999999999999999874        889999998543       35778999999999999998543      


Q ss_pred             ---------eecCCCCCCcceEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           68 ---------IIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        68 ---------~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                               ++...    ....|+||||++++|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQ----DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEET----TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccC----CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     33321    1568999999988999999876  78999999999999999999999999999999999999


Q ss_pred             EccCC--CEEEEeccCCcccCCCC--------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 019728          137 LNASC--DLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  206 (336)
Q Consensus       137 ~~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  206 (336)
                      ++.++  .++|+|||++.......        ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99998  89999999997654332        1133478999999999987 6889999999999999999999999987


Q ss_pred             CC--hHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHH
Q 019728          207 KD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  284 (336)
Q Consensus       207 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell  284 (336)
                      ..  ..............+.....                      .......++..+.+||.+||+.||.+|||+++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  328 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVG----------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLR  328 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEEC----------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhhh----------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence            53  22222222222111111100                      0011235689999999999999999999999998


Q ss_pred             c
Q 019728          285 R  285 (336)
Q Consensus       285 ~  285 (336)
                      +
T Consensus       329 ~  329 (352)
T 2jii_A          329 N  329 (352)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.6e-45  Score=314.24  Aligned_cols=249  Identities=21%  Similarity=0.350  Sum_probs=206.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|.||+|.+. ++..||+|.+.....   ....+.+|+.+++.++||||+++++++..      ...+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   83 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence            5889999999999999999985 567899999865432   34678899999999999999999999864      3479


Q ss_pred             EEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ ++|.+++....  .+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999996 59999986543  69999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+.....              
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------  228 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------  228 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------------
T ss_pred             cccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC--------------
Confidence            2  223345778999999976 678899999999999999999 9999988876665544432111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc--Cccccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  291 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~--h~~f~~  291 (336)
                                      ......++..+.++|.+||+.||++|||+.++++  ..+|..
T Consensus       229 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          229 ----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                            1112456889999999999999999999999986  444443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9e-45  Score=315.35  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=200.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC---ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||+||+|.+..++   ..||+|.+... ........+.+|+.++++++||||+++++++....    .
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  100 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----C
Confidence            6889999999999999999975433   35899988653 34556678889999999999999999999865432    4


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+++|||+++ +|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            57999999985 999999763 5689999999999999999999999999999999999999999999999999976544


Q ss_pred             CCc-----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          157 TDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       157 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ...     .....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||...+..+....+.....         
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---------  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---------
T ss_pred             cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---------
Confidence            321     223355678999999987 788999999999999999999 6677776655444333322111         


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                           .......+..+.++|.+||+.||.+|||+.++++
T Consensus       251 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 ---------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 1112356889999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=322.16  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=200.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++..... .....|
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  106 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG-AKHEAW  106 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET-TEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC-CCceeE
Confidence            589999999999999999999999999999988543  45567788899999999999999999999863211 115689


Q ss_pred             EEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           82 IVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +||||+.+ +|.+++..    ...+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999985 99999875    56799999999999999999999999999999999999999999999999998865432


Q ss_pred             CCc----------ccceeeeecccCchhcccCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Q 019728          157 TDF----------MTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSP  223 (336)
Q Consensus       157 ~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~  223 (336)
                      ...          .....++..|+|||++.+..  .++.++||||||+++|+|++|..||...... ......       
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------  259 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-------  259 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-------
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-------
Confidence            211          11234588899999987522  3688999999999999999999999431100 000000       


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                      ...      ....+..+.++..+.++|.+||+.||.+|||+.+++++
T Consensus       260 ----------------~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          260 ----------------VQN------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ----------------HHC------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------hhc------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                            000      00112234678899999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.5e-45  Score=346.08  Aligned_cols=242  Identities=18%  Similarity=0.269  Sum_probs=203.6

Q ss_pred             eeecccceEEEEEEEe--CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVN--SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      +.||.|+||.||+|.+  ..+++.||||+++...........+.+|+.++++++||||+++++++..      ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999954  5667899999997766566667889999999999999999999999864      3479999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc----
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----  159 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----  159 (336)
                      ||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9997 59999999888999999999999999999999999999999999999999999999999999876543321    


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....                 
T Consensus       529 ~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----------------  590 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-----------------  590 (635)
T ss_dssp             ------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred             ccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            223345678999999977 789999999999999999998 9999999887666555543211                 


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                   ......++.++.+||.+||+.||++||++.++++
T Consensus       591 -------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 -------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                         1122457899999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-45  Score=315.69  Aligned_cols=241  Identities=22%  Similarity=0.314  Sum_probs=194.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|++|+||++.+  +|+.||+|.+...    .....+.+|+.++++++||||+++++++....    ...|
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~   91 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   91 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceE
Confidence            589999999999999999988  4889999998643    24567889999999999999999999876542    3579


Q ss_pred             EEEecCCc-cHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+++ +|.+++...+.  +++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            99999985 99999976543  8999999999999999999999999999999999999999999999999987654432


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                        ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+...                  
T Consensus       172 --~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------------------  230 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------------  230 (278)
T ss_dssp             ------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------------
T ss_pred             --cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC------------------
Confidence              23356788999999977 788999999999999999998 99999877654443333211                  


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                  .........++.+.++|++||+.||.+|||+.++++
T Consensus       231 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 ------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                        011223467899999999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-45  Score=321.18  Aligned_cols=262  Identities=24%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             cceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            3 VKLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      |++++.||+|+||+||++.    +..+++.||+|++... ........+.+|+.++++++||||+++++++.....   .
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---A  108 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT---T
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC---c
Confidence            3899999999999997765    4567899999999754 344566778899999999999999999999987533   5


Q ss_pred             eEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      .+++||||++ |+|.+++... ++++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            6899999997 4999998764 5999999999999999999999999999999999999999999999999999876544


Q ss_pred             Cc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          158 DF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       158 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ..    .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.......     ...........      
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~------  255 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQM------  255 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHH------
T ss_pred             ccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccch------
Confidence            21    233456778999999987 678899999999999999999999986542211     00000000000      


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                       .........   ...........++..+.+||++||+.||.+|||+.++++
T Consensus       256 -~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          256 -TVLRLTELL---ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             -HHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hHHHHHHHH---hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             000000000   011122334567899999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.2e-45  Score=317.24  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=191.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhh--CCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||+||+|.+  +++.||+|++...     .......|.+++..  ++||||+++++++...... ...
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~-~~~   80 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS-STQ   80 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT-EEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC-Cce
Confidence            689999999999999999998  6899999998542     33445566666666  7899999999986543211 155


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      .++||||++ |+|.++++. ..+++..++.++.||+.||+|||        +.|++||||||+||+++.++.+||+|||+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            899999998 599999965 57999999999999999999999        99999999999999999999999999999


Q ss_pred             CcccCCCCc-----ccceeeeecccCchhcccCC-----CCCccchHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 019728          151 ARTTSETDF-----MTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTR----------EPLFPGKDY-  209 (336)
Q Consensus       151 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~~~~~-  209 (336)
                      +........     .....+++.|+|||++.+..     .++.++|||||||++|+|++|          ..||..... 
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            875443322     22347899999999997632     344689999999999999999          777754321 


Q ss_pred             ---HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          210 ---VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                         ..............+....                       .......+..+.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPN-----------------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCG-----------------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcchhhhhHHHhccCCCCCCCh-----------------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence               1111111111000000000                       0001124567999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-45  Score=326.24  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC---ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||+||+|.+..++   ..||+|.+... ........+.+|+.++++++||||+++++++....    .
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~  164 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  164 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----S
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----C
Confidence            4678899999999999999975432   45899988643 34456778899999999999999999999865432    3


Q ss_pred             eEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..++||||+++ +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            57999999985 999999865 4589999999999999999999999999999999999999999999999999976543


Q ss_pred             CCc-----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          157 TDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       157 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ...     .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....          
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~----------  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC----------
T ss_pred             cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC----------
Confidence            321     123355678999999987 788999999999999999999 778887765443333222210          


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          ........+..+.++|.+||+.||.+|||+.++++
T Consensus       314 --------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          314 --------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                01112456889999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.5e-45  Score=318.05  Aligned_cols=259  Identities=24%  Similarity=0.297  Sum_probs=201.2

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      |...+.||+|+||.||+|.+  +++.||+|++....  ........+.+|+.++++++||||+++++++...     ...
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----Cce
Confidence            34568999999999999997  68899999986532  3345567788999999999999999999999876     568


Q ss_pred             EEEEecCC-ccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           81 YIVYELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      +++|||++ ++|.+++..   ..++++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            99999996 599999863   35699999999999999999999999999999999999999999999999999876543


Q ss_pred             CC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ..   ......+++.|+|||++.+  .++.++||||||+++|+|++|..||...........+...........      
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------  257 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI------  257 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH------
T ss_pred             ccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh------
Confidence            22   1234568999999999875  578999999999999999999999977543322222222111110000      


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                         ..+   +    ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus       258 ---~~~---~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          258 ---EDY---I----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             ---HHH---S----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---hhh---c----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               000   0    000011112335678999999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-44  Score=331.84  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=202.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+.. +..||||++.....   ..+.+.+|+.++++++||||+++++++..      ...|
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            47899999999999999999964 46799999975432   34678899999999999999999999865      3479


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ |+|.+++..  ...+++.++..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++......
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999997 599999964  2569999999999999999999999999999999999999999999999999998655432


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....              
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------------  399 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------------  399 (452)
T ss_dssp             --------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------------
T ss_pred             eecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            2  223345678999999987 788999999999999999999 9999998877665554433111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc--Cccccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  291 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~--h~~f~~  291 (336)
                                      .+.....+..+.++|.+||+.||++|||++++++  ..++.+
T Consensus       400 ----------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 ----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                            1122456889999999999999999999999986  344443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.9e-45  Score=315.38  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             ccceeeeecccceEEEEEEEeCC-CCc--eEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-TRE--EVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-~~~--~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||.|++|+||+|.+.. +++  .||+|++.... ........+.+|+.++++++||||+++++++...     
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   93 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-----   93 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-----
Confidence            58999999999999999998643 333  68999986543 2345667888999999999999999999999864     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..++||||+. ++|.+++... +.+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence             2789999997 5999998764 569999999999999999999999999999999999999999999999999987665


Q ss_pred             CCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ....    .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+.....         
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  242 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------  242 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---------
T ss_pred             ccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC---------
Confidence            4322    123355678999999976 678899999999999999999 9999998876665554433111         


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          .......++..+.++|.+||+.||.+|||+.++++
T Consensus       243 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          243 --------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                11122467899999999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.4e-45  Score=316.46  Aligned_cols=240  Identities=23%  Similarity=0.361  Sum_probs=187.0

Q ss_pred             cccee-eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHH-hhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLR-GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLL-RHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l-~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+. +.||+|+||.||+|.+..+++.||+|++...       ....+|+.++ +.++||||+++++++..... ....
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~   89 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-GRKC   89 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC-CCce
Confidence            46666 7799999999999999999999999998532       3456788887 55689999999999875111 1156


Q ss_pred             EEEEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCcc
Q 019728           80 VYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLART  153 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~  153 (336)
                      .++||||++| +|.+++....  .+++.+++.++.||+.||+|||++|++|+||||+||+++.   ++.++|+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            8999999975 9999998754  6999999999999999999999999999999999999998   78899999998754


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...                      ..++.++|||||||++|+|++|..||...........+..               
T Consensus       170 ~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---------------  212 (299)
T 3m2w_A          170 TTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------------  212 (299)
T ss_dssp             CTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred             ccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence            321                      3567789999999999999999999976543221100000               


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  294 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~  294 (336)
                              ................++.++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       213 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          213 --------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             --------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             --------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence                    00000000111122467999999999999999999999999999999987643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-45  Score=334.90  Aligned_cols=253  Identities=17%  Similarity=0.168  Sum_probs=194.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCC-Cceeeec--------------
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEH-ENVIAIK--------------   66 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-p~iv~~~--------------   66 (336)
                      |++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.++| +|...+.              
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            678899999999999999999999999999987432 233445778899999999976 3221111              


Q ss_pred             -------ceecCCCCCCcceEEEEEecCCccHHHHHH------c-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCC
Q 019728           67 -------DIIRPPKKDTFNDVYIVYELMDTDLHQIIR------S-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP  132 (336)
Q Consensus        67 -------~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~------~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp  132 (336)
                             .++...........+++|+++.++|.+++.      . .+.+++..+..++.||+.||+|||++||+||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp  239 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP  239 (413)
T ss_dssp             CC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             CCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCccc
Confidence                   111111111123578999999999999884      1 24577889999999999999999999999999999


Q ss_pred             CCeEEccCCCEEEEeccCCcccCCCCcccceeeeecccCchhcc---------cCCCCCccchHHHHHHHHHHHHhCCCC
Q 019728          133 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---------NCTEYTAAIDIWSVGCILGEIMTREPL  203 (336)
Q Consensus       133 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~~p  203 (336)
                      +|||++.++.+||+|||+++..+..  .....| +.|+|||++.         ....++.++|||||||++|+|++|..|
T Consensus       240 ~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P  316 (413)
T 3dzo_A          240 VDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP  316 (413)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred             ceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999998765544  334466 9999999983         225678899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 019728          204 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  283 (336)
Q Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  283 (336)
                      |...+.....                                   .........+|..+.+||.+||+.||++|||+.++
T Consensus       317 f~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          317 NTDDAALGGS-----------------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             CCTTGGGSCS-----------------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCcchhhhH-----------------------------------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9765421100                                   00111224678999999999999999999999999


Q ss_pred             HcCcccccCc
Q 019728          284 LRHPYLQSLH  293 (336)
Q Consensus       284 l~h~~f~~~~  293 (336)
                      ++||||+.+.
T Consensus       362 l~~~~~~~~~  371 (413)
T 3dzo_A          362 METPEYEQLR  371 (413)
T ss_dssp             TTSHHHHHHH
T ss_pred             HhCHHHHHHH
Confidence            9999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-45  Score=323.02  Aligned_cols=265  Identities=20%  Similarity=0.247  Sum_probs=201.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.+++.++||||+++++++...     ...+
T Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  103 (326)
T 3uim_A           31 NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL  103 (326)
T ss_dssp             SSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SCCE
T ss_pred             ccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-----CceE
Confidence            5889999999999999999864 6899999998654211 1223578999999999999999999999877     5689


Q ss_pred             EEEecCCc-cHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728           82 IVYELMDT-DLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                      +||||+.| +|.+++....    ++++..++.++.||+.||+|||+.   |++|+||||+||+++.++.++|+|||.+..
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL  183 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence            99999975 9999997643    499999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC--cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCcc
Q 019728          154 TSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-----YVHQLRLITELIGSPDDA  226 (336)
Q Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~  226 (336)
                      .....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....     .......+....   ...
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~  259 (326)
T 3uim_A          184 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---KEK  259 (326)
T ss_dssp             CCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT---SSC
T ss_pred             cCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh---hch
Confidence            54332  2334458999999999977 678999999999999999999999995211     000000000000   000


Q ss_pred             cccccccchHHHHHHhCCcccccc-ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          227 SLGFLRSDNARRYVRQLPRCRKQQ-FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ....               ..... ........+..+.+++.+||+.||.+|||+.|+++|-.-..+
T Consensus       260 ~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          260 KLEA---------------LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             CSTT---------------SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhhh---------------hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            0000               00000 001111234679999999999999999999999998654433

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=315.98  Aligned_cols=264  Identities=19%  Similarity=0.309  Sum_probs=203.6

Q ss_pred             ccceeeeecccceEEEEEEE----eCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAV----NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++.+.||+|++|.||+|.    +..+++.||+|++...  .......+.+|+.++++++||||+++++++.....   
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  116 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---  116 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC---
Confidence            48899999999999999998    5678999999999653  44566788899999999999999999999876532   


Q ss_pred             ceEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...++||||+++ +|.+++... ..+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            357999999974 999999875 469999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....    .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.....     ......+.......   
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~---  267 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQM---  267 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHH---
T ss_pred             ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhh---
Confidence            4422    223345677999999877 6788999999999999999999988864311     11111111110000   


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ...........      ....+....++..+.++|++||+.||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 IVFHLIELLKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhhc------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00000000110      1111233567899999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=318.01  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=201.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||.|+||.||+|.+..   .||+|++.....+......+.+|+.++++++||||+++++++...     ...+
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  105 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHLA  105 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCEE
T ss_pred             HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CceE
Confidence            58899999999999999999854   499999976544444455677899999999999999999999877     5699


Q ss_pred             EEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC--
Q 019728           82 IVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  157 (336)
                      ++|||++ ++|.+++...+ .+++..++.++.||+.||+|||+.|++|+||||+||+++ ++.++|+|||++......  
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999997 59999997754 699999999999999999999999999999999999998 679999999987654321  


Q ss_pred             ----CcccceeeeecccCchhccc--------CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 019728          158 ----DFMTEYVVTRWYRAPELLLN--------CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD  225 (336)
Q Consensus       158 ----~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (336)
                          .......++..|+|||++.+        ...++.++|||||||++|+|++|..||...........+......   
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---  261 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP---  261 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC---
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC---
Confidence                12233457889999999864        245788999999999999999999999887766554443321100   


Q ss_pred             ccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          226 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                                ......++.++.++|.+||+.||.+|||+.++++  .++.+.
T Consensus       262 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~  301 (319)
T 2y4i_B          262 --------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP  301 (319)
T ss_dssp             --------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred             --------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence                                      0111256889999999999999999999999987  344443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.1e-44  Score=331.05  Aligned_cols=251  Identities=19%  Similarity=0.204  Sum_probs=200.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC-CceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||.|+||.||+|.+..+++.||||++......    ..+..|+.+++.++| +++..+..+....     ...
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~~~   78 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEG-----DYN   78 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEET-----TEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----CEE
Confidence            689999999999999999999999999999988654322    346789999999986 5555555555444     568


Q ss_pred             EEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEE---ccCCCEEEEeccCCcccCC
Q 019728           81 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  156 (336)
                      ++||||++++|.+++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99999998899999974 5679999999999999999999999999999999999999   6889999999999976554


Q ss_pred             CCc--------ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          157 TDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      ...        .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......     
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----  232 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-----  232 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-----
T ss_pred             CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-----
Confidence            322        125578999999999987 788999999999999999999999998755422222222111000     


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        ...........++.++.+||..||+.||.+||++.+|++
T Consensus       233 ------------------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          233 ------------------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             ------------------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ------------------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              000111222467899999999999999999999998864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=336.77  Aligned_cols=249  Identities=18%  Similarity=0.281  Sum_probs=201.3

Q ss_pred             ceee-eecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            4 KLRG-EYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         4 ~i~~-~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .+.+ .||+|+||.||+|.+.  .++..||||+++... .......+.+|+.++++++||||+++++++...      ..
T Consensus       338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~  410 (613)
T 2ozo_A          338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------AL  410 (613)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS------SE
T ss_pred             eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC------Ce
Confidence            3444 7999999999999875  355679999997542 334567889999999999999999999998753      48


Q ss_pred             EEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++||||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            99999997 5999999654 569999999999999999999999999999999999999999999999999998764332


Q ss_pred             c----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          159 F----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       159 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      .    .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....            
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------  557 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------  557 (613)
T ss_dssp             -----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------------
T ss_pred             ceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            1    112234578999999977 789999999999999999998 9999998877666555433110            


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHH---cCcccc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL---RHPYLQ  290 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell---~h~~f~  290 (336)
                                        ......+++++.++|.+||+.||.+||++.+++   ++.|+.
T Consensus       558 ------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          558 ------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                              112245789999999999999999999999985   444443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-44  Score=333.59  Aligned_cols=243  Identities=23%  Similarity=0.342  Sum_probs=203.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||.||++.+.. +..||||++.....   ..+.+.+|+.++++++||||+++++++..      ...|
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            47899999999999999999964 56799999975432   34678899999999999999999999865      3479


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+. |+|.+++..  ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            9999997 599999964  2569999999999999999999999999999999999999999999999999998665332


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....              
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------------  482 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------------  482 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC--------------
T ss_pred             eecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence            1  122345678999999887 788999999999999999999 9999998877666555433111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                      ......++..+.+||.+||+.||++|||+++|++
T Consensus       483 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 ----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            1122456889999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=319.78  Aligned_cols=238  Identities=16%  Similarity=0.186  Sum_probs=189.8

Q ss_pred             ccceeeeecccceEEEEEE-----EeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC---CCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAA-----VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~   73 (336)
                      +|.+.+.||+|+||+||+|     .+..+++.||+|++...     ....+..|..+++.++   |+|++++++++... 
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-  139 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-  139 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-
Confidence            4889999999999999999     46778999999999643     2345667777777776   99999999999887 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc--------
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--------  139 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~--------  139 (336)
                          ...|+||||++ |+|.+++.     ....+++..++.++.||+.||+|||++||+||||||+|||++.        
T Consensus       140 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          140 ----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             ----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             ----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence                56899999997 69999997     3567999999999999999999999999999999999999998        


Q ss_pred             ---CCCEEEEeccCCcccC---CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 019728          140 ---SCDLKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  213 (336)
Q Consensus       140 ---~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  213 (336)
                         ++.+||+|||++....   .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.......  
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence               8999999999996533   2333445678999999999987 678999999999999999999999985432100  


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                  ..                    ...... ....+..+.+++..||+.+|.+|++..+.+.
T Consensus       293 ------------~~--------------------~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          293 ------------CK--------------------PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ------------EE--------------------ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ------------ee--------------------echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                        00                    000000 0123667899999999999999975544444

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=313.91  Aligned_cols=272  Identities=19%  Similarity=0.193  Sum_probs=190.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHH--HhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKL--LRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~--l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||+|.+  +++.||+|++...     .......|..+  +..++||||+++++.+......+...
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            589999999999999999987  6899999998543     22333444444  44589999999997554333223356


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeccCCCCCCeEEccCCCEEEEecc
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVLHRDLKPSNLLLNASCDLKIGDFG  149 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~i~H~dlkp~nil~~~~~~~kl~dfg  149 (336)
                      +++||||++ |+|.+++... ..++..++.++.||+.||+|||+.         ||+||||||+||+++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            899999996 5999999764 458999999999999999999999         99999999999999999999999999


Q ss_pred             CCcccCCCC---------cccceeeeecccCchhcccC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 019728          150 LARTTSETD---------FMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQL  213 (336)
Q Consensus       150 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~  213 (336)
                      ++.......         ......|+..|+|||++.+.      ..++.++|||||||++|+|++|..||..... ....
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            997654321         12234689999999998752      2455689999999999999999766643221 1000


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhC-CccccccccccCC---CCChhHHHHHHHhcCCCCCCCCCHHHHHc----
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFP---NKSSGAVDLLEKMLVFDPNKRITVEEALR----  285 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~Rpt~~ell~----  285 (336)
                      ..+.......+          ......... ........+..+.   ..++.+.+||.+||+.||++|||+.|+++    
T Consensus       246 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          246 MAFQTEVGNHP----------TFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CTTHHHHCSSC----------CHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhhcccCCCc----------hHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            00000000000          000000000 0011111111111   13457999999999999999999999954    


Q ss_pred             --Cccccc
Q 019728          286 --HPYLQS  291 (336)
Q Consensus       286 --h~~f~~  291 (336)
                        ++|-++
T Consensus       316 ll~~~~~~  323 (336)
T 3g2f_A          316 LMMIWERN  323 (336)
T ss_dssp             HHHCCCC-
T ss_pred             HHHHHHhc
Confidence              666554

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-43  Score=309.98  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=188.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC--CCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||.|+||.||+|.+.  ++.||+|++...     .......|.+++..+  +||||+++++++...... ...
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~-~~~  109 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS-WTQ  109 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG-GCE
T ss_pred             ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC-CCc
Confidence            5899999999999999999984  899999998432     233445566666555  899999999998765321 146


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      .|+||||++| +|.+++.. ..+++..++.++.|++.||+|||+.        |++||||||+||+++.++.+||+|||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            8999999975 99999976 4799999999999999999999999        999999999999999999999999999


Q ss_pred             CcccCCCCcc-----cceeeeecccCchhcccCCCCCcc------chHHHHHHHHHHHHhC----------CCCCCCCCh
Q 019728          151 ARTTSETDFM-----TEYVVTRWYRAPELLLNCTEYTAA------IDIWSVGCILGEIMTR----------EPLFPGKDY  209 (336)
Q Consensus       151 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~------~DiwslG~il~~ll~g----------~~pf~~~~~  209 (336)
                      +.........     ....|+..|+|||++.+ ......      +|||||||++|+|++|          ..||.....
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            9765433221     24478999999999976 444443      8999999999999999          556643211


Q ss_pred             ----HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccc--cCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 019728          210 ----VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT--RFPNKSSGAVDLLEKMLVFDPNKRITVEEA  283 (336)
Q Consensus       210 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  283 (336)
                          .............                         ....+.  .....+..+.++|.+||+.||.+|||+.++
T Consensus       268 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKKL-------------------------RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             SSCCHHHHHHHHTTSCC-------------------------CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCchhhhHHHHhhhcc-------------------------CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence                1111111110000                         000000  012346679999999999999999999999


Q ss_pred             HcC
Q 019728          284 LRH  286 (336)
Q Consensus       284 l~h  286 (336)
                      +++
T Consensus       323 l~~  325 (337)
T 3mdy_A          323 KKT  325 (337)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.7e-43  Score=332.49  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCC---CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET---REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||.||+|.+..+   +..||+|.+... ........+.+|+.++++++||||+++++++..      .
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~  463 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N  463 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec------C
Confidence            578999999999999999998643   456999988643 244556788899999999999999999999854      3


Q ss_pred             eEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..|+||||++ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            4799999998 59999997653 689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc--cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ....  ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....            
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~------------  610 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------  610 (656)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC------------
T ss_pred             CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            4321  23345678999999977 688999999999999999997 9999998887766665544211            


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                        ....+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       611 ------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 ------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              1123467899999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9e-43  Score=308.58  Aligned_cols=251  Identities=20%  Similarity=0.252  Sum_probs=194.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhh--CCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH--MEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|++.+.||+|+||.||++.+  +++.||+|++...     ....+.+|.+++..  ++||||+++++++...... ...
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~-~~~  114 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-WTQ  114 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS-CCC
T ss_pred             cEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc-cce
Confidence            588999999999999999998  5899999998532     34567788888887  6899999999998876321 136


Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           80 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        80 ~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      .|+||||+++ +|.+++.. .++++.+++.++.||+.||+|||        +.|++|+||||+||+++.++.++|+|||+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            8999999985 99999976 47999999999999999999999        89999999999999999999999999999


Q ss_pred             CcccCCCC-----cccceeeeecccCchhcccCCC-----CCccchHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 019728          151 ARTTSETD-----FMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTR----------EPLFPGKDY-  209 (336)
Q Consensus       151 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~~-  209 (336)
                      +.......     ......++..|+|||++.+...     ++.++|||||||++|+|++|          ..||..... 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            97655433     1234578999999999876322     23689999999999999999          778765421 


Q ss_pred             ---HHHHHHHHHHhCCCCcccccccccchHHHHHHhCCcccccccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHH
Q 019728          210 ---VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEAL  284 (336)
Q Consensus       210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~ell  284 (336)
                         ...+.........                         ....+..  ....+..+.+||.+||+.||++|||+.+++
T Consensus       274 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~  328 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKL-------------------------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  328 (342)
T ss_dssp             SCCHHHHHHHHTTSCC-------------------------CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cccHHHHHHHHHHHHh-------------------------CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence               1111111100000                         0000000  112345789999999999999999999998


Q ss_pred             cC
Q 019728          285 RH  286 (336)
Q Consensus       285 ~h  286 (336)
                      ++
T Consensus       329 ~~  330 (342)
T 1b6c_B          329 KT  330 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.8e-45  Score=321.48  Aligned_cols=251  Identities=16%  Similarity=0.138  Sum_probs=187.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc------ChhHHHHHHHHHHHHhhCC-----------------
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD------NIIDARRTLREIKLLRHME-----------------   58 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~-----------------   58 (336)
                      +|++.+.||+|+||+||+|.+  +|+.||||++.....      .......+.+|+.+++.++                 
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            488999999999999999999  689999999965431      2334467788999888886                 


Q ss_pred             ---------CCceeeecceecCCCC--------CCcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 019728           59 ---------HENVIAIKDIIRPPKK--------DTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV  120 (336)
Q Consensus        59 ---------hp~iv~~~~~~~~~~~--------~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L  120 (336)
                               ||||+++++++.....        ......|+||||+. |++.+.+.. +.+++.+++.++.||+.||+||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence                     4555555555543100        01256999999996 556665544 6789999999999999999999


Q ss_pred             H-hCCeeccCCCCCCeEEccCC--------------------CEEEEeccCCcccCCCCcccceeeeecccCchhcccCC
Q 019728          121 H-SASVLHRDLKPSNLLLNASC--------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT  179 (336)
Q Consensus       121 H-~~~i~H~dlkp~nil~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (336)
                      | ++||+||||||+|||++.++                    .+||+|||+++.....    ...||+.|+|||++.+ .
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g-~  252 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG-D  252 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC-C
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC-C
Confidence            9 99999999999999999887                    8999999999876533    4478999999999987 3


Q ss_pred             CCCccchHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCC
Q 019728          180 EYTAAIDIWSVGCI-LGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN  257 (336)
Q Consensus       180 ~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (336)
                      . +.++||||||++ .++++.|..||....... ....+........                        .......+.
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~  307 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------------------------KCNTPAMKQ  307 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS------------------------CCCSHHHHH
T ss_pred             C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc------------------------ccchhhhhh
Confidence            3 889999998776 777888998885422111 1111111111000                        001111234


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHH-cCcccc
Q 019728          258 KSSGAVDLLEKMLVFDPNKRITVEEAL-RHPYLQ  290 (336)
Q Consensus       258 ~~~~~~~li~~~L~~dp~~Rpt~~ell-~h~~f~  290 (336)
                      +++++.+||++||+.|     |++|+| +||||+
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            5888999999999976     999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-42  Score=299.54  Aligned_cols=225  Identities=13%  Similarity=0.057  Sum_probs=183.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+++.||||++..... +......+.+|+.++.+++||||+++++++...     ...
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~  106 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AGG  106 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----CcE
Confidence            69999999999999999999999999999999976543 355667888999999999999999999999877     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++| +|.++++.+  ....++..++.||+.||+|||++||+||||||+||+++.+|.++|++++          
T Consensus       107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999984 999998543  4666889999999999999999999999999999999999999998443          


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                               |++        .++.++|||||||++|+|++|..||.+.+....+.           ....          
T Consensus       175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~~~----------  216 (286)
T 3uqc_A          175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PAER----------  216 (286)
T ss_dssp             ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------ECCB----------
T ss_pred             ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HHHH----------
Confidence                     222        36889999999999999999999998754211000           0000          


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                         .............+.++.++.++|.+||+.||.+| |+.|+++
T Consensus       217 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          217 ---DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             ---CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ---HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence               00000111112345789999999999999999999 9999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-42  Score=333.12  Aligned_cols=244  Identities=20%  Similarity=0.274  Sum_probs=197.5

Q ss_pred             ccceeeeecccceEEEEEEEeCC-CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||++.+.. +++.||||++... ........+.+|+.++++++||||+++++++......+....
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999976 7899999988643 234556678899999999999999999999987643222337


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+||||++| +|.+++..  ++++.+++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||++......  
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--  234 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence            999999985 88887754  79999999999999999999999999999999999999885 8999999999776543  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                       ....||+.|+|||++.+  ..+.++|||||||++|+|++|..||.+....           ..+..             
T Consensus       235 -~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~-------------  287 (681)
T 2pzi_A          235 -GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPED-------------  287 (681)
T ss_dssp             -SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTT-------------
T ss_pred             -CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccccc-------------
Confidence             34578999999999876  3488999999999999999999888642100           00000             


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                   ......++.+.++|.+||+.||.+||+..+.+.|+|+..
T Consensus       288 -------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          288 -------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                         000123578999999999999999999999998898854

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.3e-34  Score=271.16  Aligned_cols=184  Identities=16%  Similarity=0.106  Sum_probs=134.6

Q ss_pred             eecccceEEEEEEEeCCCCceEEEEEecCcc--------cChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcc
Q 019728            8 EYDDIIFFIFSAAVNSETREEVAIKKIGNAF--------DNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         8 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      ..+.|++|.+..++...+|+.|++|++.+..        ......+.+.+|+++|+++ .|+||+++++++.+.     .
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----Q  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----S
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----C
Confidence            3567778888887887889999999996542        2344557788999999999 699999999999988     7


Q ss_pred             eEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ..|+||||++| +|.++|...+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            79999999986 999999998888775   47899999999999999999999999999999999999999999866543


Q ss_pred             -CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC
Q 019728          158 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  201 (336)
                       ......+||+.|+|||++.+  ....++|+|++|++++.+.++.
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             CccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence             33455689999999999975  4677899999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.7e-28  Score=228.66  Aligned_cols=182  Identities=19%  Similarity=0.165  Sum_probs=139.5

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccC------hhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN------IIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .+.||+|+||.||++..  .++.+++|+.......      ......+.+|+.++++++||||+++..+....     ..
T Consensus       341 ~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~  413 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----DN  413 (540)
T ss_dssp             -------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----TT
T ss_pred             CCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----Cc
Confidence            56899999999999944  6788999986433211      12245578999999999999999444444333     33


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      .|+||||++ ++|.+++..        +..++.||+.||+|||++||+||||||+|||++.  .+||+|||+++......
T Consensus       414 ~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            699999997 699999865        5689999999999999999999999999999998  99999999998776542


Q ss_pred             c--------ccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 019728          159 F--------MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF  204 (336)
Q Consensus       159 ~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  204 (336)
                      .        .....||+.|+|||++... ..|+..+|+|+.++-..+.+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2        2356789999999998741 34677789999998888887776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=4.2e-25  Score=189.33  Aligned_cols=145  Identities=17%  Similarity=0.157  Sum_probs=115.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh----------------hHHHHHHHHHHHHhhCCCCceeeec
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI----------------IDARRTLREIKLLRHMEHENVIAIK   66 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~hp~iv~~~   66 (336)
                      |.+.+.||.|++|.||+|.+ .+|+.||+|++.....+.                .....+.+|+.++++++  | ++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55779999999999999999 889999999986432111                24567889999999999  5 6666


Q ss_pred             ceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEE
Q 019728           67 DIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        67 ~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                      +++..      ...|+||||++| +|.+ +.      ..+...++.||+.||+|||++||+||||||+|||++ ++.++|
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred             eEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence            65543      336999999975 8877 32      134557999999999999999999999999999999 999999


Q ss_pred             EeccCCcccCCCCcccceeeeecccCchhccc
Q 019728          146 GDFGLARTTSETDFMTEYVVTRWYRAPELLLN  177 (336)
Q Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~  177 (336)
                      +|||++...            ..+.|||.+..
T Consensus       234 ~DFG~a~~~------------~~~~a~e~l~r  253 (282)
T 1zar_A          234 IDFPQSVEV------------GEEGWREILER  253 (282)
T ss_dssp             CCCTTCEET------------TSTTHHHHHHH
T ss_pred             EECCCCeEC------------CCCCHHHHHHH
Confidence            999988533            33678887753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=9.5e-23  Score=172.64  Aligned_cols=139  Identities=16%  Similarity=0.098  Sum_probs=108.4

Q ss_pred             cceeeeecccceEEEEEEEeCCCCce--EEEEEecCcccCh----------------------hHHHHHHHHHHHHhhCC
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREE--VAIKKIGNAFDNI----------------------IDARRTLREIKLLRHME   58 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~   58 (336)
                      |.+.+.||.|++|.||+|.+..+|+.  ||||++.......                      .....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            57889999999999999999778999  9999875431110                      11235678999999998


Q ss_pred             CCce--eeecceecCCCCCCcceEEEEEecCCc------cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccC
Q 019728           59 HENV--IAIKDIIRPPKKDTFNDVYIVYELMDT------DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRD  129 (336)
Q Consensus        59 hp~i--v~~~~~~~~~~~~~~~~~~iv~e~~~g------~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~d  129 (336)
                      |+++  ..+++.         ...++||||+++      +|.+....   .++..+..++.||+.|+.+|| +.||+|||
T Consensus       129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            8764  333332         225899999953      67776533   235578889999999999999 99999999


Q ss_pred             CCCCCeEEccCCCEEEEeccCCcccC
Q 019728          130 LKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus       130 lkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      |||+|||++.  .++|+|||++....
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCHHHEEEcC--cEEEEECcccccCC
Confidence            9999999998  89999999986543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=5.7e-20  Score=161.75  Aligned_cols=139  Identities=12%  Similarity=0.086  Sum_probs=96.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC------------hhHHHH--------HHHHHHHHhhCCCCce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN------------IIDARR--------TLREIKLLRHMEHENV   62 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~--------~~~e~~~l~~l~hp~i   62 (336)
                      |.|.+.||.|++|.||+|.+. +|+.||||+++....+            ......        ..+|+..|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            789999999999999999995 6999999987532110            001111        1245555665543333


Q ss_pred             eeecceecCCCCCCcceEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           63 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        63 v~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ....-+..       ...++||||++| .|..+.      .......++.||+.+|.+||+.||+||||||.|||++++|
T Consensus       176 ~vp~p~~~-------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQ-------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEE-------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeeec-------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence            21111111       113799999987 654332      2234567889999999999999999999999999998876


Q ss_pred             C----------EEEEeccCCcccC
Q 019728          142 D----------LKIGDFGLARTTS  155 (336)
Q Consensus       142 ~----------~kl~dfg~~~~~~  155 (336)
                      .          +.|+||+.+....
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CcccccccccceEEEEeCCcccCC
Confidence            3          8899999776543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=9.3e-13  Score=111.42  Aligned_cols=137  Identities=13%  Similarity=0.090  Sum_probs=104.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++...++.|+.+.||.+...  +..+++|.......  .....+.+|+.+++.+. +..+.+++++....     ...
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~   85 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWS   85 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----Cce
Confidence            3678888999999999999863  68899999854221  12235778899998884 67777888887655     568


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-------------------------------------  122 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------  122 (336)
                      |+|||+++| +|.+.+.     +......++.++..+++.||+                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999998 7776531     122344678899999999998                                     


Q ss_pred             ----------------------CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ----------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ----------------------~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                                            ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876556799998653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.9e-11  Score=103.01  Aligned_cols=124  Identities=13%  Similarity=0.067  Sum_probs=89.9

Q ss_pred             cccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc--eeeecceecCCCCCCcceEEEEEecC
Q 019728           10 DDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKDTFNDVYIVYELM   87 (336)
Q Consensus        10 g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~~~~~~~~iv~e~~   87 (336)
                      +.|..+.||++.. .+|+.+++|.....     ....+..|+.+++.+.+.+  +.+++++....     +..++|||++
T Consensus        29 ~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~e~i   97 (264)
T 1nd4_A           29 IGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGEV   97 (264)
T ss_dssp             CTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEECC
T ss_pred             cCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEEEec
Confidence            4666699999965 46788999987543     1234667888888885434  55677776654     4589999999


Q ss_pred             Cc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 019728           88 DT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS------------------------------------------  124 (336)
Q Consensus        88 ~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  124 (336)
                      +| +| + .   ...+   ...++.++...++.||+..                                          
T Consensus        98 ~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           98 PGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            87 66 3 2   1122   2256677888888888754                                          


Q ss_pred             ----------------eeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          125 ----------------VLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       125 ----------------i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                                      ++|+|++|.||++++++.+.|+||+.+.
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            9999999999999877666799999764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.18  E-value=3e-11  Score=104.39  Aligned_cols=186  Identities=14%  Similarity=0.125  Sum_probs=118.4

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCc--eeeecceecCCCCCCcceEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HEN--VIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~--iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      .+.++.|..+.||.+.     ..+++|+...    ......+.+|..+++.+. +..  +.+++......  ......|+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceE
Confidence            4568999999999864     4689998632    245677889999998883 333  23343332222  11123588


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS---------------------------------------  122 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---------------------------------------  122 (336)
                      ||++++| ++.+...  ..++..+...++.++...++.||+                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999998 6554332  346777778888888888888885                                       


Q ss_pred             -------------------CCeeccCCCCCCeEEcc--CCCEEEEeccCCcccCCCCcccceeeeecccCchhcc----c
Q 019728          123 -------------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL----N  177 (336)
Q Consensus       123 -------------------~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~----~  177 (336)
                                         ..++|+|++|.||+++.  .+.+.|+||+.+.................-.+|+...    .
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                               13799999999999998  4557899999886543321111000000001222111    0


Q ss_pred             CC---------CCCccchHHHHHHHHHHHHhCCCCC
Q 019728          178 CT---------EYTAAIDIWSVGCILGEIMTREPLF  204 (336)
Q Consensus       178 ~~---------~~~~~~DiwslG~il~~ll~g~~pf  204 (336)
                      -.         ......+.|++|.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00         0112368999999999999998665

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=1e-10  Score=103.50  Aligned_cols=144  Identities=13%  Similarity=0.142  Sum_probs=104.0

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEec--CcccChhHHHHHHHHHHHHhhCC--CCceeeecceecCCCCCCcceE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIG--NAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      -++.|+.|.++.||++...  +..+++|+..  ... .......+.+|+.+++.+.  +..+.+++.+..+...  .+..
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSC
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCe
Confidence            4678899999999999874  4688999875  221 1123456778999999986  4557788887765422  1347


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-------------------------------------  122 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------  122 (336)
                      |+|||+++| .+.+.  ....++..+...++.++..+|+.||+                                     
T Consensus       117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            899999997 44221  12346788888999999999999997                                     


Q ss_pred             ---------------------CCeeccCCCCCCeEEccCCC--EEEEeccCCcccC
Q 019728          123 ---------------------ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTS  155 (336)
Q Consensus       123 ---------------------~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~  155 (336)
                                           .+++|+|+++.||+++.++.  +.|+||+.+....
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                                 36999999999999987753  6899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=2.1e-07  Score=78.59  Aligned_cols=132  Identities=18%  Similarity=0.145  Sum_probs=92.1

Q ss_pred             eecccceE-EEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEEEEEe
Q 019728            8 EYDDIIFF-IFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVYIVYE   85 (336)
Q Consensus         8 ~lg~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~iv~e   85 (336)
                      .+..|..+ .||.......+..+++|.-.     ......+..|...++.+. +-.+.+++++..+.     +..|+|||
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme  100 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGK-----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTT  100 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEE-----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECC-----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEE
Confidence            34445554 68998887778889999863     234567778999998885 33356677776655     56899999


Q ss_pred             cCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 019728           86 LMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-----------------------------------------  123 (336)
Q Consensus        86 ~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------  123 (336)
                      +++| ++.+.....    ......+..++...++-||+.                                         
T Consensus       101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            9997 666654321    122334555666666666631                                         


Q ss_pred             -----------------CeeccCCCCCCeEEccCCCEEEEeccCCcc
Q 019728          124 -----------------SVLHRDLKPSNLLLNASCDLKIGDFGLART  153 (336)
Q Consensus       124 -----------------~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  153 (336)
                                       .++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             279999999999999877677999997643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.68  E-value=2.2e-07  Score=80.08  Aligned_cols=136  Identities=19%  Similarity=0.132  Sum_probs=91.7

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCC---ceeeecceecCCCCCCcceEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHE---NVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp---~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      .+.++.|....||.+     +..+++|+..    .......+..|..+++.+.+.   .+.+++.+....    .+..++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEE
Confidence            456888999999988     5778999852    234456788999999999642   244555554321    144689


Q ss_pred             EEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 019728           83 VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------------------------------------  123 (336)
Q Consensus        83 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------------------  123 (336)
                      +|++++| .+.+...  ..++..+...++.++...++.||+.                                      
T Consensus        91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9999998 5554221  2234445555555555555555532                                      


Q ss_pred             ----------------------CeeccCCCCCCeEEcc---CCCE-EEEeccCCcccCC
Q 019728          124 ----------------------SVLHRDLKPSNLLLNA---SCDL-KIGDFGLARTTSE  156 (336)
Q Consensus       124 ----------------------~i~H~dlkp~nil~~~---~~~~-kl~dfg~~~~~~~  156 (336)
                                            .++|+|+++.||+++.   ++.+ .|+||+.+.....
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                                  3599999999999987   4554 8999998765543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.43  E-value=2.8e-06  Score=75.97  Aligned_cols=77  Identities=14%  Similarity=-0.030  Sum_probs=47.8

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCccc--C---hhHHHHHHHHHHHHhhCCC--Cc-eeeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD--N---IIDARRTLREIKLLRHMEH--EN-VIAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--p~-iv~~~~~~~~~~~~~~   77 (336)
                      .+.||.|..+.||++.+..+++.|++|.......  .   .........|..+++.+..  |. +.+++.+..       
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~-------  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC-------
Confidence            5689999999999998766678999998643211  0   1123455678888887732  33 345554422       


Q ss_pred             ceEEEEEecCCc
Q 019728           78 NDVYIVYELMDT   89 (336)
Q Consensus        78 ~~~~iv~e~~~g   89 (336)
                      ...++|||+++|
T Consensus       108 ~~~~lvmE~l~g  119 (397)
T 2olc_A          108 EMAVTVMEDLSH  119 (397)
T ss_dssp             TTTEEEECCCTT
T ss_pred             CccEEEEEeCCC
Confidence            224899999976

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.23  E-value=2.3e-05  Score=62.58  Aligned_cols=98  Identities=15%  Similarity=0.122  Sum_probs=65.7

Q ss_pred             cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceeeee
Q 019728           90 DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  167 (336)
Q Consensus        90 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  167 (336)
                      +|.+.++. +.+++++++|.++.|.+.+|.-+- ++.-...=+.|..|++..+|.+.+.+ ..+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            89999875 578999999999999999887762 22212233456899999999988874 1111           1123


Q ss_pred             cccCchhcccCCCCCccchHHHHHHHHHHHHhCC
Q 019728          168 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  201 (336)
Q Consensus       168 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  201 (336)
                      .+.|||...  ...+.+.=|+|||+++|..+--.
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            466888763  35567788999999999999744

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=3.3e-05  Score=67.30  Aligned_cols=30  Identities=20%  Similarity=0.292  Sum_probs=27.0

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999999663

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.04  E-value=1.7e-05  Score=69.75  Aligned_cols=83  Identities=7%  Similarity=0.061  Sum_probs=51.0

Q ss_pred             eeeee-cccceEEEEEEEeC--C----CCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCC-C--CceeeecceecCCC
Q 019728            5 LRGEY-DDIIFFIFSAAVNS--E----TREEVAIKKIGNAFD-NIIDARRTLREIKLLRHME-H--ENVIAIKDIIRPPK   73 (336)
Q Consensus         5 i~~~l-g~G~~g~v~~~~~~--~----~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--p~iv~~~~~~~~~~   73 (336)
                      ..+.| +.|....+|.+...  .    +++.+++|....... .......+..|+.+++.+. +  -.+.+++.+.....
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            45677 88999999988753  0    266799997643210 0001234567777777774 2  34566776654432


Q ss_pred             CCCcceEEEEEecCCc
Q 019728           74 KDTFNDVYIVYELMDT   89 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~g   89 (336)
                      .  ....|+|||+++|
T Consensus       104 ~--~g~~~~v~e~l~G  117 (357)
T 3ats_A          104 V--LGTPFFLMDYVEG  117 (357)
T ss_dssp             T--TSSCEEEEECCCC
T ss_pred             c--cCCceEEEEecCC
Confidence            1  1235899999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.99  E-value=5.9e-05  Score=64.57  Aligned_cols=68  Identities=10%  Similarity=0.033  Sum_probs=41.0

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCce-eeecceecCCCCCCcceEEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      .+.|+.|....+|++      +.+++|+........   .....|+.+++.+....+ .++++.....       -++++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~~~~-------~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVDPAT-------GVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEECTTT-------CCEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEECCC-------CEEEE
Confidence            577889999999998      568999875431111   112346666666632222 4555543322       37899


Q ss_pred             ecC-Cc
Q 019728           85 ELM-DT   89 (336)
Q Consensus        85 e~~-~g   89 (336)
                      |++ +|
T Consensus        87 e~i~~g   92 (301)
T 3dxq_A           87 RYIAGA   92 (301)
T ss_dssp             ECCTTC
T ss_pred             eecCCC
Confidence            999 65

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.99  E-value=4.8e-05  Score=68.42  Aligned_cols=79  Identities=9%  Similarity=-0.002  Sum_probs=46.2

Q ss_pred             HhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcccceee--eecccCchhcccCCC--CCccchHHHHHHHHHH
Q 019728          121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTE--YTAAIDIWSVGCILGE  196 (336)
Q Consensus       121 H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~  196 (336)
                      +...++|+|++|.||+++.++ +.|+||+.+..............  ...|.+|+.......  .....++..+...+++
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            356799999999999998876 99999998865543211111111  133555554421111  1112344466666676


Q ss_pred             HHhC
Q 019728          197 IMTR  200 (336)
Q Consensus       197 ll~g  200 (336)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6553

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00028  Score=60.57  Aligned_cols=74  Identities=12%  Similarity=0.017  Sum_probs=55.0

Q ss_pred             ceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC---CCceeeecceecCCCCCCcceE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME---HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .-.+.|+.|....+|++..  .+..+++|.....     ....+..|...|+.+.   ...+.+++......     ...
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~  106 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHS  106 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----Cce
Confidence            3457899999999999986  4678999986432     3556778888888873   35677777776554     568


Q ss_pred             EEEEecCCc
Q 019728           81 YIVYELMDT   89 (336)
Q Consensus        81 ~iv~e~~~g   89 (336)
                      ++|||+++|
T Consensus       107 ~lvme~l~G  115 (312)
T 3jr1_A          107 FLLLEALNK  115 (312)
T ss_dssp             EEEEECCCC
T ss_pred             EEEEEeccC
Confidence            999999976

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.51  E-value=0.00031  Score=59.61  Aligned_cols=74  Identities=12%  Similarity=-0.034  Sum_probs=49.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC---CceeeecceecCCCCCCcce
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH---ENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---p~iv~~~~~~~~~~~~~~~~   79 (336)
                      +.-++.+|.|..+.||++.. .+|+.|++|+.....  ......+..|+..|+.+.-   -.+.++++..         .
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~   84 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------D   84 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------T
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------C
Confidence            44567899999999999987 468899999864332  2223445678888887742   1233444431         1


Q ss_pred             EEEEEecCC
Q 019728           80 VYIVYELMD   88 (336)
Q Consensus        80 ~~iv~e~~~   88 (336)
                      -++|||++.
T Consensus        85 ~~lv~e~l~   93 (288)
T 3f7w_A           85 RTLAMEWVD   93 (288)
T ss_dssp             TEEEEECCC
T ss_pred             ceEEEEeec
Confidence            378999985

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.45  E-value=0.00058  Score=59.20  Aligned_cols=33  Identities=27%  Similarity=0.365  Sum_probs=27.8

Q ss_pred             CCeeccCCCCCCeEEccC----CCEEEEeccCCcccC
Q 019728          123 ASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTTS  155 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~----~~~kl~dfg~~~~~~  155 (336)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999874    679999999876543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.37  E-value=0.0009  Score=60.21  Aligned_cols=71  Identities=10%  Similarity=0.053  Sum_probs=47.3

Q ss_pred             eeeecccceEEEEEEEeCC-------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCce-eeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~~   77 (336)
                      .+.|+.|....+|++....       .++.+++|+.... .   ....+..|..+++.+...++ .++++.+. +     
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~-~-----  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIFS-G-----  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEET-T-----
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C---cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-C-----
Confidence            4678888889999998643       3578999988432 1   11344578888888853233 45665543 1     


Q ss_pred             ceEEEEEecCCc
Q 019728           78 NDVYIVYELMDT   89 (336)
Q Consensus        78 ~~~~iv~e~~~g   89 (336)
                         .+|+||++|
T Consensus       148 ---g~v~e~l~G  156 (429)
T 1nw1_A          148 ---GRLEEYIPS  156 (429)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---CEEEEEeCC
Confidence               388999876

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.34  E-value=0.0015  Score=57.57  Aligned_cols=135  Identities=13%  Similarity=0.134  Sum_probs=79.2

Q ss_pred             eeeecccceEEEEEEEeCC-------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~   77 (336)
                      .+.|..|-...+|++....       .++.|++|+.....   .......+|..+++.+. +.-..++++.+..      
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE------  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------
Confidence            3567778888899988742       45789999864321   23455568888888884 3223556655432      


Q ss_pred             ceEEEEEecCCc-cHH-----------HH---H---Hc-----CCCCC--HHHHHHHHHHHHH-----------------
Q 019728           78 NDVYIVYELMDT-DLH-----------QI---I---RS-----DQQLT--DDHCQYFLYQLLR-----------------  115 (336)
Q Consensus        78 ~~~~iv~e~~~g-~L~-----------~~---l---~~-----~~~~~--~~~~~~i~~qi~~-----------------  115 (336)
                         .+||||++| .|.           .+   +   +.     .++..  ..++..+..++-.                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               389999976 221           11   1   11     11122  3455555554422                 


Q ss_pred             --HHHHHH----h----CCeeccCCCCCCeEEccC----CCEEEEeccCCc
Q 019728          116 --GLKYVH----S----ASVLHRDLKPSNLLLNAS----CDLKIGDFGLAR  152 (336)
Q Consensus       116 --~l~~LH----~----~~i~H~dlkp~nil~~~~----~~~kl~dfg~~~  152 (336)
                        .+..|.    .    ..++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              123332    2    259999999999999876    689999999775

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.25  E-value=0.0012  Score=56.88  Aligned_cols=140  Identities=11%  Similarity=0.051  Sum_probs=72.4

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc--eeeecceecCCCCC--CcceEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKKD--TFNDVY   81 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~~--~~~~~~   81 (336)
                      .+.|+.|....+|.+...  +..+++|......    ....+..|..+++.+....  +.+++... .+...  ..+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEE
Confidence            456778888999998763  3378999885421    1223445666666653111  23333211 11000  013468


Q ss_pred             EEEecCCcc-H-----H------HH---HHc-CCC--------CCHHHHHH---------------HHHHHHHHHHHHHh
Q 019728           82 IVYELMDTD-L-----H------QI---IRS-DQQ--------LTDDHCQY---------------FLYQLLRGLKYVHS  122 (336)
Q Consensus        82 iv~e~~~g~-L-----~------~~---l~~-~~~--------~~~~~~~~---------------i~~qi~~~l~~LH~  122 (336)
                      ++|++++|. +     .      ..   ++. ...        .....-..               +-..+...++.+.+
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999862 1     0      01   111 001        01000000               00113334455542


Q ss_pred             -------CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 -------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 -------~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                             .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   369999999999999887656899998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.25  E-value=0.0022  Score=58.12  Aligned_cols=72  Identities=21%  Similarity=0.143  Sum_probs=45.8

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCce-eeecceecCCCCCCcceEEEEE
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENV-IAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-v~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      .+.|+.|-...+|++.....+..|++|+.........   ....|..+++.+...++ .++++.+. +        ..||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i---dR~~E~~vl~~L~~~gl~P~ll~~~~-~--------G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII---NREREKKISCILYNKNIAKKIYVFFT-N--------GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS---CHHHHHHHHHHHTTSSSBCCEEEEET-T--------EEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc---CHHHHHHHHHHHHhcCCCCCEEEEeC-C--------eEEE
Confidence            4678889999999998865458899998754221111   11478888888864444 45666652 1        3599


Q ss_pred             ecCCc
Q 019728           85 ELMDT   89 (336)
Q Consensus        85 e~~~g   89 (336)
                      ||++|
T Consensus       181 e~I~G  185 (458)
T 2qg7_A          181 EFMDG  185 (458)
T ss_dssp             ECCCS
T ss_pred             EeeCC
Confidence            99876

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.21  E-value=0.0057  Score=52.64  Aligned_cols=76  Identities=12%  Similarity=-0.019  Sum_probs=44.5

Q ss_pred             eeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC--CceeeecceecCCCCC--CcceEEE
Q 019728            7 GEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH--ENVIAIKDIIRPPKKD--TFNDVYI   82 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~~--~~~~~~i   82 (336)
                      ..++ |....||.+.. .+|+.+++|.......   ....+..|..+++.+..  -.+.+++..  .+...  ..+..++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence            4566 77788998765 3567899999853211   23445567777777642  224444443  11100  0135688


Q ss_pred             EEecCCc
Q 019728           83 VYELMDT   89 (336)
Q Consensus        83 v~e~~~g   89 (336)
                      +|++++|
T Consensus       105 l~~~i~G  111 (328)
T 1zyl_A          105 VFPSVGG  111 (328)
T ss_dssp             EEECCCC
T ss_pred             EEEecCC
Confidence            9999986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.003  Score=55.53  Aligned_cols=72  Identities=13%  Similarity=0.053  Sum_probs=40.8

Q ss_pred             eeeecccceEEEEEEEeCC--------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc-eeeecceecCCCCCC
Q 019728            6 RGEYDDIIFFIFSAAVNSE--------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN-VIAIKDIIRPPKKDT   76 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-iv~~~~~~~~~~~~~   76 (336)
                      .+.|+.|....+|++....        .++.+++|+.......   ......|..+++.+...+ ..++++...      
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~~------  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTFN------  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEecC------
Confidence            4567888888999998743        1368999987542111   112346777777764222 345554431      


Q ss_pred             cceEEEEEecCCc
Q 019728           77 FNDVYIVYELMDT   89 (336)
Q Consensus        77 ~~~~~iv~e~~~g   89 (336)
                         -++||++++|
T Consensus       109 ---~~~v~e~i~G  118 (369)
T 3c5i_A          109 ---GGRIEEWLYG  118 (369)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CcEEEEEecC
Confidence               1689999876

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.93  E-value=0.012  Score=51.02  Aligned_cols=32  Identities=19%  Similarity=0.258  Sum_probs=27.7

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999876543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.17  E-value=0.029  Score=49.86  Aligned_cols=29  Identities=28%  Similarity=0.392  Sum_probs=24.5

Q ss_pred             eeccCCCCCCeEE------ccCCCEEEEeccCCcc
Q 019728          125 VLHRDLKPSNLLL------NASCDLKIGDFGLART  153 (336)
Q Consensus       125 i~H~dlkp~nil~------~~~~~~kl~dfg~~~~  153 (336)
                      +||+|+.+.||++      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      3456799999998753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.53  E-value=0.27  Score=43.80  Aligned_cols=72  Identities=8%  Similarity=-0.019  Sum_probs=44.5

Q ss_pred             eeeecccceEEEEEEEeCCC-------CceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSET-------REEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~   77 (336)
                      ++.|..|-...+|++.....       ++.|++|+.......   .....+|..+++.+. +.-..++++.+.       
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~-------  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP-------  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC-------
Confidence            46677888889999987521       678999987543211   112246777777764 222344554332       


Q ss_pred             ceEEEEEecCCc
Q 019728           78 NDVYIVYELMDT   89 (336)
Q Consensus        78 ~~~~iv~e~~~g   89 (336)
                        -+.||+|++|
T Consensus       145 --~~~I~efI~G  154 (424)
T 3mes_A          145 --EGRIEEFIDG  154 (424)
T ss_dssp             --TEEEEECCCS
T ss_pred             --CCEEEEEeCC
Confidence              2789999986

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.01  E-value=0.019  Score=52.00  Aligned_cols=63  Identities=8%  Similarity=-0.005  Sum_probs=17.6

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEE------EEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceec
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAI------KKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIR   70 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   70 (336)
                      +.++||   ||.||.+....+...||+      |..+....+......+.+|..+++.++|||+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            456676   999999998765567888      665443334444556778889999999999999888654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.59  E-value=4.8  Score=32.01  Aligned_cols=81  Identities=19%  Similarity=0.136  Sum_probs=56.1

Q ss_pred             CCCceeeecceecCCCCCCcceEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHH-HHHhCCeeccCCCCCC
Q 019728           58 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK-YVHSASVLHRDLKPSN  134 (336)
Q Consensus        58 ~hp~iv~~~~~~~~~~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~i~H~dlkp~n  134 (336)
                      .||++  ...+-...     ..+.+.++.-+ + +....    +..+..+.++++.+|+.... ++  ..-+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~e-----D~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSE-----DEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECS-----SEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeC-----CEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCce
Confidence            57887  33333443     44666666653 3 55544    35788899998888887655 44  344677899999


Q ss_pred             eEEccCCCEEEEeccCC
Q 019728          135 LLLNASCDLKIGDFGLA  151 (336)
Q Consensus       135 il~~~~~~~kl~dfg~~  151 (336)
                      ++++.++.+++.-.|.-
T Consensus       115 L~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EEECTTCCEEESCCEET
T ss_pred             EEEeCCCcEEEEEcCCc
Confidence            99999999999876643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	336
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-87
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-85
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-83
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-70
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-68
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-68
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-64
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-61
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-60
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-60
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-58
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-58
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-57
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-57
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-56
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-56
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-55
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-52
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-48
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-41
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-33
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-31
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (673), Expect = 4e-87
 Identities = 164/318 (51%), Positives = 218/318 (68%), Gaps = 6/318 (1%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A ++  +  VAIKKI + F++    +RTLREIK+L    HEN+I I DIIR P  +   D
Sbjct: 27  AYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           VY+V  LM  DL++++++ Q L++DH  YFLYQ+LRGLKY+HSA+VLHRDLKPSNLLLN 
Sbjct: 86  VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144

Query: 140 SCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +CDLKI DFGLAR        T F+TEYV TRWYRAPE++LN   YT +IDIWSVGCIL 
Sbjct: 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E+++  P+FPGK Y+ QL  I  ++GSP    L  + +  AR Y+  LP   K  +   F
Sbjct: 205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
           PN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D +DEP+   PF FD E     
Sbjct: 265 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLP 324

Query: 316 EDHIRELIWRESVKFNPD 333
           ++ ++ELI+ E+ +F P 
Sbjct: 325 KEKLKELIFEETARFQPG 342

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 1e-85
 Identities = 156/316 (49%), Positives = 210/316 (66%), Gaps = 5/316 (1%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN 78
           A +++T   VA+KK+   F +II A+RT RE++LL+HM+HENVI + D+  P +  + FN
Sbjct: 37  AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           DVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LRGLKY+HSA ++HRDLKPSNL +N
Sbjct: 97  DVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 155

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
             C+LKI DFGLAR T +   MT YV TRWYRAPE++LN   Y   +DIWSVGCI+ E++
Sbjct: 156 EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
           T   LFPG D++ QL+LI  L+G+P    L  + S++AR Y++ L +  K  FA  F   
Sbjct: 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 273

Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDH 318
           +  AVDLLEKMLV D +KRIT  +AL H Y    HD +DEPV   P+   FE      D 
Sbjct: 274 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDE 332

Query: 319 IRELIWRESVKFNPDP 334
            + L + E + F P P
Sbjct: 333 WKSLTYDEVISFVPPP 348

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (647), Expect = 4e-83
 Identities = 142/314 (45%), Positives = 204/314 (64%), Gaps = 5/314 (1%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN 78
           AV+  T  +VAIKK+   F + + A+R  RE++LL+HM HENVI + D+  P +  D F 
Sbjct: 37  AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+GL+Y+H+A ++HRDLKP NL +N
Sbjct: 97  DFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 155

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
             C+LKI DFGLAR       MT YVVTRWYRAPE++LN   YT  +DIWSVGCI+ E++
Sbjct: 156 EDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
           T + LF G D++ QL+ I ++ G+P    +  L+SD A+ Y++ LP   K+ FA+   N 
Sbjct: 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA 273

Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDH 318
           S  AV+LLEKMLV D  +R+T  EAL HPY +SLHD  DEP     +   F+    T D 
Sbjct: 274 SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDE 332

Query: 319 IRELIWRESVKFNP 332
            + + ++E + F P
Sbjct: 333 WKRVTYKEVLSFKP 346

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 2e-70
 Identities = 100/290 (34%), Positives = 148/290 (51%), Gaps = 13/290 (4%)

Query: 20  AVNSETREEVAIKKIGNAFDNIID---ARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT 76
           A +  T + VAIKKI     +       R  LREIKLL+ + H N+I + D         
Sbjct: 17  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK---- 72

Query: 77  FNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            +++ +V++ M+TD    I  +   LT  H + ++   L+GL+Y+H   +LHRDLKP+NL
Sbjct: 73  -SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131

Query: 136 LLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           LL+ +  LK+ DFGLA++  S     T  VVTRWYRAPELL     Y   +D+W+VGCIL
Sbjct: 132 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            E++ R P  PG   + QL  I E +G+P +     + S       +  P          
Sbjct: 192 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP---GIPLHHI 248

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRP 304
           F       +DL++ + +F+P  RIT  +AL+  Y  +          PRP
Sbjct: 249 FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 1e-68
 Identities = 130/323 (40%), Positives = 195/323 (60%), Gaps = 18/323 (5%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFN 78
           A ++     VAIKK+   F N   A+R  RE+ L++ + H+N+I++ ++  P K  + F 
Sbjct: 36  AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
           DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L G+K++HSA ++HRDLKPSN+++ 
Sbjct: 96  DVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           + C LKI DFGLART   +  MT YVVTR+YRAPE++L    Y   +DIWSVGCI+GE++
Sbjct: 154 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMV 212

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN- 257
             + LFPG+DY+ Q   + E +G+P    +  L+    R YV   P+     F   FP+ 
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDS 271

Query: 258 -----------KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC-PRPF 305
                      K+S A DLL KMLV DP KRI+V++AL+HPY+   +D  +     P+ +
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 331

Query: 306 HFDFEHSSCTEDHIRELIWRESV 328
               +    T +  +ELI++E +
Sbjct: 332 DKQLDEREHTIEEWKELIYKEVM 354

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 2e-68
 Identities = 91/302 (30%), Positives = 157/302 (51%), Gaps = 20/302 (6%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPP-KKDTFN 78
           A   ++ E VAIKK+        D R   RE++++R ++H N++ ++       +K    
Sbjct: 39  AKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92

Query: 79  DVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
            + +V + +   ++++     R+ Q L   + + ++YQL R L Y+HS  + HRD+KP N
Sbjct: 93  YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152

Query: 135 LLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           LLL+  +  LK+ DFG A+     +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           L E++  +P+FPG   V QL  I +++G+P       +R  N      + P+ +   +  
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKAHPWTK 269

Query: 254 RF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD----LNDEPVCPRPFHFD 308
            F P     A+ L  ++L + P  R+T  EA  H +   L D    L +    P  F+F 
Sbjct: 270 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 329

Query: 309 FE 310
            +
Sbjct: 330 TQ 331

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 5e-66
 Identities = 94/288 (32%), Positives = 150/288 (52%), Gaps = 10/288 (3%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF-- 77
           A + +T ++VA+KK+    +        LREIK+L+ ++HENV+ + +I R         
Sbjct: 29  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88

Query: 78  -NDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
              +Y+V++  + DL  +      + T    +  +  LL GL Y+H   +LHRD+K +N+
Sbjct: 89  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 148

Query: 136 LLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           L+     LK+ DFGLAR       S+ +  T  VVT WYR PELLL   +Y   ID+W  
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQ 249
           GCI+ E+ TR P+  G    HQL LI++L GS        + +      +  +  + RK 
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268

Query: 250 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 297
           +   +   +   A+DL++K+LV DP +RI  ++AL H +  S    +D
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-64
 Identities = 107/278 (38%), Positives = 153/278 (55%), Gaps = 10/278 (3%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N  T E VA+KKI    +        +REI LL+ + H N++ + D+I      T N 
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENK 75

Query: 80  VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           +Y+V+E +  DL + + +     +     + +L+QLL+GL + HS  VLHRDLKP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135

Query: 138 NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           N    +K+ DFGLAR         T  VVT WYRAPE+LL C  Y+ A+DIWS+GCI  E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           ++TR  LFPG   + QL  I   +G+PD+    +    +   Y    P+  +Q F+   P
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPSFPKWARQDFSKVVP 253

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
                   LL +ML +DPNKRI+ + AL HP+ Q +  
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-64
 Identities = 56/287 (19%), Positives = 118/287 (41%), Gaps = 23/287 (8%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             +  +   +A K I           + +RE+++L       ++            +  +
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 78

Query: 80  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLL 137
           + I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+L+
Sbjct: 79  ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           N+  ++K+ DFG++    ++     +V TR Y +PE L     Y+   DIWS+G  L E+
Sbjct: 139 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEM 196

Query: 198 MTREPLFPGKDY-VHQLRLITELIGSPDD----------ASLGFLRSDNARRYVRQLPRC 246
                  P  D    +L    ++ G   +              +         + +L   
Sbjct: 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256

Query: 247 RKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
              +   + P+   S    D + K L+ +P +R  +++ + H +++ 
Sbjct: 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-62
 Identities = 95/273 (34%), Positives = 140/273 (51%), Gaps = 10/273 (3%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTFNDVY 81
               VA+K++            T+RE+ +LRH+   EH NV+ + D+    + D    + 
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91

Query: 82  IVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +V+E +  D   +     +  +  +  +  ++QLLRGL ++HS  V+HRDLKP N+L+ +
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 199
           S  +K+ DFGLAR  S    +T  VVT WYRAPE+LL  + Y   +D+WSVGCI  E+  
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFR 210

Query: 200 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
           R+PLF G   V QL  I ++IG P +         +     +       Q       +  
Sbjct: 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFVTDID 266

Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
               DLL K L F+P KRI+   AL HPY Q L
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-61
 Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 38/275 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           AVN  T E VA+K + +    +       +EI + + + HENV+      R       N 
Sbjct: 24  AVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NI 77

Query: 80  VYIVYELMDTDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            Y+  E          I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+
Sbjct: 78  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137

Query: 139 ASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
              +LKI DFGLA      +    + +   T  Y APELL     +   +D+WS G +L 
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            ++  E  +       Q                                   K+ +   +
Sbjct: 198 AMLAGELPWDQPSDSCQEYSD----------------------------WKEKKTYLNPW 229

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
               S  + LL K+LV +P+ RIT+ +  +  +  
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 39/297 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                T    A K +    ++  D     +EI+ +  + H  ++ + D          N+
Sbjct: 45  VTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NE 97

Query: 80  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N++ 
Sbjct: 98  MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157

Query: 138 NA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               S +LK+ DFGL         +     T  + APE+           D+WSVG +  
Sbjct: 158 TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSY 216

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++    F G++    LR +     + DD                           + F
Sbjct: 217 ILLSGLSPFGGENDDETLRNVKSCDWNMDD---------------------------SAF 249

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHS 312
              S    D + K+L+ DPN R+T+ +AL HP+L   +    +   P   +     S
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  193 bits (491), Expect = 1e-60
 Identities = 95/269 (35%), Positives = 139/269 (51%), Gaps = 9/269 (3%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
              E  A+KKI    ++      T+REI +L+ ++H N++ + D+I   K+     + +V
Sbjct: 24  NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----LVLV 78

Query: 84  YELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           +E +D      +   +  L     + FL QLL G+ Y H   VLHRDLKP NLL+N   +
Sbjct: 79  FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE 138

Query: 143 LKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 201
           LKI DFGLAR            +VT WYRAP++L+   +Y+  IDIWSVGCI  E++   
Sbjct: 139 LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

Query: 202 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 261
           PLFPG     QL  I  ++G+P+  S  +       +Y           + +        
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPN--SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256

Query: 262 AVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-60
 Identities = 92/277 (33%), Positives = 138/277 (49%), Gaps = 8/277 (2%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N ET E VA+K++    D+       LREI LL+ ++H+N++ + D++          
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH----SDKKL 76

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
             +               +  L  +  + FL+QLL+GL + HS +VLHRDLKP NLL+N 
Sbjct: 77  TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136

Query: 140 SCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           + +LK+ +FGLAR         +  VVT WYR P++L     Y+ +ID+WS GCI  E+ 
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

Query: 199 T-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
               PLFPG D   QL+ I  L+G+P +     +       Y                P 
Sbjct: 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TKLPDYKPYPMYPATTSLVNVVPK 254

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
            ++   DLL+ +L  +P +RI+ EEAL+HPY      
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-59
 Identities = 58/274 (21%), Positives = 116/274 (42%), Gaps = 40/274 (14%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A   +++  +A+K +     +      +  RE+++  H+ H N++ +             
Sbjct: 25  AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T 79

Query: 79  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            VY++ E      +++ ++   +  +     ++ +L   L Y HS  V+HRD+KP NLLL
Sbjct: 80  RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
            ++ +LKI DFG +     +   T    T  Y  PE++     +   +D+WS+G +  E 
Sbjct: 140 GSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF 197

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +  +P F    Y    + I+ +  +  D                                
Sbjct: 198 LVGKPPFEANTYQETYKRISRVEFTFPD-------------------------------F 226

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
            + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 2e-58
 Identities = 63/313 (20%), Positives = 126/313 (40%), Gaps = 42/313 (13%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A +    E VAIKK+  +   +    +  ++E++ L+ + H N I  +           +
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 88

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
             ++V E    +    +    + L +       +  L+GL Y+HS +++HRD+K  N+LL
Sbjct: 89  TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILG 195
           +    +K+GDFG A   +       +V T ++ APE++L   E  Y   +D+WS+G    
Sbjct: 149 SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E+  R+P     + +  L  I                              + +  A + 
Sbjct: 206 ELAERKPPLFNMNAMSALYHI-----------------------------AQNESPALQS 236

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND-EPVCPRPFHFDFEHSSC 314
            + S    + ++  L   P  R T E  L+H ++           +  R      E  + 
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296

Query: 315 TEDHIRELIWRES 327
               +++++++E+
Sbjct: 297 QYRKMKKILFQEA 309

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  188 bits (478), Expect = 5e-58
 Identities = 81/283 (28%), Positives = 154/283 (54%), Gaps = 21/283 (7%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN 78
           A+N    E+V +K +       +  ++  REIK+L ++    N+I + DI++ P   T  
Sbjct: 54  AINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP- 107

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
              +V+E ++ TD  Q+ ++   LTD   ++++Y++L+ L Y HS  ++HRD+KP N+++
Sbjct: 108 --ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162

Query: 138 NAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
           +     L++ D+GLA            V +R+++ PELL++   Y  ++D+WS+GC+L  
Sbjct: 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222

Query: 197 IMT-REPLFPGKDYVHQLRLITELIGSPDDAS-LGFLRSDNARRYVRQLPRCRKQQFATR 254
           ++  +EP F G D   QL  I +++G+ D    +     +   R+   L R  ++++   
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282

Query: 255 FPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
             ++     S  A+D L+K+L +D   R+T  EA+ HPY  ++
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-58
 Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 42/278 (15%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A N ET    A K I    +   +    + EI +L   +H N++ + D          N+
Sbjct: 31  AQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NN 83

Query: 80  VYIVYELMDTDL--HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           ++I+ E          ++  ++ LT+   Q    Q L  L Y+H   ++HRDLK  N+L 
Sbjct: 84  LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF 143

Query: 138 NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCT----EYTAAIDIWSVGC 192
               D+K+ DFG++   T        ++ T ++ APE+++  T     Y    D+WS+G 
Sbjct: 144 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 203

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
            L E+   EP     + +  L  I +                             +    
Sbjct: 204 TLIEMAEIEPPHHELNPMRVLLKIAK----------------------------SEPPTL 235

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            +    SS   D L+K L  + + R T  + L+HP++ 
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  187 bits (477), Expect = 1e-57
 Identities = 60/279 (21%), Positives = 113/279 (40%), Gaps = 39/279 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V   T      K I       +D      EI ++  + H  +I + D           +
Sbjct: 48  CVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YE 100

Query: 80  VYIVYELMD-TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + ++ E +   +L   I   D ++++     ++ Q   GLK++H  S++H D+KP N++ 
Sbjct: 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160

Query: 138 NASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
                  +KI DFGLA   +  + +     T  + APE++          D+W++G +  
Sbjct: 161 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGY 219

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++    F G+D +  L+ +       D+                             F
Sbjct: 220 VLLSGLSPFAGEDDLETLQNVKRCDWEFDE---------------------------DAF 252

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
            + S  A D ++ +L  +P KR+TV +AL HP+L+  H 
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-57
 Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 45/281 (16%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
                  + +  K++        + +  + E+ LLR ++H N++   D I      T   
Sbjct: 23  IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT--- 79

Query: 80  VYIVYELMD-TDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRD 129
           +YIV E  +  DL  +I    +  Q L ++     + QL   LK  H  S     VLHRD
Sbjct: 80  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139

Query: 130 LKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 188
           LKP+N+ L+   ++K+GDFGLAR    +T F   +V T +Y +PE  +N   Y    DIW
Sbjct: 140 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIW 198

Query: 189 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 248
           S+GC+L E+    P F           I                              R+
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKI------------------------------RE 228

Query: 249 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 289
            +F       S    +++ +ML      R +VEE L +P +
Sbjct: 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 4e-57
 Identities = 62/280 (22%), Positives = 119/280 (42%), Gaps = 39/280 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A++  T +EVAI+++             + EI ++R  ++ N++   D          ++
Sbjct: 39  AMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDE 91

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL  
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151

Query: 140 SCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              +K+ DFG     T E    +  V T ++ APE++     Y   +DIWS+G +  E++
Sbjct: 152 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMI 210

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
             EP +  ++ +  L LI                                     + P K
Sbjct: 211 EGEPPYLNENPLRALYLI-----------------------------ATNGTPELQNPEK 241

Query: 259 -SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 297
            S+   D L + L  D  KR + +E L+H +L+    L+ 
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  183 bits (465), Expect = 1e-56
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 46/285 (16%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDAR-------RTLREIKLLRHM-EHENVIAIKDIIRP 71
            ++  T +E A+K I         A         TL+E+ +LR +  H N+I +KD    
Sbjct: 22  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79

Query: 72  PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 130
              +T    ++V++LM   +L   +     L++   +  +  LL  +  +H  +++HRDL
Sbjct: 80  ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDL 136

Query: 131 KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAI 185
           KP N+LL+   ++K+ DFG +      + + E   T  Y APE++      N   Y   +
Sbjct: 137 KPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+WS G I+  ++   P F  +  +  LR+I                             
Sbjct: 197 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---------------------------S 229

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
              Q  +  + + S    DL+ + LV  P KR T EEAL HP+ Q
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-56
 Identities = 58/302 (19%), Positives = 125/302 (41%), Gaps = 40/302 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V + +++    K +        D     +EI +L    H N++ + +       ++  +
Sbjct: 24  CVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESF-----ESMEE 75

Query: 80  VYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
           + +++E +   D+ + I +   +L +     +++Q+   L+++HS ++ H D++P N++ 
Sbjct: 76  LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135

Query: 138 NA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               S  +KI +FG AR     D          Y APE+  +    + A D+WS+G ++ 
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVY 194

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            +++    F  +     +  I     + D+                             F
Sbjct: 195 VLLSGINPFLAETNQQIIENIMNAEYTFDE---------------------------EAF 227

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCT 315
              S  A+D ++++LV +   R+T  EAL+HP+L+   +     V     H  + H+   
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK 287

Query: 316 ED 317
           +D
Sbjct: 288 KD 289

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (456), Expect = 5e-55
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 38/275 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
           A +  T++ VAIK I        +      EI +L  ++H N++A+ DI           
Sbjct: 28  AEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKHPNIVALDDIYESG-----GH 81

Query: 80  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL- 137
           +Y++ +L+   +L   I      T+      ++Q+L  +KY+H   ++HRDLKP NLL  
Sbjct: 82  LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141

Query: 138 --NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
             +    + I DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I  
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAY 200

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
            ++   P F  ++       I +     D                              +
Sbjct: 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDS---------------------------PYW 233

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
            + S  A D +  ++  DP KR T E+AL+HP++ 
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-55
 Identities = 71/320 (22%), Positives = 130/320 (40%), Gaps = 40/320 (12%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIK-LLRHMEHENVIAIKDIIRPPKKDTFN 78
             N  T+E+ A+K +        D  +  RE++   R  +  +++ I D+          
Sbjct: 31  IFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-K 82

Query: 79  DVYIVYELMD-TDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 135
            + IV E +D  +L   I  R DQ  T+      +  +   ++Y+HS ++ HRD+KP NL
Sbjct: 83  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 142

Query: 136 LLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 192
           L  +      LK+ DFG A+ T+  + +T    T +Y APE+L    +Y  + D+WS+G 
Sbjct: 143 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGV 201

Query: 193 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 252
           I+  ++   P F     +     +   I                R    + P        
Sbjct: 202 IMYILLCGYPPFYSNHGLAISPGMKTRI----------------RMGQYEFPN------- 238

Query: 253 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC-PRPFHFDFEH 311
             +   S     L+  +L  +P +R+T+ E + HP++     +   P+   R    D E 
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298

Query: 312 SSCTEDHIRELIWRESVKFN 331
               ++ +   +    V + 
Sbjct: 299 WEDVKEEMTSALATMRVDYE 318

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 53/275 (19%), Positives = 115/275 (41%), Gaps = 36/275 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            +++ET  EVA  ++ +      + +R   E ++L+ ++H N++   D      K     
Sbjct: 28  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KC 86

Query: 80  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLL 136
           + +V ELM +  L   ++  + +     + +  Q+L+GL+++H+ +  ++HRDLK  N+ 
Sbjct: 87  IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146

Query: 137 LNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +   +  +KIGD GLA       F    + T  + APE+     +Y  ++D+++ G  + 
Sbjct: 147 ITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCML 203

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E+ T E  +       Q+         P                                
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFD---------------------------- 235

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 290
                   +++E  +  + ++R ++++ L H + Q
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-52
 Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 48/284 (16%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A    T  E AIK +               RE  ++  ++H   + +    +        
Sbjct: 27  ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E 81

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            +Y         +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LL
Sbjct: 82  KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 141

Query: 138 NASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           N    ++I DFG A+     S+      +V T  Y +PELL        + D+W++GCI+
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCII 200

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            +++   P F   +     + I +L     +                             
Sbjct: 201 YQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----------------------------- 231

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 292
                  A DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 232 --KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 4e-51
 Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 42/281 (14%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
                T  + A K I      +    +      RE+ +L+ ++H NVI + ++      +
Sbjct: 29  CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83

Query: 76  TFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
              DV ++ EL+    L   +   + LT++    FL Q+L G+ Y+HS  + H DLKP N
Sbjct: 84  NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 143

Query: 135 LLLN----ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
           ++L         +KI DFGLA      +       T  + APE++ N        D+WS+
Sbjct: 144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSI 202

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G I   +++    F G      L  ++ +    +D                         
Sbjct: 203 GVITYILLSGASPFLGDTKQETLANVSAVNYEFED------------------------- 237

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 291
               F N S+ A D + ++LV DP KR+T++++L+HP+++ 
Sbjct: 238 --EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-48
 Identities = 52/276 (18%), Positives = 105/276 (38%), Gaps = 40/276 (14%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
           +   +VA+K +          +    E+ +LR   H N++            T   + IV
Sbjct: 28  KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY------STAPQLAIV 81

Query: 84  YELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
            +  + + L+  +   + +           Q  +G+ Y+H+ S++HRDLK +N+ L+   
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141

Query: 142 DLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGE 196
            +KIGDFGLA   S    +    +   +  + APE++   +   Y+   D+++ G +L E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201

Query: 197 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           +MT +  +   +   Q+  +                    R Y+                
Sbjct: 202 LMTGQLPYSNINNRDQIIFMVG------------------RGYLSPDLS-------KVRS 236

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 292
           N       L+ + L    ++R    + L    ++ L
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS--IELL 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 7e-48
 Identities = 58/284 (20%), Positives = 111/284 (39%), Gaps = 52/284 (18%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHM--EHENVIAIKDIIRPPK 73
            +       VAIK +     + +  + +  R   E+ LL+ +      VI + D    P 
Sbjct: 23  GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81

Query: 74  KDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 131
               +   ++ E  +   DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K
Sbjct: 82  ----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK 137

Query: 132 PSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 190
             N+L++ +  +LK+ DFG      +T   T++  TR Y  PE +     +  +  +WS+
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196

Query: 191 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 250
           G +L +++  +  F   + + + ++                                   
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFFR-------------------------------- 224

Query: 251 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
                   SS    L+   L   P+ R T EE   HP++Q +  
Sbjct: 225 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 56/283 (19%), Positives = 111/283 (39%), Gaps = 44/283 (15%)

Query: 20  AVNSETREEVAIKKI----GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD 75
              ++T +  A+K +             A      + L+   +   ++ +      P   
Sbjct: 23  CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--- 79

Query: 76  TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
             + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 80  --DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 137

Query: 135 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 138 ILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 196

Query: 195 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
            +++     F       +  +                             R         
Sbjct: 197 FKLLRGHSPFRQHKTKDKHEID----------------------------RMTLTMAVEL 228

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQSL 292
             + S     LLE +L  D N+R+       +E    P+ +SL
Sbjct: 229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (382), Expect = 2e-44
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 36/281 (12%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
           A +     +VA+K +  +   +     R  RE +    + H  ++A+ D           
Sbjct: 26  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA-GP 84

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
             YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N+++
Sbjct: 85  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144

Query: 138 NASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           +A+  +K+ DFG+AR    + +        + T  Y +PE         A  D++S+GC+
Sbjct: 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCV 203

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           L E++T EP F G   V            P  A                           
Sbjct: 204 LYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA--------------------------- 236

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 294
           R    S+    ++ K L  +P  R      +R   L  +H+
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD-LVRVHN 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 42/278 (15%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPPKKDTF 77
           A   +T +  AIK +  +      D   T+ E ++L    EH  +  +    +     T 
Sbjct: 21  AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TK 75

Query: 78  NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
            +++ V E ++  DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+L
Sbjct: 76  ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135

Query: 137 LNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           L+    +KI DFG+ +           +  T  Y APE+LL   +Y  ++D WS G +L 
Sbjct: 136 LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLY 194

Query: 196 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           E++  +  F G+D       I                               +       
Sbjct: 195 EMLIGQSPFHGQDEEELFHSI-------------------------------RMDNPFYP 223

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSL 292
                 A DLL K+ V +P KR+ V  +  +HP  + +
Sbjct: 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 5e-42
 Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 45/281 (16%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
                T    A+K +         +   T+ E ++L++  H  + A+K   +       +
Sbjct: 24  VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78

Query: 79  DVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            +  V E  +   L   +  ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +    +KI DFGL +         +            +L   +Y  A+D W +G ++ E+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           M     F  +D+     LI                                ++   RFP 
Sbjct: 199 MCGRLPFYNQDHERLFELI------------------------------LMEEI--RFPR 226

Query: 258 K-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
             S  A  LL  +L  DP +R+       +E + H +  S+
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-41
 Identities = 52/265 (19%), Positives = 95/265 (35%), Gaps = 43/265 (16%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
              +VA+K I     N   A+  L E  ++  + H N++ +  +I     +    +YIV 
Sbjct: 29  RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVT 80

Query: 85  ELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 141
           E M    L   +RS     L  D    F   +   ++Y+   + +HRDL   N+L++   
Sbjct: 81  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140

Query: 142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 201
             K+ DFGL +  S T       +   + APE L    +++   D+WS G +L EI +  
Sbjct: 141 VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFG 197

Query: 202 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 261
            +   +  +  +                             +PR  K             
Sbjct: 198 RVPYPRIPLKDV-----------------------------VPRVEKGYKMDAPDGCPPA 228

Query: 262 AVDLLEKMLVFDPNKRITVEEALRH 286
             ++++     D   R +  +    
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-41
 Identities = 48/280 (17%), Positives = 105/280 (37%), Gaps = 46/280 (16%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
             +  + VA+K + N  ++       L E  +++ +++  ++ +  I             
Sbjct: 30  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC------EAESWM 83

Query: 82  IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
           +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL   
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143

Query: 141 CDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
              KI DFGL++      +     T       + APE +    ++++  D+WS G ++ E
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWE 202

Query: 197 IMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
             +  +  + G        ++                               K +     
Sbjct: 203 AFSYGQKPYRGMKGSEVTAML------------------------------EKGERMGCP 232

Query: 256 PNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSL 292
                   DL+     +D   R     VE  LR+ Y   +
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  143 bits (362), Expect = 5e-41
 Identities = 52/280 (18%), Positives = 111/280 (39%), Gaps = 46/280 (16%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             +       A+K +       +     T  E  +L  + H  +I +    +        
Sbjct: 23  IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q 77

Query: 79  DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 137
            ++++ + ++  +L  ++R  Q+  +   +++  ++   L+Y+HS  +++RDLKP N+LL
Sbjct: 78  QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137

Query: 138 NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           + +  +KI DFG A+   +         T  Y APE +++   Y  +ID WS G ++ E+
Sbjct: 138 DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEM 194

Query: 198 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           +     F   + +     I                         + P           P 
Sbjct: 195 LAGYTPFYDSNTMKTYEKI--------------------LNAELRFP-----------PF 223

Query: 258 KSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 292
            +    DLL +++  D ++R+       E+   HP+ + +
Sbjct: 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 66/335 (19%), Positives = 116/335 (34%), Gaps = 38/335 (11%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRP-------- 71
           A +      VA+K +     + +       EIKLL+ +   +      +           
Sbjct: 32  AKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88

Query: 72  ----PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVL 126
                       +       +          + +   + +    QLL GL Y+H    ++
Sbjct: 89  FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148

Query: 127 HRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 182
           H D+KP N+L+         ++I    L       +  T  + TR YR+PE+LL    + 
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWG 207

Query: 183 AAIDIWSVGCILGEIMTREPLFPGKDY------VHQLRLITELIGSPDDASL-------G 229
              DIWS  C++ E++T + LF   +          +  I EL+G      L        
Sbjct: 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 267

Query: 230 FLRSDNARRYVRQLPRCRKQQFATR----FPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
           F  S    R + +L     +   T       +++    D L  ML  DP KR      + 
Sbjct: 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327

Query: 286 HPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR 320
           HP+L+    + +  V  R  +          + +R
Sbjct: 328 HPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-40
 Identities = 45/285 (15%), Positives = 110/285 (38%), Gaps = 42/285 (14%)

Query: 20  AVNSETREEVAIKKI--GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF 77
               +T +  A+K +              T  E ++L H+     +    +       T 
Sbjct: 46  ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL----VTLHYAFQTE 101

Query: 78  NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 136
             ++++ + ++  +L   +   ++ T+   Q ++ +++  L+++H   +++RD+K  N+L
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161

Query: 137 LNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 193
           L+++  + + DFGL++                  +     +    + +  A+D WS+G +
Sbjct: 162 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221

Query: 194 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
           + E++T    F      +    I+  I   +                             
Sbjct: 222 MYELLTGASPFTVDGEKNSQAEISRRILKSEP---------------------------P 254

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 293
                S+ A DL++++L+ DP KR+       +E   H + Q ++
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-39
 Identities = 56/275 (20%), Positives = 98/275 (35%), Gaps = 48/275 (17%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVYEL 86
             VAIK +       +     L+E ++++ + HE ++ +  ++      +   +YIV E 
Sbjct: 42  TRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEY 92

Query: 87  MD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 143
           M            + + L          Q+  G+ YV   + +HRDL+ +N+L+  +   
Sbjct: 93  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152

Query: 144 KIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR- 200
           K+ DFGLAR   + ++           + APE  L    +T   D+WS G +L E+ T+ 
Sbjct: 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKG 211

Query: 201 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS 260
              +PG      L  +      P                                P    
Sbjct: 212 RVPYPGMVNREVLDQVERGYRMPCP------------------------------PECPE 241

Query: 261 GAVDLLEKMLVFDPNKRITVEEALR--HPYLQSLH 293
              DL+ +    +P +R T E        Y  S  
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 57/311 (18%), Positives = 120/311 (38%), Gaps = 26/311 (8%)

Query: 20  AVNSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN 78
             + E+    A+K +       +     TL E ++L+ +    ++ ++   +    D  N
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK----DNSN 115

Query: 79  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
              ++  +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL++
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175

Query: 139 ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
               +++ DFG A+             T    APE++L+   Y  A+D W++G ++ E+ 
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMA 232

Query: 199 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 258
              P F     +     I                S + +  +R      +     RF N 
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDLKDLLR---NLLQVDLTKRFGNL 284

Query: 259 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDH 318
            +G  D+         +     +  +  P++       D        +FD       E+ 
Sbjct: 285 KNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS------NFD----DYEEEE 334

Query: 319 IRELIWRESVK 329
           IR  I  +  K
Sbjct: 335 IRVSINEKCGK 345

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-38
 Identities = 47/279 (16%), Positives = 103/279 (36%), Gaps = 48/279 (17%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
             + + +VAIK +    +   D    +RE +++  +++  ++ +  + +         + 
Sbjct: 32  MRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVCQAEA------LM 84

Query: 82  IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +V E+     LH+ +    +++   +    L+Q+  G+KY+   + +HRDL   N+LL  
Sbjct: 85  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144

Query: 140 SCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               KI DFGL++     D      +       + APE  +N  ++++  D+WS G  + 
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMW 203

Query: 196 EIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           E ++  +  +        +  I                               + +    
Sbjct: 204 EALSYGQKPYKKMKGPEVMAFI------------------------------EQGKRMEC 233

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQ 290
            P        L+    ++    R     VE+ +R  Y  
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 4e-38
 Identities = 51/276 (18%), Positives = 99/276 (35%), Gaps = 48/276 (17%)

Query: 24  ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIV 83
               +VA+K +       +     L E  L++ ++H+ ++ +  ++      T   +YI+
Sbjct: 35  NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV------TQEPIYII 85

Query: 84  YELMDTDL---HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 140
            E M+           S  +LT +       Q+  G+ ++   + +HRDL+ +N+L++ +
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145

Query: 141 CDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
              KI DFGLAR   + ++           + APE  +N   +T   D+WS G +L EI+
Sbjct: 146 LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIV 204

Query: 199 TR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           T     +PG      ++ +                                        N
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRP------------------------------DN 234

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS 291
                  L+       P  R T +        +  +
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-37
 Identities = 51/270 (18%), Positives = 92/270 (34%), Gaps = 42/270 (15%)

Query: 22  NSETREEVAIKKI-GNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
            S     VA+K +  +           +RE+  +  ++H N+I +  ++          +
Sbjct: 32  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV------LTPPM 85

Query: 81  YIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
            +V EL    + L ++ +            +  Q+  G+ Y+ S   +HRDL   NLLL 
Sbjct: 86  KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 145

Query: 139 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
               +KIGDFGL R   + D    M E+    +       L    ++ A D W  G  L 
Sbjct: 146 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205

Query: 196 EIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           E+ T  +  + G +    L  I                              ++ +   R
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKI-----------------------------DKEGERLPR 236

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEAL 284
             +      +++ +     P  R T     
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-36
 Identities = 43/267 (16%), Positives = 95/267 (35%), Gaps = 44/267 (16%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
            + +VAIK I    +  +     + E K++ ++ HE ++ +  +           ++I+ 
Sbjct: 27  GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIIT 78

Query: 85  ELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           E M     L+ +     +            +   ++Y+ S   LHRDL   N L+N    
Sbjct: 79  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV 138

Query: 143 LKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           +K+ DFGL+R   + ++           +  PE+L+  +++++  DIW+ G ++ EI + 
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSL 197

Query: 201 -EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
            +  +           I + +                                      S
Sbjct: 198 GKMPYERFTNSETAEHIAQGLRLYRP------------------------------HLAS 227

Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRH 286
                ++        ++R T +  L +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-36
 Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 65/294 (22%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV 80
            +    +VA+K +    D+  +    + E+K++  +  HEN++ +              +
Sbjct: 63  KTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHENIVNLLGACT-----LSGPI 116

Query: 81  YIVYELMD-TDLHQIIRSDQQ-----------------------LTDDHCQYFLYQLLRG 116
           Y+++E     DL   +RS ++                       LT +    F YQ+ +G
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176

Query: 117 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPE 173
           ++++   S +HRDL   N+L+     +KI DFGLAR               +   + APE
Sbjct: 177 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236

Query: 174 LLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLR 232
            L     YT   D+WS G +L EI +     +PG         + +              
Sbjct: 237 SLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-------------- 281

Query: 233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
                 +    P              +     +++    FD  KR +       
Sbjct: 282 ----NGFKMDQP-----------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-36
 Identities = 52/280 (18%), Positives = 97/280 (34%), Gaps = 33/280 (11%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
             EEVA+K   +  +    +     EI     + HEN++            T+  +++V 
Sbjct: 25  RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80

Query: 85  ELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLHRDLKPSNL 135
           +  +   L   +     +T +           GL ++H          ++ HRDLK  N+
Sbjct: 81  DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139

Query: 136 LLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNC-----TEYTAAI 185
           L+  +    I D GLA      T +        V T+ Y APE+L +       E     
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           DI+++G +  EI  R  +  G    +QL     +   P    +  +  +   R     P 
Sbjct: 200 DIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-----PN 253

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
              +  +            ++ +    +   R+T     +
Sbjct: 254 IPNRWQSCEALRV---MAKIMRECWYANGAARLTALRIKK 290

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-35
 Identities = 43/267 (16%), Positives = 94/267 (35%), Gaps = 44/267 (16%)

Query: 25  TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY 84
            +++VAIK I    +  +     + E +++  + H  ++ +  +           + +V+
Sbjct: 28  NKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVF 79

Query: 85  ELMDT-DLHQIIRSDQQLTD-DHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 142
           E M+   L   +R+ + L   +        +  G+ Y+  A V+HRDL   N L+  +  
Sbjct: 80  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV 139

Query: 143 LKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 200
           +K+ DFG+ R     +    T       + +PE+    + Y++  D+WS G ++ E+ + 
Sbjct: 140 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSE 198

Query: 201 -EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS 259
            +  +  +     +  I+                                         S
Sbjct: 199 GKIPYENRSNSEVVEDISTGFRLYKP------------------------------RLAS 228

Query: 260 SGAVDLLEKMLVFDPNKRITVEEALRH 286
           +    ++       P  R      LR 
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (319), Expect = 6e-35
 Identities = 45/293 (15%), Positives = 87/293 (29%), Gaps = 47/293 (16%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             +    EEVAIK       +     +   E K+ + M+    I              + 
Sbjct: 26  GTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWC----GAEGDY 77

Query: 80  VYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL-- 136
             +V EL+   L  +     ++ +         Q++  ++Y+HS + +HRD+KP N L  
Sbjct: 78  NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137

Query: 137 -LNASCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDI 187
                  + I DFGLA+   +                 T  Y +    L   E +   D+
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDL 196

Query: 188 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 247
            S+G +L         + G     +                        ++Y R   +  
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKR-----------------------QKYERISEKKM 233

Query: 248 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLHDLND 297
                       S     L        + +     + +  R+ + +     + 
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-34
 Identities = 57/270 (21%), Positives = 102/270 (37%), Gaps = 43/270 (15%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
                  VAIK   N   + +   + L+E   +R  +H +++ +  +I      T N V+
Sbjct: 31  PENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVKLIGVI------TENPVW 83

Query: 82  IVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           I+ EL         +      L       + YQL   L Y+ S   +HRD+   N+L+++
Sbjct: 84  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143

Query: 140 SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 197
           +  +K+GDFGL+R   ++ +   ++  +   + APE + N   +T+A D+W  G  + EI
Sbjct: 144 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEI 202

Query: 198 MTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 256
           +      F G      +  I                                 +     P
Sbjct: 203 LMHGVKPFQGVKNNDVIGRI------------------------------ENGERLPMPP 232

Query: 257 NKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
           N       L+ K   +DP++R    E    
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (313), Expect = 4e-34
 Identities = 53/273 (19%), Positives = 96/273 (35%), Gaps = 44/273 (16%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
             +    VAIK + + +      R  L E  ++   +H NVI ++ ++          V 
Sbjct: 50  PGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVM 103

Query: 82  IVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           I+ E M+         ++D Q T       L  +  G+KY+   + +HRDL   N+L+N+
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163

Query: 140 SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAIDIWSVGCIL 194
           +   K+ DFGL+R   +      Y      + P            ++T+A D+WS G ++
Sbjct: 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223

Query: 195 GEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
            E+M+  E  +        +  I +    P                              
Sbjct: 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPP---------------------------- 255

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
              +  S    L+      D N R    + +  
Sbjct: 256 --MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (310), Expect = 9e-34
 Identities = 46/268 (17%), Positives = 100/268 (37%), Gaps = 37/268 (13%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
            V  +    VA+K +    ++ ++    L+E  +++ ++H N++ +  +           
Sbjct: 36  GVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92

Query: 80  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
            ++ Y  +   L +   + Q+++     Y   Q+   ++Y+   + +HRDL   N L+  
Sbjct: 93  EFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 150

Query: 140 SCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 198
           +  +K+ DFGL+R  T +T                  L   +++   D+W+ G +L EI 
Sbjct: 151 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210

Query: 199 T-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 257
           T     +PG D      L+                    + Y  + P             
Sbjct: 211 TYGMSPYPGIDLSQVYELLE-------------------KDYRMERP-----------EG 240

Query: 258 KSSGAVDLLEKMLVFDPNKRITVEEALR 285
                 +L+     ++P+ R +  E  +
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-33
 Identities = 54/284 (19%), Positives = 95/284 (33%), Gaps = 56/284 (19%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV 80
               R + AIK++   + +  D R    E+++L  +  H N+I +              +
Sbjct: 33  KDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYL 86

Query: 81  YIVYELMD-TDLHQIIR----------------SDQQLTDDHCQYFLYQLLRGLKYVHSA 123
           Y+  E     +L   +R                +   L+     +F   + RG+ Y+   
Sbjct: 87  YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146

Query: 124 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA 183
             +HRDL   N+L+  +   KI DFGL+R        T   +   + A E  LN + YT 
Sbjct: 147 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE-SLNYSVYTT 205

Query: 184 AIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 242
             D+WS G +L EI++     + G         + +                        
Sbjct: 206 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----------------- 248

Query: 243 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
                         N      DL+ +     P +R +  + L  
Sbjct: 249 -------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 3e-33
 Identities = 51/273 (18%), Positives = 96/273 (35%), Gaps = 44/273 (16%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           N   +   A+K + N   +I +  + L E  +++   H NV+++  I    +        
Sbjct: 51  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPL 105

Query: 82  IVYELMDTDLHQIIRSDQQLTDDHCQ--YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           +V   M     +    ++           F  Q+ +G+K++ S   +HRDL   N +L+ 
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165

Query: 140 SCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 194
              +K+ DFGLAR   + +F      T   +   + A E L    ++T   D+WS G +L
Sbjct: 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLL 224

Query: 195 GEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 253
            E+MTR  P +P  +       + +                                   
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC------------------------- 259

Query: 254 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
                     +++ K        R +  E +  
Sbjct: 260 -----PDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (306), Expect = 4e-33
 Identities = 49/294 (16%), Positives = 91/294 (30%), Gaps = 66/294 (22%)

Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           +  E    VA+K +       +      RE  L+   ++ N++ +  +           +
Sbjct: 38  LPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVG-----KPM 91

Query: 81  YIVYELMD-TDLHQIIRS------------------------DQQLTDDHCQYFLYQLLR 115
            +++E M   DL++ +RS                           L+         Q+  
Sbjct: 92  CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 151

Query: 116 GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAP 172
           G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+        +   +  P
Sbjct: 152 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

Query: 173 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFL 231
           E +     YT   D+W+ G +L EI +     + G  +   +  +               
Sbjct: 212 ESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV--------------- 255

Query: 232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
                          R         N      +L+       P  R +     R
Sbjct: 256 ---------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 62/290 (21%)

Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFND 79
           + S+    VA+K +     ++ +    + E+K+L ++  H N++ +              
Sbjct: 48  IKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-----GP 101

Query: 80  VYIVYELMD-TDLHQIIRS------------------DQQLTDDHCQYFLYQLLRGLKYV 120
             ++ E     DL   +R                   +  L  +    F YQ+ +G+ ++
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 121 HSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLN 177
            S + +HRDL   N+LL      KI DFGLAR     S         +   + APE + N
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221

Query: 178 CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 236
           C  YT   D+WS G  L E+ +     +PG     +   +                    
Sbjct: 222 C-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI------------------- 261

Query: 237 RRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALR 285
                      K+ F    P    +   D+++     DP KR T ++ ++
Sbjct: 262 -----------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-32
 Identities = 54/315 (17%), Positives = 112/315 (35%), Gaps = 51/315 (16%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
             + +  VAIK++  A     + +  L E  ++  +++ +V  +  I           V 
Sbjct: 34  GEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTS------TVQ 86

Query: 82  IVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           ++ +LM     L  +      +   +   +  Q+ +G+ Y+    ++HRDL   N+L+  
Sbjct: 87  LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146

Query: 140 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 196
              +KI DFGLA+     +         V   + A E +L+   YT   D+WS G  + E
Sbjct: 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWE 205

Query: 197 IMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 255
           +MT     + G        ++                               K +   + 
Sbjct: 206 LMTFGSKPYDGIPASEISSIL------------------------------EKGERLPQP 235

Query: 256 PNKSSGAVDLLEKMLVFDPNKRITVEEALRH-------PYLQSLHDLNDEPVCPRPFHFD 308
           P  +     ++ K  + D + R    E +         P    +   ++    P P   +
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295

Query: 309 FEHSSCTEDHIRELI 323
           F  +   E+ + +++
Sbjct: 296 FYRALMDEEDMDDVV 310

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  119 bits (298), Expect = 5e-32
 Identities = 41/265 (15%), Positives = 83/265 (31%), Gaps = 25/265 (9%)

Query: 20  AVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND 79
             N    ++VAIK       +    R   R  KLL       +  +              
Sbjct: 24  GTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAG--CTGIPNVYYFG-----QEGLH 75

Query: 80  VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 138
             +V +L+   L  ++    ++ +         Q+L  ++ +H  S+++RD+KP N L+ 
Sbjct: 76  NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135

Query: 139 ASC-----DLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAI 185
                    + + DFG+ +                     T  Y +    L   E +   
Sbjct: 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRD 194

Query: 186 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           D+ ++G +    +     + G       +    +        L  L +     + + +  
Sbjct: 195 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHY 254

Query: 246 CRKQQFATRFPNKSSGAVDLLEKML 270
            R   F    P+       L  K+L
Sbjct: 255 ARNLAFDAT-PDYDY-LQGLFSKVL 277

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 49/271 (18%), Positives = 99/271 (36%), Gaps = 44/271 (16%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
           + +    VAIK +   +         L E  ++    H N+I ++ +I       +  + 
Sbjct: 32  SGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KYKPMM 85

Query: 82  IVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 139
           I+ E M        +   D + +       L  +  G+KY+ + + +HRDL   N+L+N+
Sbjct: 86  IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 145

Query: 140 SCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 195
           +   K+ DFGL+R        T   +   +   + APE +      +A+ D+WS G ++ 
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMW 204

Query: 196 EIMTREPLFPGKDYVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 254
           E+MT       +   H++ + I +    P                               
Sbjct: 205 EVMTYGERPYWELSNHEVMKAINDGFRLPTP----------------------------- 235

Query: 255 FPNKSSGAVDLLEKMLVFDPNKRITVEEALR 285
             +  S    L+ +    +  +R    + + 
Sbjct: 236 -MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 9e-31
 Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 52/281 (18%)

Query: 21  VNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV 80
           V  E    VAIK + N   ++ +    L E  +++     +V+ +  ++           
Sbjct: 45  VKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPT 98

Query: 81  YIVYELMD-TDLHQIIRSDQQ----------LTDDHCQYFLYQLLRGLKYVHSASVLHRD 129
            ++ ELM   DL   +RS +            +         ++  G+ Y+++   +HRD
Sbjct: 99  LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRD 158

Query: 130 LKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAID 186
           L   N ++     +KIGDFG+ R   ETD+     + ++   + +PE L +   +T   D
Sbjct: 159 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSD 217

Query: 187 IWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 245
           +WS G +L EI T  E  + G      LR +                             
Sbjct: 218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----------------------------- 248

Query: 246 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
             +     +  N      +L+     ++P  R +  E +  
Sbjct: 249 -MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 9e-30
 Identities = 59/296 (19%), Positives = 106/296 (35%), Gaps = 57/296 (19%)

Query: 22  NSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY 81
            + T   VA+K +     +            L+    H NV+ +      P       + 
Sbjct: 39  KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLM 94

Query: 82  IVYELMD-TDLHQIIRSDQQ----------------LTDDHCQYFLYQLLRGLKYVHSAS 124
           ++ E     +L   +RS +                 LT +H   + +Q+ +G++++ S  
Sbjct: 95  VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154

Query: 125 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEY 181
            +HRDL   N+LL+    +KI DFGLAR   +        +  +   + APE + +   Y
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-Y 213

Query: 182 TAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 240
           T   D+WS G +L EI +     +PG     +                         R +
Sbjct: 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----------------------CRRL 250

Query: 241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 296
           ++  R R           +      +      +P++R T  E + H  L +L   N
Sbjct: 251 KEGTRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQAN 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 3e-29
 Identities = 55/282 (19%), Positives = 110/282 (39%), Gaps = 59/282 (20%)

Query: 27  EEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFNDVYIVYE 85
            +VA+K + +      D    + E+++++ + +H+N+I +              +Y++ E
Sbjct: 46  TKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVE 99

Query: 86  LMD-TDLHQIIR----------------SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 128
                +L + ++                 ++QL+        YQ+ RG++Y+ S   +HR
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159

Query: 129 DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAI 185
           DL   N+L+     +KI DFGLAR     D+  +     +   + APE L +   YT   
Sbjct: 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQS 218

Query: 186 DIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 244
           D+WS G +L EI T     +PG       +L+                            
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL---------------------------- 250

Query: 245 RCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 286
             ++     +  N ++    ++       P++R T ++ +  
Sbjct: 251 --KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.4 bits (182), Expect = 2e-16
 Identities = 25/182 (13%), Positives = 52/182 (28%), Gaps = 29/182 (15%)

Query: 23  SETREEVAIKKIGNAFDNIIDAR--------RTLREIKLLRHMEHENVIAIKDIIRPPKK 74
           SE   E  +K       +    +                    E   +  ++ +  P   
Sbjct: 21  SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80

Query: 75  DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 134
             +    ++ EL+D      +R       ++    L  +L  +   +   ++H DL   N
Sbjct: 81  A-WEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYN 133

Query: 135 LLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 189
           +L++    + I DF  +    E             +  ++           Y    DI S
Sbjct: 134 VLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINS 184

Query: 190 VG 191
             
Sbjct: 185 AI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	336
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.56
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.28
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.49

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-63  Score=439.94  Aligned_cols=327  Identities=43%  Similarity=0.766  Sum_probs=276.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      +|+++++||+|+||+||+|.+..+|+.||||++.....+......+.+|+.+|++++||||+++++++...... ...++
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            68999999999999999999999999999999987766777788899999999999999999999999876432 23468


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+||||++++|..+++. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+......  .
T Consensus        99 ~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~  175 (346)
T d1cm8a_          99 YLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--M  175 (346)
T ss_dssp             EEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--C
T ss_pred             EEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--c
Confidence            99999998888888765 57999999999999999999999999999999999999999999999999999876544  3


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.++................
T Consensus       176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (346)
T d1cm8a_         176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM  255 (346)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred             ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhh
Confidence            45678999999999987667899999999999999999999999999999999999999999888777777777777777


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..................++.+.+||++||..||++|||++|+|+||||+++....+++.++ .+...++....+.+.++
T Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~k  334 (346)
T d1cm8a_         256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWK  334 (346)
T ss_dssp             HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC-----CCHHHHH
T ss_pred             ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC-CCCCchhhhhcCHHHHH
Confidence            78877777777788889999999999999999999999999999999999998777666654 45566667778889999


Q ss_pred             HHHHHHHhhcCC
Q 019728          321 ELIWRESVKFNP  332 (336)
Q Consensus       321 ~~~~~~~~~~~~  332 (336)
                      .++..|++.|+|
T Consensus       335 ~~~~~e~~~~~~  346 (346)
T d1cm8a_         335 RVTYKEVLSFKP  346 (346)
T ss_dssp             HHHHHHHHTCCC
T ss_pred             HHHHHHhhcCCC
Confidence            999999999997

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-63  Score=418.97  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=221.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.++++++||||+++++++.+.     ..+
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   81 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRV   81 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CEE
Confidence            5889999999999999999999999999999986533 2334456778999999999999999999999987     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+|||||+ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            99999998 5999999988899999999999999999999999999999999999999999999999999997765443 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+...                  
T Consensus       161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------------  221 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------------  221 (263)
T ss_dssp             CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------------
T ss_pred             ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            345579999999999988 7789999999999999999999999998887766665543111                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                   .....+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       222 -------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 -------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             -------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                         112356899999999999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-62  Score=430.02  Aligned_cols=329  Identities=48%  Similarity=0.828  Sum_probs=283.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC-CcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD-TFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~   80 (336)
                      ||+++++||+|+||+||+|++..+|+.||||++.+...+......+.+|+.++++++|||++++++++...... .....
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            69999999999999999999999999999999987777777788899999999999999999999998765322 12345


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      ++++++++|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+......  .
T Consensus        99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~--~  175 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--M  175 (348)
T ss_dssp             EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--G
T ss_pred             EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc--c
Confidence            66666666899998865 57999999999999999999999999999999999999999999999999998765443  3


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....|++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+...............+.
T Consensus       176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  255 (348)
T d2gfsa1         176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI  255 (348)
T ss_dssp             SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred             ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence            45578999999999877567899999999999999999999999999999999999998888877766666666666666


Q ss_pred             HhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHHHHH
Q 019728          241 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR  320 (336)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (336)
                      ..............+...++++.+||++||+.||++|||++|+|+||||+.+.....++.+. ++..++...+...++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~k  334 (348)
T d2gfsa1         256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK  334 (348)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC-CCCCGGGGCCCCHHHHH
T ss_pred             hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC-CCCCcccchhcCHHHHH
Confidence            66666666666667788999999999999999999999999999999999998877777654 77778888899999999


Q ss_pred             HHHHHHHhhcCCCC
Q 019728          321 ELIWRESVKFNPDP  334 (336)
Q Consensus       321 ~~~~~~~~~~~~~~  334 (336)
                      +++.+|.++|+|.|
T Consensus       335 ~~~~~e~~~~~p~~  348 (348)
T d2gfsa1         335 SLTYDEVISFVPPP  348 (348)
T ss_dssp             HHHHHHHHTCCCCC
T ss_pred             HHHHHHhhccCCCC
Confidence            99999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-61  Score=426.36  Aligned_cols=330  Identities=49%  Similarity=0.858  Sum_probs=276.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      ||+++++||+|+||+||+|.+..+|+.||||++.+.. .......+.+|+.++++++||||+++++++..........+|
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            6999999999999999999999999999999996532 455567888999999999999999999999776543335578


Q ss_pred             EEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC---
Q 019728           82 IVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (336)
                      +++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        88 l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             EEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             EEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence            8888778899999976 479999999999999999999999999999999999999999999999999987654332   


Q ss_pred             -cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 -FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ......+++.|+|||++.....++.++||||+||++|+|++|..||.+.+..+...........+..............
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR  246 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence             2345578999999999876577899999999999999999999999999988888888888888777665555555555


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCCCCCCCcCCCcCCHH
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED  317 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (336)
                      ..................+.+++++.+||.+||+.||++|||++|+|+||||+......+.+....++.++.+..+...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (345)
T d1pmea_         247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKE  326 (345)
T ss_dssp             HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--------CCHH
T ss_pred             cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhhhhCCHH
Confidence            66666666666666667788999999999999999999999999999999999998888888888888888888889999


Q ss_pred             HHHHHHHHHHhhcCCC
Q 019728          318 HIRELIWRESVKFNPD  333 (336)
Q Consensus       318 ~~~~~~~~~~~~~~~~  333 (336)
                      ++++++.+|..+|.|.
T Consensus       327 ~l~~l~~~e~~~~~~~  342 (345)
T d1pmea_         327 KLKELIFEETARFQPG  342 (345)
T ss_dssp             HHHHHHHHHSGGGSTT
T ss_pred             HHHHHHHHHHHhcCCC
Confidence            9999999999999885

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-63  Score=421.04  Aligned_cols=256  Identities=27%  Similarity=0.373  Sum_probs=213.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.++++++||||+++++++.+.     ..+|
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~   79 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY   79 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeE
Confidence            4899999999999999999999999999999996542 222345678999999999999999999999887     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC---
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (336)
                      +|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....   
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999998 599999988889999999999999999999999999999999999999999999999999999865432   


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|+.||................                 
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-----------------  222 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-----------------  222 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-----------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------------
Confidence            234456899999999999874445788999999999999999999997765432222211110                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                 ......+..+|+++.+||++||+.||++|||++|+|+||||+.
T Consensus       223 -----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         223 -----------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -----------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -----------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                       0111223467899999999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-62  Score=418.14  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=220.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.     ..+|
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~   93 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEE
Confidence            6999999999999999999999999999999986543  22356788999999999999999999999887     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      +|||||+ |+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            9999998 599988766 57999999999999999999999999999999999999999999999999999876543 33


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........               
T Consensus       173 ~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~---------------  236 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------------  236 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------------
T ss_pred             ccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence            456689999999999987 7889999999999999999999999998887776665544221110               


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                   .....+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       237 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         237 -------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                         112356899999999999999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-62  Score=420.06  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=206.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.++++++||||+++++++.++     ..+|
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~   83 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GHLY   83 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            489999999999999999999999999999999654322 2235567899999999999999999999887     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc---cCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~  157 (336)
                      +|||||+ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+||++.   +++.+||+|||+++.....
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999998 59999999989999999999999999999999999999999999999994   5788999999999887766


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.+....+              
T Consensus       164 ~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  228 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--------------  228 (307)
T ss_dssp             ---------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC--------------
T ss_pred             CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC--------------
Confidence            66667789999999999987 788999999999999999999999999887776665554421111              


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   ..+..+.+|+++.+||++||+.||++|||++|+++||||++.
T Consensus       229 -------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         229 -------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             -------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             -------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                         112335789999999999999999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-61  Score=416.52  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=225.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc----ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD----NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|++++.||+|+||+||+|++..+|+.||||++.+...    .....+.+.+|+.++++++||||+++++++.+.     
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----   85 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----   85 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            58999999999999999999999999999999965432    223467788999999999999999999999987     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC----CEEEEeccCCc
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLAR  152 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~  152 (336)
                      ..+|+|||||+ |+|.+++...+++++.+++.++.||+.||+|||+.||+||||||+||+++.++    .+||+|||++.
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            77999999998 59999998888999999999999999999999999999999999999998776    49999999998


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+        
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------  236 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--------  236 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred             hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence            8776656666788999999999987 7889999999999999999999999999887777666544221111        


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                         ....+.+|..+.+||++||+.||++|||++|+++||||+...
T Consensus       237 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         237 -------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             -------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                               122356799999999999999999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-61  Score=423.37  Aligned_cols=259  Identities=24%  Similarity=0.401  Sum_probs=227.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|.+++.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.++++++||||+++++++.+.     ..+|
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~   99 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV   99 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            589999999999999999999999999999999654  344567788999999999999999999999887     7799


Q ss_pred             EEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc--CCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~~  157 (336)
                      +|||||+ |+|.+++.. .+++++.+++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++.....
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999997 599999954 467999999999999999999999999999999999999964  678999999999887777


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.            
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------  246 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------------  246 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC------------
T ss_pred             cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------
Confidence            66667789999999999987 78899999999999999999999999998888777777653322221            


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                                     ...+.+|+++++||++||+.||++|||++|+|+||||+.....
T Consensus       247 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 ---------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             ---------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             ---------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                           2224678999999999999999999999999999999986543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-61  Score=416.88  Aligned_cols=291  Identities=34%  Similarity=0.556  Sum_probs=233.1

Q ss_pred             eeeeecccceEEEEEEEeCCCCceEEEEEecCcccCh---hHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            5 LRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNI---IDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         5 i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .++.||+|+||+||+|.+..+|+.||||++.......   .....+.+|+.++++++||||+++++++...     .++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence            4689999999999999999999999999996543221   2235678999999999999999999999987     6699


Q ss_pred             EEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      +||||+.|++...+ ..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.++...... .
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            99999997555544 446779999999999999999999999999999999999999999999999999997765432 3


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+|+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.........  
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~--  234 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY--  234 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh--
Confidence            445678999999999876567899999999999999999999999999999999999999888776544322111100  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCCCCCCC
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR  303 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~~~~~~  303 (336)
                       ...............+..++++.+||++||+.||++|||++|+|+||||++.+.+......|.
T Consensus       235 -~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~  297 (299)
T d1ua2a_         235 -VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR  297 (299)
T ss_dssp             -CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred             -hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence             000111112223345577999999999999999999999999999999998776544444343

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-61  Score=407.39  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=214.8

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++.++||+|+||+||+|.+..+++.||+|++............+.+|++++++++||||+++++++...... ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG-KKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS-CEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc-CCEEEE
Confidence            3678899999999999999999999999999977665666778889999999999999999999998653211 156899


Q ss_pred             EEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCCCCeEEc-cCCCEEEEeccCCcccCCCC
Q 019728           83 VYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ||||++ |+|.+++...+.+++.+++.++.||+.||+|||++|  |+||||||+|||++ +++.+||+|||+++..... 
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            999997 599999988889999999999999999999999999  99999999999996 5789999999999765443 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.....  ....+             
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~--~~~~~-------------  231 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKP-------------  231 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCCC-------------
T ss_pred             ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH--cCCCC-------------
Confidence            3345689999999999865  689999999999999999999999987654443322111  11110             


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  290 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~  290 (336)
                                   .......++++.+||++||+.||++|||++|+|+||||+
T Consensus       232 -------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                         111235688999999999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-61  Score=408.82  Aligned_cols=254  Identities=28%  Similarity=0.408  Sum_probs=209.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.+.||+|+||+||+|++..+|+.||+|++.....+....+.+.+|+.++++++||||+++++++.+...   ..+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~~   81 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLY   81 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CEEE
Confidence            4899999999999999999999999999999998776667777888999999999999999999999875432   4589


Q ss_pred             EEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCCCCeEEccCCCEEEEeccCC
Q 019728           82 IVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLA  151 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~  151 (336)
                      +|||||+ |+|.+++..    ++.+++.+++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999997 599998853    467999999999999999999999976     999999999999999999999999999


Q ss_pred             cccCCCC-cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          152 RTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      +...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~----------  230 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK----------  230 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred             eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence            8765432 3345688999999999977 788999999999999999999999999888776666554411          


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  289 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f  289 (336)
                                          .......+|+++.+||++||+.||++|||++|+++|||+
T Consensus       231 --------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 --------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                112224578999999999999999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=414.84  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=220.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||+||+|.+..+|+.||||++.+.. .+......+.+|+.++++++||||+++++++.+.     ..+
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~   83 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKL   83 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SEE
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CEE
Confidence            4899999999999999999999999999999996532 2334557788999999999999999999999887     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999998 5999999988999999999999999999999999999999999999999999999999999998765332 


Q ss_pred             --cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          159 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+..                
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----------------  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE----------------  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC----------------
T ss_pred             ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC----------------
Confidence              2344579999999999987 788999999999999999999999999888777666554311                


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE------ALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e------ll~h~~f~~~~  293 (336)
                                     ......+++++++||++||+.||++|||++|      +++||||+++.
T Consensus       227 ---------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         227 ---------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ---------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence                           0112357899999999999999999999988      57899998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-60  Score=420.30  Aligned_cols=257  Identities=24%  Similarity=0.413  Sum_probs=226.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++++.||+|+||+||+|.+..+|+.||||++....  ......+.+|+.++++++||||+++++++.++     ..+|
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~  102 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV  102 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            4899999999999999999999999999999986543  34456778999999999999999999999987     7799


Q ss_pred             EEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc--cCCCEEEEeccCCcccCCC
Q 019728           82 IVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN--ASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~--~~~~~kl~dfg~~~~~~~~  157 (336)
                      +|||||+ |+|.+.+...+ ++++.+++.|+.||+.||+|||++||+||||||+|||++  .++.+||+|||++......
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998 59999886654 699999999999999999999999999999999999997  5789999999999988777


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......++             
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------  248 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------------  248 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            66677789999999999987 7899999999999999999999999999888887777665322221             


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                    ...++.+|+++.+||++||+.||.+|||+.|+|+||||+...
T Consensus       249 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         249 --------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             --------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             --------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                          122356799999999999999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-61  Score=412.01  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=217.5

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYI   82 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~i   82 (336)
                      |++++.||+|+||+||+|++..+|+.||+|++...  +....+.+.+|++++++++||||+++++++...     ..+|+
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l   86 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence            89999999999999999999999999999999654  344556788999999999999999999999887     67999


Q ss_pred             EEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-Cc
Q 019728           83 VYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DF  159 (336)
Q Consensus        83 v~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~~  159 (336)
                      |||||+ |+|.+++.. .+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            999997 599998764 567999999999999999999999999999999999999999999999999998765432 22


Q ss_pred             ccceeeeecccCchhccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          160 MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .....||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+..+.+..+......             
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-------------  233 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-------------  233 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-------------
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            345688999999999852    256789999999999999999999999988776666655442110             


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                     .......+|+++.+||++||+.||++|||++|+++||||+.
T Consensus       234 ---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ---------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ---------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ---------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                           01112356899999999999999999999999999999974

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-60  Score=412.50  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=218.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|+++++||+|+||+||+|++..+|+.||||++.... ........+.+|+.++++++||||+++++++.+.     ..+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence            3889999999999999999999999999999997654 3445567788999999999999999999999877     679


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+|||||.| +|..++..++++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            999999985 66666677788999999999999999999999999999999999999999999999999999866543  


Q ss_pred             ccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          160 MTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       ....||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.+.+..+.+..+......               
T Consensus       169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~---------------  232 (309)
T d1u5ra_         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------------  232 (309)
T ss_dssp             -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------------
T ss_pred             -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence             345799999999998642  46889999999999999999999999988877666555442111               


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                    ......+|+++.+||++||+.||.+|||++|+|+||||+.
T Consensus       233 --------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         233 --------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             --------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             --------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                          1112356899999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=412.70  Aligned_cols=287  Identities=37%  Similarity=0.644  Sum_probs=236.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++++.||+|+||+||+|.+..+|+.||||+++....+......+.+|++++++++||||+++++++.+.     ..+|
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~~   77 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY   77 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----ccee
Confidence            58999999999999999999999999999999976544444567888999999999999999999999987     7799


Q ss_pred             EEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-C
Q 019728           82 IVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-D  158 (336)
Q Consensus        82 iv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-~  158 (336)
                      +||||++|++.+.+..  .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|+..... .
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9999999887777643  467999999999999999999999999999999999999999999999999999776543 3


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      ......+++.|+|||++.....++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.+..........  ...
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~  235 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPD  235 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STT
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc--ccc
Confidence            445568899999999988756678999999999999999999999999999999988888887766554332111  001


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      .................+.++.++.+||++||+.||++|||++|+|+||||+++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            111122222333344556789999999999999999999999999999999988653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-60  Score=414.27  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=224.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.++++++||||+++++++.+.     ..+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~   80 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRL   80 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----ccc
Confidence            3899999999999999999999999999999996542 2334567788999999999999999999999988     779


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC-CC
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-~~  158 (336)
                      |+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999998 59999999989999999999999999999999999999999999999999999999999999987544 33


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+....                  
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~------------------  221 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------------  221 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------
T ss_pred             ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC------------------
Confidence            4556789999999999988 788999999999999999999999999988777666554411                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL  292 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~  292 (336)
                                   ...+..+|+++.+||++||+.||++|+     +++|+++||||+++
T Consensus       222 -------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         222 -------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             -------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence                         112245799999999999999999999     49999999999876

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-61  Score=422.15  Aligned_cols=281  Identities=20%  Similarity=0.279  Sum_probs=216.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|+++++||+|+||+||+|.+..+|+.||+|+++... .......+.+|+.++++++||||+++++++.+.     .++|
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~   80 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS   80 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEEE
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            4889999999999999999999999999999996543 344567888999999999999999999999987     6799


Q ss_pred             EEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||+. |+|.+++.+.+.+++.+++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|...... .
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-T
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-c
Confidence            9999998 5999999888899999999999999999999997 59999999999999999999999999999865433 2


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCcccc----------
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR-LITELIGSPDDASL----------  228 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~----------  228 (336)
                      .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+...... ......+.......          
T Consensus       160 ~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            345689999999999988 789999999999999999999999998765433211 11111111111000          


Q ss_pred             ----cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          229 ----GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                          ...+.................  .......|.++.+||.+||+.||++|||++|+|+||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCC--CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCc--cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                000000001111111000000  00112468899999999999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-60  Score=409.40  Aligned_cols=289  Identities=34%  Similarity=0.546  Sum_probs=233.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCC-CceEEEEEecCcccChhHHHHHHHHHHHHhhC---CCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSET-REEVAIKKIGNAFDNIIDARRTLREIKLLRHM---EHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~hp~iv~~~~~~~~~~~~~~   77 (336)
                      +|+++++||+|+||+||+|.+..+ ++.||||++..............+|+.+++.+   +||||+++++++........
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            699999999999999999999765 56799999865443333333455666665554   79999999999865433333


Q ss_pred             ceEEEEEecCCccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ..++++||++++++.....  ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~  167 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  167 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence            6789999999976555443  34679999999999999999999999999999999999999999999999999998777


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.......
T Consensus       168 ~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  246 (305)
T d1blxa_         168 FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP  246 (305)
T ss_dssp             GGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred             ccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence            6666677889999999999987 789999999999999999999999999999999999999988887665443211111


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  295 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~  295 (336)
                      .    .................+++.+.+||++||+.||++|||++|+|+||||+++...
T Consensus       247 ~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         247 R----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             G----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             h----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            0    0111112222334456789999999999999999999999999999999998654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.9e-60  Score=401.05  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=224.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC-------hhHHHHHHHHHHHHhhCC-CCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN-------IIDARRTLREIKLLRHME-HENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   73 (336)
                      +|++.+.||+|+||+||+|++..+|+.||||++.+....       ....+.+.+|+.++++++ ||||+++++++.++ 
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-   82 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-   82 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC-
Confidence            689999999999999999999999999999999654321       123356778999999997 99999999999987 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                          .++|+|||||+ |+|.+++..++++++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus        83 ----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 ----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence                77999999997 5999999988899999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccCchhccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS  227 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (336)
                      ..+.........||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+......++   
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~---  235 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG---  235 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            8776655666789999999999863     24568899999999999999999999999887777666655321111   


Q ss_pred             ccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          228 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                              .+....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       236 ------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         236 ------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                                    1223467999999999999999999999999999999985

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.8e-60  Score=408.57  Aligned_cols=253  Identities=21%  Similarity=0.359  Sum_probs=223.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.++++++||||+++++++.+.     ..+
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~   79 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQI   79 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEE
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Cee
Confidence            4899999999999999999999999999999996543 2334467788999999999999999999999987     779


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      |+|||||.| +|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            999999984 99999999899999999999999999999999999999999999999999999999999999876544  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....                  
T Consensus       158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------------  218 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------  218 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------------
Confidence            345689999999999987 7789999999999999999999999999887777666654211                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                   ...+.+|+++.++|++||+.||.+|+     |++++++||||+++.
T Consensus       219 -------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         219 -------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             -------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence                         11245789999999999999999996     999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-59  Score=412.17  Aligned_cols=253  Identities=21%  Similarity=0.337  Sum_probs=223.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++++.||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+.+++.++||||+++++++...     ...
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~  116 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNL  116 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----ccc
Confidence            5899999999999999999999999999999986532 2334557788999999999999999999999987     679


Q ss_pred             EEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           81 YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      ++||||+. |+|...+...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999997 599999988889999999999999999999999999999999999999999999999999999876544  


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....                  
T Consensus       195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------------  255 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------------  255 (350)
T ss_dssp             BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------------------
Confidence            345689999999999987 7889999999999999999999999999887777666654211                  


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                   .....+++++.+||++||+.||.+|+     |++++++||||+++.
T Consensus       256 -------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         256 -------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             -------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence                         11245799999999999999999995     999999999998863

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=409.48  Aligned_cols=323  Identities=40%  Similarity=0.697  Sum_probs=247.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|+++++||+|+||+||+|.+..+|+.||||++.....+......+.+|+.++++++||||+++++++..... ....++
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            5999999999999999999999999999999998776677777889999999999999999999999976533 123679


Q ss_pred             EEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCcc
Q 019728           81 YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM  160 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (336)
                      |+|||||.|++.+.+.  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.++++|||.++........
T Consensus        98 ~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~  175 (355)
T d2b1pa1          98 YLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  175 (355)
T ss_dssp             EEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccccc
Confidence            9999999998888774  56899999999999999999999999999999999999999999999999999887777666


Q ss_pred             cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHHH
Q 019728          161 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV  240 (336)
Q Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
                      ....+|+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+.......+......+....+.... .....+.
T Consensus       176 ~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~  253 (355)
T d2b1pa1         176 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYV  253 (355)
T ss_dssp             -----CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC-HHHHHHH
T ss_pred             ccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh-hhHHHHh
Confidence            77789999999999988 789999999999999999999999999999999999998888877665544322 2222223


Q ss_pred             HhCCcccccccccc------------CCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCCCC-CCCCCCCCC
Q 019728          241 RQLPRCRKQQFATR------------FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDE-PVCPRPFHF  307 (336)
Q Consensus       241 ~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~~~-~~~~~~~~~  307 (336)
                      ..............            ....++++.+||++||..||++|||++|+|+||||+........ ..++..++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~  333 (355)
T d2b1pa1         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDK  333 (355)
T ss_dssp             HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-----
T ss_pred             hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCc
Confidence            32222111111111            11246789999999999999999999999999999986533222 233455566


Q ss_pred             CcCCCcCCHHHHHHHHHHHHh
Q 019728          308 DFEHSSCTEDHIRELIWRESV  328 (336)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~  328 (336)
                      +.++.+...+.+++++..|.+
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~  354 (355)
T d2b1pa1         334 QLDEREHTIEEWKELIYKEVM  354 (355)
T ss_dssp             --CCCCCCHHHHHHHHHHHHH
T ss_pred             chhhhhcCHHHHHHHHHHHhc
Confidence            777788889999999998875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=407.75  Aligned_cols=254  Identities=22%  Similarity=0.375  Sum_probs=223.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++++.||+|+||+||+|.+..+|+.||+|+++...   .....+.+|++++++++||||+++++++.+.     ..+|
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~   77 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence            6999999999999999999999999999999997642   3345677999999999999999999999887     6799


Q ss_pred             EEEecCCc-cHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC--CCEEEEeccCCcccCCC
Q 019728           82 IVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS--CDLKIGDFGLARTTSET  157 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~--~~~kl~dfg~~~~~~~~  157 (336)
                      +|||||+| +|.+++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.+  +.++|+|||++......
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999985 9999998765 79999999999999999999999999999999999999854  47999999999887766


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......+++.|+|||...+ ..++.++|||||||++|+|++|..||.+.+..+....+.+....++.            
T Consensus       158 ~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------  224 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------------  224 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------------
T ss_pred             CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh------------
Confidence            66666788999999999887 77899999999999999999999999998888777777653322221            


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                                     ..++.+|+++.+||++||..||++|||++|+++||||+.
T Consensus       225 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         225 ---------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                           223567999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.7e-59  Score=411.73  Aligned_cols=257  Identities=22%  Similarity=0.309  Sum_probs=215.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc----cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF----DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++.+.||+|+||+||+|.+..+|+.||||++.+..    ...........++.+++.++||||+++++++...     
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-----   79 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----   79 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-----
Confidence            5899999999999999999999999999999986432    1222233344567788888999999999999987     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      ..+|+|||||+ |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            67999999998 59999999888999999999999999999999999999999999999999999999999999987665


Q ss_pred             CCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          157 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                      .. .....||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+...........              
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--------------  224 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------------  224 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC--------------
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------------
Confidence            43 344589999999999976467899999999999999999999999876533322222111111              


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQSL  292 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~ell~h~~f~~~  292 (336)
                                    .......+|+++.+||.+||+.||++|||     ++|+++||||+++
T Consensus       225 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         225 --------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             --------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence                          11223467999999999999999999999     8999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7e-59  Score=399.51  Aligned_cols=282  Identities=35%  Similarity=0.600  Sum_probs=232.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|+++++||+|+||+||+|+++ +|+.||||++.....+......+.+|+.++++++||||+++++++...     ...+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~   76 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV   76 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Ccee
Confidence            6999999999999999999995 789999999977655555567889999999999999999999999988     6799


Q ss_pred             EEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc-
Q 019728           82 IVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-  159 (336)
Q Consensus        82 iv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (336)
                      ++||++.+++...+ ...+.+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+........ 
T Consensus        77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99999998655555 5568899999999999999999999999999999999999999999999999999877554332 


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY  239 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
                      .....+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.++...+.....  ....
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~  234 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE--LPKY  234 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STTC
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh--hhhc
Confidence            34456889999999998767789999999999999999999999999999999999988888776554322111  1111


Q ss_pred             HHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 019728          240 VRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  291 (336)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~  291 (336)
                      ................+..++.+.+||++||+.||++|||++|+|+||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            1111222222334455678999999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-58  Score=401.42  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=220.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcc-cChhHHHHHHHHHHHHh-hCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-DNIIDARRTLREIKLLR-HMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|++++.||+|+||+||+|.+..+|+.||||++.+.. ...........|..++. .++||||+++++++.+.     ..
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~~   77 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----EN   77 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----Cc
Confidence            5899999999999999999999999999999996532 22334456666766654 68999999999999988     77


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC-
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  157 (336)
                      +|+||||++ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             eeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999998 599999998889999999999999999999999999999999999999999999999999999865543 


Q ss_pred             CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          158 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                 
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----------------  219 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-----------------  219 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------
T ss_pred             ccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            33445688999999999988 788999999999999999999999999988777766664311                 


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHHcCcccccCc
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  293 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-ell~h~~f~~~~  293 (336)
                                    ......+|+++.+||++||+.||++|||+. ++++||||++++
T Consensus       220 --------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         220 --------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             --------------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                          111235699999999999999999999996 899999999863

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=397.71  Aligned_cols=290  Identities=32%  Similarity=0.509  Sum_probs=228.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCC---Ccc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKD---TFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~---~~~   78 (336)
                      +|+++++||+|+||+||+|.+..+|+.||||++............+.+|+.++++++|||++++++++......   ...
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            69999999999999999999999999999999976655555667788999999999999999999998664311   124


Q ss_pred             eEEEEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           79 DVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        79 ~~~iv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      ++|++|||+++++...+ .....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~  170 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA  170 (318)
T ss_dssp             CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-
T ss_pred             eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccc
Confidence            68999999997666555 44567999999999999999999999999999999999999999999999999999755432


Q ss_pred             -----CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 -----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                           .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+.++........
T Consensus       171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  250 (318)
T d3blha1         171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD  250 (318)
T ss_dssp             ----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCC
T ss_pred             cccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccc
Confidence                 223345789999999999876788999999999999999999999999999999999999998887776544433


Q ss_pred             cchHHHHHHhCCccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                      ................ .....+  ...++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         251 NYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             CC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            3322222221111110 000000  1247788999999999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=401.18  Aligned_cols=286  Identities=29%  Similarity=0.521  Sum_probs=231.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCC-CCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKK-DTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~   80 (336)
                      +|+.++.||+|+||+||+|++..+|+.||||++......      ..+|+.++++++||||+++++++..... ....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            688999999999999999999999999999999654321      2379999999999999999999854322 223568


Q ss_pred             EEEEecCCccHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccC
Q 019728           81 YIVYELMDTDLHQII----RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTS  155 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (336)
                      |+|||||++++...+    ....++++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999999998765554    3456799999999999999999999999999999999999999775 89999999998877


Q ss_pred             CCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          156 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .........++..|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+.+..+.+....+.......
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            66666677899999999998775789999999999999999999999999999999999999888877655432111100


Q ss_pred             HHHHHHhCCccccc-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCcCCC
Q 019728          236 ARRYVRQLPRCRKQ-QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  296 (336)
Q Consensus       236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~~~~  296 (336)
                      ..   ......... ......+..++++.+||++||+.||++|||+.|+|+||||+.+....
T Consensus       255 ~~---~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         255 TE---FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             -C---CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hh---ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence            00   000000000 11122346789999999999999999999999999999999986543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-57  Score=388.37  Aligned_cols=285  Identities=32%  Similarity=0.541  Sum_probs=235.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|+++++||+|+||+||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++...     ...+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~   77 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----ccee
Confidence            69999999999999999999999999999999977666667788899999999999999999999999988     6799


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-c
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-F  159 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (336)
                      ++++++.| +|..++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... .
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99999986 777777888899999999999999999999999999999999999999999999999999998765443 3


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....++..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+....+....+.+.............  
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc--
Confidence            344567888999999887566899999999999999999999884 66667778888888777766544322111000  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      .................+..++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            0000001111223344567789999999999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=393.03  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=210.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC----hhHHHHHHHHHHHHhhCC--CCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN----IIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++.+....    .....++.+|+.++++++  ||||+++++++.+.   
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~---   81 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP---   81 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS---
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC---
Confidence            699999999999999999999999999999998653211    112234568999999996  89999999999887   


Q ss_pred             CcceEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccC-CCEEEEeccCCc
Q 019728           76 TFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLAR  152 (336)
Q Consensus        76 ~~~~~~iv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~  152 (336)
                        ...|+||||+.  +++.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus        82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence              67999999996  3888999888899999999999999999999999999999999999999854 789999999997


Q ss_pred             ccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          153 TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+      .+...             
T Consensus       160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------------  219 (273)
T d1xwsa_         160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------------  219 (273)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------------
T ss_pred             ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------------
Confidence            65544 33456899999999999874556788999999999999999999997532      11110             


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                                        .......+|+++.+||++||+.||++|||++|+++||||+++.
T Consensus       220 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                              0011246799999999999999999999999999999999863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-58  Score=400.01  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=208.4

Q ss_pred             ccceee-eecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhh-CCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRG-EYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRH-MEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~-~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      .|.+.+ .||+|+||+||+|.+..+++.||||++...       ....+|+.++.+ .+||||+++++++.+... ....
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA-GRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCE
Confidence            477775 599999999999999999999999998542       346689988655 489999999999865211 1156


Q ss_pred             EEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc---CCCEEEEeccCCcc
Q 019728           80 VYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLART  153 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~  153 (336)
                      +|+|||||+ |+|.+++...  .++++.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||+++.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999997 5999999874  46999999999999999999999999999999999999975   56799999999988


Q ss_pred             cCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          154 TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...+...          
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~----------  232 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----------  232 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC----------
T ss_pred             ccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC----------
Confidence            776666677789999999999987 789999999999999999999999997765443333222211100          


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                   ........+..+|+++.+||++||+.||++|||+.|+++||||+.-
T Consensus       233 -------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         233 -------------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -------------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                         0000011123578999999999999999999999999999999753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-56  Score=376.45  Aligned_cols=251  Identities=20%  Similarity=0.248  Sum_probs=206.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|+..   ..||||+++....+......+.+|+.++++++||||++++++...      ..++
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~~~   79 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQLA   79 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cEEE
Confidence            5889999999999999999864   359999997766667778889999999999999999999998754      3479


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      +|||||+ |+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999998 5999999654 569999999999999999999999999999999999999999999999999997755332 


Q ss_pred             --cccceeeeecccCchhcccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccc
Q 019728          159 --FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD  234 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
                        ......||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+....+.........+           
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-----------  228 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-----------  228 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC-----------
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC-----------
Confidence              23455789999999998642  457899999999999999999999998876655544443321111           


Q ss_pred             hHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          235 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                    .........+++++.+||.+||+.||++|||+.|++.+
T Consensus       229 --------------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 --------------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                          11123345678999999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.2e-56  Score=379.53  Aligned_cols=259  Identities=23%  Similarity=0.309  Sum_probs=211.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCccc-ChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFD-NIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||+||+|.+..+|+.||||++..... +......+.+|+.++++++||||+++++++....... ..+
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~-~~~   86 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLP   86 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS-EEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC-ceE
Confidence            69999999999999999999999999999999976543 4556677889999999999999999999987653211 348


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC-
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (336)
                      |+||||++| +|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+....... 
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            999999985 999999888899999999999999999999999999999999999999999999999999886543322 


Q ss_pred             ---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 ---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+            
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~------------  233 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------------  233 (277)
T ss_dssp             ------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC------------
T ss_pred             cccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC------------
Confidence               2345578999999999987 788999999999999999999999999888776655554421111            


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHHcCcccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-TVEEALRHPYLQ  290 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~ell~h~~f~  290 (336)
                                     .....+.+|+++.+||++||+.||.+|| |+++++ |+|.+
T Consensus       234 ---------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~r  273 (277)
T d1o6ya_         234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLVR  273 (277)
T ss_dssp             ---------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred             ---------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHHH
Confidence                           1123357899999999999999999999 666654 56654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-56  Score=378.38  Aligned_cols=248  Identities=19%  Similarity=0.284  Sum_probs=205.2

Q ss_pred             eeecccceEEEEEEEeC--CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEEEEE
Q 019728            7 GEYDDIIFFIFSAAVNS--ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         7 ~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      ++||+|+||+||+|.+.  .+++.||||+++....+....+.+.+|+.++++++||||+++++++..+      ..|+||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            46999999999999864  4567899999976555566678899999999999999999999998643      478999


Q ss_pred             ecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc----
Q 019728           85 ELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----  159 (336)
Q Consensus        85 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----  159 (336)
                      |||+ |+|.+++....++++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9997 59999999989999999999999999999999999999999999999999999999999999986544322    


Q ss_pred             ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHHH
Q 019728          160 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARR  238 (336)
Q Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.+..                  
T Consensus       167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~------------------  227 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------------  227 (277)
T ss_dssp             ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred             ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            223467889999999987 778999999999999999998 899999887766555443311                  


Q ss_pred             HHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---HcCccccc
Q 019728          239 YVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA---LRHPYLQS  291 (336)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el---l~h~~f~~  291 (336)
                                  ..+....+|+++.+||.+||+.||++|||+.++   |+|+|+..
T Consensus       228 ------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 ------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                        112234678999999999999999999999998   46766543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.6e-56  Score=389.24  Aligned_cols=281  Identities=28%  Similarity=0.506  Sum_probs=218.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|+++++||+|+||+||+|++..+|+.||||+++..     ...++.+|+.+++.++ ||||+++++++.....   ..+
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~~~  107 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTP  107 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CSE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---Cce
Confidence            489999999999999999999999999999998643     2456789999999995 9999999999976533   568


Q ss_pred             EEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC-CEEEEeccCCcccCCCC
Q 019728           81 YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||||++ +|...   .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.|.......
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999985 77654   35799999999999999999999999999999999999998765 58999999998877666


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccc-cccchH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGF-LRSDNA  236 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  236 (336)
                      ......+|+.|+|||.+.+...++.++||||+||++|+|++|..||.... ..+....+...++.+....... ......
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            66677889999999998875678999999999999999999999997654 3455555555554322111000 000000


Q ss_pred             HHHHHhCCccccc-----cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccCc
Q 019728          237 RRYVRQLPRCRKQ-----QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  293 (336)
Q Consensus       237 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~~  293 (336)
                      ..+..........     ........+++++.+||++||+.||++|||++|+|+||||+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            0000000000000     11112235788999999999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-55  Score=377.58  Aligned_cols=250  Identities=20%  Similarity=0.338  Sum_probs=208.1

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+++.||||+++...   ...+.+.+|+.++++++||||+++++++.+.     ..+|
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~   89 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY   89 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeE
Confidence            4788999999999999999999999999999986543   2356788999999999999999999999877     5689


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +|||||+ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            9999998 6999998653  568999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                      .  .....++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+.......+...                
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~----------------  232 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------------  232 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----------------
T ss_pred             ceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC----------------
Confidence            2  234467889999999987 78999999999999999999976655 444433333322221                


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  292 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h~~f~~~  292 (336)
                                    ...+....+|+++.+||.+||+.||++|||+.|+++  +|+.+
T Consensus       233 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         233 --------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             --------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                          011223467899999999999999999999999965  55544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-55  Score=375.41  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=198.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc---eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE---EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||+||+|.+..+++   .||||++... ........+.+|+.++++++|||||++++++...     .
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            47889999999999999999987765   4888887543 2445667789999999999999999999999877     5


Q ss_pred             eEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .+|+|||||+ |+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            6899999998 5999988764 5699999999999999999999999999999999999999999999999999986554


Q ss_pred             CCcc------cceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 019728          157 TDFM------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLG  229 (336)
Q Consensus       157 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (336)
                      ....      ....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.....        
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~--------  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR--------  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------
T ss_pred             CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            3221      12356889999999987 789999999999999999998 8999998887766655543211        


Q ss_pred             ccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          230 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                            .+.....+..+.+||.+||+.||++|||+.|++++
T Consensus       252 ----------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 ----------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  11224578999999999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-55  Score=369.75  Aligned_cols=245  Identities=18%  Similarity=0.317  Sum_probs=198.8

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+. +++.||||++.....   ..+.+.+|+.++++++||||+++++++...     ...+
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~   76 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   76 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccC-----CceE
Confidence            5889999999999999999986 567899999975432   345788999999999999999999999877     5689


Q ss_pred             EEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++ |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            9999997 6999998755 5689999999999999999999999999999999999999999999999999987654432


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        .....||..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+......              
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------------  221 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------  221 (263)
T ss_dssp             --------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC--------------
T ss_pred             eeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence              233567899999999987 789999999999999999999 56777777766666655442111              


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                      ......++++.+||.+||+.||++|||++|+++|
T Consensus       222 ----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 ----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            1123458899999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-55  Score=367.15  Aligned_cols=245  Identities=19%  Similarity=0.289  Sum_probs=210.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++.++||+|+||+||+|+++ +++.||||+++....   ..+.+.+|+.++++++||||+++++++...     ..++
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~   75 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIF   75 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceE
Confidence            4789999999999999999984 788999999976433   346788999999999999999999999876     5699


Q ss_pred             EEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCCc
Q 019728           82 IVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF  159 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (336)
                      +||||++ |+|.+++.. ...+++..++.++.||++||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999997 688888755 46789999999999999999999999999999999999999999999999999976554432


Q ss_pred             --ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchH
Q 019728          160 --MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  236 (336)
Q Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
                        .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+.+....              
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------------  220 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------------  220 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC--------------
T ss_pred             eeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence              234568899999999987 788999999999999999998 89999998877766665442111              


Q ss_pred             HHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          237 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                      ......+.++.+||++||+.||++|||++++++|
T Consensus       221 ----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 ----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            1123557899999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-55  Score=380.26  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=205.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc-----eEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE-----EVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++++.||+|+||+||+|.+..+++     .||+|++.... .......+.+|+.+++++ +|||||++++++...   
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~---  113 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS---  113 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC---
Confidence            47899999999999999999876554     69999886532 334456788999999998 899999999999887   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD-----------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                        ..+|+|||||+ |+|.++++..                       ..+++.+++.++.||+.||+|||++||+|||||
T Consensus       114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         114 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             --CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence              66899999997 5999999764                       248999999999999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  207 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  207 (336)
                      |+||+++.++.+||+|||+|+......   ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998654433   2335677999999999987 789999999999999999997 89999887


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      +....+..+...-.                             ..+.....|+++.+||.+||+.||++|||++||++|
T Consensus       271 ~~~~~~~~~~~~~~-----------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGF-----------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCC-----------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            65555444433111                             112234678999999999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=373.91  Aligned_cols=249  Identities=21%  Similarity=0.337  Sum_probs=207.5

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+. ++..||||++.....   ..+.+.+|+.++++++||||+++++++..+      ..|
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~   83 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIY   83 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeE
Confidence            5789999999999999999985 578899999965432   346788999999999999999999987643      469


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ |+|.+++...  .++++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999997 6998877543  359999999999999999999999999999999999999999999999999998765443


Q ss_pred             --cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                        ......+++.|+|||++.+ ..++.++|||||||++|||++| ..||......+....+.....              
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--------------  228 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------  228 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------------
T ss_pred             cccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--------------
Confidence              2334567889999999987 6789999999999999999995 555666665555554433111              


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc--Cccccc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQS  291 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~--h~~f~~  291 (336)
                                      ......+++++.+||++||+.||++|||++++++  ++||++
T Consensus       229 ----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 ----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                            1122457889999999999999999999999998  888875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=370.29  Aligned_cols=251  Identities=19%  Similarity=0.284  Sum_probs=209.0

Q ss_pred             cceee-eecccceEEEEEEEeCCC--CceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            3 VKLRG-EYDDIIFFIFSAAVNSET--REEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         3 ~~i~~-~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      |.+.+ +||+|+||+||+|.+..+  +..||||+++.. ........+.+|+.++++++||||+++++++..+      .
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~   82 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------A   82 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------S
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------e
Confidence            55666 599999999999987543  457999999654 3455677889999999999999999999998653      4


Q ss_pred             EEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCC
Q 019728           80 VYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  157 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (336)
                      +|+|||||+ |+|.+++.. +..+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            899999998 599998865 467999999999999999999999999999999999999999999999999999876543


Q ss_pred             Cc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 019728          158 DF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       158 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      ..    .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.+..            
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~------------  229 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------  229 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------------
T ss_pred             ccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            22    233467889999999987 688999999999999999998 999999887766655553311            


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---HcCccccc
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA---LRHPYLQS  291 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el---l~h~~f~~  291 (336)
                                        ..+..+.+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       230 ------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 ------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                              112235678999999999999999999999888   57888753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=364.64  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      +|++.+.||+|+||+||+|.+..+ +.||||+++....+   .+.+.+|+.++++++|||||++++++...      ..+
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~   87 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIY   87 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEecC------CeE
Confidence            588999999999999999999654 57999999754333   46788999999999999999999998543      379


Q ss_pred             EEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||+. |+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999998 588888754  3579999999999999999999999999999999999999999999999999998764433


Q ss_pred             --cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccccccch
Q 019728          159 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN  235 (336)
Q Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
                        ......+++.|+|||++.. ..++.++|||||||++|+|++|. .|+......+.+..+.+..               
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---------------  231 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------------  231 (285)
T ss_dssp             --------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------------
T ss_pred             ceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---------------
Confidence              2234567899999999987 78899999999999999999965 5556565555555443311               


Q ss_pred             HHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc--CcccccCc
Q 019728          236 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPYLQSLH  293 (336)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~--h~~f~~~~  293 (336)
                                     ..+..+.++.++.+||.+||+.||++|||+++++.  ++||++..
T Consensus       232 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         232 ---------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                           11233567899999999999999999999999987  88998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=377.95  Aligned_cols=260  Identities=19%  Similarity=0.317  Sum_probs=214.3

Q ss_pred             ccceeeeecccceEEEEEEEe---CCCCceEEEEEecCcc--cChhHHHHHHHHHHHHhhCCC-CceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN---SETREEVAIKKIGNAF--DNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~   75 (336)
                      +|++++.||+|+||+||+|.+   ..+|+.||||++.+..  .+....+.+.+|+.++++++| |||+++++++.+.   
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~---  101 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE---  101 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET---
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC---
Confidence            488999999999999999997   4578999999996543  223345667799999999966 8999999999887   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCccc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT  154 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (336)
                        ...+++|||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++..
T Consensus       102 --~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 --TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             --TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             --CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence              67999999998 599999999889999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC--CcccceeeeecccCchhcccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          155 SET--DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ...  .......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||...+..+....+......         
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---------  250 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---------  250 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---------
Confidence            433  223456789999999998753 35788999999999999999999999776544333333221100         


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCc
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH  293 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~ell~h~~f~~~~  293 (336)
                                        ........+|+++.+||++||+.||.+||     |++|+++||||+.++
T Consensus       251 ------------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         251 ------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             ------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             ------------------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                              01122346799999999999999999999     589999999999865

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=360.19  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=197.7

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC---ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++++.||+|+||.||+|.+..++   ..||||.+... ........+.+|+.++++++||||+++++++.+      .
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~   80 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N   80 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence            5899999999999999999986543   45889988543 345556788899999999999999999999864      3


Q ss_pred             eEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (336)
                      .+|+||||++ |+|.+++.. ..++++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            4799999998 588887755 45799999999999999999999999999999999999999999999999999987554


Q ss_pred             CC--cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccccc
Q 019728          157 TD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRS  233 (336)
Q Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
                      ..  ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+....             
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-------------  226 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------------
T ss_pred             CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            32  2234567889999999987 789999999999999999998 899998887766655543311             


Q ss_pred             chHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          234 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                       ..+..+.+|+++.+||.+||+.||++|||+.|++.|
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 -----------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                             112345679999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=357.20  Aligned_cols=247  Identities=20%  Similarity=0.286  Sum_probs=196.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC----ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR----EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++.+.||+|+||+||+|.+..++    ..||||++.... .......+.+|+.++++++||||+++++++...     
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----   81 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----   81 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence            4788999999999999999986554    369999986543 344556788999999999999999999999877     


Q ss_pred             ceEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                      ...++||||+. |++.+.+... +.+++.++..++.||+.|++|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            56999999998 4788877654 679999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP-LFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ...    ......||..|+|||++.+ ..++.++|||||||++|||++|.. |+...+..+....+....          
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------  230 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----------  230 (283)
T ss_dssp             ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred             CCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC----------
Confidence            332    1223467889999999987 789999999999999999999654 455555544444433211          


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                          ..+.....+..+.+||.+||+.||++|||+.|+++
T Consensus       231 --------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 --------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             --------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                11223456889999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=363.71  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=200.6

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCc----eEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETRE----EVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++++.||+|+||+||+|.+..+|+    .||+|++... .+....+.+.+|+.++++++||||+++++++.++     
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            48999999999999999999988876    4788877543 2334567789999999999999999999999864     


Q ss_pred             ceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..+++++++. |+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence             3567777775 688888765 4679999999999999999999999999999999999999999999999999998755


Q ss_pred             CCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 019728          156 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  231 (336)
Q Consensus       156 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (336)
                      ....   .....||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+.....          
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~----------  231 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----------  231 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC----------
T ss_pred             cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            4322   223457899999999987 789999999999999999998 8999988776555544433111          


Q ss_pred             ccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          232 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                          .+..+..++.+.+||.+||+.||++|||+.|++.|
T Consensus       232 --------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         232 --------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             --------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                12234568899999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=356.69  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=197.4

Q ss_pred             ccceeeeecccceEEEEEEEeC-CCC--ceEEEEEecCcc-cChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-ETR--EEVAIKKIGNAF-DNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-~~~--~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~   77 (336)
                      .|++.+.||+|+||.||+|... .++  ..||||++.... ......+.+.+|+.++++++||||+++++++.++     
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-----   83 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-----   83 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-----
Confidence            4889999999999999999864 333  368999987654 3445567889999999999999999999999753     


Q ss_pred             ceEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccC
Q 019728           78 NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS  155 (336)
Q Consensus        78 ~~~~iv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (336)
                       ..++||||++ |++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence             3689999997 588887654 4579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 019728          156 ETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  230 (336)
Q Consensus       156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (336)
                      ....    .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.+..          
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~----------  231 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----------  231 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----------
T ss_pred             cCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC----------
Confidence            4422    223456788999999987 788999999999999999998 899999988877766554321          


Q ss_pred             cccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          231 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                         ...+....+|+.+.+||.+||+.||++|||+.|+++
T Consensus       232 -------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         232 -------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                               112233567899999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=359.14  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=195.2

Q ss_pred             ccceeeeecccceEEEEEEEeCC-----CCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++.+.||+|+||.||+|.+..     +++.||||+++... .......+.+|..++.++ +||||+.+++++....  
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--   90 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   90 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC--
Confidence            58999999999999999999753     45689999986432 344456677788877777 6899999999876542  


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN  138 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~  138 (336)
                        ..+++|||||+ |+|.+++...                ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus        91 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          91 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             --SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             --CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence              45899999998 6999999653                3489999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHH
Q 019728          139 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLR  214 (336)
Q Consensus       139 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~  214 (336)
                      .++.+||+|||+|+......   ......||+.|+|||++.+ ..++.++|||||||++|+|++| ..||.+....+...
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999997654332   2334578999999999987 7899999999999999999986 56787765444333


Q ss_pred             HHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          215 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                      .....-.                             ........++++.++|.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCC-----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3322111                             112234578999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=353.04  Aligned_cols=242  Identities=22%  Similarity=0.307  Sum_probs=196.3

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceEE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      .|++++.||+|+||.||+|.+  +|..||||+++..    ...+.+.+|+.++++++||||+++++++.+..    ..+|
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~   77 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   77 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             HeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEE
Confidence            478999999999999999998  4788999999653    23467889999999999999999999886532    3479


Q ss_pred             EEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           82 IVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        82 iv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      +||||++ |+|.+++...  ..+++..++.|+.||+.||+|||+.+++||||||+||+++.++.++|+|||.++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999997 6999998654  35899999999999999999999999999999999999999999999999999876544 


Q ss_pred             cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccccchHH
Q 019728          159 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR  237 (336)
Q Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
                       .....++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+.+.                  
T Consensus       157 -~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~------------------  216 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------------  216 (262)
T ss_dssp             ------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------------
T ss_pred             -CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------------
Confidence             234467889999999987 789999999999999999998 78888877655554444221                  


Q ss_pred             HHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          238 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                  ...+.....++++.+||++||+.||++|||+.+++++
T Consensus       217 ------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 ------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                        1122335678999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-51  Score=356.45  Aligned_cols=247  Identities=20%  Similarity=0.275  Sum_probs=206.8

Q ss_pred             ccceeeeecccceEEEEEEEeC-----CCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNS-----ETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|++++.||+|+||+||+|++.     .+++.||||++... ........+.+|+.++++++||||+++++++...    
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~----   88 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG----   88 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC----
Confidence            4889999999999999999974     35678999998653 2445567789999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK  131 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlk  131 (336)
                       ...+++|||+. |+|.+++...                        ..+++.++..++.||+.||+|||++|++|||||
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          89 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             -CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence             56899999997 6999998642                        248899999999999999999999999999999


Q ss_pred             CCCeEEccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC-CCCCCC
Q 019728          132 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGK  207 (336)
Q Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~  207 (336)
                      |+|||++.++.+||+|||+|+......   ......+++.|+|||.+.+ ..++.++|||||||++|||++|. .||.+.
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            999999999999999999987543332   2234567889999999987 78999999999999999999985 678888


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          208 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      +..+....+.+.                              ...+....+++++.+||.+||+.||++|||+.||++
T Consensus       247 ~~~e~~~~v~~~------------------------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         247 AHEEVIYYVRDG------------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHcC------------------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777666555331                              112233467899999999999999999999999954

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=354.34  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             ccceeeeecccceEEEEEEEeCCCC-------ceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETR-------EEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPK   73 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~   73 (336)
                      +|++++.||+|+||.||+|++..++       ..||||+++... .......+.+|...+.++ +||||+++++++.++ 
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-   91 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-   91 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-
Confidence            5889999999999999999986554       369999996543 445567788899988888 799999999999887 


Q ss_pred             CCCcceEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           74 KDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        74 ~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                          ..+++|||||. |+|.+++...                ..+++.+++.++.||+.||+|||+.||+||||||+|||
T Consensus        92 ----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          92 ----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence                56899999997 6999999754                35899999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.+||+|||.+.......   ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            9999999999999998665433   2334578899999999987 789999999999999999998 7899988776655


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      ...+....                              ..+.....++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTC------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCC------------------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            54443211                              11223467899999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=358.16  Aligned_cols=248  Identities=22%  Similarity=0.274  Sum_probs=205.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCce--EEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCCCcc
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREE--VAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKDTFN   78 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~~~   78 (336)
                      +|++.+.||+|+||+||+|.+..+|..  ||||++.... .....+.+.+|+.++.++ +||||+++++++...     .
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            578999999999999999999888875  6777764322 334556788999999999 799999999999877     6


Q ss_pred             eEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCC
Q 019728           79 DVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC  141 (336)
Q Consensus        79 ~~~iv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~  141 (336)
                      ..|+||||++ |+|.+++...                ..+++.++..++.||+.||.|||+.||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            7999999998 6999999653                5689999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHh
Q 019728          142 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDYVHQLRLITELI  220 (336)
Q Consensus       142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~  220 (336)
                      .+||+|||+++............++..|+|||.+.+ ..++.++|||||||++|+|++|. .||.+.+..+....+.+. 
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-  242 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Confidence            999999999987665544555678999999999987 78899999999999999999965 678877766655444221 


Q ss_pred             CCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                                   ...+....+++++.+||++||+.||++|||++|++++
T Consensus       243 -----------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -----------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -----------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                         1122234678999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-51  Score=351.59  Aligned_cols=254  Identities=23%  Similarity=0.370  Sum_probs=212.5

Q ss_pred             ccceeeeecccceEEEEEEEeCC-----CCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSE-----TREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDT   76 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   76 (336)
                      +|.+++.||+|+||+||+|.+..     ++..||||+++.. ........+.+|+.++++++||||+++++++...    
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----   95 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG----   95 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS----
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC----
Confidence            47899999999999999999853     3578999999654 3455667788999999999999999999999876    


Q ss_pred             cceEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEE
Q 019728           77 FNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI  145 (336)
Q Consensus        77 ~~~~~iv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl  145 (336)
                       ...++||||+. |+|.+++...          ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||
T Consensus        96 -~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          96 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             -CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence             56899999997 6999988532          34789999999999999999999999999999999999999999999


Q ss_pred             EeccCCcccCCCCc---ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhC
Q 019728          146 GDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIG  221 (336)
Q Consensus       146 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~  221 (336)
                      +|||+++.......   .....+++.|+|||.+.+ ..++.++|||||||++|||++| ..||.+.+..+....+.+.. 
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-  252 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-  252 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-
Confidence            99999986544322   234478999999999987 7889999999999999999998 57888887776666554311 


Q ss_pred             CCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc------CcccccC
Q 019728          222 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR------HPYLQSL  292 (336)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~------h~~f~~~  292 (336)
                                                   ........+..+.++|.+||+.||++|||++++++      +|+|+++
T Consensus       253 -----------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         253 -----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             -----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence                                         11223466889999999999999999999999997      6666553

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=349.65  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=207.2

Q ss_pred             ccceeeeecccceEEEEEEEe-----CCCCceEEEEEecCcccChhHHHHHHHHHHHHhhC-CCCceeeecceecCCCCC
Q 019728            2 SVKLRGEYDDIIFFIFSAAVN-----SETREEVAIKKIGNAFDNIIDARRTLREIKLLRHM-EHENVIAIKDIIRPPKKD   75 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~   75 (336)
                      +|++++.||+|+||.||+|.+     ..+++.||||+++... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~---   99 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG---   99 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC---
Confidence            477899999999999999986     3567789999996543 445566788999999999 699999999999887   


Q ss_pred             CcceEEEEEecCC-ccHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeE
Q 019728           76 TFNDVYIVYELMD-TDLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL  136 (336)
Q Consensus        76 ~~~~~~iv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil  136 (336)
                        ...|++||||+ |+|.++++...                  .+++..+..++.||+.|++|||++|++||||||+||+
T Consensus       100 --~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         100 --GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             --CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence              55899999997 59999986532                  5899999999999999999999999999999999999


Q ss_pred             EccCCCEEEEeccCCcccCCCC---cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 019728          137 LNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  212 (336)
Q Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  212 (336)
                      ++.++.++++|||.++......   ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998765432   2344678999999999987 789999999999999999998 6677777665555


Q ss_pred             HHHHHHHhCCCCcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          213 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                      +..+...-.                             ........+..+.+||.+||+.||++|||++++++
T Consensus       257 ~~~~i~~~~-----------------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGF-----------------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCC-----------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            544433211                             11122356899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=344.62  Aligned_cols=247  Identities=21%  Similarity=0.271  Sum_probs=197.5

Q ss_pred             ceeeeecccceEEEEEEEeCCCC---ceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceeeecceecCCCCCCcceE
Q 019728            4 KLRGEYDDIIFFIFSAAVNSETR---EEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         4 ~i~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   80 (336)
                      .+.+.||+|+||+||+|.+..++   ..||||+++. ..+......+.+|++++++++||||+++++++....    ...
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~  104 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP  104 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence            44678999999999999986543   3589999864 235666788999999999999999999999876432    468


Q ss_pred             EEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEEeccCCcccCCCC
Q 019728           81 YIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD  158 (336)
Q Consensus        81 ~iv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (336)
                      ++|||||+ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++......
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999998 5999988754 457788899999999999999999999999999999999999999999999998654432


Q ss_pred             c-----ccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccc
Q 019728          159 F-----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLR  232 (336)
Q Consensus       159 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (336)
                      .     .....++..|+|||.+.+ ..++.++||||||+++|||++|..||...... +....+...             
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-------------  250 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------------  250 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-------------
T ss_pred             cccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------
Confidence            2     223467899999999887 78899999999999999999987777553322 222221110             


Q ss_pred             cchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          233 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                                       .........++.+.+||.+||+.||++|||+.|+++|
T Consensus       251 -----------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         251 -----------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                             0112224568899999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-49  Score=344.28  Aligned_cols=257  Identities=18%  Similarity=0.166  Sum_probs=200.4

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCceee-ecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHENVIA-IKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~-~~~~~~~~~~~~~~~~   80 (336)
                      +|++.+.||+|+||.||+|.+..+|+.||||++......    ..+..|+.+++.++|+|++. +.+++...     ...
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-----~~~   78 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG-----DYN   78 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEET-----TEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecC-----CEE
Confidence            589999999999999999999999999999988654322    34678999999998766554 55555554     668


Q ss_pred             EEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEc---cCCCEEEEeccCCcccCC
Q 019728           81 YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN---ASCDLKIGDFGLARTTSE  156 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~  156 (336)
                      ++||||++++|...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++   .+..++|+|||+|+....
T Consensus        79 ~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          79 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999999988777754 56799999999999999999999999999999999999985   455799999999986543


Q ss_pred             CC--------cccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 019728          157 TD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL  228 (336)
Q Consensus       157 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (336)
                      ..        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......     
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----  232 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----  232 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-----
T ss_pred             cccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-----
Confidence            32        1234578999999999987 779999999999999999999999998766544433332211000     


Q ss_pred             cccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHH---HHcCccccc
Q 019728          229 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE---ALRHPYLQS  291 (336)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e---ll~h~~f~~  291 (336)
                                        ...........+|+++.+||..||+.||++||++.+   +|+|+|.+.
T Consensus       233 ------------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         233 ------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ------------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                              000112233577999999999999999999999874   567877654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.7e-49  Score=337.19  Aligned_cols=248  Identities=15%  Similarity=0.133  Sum_probs=202.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCC-CceeeecceecCCCCCCcceE
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEH-ENVIAIKDIIRPPKKDTFNDV   80 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~~~~~   80 (336)
                      +|+|.+.||+|+||+||+|++..+|+.||||++.....    ...+.+|+..++.++| +|++.+++++...     ...
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~   76 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN   76 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----Ccc
Confidence            69999999999999999999999999999998854322    2345678889999964 8999999998877     679


Q ss_pred             EEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEcc-----CCCEEEEeccCCccc
Q 019728           81 YIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-----SCDLKIGDFGLARTT  154 (336)
Q Consensus        81 ~iv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~-----~~~~kl~dfg~~~~~  154 (336)
                      ++||||++++|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.     ++.++|+|||+|+..
T Consensus        77 ~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          77 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999999999998765 46999999999999999999999999999999999999964     577999999999765


Q ss_pred             CCC--------CcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 019728          155 SET--------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV---HQLRLITELIGSP  223 (336)
Q Consensus       155 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~  223 (336)
                      ...        .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....   .....+...... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~-  234 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-  234 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-
Confidence            432        12234578999999999987 78999999999999999999999999765432   222222221100 


Q ss_pred             CcccccccccchHHHHHHhCCccccccccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHHc
Q 019728          224 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  285 (336)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ell~  285 (336)
                                               .......+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus       235 -------------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 -------------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -------------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                     0112233567899999999999999999998877654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-48  Score=343.42  Aligned_cols=284  Identities=25%  Similarity=0.354  Sum_probs=207.2

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-----------CCceeeecceec
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-----------HENVIAIKDIIR   70 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------hp~iv~~~~~~~   70 (336)
                      ||+++++||+|+||+||+|++..+|+.||||++.+.   ........+|+.+++.++           |+||+++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            699999999999999999999999999999999754   334456678888888775           578999998876


Q ss_pred             CCCCCCcceEEEEEecC--CccHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCCCCeEEccCCC---
Q 019728           71 PPKKDTFNDVYIVYELM--DTDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCD---  142 (336)
Q Consensus        71 ~~~~~~~~~~~iv~e~~--~g~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~nil~~~~~~---  142 (336)
                      ....   ...+.++.++  .++.....  .....+++..++.++.||+.|++|||+ .||+||||||+|||++.++.   
T Consensus        91 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          91 HKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             eccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            5432   3345555555  34433333  344678999999999999999999998 89999999999999987654   


Q ss_pred             ---EEEEeccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 019728          143 ---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD------YVHQL  213 (336)
Q Consensus       143 ---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~  213 (336)
                         ++++|||.+......  .....+++.|+|||++.+ ..++.++|+||+||++++|++|+.||....      ..+.+
T Consensus       168 ~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceeeEeecccccccccc--cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence               899999998765433  345678999999999987 778999999999999999999999996543      33455


Q ss_pred             HHHHHHhCCCCcccccccccchHHHHHHhC------Cccccc-------cccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 019728          214 RLITELIGSPDDASLGFLRSDNARRYVRQL------PRCRKQ-------QFATRFPNKSSGAVDLLEKMLVFDPNKRITV  280 (336)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  280 (336)
                      ......++.++........  ....+....      ......       .........++++.+||.+||..||.+|||+
T Consensus       245 ~~~~~~lg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGK--YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCT--THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHhCCCCHHHhhccc--ccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            5666666665443221100  000000000      000000       0011112346789999999999999999999


Q ss_pred             HHHHcCcccccCcCCC
Q 019728          281 EEALRHPYLQSLHDLN  296 (336)
Q Consensus       281 ~ell~h~~f~~~~~~~  296 (336)
                      +|+|+||||++.....
T Consensus       323 ~e~L~Hp~f~~~~~~~  338 (362)
T d1q8ya_         323 GGLVNHPWLKDTLGME  338 (362)
T ss_dssp             HHHHTCGGGTTCTTCT
T ss_pred             HHHhcCcccCCCCCcc
Confidence            9999999999764433

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=334.22  Aligned_cols=264  Identities=19%  Similarity=0.212  Sum_probs=188.9

Q ss_pred             ccceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHH--HHHHHhhCCCCceeeecceecCCCCCCcce
Q 019728            2 SVKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLR--EIKLLRHMEHENVIAIKDIIRPPKKDTFND   79 (336)
Q Consensus         2 ~~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--e~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   79 (336)
                      +|.+.+.||+|+||.||+|+.  +|+.||||++...     .......  |+..+.+++||||+++++++..... ....
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-~~~~   75 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQ   75 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-cceE
Confidence            578999999999999999997  6899999998543     2233334  4555567899999999999876532 1246


Q ss_pred             EEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeccCCCCCCeEEccCCCEEEEeccC
Q 019728           80 VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------ASVLHRDLKPSNLLLNASCDLKIGDFGL  150 (336)
Q Consensus        80 ~~iv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~i~H~dlkp~nil~~~~~~~kl~dfg~  150 (336)
                      +|+|||||. |+|.+++++. ++++..+..++.|++.||+|||+        +||+||||||+|||++.++.+||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            899999997 5999999874 68999999999999999999996        5999999999999999999999999999


Q ss_pred             CcccCCCC-----cccceeeeecccCchhcccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 019728          151 ARTTSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI  220 (336)
Q Consensus       151 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  220 (336)
                      ++......     ......||+.|+|||++.+..     .++.++|||||||++|||++|..||........        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~--------  226 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL--------  226 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC--------
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc--------
Confidence            87654332     223457899999999987522     256689999999999999999887744321100        


Q ss_pred             CCCCcccccccccchHHHHHHhCC-ccccccccccC--CCCChhHHHHHHHhcCCCCCCCCCHHHHHcC
Q 019728          221 GSPDDASLGFLRSDNARRYVRQLP-RCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRH  286 (336)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~ell~h  286 (336)
                         +....... ............ ...+...+...  ......+.+|+.+||+.||++|||+.|++++
T Consensus       227 ---~~~~~~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         227 ---PYYDLVPS-DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             ---TTTTTSCS-SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ---chhhcccc-cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               00000000 000111111110 00001111111  1123458899999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.5e-26  Score=185.16  Aligned_cols=170  Identities=14%  Similarity=0.084  Sum_probs=121.6

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccC----------------hhHHHHHHHHHHHHhhCCCCceeeec
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDN----------------IIDARRTLREIKLLRHMEHENVIAIK   66 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~hp~iv~~~   66 (336)
                      +.+.++||+|+||+||+|.+. +|+.||||++.....+                .........|+..+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468999999999999999985 7899999987432110                11223445688999999999999887


Q ss_pred             ceecCCCCCCcceEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCCeEEccCCCEEEE
Q 019728           67 DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG  146 (336)
Q Consensus        67 ~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~nil~~~~~~~kl~  146 (336)
                      ++..         .+++||++++...      ..++...+..++.|++.+++|||++||+||||||+|||+++++ ++|+
T Consensus        81 ~~~~---------~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          81 AWEG---------NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             EEET---------TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEEC
T ss_pred             EecC---------CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEE
Confidence            6532         2799999987321      2345566778999999999999999999999999999999765 8999


Q ss_pred             eccCCcccCCCCcccceeeeecccCchhcccCCCCCccchHHHHHH
Q 019728          147 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC  192 (336)
Q Consensus       147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  192 (336)
                      |||.|.....+........... .-.+.+ . ..++..+|+||+.-
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVR-NIITYF-S-RTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHH
Confidence            9999876654322110000000 001222 2 56788999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.56  E-value=1.6e-07  Score=76.84  Aligned_cols=136  Identities=13%  Similarity=0.084  Sum_probs=85.3

Q ss_pred             cceeeeecccceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCcceEE
Q 019728            3 VKLRGEYDDIIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTFNDVY   81 (336)
Q Consensus         3 ~~i~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~   81 (336)
                      |++.+..+.++.+.||.+..  .+..+++|......  ......+.+|...++.+. +-.+.+++++...+     +..+
T Consensus        16 ~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-----~~~~   86 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSN   86 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEE
T ss_pred             eEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecC-----CceE
Confidence            55666666666679998764  56678889875432  122334566777777664 33345566665544     5689


Q ss_pred             EEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 019728           82 IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------------------------------------  122 (336)
Q Consensus        82 iv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------  122 (336)
                      +||++++| .+.+....     ......++.++...++.||+                                      
T Consensus        87 lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred             EEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence            99999987 55444321     11112233344444444441                                      


Q ss_pred             ---------------------CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ---------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ---------------------~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                                           ..++|+|+.|.||++++++.+.|+||+.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 127999999999999987666799999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.28  E-value=1e-06  Score=76.44  Aligned_cols=77  Identities=16%  Similarity=-0.044  Sum_probs=47.9

Q ss_pred             eeeecccceEEEEEEEeCCCCceEEEEEecCcc-----cChhHHHHHHHHHHHHhhCC-C--CceeeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSETREEVAIKKIGNAF-----DNIIDARRTLREIKLLRHME-H--ENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~e~~~l~~l~-h--p~iv~~~~~~~~~~~~~~   77 (336)
                      .+.||.|....||.+.+..+++.|++|.-....     ..+....+...|...++.+. +  ..+.+++.+...      
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------
Confidence            457899999999999988788899999653211     11123344556777777663 2  345556655332      


Q ss_pred             ceEEEEEecCCc
Q 019728           78 NDVYIVYELMDT   89 (336)
Q Consensus        78 ~~~~iv~e~~~g   89 (336)
                       ..++|||++++
T Consensus       105 -~~~lvmE~L~~  115 (392)
T d2pula1         105 -MAVTVMEDLSH  115 (392)
T ss_dssp             -TTEEEECCCTT
T ss_pred             -CCEEEEeccCC
Confidence             24789999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=1.3e-05  Score=64.75  Aligned_cols=71  Identities=8%  Similarity=-0.043  Sum_probs=45.5

Q ss_pred             eecccc-eEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCC--CCceeeecceecCCCCCCcceEEEEE
Q 019728            8 EYDDII-FFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHME--HENVIAIKDIIRPPKKDTFNDVYIVY   84 (336)
Q Consensus         8 ~lg~G~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~~~~~~~~iv~   84 (336)
                      .+..|. .+.||.+.. ..+..+++|......     ...+..|...++.+.  .-.+.+++.+..++     ...++||
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEE
Confidence            344444 467898887 356678899764432     223556777776663  23355667666555     4589999


Q ss_pred             ecCCc
Q 019728           85 ELMDT   89 (336)
Q Consensus        85 e~~~g   89 (336)
                      ++++|
T Consensus        86 ~~i~G   90 (255)
T d1nd4a_          86 GEVPG   90 (255)
T ss_dssp             ECCSS
T ss_pred             Eeeec
Confidence            99976

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.23  E-value=0.00068  Score=58.21  Aligned_cols=71  Identities=10%  Similarity=0.012  Sum_probs=48.0

Q ss_pred             eeeecccceEEEEEEEeCC-------CCceEEEEEecCcccChhHHHHHHHHHHHHhhCC-CCceeeecceecCCCCCCc
Q 019728            6 RGEYDDIIFFIFSAAVNSE-------TREEVAIKKIGNAFDNIIDARRTLREIKLLRHME-HENVIAIKDIIRPPKKDTF   77 (336)
Q Consensus         6 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~~   77 (336)
                      ++.|+.|-.-.+|++....       ..+.|++++.... ..   .....+|..+++.+. +.-..++++++..      
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC------
Confidence            4678889999999998743       3466888887532 11   234457888888885 4334467776642      


Q ss_pred             ceEEEEEecCCc
Q 019728           78 NDVYIVYELMDT   89 (336)
Q Consensus        78 ~~~~iv~e~~~g   89 (336)
                         ++|+||++|
T Consensus       117 ---g~I~efi~g  125 (395)
T d1nw1a_         117 ---GRLEEYIPS  125 (395)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---ceEEEEecc
Confidence               688999876

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.11  E-value=0.0035  Score=51.98  Aligned_cols=72  Identities=13%  Similarity=0.035  Sum_probs=42.5

Q ss_pred             cceEEEEEEEeCCCCceEEEEEecCcccChhHHHHHHHHHHHHhhCCCCc--eeeecceecCCCC--CCcceEEEEEecC
Q 019728           12 IIFFIFSAAVNSETREEVAIKKIGNAFDNIIDARRTLREIKLLRHMEHEN--VIAIKDIIRPPKK--DTFNDVYIVYELM   87 (336)
Q Consensus        12 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hp~--iv~~~~~~~~~~~--~~~~~~~iv~e~~   87 (336)
                      +..-.||.+.. .+|..|++|+....   ..+.+++..|...+..|....  ++....  ..+..  ......+.+++++
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~--~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVA--FNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCC--BTTBSCEEETTEEEEEEECC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCcee--cCCCeeeeeeeEEEEEEeec
Confidence            33457999888 57889999987543   223456677888877774222  222211  11110  1124578889988


Q ss_pred             Cc
Q 019728           88 DT   89 (336)
Q Consensus        88 ~g   89 (336)
                      +|
T Consensus       107 ~G  108 (325)
T d1zyla1         107 GG  108 (325)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.49  E-value=0.012  Score=48.23  Aligned_cols=30  Identities=30%  Similarity=0.287  Sum_probs=26.5

Q ss_pred             CCeeccCCCCCCeEEccCCCEEEEeccCCc
Q 019728          123 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR  152 (336)
Q Consensus       123 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  152 (336)
                      .|++|+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999764